Clustering O 0 0.19261133670806885
of O 0 0.032995570451021194
missense O 0 0.22806726396083832
mutations O 0 0.11099234968423843
in O 0 0.019714271649718285
the O 0 0.03505178540945053
ataxia B-Disease 1 1.0
- I-Disease 1 0.9980118274688721
telangiectasia I-Disease 1 0.9999643564224243
gene O 0 0.09786941856145859
in O 0 0.0152420774102211
a O 0 0.026512734591960907
sporadic B-Disease 1 0.7925383448600769
T I-Disease 1 0.9999929666519165
- I-Disease 1 0.9330590963363647
cell I-Disease 1 0.8119586110115051
leukaemia I-Disease 1 0.9999957084655762
. O 0 0.0453849658370018

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9983232617378235
telangiectasia I-Disease 1 0.9999939203262329
( O 0 0.07629262655973434
A B-Disease 1 0.9185425043106079
- I-Disease 1 0.9740042686462402
T I-Disease 1 0.9999134540557861
) O 0 0.021345196291804314
is O 0 0.012385789304971695
a O 0 0.02291327714920044
recessive B-Disease 1 0.9994474053382874
multi I-Disease 1 0.9992417097091675
- I-Disease 1 0.997194766998291
system I-Disease 1 0.967779278755188
disorder I-Disease 1 0.9999997615814209
caused O 0 0.17079201340675354
by O 0 0.015201536938548088
mutations O 0 0.07676376402378082
in O 0 0.013053006492555141
the O 0 0.017040077596902847
ATM O 0 0.1534559726715088
gene O 0 0.09092753380537033
at O 0 0.04319306090474129
11q22 O 1 0.7442076802253723
- O 0 0.1312817931175232
q23 O 0 0.3143472969532013
( O 0 0.05646609887480736
ref O 0 0.16475103795528412
. O 0 0.017643017694354057
3 O 0 0.030013611540198326
) O 0 0.02451738528907299
. O 0 0.024211544543504715

The O 0 0.03210673853754997
risk O 1 0.6240060925483704
of O 0 0.01842750981450081
cancer B-Disease 1 0.9999991655349731
, O 0 0.017604704946279526
especially O 0 0.03120979480445385
lymphoid B-Disease 1 0.9996477365493774
neoplasias I-Disease 1 0.9296668171882629
, O 0 0.014453054405748844
is O 0 0.013657991774380207
substantially O 0 0.04218762367963791
elevated O 0 0.08204754441976547
in O 0 0.014457572251558304
A B-Disease 1 0.99820876121521
- I-Disease 1 0.9999357461929321
T I-Disease 1 0.9999998807907104
patients O 1 0.9999624490737915
and O 0 0.010398240759968758
has O 0 0.010852004401385784
long O 0 0.019710391759872437
been O 0 0.011642520315945148
associated O 0 0.022125016897916794
with O 0 0.020136505365371704
chromosomal O 1 0.9996438026428223
instability O 1 0.9959278702735901
. O 0 0.03762604296207428

By O 0 0.04048425704240799
analysing O 0 0.1796429306268692
tumour B-Disease 1 0.9999972581863403
DNA O 0 0.09750405699014664
from O 0 0.02616957016289234
patients O 1 0.99970942735672
with O 0 0.02479720488190651
sporadic B-Disease 1 0.8101887702941895
T I-Disease 1 0.9999710321426392
- I-Disease 1 0.5496631860733032
cell I-Disease 0 0.37349221110343933
prolymphocytic I-Disease 1 0.9994063377380371
leukaemia I-Disease 1 0.9999997615814209
( O 0 0.35971614718437195
T B-Disease 1 0.9999921321868896
- I-Disease 1 0.8765944838523865
PLL I-Disease 1 0.9998912811279297
) O 0 0.028595484793186188
, O 0 0.01209466252475977
a O 0 0.021372996270656586
rare O 0 0.06886027008295059
clonal B-Disease 1 0.9129396677017212
malignancy I-Disease 1 0.9996856451034546
with O 0 0.015619452111423016
similarities O 0 0.03228987380862236
to O 0 0.012001565657556057
a O 0 0.02643418125808239
mature B-Disease 1 0.8254303336143494
T I-Disease 1 0.9999865293502808
- I-Disease 1 0.7491183280944824
cell I-Disease 1 0.5271557569503784
leukaemia I-Disease 1 0.999995231628418
seen O 0 0.035856857895851135
in O 0 0.015554464422166348
A B-Disease 1 0.9236286878585815
- I-Disease 1 0.9850885272026062
T I-Disease 1 0.9999662637710571
, O 0 0.013312689028680325
we O 0 0.008922903798520565
demonstrate O 0 0.025134580209851265
a O 0 0.016257956624031067
high O 0 0.027612732723355293
frequency O 0 0.04088020697236061
of O 0 0.013877135701477528
ATM O 0 0.1536487489938736
mutations O 0 0.115718774497509
in O 0 0.028419360518455505
T B-Disease 1 0.9999631643295288
- I-Disease 1 0.5468503832817078
PLL I-Disease 1 0.9995391368865967
. O 0 0.04620170593261719

In O 0 0.02360730618238449
marked O 0 0.03765896335244179
contrast O 0 0.03465288132429123
to O 0 0.010335968807339668
the O 0 0.01697208359837532
ATM O 0 0.15358449518680573
mutation O 0 0.12872110307216644
pattern O 0 0.04958373308181763
in O 0 0.014268930070102215
A B-Disease 1 0.9683285355567932
- I-Disease 1 0.994500994682312
T I-Disease 1 0.9999819993972778
, O 0 0.011913887225091457
the O 0 0.009769649244844913
most O 0 0.013499242253601551
frequent O 0 0.0530589334666729
nucleotide O 0 0.07415752857923508
changes O 0 0.020564937964081764
in O 0 0.011502975597977638
this O 0 0.017471324652433395
leukaemia B-Disease 1 0.999997615814209
were O 0 0.024809878319501877
missense O 1 0.5619243383407593
mutations O 0 0.16093875467777252
. O 0 0.035000041127204895

These O 0 0.01814267598092556
clustered O 0 0.05164060741662979
in O 0 0.008610821329057217
the O 0 0.009101205505430698
region O 0 0.026569701731204987
corresponding O 0 0.020065879449248314
to O 0 0.008675670251250267
the O 0 0.014769690111279488
kinase O 0 0.1710716336965561
domain O 0 0.03476584702730179
, O 0 0.008890444412827492
which O 0 0.007179223466664553
is O 0 0.009513468481600285
highly O 0 0.02104051783680916
conserved O 0 0.037112049758434296
in O 0 0.01784709095954895
ATM O 0 0.2300257682800293
- O 0 0.07254862785339355
related O 0 0.035554803907871246
proteins O 0 0.04062458127737045
in O 0 0.01743144728243351
mouse O 0 0.11115176230669022
, O 0 0.021646270528435707
yeast O 0 0.10843689739704132
and O 0 0.019605431705713272
Drosophila O 0 0.118843674659729
. O 0 0.03569348156452179

The O 0 0.03695135936141014
resulting O 0 0.0818549171090126
amino O 0 0.10655628144741058
- O 0 0.13539548218250275
acid O 0 0.14892053604125977
substitutions O 0 0.06380775570869446
are O 0 0.009992783889174461
predicted O 0 0.02709055319428444
to O 0 0.01012883335351944
interfere O 0 0.04241051524877548
with O 0 0.019058439880609512
ATP O 1 0.6286033391952515
binding O 0 0.05434896796941757
or O 0 0.027089925482869148
substrate O 0 0.08683878928422928
recognition O 0 0.05236083269119263
. O 0 0.030712105333805084

Two O 0 0.01653772033751011
of O 0 0.01662316918373108
seventeen O 0 0.07726933062076569
mutated O 1 0.7731021046638489
T B-Disease 1 0.9998742341995239
- I-Disease 0 0.20208902657032013
PLL I-Disease 1 0.9987755417823792
samples O 0 0.04862181842327118
had O 0 0.014527760446071625
a O 0 0.01255747303366661
previously O 0 0.018672838807106018
reported O 0 0.0395955853164196
A B-Disease 1 0.5953486561775208
- I-Disease 1 0.8874744176864624
T I-Disease 1 0.9998236298561096
allele O 0 0.20857301354408264
. O 0 0.039902519434690475

In O 0 0.02393495850265026
contrast O 0 0.04157127067446709
, O 0 0.014456938952207565
no O 0 0.018225859850645065
mutations O 0 0.07015205919742584
were O 0 0.01136109884828329
detected O 0 0.05098913982510567
in O 0 0.009815238416194916
the O 0 0.016449935734272003
p53 O 0 0.16808924078941345
gene O 0 0.07923180609941483
, O 0 0.014782879501581192
suggesting O 0 0.0338081456720829
that O 0 0.011342250742018223
this O 0 0.02076449617743492
tumour B-Disease 1 0.9999997615814209
suppressor O 1 0.9097661375999451
is O 0 0.013942711055278778
not O 0 0.008025135844945908
frequently O 0 0.021391073241829872
altered O 0 0.02943563275039196
in O 0 0.012668951414525509
this O 0 0.021137986332178116
leukaemia B-Disease 1 0.999998927116394
. O 0 0.042787592858076096

Occasional O 0 0.1743987798690796
missense O 0 0.29399558901786804
mutations O 0 0.13514551520347595
in O 0 0.021591104567050934
ATM O 0 0.08197135478258133
were O 0 0.008954324759542942
also O 0 0.009278054349124432
found O 0 0.016255363821983337
in O 0 0.017046818509697914
tumour B-Disease 1 0.9999995231628418
DNA O 0 0.06949760764837265
from O 0 0.019753649830818176
patients O 1 0.9994671940803528
with O 0 0.019706139340996742
B B-Disease 1 0.9952357411384583
- I-Disease 0 0.17924976348876953
cell I-Disease 0 0.13089461624622345
non I-Disease 0 0.21402607858181
- I-Disease 1 0.9989718198776245
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999933242797852
( O 0 0.06760594248771667
B B-Disease 1 0.9701629281044006
- I-Disease 0 0.08643193542957306
NHL I-Disease 0 0.0735665112733841
) O 0 0.018202273175120354
and O 0 0.009352165274322033
a O 0 0.02421828918159008
B B-Disease 1 0.7966176271438599
- I-Disease 0 0.09800132364034653
NHL I-Disease 0 0.11566510796546936
cell O 0 0.09263285249471664
line O 0 0.037781376391649246
. O 0 0.02613227069377899

The O 0 0.018039101734757423
evidence O 0 0.01418542955070734
of O 0 0.006837858352810144
a O 0 0.012291832827031612
significant O 0 0.016830721870064735
proportion O 0 0.023474743589758873
of O 0 0.009893840178847313
loss O 0 0.24597889184951782
- O 0 0.06389809399843216
of O 0 0.016608063131570816
- O 0 0.09208476543426514
function O 0 0.05166158452630043
mutations O 0 0.08459937572479248
and O 0 0.008507324382662773
a O 0 0.01351404469460249
complete O 0 0.01970846951007843
absence O 0 0.02500169165432453
of O 0 0.006728057283908129
the O 0 0.010118626989424229
normal O 0 0.02926725335419178
copy O 0 0.023666510358452797
of O 0 0.01073318812996149
ATM O 0 0.06833263486623764
in O 0 0.00786641426384449
the O 0 0.009505006484687328
majority O 0 0.020879533141851425
of O 0 0.01964983157813549
mutated O 1 0.9724818468093872
tumours B-Disease 1 0.9999961853027344
establishes O 1 0.9223096966743469
somatic O 0 0.39442896842956543
inactivation O 0 0.19770090281963348
of O 0 0.01068176794797182
this O 0 0.009437724947929382
gene O 0 0.04409986734390259
in O 0 0.007613860070705414
the O 0 0.010953170247375965
pathogenesis O 1 0.9996967315673828
of O 0 0.016817517578601837
sporadic B-Disease 1 0.9645707011222839
T I-Disease 1 0.9999960660934448
- I-Disease 1 0.6723162531852722
PLL I-Disease 1 0.999816358089447
and O 0 0.01754523254930973
suggests O 0 0.034329526126384735
that O 0 0.012540397234261036
ATM O 0 0.094384104013443
acts O 0 0.022224199026823044
as O 0 0.014185801148414612
a O 0 0.043642256408929825
tumour B-Disease 1 0.9999997615814209
suppressor O 1 0.9803952574729919
. O 0 0.04527468606829643

As O 0 0.021161656826734543
constitutional O 0 0.025663288310170174
DNA O 0 0.046090975403785706
was O 0 0.01075150165706873
not O 0 0.006573668215423822
available O 0 0.009194284677505493
, O 0 0.008723961189389229
a O 0 0.020153190940618515
putative O 0 0.14543698728084564
hereditary O 1 0.9986535310745239
predisposition O 1 0.9996626377105713
to O 0 0.034992948174476624
T B-Disease 1 0.9999860525131226
- I-Disease 1 0.840668797492981
PLL I-Disease 1 0.999670147895813
will O 0 0.014314258471131325
require O 0 0.02072935551404953
further O 0 0.01468933466821909
investigation O 0 0.02913052774965763
. O 0 0.013420511037111282
. O 0 0.020566847175359726

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.2445998191833496
kinase O 0 0.2759533226490021
is O 0 0.017303630709648132
involved O 0 0.017070749774575233
in O 0 0.00864659994840622
the O 0 0.011747356504201889
modulation O 0 0.08688909560441971
of O 0 0.011631677858531475
the O 0 0.025665316730737686
Ca2 O 1 0.9796106815338135
+ O 1 0.7187874913215637
homeostasis O 1 0.9831647872924805
in O 0 0.03717877343297005
skeletal O 1 0.9999758005142212
muscle O 1 0.9999632835388184
cells O 0 0.13888002932071686
. O 0 0.030846212059259415

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9958048462867737
DM B-Disease 1 1.0
) O 0 0.026768038049340248
, O 0 0.009644768200814724
the O 0 0.010782084427773952
most O 0 0.016467973589897156
prevalent O 1 0.9986119270324707
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
in O 0 0.01641148142516613
adults O 0 0.2127276062965393
, O 0 0.011036432348191738
is O 0 0.01188672799617052
caused O 0 0.04611886665225029
by O 0 0.01675053872168064
( O 0 0.04530861973762512
CTG O 1 0.9978892207145691
) O 0 0.03950344771146774
n O 0 0.07343263179063797
- O 0 0.07430227845907211
repeat O 0 0.08013490587472916
expansion O 0 0.03734402731060982
in O 0 0.012489458546042442
a O 0 0.026625754311680794
gene O 0 0.07410489022731781
encoding O 0 0.05978225916624069
a O 0 0.03911261260509491
protein O 0 0.11586843430995941
kinase O 1 0.6501790881156921
( O 0 0.10149697214365005
DM B-Disease 1 0.9999995231628418
protein O 0 0.15821120142936707
kinase O 0 0.3632132112979889
; O 0 0.03704691305756569
DMPK O 1 0.9378157258033752
) O 0 0.01965384930372238
and O 0 0.010991928167641163
involves O 0 0.03884439170360565
changes O 0 0.020217929035425186
in O 0 0.016310034319758415
cytoarchitecture O 1 0.5686651468276978
and O 0 0.024964869022369385
ion O 0 0.19912652671337128
homeostasis O 1 0.9603464603424072
. O 0 0.03753311559557915

To O 0 0.019880415871739388
obtain O 0 0.030625825747847557
clues O 0 0.03522419184446335
to O 0 0.00705522857606411
the O 0 0.010925181210041046
normal O 0 0.03605113551020622
biological O 0 0.029669398441910744
role O 0 0.023430857807397842
of O 0 0.012203555554151535
DMPK O 1 0.9731141328811646
in O 0 0.022881442680954933
cellular O 0 0.09682325273752213
ion O 0 0.2492571622133255
homeostasis O 1 0.9834471940994263
, O 0 0.012840637937188148
we O 0 0.007572888396680355
have O 0 0.00782465748488903
compared O 0 0.021751584485173225
the O 0 0.014067462645471096
resting O 1 0.760861873626709
[ O 0 0.1519545316696167
Ca2 O 1 0.9936286807060242
+ O 1 0.7567238807678223
] O 0 0.07634343206882477
i O 0 0.017138386145234108
, O 0 0.008320766501128674
the O 0 0.010715045966207981
amplitude O 0 0.0669448971748352
and O 0 0.013745785690844059
shape O 0 0.04499344155192375
of O 0 0.022365443408489227
depolarization O 1 0.9992469549179077
- O 1 0.9708544611930847
induced O 1 0.9993240833282471
Ca2 O 1 0.9959165453910828
+ O 1 0.7814072966575623
transients O 1 0.7243192195892334
, O 0 0.011791770346462727
and O 0 0.005730583332479
the O 0 0.007938767783343792
content O 0 0.014496935531497002
of O 0 0.011828131973743439
ATP O 1 0.9854975938796997
- O 0 0.09162364900112152
driven O 0 0.08733579516410828
ion O 0 0.14266197383403778
pumps O 0 0.14192627370357513
in O 0 0.02489454858005047
cultured O 0 0.36427605152130127
skeletal O 1 0.9998875856399536
muscle O 1 0.9997571110725403
cells O 0 0.0671246200799942
of O 0 0.011309989728033543
wild O 0 0.046929121017456055
- O 0 0.07588328421115875
type O 0 0.06638579815626144
and O 0 0.022687552496790886
DMPK O 1 0.999758780002594
[ O 1 0.7400668263435364
- O 1 0.9062561988830566
/ O 1 0.9987234473228455
- O 0 0.14089494943618774
] O 0 0.13324005901813507
knockout O 0 0.1930912435054779
mice O 0 0.1960393339395523
. O 0 0.03738325089216232

In O 0 0.036657482385635376
vitro O 0 0.15329016745090485
- O 0 0.12679146230220795
differentiated O 0 0.19599391520023346
DMPK O 1 0.9995172023773193
[ O 1 0.8499161601066589
- O 1 0.9581784605979919
/ O 1 0.9985648989677429
- O 0 0.1465696096420288
] O 0 0.12648113071918488
myotubes O 0 0.18383903801441193
exhibit O 0 0.06109560653567314
a O 0 0.025804836302995682
higher O 0 0.04593715816736221
resting O 0 0.27761489152908325
[ O 0 0.12778590619564056
Ca2 O 1 0.9879763722419739
+ O 1 0.5553871989250183
] O 0 0.0765298381447792
i O 0 0.021558891981840134
than O 0 0.010640084743499756
do O 0 0.016216734424233437
wild O 0 0.04216217249631882
- O 0 0.08650467544794083
type O 0 0.08258814364671707
myotubes O 0 0.37411513924598694
because O 0 0.015266732312738895
of O 0 0.007601792458444834
an O 0 0.01385859027504921
altered O 0 0.03826741501688957
open O 0 0.033123716711997986
probability O 0 0.03294294700026512
of O 0 0.01425595860928297
voltage O 0 0.08448460698127747
- O 0 0.09360155463218689
dependent O 0 0.10749293118715286
l O 1 0.9694297909736633
- O 0 0.14144623279571533
type O 0 0.14057938754558563
Ca2 O 1 0.9251213073730469
+ O 0 0.16095107793807983
and O 0 0.029492301866412163
Na O 1 0.6075371503829956
+ O 0 0.15262407064437866
channels O 0 0.053846243768930435
. O 0 0.029722362756729126

The O 0 0.040323056280612946
mutant O 0 0.1771538257598877
myotubes O 0 0.3109789192676544
exhibit O 0 0.07527917623519897
smaller O 0 0.029478123411536217
and O 0 0.01901932619512081
slower O 0 0.08323884755373001
Ca2 O 1 0.9683095812797546
+ O 0 0.1632944941520691
responses O 0 0.06010504812002182
upon O 0 0.0268253143876791
triggering O 0 0.09206686168909073
by O 0 0.024284081533551216
acetylcholine O 0 0.22368232905864716
or O 0 0.025357849895954132
high O 0 0.04267095774412155
external O 0 0.06623441725969315
K O 0 0.2940596640110016
+ O 0 0.14910642802715302
. O 0 0.034674033522605896

In O 0 0.021067015826702118
addition O 0 0.01937199756503105
, O 0 0.01108605694025755
we O 0 0.010119687765836716
observed O 0 0.02005053497850895
that O 0 0.008235751651227474
these O 0 0.017017990350723267
Ca2 O 1 0.9911264777183533
+ O 1 0.8922272324562073
transients O 1 0.9568484425544739
partially O 0 0.08351735025644302
result O 0 0.027286162599921227
from O 0 0.013360275886952877
an O 0 0.015203705988824368
influx O 0 0.06515789031982422
of O 0 0.01896130107343197
extracellular O 0 0.15813642740249634
Ca2 O 1 0.8061020374298096
+ O 0 0.1303378790616989
through O 0 0.023658785969018936
the O 0 0.02545381337404251
l O 1 0.9609266519546509
- O 0 0.13673023879528046
type O 0 0.14511287212371826
Ca2 O 1 0.884309709072113
+ O 0 0.15886051952838898
channel O 0 0.07431413978338242
. O 0 0.028940102085471153

Neither O 0 0.051946625113487244
the O 0 0.014197130687534809
content O 0 0.019763080403208733
nor O 0 0.024526607245206833
the O 0 0.010706083849072456
activity O 0 0.03143298998475075
of O 0 0.018500471487641335
Na O 1 0.9975511431694031
+ O 1 0.971291184425354
/ O 1 0.9879375100135803
K O 0 0.24729162454605103
+ O 0 0.20826005935668945
ATPase O 1 0.8242788910865784
and O 0 0.049526315182447433
sarcoplasmic O 1 0.9994070529937744
reticulum O 1 0.9991475343704224
Ca2 O 1 0.9980953335762024
+ O 1 0.9476742744445801
- O 0 0.141862154006958
ATPase O 1 0.7697566151618958
are O 0 0.01656528376042843
affected O 0 0.0477125309407711
by O 0 0.020330889150500298
DMPK O 1 0.996620774269104
absence O 0 0.07570531964302063
. O 0 0.034329790621995926

In O 0 0.021291621029376984
conclusion O 0 0.03028348833322525
, O 0 0.010087477043271065
our O 0 0.010849989019334316
data O 0 0.013167214579880238
suggest O 0 0.021180754527449608
that O 0 0.010908957570791245
DMPK O 1 0.9417975544929504
is O 0 0.014432515017688274
involved O 0 0.016761906445026398
in O 0 0.012079991400241852
modulating O 0 0.13804329931735992
the O 0 0.012309391982853413
initial O 0 0.03213145583868027
events O 0 0.02045193314552307
of O 0 0.014490662142634392
excitation O 1 0.8770795464515686
- O 0 0.1394684910774231
contraction O 0 0.18348276615142822
coupling O 0 0.11645675450563431
in O 0 0.026345163583755493
skeletal O 1 0.9999673366546631
muscle O 1 0.9999028444290161
. O 0 0.01713677868247032
. O 0 0.02321840263903141

Constitutional O 0 0.116488978266716
RB1 O 1 0.999991774559021
- O 1 0.5999100208282471
gene O 0 0.1584334373474121
mutations O 0 0.13419820368289948
in O 0 0.023703141137957573
patients O 1 0.9997456669807434
with O 0 0.01996951922774315
isolated O 0 0.11298985779285431
unilateral B-Disease 0 0.31178271770477295
retinoblastoma I-Disease 1 0.9999256134033203
. O 0 0.04184645786881447

In O 0 0.026147007942199707
most O 0 0.022409360855817795
patients O 1 0.9997444748878479
with O 0 0.019997084513306618
isolated O 0 0.10563229769468307
unilateral B-Disease 1 0.758109450340271
retinoblastoma I-Disease 1 0.999995231628418
, O 0 0.03580201044678688
tumor B-Disease 1 0.9999374151229858
development O 0 0.027204548940062523
is O 0 0.014899369329214096
initiated O 0 0.04124143347144127
by O 0 0.01702003926038742
somatic O 0 0.17176774144172668
inactivation O 0 0.14073097705841064
of O 0 0.011492141522467136
both O 0 0.013846760615706444
alleles O 0 0.10802583396434784
of O 0 0.014605303294956684
the O 0 0.030409475788474083
RB1 O 1 0.999976396560669
gene O 0 0.14276711642742157
. O 0 0.03713356330990791

However O 0 0.01945180632174015
, O 0 0.009655861184000969
some O 0 0.005675076972693205
of O 0 0.006566021591424942
these O 0 0.01152794249355793
patients O 1 0.99993896484375
can O 0 0.025013526901602745
transmit O 0 0.1295175999403
retinoblastoma B-Disease 1 0.999980092048645
predisposition O 1 0.9932000041007996
to O 0 0.012904366478323936
their O 0 0.014294142834842205
offspring O 0 0.08008119463920593
. O 0 0.03287242725491524

To O 0 0.016454100608825684
determine O 0 0.020507099106907845
the O 0 0.011224993504583836
frequency O 0 0.031838200986385345
and O 0 0.007964368909597397
nature O 0 0.018143484368920326
of O 0 0.010008083656430244
constitutional O 0 0.04453897848725319
RB1 O 1 0.9999990463256836
- O 0 0.42760002613067627
gene O 0 0.13584572076797485
mutations O 0 0.13240933418273926
in O 0 0.024102164432406425
patients O 1 0.9998363256454468
with O 0 0.018958861008286476
isolated O 0 0.10338878631591797
unilateral B-Disease 0 0.20370307564735413
retinoblastoma I-Disease 1 0.9999462366104126
, O 0 0.01870032213628292
we O 0 0.012401840649545193
analyzed O 0 0.04062730073928833
DNA O 0 0.05466719716787338
from O 0 0.021014276891946793
peripheral O 1 0.9988527297973633
blood O 1 0.8800095319747925
and O 0 0.016314564272761345
from O 0 0.02952485904097557
tumor B-Disease 1 0.9999970197677612
tissue O 1 0.9962956309318542
. O 0 0.03479640558362007

The O 0 0.023521654307842255
analysis O 0 0.03305886685848236
of O 0 0.01736329309642315
tumors B-Disease 1 0.9999566078186035
from O 0 0.02090461179614067
54 O 0 0.0603150948882103
( O 0 0.03173382952809334
71 O 0 0.06114514172077179
% O 0 0.024251554161310196
) O 0 0.016375621780753136
of O 0 0.01115638017654419
76 O 0 0.07991264760494232
informative O 0 0.08783558756113052
patients O 1 0.9998928308486938
showed O 0 0.03848116844892502
loss O 0 0.043323349207639694
of O 0 0.011910767294466496
constitutional O 0 0.04053172469139099
heterozygosity O 1 0.9994995594024658
( O 0 0.09491591900587082
LOH O 1 0.9999548196792603
) O 0 0.050139229744672775
at O 0 0.04113641008734703
intragenic O 1 0.6334523558616638
loci O 0 0.20065955817699432
. O 0 0.03590737283229828

Three O 0 0.022186048328876495
of O 0 0.016988448798656464
13 O 0 0.05198919028043747
uninformative O 1 0.9997257590293884
patients O 1 0.9998477697372437
had O 0 0.022151220589876175
constitutional O 0 0.03240717574954033
deletions O 0 0.11328534781932831
. O 0 0.035756032913923264

For O 0 0.0315915048122406
39 O 0 0.06559723615646362
randomly O 0 0.0668400377035141
selected O 0 0.04639280214905739
tumors B-Disease 1 0.9999793767929077
, O 0 0.03209705650806427
SSCP O 1 0.9987180233001709
, O 0 0.03972439840435982
hetero O 1 0.9998643398284912
- O 0 0.15367253124713898
duplex O 0 0.4528980851173401
analysis O 0 0.03778890147805214
, O 0 0.015506335534155369
sequencing O 0 0.05013604089617729
, O 0 0.011031310074031353
and O 0 0.009583786129951477
Southern O 0 0.033453457057476044
blot O 0 0.15556985139846802
analysis O 0 0.022694172337651253
were O 0 0.007248152978718281
used O 0 0.011512966826558113
to O 0 0.011359919793903828
identify O 0 0.0423344187438488
mutations O 0 0.11413707584142685
. O 0 0.03227110579609871

Mutations O 0 0.17094303667545319
were O 0 0.022862164303660393
detected O 0 0.07172629982233047
in O 0 0.013318341225385666
21 O 0 0.0290294848382473
( O 0 0.027388179674744606
91 O 0 0.062190499156713486
% O 0 0.02409239299595356
) O 0 0.016310418024659157
of O 0 0.010227023623883724
23 O 0 0.0517687126994133
tumors B-Disease 1 0.9999979734420776
with O 0 0.03503577038645744
LOH O 1 0.9999817609786987
. O 0 0.04429537430405617

In O 0 0.028008855879306793
6 O 0 0.04000890254974365
( O 0 0.029278574511408806
38 O 0 0.03679043799638748
% O 0 0.02210301160812378
) O 0 0.01464607659727335
of O 0 0.009154155850410461
16 O 0 0.04197913780808449
tumors B-Disease 1 0.9999994039535522
without O 0 0.0383746400475502
LOH O 1 0.9999924898147583
, O 0 0.01782548986375332
one O 0 0.017827261239290237
mutation O 0 0.10910499095916748
was O 0 0.02267986536026001
detected O 0 0.05986559018492699
, O 0 0.009461465291678905
and O 0 0.007274304516613483
in O 0 0.010498418472707272
9 O 0 0.029782123863697052
( O 0 0.02209112048149109
56 O 0 0.035692423582077026
% O 0 0.018735377117991447
) O 0 0.012735016644001007
of O 0 0.007018923293799162
the O 0 0.022850338369607925
tumors B-Disease 1 0.9999996423721313
without O 0 0.04278907924890518
LOH O 1 0.9999920129776001
, O 0 0.01748642325401306
both O 0 0.014831501990556717
mutations O 0 0.08534438163042068
were O 0 0.013517159968614578
found O 0 0.02369261533021927
. O 0 0.023360390216112137

Thus O 0 0.029444899410009384
, O 0 0.010701469145715237
a O 0 0.012447924353182316
total O 0 0.01261131465435028
of O 0 0.008891603909432888
45 O 0 0.033219579607248306
mutations O 0 0.07566031813621521
were O 0 0.0103806983679533
identified O 0 0.026434745639562607
in O 0 0.01866419054567814
tumors B-Disease 1 0.9999912977218628
of O 0 0.016247587278485298
36 O 0 0.06285004317760468
patients O 1 0.9998804330825806
. O 0 0.03202304616570473

Thirty O 0 0.080164834856987
- O 0 0.060168489813804626
nine O 0 0.019884096458554268
of O 0 0.0094075882807374
the O 0 0.019405679777264595
mutations O 0 0.12998376786708832
- O 0 0.06647003442049026
including O 0 0.017388304695487022
34 O 0 0.043539922684431076
small O 0 0.02762829326093197
mutations O 0 0.09655207395553589
, O 0 0.016404954716563225
2 O 0 0.021864984184503555
large O 0 0.018432945013046265
structural O 0 0.06886211037635803
alterations O 0 0.0485890731215477
, O 0 0.012371649034321308
and O 0 0.014305493794381618
hypermethylation O 1 0.9976497292518616
in O 0 0.023647254332900047
3 O 0 0.06489653885364532
tumors O 1 0.9999995231628418
- O 0 0.05981416255235672
were O 0 0.010456162504851818
not O 0 0.010783731937408447
detected O 0 0.04593474790453911
in O 0 0.009332799352705479
the O 0 0.012696141377091408
corresponding O 0 0.05023869127035141
peripheral O 1 0.9995782971382141
blood O 1 0.9951436519622803
DNA O 0 0.08969009667634964
. O 0 0.027141567319631577

In O 0 0.02906608022749424
6 O 0 0.03837205842137337
( O 0 0.028679821640253067
17 O 0 0.030120225623250008
% O 0 0.020253276452422142
) O 0 0.012203873135149479
of O 0 0.005618054419755936
the O 0 0.011493665166199207
36 O 0 0.0463700145483017
patients O 1 0.9996562004089355
, O 0 0.01338491216301918
a O 0 0.02378186583518982
mutation O 0 0.12090253084897995
was O 0 0.02356446534395218
detected O 0 0.06081055849790573
in O 0 0.01188268419355154
constitutional O 0 0.02036946639418602
DNA O 0 0.044777996838092804
, O 0 0.00924316793680191
and O 0 0.007311732973903418
1 O 0 0.012754593044519424
of O 0 0.006087802350521088
these O 0 0.00932229496538639
mutations O 0 0.06570718437433243
is O 0 0.011573788709938526
known O 0 0.012983315624296665
to O 0 0.006462553050369024
be O 0 0.006798852235078812
associated O 0 0.016629282385110855
with O 0 0.012767431326210499
reduced O 0 0.05929262563586235
expressivity O 1 0.9986060261726379
. O 0 0.0417926050722599

The O 0 0.020338553935289383
presence O 0 0.028491489589214325
of O 0 0.00847537163645029
a O 0 0.016404524445533752
constitutional O 0 0.02817089855670929
mutation O 0 0.10299745947122574
was O 0 0.0146141042932868
not O 0 0.008038634434342384
associated O 0 0.014309906400740147
with O 0 0.0073088123463094234
an O 0 0.010537962429225445
early O 0 0.02010347507894039
age O 0 0.029497012495994568
at O 0 0.024593640118837357
treatment O 1 0.9997957348823547
. O 0 0.02606615610420704

In O 0 0.03240787982940674
1 O 0 0.052657175809144974
patient O 1 0.9922184944152832
, O 0 0.029359690845012665
somatic O 1 0.527910590171814
mosaicism O 1 0.9980891346931458
was O 0 0.021833373233675957
demonstrated O 0 0.031112536787986755
by O 0 0.012650051154196262
molecular O 0 0.041624367237091064
analysis O 0 0.020009411498904228
of O 0 0.007984972558915615
DNA O 0 0.04564957320690155
and O 0 0.011909757740795612
RNA O 0 0.0827212855219841
from O 0 0.024592764675617218
peripheral O 1 0.9985826015472412
blood O 1 0.9684258103370667
. O 0 0.035850174725055695

In O 0 0.03105810657143593
2 O 0 0.0467875674366951
patients O 1 0.9992511868476868
without O 0 0.01950170285999775
a O 0 0.026512926444411278
detectable O 0 0.16171669960021973
mutation O 0 0.15730217099189758
in O 0 0.026382800191640854
peripheral O 1 0.99985671043396
blood O 1 0.9946084022521973
, O 0 0.02412785217165947
mosaicism O 1 0.9992732405662537
was O 0 0.020698687061667442
suggested O 0 0.0221879705786705
because O 0 0.012514478527009487
1 O 0 0.014172619208693504
of O 0 0.007687828969210386
the O 0 0.01984405890107155
patients O 1 0.9999984502792358
showed O 1 0.9949148893356323
multifocal O 1 1.0
tumors B-Disease 1 0.9999996423721313
and O 0 0.010924207046627998
the O 0 0.008589649572968483
other O 0 0.006902007386088371
later O 0 0.014262666925787926
developed O 0 0.032524727284908295
bilateral B-Disease 0 0.05399174988269806
retinoblastoma I-Disease 1 0.9999152421951294
. O 0 0.04104763641953468

In O 0 0.021816615015268326
conclusion O 0 0.03038792498409748
, O 0 0.010675953701138496
our O 0 0.011904224753379822
results O 0 0.020317841321229935
emphasize O 0 0.03594977781176567
that O 0 0.007025653962045908
the O 0 0.01004061195999384
manifestation O 0 0.24318230152130127
and O 0 0.017965300008654594
transmissibility O 1 0.9889406561851501
of O 0 0.01946388930082321
retinoblastoma B-Disease 1 0.9996165037155151
depend O 0 0.022802237421274185
on O 0 0.006893781945109367
the O 0 0.007490223739296198
nature O 0 0.017862655222415924
of O 0 0.00600077910348773
the O 0 0.009477956220507622
first O 0 0.015399683266878128
mutation O 0 0.09045981615781784
, O 0 0.0092881228774786
its O 0 0.00712368031963706
time O 0 0.008377490565180779
in O 0 0.007195360958576202
development O 0 0.013055477291345596
, O 0 0.006312246900051832
and O 0 0.004759557545185089
the O 0 0.006193565204739571
number O 0 0.006289634387940168
and O 0 0.0070123737677931786
types O 0 0.01868416741490364
of O 0 0.008422056213021278
cells O 0 0.04638192802667618
that O 0 0.007729248609393835
are O 0 0.007462854031473398
affected O 0 0.03813673183321953
. O 0 0.015169331803917885
. O 0 0.0232086181640625

Hereditary B-Disease 1 0.9999912977218628
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.013587280176579952
the I-Disease 0 0.011762856505811214
fifth I-Disease 0 0.03378249332308769
component I-Disease 0 0.03645416349172592
of I-Disease 0 0.008351674303412437
complement I-Disease 0 0.042743582278490067
in O 0 0.01598077081143856
man O 0 0.043531496077775955
. O 0 0.026534471660852432

I O 0 0.07858148962259293
. O 0 0.03451000899076462

Clinical O 1 0.9943591952323914
, O 0 0.026014618575572968
immunochemical O 0 0.3098333179950714
, O 0 0.013251746073365211
and O 0 0.01110547874122858
family O 0 0.028651950880885124
studies O 0 0.03593405708670616
. O 0 0.025075236335396767

The O 0 0.017285233363509178
first O 0 0.015683583915233612
recognized O 0 0.034114398062229156
human O 0 0.03535573184490204
kindred O 1 0.999841570854187
with O 0 0.02803877741098404
hereditary B-Disease 1 0.9999983310699463
deficiency I-Disease 1 1.0
of I-Disease 0 0.009347076527774334
the I-Disease 0 0.010834544897079468
fifth I-Disease 0 0.034848034381866455
component I-Disease 0 0.0397808738052845
of I-Disease 0 0.012061179615557194
complement I-Disease 0 0.07518114149570465
( O 0 0.04989743232727051
C5 O 1 0.9887561202049255
) O 0 0.02364146150648594
is O 0 0.014112120494246483
described O 0 0.031797949224710464
. O 0 0.025121310725808144

The O 0 0.03316626325249672
proband O 0 0.1463615596294403
, O 0 0.013956805691123009
a O 0 0.017625391483306885
20 O 0 0.022581245750188828
- O 0 0.05501703545451164
year O 0 0.023660505190491676
- O 0 0.057098936289548874
old O 0 0.037115953862667084
black O 0 0.05683879181742668
female O 0 0.06425407528877258
with O 0 0.3785262703895569
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.046864356845617294
age O 0 0.036416783928871155
11 O 0 0.024145090952515602
, O 0 0.016609488055109978
lacked O 1 0.850304901599884
serum O 1 0.9999876022338867
hemolytic O 1 0.9999998807907104
complement O 0 0.09018465131521225
activity O 0 0.03582195192575455
, O 0 0.01241432223469019
even O 0 0.016298577189445496
during O 0 0.033875759690999985
remission O 1 0.999859094619751
. O 0 0.03390636295080185

C5 O 1 0.9874809384346008
was O 0 0.04364508017897606
undetectable O 1 0.7548553347587585
in O 0 0.01717366836965084
her O 0 0.03216416388750076
serum O 1 0.7885189056396484
by O 0 0.0139385424554348
both O 0 0.016589224338531494
immunodiffusion O 1 0.9710359573364258
and O 0 0.036174435168504715
hemolytic O 1 0.9999994039535522
assays O 0 0.15744751691818237
. O 0 0.034746766090393066

Other O 0 0.019349511712789536
complement O 0 0.052269354462623596
components O 0 0.031609561294317245
were O 0 0.012424827553331852
normal O 0 0.04119089990854263
during O 0 0.034666310995817184
remission O 1 0.9999794960021973
of O 0 0.02774965576827526
lupus O 1 1.0
, O 0 0.02060881443321705
but O 0 0.02089104615151882
C1 O 1 0.9999886751174927
, O 0 0.030711224302649498
C4 O 1 0.9932500123977661
, O 0 0.026165137067437172
C2 O 1 0.999943733215332
, O 0 0.020192235708236694
and O 0 0.01849181018769741
C3 O 1 0.9998124241828918
levels O 0 0.06956436485052109
fell O 0 0.06881728768348694
during O 0 0.049084339290857315
exacerbations O 1 0.9999245405197144
. O 0 0.042427536100149155

A O 0 0.04448799043893814
younger O 0 0.051038362085819244
half O 0 0.030738474801182747
- O 0 0.07016517221927643
sister O 0 0.04749976098537445
, O 0 0.011904281564056873
who O 0 0.01471454557031393
had O 0 0.014294962398707867
no O 0 0.016438990831375122
underlying O 1 0.9994992017745972
disease O 1 0.9999997615814209
, O 0 0.010394218377768993
was O 0 0.009953029453754425
also O 0 0.007314553949981928
found O 0 0.010768595151603222
to O 0 0.010092601180076599
lack O 0 0.044581711292266846
immunochemically O 1 0.9955880641937256
detectable O 1 0.6297762393951416
C5 O 1 0.984127938747406
. O 0 0.04533695429563522

By O 0 0.06893394142389297
hemolytic O 1 0.9999979734420776
assay O 0 0.1911333203315735
, O 0 0.018830880522727966
she O 0 0.021351352334022522
exhibited O 0 0.0527021624147892
1 O 0 0.029310317710042
- O 0 0.052265942096710205
2 O 0 0.024222055450081825
% O 0 0.014707496389746666
of O 0 0.00659557431936264
the O 0 0.013725528493523598
normal O 0 0.07009373605251312
serum O 1 0.9954487681388855
C5 O 1 0.9904182553291321
level O 0 0.03252657130360603
and O 0 0.011980380862951279
normal O 0 0.038722969591617584
concentrations O 0 0.05429624393582344
of O 0 0.0070706577971577644
other O 0 0.008940151892602444
complement O 0 0.0499035120010376
components O 0 0.038805145770311356
. O 0 0.02828235737979412

C5 O 1 0.9613304734230042
levels O 0 0.05306488648056984
of O 0 0.00842084176838398
other O 0 0.006847758311778307
family O 0 0.01660834066569805
members O 0 0.011171739548444748
were O 0 0.007924120873212814
either O 0 0.0164678655564785
normal O 0 0.032075971364974976
or O 0 0.014472614973783493
approximately O 0 0.02125452272593975
half O 0 0.02308613248169422
- O 0 0.05780276283621788
normal O 0 0.03797793388366699
, O 0 0.012839779257774353
consistent O 0 0.036787066608667374
with O 0 0.021263595670461655
autosomal O 1 0.9992272853851318
codominant O 1 0.9867271780967712
inheritance O 0 0.0631338581442833
of O 0 0.010767629370093346
the O 0 0.018542364239692688
gene O 0 0.11800850182771683
determining O 0 0.11684688925743103
C5 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.05276213958859444

Normal O 1 0.9399851560592651
hemolytic O 1 0.9999996423721313
titers O 1 0.9842601418495178
were O 0 0.018510984256863594
restored O 0 0.03142216429114342
to O 0 0.011930093169212341
both O 0 0.018043959513306618
homozygous O 0 0.2728224992752075
C5 B-Disease 1 0.9999984502792358
- I-Disease 1 0.9892483949661255
deficient I-Disease 1 0.9999861717224121
( O 0 0.08167265355587006
C5D B-Disease 1 0.9999861717224121
) O 0 0.04113970324397087
sera O 0 0.0874115526676178
by O 0 0.009462430141866207
addition O 0 0.015400457195937634
of O 0 0.010093898512423038
highly O 0 0.042605869472026825
purified O 0 0.13527345657348633
human O 0 0.06106055527925491
C5 O 1 0.9905014038085938
. O 0 0.03930780664086342

In O 0 0.03241969645023346
specific O 0 0.05215032771229744
C5 O 1 0.998065173625946
titrations O 1 0.9950756430625916
, O 0 0.015416747890412807
however O 0 0.009930255822837353
, O 0 0.007760914973914623
it O 0 0.006771345157176256
was O 0 0.00944926030933857
noted O 0 0.009600494056940079
that O 0 0.005302241537719965
when O 0 0.01048960629850626
limited O 0 0.01840861886739731
amounts O 0 0.023007700219750404
of O 0 0.01196124404668808
C5 O 1 0.8052522540092468
were O 0 0.011777542531490326
assayed O 0 0.07759758830070496
in O 0 0.00873980950564146
the O 0 0.009391140192747116
presence O 0 0.024623816832900047
of O 0 0.011655344627797604
low O 0 0.06149766966700554
dilutions O 1 0.9101066589355469
of O 0 0.019265348091721535
either O 0 0.04880373552441597
C5D B-Disease 1 0.9999935626983643
serum O 1 0.9918549060821533
, O 0 0.021201925352215767
curving O 0 0.07598544657230377
rather O 0 0.020363107323646545
than O 0 0.018885644152760506
linear O 0 0.0976908728480339
dose O 1 0.9995232820510864
- O 0 0.0808665081858635
response O 0 0.041897885501384735
plots O 0 0.029483318328857422
were O 0 0.010784679092466831
consistently O 0 0.03344912827014923
obtained O 0 0.01929856278002262
, O 0 0.011102337390184402
suggesting O 0 0.03914692997932434
some O 0 0.01822209730744362
inhibitory O 0 0.18933631479740143
effect O 0 0.05649498850107193
. O 0 0.029135772958397865

Further O 0 0.03756498917937279
studies O 0 0.03392556682229042
suggested O 0 0.02733621373772621
that O 0 0.013118060305714607
low O 0 0.056174878031015396
dilutions O 1 0.9853008389472961
of O 0 0.026769356802105904
C5D B-Disease 1 0.9999936819076538
serum O 1 0.9948764443397522
contain O 0 0.035783518105745316
a O 0 0.026689736172556877
factor O 0 0.06341923028230667
( O 0 0.029555669054389
or O 0 0.018221722915768623
factors O 0 0.03340454772114754
) O 0 0.019855469465255737
interfering O 0 0.04144241660833359
at O 0 0.01214301772415638
some O 0 0.00672205351293087
step O 0 0.018906502053141594
in O 0 0.010815754532814026
the O 0 0.02426215261220932
hemolytic O 1 0.9999990463256836
assay O 0 0.14699240028858185
of O 0 0.020428715273737907
C5 O 1 0.9946309328079224
, O 0 0.011915089562535286
rather O 0 0.011559462174773216
than O 0 0.009181348606944084
a O 0 0.020131852477788925
true O 0 0.04597379267215729
C5 O 1 0.9995527863502502
inhibitor O 1 0.9950162768363953
or O 0 0.0393231138586998
inactivator O 1 0.8898407816886902
. O 0 0.03164565935730934

Of O 0 0.024885432794690132
clinical O 0 0.3009260594844818
interest O 0 0.020153896883130074
are O 0 0.008207262493669987
( O 0 0.017109045758843422
a O 0 0.013694731518626213
) O 0 0.012988138012588024
the O 0 0.008917577564716339
documentation O 0 0.033176206052303314
of O 0 0.019594157114624977
membranous O 1 0.9999990463256836
glomerulonephritis B-Disease 1 1.0
, O 0 0.09087910503149033
vasculitis B-Disease 1 1.0
, O 0 0.025156309828162193
and O 0 0.023701980710029602
arthritis B-Disease 1 1.0
in O 0 0.013238341547548771
an O 0 0.013879314996302128
individual O 0 0.029168615117669106
lacking O 0 0.3918701708316803
C5 O 1 0.9983189702033997
( O 0 0.020922726020216942
and O 0 0.008763076737523079
its O 0 0.014249352738261223
biologic O 0 0.48649752140045166
functions O 0 0.02323296293616295
) O 0 0.015689976513385773
, O 0 0.009111505001783371
and O 0 0.009800267405807972
( O 0 0.025923607870936394
b O 0 0.07032136619091034
) O 0 0.017252590507268906
a O 0 0.01787370815873146
remarkable O 0 0.045716118067502975
propensity O 1 0.9132944941520691
to O 0 0.030238669365644455
bacterial B-Disease 1 0.9999997615814209
infections I-Disease 1 0.9999998807907104
in O 0 0.014596836641430855
the O 0 0.017347825691103935
proband O 1 0.9915307760238647
, O 0 0.011515702120959759
even O 0 0.010966557078063488
during O 0 0.016115738078951836
periods O 0 0.030202992260456085
of O 0 0.010361583903431892
low O 0 0.05856877937912941
- O 0 0.11189843714237213
dose O 1 0.9834022521972656
or O 0 0.024221457540988922
alternate O 0 0.049957484006881714
- O 0 0.12224479764699936
day O 0 0.06617613881826401
corticosteroid O 1 0.9999979734420776
therapy O 1 0.999977707862854
. O 0 0.040549807250499725

Other O 0 0.020531363785266876
observations O 0 0.03809559345245361
indicate O 0 0.02887469157576561
that O 0 0.008772521279752254
the O 0 0.01459476724267006
C5D B-Disease 1 0.9997774958610535
state O 0 0.014247310347855091
is O 0 0.010874437168240547
compatible O 0 0.027901791036128998
with O 0 0.01351957581937313
normal O 0 0.06059466674923897
coagulation O 1 0.9845935702323914
function O 0 0.026787249371409416
and O 0 0.006819800473749638
the O 0 0.007790806703269482
capacity O 0 0.01891150325536728
to O 0 0.01136013399809599
mount O 0 0.06462159752845764
a O 0 0.04826997593045235
neutrophilic O 1 0.999988317489624
leukocytosis O 1 0.9999765157699585
during O 0 0.24928605556488037
pyogenic B-Disease 1 0.9999980926513672
infection I-Disease 1 0.9999977350234985
. O 0 0.027761831879615784
. O 0 0.028020808473229408

Susceptibility O 1 0.9982971549034119
to O 0 0.06629838049411774
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.030248058959841728
twins O 0 0.10193654894828796
: O 0 0.014683213084936142
the O 0 0.008380857296288013
role O 0 0.017754128202795982
of O 0 0.010261659510433674
genes O 0 0.058647532016038895
, O 0 0.023261308670043945
HLA O 1 0.9999246597290039
, O 0 0.011744883842766285
and O 0 0.00790036004036665
the O 0 0.01246859785169363
environment O 0 0.04093175008893013
. O 0 0.02740846388041973

OBJECTIVE O 0 0.06166205182671547
To O 0 0.011690420098602772
determine O 0 0.018856670707464218
the O 0 0.012136886827647686
relative O 0 0.03547828644514084
effects O 0 0.059195879846811295
of O 0 0.00998164713382721
genetic O 0 0.05066617578268051
and O 0 0.012823252938687801
environmental O 0 0.03203720226883888
factors O 0 0.03219803422689438
in O 0 0.019026873633265495
susceptibility O 1 0.9983080625534058
to O 0 0.04805876687169075
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.05811538174748421
AS B-Disease 0 0.03310956433415413
) O 0 0.026305874809622765
. O 0 0.0245022214949131

METHODS O 0 0.07243335247039795
Twins O 0 0.10247012972831726
with O 0 0.014870304614305496
AS B-Disease 0 0.017373694106936455
were O 0 0.007603692356497049
identified O 0 0.016118105500936508
from O 0 0.007812617346644402
the O 0 0.010608757846057415
Royal O 0 0.042059071362018585
National O 0 0.036734819412231445
Hospital O 1 0.9999970197677612
for O 0 0.04505495727062225
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999997615814209
database O 0 0.07902485132217407
. O 0 0.03348653018474579

Clinical O 1 0.9954004883766174
and O 0 0.026441864669322968
radiographic O 1 0.9890366196632385
examinations O 0 0.0785495936870575
were O 0 0.010167853906750679
performed O 0 0.023698097094893456
to O 0 0.010919983498752117
establish O 0 0.04388820752501488
diagnoses O 1 0.999874472618103
, O 0 0.018387040123343468
and O 0 0.021627366542816162
disease O 1 1.0
severity O 1 0.9995725750923157
was O 0 0.017745042219758034
assessed O 0 0.042983535677194595
using O 0 0.014631561934947968
a O 0 0.015901867300271988
combination O 0 0.049084700644016266
of O 0 0.010632970370352268
validated O 0 0.060138508677482605
scoring O 0 0.031207984313368797
systems O 0 0.04196598380804062
. O 0 0.027234762907028198

HLA O 1 0.9984037280082703
typing O 0 0.18435046076774597
for O 0 0.046565186232328415
HLA O 1 0.9999667406082153
- O 0 0.17348603904247284
B27 O 0 0.49961617588996887
, O 0 0.04368032142519951
HLA O 1 0.9999690055847168
- O 0 0.1360609233379364
B60 O 0 0.1713186800479889
, O 0 0.02488446794450283
and O 0 0.0253924410790205
HLA O 1 0.999990701675415
- O 0 0.16997967660427094
DR1 O 1 0.9870691299438477
was O 0 0.02633819170296192
performed O 0 0.03348265215754509
by O 0 0.018981073051691055
polymerase O 0 0.15465734899044037
chain O 0 0.08543285727500916
reaction O 0 0.05905025452375412
with O 0 0.014780783094465733
sequence O 0 0.03994825854897499
- O 0 0.05689573660492897
specific O 0 0.028051365166902542
primers O 0 0.11709293723106384
, O 0 0.014697783626616001
and O 0 0.013602467253804207
zygosity O 0 0.14783906936645508
was O 0 0.023878861218690872
assessed O 0 0.06265336275100708
using O 0 0.03421473503112793
microsatellite O 1 0.5294788479804993
markers O 0 0.11472098529338837
. O 0 0.03873712569475174

Genetic O 0 0.11579535156488419
and O 0 0.017214132472872734
environmental O 0 0.043928924947977066
variance O 0 0.04716682434082031
components O 0 0.025283804163336754
were O 0 0.00944458320736885
assessed O 0 0.03570830821990967
with O 0 0.009478332474827766
the O 0 0.014387561939656734
program O 0 0.04760240763425827
Mx O 1 0.9794996976852417
, O 0 0.01116096694022417
using O 0 0.010022593662142754
data O 0 0.00954076275229454
from O 0 0.0064270272850990295
this O 0 0.005181069485843182
and O 0 0.005757865495979786
previous O 0 0.013434547930955887
studies O 0 0.020450061187148094
of O 0 0.009140266105532646
twins O 0 0.06853464245796204
with O 0 0.01418706402182579
AS B-Disease 0 0.030296172946691513
. O 0 0.028736943379044533

RESULTS O 0 0.05088743194937706
Six O 0 0.022006221115589142
of O 0 0.015139328315854073
8 O 0 0.05235631391406059
monozygotic O 1 0.9975727200508118
( O 0 0.07754483819007874
MZ O 1 0.9999836683273315
) O 0 0.04572984576225281
twin O 0 0.1211770623922348
pairs O 0 0.07034735381603241
were O 0 0.028574420139193535
disease O 1 0.9999951124191284
concordant O 1 0.8404785394668579
, O 0 0.017429478466510773
compared O 0 0.020868957042694092
with O 0 0.009655148722231388
4 O 0 0.018590956926345825
of O 0 0.010046367533504963
15 O 0 0.031208965927362442
B27 O 1 0.6234872341156006
- O 0 0.1098136380314827
positive O 0 0.09886868298053741
dizygotic O 1 0.9879317879676819
( O 0 0.07853047549724579
DZ O 1 0.9985927939414978
) O 0 0.04162314906716347
twin O 0 0.11592638492584229
pairs O 0 0.062336504459381104
( O 0 0.03113975003361702
27 O 0 0.0294953603297472
% O 0 0.02279706858098507
) O 0 0.013804593123495579
and O 0 0.008240967988967896
4 O 0 0.01733545772731304
of O 0 0.012196999974548817
32 O 0 0.05639045313000679
DZ O 1 0.9985439777374268
twin O 0 0.1389717012643814
pairs O 0 0.06962639093399048
overall O 0 0.05123861879110336
( O 0 0.02635875530540943
12 O 0 0.018395118415355682
. O 0 0.010689964517951012
5 O 0 0.026851095259189606
% O 0 0.02646566741168499
) O 0 0.026875663548707962
. O 0 0.025337044149637222

Nonsignificant O 1 0.8628352880477905
increases O 0 0.05461491644382477
in O 0 0.013124026358127594
similarity O 0 0.03325687348842621
with O 0 0.009885183535516262
regard O 0 0.021671447902917862
to O 0 0.011591209098696709
age O 0 0.04010182246565819
at O 0 0.10406509041786194
disease O 1 1.0
onset O 1 0.9999920129776001
and O 0 0.009653206914663315
all O 0 0.005222389008849859
of O 0 0.007572301663458347
the O 0 0.02385433204472065
disease O 1 0.9999998807907104
severity O 1 0.9998853206634521
scores O 0 0.04301173985004425
assessed O 0 0.04378219693899155
were O 0 0.009629758074879646
noted O 0 0.019482193514704704
in O 0 0.019631441682577133
disease O 1 1.0
- O 1 0.9888831973075867
concordant O 1 0.9992013573646545
MZ O 1 0.9999977350234985
twins O 0 0.19886328279972076
compared O 0 0.04693307355046272
with O 0 0.028675111010670662
concordant O 1 0.984228253364563
DZ O 1 0.9999086856842041
twins O 0 0.2988186478614807
. O 0 0.04907165840268135

HLA O 1 0.9999779462814331
- O 0 0.1795351505279541
B27 O 0 0.18161453306674957
and O 0 0.020327948033809662
B60 O 0 0.1136355996131897
were O 0 0.010721330530941486
associated O 0 0.017551014199852943
with O 0 0.011585882864892483
the O 0 0.01712346263229847
disease O 1 0.9999960660934448
in O 0 0.015386378392577171
probands O 1 0.9549422264099121
, O 0 0.009423390962183475
and O 0 0.006290515884757042
the O 0 0.009664277546107769
rate O 0 0.029943663626909256
of O 0 0.0175706185400486
disease O 1 0.9999982118606567
concordance O 0 0.35190173983573914
was O 0 0.02426367625594139
significantly O 0 0.041293106973171234
increased O 0 0.029700499027967453
among O 0 0.02569579891860485
DZ O 1 0.9998277425765991
twin O 0 0.11122310161590576
pairs O 0 0.03873138874769211
in O 0 0.009735074825584888
which O 0 0.010110653005540371
the O 0 0.014633674174547195
co O 0 0.3003709614276886
- O 0 0.08424492925405502
twin O 0 0.09877575933933258
was O 0 0.02086777240037918
positive O 0 0.02775309421122074
for O 0 0.008751310408115387
both O 0 0.013692928478121758
B27 O 0 0.14195871353149414
and O 0 0.025061694905161858
DR1 O 1 0.9991301894187927
. O 0 0.03831508755683899

Additive O 0 0.3003856837749481
genetic O 0 0.14593073725700378
effects O 0 0.08398832380771637
were O 0 0.012395121157169342
estimated O 0 0.02420164830982685
to O 0 0.012747413478791714
contribute O 0 0.049572404474020004
97 O 0 0.06324406713247299
% O 0 0.017561376094818115
of O 0 0.006315609440207481
the O 0 0.010955138131976128
population O 0 0.02620282582938671
variance O 0 0.061642732471227646
. O 0 0.025464873760938644

CONCLUSION O 0 0.10571669042110443
Susceptibility O 0 0.2429201304912567
to O 0 0.016182269901037216
AS B-Disease 0 0.019842147827148438
is O 0 0.01402334589511156
largely O 0 0.024412523955106735
genetically O 0 0.04078679531812668
determined O 0 0.024972686544060707
, O 0 0.00824801716953516
and O 0 0.006978054065257311
the O 0 0.01085975207388401
environmental O 0 0.035062700510025024
trigger O 0 0.08049729466438293
for O 0 0.01043049804866314
the O 0 0.019281070679426193
disease O 1 0.9999984502792358
is O 0 0.020815225318074226
probably O 0 0.03691110014915466
ubiquitous O 0 0.07760697603225708
. O 0 0.028509363532066345

HLA O 1 0.9999759197235107
- O 0 0.15491586923599243
B27 O 0 0.15401780605316162
accounts O 0 0.023492055013775826
for O 0 0.007861007936298847
a O 0 0.011989284306764603
minority O 0 0.020082304254174232
of O 0 0.006947952788323164
the O 0 0.011102604679763317
overall O 0 0.05446961149573326
genetic O 0 0.10589288175106049
susceptibility O 1 0.9156038761138916
to O 0 0.01583739183843136
AS B-Disease 0 0.029532475396990776
. O 0 0.02467394806444645

Cell O 0 0.1818610280752182
cycle O 0 0.134384885430336
- O 0 0.09455469995737076
dependent O 0 0.07969203591346741
colocalization O 0 0.15045860409736633
of O 0 0.021367022767663002
BARD1 O 1 0.9915521144866943
and O 0 0.021661071106791496
BRCA1 O 1 0.9881796836853027
proteins O 0 0.04676950350403786
in O 0 0.015084199607372284
discrete O 0 0.05439675226807594
nuclear O 0 0.0529804453253746
domains O 0 0.0659652054309845
. O 0 0.03131991624832153

Germ O 1 0.9997363686561584
- O 0 0.13314636051654816
line O 0 0.05242273211479187
mutations O 0 0.08472723513841629
of O 0 0.013438871130347252
the O 0 0.02618839405477047
BRCA1 O 1 0.9996680021286011
gene O 0 0.1628423035144806
predispose O 1 0.855549156665802
women O 0 0.03410771116614342
to O 0 0.01413805689662695
early O 0 0.04064391553401947
- O 1 0.9997467398643494
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 0.9640770554542542
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.018857570365071297
compromising O 0 0.06901125609874725
the O 0 0.018476685509085655
genes O 0 0.06891009956598282
presumptive O 0 0.29574280977249146
function O 0 0.03914353623986244
as O 0 0.014707723632454872
a O 0 0.037969231605529785
tumor B-Disease 1 0.9999674558639526
suppressor O 1 0.9686233997344971
. O 0 0.03931000456213951

Although O 0 0.0259852334856987
the O 0 0.01799120381474495
biochemical O 0 0.09039127826690674
properties O 0 0.039481233805418015
of O 0 0.018673241138458252
BRCA1 O 1 0.9971640706062317
polypeptides O 0 0.10948611795902252
are O 0 0.009298909455537796
not O 0 0.009232301265001297
understood O 0 0.027271240949630737
, O 0 0.007961874827742577
their O 0 0.009609388187527657
expression O 0 0.03807557374238968
pattern O 0 0.04955168440937996
and O 0 0.014890456572175026
subcellular O 0 0.1006084680557251
localization O 0 0.07836432009935379
suggest O 0 0.02604437619447708
a O 0 0.015021448023617268
role O 0 0.023182427510619164
in O 0 0.01702233962714672
cell O 0 0.11088468134403229
- O 0 0.11167309433221817
cycle O 0 0.11280184239149094
regulation O 0 0.062464915215969086
. O 0 0.026987317949533463

When O 0 0.05754740536212921
resting O 1 0.5884110331535339
cells O 0 0.08893527090549469
are O 0 0.01698089763522148
induced O 1 0.8047176003456116
to O 0 0.016116252169013023
proliferate O 0 0.08173158019781113
, O 0 0.011102301068603992
the O 0 0.012512191198766232
steady O 0 0.05769156292080879
- O 0 0.053709764033555984
state O 0 0.014941595494747162
levels O 0 0.03591350093483925
of O 0 0.01618814840912819
BRCA1 O 1 0.9817215204238892
increase O 0 0.030321728438138962
in O 0 0.014226658269762993
late O 0 0.03186215087771416
G1 O 1 0.9759224653244019
and O 0 0.011060934513807297
reach O 0 0.021378109231591225
a O 0 0.01624307595193386
maximum O 0 0.03342941403388977
during O 0 0.03259539231657982
S O 1 0.9219549298286438
phase O 0 0.09340092539787292
. O 0 0.029434747993946075

Moreover O 0 0.057314347475767136
, O 0 0.015547801740467548
in O 0 0.015566020272672176
S O 1 0.9905291199684143
phase O 0 0.10564399510622025
cells O 0 0.08311548084020615
, O 0 0.025235647335648537
BRCA1 O 1 0.9828457236289978
polypeptides O 0 0.11023039370775223
are O 0 0.017021557316184044
hyperphosphorylated O 0 0.1318526417016983
and O 0 0.018546411767601967
accumulate O 0 0.0791061520576477
into O 0 0.024430563673377037
discrete O 0 0.08553053438663483
subnuclear O 1 0.7808580994606018
foci O 1 0.7199685573577881
termed O 0 0.11569275707006454
" O 0 0.03838041424751282
BRCA1 O 1 0.9981265664100647
nuclear O 0 0.08503055572509766
dots O 0 0.12845437228679657
. O 0 0.03494231030344963

" O 0 0.06871366500854492
BRCA1 O 1 0.9976007342338562
associates O 1 0.6570110321044922
in O 0 0.021048814058303833
vivo O 0 0.11299622058868408
with O 0 0.01587291993200779
a O 0 0.02444075234234333
structurally O 0 0.12108106166124344
related O 0 0.04521280527114868
protein O 0 0.08661403506994247
termed O 0 0.12960104644298553
BARD1 O 1 0.9944682121276855
. O 0 0.041392985731363297

Here O 0 0.02337074466049671
we O 0 0.01044764369726181
show O 0 0.015051610767841339
that O 0 0.005175286903977394
the O 0 0.010521655902266502
steady O 0 0.059916961938142776
- O 0 0.055011484771966934
state O 0 0.01600923016667366
levels O 0 0.03476604446768761
of O 0 0.013556166552007198
BARD1 O 1 0.9971988201141357
, O 0 0.01160444226115942
unlike O 0 0.019082745537161827
those O 0 0.007520461454987526
of O 0 0.012865307740867138
BRCA1 O 1 0.9984195232391357
, O 0 0.01680712215602398
remain O 0 0.020020602270960808
relatively O 0 0.027071058750152588
constant O 0 0.04064258560538292
during O 0 0.03195438161492348
cell O 0 0.11081531643867493
cycle O 0 0.14347800612449646
progression O 1 0.7434165477752686
. O 0 0.039219822734594345

However O 0 0.02904375083744526
, O 0 0.02087993174791336
immunostaining O 1 0.5938657522201538
revealed O 0 0.04340759664773941
that O 0 0.015724588185548782
BARD1 O 1 0.8747138977050781
resides O 0 0.0790051817893982
within O 0 0.0335853286087513
BRCA1 O 1 0.9925625920295715
nuclear O 0 0.06881457567214966
dots O 0 0.09749855101108551
during O 0 0.03461984172463417
S O 1 0.6204531788825989
phase O 0 0.054161906242370605
of O 0 0.009684511460363865
the O 0 0.015123056247830391
cell O 0 0.07270980626344681
cycle O 0 0.06016989424824715
, O 0 0.008129282854497433
but O 0 0.006187117658555508
not O 0 0.006241247523576021
during O 0 0.015208524651825428
the O 0 0.019596973434090614
G1 O 1 0.999517560005188
phase O 0 0.10890562832355499
. O 0 0.03474922105669975

Nevertheless O 0 0.07411286979913712
, O 0 0.03086213581264019
BARD1 O 1 0.9727544188499451
polypeptides O 0 0.09760148823261261
are O 0 0.008739827200770378
found O 0 0.013382217846810818
exclusively O 0 0.015387937426567078
in O 0 0.007963520474731922
the O 0 0.009769639000296593
nuclear O 0 0.026672665029764175
fractions O 0 0.026005635038018227
of O 0 0.007764837238937616
both O 0 0.015932222828269005
G1 O 1 0.9995226860046387
- O 0 0.08575456589460373
and O 0 0.021631654351949692
S O 1 0.9980037808418274
- O 0 0.11866796016693115
phase O 0 0.11661805957555771
cells O 0 0.10493957251310349
. O 0 0.03179113566875458

Therefore O 0 0.04108024761080742
, O 0 0.021873900666832924
progression O 0 0.3724738359451294
to O 0 0.0195405725389719
S O 1 0.9202786087989807
phase O 0 0.06422250717878342
is O 0 0.013119639828801155
accompanied O 0 0.024061495438218117
by O 0 0.008516608737409115
the O 0 0.011812379583716393
aggregation O 0 0.05364067852497101
of O 0 0.013555146753787994
nuclear O 0 0.05621815100312233
BARD1 O 1 0.9325212836265564
polypeptides O 0 0.11964816600084305
into O 0 0.03393189609050751
BRCA1 O 1 0.9874657988548279
nuclear O 0 0.10068066418170929
dots O 0 0.14198414981365204
. O 0 0.038214895874261856

This O 0 0.03265160322189331
cell O 0 0.11577921360731125
cycle O 0 0.12940436601638794
- O 0 0.09442997723817825
dependent O 0 0.08535066992044449
colocalization O 0 0.1672481894493103
of O 0 0.019985435530543327
BARD1 O 1 0.9833139181137085
and O 0 0.026630695909261703
BRCA1 O 1 0.9951926469802856
indicates O 0 0.04882316663861275
a O 0 0.015887003391981125
role O 0 0.019157707691192627
for O 0 0.014374022372066975
BARD1 O 1 0.9905498623847961
in O 0 0.033757247030735016
BRCA1 O 1 0.9999732971191406
- O 1 0.9590387940406799
mediated O 1 0.9982684850692749
tumor B-Disease 1 0.999981164932251
suppression O 1 0.8315252661705017
. O 0 0.03822765499353409

Ethnic O 0 0.03641880676150322
differences O 0 0.029317958280444145
in O 0 0.016537705436348915
the O 0 0.03153584152460098
HFE O 1 0.9979129433631897
codon O 0 0.23917800188064575
282 O 0 0.24459713697433472
( O 0 0.10101897269487381
Cys O 1 0.9999809265136719
/ O 1 0.9981684684753418
Tyr O 1 0.9984431862831116
) O 0 0.05083049461245537
polymorphism O 0 0.14447538554668427
. O 0 0.039373479783535004

Recent O 0 0.04555699974298477
studies O 0 0.02991310879588127
have O 0 0.011288297362625599
shown O 0 0.02467416040599346
that O 0 0.020110711455345154
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9717146158218384
HH B-Disease 1 1.0
) O 0 0.02428962104022503
is O 0 0.011323892511427402
likely O 0 0.015115024521946907
to O 0 0.0076707229018211365
be O 0 0.008395715616643429
caused O 0 0.03780477121472359
by O 0 0.013427319005131721
homozygosity O 0 0.12250547111034393
for O 0 0.013657618314027786
a O 0 0.02807513251900673
Cys282Tyr O 1 0.9003850221633911
mutation O 0 0.12978388369083405
in O 0 0.01591700129210949
the O 0 0.0248672217130661
HFE O 1 0.9995970129966736
gene O 0 0.10407287627458572
located O 0 0.042638860642910004
4 O 0 0.03848071023821831
. O 0 0.027281804010272026

5 O 0 0.08995142579078674
Mb O 1 0.9599801301956177
telomeric O 1 0.9811510443687439
to O 0 0.0433889664709568
HLA O 1 0.9999139308929443
- O 0 0.10644211620092392
A O 0 0.04730784520506859
. O 0 0.03222055733203888

Population O 0 0.04370155930519104
studies O 0 0.027294263243675232
of O 0 0.007634737994521856
this O 0 0.011574863456189632
polymorphism O 0 0.0759899914264679
are O 0 0.008620934560894966
facilitated O 0 0.04113044962286949
by O 0 0.0071334317326545715
the O 0 0.00794412475079298
fact O 0 0.01258097868412733
that O 0 0.008167778141796589
the O 0 0.016820797696709633
Cys282Tyr O 1 0.9892585873603821
mutation O 0 0.19094137847423553
creates O 0 0.07415582239627838
a O 0 0.03530324250459671
Rsal O 1 0.7097476720809937
restriction O 0 0.064937062561512
site O 0 0.040140748023986816
. O 0 0.031517963856458664

We O 0 0.019245952367782593
have O 0 0.011695797555148602
studied O 0 0.027794785797595978
the O 0 0.022224707528948784
codon O 0 0.16154690086841583
282 O 0 0.19608601927757263
( O 0 0.09480062872171402
Cys O 1 0.9999822378158569
/ O 1 0.9973607659339905
Tyr O 1 0.9948845505714417
) O 0 0.03913275897502899
polymorphism O 0 0.07711225003004074
in O 0 0.011185064911842346
different O 0 0.007861052639782429
ethnic O 0 0.01852327398955822
groups O 0 0.029462363570928574
. O 0 0.029362069442868233

In O 0 0.017932645976543427
agreement O 0 0.017112158238887787
with O 0 0.00987898837774992
previous O 0 0.016844021156430244
observations O 0 0.028794173151254654
the O 0 0.018742399290204048
Tyr O 1 0.9988226294517517
allele O 0 0.14944949746131897
appeared O 0 0.026706600561738014
to O 0 0.009501905180513859
be O 0 0.009429765865206718
rare O 0 0.03343614190816879
or O 0 0.01978858932852745
absent O 0 0.05541832372546196
in O 0 0.01617514342069626
Asiatic O 1 0.9918971657752991
( O 0 0.023521188646554947
Indian O 0 0.02347971685230732
, O 0 0.010775953531265259
Chinese O 0 0.01919514127075672
) O 0 0.026385555043816566
populations O 0 0.06001715362071991
. O 0 0.027460705488920212

The O 0 0.03249955177307129
highest O 0 0.06842902302742004
allele O 0 0.17367908358573914
frequency O 0 0.07114151120185852
( O 0 0.029844870790839195
7 O 0 0.02425030805170536
. O 0 0.010063555091619492
5 O 0 0.023052772507071495
% O 0 0.019696012139320374
) O 0 0.016705140471458435
was O 0 0.011552540585398674
found O 0 0.013661691918969154
in O 0 0.012586134485900402
Swedes O 0 0.08684041351079941
. O 0 0.029781797900795937

Saamis O 1 0.6505728960037231
( O 0 0.044568855315446854
2 O 0 0.029192999005317688
% O 0 0.025799518451094627
) O 0 0.02328609861433506
and O 0 0.015439142473042011
Mordvinians O 0 0.4973432123661041
( O 0 0.030487053096294403
1 O 0 0.021035656332969666
. O 0 0.011859886348247528
8 O 0 0.024793410673737526
% O 0 0.023628782480955124
) O 0 0.019066473469138145
had O 0 0.017205987125635147
significantly O 0 0.04162510111927986
lower O 0 0.03652927652001381
frequencies O 0 0.03140918165445328
of O 0 0.009658532217144966
the O 0 0.023324359208345413
Tyr O 1 0.9985881447792053
allele O 0 0.24188648164272308
. O 0 0.04597344249486923

Comparisons O 0 0.07149709761142731
with O 0 0.026432253420352936
allele O 0 0.14178840816020966
frequencies O 0 0.051700446754693985
based O 0 0.020672587677836418
on O 0 0.01463105995208025
prevalence O 1 0.9552343487739563
estimates O 0 0.039484959095716476
of O 0 0.018369639292359352
HH B-Disease 1 0.9999997615814209
showed O 0 0.03227510675787926
some O 0 0.007999634370207787
disagreements O 0 0.026908239349722862
with O 0 0.010454562492668629
the O 0 0.01644788309931755
RFLP O 1 0.9433283805847168
data O 0 0.018278013914823532
, O 0 0.009957240894436836
particularly O 0 0.018063681200146675
in O 0 0.012301046401262283
Finns O 0 0.10166631639003754
. O 0 0.03176330775022507

The O 0 0.027471989393234253
newly O 0 0.05452821031212807
described O 0 0.06687939912080765
HFE O 1 0.9987599849700928
marker O 0 0.10773049294948578
provides O 0 0.03617238625884056
a O 0 0.013628923334181309
new O 0 0.011423157528042793
approach O 0 0.022593490779399872
to O 0 0.007651694118976593
the O 0 0.010818755254149437
screening O 0 0.06581146270036697
of O 0 0.01695392094552517
HH B-Disease 1 0.9999988079071045
as O 0 0.011233899742364883
well O 0 0.008426608517765999
as O 0 0.006101478822529316
studies O 0 0.012489947490394115
of O 0 0.005022391211241484
the O 0 0.009494811296463013
relationship O 0 0.026810554787516594
between O 0 0.01637425273656845
the O 0 0.02497413568198681
HFE O 1 0.9999666213989258
Tyr O 1 0.999681830406189
allele O 0 0.17613445222377777
and O 0 0.017819711938500404
different O 0 0.025665543973445892
disorders O 1 0.9999997615814209
including O 0 0.04461583122611046
cancer B-Disease 1 0.9999996423721313

Autosomal B-Disease 1 0.9996318817138672
dominant I-Disease 1 0.984900951385498
neurohypophyseal I-Disease 1 0.9999892711639404
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
associated O 0 0.0420883409678936
with O 0 0.0154953608289361
a O 0 0.03421245515346527
missense O 0 0.2223835438489914
mutation O 0 0.2025008499622345
encoding O 0 0.11717201769351959
Gly23 O 1 0.9986132383346558
- O 1 0.830888569355011
- O 0 0.18803413212299347
> O 0 0.27825692296028137
Val O 1 0.8714308142662048
in O 0 0.031619682908058167
neurophysin O 1 0.9602591395378113
II O 0 0.3425596058368683
. O 0 0.037148620933294296

Autosomal B-Disease 1 0.9990185499191284
dominant I-Disease 1 0.9757698178291321
neurohypophyseal I-Disease 1 0.999984622001648
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
( O 0 0.08447913825511932
ADNDI B-Disease 1 0.9996310472488403
) O 0 0.02172042801976204
is O 0 0.012330489233136177
an O 0 0.019185202196240425
inherited B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
caused O 1 0.9909493327140808
by O 0 0.023903731256723404
progressive O 1 0.9880542159080505
degeneration O 1 0.9999904632568359
of O 0 0.01642497070133686
the O 0 0.02690386213362217
magnocellular O 1 0.9994372725486755
neurons O 0 0.1308080404996872
of O 0 0.011223183013498783
the O 0 0.01650218479335308
hypothalamus O 1 0.73419588804245
leading O 0 0.02853078953921795
to O 0 0.012257677502930164
decreased O 0 0.04748137667775154
ability O 0 0.02450030855834484
to O 0 0.00974036194384098
produce O 0 0.018467340618371964
the O 0 0.02225535362958908
hormone O 1 0.9585513472557068
arginine O 1 0.6174813508987427
vasopressin O 1 0.9908275008201599
( O 0 0.07170400768518448
AVP O 1 0.9996325969696045
) O 0 0.04300213232636452
. O 0 0.02931864932179451

Affected O 0 0.08506174385547638
individuals O 0 0.026830121874809265
are O 0 0.008748778142035007
not O 0 0.014692343771457672
symptomatic O 1 0.9999856948852539
at O 0 0.02450697496533394
birth O 0 0.036858655512332916
, O 0 0.009359072893857956
but O 0 0.010312830097973347
usually O 0 0.023785943165421486
develop O 1 0.8946033716201782
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999992847442627
at O 0 0.0403590127825737
1 O 0 0.03399590030312538
- O 0 0.07887136191129684
6 O 0 0.050130147486925125
yr O 0 0.3280850052833557
of O 0 0.02047739364206791
age O 0 0.043757639825344086
. O 0 0.029857037588953972

The O 0 0.034873172640800476
genetic O 0 0.08493998646736145
locus O 0 0.10886453092098236
of O 0 0.011950181797146797
the O 0 0.020490648224949837
disease O 1 0.9999938011169434
is O 0 0.01724920980632305
the O 0 0.02186836116015911
AVP O 1 0.9999958276748657
- O 0 0.4012032151222229
neurophysin O 1 0.9938955903053284
II O 1 0.811898410320282
( O 0 0.060325738042593
NPII O 1 0.9962320923805237
) O 0 0.03722922131419182
gene O 0 0.06358245015144348
, O 0 0.012424147687852383
and O 0 0.013280757702887058
mutations O 0 0.0891958549618721
that O 0 0.017127079889178276
cause O 0 0.3471209406852722
ADNDI B-Disease 1 0.9977353811264038
have O 0 0.009891228750348091
been O 0 0.008087321184575558
found O 0 0.009668955579400063
in O 0 0.005825728178024292
both O 0 0.0065248762257397175
the O 0 0.011611515656113625
signal O 0 0.05262277275323868
peptide O 0 0.0802643820643425
of O 0 0.009409468621015549
the O 0 0.02148093655705452
prepro O 1 0.9981675148010254
- O 1 0.7592058777809143
AVP O 1 0.9999439716339111
- O 0 0.216226264834404
NPII O 1 0.9875631332397461
precursor O 0 0.09930653125047684
and O 0 0.013768881559371948
within O 0 0.021338166669011116
NPII O 1 0.9878907203674316
itself O 0 0.05203678831458092
. O 0 0.027814829722046852

An O 0 0.04443816468119621
affected O 0 0.07773609459400177
girl O 0 0.09089791774749756
who O 0 0.022610312327742577
presented O 0 0.022511791437864304
at O 0 0.017127208411693573
9 O 0 0.01962188258767128
months O 0 0.01428651250898838
of O 0 0.0073910546489059925
age O 0 0.020250054076313972
and O 0 0.008479468524456024
her O 0 0.020638147369027138
similarly O 0 0.04762910678982735
affected O 0 0.046409234404563904
younger O 0 0.041927505284547806
brother O 0 0.03136010095477104
and O 0 0.008298595435917377
father O 0 0.01690359227359295
were O 0 0.005522446241229773
all O 0 0.004755448084324598
found O 0 0.009900189936161041
to O 0 0.00658086221665144
have O 0 0.007926017045974731
a O 0 0.0177205391228199
novel O 0 0.04797027260065079
missense O 0 0.21397876739501953
mutation O 0 0.21224363148212433
( O 0 0.06031480059027672
G1758 O 1 0.9974188804626465
- O 1 0.9322185516357422
- O 1 0.5098227858543396
> O 1 0.7318084836006165
T O 1 0.666447103023529
) O 0 0.026885442435741425
encoding O 0 0.03999708592891693
the O 0 0.019095465540885925
amino O 0 0.08436665683984756
acid O 0 0.1886761337518692
substitution O 0 0.13915221393108368
Gly23 O 1 0.996059775352478
- O 1 0.6124897599220276
- O 0 0.18790137767791748
> O 0 0.31028756499290466
Val O 1 0.5931792259216309
within O 0 0.04984182491898537
NPII O 1 0.9767459630966187
. O 0 0.03569174185395241

The O 0 0.03743153065443039
mutation O 0 0.14992737770080566
was O 0 0.024309517815709114
confirmed O 0 0.031573571264743805
by O 0 0.017579741775989532
restriction O 0 0.07397415488958359
endonuclease O 0 0.3288938105106354
analysis O 0 0.045477934181690216
. O 0 0.02978181093931198

A O 0 0.08938232809305191
T1 O 1 0.9988501071929932
- O 0 0.10237033665180206
weighted O 0 0.0897819772362709
magnetic O 0 0.08895909041166306
resonance O 0 0.11099667847156525
imaging O 0 0.1030493974685669
of O 0 0.010550171136856079
the O 0 0.018735146149992943
fathers O 0 0.10733967274427414
pituitary O 1 0.9999688863754272
gland O 1 0.9999310970306396
demonstrates O 0 0.09006516635417938
an O 0 0.03471412882208824
attenuated O 1 0.997916042804718
posterior O 1 0.9997076392173767
pituitary O 1 0.999974250793457
bright O 0 0.47488051652908325
spot O 0 0.06550659239292145
. O 0 0.030624061822891235

This O 0 0.031676050275564194
mutation O 0 0.1274670511484146
may O 0 0.02089199237525463
be O 0 0.007260299287736416
valuable O 0 0.016011949628591537
for O 0 0.008313296362757683
developing O 0 0.03014187514781952
models O 0 0.03087141551077366
of O 0 0.014674213714897633
dominantly B-Disease 1 0.9966351389884949
inherited I-Disease 1 0.9999253749847412
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 0.013688062317669392
as O 0 0.006771454121917486
the O 0 0.008329762145876884
early O 0 0.017372414469718933
age O 0 0.020584220066666603
of O 0 0.015529731288552284
onset O 1 0.9999895095825195
of O 0 0.020144527778029442
symptoms O 1 1.0
suggests O 0 0.035976309329271317
that O 0 0.008407671935856342
this O 0 0.009996501728892326
mutation O 0 0.13408559560775757
may O 0 0.019432568922638893
be O 0 0.008692949078977108
particularly O 0 0.02221003547310829
deleterious O 0 0.1113949790596962
to O 0 0.014264717698097229
the O 0 0.023813974112272263
magnocellular O 1 0.9998263716697693
neuron O 1 0.9665359258651733
. O 0 0.022319519892334938
. O 0 0.028189459815621376

Frequent O 0 0.14346443116664886
inactivation O 1 0.520256519317627
of O 0 0.03264952450990677
PTEN O 1 0.9999970197677612
/ O 1 0.999777615070343
MMAC1 O 1 0.9989160299301147
in O 0 0.025025567039847374
primary O 1 0.9988848567008972
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04170224443078041

Sporadic B-Disease 1 0.9998146891593933
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.017574099823832512
the O 0 0.010078899562358856
most O 0 0.010720188729465008
common O 0 0.031039362773299217
male B-Disease 1 0.8746145367622375
cancer I-Disease 1 0.9999980926513672
in O 0 0.008887183852493763
the O 0 0.008083919994533062
Western O 0 0.01976858079433441
world O 0 0.01671190932393074
, O 0 0.007861551828682423
yet O 0 0.00947269331663847
many O 0 0.004313008394092321
of O 0 0.0047036889009177685
the O 0 0.010175333358347416
major O 0 0.021151382476091385
genetic O 0 0.051161762326955795
events O 0 0.019514063373208046
involved O 0 0.016435375437140465
in O 0 0.007952013052999973
the O 0 0.011620006524026394
progression O 1 0.6821785569190979
of O 0 0.008390025235712528
this O 0 0.012278958223760128
often O 0 0.04059949889779091
fatal O 1 0.9999998807907104
cancer B-Disease 1 0.9999996423721313
remain O 0 0.01779104396700859
to O 0 0.008896815590560436
be O 0 0.011773603968322277
elucidated O 0 0.12416784465312958
. O 0 0.02893812023103237

Numerous O 0 0.059393513947725296
cytogenetic O 1 0.9282569289207458
and O 0 0.025394171476364136
allelotype O 1 0.7527367472648621
studies O 0 0.03355924040079117
have O 0 0.012948707677423954
reported O 0 0.030690521001815796
frequent O 0 0.051299478858709335
loss O 0 0.046345971524715424
of O 0 0.015390720218420029
heterozygosity O 1 0.9837244749069214
on O 0 0.024990394711494446
chromosomal O 1 0.5231684446334839
arm O 1 0.9704082608222961
10q O 1 0.9740095734596252
in O 0 0.02812870405614376
sporadic B-Disease 1 0.9997888207435608
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04994173347949982

Deletion O 0 0.226457417011261
mapping O 0 0.1057412326335907
studies O 0 0.04024010896682739
have O 0 0.015011841431260109
unambiguously O 0 0.06505198776721954
identified O 0 0.022009778767824173
a O 0 0.01598370261490345
region O 0 0.0293431393802166
of O 0 0.013711851090192795
chromosome O 0 0.15448333323001862
10q23 O 0 0.1170506626367569
to O 0 0.00919854361563921
be O 0 0.007203316316008568
the O 0 0.009601504541933537
minimal O 0 0.04355049878358841
area O 0 0.020564962178468704
of O 0 0.011738806031644344
loss O 0 0.07303847372531891
. O 0 0.029317300766706467

A O 0 0.059163838624954224
new O 0 0.05348162725567818
tumor B-Disease 1 0.9998701810836792
suppressor O 1 0.9771046042442322
gene O 0 0.13502664864063263
, O 0 0.045056987553834915
PTEN O 1 0.9999889135360718
/ O 1 0.9993734955787659
MMAC1 O 1 0.9877061247825623
, O 0 0.01613795757293701
was O 0 0.018014801666140556
isolated O 0 0.05580908805131912
recently O 0 0.025705114006996155
at O 0 0.014031200669705868
this O 0 0.007847998291254044
region O 0 0.026896698400378227
of O 0 0.014460588805377483
chromosome O 0 0.15457171201705933
10q23 O 0 0.14437095820903778
and O 0 0.010700449347496033
found O 0 0.011792503297328949
to O 0 0.008112229406833649
be O 0 0.010188327170908451
inactivated O 0 0.10186415910720825
by O 0 0.016803724691271782
mutation O 0 0.10156215727329254
in O 0 0.01825638674199581
three O 0 0.033553704619407654
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.4530385732650757
lines O 0 0.04356340318918228
. O 0 0.02593412436544895

We O 0 0.04191751778125763
screened O 0 0.12448642402887344
80 O 0 0.15003730356693268
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999959468841553
by O 0 0.02755032107234001
microsatellite O 0 0.45347338914871216
analysis O 0 0.032981231808662415
and O 0 0.012799854390323162
found O 0 0.026608221232891083
chromosome O 0 0.12948180735111237
10q23 O 0 0.12317516654729843
to O 0 0.011674859561026096
be O 0 0.009086384437978268
deleted O 0 0.033248502761125565
in O 0 0.012480439618229866
23 O 0 0.030515380203723907
cases O 0 0.030431024730205536
. O 0 0.026676664128899574

We O 0 0.020785482600331306
then O 0 0.016711315140128136
proceeded O 0 0.029682744294404984
with O 0 0.010827360674738884
sequence O 0 0.024323511868715286
analysis O 0 0.016366899013519287
of O 0 0.006942324806004763
the O 0 0.0149123165756464
entire O 0 0.06304483860731125
PTEN O 1 0.9999873638153076
/ O 1 0.9986326098442078
MMAC1 O 1 0.9900661706924438
coding O 0 0.1319562941789627
region O 0 0.03618719428777695
and O 0 0.013030298054218292
tested O 0 0.06570345163345337
for O 0 0.01755547896027565
homozygous O 0 0.1145058125257492
deletion O 0 0.10892785340547562
with O 0 0.016577577218413353
new O 0 0.02234135940670967
intragenic O 1 0.6044266819953918
markers O 0 0.05807152017951012
in O 0 0.010720709338784218
these O 0 0.007783794775605202
23 O 0 0.02315758354961872
cases O 0 0.020877601578831673
with O 0 0.01729341596364975
10q23 O 1 0.7187778949737549
loss O 0 0.073837049305439
of O 0 0.022847557440400124
heterozygosity O 1 0.994097113609314
. O 0 0.04433674365282059

The O 0 0.02040393091738224
identification O 0 0.02763209491968155
of O 0 0.007607038598507643
the O 0 0.010705649852752686
second O 0 0.03124264068901539
mutational O 1 0.9511412382125854
event O 0 0.0397316999733448
in O 0 0.012060095556080341
10 O 0 0.017609192058444023
( O 0 0.025780094787478447
43 O 0 0.04377147927880287
% O 0 0.04032731056213379
) O 0 0.05493270978331566
tumors B-Disease 1 0.9999985694885254
establishes O 1 0.9958011507987976
PTEN O 1 0.9999938011169434
/ O 1 0.9987754225730896
MMAC1 O 1 0.9220132231712341
as O 0 0.014178476296365261
a O 0 0.017857348546385765
main O 0 0.030699843540787697
inactivation O 0 0.13772155344486237
target O 0 0.03138158842921257
of O 0 0.012959134764969349
10q O 1 0.910355269908905
loss O 0 0.14162114262580872
in O 0 0.023993927985429764
sporadic B-Disease 1 0.9998780488967896
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.022017791867256165
. O 0 0.02813984453678131

Risk O 1 0.9553513526916504
reversals O 0 0.12195894867181778
in O 0 0.021743834018707275
predictive O 0 0.134503573179245
testing O 0 0.08259814232587814
for O 0 0.030000435188412666
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0351649671792984

The O 0 0.021168019622564316
first O 0 0.02506713941693306
predictive O 0 0.1205216720700264
testing O 0 0.07933946698904037
for O 0 0.03471392020583153
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.04931216686964035
HD B-Disease 0 0.3749653398990631
) O 0 0.017488833516836166
was O 0 0.01014883816242218
based O 0 0.010733198374509811
on O 0 0.007245813030749559
analysis O 0 0.01861102506518364
of O 0 0.010823174379765987
linked O 0 0.09176945686340332
polymorphic O 1 0.6457582712173462
DNA O 0 0.08609166741371155
markers O 0 0.05449562147259712
to O 0 0.00954580120742321
estimate O 0 0.023042166605591774
the O 0 0.012340283952653408
likelihood O 0 0.04959547147154808
of O 0 0.011187590658664703
inheriting O 0 0.1066807210445404
the O 0 0.021985722705721855
mutation O 0 0.1292259842157364
for O 0 0.02335505746304989
HD B-Disease 0 0.2119493931531906
. O 0 0.03576069697737694

Limits O 0 0.04563140124082565
to O 0 0.013370538130402565
accuracy O 0 0.033432524651288986
included O 0 0.018532073125243187
recombination O 0 0.096019446849823
between O 0 0.013566333800554276
the O 0 0.012904804199934006
DNA O 0 0.060886140912771225
markers O 0 0.05500449612736702
and O 0 0.010429770685732365
the O 0 0.01567341387271881
mutation O 0 0.1205664724111557
, O 0 0.01897215098142624
pedigree O 0 0.09442876279354095
structure O 0 0.02273571863770485
, O 0 0.008728069253265858
and O 0 0.007664945907890797
whether O 0 0.014768537133932114
DNA O 0 0.0439780130982399
samples O 0 0.025840777903795242
were O 0 0.0069301798939704895
available O 0 0.009327559731900692
from O 0 0.010158766992390156
family O 0 0.020174076780676842
members O 0 0.01411793939769268
. O 0 0.02175118960440159

With O 0 0.021683812141418457
direct O 0 0.028612609952688217
tests O 0 0.0293289627879858
for O 0 0.00879919808357954
the O 0 0.015935901552438736
HD B-Disease 1 0.5608375668525696
mutation O 0 0.11911217868328094
, O 0 0.011658146977424622
we O 0 0.007471307180821896
have O 0 0.007255108095705509
assessed O 0 0.025920839980244637
the O 0 0.007838373072445393
accuracy O 0 0.0219565462321043
of O 0 0.006611150689423084
results O 0 0.01759248599410057
obtained O 0 0.01605268009006977
by O 0 0.013107286766171455
linkage O 0 0.10791286081075668
approaches O 0 0.044347357004880905
when O 0 0.013105529360473156
requested O 0 0.022382454946637154
to O 0 0.008536986075341702
do O 0 0.008548560552299023
so O 0 0.007011414039880037
by O 0 0.005731032229959965
the O 0 0.009925696067512035
test O 0 0.04066161438822746
individuals O 0 0.02537929266691208
. O 0 0.026211678981781006

For O 0 0.014429876580834389
six O 0 0.01422097533941269
such O 0 0.008777523413300514
individuals O 0 0.016226505860686302
, O 0 0.008287843316793442
there O 0 0.007235404569655657
was O 0 0.010843459516763687
significant O 0 0.01738346368074417
disparity O 0 0.05866673216223717
between O 0 0.011551722884178162
the O 0 0.014755860902369022
tests O 0 0.05095374956727028
. O 0 0.025442445650696754

Three O 0 0.022767342627048492
went O 0 0.02805369161069393
from O 0 0.012624675408005714
a O 0 0.021593550220131874
decreased O 0 0.15838000178337097
risk O 0 0.09789590537548065
to O 0 0.010114644654095173
an O 0 0.012165023945271969
increased O 0 0.031057175248861313
risk O 0 0.37943410873413086
, O 0 0.008246059529483318
while O 0 0.007383082527667284
in O 0 0.005813741125166416
another O 0 0.011577009223401546
three O 0 0.008890573866665363
the O 0 0.014017563313245773
risk O 0 0.44323304295539856
was O 0 0.02382970228791237
decreased O 0 0.08126110583543777
. O 0 0.027522919699549675

Knowledge O 0 0.032275356352329254
of O 0 0.008296885527670383
the O 0 0.009114472195506096
potential O 0 0.02436903305351734
reasons O 0 0.013124531134963036
for O 0 0.004873967729508877
these O 0 0.0052223228849470615
changes O 0 0.010010678321123123
in O 0 0.006405678112059832
results O 0 0.01621289923787117
and O 0 0.0062769087962806225
impact O 0 0.01878553070127964
of O 0 0.005893009714782238
these O 0 0.009971502237021923
risk O 1 0.7861068844795227
reversals O 0 0.0822163075208664
on O 0 0.008745122700929642
both O 0 0.012177928350865841
patients O 1 0.9998323917388916
and O 0 0.008142727427184582
the O 0 0.01180584728717804
counseling O 1 0.9936773180961609
team O 0 0.021058136597275734
can O 0 0.010310717858374119
assist O 0 0.023012110963463783
in O 0 0.006384356878697872
the O 0 0.006997589487582445
development O 0 0.012680365703999996
of O 0 0.006859891582280397
strategies O 0 0.03723207488656044
for O 0 0.00736036105081439
the O 0 0.013181833550333977
prevention O 1 0.9986034035682678
and O 0 0.008227362297475338
, O 0 0.0069593945518136024
where O 0 0.00933118723332882
necessary O 0 0.01350885909050703
, O 0 0.009344277903437614
management O 0 0.026185549795627594
of O 0 0.007120639085769653
a O 0 0.020796941593289375
risk O 1 0.905452311038971
reversal O 0 0.06980244815349579
in O 0 0.010962395928800106
any O 0 0.014886210672557354
predictive O 0 0.11131498217582703
testing O 0 0.06079844385385513
program O 0 0.03605000674724579
. O 0 0.014531276188790798
. O 0 0.020441994071006775

A O 0 0.05522441118955612
novel O 0 0.05444268137216568
common O 0 0.06376613676548004
missense O 0 0.293844610452652
mutation O 0 0.20448561012744904
G301C O 0 0.1370864361524582
in O 0 0.014324179850518703
the O 0 0.019341621547937393
N O 0 0.11493333429098129
- O 0 0.1080830916762352
acetylgalactosamine O 1 0.943024218082428
- O 0 0.13375721871852875
6 O 0 0.08150031417608261
- O 1 0.7207853198051453
sulfate O 1 0.9997144341468811
sulfatase O 1 0.9998121857643127
gene O 0 0.13006673753261566
in O 0 0.03084319643676281
mucopolysaccharidosis B-Disease 1 0.9970165491104126
IVA I-Disease 1 0.999812662601471
. O 0 0.047307658940553665

Mucopolysaccharidosis B-Disease 1 0.9979920387268066
IVA I-Disease 1 0.9998772144317627
( O 0 0.09081458300352097
MPS B-Disease 1 0.988529622554779
IVA I-Disease 1 0.9999833106994629
) O 0 0.03324389457702637
is O 0 0.016956130042672157
an O 0 0.02800668217241764
autosomal B-Disease 1 0.9999644756317139
recessive I-Disease 1 0.9999973773956299
lysosomal I-Disease 1 0.9999997615814209
storage I-Disease 1 0.9999021291732788
disorder I-Disease 1 1.0
caused O 0 0.3083352744579315
by O 0 0.014369761571288109
a O 0 0.028253741562366486
genetic B-Disease 1 0.9676571488380432
defect I-Disease 1 0.9998679161071777
in O 0 0.02446725033223629
N O 0 0.35285723209381104
- O 0 0.12817636132240295
acetylgalactosamine O 1 0.9774061441421509
- O 0 0.15428540110588074
6 O 0 0.0781874880194664
- O 1 0.8179800510406494
sulfate O 1 0.9998263716697693
sulfatase O 1 0.9999371767044067
( O 0 0.0797366350889206
GALNS O 1 0.9948144555091858
) O 0 0.0348990373313427
. O 0 0.025436999276280403

In O 0 0.019446542486548424
previous O 0 0.02470402978360653
studies O 0 0.023496078327298164
, O 0 0.009436003863811493
we O 0 0.0067358845844864845
have O 0 0.006756569724529982
found O 0 0.009774119593203068
two O 0 0.007755243685096502
common O 0 0.03107813000679016
mutations O 0 0.09279980510473251
in O 0 0.01659419760107994
Caucasians O 1 0.5065514445304871
and O 0 0.012671038508415222
Japanese O 0 0.024813342839479446
, O 0 0.012171409092843533
respectively O 0 0.02911362051963806
. O 0 0.025152642279863358

To O 0 0.026020146906375885
characterize O 0 0.09595709294080734
the O 0 0.02905663475394249
mutational O 1 0.9476395845413208
spectrum O 0 0.05920131877064705
in O 0 0.008955787867307663
various O 0 0.007720016408711672
ethnic O 0 0.015294630080461502
groups O 0 0.018805619329214096
, O 0 0.014033515937626362
mutations O 0 0.07351180911064148
in O 0 0.01301898155361414
the O 0 0.018911413848400116
GALNS O 1 0.9957273006439209
gene O 0 0.08481226116418839
in O 0 0.020115183666348457
Colombian O 0 0.11016003042459488
MPS B-Disease 1 0.999702513217926
IVA I-Disease 1 1.0
patients O 1 0.9999653100967407
were O 0 0.014298470690846443
investigated O 0 0.05060901492834091
, O 0 0.012550952844321728
and O 0 0.011499114334583282
genetic O 0 0.054987940937280655
backgrounds O 0 0.03310280665755272
were O 0 0.008857780136168003
extensively O 0 0.025975851342082024
analyzed O 0 0.02947058156132698
to O 0 0.010923507623374462
identify O 0 0.029170438647270203
racial O 0 0.03314447030425072
origin O 0 0.01669621653854847
, O 0 0.00920980516821146
based O 0 0.013562295585870743
on O 0 0.013808968476951122
mitochondrial O 0 0.11441247910261154
DNA O 0 0.08863797038793564
( O 0 0.04404512420296669
mtDNA O 0 0.14250369369983673
) O 0 0.037968795746564865
lineages O 0 0.09837236255407333
. O 0 0.03541254252195358

Three O 0 0.03656342998147011
novel O 0 0.07746382802724838
missense O 0 0.38305434584617615
mutations O 0 0.13293343782424927
never O 0 0.03334110230207443
identified O 0 0.02297057956457138
previously O 0 0.013927116990089417
in O 0 0.007255485747009516
other O 0 0.007033861707895994
populations O 0 0.028848987072706223
and O 0 0.007643179502338171
found O 0 0.012018012814223766
in O 0 0.0071267238818109035
16 O 0 0.013052123598754406
out O 0 0.009520812891423702
of O 0 0.009067218750715256
19 O 0 0.03574042767286301
Colombian O 0 0.091258704662323
MPS B-Disease 1 0.9893237948417664
IVA I-Disease 1 0.9999940395355225
unrelated O 0 0.10076557099819183
alleles O 0 0.1323661357164383
account O 0 0.026199212297797203
for O 0 0.015611096285283566
84 O 0 0.07384754717350006
. O 0 0.025695955380797386

2 O 0 0.03856155648827553
% O 0 0.019328411668539047
of O 0 0.008534609340131283
the O 0 0.01317423116415739
alleles O 0 0.10049907118082047
in O 0 0.012362690642476082
this O 0 0.009079736657440662
study O 0 0.02665391005575657
. O 0 0.02268715389072895

The O 0 0.03610381484031677
G301C O 0 0.1621466875076294
and O 0 0.025689641013741493
S162F O 0 0.19078747928142548
mutations O 0 0.10922744125127792
account O 0 0.023743897676467896
for O 0 0.014732621610164642
68 O 0 0.0693727657198906
. O 0 0.028058672323822975

4 O 0 0.04468844085931778
% O 0 0.026012755930423737
and O 0 0.012477125972509384
10 O 0 0.02254095859825611
. O 0 0.023640785366296768

5 O 0 0.04458193480968475
% O 0 0.0262648593634367
of O 0 0.013232486322522163
mutations O 0 0.08375606685876846
, O 0 0.012655049562454224
respectively O 0 0.020445851609110832
, O 0 0.010043498128652573
whereas O 0 0.023795049637556076
the O 0 0.009546901099383831
remaining O 0 0.02628692053258419
F69V O 1 0.8365309834480286
is O 0 0.013936562463641167
limited O 0 0.018500633537769318
to O 0 0.00828210636973381
a O 0 0.017824864014983177
single O 0 0.039571620523929596
allele O 0 0.1664676070213318
. O 0 0.04019654542207718

The O 0 0.04049506038427353
skewed O 0 0.13612450659275055
prevalence O 1 0.7696369290351868
of O 0 0.018763357773423195
G301C O 0 0.12202775478363037
in O 0 0.013364054262638092
only O 0 0.01346448715776205
Colombian O 0 0.09110871702432632
patients O 1 0.9997727274894714
and O 0 0.02251918986439705
haplotype O 1 0.9732159972190857
analysis O 0 0.030073054134845734
by O 0 0.016084443777799606
restriction O 0 0.05528058856725693
fragment O 0 0.09221982955932617
length O 0 0.04571342095732689
polymorphisms O 0 0.10811910778284073
in O 0 0.015380238182842731
the O 0 0.021694527938961983
GALNS O 1 0.9992269277572632
gene O 0 0.0869034007191658
suggest O 0 0.03353382274508476
that O 0 0.013782888650894165
G301C O 0 0.12124058604240417
originated O 0 0.03587076812982559
from O 0 0.010186096653342247
a O 0 0.015349903143942356
common O 0 0.026697520166635513
ancestor O 0 0.0703178197145462
. O 0 0.0304041039198637

Investigation O 0 0.05002467334270477
of O 0 0.010627192445099354
the O 0 0.016406092792749405
genetic O 0 0.06152671203017235
background O 0 0.0314333401620388
by O 0 0.011100087314844131
means O 0 0.02013172209262848
of O 0 0.013333362527191639
mtDNA O 0 0.13583873212337494
lineages O 0 0.09334947913885117
indicate O 0 0.029219163581728935
that O 0 0.006867321208119392
all O 0 0.006123445462435484
our O 0 0.015324225649237633
patients O 1 0.9996893405914307
are O 0 0.007421826012432575
probably O 0 0.016559908166527748
of O 0 0.007375325076282024
native O 0 0.024380618706345558
American O 0 0.04319862648844719
descent O 0 0.13518421351909637

Low O 0 0.09996090829372406
frequency O 0 0.07810940593481064
of O 0 0.02742047980427742
BRCA1 O 1 0.9985125660896301
germline O 1 0.9488994479179382
mutations O 0 0.1288793832063675
in O 0 0.018781231716275215
45 O 0 0.04652245715260506
German O 1 0.9996203184127808
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.04712127894163132
. O 0 0.030202923342585564

In O 0 0.01710348203778267
this O 0 0.010015470907092094
study O 0 0.023052165284752846
we O 0 0.011927559040486813
investigated O 0 0.048994600772857666
45 O 0 0.05232248082756996
German O 1 0.9991928935050964
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.04424838721752167
for O 0 0.021878419443964958
germline O 1 0.9616264700889587
mutations O 0 0.10624329000711441
in O 0 0.01504923589527607
the O 0 0.026645418256521225
BRCA1 O 1 0.9987389445304871
gene O 0 0.15147720277309418
. O 0 0.03845538571476936

We O 0 0.02427961491048336
identified O 0 0.031879622489213943
four O 0 0.026710787788033485
germline O 1 0.5977270603179932
mutations O 0 0.10655471682548523
in O 0 0.014297234825789928
three O 0 0.023426171392202377
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.023891225457191467
and O 0 0.007635313551872969
in O 0 0.010112362913787365
one O 0 0.05391688644886017
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.039184678345918655
. O 0 0.008172948844730854
among O 0 0.008857646957039833
these O 0 0.005320859607309103
were O 0 0.008576666004955769
one O 0 0.021780814975500107
frameshift O 1 0.9801658391952515
mutation O 0 0.14854514598846436
, O 0 0.017597496509552002
one O 0 0.01808677613735199
nonsense O 0 0.08780359476804733
mutation O 0 0.10707618296146393
, O 0 0.013788864016532898
one O 0 0.015835728496313095
novel O 0 0.041441675275564194
splice O 0 0.17621225118637085
site O 0 0.048191800713539124
mutation O 0 0.11128029972314835
, O 0 0.0141276391223073
and O 0 0.01325079333037138
one O 0 0.024387836456298828
missense O 0 0.218955859541893
mutation O 0 0.19166824221611023
. O 0 0.03748909384012222

The O 0 0.05025181919336319
missense O 0 0.23920811712741852
mutation O 0 0.13180029392242432
was O 0 0.019222721457481384
also O 0 0.010688936337828636
found O 0 0.012530269101262093
in O 0 0.009898839518427849
2 O 0 0.028065389022231102
. O 0 0.02189793810248375

8 O 0 0.04499337822198868
% O 0 0.01906745322048664
of O 0 0.007028814870864153
the O 0 0.008176092989742756
general O 0 0.015529674477875233
population O 0 0.020640207454562187
, O 0 0.011148743331432343
suggesting O 0 0.02781795524060726
that O 0 0.0060496143996715546
it O 0 0.0069193849340081215
is O 0 0.010539035312831402
not O 0 0.01391846127808094
disease O 1 0.9999974966049194
associated O 0 0.03473382815718651
. O 0 0.027921659871935844

The O 0 0.02486308664083481
average O 0 0.04521869868040085
age O 0 0.03457115963101387
of O 0 0.021496525034308434
disease O 1 1.0
onset O 1 0.9999908208847046
in O 0 0.01328170858323574
those O 0 0.013999669812619686
families O 0 0.04035365208983421
harbouring O 1 0.9997281432151794
causative O 1 0.997497022151947
mutations O 0 0.12036672979593277
was O 0 0.0202118419110775
between O 0 0.01778215542435646
32 O 0 0.04347696155309677
. O 0 0.0264945887029171

3 O 0 0.041251879185438156
and O 0 0.01598726399242878
37 O 0 0.05208547040820122
. O 0 0.02593066543340683

4 O 0 0.04526030272245407
years O 0 0.01811649091541767
, O 0 0.011721168644726276
whereas O 0 0.024633299559354782
the O 0 0.011831175535917282
family O 0 0.033064454793930054
harbouring O 1 0.9574047327041626
the O 0 0.02703981287777424
missense O 0 0.2191825658082962
mutation O 0 0.1455538421869278
had O 0 0.019499266520142555
an O 0 0.01261779386550188
average O 0 0.0338016040623188
age O 0 0.02686178684234619
of O 0 0.01290096528828144
onset O 1 0.9990711212158203
of O 0 0.015143608674407005
51 O 0 0.05723517760634422
. O 0 0.030734512954950333

2 O 0 0.046884965151548386
years O 0 0.02893723174929619
. O 0 0.030242284759879112

These O 0 0.016661617904901505
findings O 0 0.03850680962204933
show O 0 0.02519860677421093
that O 0 0.014458012767136097
BRCA1 O 1 0.9947856068611145
is O 0 0.019646432250738144
implicated O 0 0.05561365187168121
in O 0 0.009479353204369545
a O 0 0.012506184168159962
small O 0 0.015190012753009796
fraction O 0 0.04460407420992851
of O 0 0.026043513789772987
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.03792861849069595
suggesting O 0 0.03277750313282013
the O 0 0.010692345909774303
involvement O 0 0.04542765021324158
of O 0 0.011890066787600517
another O 0 0.041420117020606995
susceptibility O 1 0.9870045781135559
gene O 0 0.12194537371397018
( O 0 0.05457117035984993
s O 0 0.20654931664466858
) O 0 0.05391034111380577

Paternal O 0 0.40063661336898804
transmission O 1 0.7934781312942505
of O 0 0.05533881485462189
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0603199303150177

We O 0 0.020882852375507355
report O 0 0.018419289961457253
a O 0 0.01927860453724861
rare O 0 0.03520922362804413
case O 0 0.019656069576740265
of O 0 0.019863100722432137
paternally O 1 0.9994433522224426
transmitted O 1 0.9999456405639648
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999177873134613
DM B-Disease 1 1.0
) O 0 0.04852369800209999
. O 0 0.027155179530382156

The O 0 0.03567354381084442
proband O 0 0.15806718170642853
is O 0 0.015570024028420448
a O 0 0.015313493087887764
23 O 0 0.021562080830335617
year O 0 0.01530260406434536
old O 0 0.031325340270996094
, O 0 0.024559473618865013
mentally B-Disease 1 0.999998927116394
retarded I-Disease 1 0.9999901056289673
male O 1 0.8174590468406677
who O 1 0.7905372381210327
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 0.9999998807907104
weakness I-Disease 1 0.9999872446060181
. O 0 0.03693210706114769

He O 0 0.025575406849384308
presented O 0 0.03277137503027916
with O 0 0.02293359860777855
respiratory O 1 1.0
and O 0 0.017128026112914085
feeding O 0 0.07989050447940826
difficulties O 0 0.07028544694185257
at O 0 0.029399853199720383
birth O 0 0.056992143392562866
. O 0 0.029620345681905746

His O 0 0.03308100998401642
two O 0 0.03036576695740223
sibs O 1 0.9998393058776855
suffer O 1 0.999756395816803
from O 0 0.041331809014081955
childhood O 1 0.9999576807022095
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
. O 0 0.0565231591463089

Their O 0 0.019536646082997322
late O 0 0.02728605456650257
father O 0 0.024137243628501892
had O 0 0.014580960385501385
the O 0 0.01168578676879406
adult O 0 0.04615086689591408
type O 0 0.06377099454402924
of O 0 0.022758454084396362
DM B-Disease 1 1.0
, O 0 0.021131690591573715
with O 0 0.020221730694174767
onset O 1 0.9993730187416077
around O 0 0.022696053609251976
30 O 0 0.022513089701533318
years O 0 0.018492912873625755
. O 0 0.024860944598913193

Only O 0 0.016840357333421707
six O 0 0.015176215209066868
other O 0 0.008354858495295048
cases O 0 0.018148036673665047
of O 0 0.011731723323464394
paternal O 0 0.14851120114326477
transmission O 1 0.8339524865150452
of O 0 0.02985522150993347
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.01630059815943241
been O 0 0.013821584172546864
reported O 0 0.029095591977238655
recently O 0 0.03475155681371689
. O 0 0.024996235966682434

We O 0 0.02067410759627819
review O 0 0.019735421985387802
the O 0 0.012065772898495197
sex O 0 0.0408119298517704
related O 0 0.03035973198711872
effects O 0 0.0637483075261116
on O 0 0.013594888150691986
transmission O 0 0.10705356299877167
of O 0 0.03520776703953743
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.04873521998524666

Decreased O 1 0.5578745007514954
fertility O 0 0.38863199949264526
of O 0 0.016075903549790382
males O 0 0.05997120961546898
with O 0 0.023262809962034225
adult O 1 0.6949508190155029
onset O 1 0.9999997615814209
DM B-Disease 1 1.0
and O 0 0.021350348368287086
contraction O 0 0.0723411813378334
of O 0 0.0090129179880023
the O 0 0.013769191689789295
repeat O 0 0.06589499861001968
upon O 0 0.02248297445476055
male O 0 0.060067176818847656
transmission O 0 0.08363398164510727
contribute O 0 0.037192452698946
to O 0 0.008386312052607536
the O 0 0.010168351233005524
almost O 0 0.019902635365724564
absent O 0 0.06048925220966339
occurrence O 0 0.0703492984175682
of O 0 0.014329591765999794
paternal O 0 0.13274261355400085
transmission O 0 0.4437743127346039
of O 0 0.039031755179166794
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.054193396121263504

Also O 0 0.01963958889245987
the O 0 0.011320860125124454
fathers O 0 0.03368544206023216
of O 0 0.008601434528827667
the O 0 0.014255402609705925
reported O 0 0.05519498139619827
congenitally O 1 0.9996693134307861
affected O 0 0.07222354412078857
children O 0 0.03359907120466232
showed O 0 0.026812676340341568
, O 0 0.008786465041339397
on O 0 0.00785311684012413
average O 0 0.02821510285139084
, O 0 0.018010564148426056
shorter O 0 0.08435246348381042
CTG O 1 0.9965555667877197
repeat O 0 0.09930560737848282
lengths O 0 0.061184704303741455
and O 0 0.015941869467496872
hence O 0 0.04173024743795395
less O 0 0.03736880421638489
severe O 1 0.9999995231628418
clinical O 1 0.9999992847442627
symptoms O 1 0.9999998807907104
than O 0 0.011806308291852474
the O 0 0.012230273336172104
mothers O 0 0.06571266055107117
of O 0 0.01048368401825428
children O 0 0.039124369621276855
with O 0 0.04540498927235603
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.052270568907260895

We O 0 0.026965651661157608
conclude O 0 0.05405740439891815
that O 0 0.014489981345832348
paternal O 0 0.11438810080289841
transmission O 0 0.1655654013156891
of O 0 0.03590825945138931
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.02568439021706581
rare O 0 0.04230998083949089
and O 0 0.013848922215402126
preferentially O 0 0.12290861457586288
occurs O 0 0.05330418795347214
with O 0 0.020409945398569107
onset O 1 0.9999338388442993
of O 0 0.02917022816836834
DM B-Disease 1 1.0
past O 0 0.02737635187804699
30 O 0 0.01539879385381937
years O 0 0.009146632626652718
in O 0 0.006637634243816137
the O 0 0.009272611699998379
father O 0 0.025011394172906876
. O 0 0.013267111964523792
. O 0 0.022904934361577034

The O 0 0.05998266860842705
RB1 O 1 0.9999164342880249
gene O 0 0.14909949898719788
mutation O 0 0.1297919750213623
in O 0 0.013248990289866924
a O 0 0.023316342383623123
child O 0 0.05757035315036774
with O 0 0.039547208696603775
ectopic B-Disease 1 0.9999747276306152
intracranial I-Disease 1 0.9999980926513672
retinoblastoma I-Disease 1 0.9999767541885376
. O 0 0.055140312761068344

The O 0 0.07172609120607376
RB1 O 1 0.9999363422393799
gene O 0 0.16142496466636658
mutation O 0 0.1533469259738922
was O 0 0.02409267984330654
investigated O 0 0.04273154214024544
in O 0 0.01010157074779272
a O 0 0.016693701967597008
child O 0 0.047776542603969574
with O 0 0.025683065876364708
ectopic B-Disease 1 0.9999866485595703
intracranial I-Disease 1 0.9999953508377075
retinoblastoma I-Disease 1 0.9998878240585327
using O 0 0.025415845215320587
DNA O 0 0.046742457896471024
obtained O 0 0.0158074963837862
from O 0 0.008582117967307568
both O 0 0.008565482683479786
the O 0 0.016908247023820877
pineal B-Disease 1 0.9999816417694092
and I-Disease 0 0.031277213245630264
retinal I-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999958276748657
of O 0 0.01385052502155304
the O 0 0.020192353054881096
patient O 1 0.9994114637374878
. O 0 0.03005019761621952

A O 0 0.07633114606142044
nonsense O 0 0.12979057431221008
mutation O 0 0.1468706578016281
in O 0 0.028190478682518005
exon O 0 0.159327894449234
17 O 0 0.06267254799604416
( O 0 0.052181050181388855
codon O 0 0.150493323802948
556 O 0 0.1469125598669052
) O 0 0.02326255664229393
of O 0 0.010662625543773174
the O 0 0.025758033618330956
RB1 O 1 0.9999774694442749
gene O 0 0.07804940640926361
was O 0 0.014117203652858734
found O 0 0.010347803123295307
to O 0 0.006919289007782936
be O 0 0.0068784235045313835
present O 0 0.014768032357096672
homozygously O 0 0.10702314227819443
in O 0 0.008335699327290058
both O 0 0.009082990698516369
the O 0 0.01610005646944046
retinal B-Disease 1 0.9999768733978271
and I-Disease 0 0.01760452799499035
the I-Disease 0 0.028667256236076355
pineal I-Disease 1 0.9999982118606567
tumours I-Disease 1 0.9999979734420776
. O 0 0.04548364132642746

The O 0 0.02532128617167473
same O 0 0.025704313069581985
mutation O 0 0.10684723407030106
was O 0 0.018763994798064232
present O 0 0.019908107817173004
heterozygously O 0 0.11368333548307419
in O 0 0.010071756318211555
the O 0 0.011250087060034275
DNA O 0 0.03607860207557678
from O 0 0.008876572363078594
the O 0 0.00896152202039957
constitutional O 0 0.0187868382781744
cells O 0 0.04747750237584114
of O 0 0.007979187183082104
the O 0 0.0158497653901577
patient O 1 0.9995532631874084
, O 0 0.014178655110299587
proving O 0 0.036671195179224014
it O 0 0.005817085038870573
to O 0 0.006469779182225466
be O 0 0.006774956826120615
of O 0 0.010914118029177189
germline O 0 0.2417919784784317
origin O 0 0.04041924327611923
. O 0 0.028518998995423317

The O 0 0.0323006771504879
initial O 0 0.07255420088768005
mutation O 0 0.1238948181271553
was O 0 0.018752822652459145
shown O 0 0.018305843695998192
to O 0 0.007104832679033279
have O 0 0.009088038466870785
occurred O 0 0.025948170572519302
in O 0 0.01007069181650877
the O 0 0.01754816807806492
paternally O 0 0.23852145671844482
derived O 0 0.10647625476121902
RB1 O 1 0.9998729228973389
allele O 0 0.22538679838180542
. O 0 0.04427344352006912

The O 0 0.03295397385954857
mutation O 0 0.10490293800830841
is O 0 0.011269090697169304
in O 0 0.007570033892989159
an O 0 0.00905249547213316
area O 0 0.015608609654009342
of O 0 0.00671784533187747
the O 0 0.012637955136597157
gene O 0 0.054231543093919754
that O 0 0.011204720474779606
encodes O 0 0.056038666516542435
the O 0 0.019496619701385498
protein O 0 0.07844475656747818
- O 0 0.0663607195019722
binding O 0 0.04268409311771393
region O 0 0.029266947880387306
known O 0 0.01750917173922062
as O 0 0.007812902331352234
the O 0 0.011682752519845963
pocket O 0 0.09496800601482391
region O 0 0.02967514470219612
and O 0 0.009442140348255634
has O 0 0.01077875867486
been O 0 0.012507031671702862
detected O 0 0.04594592750072479
in O 0 0.0072160265408456326
other O 0 0.006144812796264887
cases O 0 0.01908200792968273
of O 0 0.01461564190685749
retinoblastoma B-Disease 1 0.9999688863754272
. O 0 0.018297865986824036
. O 0 0.02597573772072792

Low O 0 0.08527179062366486
levels O 0 0.046060312539339066
of O 0 0.013940921053290367
beta O 0 0.08267597109079361
hexosaminidase O 0 0.2645933926105499
A O 0 0.027609774842858315
in O 0 0.013216527178883553
healthy O 0 0.09824397414922714
individuals O 0 0.01788165234029293
with O 0 0.01604931615293026
apparent O 1 0.9985438585281372
deficiency O 1 0.9999998807907104
of O 0 0.012308986857533455
this O 0 0.0149260014295578
enzyme O 0 0.1072954460978508
. O 0 0.030644085258245468

Appreciable O 0 0.2545756995677948
beta O 0 0.17180901765823364
hexosaminidase O 0 0.21564032137393951
A O 0 0.05080151930451393
( O 0 0.03592059761285782
hex O 0 0.08169698715209961
A O 0 0.029140209779143333
) O 0 0.0197601355612278
activity O 0 0.025583015754818916
has O 0 0.01195541862398386
been O 0 0.013382217846810818
detected O 0 0.061064865440130234
in O 0 0.0188615582883358
cultured O 1 0.9939664602279663
skin O 1 0.9999997615814209
fibroblasts O 1 0.9999399185180664
and O 0 0.06427033990621567
melanoma B-Disease 1 1.0
tissue O 1 0.99955815076828
from O 0 0.02119089663028717
healthy O 0 0.1864779144525528
individuals O 0 0.0168398916721344
previously O 0 0.018583307042717934
reported O 0 0.02591591514647007
as O 0 0.012843577191233635
having O 0 0.04484744369983673
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.019614726305007935
hex I-Disease 0 0.09240210056304932
A I-Disease 0 0.02902710810303688
activity O 0 0.03536952659487724
indistinguishable O 0 0.05297287181019783
from O 0 0.009633433073759079
that O 0 0.006584207993000746
of O 0 0.011916065588593483
patients O 1 0.9999994039535522
with O 0 0.3511332869529724
Tay B-Disease 1 1.0
- I-Disease 1 0.9999905824661255
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999997615814209
( O 0 0.09915781766176224
TSD B-Disease 1 0.9999927282333374
) O 0 0.04849471524357796
. O 0 0.02792348712682724

Identification O 0 0.06648212671279907
and O 0 0.021853026002645493
quantitation O 0 0.17422784864902496
of O 0 0.015539168380200863
hex O 0 0.0774112194776535
A O 0 0.02383558079600334
, O 0 0.01239518541842699
amounting O 0 0.050636593252420425
to O 0 0.013537559658288956
3 O 0 0.031322866678237915
. O 0 0.023330481722950935

5 O 0 0.05631735548377037
% O 0 0.042546432465314865
- O 0 0.08213864266872406
6 O 0 0.050847556442022324
. O 0 0.028474558144807816

9 O 0 0.045566901564598083
% O 0 0.02120627835392952
of O 0 0.008736719377338886
total O 0 0.025593653321266174
beta O 0 0.08410807698965073
hexosaminidase O 0 0.4123588800430298
activity O 0 0.034366726875305176
, O 0 0.009587937965989113
has O 0 0.009879128076136112
been O 0 0.01006605289876461
obtained O 0 0.014310799539089203
by O 0 0.015066994354128838
cellulose O 0 0.2941082715988159
acetate O 1 0.9379482865333557
gel O 1 0.9878948330879211
electrophoresis O 1 0.5696805715560913
, O 0 0.039414383471012115
DEAE O 1 0.9995443224906921
- O 0 0.13640686869621277
cellulose O 0 0.25610753893852234
ion O 0 0.1768135279417038
- O 0 0.11059064418077469
exchange O 0 0.06801296770572662
chromatography O 0 0.34015339612960815
, O 0 0.0333876758813858
radial O 1 0.9835401177406311
immunodiffusion O 1 0.6680763363838196
, O 0 0.017635086551308632
and O 0 0.016880225390195847
radioimmunoassay O 1 0.7748192548751831
. O 0 0.033182140439748764

Previous O 0 0.04131839796900749
family O 0 0.03566574677824974
studies O 0 0.029490984976291656
suggested O 0 0.02038663811981678
that O 0 0.005812297109514475
these O 0 0.005676844622939825
individuals O 0 0.01481352373957634
may O 0 0.015509079210460186
be O 0 0.0099532725289464
compound O 0 0.07246149331331253
heterozygotes O 0 0.47144535183906555
for O 0 0.009581012651324272
the O 0 0.012146838009357452
common O 0 0.041798949241638184
mutant O 0 0.21698610484600067
TSD B-Disease 1 0.9999666213989258
gene O 0 0.08976783603429794
and O 0 0.010909687727689743
a O 0 0.018878482282161713
rare O 0 0.052425820380449295
( O 0 0.04161689430475235
allelic O 1 0.6822288632392883
) O 0 0.042998481541872025
mutant O 0 0.14212945103645325
gene O 0 0.10817968100309372
. O 0 0.03336213529109955

Thus O 0 0.03559919819235802
, O 0 0.01588694378733635
the O 0 0.01793888583779335
postulated O 0 0.10942242294549942
rate O 0 0.056393351405858994
mutant O 0 0.11971583217382431
gene O 0 0.08350508660078049
appears O 0 0.02927151508629322
to O 0 0.007680651731789112
code O 0 0.013121455907821655
for O 0 0.0058003016747534275
the O 0 0.00786585547029972
expression O 0 0.025619829073548317
of O 0 0.008871304802596569
low O 0 0.03317954018712044
amounts O 0 0.023406442254781723
of O 0 0.01127546839416027
hex O 0 0.09530878812074661
A O 0 0.03460158407688141
. O 0 0.029665471985936165

Heterozygotes O 1 0.7070859670639038
for O 0 0.017236314713954926
the O 0 0.01708076149225235
rare O 0 0.0548526830971241
mutant O 0 0.10301287472248077
may O 0 0.025735946372151375
be O 0 0.01132266502827406
indistinguishable O 0 0.060808517038822174
from O 0 0.018465133383870125
heterozygotes O 1 0.5047333836555481
for O 0 0.012263655662536621
the O 0 0.016972407698631287
common O 0 0.05812591314315796
TSD B-Disease 1 0.99991774559021
mutant O 0 0.17029334604740143
. O 0 0.038679078221321106

However O 0 0.026768436655402184
, O 0 0.016133401542901993
direct O 0 0.03362924978137016
visualization O 0 0.09508474171161652
and O 0 0.015893535688519478
quantitation O 0 0.1491532027721405
of O 0 0.012299574911594391
hex O 0 0.07469414174556732
A O 0 0.017675336450338364
by O 0 0.008651585318148136
the O 0 0.009449808858335018
methods O 0 0.02185114100575447
described O 0 0.026530345901846886
may O 0 0.02165147475898266
prevent O 0 0.04589279368519783
false O 0 0.051777184009552
- O 0 0.16476799547672272
positive O 0 0.10473363101482391
prenatal O 1 0.9999773502349854
diagnosis O 1 0.9999810457229614
of O 0 0.022258998826146126
TSD B-Disease 1 0.9999879598617554
in O 0 0.021617408841848373
fetuses O 0 0.10621578991413116
having O 0 0.022081712260842323
the O 0 0.012858856469392776
incomplete O 0 0.04160815104842186
hex B-Disease 0 0.12428595125675201
A I-Disease 0 0.055626802146434784
deficiency I-Disease 1 0.9999997615814209
of O 0 0.009916568174958229
the O 0 0.01241099089384079
type O 0 0.04645692929625511
described O 0 0.01826203055679798
in O 0 0.007984375581145287
the O 0 0.010219997726380825
four O 0 0.017626387998461723
healthy O 0 0.10876516252756119
individuals O 0 0.055910009890794754

The O 0 0.06805362552404404
tumor B-Disease 1 0.9998879432678223
suppressor O 1 0.9906278848648071
gene O 0 0.20063425600528717
Smad4 O 1 0.9984207153320312
/ O 1 0.9920721650123596
Dpc4 O 0 0.48564279079437256
is O 0 0.015805553644895554
required O 0 0.01553267054259777
for O 0 0.010294356383383274
gastrulation O 1 0.9747294187545776
and O 0 0.009289276786148548
later O 0 0.011363540776073933
for O 0 0.010144824162125587
anterior O 1 0.9529241919517517
development O 0 0.020466597750782967
of O 0 0.009118129499256611
the O 0 0.01864047534763813
mouse O 0 0.16275732219219208
embryo O 0 0.13495329022407532
. O 0 0.03522061929106712

Mutations O 0 0.1472138911485672
in O 0 0.022421088069677353
the O 0 0.03009045496582985
SMAD4 O 1 0.9999362230300903
/ O 1 0.9999256134033203
DPC4 O 1 0.999943733215332
tumor B-Disease 1 0.9999731779098511
suppressor O 1 0.9770548343658447
gene O 0 0.09710482507944107
, O 0 0.015015671029686928
a O 0 0.018909059464931488
key O 0 0.027276501059532166
signal O 0 0.0580562949180603
transducer O 0 0.12804001569747925
in O 0 0.012932860292494297
most O 0 0.016477229073643684
TGFbeta O 1 0.9990886449813843
- O 0 0.08910515159368515
related O 0 0.04188033193349838
pathways O 0 0.08769465237855911
, O 0 0.010597742162644863
are O 0 0.007021715864539146
involved O 0 0.015392085537314415
in O 0 0.009184584952890873
50 O 0 0.02119695581495762
% O 0 0.023711582645773888
of O 0 0.022020729258656502
pancreatic B-Disease 1 0.9999988079071045
cancers I-Disease 1 0.9999929666519165
. O 0 0.04554233327507973

Homozygous O 0 0.2794167995452881
Smad4 O 1 0.9624360203742981
mutant O 0 0.2798408269882202
mice O 1 0.9637835025787354
die O 0 0.47511082887649536
before O 0 0.024185800924897194
day O 0 0.028279399499297142
7 O 0 0.038204729557037354
. O 0 0.02526462823152542

5 O 0 0.050862520933151245
of O 0 0.019687416031956673
embryogenesis O 0 0.21336564421653748
. O 0 0.04160037636756897

Mutant O 0 0.18574094772338867
embryos O 0 0.06986947357654572
have O 0 0.013973108492791653
reduced O 0 0.0328548327088356
size O 0 0.022986186668276787
, O 0 0.012986084446310997
fail O 0 0.04943287372589111
to O 0 0.013925374485552311
gastrulate O 0 0.23900513350963593
or O 0 0.020314527675509453
express O 0 0.051315344870090485
a O 0 0.02917446754872799
mesodermal O 1 0.937540590763092
marker O 0 0.09425434470176697
, O 0 0.014431804418563843
and O 0 0.012857154943048954
show O 0 0.04532869905233383
abnormal O 1 0.9677022099494934
visceral O 1 0.9923292994499207
endoderm O 1 0.9947103261947632
development O 0 0.04637889191508293
. O 0 0.03195270523428917

Growth B-Disease 1 0.9806883335113525
retardation I-Disease 1 0.9999743700027466
of O 0 0.01525497529655695
the O 0 0.02320278249680996
Smad4 O 1 0.9999394416809082
- O 1 0.8141502141952515
deficient O 1 0.9952538013458252
embryos O 0 0.06848878413438797
results O 0 0.03160678967833519
from O 0 0.01705743372440338
reduced O 0 0.048552822321653366
cell O 0 0.08281159400939941
proliferation O 0 0.06658665835857391
rather O 0 0.01783525012433529
than O 0 0.014800835400819778
increased O 0 0.047355975955724716
apoptosis O 0 0.17037858068943024
. O 0 0.03756842389702797

Aggregation O 0 0.13367199897766113
of O 0 0.02455287054181099
mutant O 0 0.17774608731269836
Smad4 O 1 0.9945512413978577
ES O 1 0.994231641292572
cells O 0 0.08260583877563477
with O 0 0.02010287344455719
wild O 0 0.06129630282521248
- O 0 0.11944345384836197
type O 0 0.11186037957668304
tetraploid O 1 0.7148457765579224
morulae O 1 0.9425493478775024
rescues O 0 0.42868277430534363
the O 0 0.037334688007831573
gastrulation B-Disease 1 0.9995112419128418
defect I-Disease 1 0.9979269504547119
. O 0 0.03661738708615303

These O 0 0.01883229985833168
results O 0 0.029622873291373253
indicate O 0 0.028081463649868965
that O 0 0.011378324590623379
Smad4 O 0 0.4017370939254761
is O 0 0.011615335941314697
initially O 0 0.015843411907553673
required O 0 0.010118579491972923
for O 0 0.005631249863654375
the O 0 0.00862899050116539
differentiation O 0 0.04635055735707283
of O 0 0.007894064299762249
the O 0 0.017726780846714973
visceral O 1 0.972170889377594
endoderm O 1 0.9918219447135925
and O 0 0.010493416339159012
that O 0 0.008656658232212067
the O 0 0.017556237056851387
gastrulation B-Disease 1 0.999790370464325
defect I-Disease 1 0.9800412058830261
in O 0 0.017150212079286575
the O 0 0.02060186304152012
epiblast O 1 0.9989499449729919
is O 0 0.018044525757431984
secondary O 0 0.03459594398736954
and O 0 0.010796640999615192
non O 0 0.0432271808385849
- O 0 0.07854020595550537
cell O 0 0.08011144399642944
autonomous O 0 0.04971401020884514
. O 0 0.029897194355726242

Rescued O 0 0.20936301350593567
embryos O 0 0.1260887086391449
show O 0 0.07416701316833496
severe O 1 0.9999181032180786
anterior O 1 0.9999269247055054
truncations O 1 0.8871257901191711
, O 0 0.019340822473168373
indicating O 0 0.03623060882091522
a O 0 0.011161677539348602
second O 0 0.013195176608860493
important O 0 0.009214479476213455
role O 0 0.016781460493803024
for O 0 0.01233506016433239
Smad4 O 1 0.8526029586791992
in O 0 0.02223118580877781
anterior O 1 0.9998396635055542
patterning O 1 0.9962245225906372
during O 0 0.053089678287506104
embryogenesis O 1 0.7672773003578186
. O 0 0.03762942925095558

Prevalence O 1 0.9792169332504272
of O 0 0.03145070746541023
p16 O 1 0.9888385534286499
and O 0 0.030572935938835144
CDK4 O 1 0.9994779229164124
germline O 1 0.9753706455230713
mutations O 0 0.13590332865715027
in O 0 0.027997149154543877
48 O 0 0.37886980175971985
melanoma B-Disease 1 1.0
- O 1 0.8075358271598816
prone O 1 0.8528658747673035
families O 0 0.032228972762823105
in O 0 0.016911186277866364
France O 0 0.053896065801382065
. O 0 0.029155701398849487

The O 0 0.040189627557992935
French O 0 0.2290796935558319
Familial B-Disease 1 0.9999995231628418
Melanoma I-Disease 1 1.0
Study O 0 0.06789524108171463
Group O 0 0.053943194448947906
. O 0 0.026784339919686317

Germline O 1 0.9264326691627502
mutations O 0 0.14969231188297272
in O 0 0.017392607405781746
the O 0 0.02295968122780323
p16 O 1 0.9733635783195496
and O 0 0.02302229218184948
CDK4 O 1 0.9975232481956482
genes O 0 0.04502059519290924
have O 0 0.010384529829025269
been O 0 0.01089186780154705
reported O 0 0.017598800361156464
in O 0 0.007857361808419228
a O 0 0.018445845693349838
subset O 0 0.07176519930362701
of O 0 0.021303638815879822
melanoma B-Disease 1 1.0
pedigrees O 0 0.37946534156799316
, O 0 0.012517524883151054
but O 0 0.0078970268368721
their O 0 0.009826533496379852
prevalence O 1 0.9905977845191956
is O 0 0.01123425830155611
not O 0 0.0075208814814686775
well O 0 0.010948961600661278
known O 0 0.02578551694750786
. O 0 0.023894289508461952

We O 0 0.023143509402871132
searched O 0 0.04340783506631851
for O 0 0.010663291439414024
such O 0 0.016238635405898094
germline O 1 0.7374293208122253
mutations O 0 0.10415422171354294
in O 0 0.019843153655529022
48 O 0 0.05741444230079651
French O 1 0.9452055096626282
melanoma B-Disease 1 1.0
- O 1 0.9189633131027222
prone O 1 0.9327294826507568
families O 0 0.027328377589583397
selected O 0 0.012539735063910484
according O 0 0.008857227861881256
to O 0 0.005978865083307028
two O 0 0.007721331901848316
major O 0 0.017099633812904358
criteria O 0 0.025543002411723137
families O 0 0.019013117998838425
with O 0 0.008490227162837982
at O 0 0.01424428354948759
least O 0 0.012280578725039959
three O 0 0.011189294047653675
affected O 0 0.03766445815563202
members O 0 0.019688302651047707
( O 0 0.03527911379933357
n O 0 0.07594598084688187
= O 0 0.09763261675834656
20 O 0 0.02408621460199356
) O 0 0.01711055263876915
or O 0 0.01333063468337059
families O 0 0.016811400651931763
with O 0 0.008663072250783443
two O 0 0.008565499447286129
affected O 0 0.03325818479061127
members O 0 0.011014713905751705
, O 0 0.00684358598664403
one O 0 0.005928286351263523
of O 0 0.004896792117506266
them O 0 0.006690549664199352
affected O 0 0.02943647839128971
before O 0 0.011034010909497738
the O 0 0.009653739631175995
age O 0 0.02124141715466976
of O 0 0.010020333342254162
50 O 0 0.032179299741983414
( O 0 0.03526299074292183
n O 0 0.07833432406187057
= O 0 0.0994945541024208
28 O 0 0.03022361919283867
) O 0 0.01604570262134075
, O 0 0.007506260648369789
and O 0 0.005777925718575716
one O 0 0.009038541465997696
additional O 0 0.021324239671230316
minor O 0 0.054653141647577286
criterion O 0 0.08124598115682602
. O 0 0.027153225615620613

Sixteen O 0 0.0925784483551979
different O 0 0.044564083218574524
p16 O 1 0.9957874417304993
germline O 1 0.979440450668335
mutations O 0 0.11591391265392303
were O 0 0.010631940327584743
found O 0 0.013993510976433754
in O 0 0.009005832485854626
21 O 0 0.01952596940100193
families O 0 0.01754501275718212
, O 0 0.009329167194664478
while O 0 0.012203083373606205
one O 0 0.021054184064269066
germline O 1 0.9634509086608887
mutation O 0 0.1802442967891693
, O 0 0.022950388491153717
Arg24His O 1 0.7878854274749756
, O 0 0.013906811363995075
was O 0 0.01753854751586914
detected O 0 0.058026235550642014
in O 0 0.011266402900218964
the O 0 0.01911112107336521
CDK4 O 1 0.9978740215301514
gene O 0 0.11644619703292847
. O 0 0.03423969820141792

The O 0 0.028192609548568726
frequency O 0 0.06516257673501968
of O 0 0.024615274742245674
p16 O 1 0.98358154296875
gene O 0 0.12442290037870407
mutation O 0 0.1119932234287262
in O 0 0.0133118387311697
our O 0 0.01671946607530117
sample O 0 0.03836633265018463
( O 0 0.024493152275681496
44 O 0 0.032029375433921814
% O 0 0.023499462753534317
) O 0 0.015570317395031452
is O 0 0.008439719676971436
among O 0 0.007945199497044086
the O 0 0.008498016744852066
highest O 0 0.030776826664805412
rates O 0 0.033200379461050034
yet O 0 0.016056455671787262
reported O 0 0.020329482853412628
and O 0 0.009035691618919373
the O 0 0.01856495626270771
CDK4 O 1 0.9989405274391174
mutation O 0 0.12882009148597717
is O 0 0.01284840703010559
the O 0 0.012515715323388577
second O 0 0.029681798070669174
mutation O 0 0.15060126781463623
detected O 0 0.08009615540504456
in O 0 0.0106575982645154
this O 0 0.012149618938565254
gene O 0 0.07324351370334625
worldwide O 0 0.04925365373492241
. O 0 0.02746494673192501

In O 0 0.022573396563529968
summary O 0 0.04692495986819267
, O 0 0.012326094321906567
our O 0 0.0128188356757164
results O 0 0.0192299485206604
show O 0 0.022888347506523132
frequent O 0 0.042610760778188705
involvement O 0 0.03818691521883011
of O 0 0.007818648591637611
the O 0 0.01988338865339756
p16 O 1 0.9990831613540649
gene O 0 0.10831422358751297
in O 0 0.029264625161886215
familial B-Disease 1 0.9999998807907104
melanoma I-Disease 1 1.0
and O 0 0.015388227067887783
confirm O 0 0.024050496518611908
the O 0 0.0078002773225307465
role O 0 0.014895571395754814
of O 0 0.008295724168419838
the O 0 0.019171033054590225
CDK4 O 1 0.998823344707489
gene O 0 0.07358205318450928
as O 0 0.017371969297528267
a O 0 0.047144580632448196
melanoma B-Disease 1 1.0
- O 1 0.7901322245597839
predisposing O 1 0.9333864450454712
gene O 0 0.11821643263101578
. O 0 0.02214791066944599
. O 0 0.028811251744627953

Progression O 0 0.4420194923877716
of O 0 0.030004112049937248
somatic O 0 0.2876875400543213
CTG O 1 0.9962579011917114
repeat O 0 0.12160823494195938
length O 0 0.046527571976184845
heterogeneity O 0 0.08999461680650711
in O 0 0.013316812925040722
the O 0 0.01783769018948078
blood O 1 0.9875084757804871
cells O 1 0.5576703548431396
of O 0 0.04216014966368675
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999995231628418
. O 0 0.04525665193796158

The O 0 0.026042049750685692
genetic O 0 0.06720875203609467
basis O 0 0.024949224665760994
of O 0 0.035703495144844055
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9951452612876892
DM B-Disease 1 1.0
) O 0 0.02335340529680252
is O 0 0.00891764834523201
the O 0 0.0069350250996649265
expansion O 0 0.022420663386583328
of O 0 0.009300539270043373
an O 0 0.020049000158905983
unstable O 1 0.9913983345031738
CTG O 1 0.9979318380355835
repeat O 0 0.08551531285047531
in O 0 0.013255275785923004
the O 0 0.01508252788335085
34 O 0 0.05001846328377724
UTR O 0 0.16232356429100037
of O 0 0.016353130340576172
the O 0 0.03790895268321037
DM B-Disease 1 0.9999991655349731
protein O 0 0.1645275354385376
kinase O 0 0.2818472683429718
gene O 0 0.0829395279288292
on O 0 0.021123703569173813
chromosome O 0 0.1351008415222168
19 O 0 0.04447777941823006
. O 0 0.027115819975733757

One O 0 0.016009649261832237
of O 0 0.006890387739986181
the O 0 0.009621131233870983
principal O 0 0.025956861674785614
features O 0 0.015909794718027115
of O 0 0.010284150019288063
the O 0 0.03153889626264572
DM B-Disease 1 1.0
mutation O 0 0.1755063235759735
is O 0 0.01895161159336567
an O 0 0.015757545828819275
extraordinarily O 0 0.07793724536895752
high O 0 0.03175880387425423
level O 0 0.02484346553683281
of O 0 0.013485380448400974
somatic O 0 0.4918852746486664
mosaicism O 1 0.9987725615501404
, O 0 0.016057457774877548
due O 0 0.015624897554516792
to O 0 0.008029976859688759
an O 0 0.010798249393701553
extremely O 0 0.029333852231502533
high O 0 0.024992359802126884
degree O 0 0.027511363849043846
of O 0 0.012761866673827171
somatic O 0 0.15226566791534424
instability O 0 0.07768090814352036
both O 0 0.009305602870881557
within O 0 0.009885333478450775
and O 0 0.008055450394749641
between O 0 0.012325379997491837
different O 0 0.013921172358095646
tissues O 0 0.10358185321092606
. O 0 0.028872329741716385

This O 0 0.028693294152617455
instability O 0 0.10375133156776428
appears O 0 0.03270977735519409
to O 0 0.009642167948186398
be O 0 0.008043000474572182
biased O 0 0.04254796355962753
towards O 0 0.017553316429257393
further O 0 0.01164536364376545
expansion O 0 0.02325703203678131
and O 0 0.009140577167272568
continuous O 0 0.02852093055844307
throughout O 0 0.00948417093604803
the O 0 0.0066566006280481815
life O 0 0.011032810434699059
of O 0 0.00537377642467618
an O 0 0.00886224489659071
individual O 0 0.016420835629105568
, O 0 0.00854997057467699
features O 0 0.014310208149254322
that O 0 0.005414621904492378
could O 0 0.007671342696994543
be O 0 0.005996258929371834
associated O 0 0.011526910588145256
with O 0 0.006841531954705715
the O 0 0.010256933979690075
progressive O 0 0.05015696957707405
nature O 0 0.022839996963739395
of O 0 0.010271689854562283
the O 0 0.020787624642252922
disease O 1 0.9999994039535522
. O 0 0.029760269448161125

Although O 0 0.04221220687031746
increasing O 0 0.045821577310562134
measured O 0 0.06216616928577423
allele O 0 0.13756850361824036
size O 0 0.03513089567422867
between O 0 0.02452436089515686
patients O 1 0.9999289512634277
clearly O 0 0.03354639559984207
correlates O 0 0.06561983376741409
with O 0 0.01015498023480177
an O 0 0.013939826749265194
increased O 0 0.036797523498535156
severity O 1 0.9993535876274109
of O 0 0.01811697706580162
symptoms O 1 0.9999995231628418
and O 0 0.00850904081016779
an O 0 0.008763732388615608
earlier O 0 0.018248705193400383
age O 0 0.026393825188279152
of O 0 0.01380132045596838
onset O 1 0.9999369382858276
, O 0 0.01288618240505457
this O 0 0.009565956890583038
correlation O 0 0.0470159687101841
is O 0 0.010270390659570694
not O 0 0.007497717626392841
precise O 0 0.026389243081212044
and O 0 0.01281278021633625
measured O 0 0.04513140022754669
allele O 0 0.11183945089578629
length O 0 0.027564220130443573
cannot O 0 0.016978399828076363
be O 0 0.0063982559368014336
used O 0 0.008087350986897945
as O 0 0.006891301367431879
an O 0 0.01077939011156559
accurate O 0 0.032467059791088104
predictor O 0 0.1289164125919342
of O 0 0.013319066725671291
age O 0 0.03250368312001228
of O 0 0.01868772692978382
onset O 1 0.999902606010437
. O 0 0.03616752475500107

In O 0 0.016577450558543205
order O 0 0.011884817853569984
to O 0 0.01022341288626194
further O 0 0.014667237177491188
characterize O 0 0.0634622648358345
the O 0 0.015708385035395622
dynamics O 0 0.0860559493303299
of O 0 0.03330015391111374
DM B-Disease 1 1.0
CTG O 1 0.9999457597732544
repeat O 1 0.7257194519042969
somatic O 0 0.35365962982177734
instability O 0 0.11662594228982925
, O 0 0.01380172185599804
we O 0 0.008197775110602379
have O 0 0.008029073476791382
studied O 0 0.024473847821354866
repeat O 0 0.0487508662045002
length O 0 0.021851852536201477
changes O 0 0.013631808571517467
over O 0 0.01020864024758339
time O 0 0.014783088117837906
in O 0 0.021784957498311996
111 O 1 0.9997989535331726
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999982118606567
with O 0 0.021116260439157486
varying O 0 0.05692358687520027
clinical O 1 0.9998055100440979
severity O 1 0.9997990727424622
and O 0 0.02152341604232788
CTG O 1 0.999573290348053
repeat O 0 0.08636853843927383
size O 0 0.025453506037592888
over O 0 0.011207214556634426
time O 0 0.014559625647962093
intervals O 0 0.033735573291778564
of O 0 0.00932558998465538
1 O 0 0.029690902680158615
- O 0 0.06626606732606888
7 O 0 0.036246564239263535
years O 0 0.023002181202173233
. O 0 0.026946498081088066

We O 0 0.01887441612780094
have O 0 0.010064694099128246
found O 0 0.015436998568475246
a O 0 0.015355389565229416
direct O 0 0.02717687003314495
progression O 0 0.09143199771642685
of O 0 0.0072848377749323845
the O 0 0.0118932593613863
size O 0 0.027626991271972656
heterogeneity O 0 0.09016267210245132
over O 0 0.011914830654859543
time O 0 0.012386304326355457
related O 0 0.019328925758600235
to O 0 0.012901494279503822
initial O 0 0.060788579285144806
CTG O 1 0.9985308647155762
repeat O 0 0.0808984786272049
size O 0 0.020398156717419624
and O 0 0.007132185623049736
the O 0 0.008842899464070797
time O 0 0.017053594812750816
interval O 0 0.053401462733745575
and O 0 0.010054076090455055
always O 0 0.01845662295818329
biased O 0 0.04522879421710968
towards O 0 0.020405257120728493
further O 0 0.01695897802710533
expansion O 0 0.03822570666670799
. O 0 0.02600003406405449

Attempts O 0 0.05380522459745407
to O 0 0.016624346375465393
mathematically O 0 0.06359099596738815
model O 0 0.031801603734493256
the O 0 0.013786143623292446
dynamics O 0 0.05874142795801163
have O 0 0.011115957982838154
proved O 0 0.0309128575026989
only O 0 0.010792484506964684
partially O 0 0.05096758157014847
successful O 0 0.030604762956500053
suggesting O 0 0.031108438968658447
that O 0 0.007847893983125687
individual O 0 0.015653815120458603
specific O 0 0.020115230232477188
genetic O 0 0.058498602360486984
and O 0 0.01589839905500412
/ O 1 0.9916905164718628
or O 0 0.017656229436397552
environmental O 0 0.025180328637361526
factors O 0 0.020832819864153862
also O 0 0.007652573753148317
play O 0 0.008470824919641018
a O 0 0.01277117058634758
role O 0 0.022505486384034157
in O 0 0.018050558865070343
somatic O 0 0.4522772431373596
mosaicism O 1 0.9982276558876038
. O 0 0.024767495691776276
. O 0 0.02740996889770031

Aspartylglucosaminuria B-Disease 1 0.9970418810844421
among O 0 0.03604136407375336
Palestinian O 0 0.05494052171707153
Arabs O 0 0.061971601098775864
. O 0 0.031784698367118835

Aspartylglucosaminuria B-Disease 1 0.999853253364563
( O 0 0.11186519265174866
AGU B-Disease 1 0.9999986886978149
) O 0 0.02956198714673519
is O 0 0.012726140208542347
a O 0 0.02137184329330921
rare O 0 0.3389323055744171
disorder B-Disease 1 0.9999977350234985
of I-Disease 0 0.024146266281604767
glycoprotein I-Disease 1 0.9993065595626831
metabolism I-Disease 1 0.9975399971008301
caused O 0 0.0636393129825592
by O 0 0.012983101420104504
the O 0 0.02032356895506382
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.012458479031920433
the I-Disease 0 0.022952184081077576
lysosomal I-Disease 1 0.999457061290741
enzyme I-Disease 0 0.29211610555648804
aspartylglucosaminidase I-Disease 1 0.9819654822349548
( O 0 0.0577840693295002
AGA O 1 0.9910815954208374
) O 0 0.035081855952739716
. O 0 0.023325376212596893

AGU B-Disease 1 0.999994158744812
is O 0 0.041903700679540634
inherited O 0 0.12361893802881241
as O 0 0.017224784940481186
an O 0 0.028768310323357582
autosomal O 1 0.9999582767486572
recessive O 1 0.999968409538269
trait O 1 0.9964714050292969
and O 0 0.01971765235066414
occurs O 0 0.03734176233410835
with O 0 0.009246583096683025
a O 0 0.013076076284050941
high O 0 0.025433210656046867
frequency O 0 0.03394746035337448
in O 0 0.008964854292571545
Finland O 0 0.0297709871083498
because O 0 0.010334691032767296
of O 0 0.006997298449277878
a O 0 0.022825300693511963
founder O 0 0.06464798003435135
effect O 0 0.051813531666994095
. O 0 0.028865700587630272

While O 0 0.030760491266846657
very O 0 0.02151336520910263
few O 0 0.0235578790307045
patients O 1 0.9999779462814331
with O 0 0.025704791769385338
AGU B-Disease 1 0.9999998807907104
have O 0 0.014757968485355377
been O 0 0.01219705119729042
reported O 0 0.024858439341187477
from O 0 0.01358021516352892
non O 0 0.03491019457578659
- O 0 0.06404998153448105
Finnish O 0 0.05796678736805916
origin O 0 0.021560322493314743
, O 0 0.014120706357061863
we O 0 0.018286213278770447
diagnosed O 1 0.9999998807907104
the O 0 0.027826862409710884
disorder O 1 0.9999990463256836
in O 0 0.018556294962763786
8 O 0 0.03887273371219635
patients O 1 0.9995070695877075
originating O 0 0.048962514847517014
from O 0 0.01440037414431572
3 O 0 0.025360168889164925
unrelated O 0 0.03991404548287392
families O 0 0.01915113814175129
, O 0 0.008268159814178944
all O 0 0.006505838129669428
Palestinian O 0 0.02647767961025238
Arabs O 0 0.02892671711742878
from O 0 0.009806705638766289
the O 0 0.008900301530957222
region O 0 0.02340264618396759
of O 0 0.009965897537767887
Jerusalem O 0 0.03777652606368065
. O 0 0.023588022217154503

The O 0 0.04464302584528923
clinical O 1 0.9998968839645386
diagnosis O 1 0.9999957084655762
of O 0 0.02410421147942543
AGU B-Disease 1 0.9999998807907104
is O 0 0.019349006935954094
often O 0 0.013834850862622261
difficult O 0 0.01779267005622387
, O 0 0.0069907112047076225
in O 0 0.00578985596075654
particular O 0 0.012945211492478848
early O 0 0.011940406635403633
in O 0 0.006277825217694044
the O 0 0.008737455122172832
course O 0 0.029102899134159088
of O 0 0.0085558220744133
the O 0 0.018061194568872452
disease O 1 0.9999985694885254
, O 0 0.008729198947548866
and O 0 0.004781716503202915
most O 0 0.004799403715878725
of O 0 0.00546116242185235
the O 0 0.014481554739177227
patients O 1 0.9999978542327881
are O 0 0.0128910718485713
diagnosed O 1 0.9999998807907104
after O 0 0.01789119467139244
the O 0 0.00997086800634861
age O 0 0.018889587372541428
of O 0 0.008210020139813423
5 O 0 0.02424699068069458
years O 0 0.019594259560108185
. O 0 0.024686051532626152

However O 0 0.02626323327422142
, O 0 0.013846161775290966
since O 0 0.018080906942486763
these O 0 0.015958266332745552
patients O 1 0.9999308586120605
excrete O 1 0.808994710445404
early O 0 0.02500518038868904
large O 0 0.017171718180179596
amounts O 0 0.027963688597083092
of O 0 0.013412142172455788
aspartylglucosamine O 0 0.49452266097068787
in O 0 0.020923877134919167
urine O 0 0.12131698429584503
, O 0 0.02010163851082325
biochemical O 0 0.10322525352239609
screening O 0 0.07357148081064224
is O 0 0.01317561324685812
easy O 0 0.024079982191324234
by O 0 0.014662566594779491
urine O 0 0.13713091611862183
chromatography O 0 0.4293762445449829
. O 0 0.021444858983159065
. O 0 0.02712034247815609

Detection O 0 0.14842817187309265
of O 0 0.020142851397395134
heterozygous O 0 0.1269451528787613
carriers O 0 0.0744391605257988
of O 0 0.015077273361384869
the O 0 0.03672331944108009
ataxia B-Disease 1 1.0
- I-Disease 1 0.9975007176399231
telangiectasia I-Disease 1 0.9999696016311646
( O 0 0.08043929189443588
ATM O 0 0.17161615192890167
) O 0 0.038194071501493454
gene O 0 0.07256916910409927
by O 0 0.028176324442029
G2 O 1 0.999808132648468
phase O 0 0.15735837817192078
chromosomal O 0 0.2508661448955536
radiosensitivity O 0 0.47545289993286133
of O 0 0.029550062492489815
peripheral O 1 0.9998595714569092
blood O 1 0.9994136095046997
lymphocytes O 1 0.9984930753707886
. O 0 0.04186945781111717

In O 0 0.06502962112426758
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.997805655002594
telangiectasia I-Disease 1 0.9999934434890747
( O 0 0.07072798907756805
A B-Disease 1 0.9924308657646179
- I-Disease 1 0.9985997080802917
T I-Disease 1 0.9999979734420776
) O 0 0.04928373172879219
patients O 1 0.9998379945755005
, O 0 0.01652279868721962
mutations O 0 0.06903129070997238
in O 0 0.01131014246493578
a O 0 0.01609097421169281
single O 0 0.031344689428806305
gene O 0 0.07582978904247284
, O 0 0.018574684858322144
ATM O 0 0.09087850898504257
, O 0 0.011436271481215954
result O 0 0.018123097717761993
in O 0 0.01159619726240635
an O 0 0.028963766992092133
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.019046831876039505
embraces O 0 0.07055774331092834
a O 0 0.013291080482304096
variety O 0 0.014084164053201675
of O 0 0.009957375936210155
clinical O 1 0.7251806259155273
features O 0 0.024336352944374084
and O 0 0.012903043068945408
manifests O 0 0.47752806544303894
extreme O 0 0.08044163882732391
radiosensitivity O 1 0.6349490284919739
and O 0 0.008599239401519299
a O 0 0.014261734671890736
strong O 0 0.027009889483451843
pre O 0 0.16796600818634033
- O 0 0.09797610342502594
disposition O 0 0.12792572379112244
to O 0 0.02779046818614006
malignancy B-Disease 1 0.9998922348022461
. O 0 0.0360206738114357

Heterozygotes O 0 0.4288990795612335
for O 0 0.01672692969441414
the O 0 0.020634403452277184
ATM O 0 0.15421438217163086
gene O 0 0.06951282173395157
have O 0 0.012066981755197048
no O 0 0.01634158380329609
clinical O 0 0.18584279716014862
expression O 0 0.03178367018699646
of O 0 0.010609193705022335
A B-Disease 1 0.944523274898529
- I-Disease 1 0.9986262321472168
T I-Disease 1 0.9999954700469971
but O 0 0.017265820875763893
may O 0 0.022950848564505577
be O 0 0.015286128968000412
cancer B-Disease 1 0.9999991655349731
prone O 1 0.659461259841919
with O 0 0.010446121916174889
a O 0 0.016548791900277138
moderate O 0 0.038698963820934296
increase O 0 0.018379606306552887
in O 0 0.009738652035593987
in O 0 0.016887135803699493
vitro O 0 0.1369454562664032
radiosensitivity O 1 0.8583023548126221
. O 0 0.03895723074674606

We O 0 0.025987409055233
performed O 0 0.0334019660949707
a O 0 0.028643954545259476
blind O 0 0.13363434374332428
chromosomal O 0 0.16401976346969604
analysis O 0 0.0374358594417572
on O 0 0.024528853595256805
G2 O 1 0.9999865293502808
- O 0 0.14767757058143616
phase O 0 0.1363440752029419
lymphocytes O 0 0.4158911108970642
from O 0 0.02231621742248535
7 O 0 0.03497716039419174
unrelated O 0 0.06100836023688316
A B-Disease 1 0.9914167523384094
- I-Disease 1 0.9997393488883972
T I-Disease 1 0.9999994039535522
patients O 1 0.9997925162315369
, O 0 0.017789745703339577
13 O 0 0.030749045312404633
obligate O 0 0.38436025381088257
A B-Disease 1 0.9352236390113831
- I-Disease 1 0.99695885181427
T I-Disease 1 0.9999892711639404
heterozygotes O 1 0.9959567189216614
( O 0 0.03382660821080208
parents O 0 0.02849523536860943
of O 0 0.00902767013758421
the O 0 0.01800982467830181
patients O 1 0.9999595880508423
) O 0 0.020355917513370514
, O 0 0.008806763216853142
and O 0 0.0076302420347929
14 O 0 0.01925378106534481
normal O 0 0.032239340245723724
controls O 0 0.03764686360955238
following O 0 0.027785340324044228
X O 0 0.38630419969558716
- O 0 0.0851442739367485
irradiation O 0 0.10991690307855606
with O 0 0.017935141921043396
1 O 0 0.037826184183359146
Gy O 0 0.2501835227012634
in O 0 0.010488813742995262
order O 0 0.010668996721506119
to O 0 0.011072306893765926
evaluate O 0 0.05061507597565651
this O 0 0.01341409794986248
cytogenetic O 0 0.337802529335022
method O 0 0.024525994434952736
as O 0 0.0073511237278580666
a O 0 0.014531726017594337
tool O 0 0.034234337508678436
for O 0 0.01240269374102354
detection O 0 0.06835737824440002
of O 0 0.014993555843830109
ATM O 0 0.18770532310009003
carriers O 0 0.10860906541347504
. O 0 0.0323064811527729

Both O 0 0.02906329743564129
A B-Disease 1 0.7510687708854675
- I-Disease 1 0.9960852861404419
T I-Disease 1 0.9999853372573853
homozygotes O 1 0.9937368631362915
and O 0 0.029538528993725777
heterozygotes O 1 0.9731263518333435
showed O 0 0.04743063077330589
significantly O 0 0.041761934757232666
increased O 0 0.029446111992001534
levels O 0 0.04192427545785904
of O 0 0.019950803369283676
radiation O 1 0.9999803304672241
- O 1 0.9866928458213806
induced O 1 0.9994910955429077
chromatid O 1 0.9997382760047913
damage O 0 0.1373918056488037
relative O 0 0.02786349505186081
to O 0 0.007191288750618696
that O 0 0.005306720733642578
of O 0 0.006928528659045696
normal O 0 0.03924792632460594
controls O 0 0.05223260447382927
. O 0 0.027161382138729095

These O 0 0.01655861921608448
results O 0 0.022016597911715508
show O 0 0.01647847518324852
that O 0 0.007987117394804955
the O 0 0.020978445187211037
G2 O 1 0.9999963045120239
- O 0 0.1553504914045334
phase O 0 0.1586732268333435
chromosomal O 0 0.42980507016181946
radiosensitivity O 1 0.8549504280090332
assay O 0 0.11646484583616257
can O 0 0.011273575946688652
be O 0 0.004786438774317503
used O 0 0.006963646970689297
for O 0 0.005368123762309551
the O 0 0.009231935255229473
detection O 0 0.05494294688105583
of O 0 0.011736245825886726
A B-Disease 1 0.8533492088317871
- I-Disease 1 0.992374837398529
T I-Disease 1 0.999970555305481
heterozygotes O 1 0.9871184825897217
. O 0 0.04300738498568535

In O 0 0.025628061965107918
combination O 0 0.07118343561887741
with O 0 0.020786691457033157
molecular O 0 0.07478781044483185
genetic O 0 0.07136332243680954
analyses O 0 0.03983476012945175
, O 0 0.009866579435765743
this O 0 0.007843228988349438
test O 0 0.027560202404856682
may O 0 0.010989793576300144
be O 0 0.004443036392331123
of O 0 0.004483301658183336
value O 0 0.010165323503315449
in O 0 0.007353173103183508
studies O 0 0.018300676718354225
of O 0 0.010460533201694489
familial B-Disease 1 0.9999281167984009
and I-Disease 0 0.02285376563668251
sporadic I-Disease 1 0.8814160823822021
cancers I-Disease 1 0.9999651908874512
aimed O 0 0.04387212544679642
at O 0 0.018360383808612823
determination O 0 0.02555328980088234
of O 0 0.00508686201646924
the O 0 0.010051059536635876
potential O 0 0.0277977604418993
involvement O 0 0.0434599407017231
of O 0 0.014431864954531193
ATM O 1 0.8295456767082214
mutations O 0 0.12758460640907288
in O 0 0.027121594175696373
tumor B-Disease 1 0.999998927116394
risk O 1 0.9959501028060913
or O 0 0.01869697868824005
development O 0 0.02118801698088646
. O 0 0.012576253153383732
. O 0 0.02426009811460972

Ataxia B-Disease 1 1.0
- I-Disease 1 0.999049961566925
telangiectasia I-Disease 1 0.9999644756317139
: O 0 0.041095566004514694
identification O 0 0.03352552652359009
and O 0 0.013068164698779583
detection O 0 0.06830006837844849
of O 0 0.013298003934323788
founder O 0 0.1255999207496643
- O 0 0.09808055311441422
effect O 0 0.061165399849414825
mutations O 0 0.08698424696922302
in O 0 0.01331020426005125
the O 0 0.019161423668265343
ATM O 0 0.13010235130786896
gene O 0 0.06860199570655823
in O 0 0.013050458393990993
ethnic O 0 0.027384372428059578
populations O 0 0.06296530365943909
. O 0 0.03039959818124771

To O 0 0.018041567876935005
facilitate O 0 0.029815008863806725
the O 0 0.013365570455789566
evaluation O 0 0.06561977416276932
of O 0 0.017610400915145874
ATM O 0 0.34225842356681824
heterozygotes O 1 0.9660311937332153
for O 0 0.018584150820970535
susceptibility O 1 0.6561440825462341
to O 0 0.012387797236442566
other O 0 0.012365800328552723
diseases O 1 0.9999935626983643
, O 0 0.010874549858272076
such O 0 0.00948889460414648
as O 0 0.021333524957299232
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.012768909335136414
we O 0 0.006948525086045265
have O 0 0.005898973438888788
attempted O 0 0.018384035676717758
to O 0 0.007744839880615473
define O 0 0.02071424573659897
the O 0 0.0081457095220685
most O 0 0.009077302180230618
common O 0 0.025155069306492805
mutations O 0 0.06527585536241531
and O 0 0.0072266715578734875
their O 0 0.007897019386291504
frequencies O 0 0.04007989913225174
in O 0 0.022407060489058495
ataxia B-Disease 1 1.0
- I-Disease 1 0.998668909072876
telangiectasia I-Disease 1 0.9999966621398926
( O 0 0.07227886468172073
A B-Disease 1 0.9565151333808899
- I-Disease 1 0.9931007623672485
T I-Disease 1 0.9999624490737915
) O 0 0.0438099168241024
homozygotes O 1 0.7944871187210083
from O 0 0.01831316202878952
10 O 0 0.017834067344665527
ethnic O 0 0.023151826113462448
populations O 0 0.06388765573501587
. O 0 0.034133926033973694

Both O 0 0.0344914011657238
genomic O 0 0.14066432416439056
mutations O 0 0.10061624646186829
and O 0 0.010500782169401646
their O 0 0.01239678543061018
effects O 0 0.0616634376347065
on O 0 0.015563330613076687
cDNA O 0 0.11048956960439682
were O 0 0.01729748584330082
characterized O 0 0.08046875149011612
. O 0 0.02618623711168766

Protein O 0 0.14097076654434204
- O 0 0.10084177553653717
truncation O 0 0.1391049027442932
testing O 0 0.047042787075042725
of O 0 0.008568432182073593
the O 0 0.014022746123373508
entire O 0 0.04616903141140938
ATM O 0 0.17354319989681244
cDNA O 0 0.1821698099374771
detected O 0 0.12940523028373718
92 O 0 0.10796885937452316
( O 0 0.04324889928102493
66 O 0 0.07381176203489304
% O 0 0.03905734419822693
) O 0 0.032867733389139175
truncating O 0 0.38461679220199585
mutations O 0 0.11935886740684509
in O 0 0.021236177533864975
140 O 0 0.08502589911222458
mutant O 0 0.15628863871097565
alleles O 0 0.20748694241046906
screened O 0 0.13457363843917847
. O 0 0.041809603571891785

The O 0 0.03238574415445328
haplotyping O 1 0.5954774618148804
of O 0 0.020398564636707306
patients O 1 0.9997202754020691
with O 0 0.01834995672106743
identical O 0 0.05202994495630264
mutations O 0 0.12062955647706985
indicates O 0 0.037009354680776596
that O 0 0.006647136062383652
almost O 0 0.008439671248197556
all O 0 0.004197623115032911
of O 0 0.004604756832122803
these O 0 0.005651954095810652
represent O 0 0.013845671899616718
common O 0 0.022504769265651703
ancestry O 0 0.035757727921009064
and O 0 0.008470379747450352
that O 0 0.007544434629380703
very O 0 0.014313800260424614
few O 0 0.0198617335408926
spontaneously O 0 0.11734537035226822
recurring O 1 0.7074549794197083
ATM O 1 0.5352219939231873
mutations O 0 0.14689096808433533
exist O 0 0.033878225833177567
. O 0 0.02649330161511898

Assays O 0 0.17578482627868652
requiring O 0 0.0755113884806633
minimal O 0 0.06275559961795807
amounts O 0 0.02914891391992569
of O 0 0.012817351147532463
genomic O 0 0.08777705579996109
DNA O 0 0.047141361981630325
were O 0 0.008409207686781883
designed O 0 0.02052503451704979
to O 0 0.008980784565210342
allow O 0 0.0190742127597332
rapid O 0 0.06452761590480804
screening O 0 0.0650995671749115
for O 0 0.01109449751675129
common O 0 0.026378881186246872
ethnic O 0 0.030539024621248245
mutations O 0 0.13726158440113068
. O 0 0.03240785002708435

These O 0 0.03391190245747566
rapid O 0 0.1231185719370842
assays O 0 0.1513909548521042
detected O 0 0.12838114798069
mutations O 0 0.10930207371711731
in O 0 0.018040113151073456
76 O 0 0.0632290169596672
% O 0 0.022460922598838806
of O 0 0.013167722150683403
Costa O 0 0.0719158798456192
Rican O 0 0.10285986959934235
patients O 1 0.9996787309646606
( O 0 0.033578060567379
3 O 0 0.027577385306358337
) O 0 0.016472646966576576
, O 0 0.008729908615350723
50 O 0 0.019535813480615616
% O 0 0.019437819719314575
of O 0 0.011077528819441795
Norwegian O 0 0.06197164207696915
patients O 1 0.9996857643127441
( O 0 0.030065538361668587
1 O 0 0.024507280439138412
) O 0 0.015961915254592896
, O 0 0.009238705970346928
25 O 0 0.01515191700309515
% O 0 0.017623605206608772
of O 0 0.011703926138579845
Polish O 0 0.4049495458602905
patients O 1 0.9999210834503174
( O 0 0.028847310692071915
4 O 0 0.021661672741174698
) O 0 0.014123070053756237
, O 0 0.007433180231601
and O 0 0.00739910826086998
14 O 0 0.017489874735474586
% O 0 0.016409771516919136
of O 0 0.010827096179127693
Italian O 0 0.22819426655769348
patients O 1 0.9999817609786987
( O 0 0.03431704267859459
1 O 0 0.0237124003469944
) O 0 0.014913464896380901
, O 0 0.0077649508602917194
as O 0 0.00610395148396492
well O 0 0.007414241787046194
as O 0 0.007020518649369478
in O 0 0.012717574834823608
patients O 1 0.9995607733726501
of O 0 0.016400355845689774
Amish O 1 0.9778807163238525
/ O 1 0.9861422181129456
Mennonite O 0 0.11978979408740997
and O 0 0.014048018492758274
Irish O 0 0.03424518182873726
English O 0 0.023798808455467224
backgrounds O 0 0.05925603210926056
. O 0 0.028641797602176666

Additional O 0 0.06497595459222794
mutations O 0 0.10988511145114899
were O 0 0.011543047614395618
observed O 0 0.025743165984749794
in O 0 0.008837403729557991
Japanese O 0 0.026407262310385704
, O 0 0.013796104118227959
Utah O 0 0.047256991267204285
Mormon O 0 0.04471614211797714
, O 0 0.009452678263187408
and O 0 0.009516030550003052
African O 0 0.0463898591697216
American O 0 0.047981731593608856
patients O 1 0.9998531341552734
. O 0 0.03467175364494324

These O 0 0.022712750360369682
assays O 0 0.07269827276468277
should O 0 0.015175332315266132
facilitate O 0 0.030854161828756332
screening O 0 0.0669892281293869
for O 0 0.014651546254754066
A B-Disease 1 0.8134933710098267
- I-Disease 1 0.9922539591789246
T I-Disease 1 0.9999631643295288
heterozygotes O 1 0.8769334554672241
in O 0 0.01349567249417305
the O 0 0.01328414585441351
populations O 0 0.045106470584869385
studied O 0 0.031673651188611984
. O 0 0.014874831773340702
. O 0 0.02270912192761898

The O 0 0.05452762171626091
von B-Disease 1 0.9940431714057922
Hippel I-Disease 1 0.9999161958694458
- I-Disease 1 0.9957653284072876
Lindau I-Disease 1 0.9999885559082031
tumor I-Disease 1 0.9999874830245972
suppressor O 1 0.9600972533226013
gene O 0 0.0836123675107956
is O 0 0.01400789339095354
required O 0 0.015965661033988
for O 0 0.012698856182396412
cell O 0 0.07985416054725647
cycle O 0 0.09503388404846191
exit O 0 0.08749791979789734
upon O 0 0.0359489843249321
serum O 1 0.9791858792304993
withdrawal O 0 0.11747406423091888
. O 0 0.03655945137143135

The O 0 0.034131355583667755
inactivation O 0 0.14008769392967224
of O 0 0.013377949595451355
the O 0 0.027403682470321655
von B-Disease 1 0.9924813508987427
Hippel I-Disease 1 0.9998869895935059
- I-Disease 1 0.9490877389907837
Lindau I-Disease 1 0.9995280504226685
( I-Disease 0 0.10932514816522598
VHL I-Disease 1 0.9999901056289673
) I-Disease 0 0.10182929784059525
tumor I-Disease 1 0.9999674558639526
suppressor O 1 0.9929176568984985
gene O 0 0.19478090107440948
predisposes O 1 0.9981207251548767
affected O 0 0.0633619874715805
individuals O 0 0.01945457234978676
to O 0 0.007960940711200237
the O 0 0.013647639192640781
human O 1 0.8424029350280762
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.01345700304955244
is O 0 0.011801832355558872
associated O 0 0.018597416579723358
with O 0 0.019022932276129723
sporadic B-Disease 1 0.9974349141120911
renal I-Disease 1 1.0
cell I-Disease 1 0.9998499155044556
carcinomas I-Disease 1 0.9999998807907104
( O 0 0.18932127952575684
RCC B-Disease 1 0.9999992847442627
) O 0 0.03122355416417122
and O 0 0.0205419659614563
brain B-Disease 1 0.9985858201980591
hemangioblastomas I-Disease 1 0.9643531441688538
. O 0 0.032029055058956146

VHL O 1 0.999929666519165
- O 0 0.19499878585338593
negative O 0 0.1299678087234497
786 O 1 0.9950869679450989
- O 0 0.1805403083562851
0 O 0 0.13363204896450043
RCC B-Disease 1 0.9999480247497559
cells O 0 0.09438575059175491
are O 0 0.015049498528242111
tumorigenic O 0 0.201532781124115
in O 0 0.019702516496181488
nude O 0 0.11872687190771103
mice O 0 0.11874278634786606
which O 0 0.013711681589484215
is O 0 0.012842487543821335
suppressed O 0 0.04189986363053322
by O 0 0.00996561162173748
the O 0 0.015559283085167408
reintroduction O 0 0.12856042385101318
of O 0 0.026321163401007652
VHL B-Disease 1 0.9999129772186279
. O 0 0.04371698573231697

Remarkably O 0 0.09986361116170883
, O 0 0.01581588387489319
this O 0 0.012017956003546715
occurs O 0 0.040294349193573
without O 0 0.01482846587896347
affecting O 0 0.040338389575481415
the O 0 0.013601859100162983
growth O 0 0.03138895332813263
rate O 0 0.02711551822721958
and O 0 0.012343434616923332
cell O 0 0.0694972351193428
cycle O 0 0.06934294104576111
profile O 0 0.03867669403553009
of O 0 0.007778791710734367
these O 0 0.008759243413805962
cells O 0 0.04690782353281975
in O 0 0.012261610478162766
culture O 0 0.030116809532046318
. O 0 0.023430416360497475

The O 0 0.043070293962955475
786 O 1 0.9915217161178589
- O 0 0.13206912577152252
0 O 0 0.07705427706241608
cell O 0 0.06310847401618958
line O 0 0.023959459736943245
, O 0 0.011731396429240704
like O 0 0.01562134176492691
many O 0 0.01550035085529089
cancer B-Disease 1 0.9999994039535522
cells O 0 0.08127043396234512
, O 0 0.0139082046225667
fails O 0 0.0581432543694973
to O 0 0.012126062996685505
exit O 0 0.05598733201622963
the O 0 0.01774810068309307
cell O 0 0.07983232289552689
cycle O 0 0.08309607207775116
upon O 0 0.033099688589572906
serum O 1 0.9878262877464294
withdrawal O 0 0.10533618927001953
. O 0 0.03458264842629433

Here O 0 0.023152010515332222
, O 0 0.011178658343851566
it O 0 0.007902688346803188
is O 0 0.009015711024403572
shown O 0 0.016750724986195564
that O 0 0.007724094204604626
reintroduction O 0 0.07201166450977325
of O 0 0.008487377315759659
the O 0 0.013662309385836124
wild O 0 0.05976251885294914
- O 0 0.16020648181438446
type O 0 0.3762364089488983
VHL B-Disease 1 0.9999152421951294
gene O 0 0.11915026605129242
restores O 0 0.0951281189918518
the O 0 0.015809914097189903
ability O 0 0.033792633563280106
of O 0 0.020889131352305412
VHL O 1 0.9999990463256836
- O 1 0.9794054627418518
negative O 1 0.9010207056999207
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
cells O 0 0.08207745105028152
to O 0 0.014182175509631634
exit O 0 0.055157918483018875
the O 0 0.01564282551407814
cell O 0 0.07186263799667358
cycle O 0 0.07213236391544342
and O 0 0.016675889492034912
enter O 0 0.06769364327192307
G0 O 1 0.9999911785125732
/ O 1 0.997589111328125
quiescence O 1 0.8229999542236328
in O 0 0.027789566665887833
low O 0 0.09454599022865295
serum O 1 0.9569727778434753
. O 0 0.03980395197868347

Both O 0 0.053389061242341995
VHL O 1 0.9999533891677856
- O 0 0.12262685596942902
positive O 0 0.05967925488948822
and O 0 0.02695155330002308
VHL O 1 0.9999967813491821
- O 1 0.6383358836174011
negative O 0 0.13186003267765045
RCC B-Disease 1 0.9999854564666748
cells O 0 0.102809838950634
exit O 0 0.06667249649763107
the O 0 0.016216598451137543
cell O 0 0.07017479091882706
cycle O 0 0.07595466822385788
by O 0 0.018888264894485474
contact O 0 0.07750062644481659
inhibition O 0 0.1972324550151825
. O 0 0.033539775758981705

The O 0 0.06543232500553131
cyclin O 1 0.9920935034751892
- O 0 0.16232465207576752
dependent O 0 0.166806161403656
kinase O 1 0.9362918734550476
inhibitor O 1 0.989343523979187
, O 0 0.03554835915565491
p27 O 1 0.9891834259033203
, O 0 0.0284398403018713
accumulates O 0 0.1366572231054306
upon O 0 0.03727630153298378
serum O 1 0.9819712042808533
withdrawal O 0 0.05974966287612915
, O 0 0.00924848485738039
only O 0 0.00571346003562212
in O 0 0.006580724846571684
the O 0 0.009071262553334236
presence O 0 0.027903754264116287
of O 0 0.015216548927128315
VHL B-Disease 1 0.9999709129333496
, O 0 0.01226804405450821
as O 0 0.006622722372412682
a O 0 0.011197401210665703
result O 0 0.014152325689792633
of O 0 0.0062441579066216946
the O 0 0.011615523137152195
stabilization O 0 0.09588316828012466
of O 0 0.010347607545554638
the O 0 0.0183777566999197
protein O 0 0.07100214064121246
. O 0 0.0285502802580595

We O 0 0.02322698011994362
propose O 0 0.03760187700390816
that O 0 0.007088255137205124
the O 0 0.010322382673621178
loss O 0 0.03984581679105759
of O 0 0.012794938869774342
wild O 0 0.06469284743070602
- O 0 0.4290759563446045
type O 1 0.6277812719345093
VHL B-Disease 1 0.9999382495880127
gene O 0 0.0925162062048912
results O 0 0.023904256522655487
in O 0 0.008113442920148373
a O 0 0.01491436269134283
specific O 0 0.024094577878713608
cellular O 0 0.08308222889900208
defect O 1 0.9852042198181152
in O 0 0.023968003690242767
serum O 1 0.9993259906768799
- O 0 0.09069320559501648
dependent O 0 0.06346481293439865
growth O 0 0.03629370778799057
control O 0 0.03033607080578804
, O 0 0.011415427550673485
which O 0 0.012562014162540436
may O 0 0.03262326866388321
initiate O 0 0.3038448393344879
tumor B-Disease 1 0.999946117401123
formation O 0 0.09615948796272278
. O 0 0.03321587294340134

This O 0 0.02006356418132782
is O 0 0.017239820212125778
corrected O 0 0.058839552104473114
by O 0 0.009833124466240406
the O 0 0.012627660296857357
reintroduction O 0 0.10106141120195389
of O 0 0.015984728932380676
wild O 0 0.061097197234630585
- O 0 0.2340744435787201
type O 1 0.8640332818031311
VHL B-Disease 1 0.9999889135360718
, O 0 0.03612088784575462
implicating O 1 0.8395100831985474
VHL B-Disease 1 0.9995549321174622
as O 0 0.012440282851457596
the O 0 0.012614122591912746
first O 0 0.028300311416387558
tumor B-Disease 1 0.9999767541885376
suppressor O 1 0.8656930327415466
involved O 0 0.021551460027694702
in O 0 0.009067020379006863
the O 0 0.009937901049852371
regulation O 0 0.04010114073753357
of O 0 0.01505348365753889
cell O 0 0.08254880458116531
cycle O 0 0.08881689608097076
exit O 0 0.06442536413669586
, O 0 0.01020174752920866
which O 0 0.007085513789206743
is O 0 0.010041329078376293
consistent O 0 0.02203199826180935
with O 0 0.008251591585576534
its O 0 0.01515459269285202
gatekeeper O 1 0.8088527917861938
function O 0 0.03198065236210823
in O 0 0.012652118690311909
the O 0 0.01889137178659439
kidney O 1 0.9999991655349731
. O 0 0.02110864222049713
. O 0 0.02721448987722397

Piebaldism B-Disease 1 0.999830961227417
with O 0 0.053777217864990234
deafness B-Disease 1 0.9999998807907104
: O 0 0.029522119089961052
molecular O 0 0.039438437670469284
evidence O 0 0.012903175316751003
for O 0 0.008141741156578064
an O 0 0.015456156805157661
expanded O 0 0.06266634911298752
syndrome O 1 1.0
. O 0 0.045034002512693405

In O 0 0.021179720759391785
a O 0 0.019979093223810196
South O 0 0.032770562916994095
African O 0 0.04602642357349396
girl O 0 0.07259400188922882
of O 0 0.014165797270834446
Xhosa O 1 0.9952527284622192
stock O 0 0.09433908760547638
with O 0 0.024474337697029114
severe O 1 0.9999872446060181
piebaldism B-Disease 1 0.9996064305305481
and O 0 0.03326410427689552
profound O 1 0.9999185800552368
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.021265873685479164
identified O 0 0.026930805295705795
a O 0 0.021435735747218132
novel O 0 0.04344870150089264
missense O 0 0.1691882610321045
substitution O 0 0.07265017181634903
at O 0 0.0233906377106905
a O 0 0.019768400117754936
highly O 0 0.035934995859861374
conserved O 0 0.04965377599000931
residue O 0 0.07927793264389038
in O 0 0.01208566501736641
the O 0 0.019524825736880302
intracellular O 0 0.17346854507923126
kinase O 0 0.1863495260477066
domain O 0 0.032677315175533295
of O 0 0.011023557744920254
the O 0 0.020206790417432785
KIT O 1 0.9965013265609741
proto O 1 0.9948443174362183
- O 0 0.20315928757190704
oncogene O 1 0.9060751795768738
, O 0 0.042276594787836075
R796G O 0 0.19490666687488556
. O 0 0.04402685910463333

Though O 0 0.07083528488874435
auditory B-Disease 1 0.9965628981590271
anomalies I-Disease 0 0.40449297428131104
have O 0 0.01125391572713852
been O 0 0.011668557301163673
observed O 0 0.02467644400894642
in O 0 0.010966908186674118
mice O 0 0.0877433568239212
with O 0 0.018033357337117195
dominant O 0 0.0747545138001442
white O 0 0.11304488033056259
spotting O 1 0.9989408850669861
( O 0 0.056458741426467896
W O 1 0.9987461566925049
) O 0 0.020168600603938103
due O 0 0.01635541208088398
to O 0 0.016458652913570404
KIT O 1 0.9992178678512573
mutations O 0 0.2876393795013428
, O 0 0.03521762415766716
deafness B-Disease 1 0.9999992847442627
is O 0 0.01469986978918314
not O 0 0.0092480992898345
typical O 0 0.030077310279011726
in O 0 0.013476020656526089
human O 0 0.03357987850904465
piebaldism B-Disease 1 0.9157257080078125
. O 0 0.03377045691013336

Thus O 0 0.03206660598516464
, O 0 0.011746714822947979
the O 0 0.013037045486271381
occurrence O 0 0.08480626344680786
of O 0 0.025565877556800842
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.019856151193380356
this O 0 0.015221551060676575
patient O 1 0.9993981122970581
extends O 0 0.06607663631439209
considerably O 0 0.037891894578933716
the O 0 0.01267313864082098
phenotypic O 0 0.07836390286684036
range O 0 0.029143821448087692
of O 0 0.012058879248797894
piebaldism B-Disease 0 0.4648248255252838
due O 0 0.026308273896574974
to O 0 0.01899673417210579
KIT O 1 0.9944285154342651
gene O 0 0.11854290217161179
mutation O 0 0.13116887211799622
in O 0 0.01548660360276699
humans O 0 0.03574615716934204
and O 0 0.014004007913172245
tightens O 1 0.9929293990135193
the O 0 0.018018165603280067
clinical O 1 0.7357564568519592
similarity O 0 0.045491646975278854
between O 0 0.017451157793402672
piebaldism B-Disease 0 0.12401369959115982
and O 0 0.007609062362462282
the O 0 0.006659682374447584
various O 0 0.008767005056142807
forms O 0 0.02791999839246273
of O 0 0.03210839629173279
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0246712788939476
. O 0 0.025754911825060844

Cycloheximide O 1 0.5863873958587646
facilitates O 0 0.10803235322237015
the O 0 0.016808411106467247
identification O 0 0.034551333636045456
of O 0 0.015467900782823563
aberrant O 0 0.17962001264095306
transcripts O 0 0.05266577750444412
resulting O 0 0.035012226551771164
from O 0 0.015694262459874153
a O 0 0.024605795741081238
novel O 0 0.05262814089655876
splice O 0 0.208308145403862
- O 0 0.09369980543851852
site O 0 0.04755198955535889
mutation O 0 0.11500100046396255
in O 0 0.018543243408203125
COL17A1 O 1 0.8471302390098572
in O 0 0.01607501320540905
a O 0 0.026269102469086647
patient O 1 0.9993225336074829
with O 0 0.02833043783903122
generalized O 1 0.9993324875831604
atrophic B-Disease 1 0.9999997615814209
benign I-Disease 1 0.9999992847442627
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999973773956299
. O 0 0.07123962789773941

Patients O 1 0.9999483823776245
with O 0 0.05002877116203308
generalized O 1 0.9989905953407288
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999991655349731
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999990463256836
often O 0 0.04891606792807579
show O 0 0.03495033085346222
decreased O 0 0.06486163288354874
expression O 0 0.03829570859670639
of O 0 0.015422750264406204
type O 1 0.9888532161712646
XVII O 1 0.999997615814209
collagen O 1 0.9995412826538086
, O 0 0.02207646705210209
a O 0 0.03439706563949585
transmembrane O 0 0.184594064950943
hemidesmosomal O 0 0.2277713418006897
protein O 0 0.07114116102457047
encoded O 0 0.03475016728043556
by O 0 0.02377934753894806
COL17A1 O 1 0.9367019534111023
. O 0 0.04039456322789192

This O 0 0.01631009578704834
report O 0 0.01629767008125782
documents O 0 0.011928051710128784
a O 0 0.018941354006528854
novel O 0 0.045093387365341187
splice O 0 0.18236172199249268
- O 0 0.08946310728788376
site O 0 0.04581063240766525
mutation O 0 0.11697623133659363
in O 0 0.018454402685165405
COL17A1 O 1 0.9205051064491272
in O 0 0.014083456248044968
a O 0 0.02560552768409252
patient O 1 0.9992862343788147
with O 0 0.024736149236559868
generalized O 1 0.999840259552002
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
, O 0 0.02338436432182789
and O 0 0.011207224801182747
applies O 0 0.028976423665881157
a O 0 0.013511870987713337
new O 0 0.013845822773873806
methodology O 0 0.03158119320869446
to O 0 0.008710738271474838
define O 0 0.026903701946139336
and O 0 0.01180772203952074
characterize O 0 0.07165262848138809
the O 0 0.016725219786167145
resulting O 0 0.055108413100242615
mRNA O 0 0.09749629348516464
splice O 0 0.20420369505882263
variants O 0 0.08823199570178986
. O 0 0.032471466809511185

Mutational O 1 0.8372430801391602
analysis O 0 0.048229966312646866
of O 0 0.017098471522331238
COL17A1 O 1 0.9478088617324829
identified O 0 0.03644583001732826
a O 0 0.027988145127892494
maternally O 0 0.30035796761512756
inherited O 1 0.9850469827651978
G O 1 0.9934422969818115
- O 0 0.08578609675168991
to O 0 0.026007574051618576
- O 0 0.20638936758041382
T O 1 0.9928445219993591
transversion O 0 0.16188038885593414
at O 0 0.02079845778644085
the O 0 0.012813443318009377
- O 0 0.05319276824593544
1 O 0 0.021677114069461823
position O 0 0.01882287487387657
of O 0 0.01451107207685709
exon O 0 0.1475180685520172
32 O 0 0.06437115371227264
. O 0 0.03406330198049545

This O 0 0.03498617932200432
acceptor O 0 0.4813600778579712
splice O 0 0.36729881167411804
- O 0 0.11572825908660889
site O 0 0.05075965076684952
mutation O 0 0.11434740573167801
led O 0 0.02384144254028797
to O 0 0.008717472665011883
the O 0 0.011949517764151096
formation O 0 0.041713811457157135
of O 0 0.012288435362279415
aberrant O 0 0.1501317024230957
transcripts O 0 0.05035500228404999
present O 0 0.021822387352585793
at O 0 0.02530508115887642
extremely O 0 0.04411622881889343
low O 0 0.05462386831641197
levels O 0 0.06066485866904259
. O 0 0.028574928641319275

Based O 0 0.02664986066520214
on O 0 0.01035364530980587
our O 0 0.012604636140167713
recent O 0 0.019222186878323555
finding O 0 0.02660803496837616
that O 0 0.01758914813399315
cycloheximide O 1 0.9080493450164795
stabilized O 1 0.9334516525268555
mutant O 0 0.17343902587890625
COL17A1 O 1 0.9702702164649963
transcripts O 0 0.0663844645023346
in O 0 0.023921718820929527
keratinocytes O 1 0.5883082151412964
homozygous O 0 0.10509900003671646
for O 0 0.01832345314323902
a O 0 0.041251301765441895
frameshift O 1 0.9870842099189758
mutation O 0 0.13977494835853577
, O 0 0.013178185559809208
the O 0 0.011405277997255325
effects O 0 0.04655392840504646
of O 0 0.008577225729823112
the O 0 0.016827067360281944
splice O 0 0.3806001543998718
- O 0 0.09640625864267349
site O 0 0.04710494726896286
mutation O 0 0.11230353266000748
on O 0 0.01668458618223667
splicing O 0 0.08999999612569809
of O 0 0.0183884184807539
COL17A1 O 1 0.9085633158683777
transcripts O 0 0.044197630137205124
were O 0 0.011432831175625324
determined O 0 0.03268427401781082
using O 0 0.027056103572249413
reverse O 0 0.11174272000789642
transcriptase O 0 0.49223995208740234
polymerase O 0 0.22288751602172852
chain O 0 0.0884501188993454
reaction O 0 0.05646799877285957
of O 0 0.011713432148098946
total O 0 0.024480193853378296
RNA O 0 0.09408338367938995
from O 0 0.024364499375224113
keratinocytes O 1 0.5472519993782043
incubated O 0 0.09460616111755371
for O 0 0.016694869846105576
2 O 0 0.03321690484881401
. O 0 0.02432456612586975

5 O 0 0.05798714607954025
h O 0 0.08547671139240265
in O 0 0.0102087939158082
the O 0 0.009977595880627632
presence O 0 0.027085255831480026
or O 0 0.015623234212398529
absence O 0 0.03226147219538689
of O 0 0.010834278538823128
10 O 0 0.030175888910889626
microg O 1 0.8728688359260559
cycloheximide O 1 0.745498538017273
per O 0 0.051321275532245636
ml O 1 0.7459743022918701
. O 0 0.03712860122323036

Using O 0 0.02718191221356392
this O 0 0.012856247834861279
approach O 0 0.030072856694459915
, O 0 0.013392074964940548
an O 0 0.021033812314271927
abnormally O 1 0.9560355544090271
spliced O 0 0.14469079673290253
transcript O 0 0.07343443483114243
was O 0 0.017372148111462593
identified O 0 0.01864478923380375
that O 0 0.0074774413369596004
contains O 0 0.01356551144272089
an O 0 0.012990785762667656
extra O 0 0.03669774904847145
264 O 0 0.08628049492835999
bases O 0 0.03868303447961807
upstream O 0 0.06305371969938278
from O 0 0.02195415459573269
exon O 0 0.13008157908916473
32 O 0 0.04016508162021637
, O 0 0.013473661616444588
resulting O 0 0.031017785891890526
in O 0 0.014875095337629318
a O 0 0.035330697894096375
premature O 1 0.955842137336731
termination O 1 0.8332898616790771
codon O 0 0.18133780360221863
27 O 0 0.06330812722444534
bp O 0 0.12093141674995422
downstream O 0 0.06943654268980026
from O 0 0.017231808975338936
the O 0 0.021006178110837936
cryptic O 0 0.1588103473186493
splice O 0 0.2126612365245819
site O 0 0.05027977377176285
. O 0 0.03140684962272644

Three O 0 0.024930767714977264
other O 0 0.018438424915075302
splice O 0 0.16678309440612793
variants O 0 0.058659616857767105
, O 0 0.010143090970814228
including O 0 0.007438909728080034
one O 0 0.009322093799710274
derived O 0 0.01966238208115101
from O 0 0.010613689199090004
the O 0 0.012303967028856277
skipping O 0 0.07278183102607727
of O 0 0.012710842303931713
exon O 0 0.1201462373137474
32 O 0 0.03230849280953407
, O 0 0.009886928834021091
were O 0 0.00782470591366291
also O 0 0.010658366605639458
identified O 0 0.028760774061083794
. O 0 0.022874243557453156

These O 0 0.017111144959926605
results O 0 0.025966761633753777
indicate O 0 0.024122873321175575
the O 0 0.010498310439288616
usefulness O 0 0.06082887947559357
of O 0 0.013493286445736885
cycloheximide O 1 0.9992257356643677
treatment O 1 0.9991016387939453
in O 0 0.01199629157781601
evaluating O 0 0.049378883093595505
the O 0 0.017418857663869858
abnormal O 0 0.19522982835769653
processing O 0 0.024981964379549026
of O 0 0.008563240058720112
mRNA O 0 0.04621860757470131
due O 0 0.023011114448308945
to O 0 0.019553441554307938
splice O 0 0.18900983035564423
- O 0 0.09831138700246811
site O 0 0.0540994293987751
mutations O 0 0.10705631226301193
, O 0 0.016858438029885292
because O 0 0.021536603569984436
( O 0 0.027298713102936745
i O 0 0.031041041016578674
) O 0 0.028868908062577248
aberrant O 0 0.16022981703281403
splicing O 0 0.12542299926280975
often O 0 0.03031875565648079
generates O 0 0.07518012821674347
a O 0 0.03551866114139557
premature O 1 0.9462429881095886
termination O 1 0.6316444873809814
codon O 0 0.15468238294124603
, O 0 0.024554762989282608
( O 0 0.031584352254867554
ii O 0 0.06299050152301788
) O 0 0.024772586300969124
transcripts O 0 0.04433371126651764
with O 0 0.02262123115360737
premature O 1 0.9809009432792664
termination O 1 0.9139482975006104
codons O 0 0.13171283900737762
can O 0 0.024483054876327515
occur O 0 0.03360772877931595
at O 0 0.02196313627064228
low O 0 0.046306416392326355
or O 0 0.027184782549738884
undetectable O 1 0.9925981760025024
levels O 0 0.049617886543273926
due O 0 0.023430410772562027
to O 0 0.0162105280905962
nonsense O 0 0.0946943387389183
- O 0 0.09661951661109924
mediated O 0 0.18066458404064178
mRNA O 0 0.09563152492046356
decay O 0 0.06376855075359344
, O 0 0.013389334082603455
and O 0 0.012757769785821438
( O 0 0.03128340467810631
iii O 0 0.06289342045783997
) O 0 0.012863881886005402
the O 0 0.008570189587771893
levels O 0 0.023610800504684448
of O 0 0.005852950736880302
these O 0 0.005948778707534075
transcripts O 0 0.02901877649128437
can O 0 0.009207237511873245
be O 0 0.0066703809425234795
increased O 0 0.02195107564330101
by O 0 0.016761017963290215
cycloheximide O 1 0.5366306304931641
. O 0 0.033527813851833344

A O 0 0.0782942995429039
deletion O 0 0.19863268733024597
mutation O 0 0.1574452519416809
in O 0 0.021643828600645065
COL17A1 O 1 0.7551912665367126
in O 0 0.014051399193704128
five O 0 0.01722913607954979
Austrian O 0 0.06450269371271133
families O 0 0.03183847665786743
with O 0 0.02831202931702137
generalized O 1 0.9991388320922852
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999994039535522
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9999915361404419
represents O 0 0.07312473654747009
propagation O 0 0.060727011412382126
of O 0 0.010321954265236855
an O 0 0.017907923087477684
ancestral O 0 0.08922470360994339
allele O 0 0.21033857762813568
. O 0 0.044185929000377655

Patients O 1 0.9999406337738037
with O 0 0.04241032153367996
generalized O 1 0.9996532201766968
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
, O 0 0.024255402386188507
a O 0 0.019894124940037727
usually O 0 0.025538569316267967
nonlethal O 0 0.13380463421344757
form O 0 0.03132393956184387
of O 0 0.027881890535354614
junctional B-Disease 1 0.9999967813491821
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.999998927116394
, O 0 0.024638706818223
have O 0 0.018053043633699417
generalized O 1 0.7454622983932495
blistering B-Disease 1 0.9954584836959839
, O 0 0.03929544612765312
nail B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
, O 0 0.0608583502471447
patchy B-Disease 1 0.9999983310699463
alopecia I-Disease 1 1.0
, O 0 0.02496708743274212
and O 0 0.02197890542447567
dental B-Disease 1 0.9999997615814209
abnormalities I-Disease 1 0.999758780002594
. O 0 0.03359174355864525

Skin B-Disease 1 0.9999991655349731
fragility I-Disease 1 0.999518871307373
in O 0 0.01757214032113552
most O 0 0.012487517669796944
cases O 0 0.021163254976272583
is O 0 0.009654218330979347
due O 0 0.015142086893320084
to O 0 0.010092039592564106
mutations O 0 0.06344109773635864
in O 0 0.00994536280632019
the O 0 0.014356651343405247
gene O 0 0.08585522323846817
encoding O 0 0.08216073364019394
type O 1 0.6991167664527893
XVII O 1 0.9999955892562866
collagen O 1 0.9999226331710815
( O 0 0.06724055111408234
COL17A1 O 1 0.9981106519699097
) O 0 0.03434157371520996
. O 0 0.027386443689465523

Recently O 0 0.05644235014915466
, O 0 0.015374008566141129
we O 0 0.012237044982612133
reported O 0 0.024004986509680748
five O 0 0.01589910127222538
Austrian O 0 0.05897495150566101
families O 0 0.029846686869859695
with O 0 0.026532677933573723
generalized O 1 0.9990103244781494
atrophic B-Disease 1 0.9999998807907104
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999990463256836
who O 0 0.033797990530729294
share O 0 0.024312589317560196
the O 0 0.01366444118320942
same O 0 0.02682924084365368
COL17A1 O 1 0.9983750581741333
mutation O 0 0.21497440338134766
. O 0 0.0373435877263546

Affected O 0 0.07149894535541534
individuals O 0 0.020006751641631126
in O 0 0.008754064328968525
three O 0 0.008212395943701267
families O 0 0.019515128806233406
are O 0 0.01005090307444334
homozygous O 0 0.07557186484336853
for O 0 0.014600527472794056
4003delTC O 0 0.13891097903251648
, O 0 0.012178336270153522
whereas O 0 0.022999314591288567
those O 0 0.00613626791164279
in O 0 0.005898268893361092
two O 0 0.006345408968627453
others O 0 0.012638889253139496
are O 0 0.011047199368476868
compound O 0 0.09119022637605667
heterozygotes O 1 0.9898147583007812
. O 0 0.03577117249369621

To O 0 0.020592471584677696
determine O 0 0.024015098810195923
if O 0 0.012555723078548908
the O 0 0.010914607904851437
occurrence O 0 0.06281431019306183
of O 0 0.011753834784030914
4003delTC O 0 0.13209886848926544
in O 0 0.010719435289502144
these O 0 0.008662487380206585
unrelated O 0 0.0484171062707901
families O 0 0.03536708652973175
signifies O 0 0.07975834608078003
propagation O 0 0.05418594181537628
of O 0 0.008662151172757149
an O 0 0.014275336638092995
ancestral O 0 0.08391872048377991
allele O 0 0.1502508521080017
or O 0 0.026116404682397842
a O 0 0.03619890660047531
mutational O 1 0.9977042078971863
hot O 0 0.1019628494977951
spot O 0 0.05397200584411621
, O 0 0.019292093813419342
haplotypes O 0 0.14168158173561096
were O 0 0.010421830229461193
determined O 0 0.02450706623494625
for O 0 0.011887802742421627
polymorphisms O 0 0.07455909252166748
both O 0 0.010064005851745605
within O 0 0.013325034640729427
and O 0 0.01535054575651884
flanking O 0 0.2794063091278076
COL17A1 O 1 0.9955852031707764
. O 0 0.03346594050526619

Five O 0 0.052303630858659744
intragenic O 0 0.27280092239379883
polymorphisms O 0 0.12708014249801636
were O 0 0.012042318470776081
chosen O 0 0.016660602763295174
based O 0 0.012637829408049583
on O 0 0.008708246983587742
their O 0 0.013289335183799267
informativeness O 0 0.2713635563850403
. O 0 0.03581368923187256

One O 0 0.014477071352303028
of O 0 0.006197064649313688
these O 0 0.006101764738559723
, O 0 0.007910478860139847
not O 0 0.007256564684212208
previously O 0 0.015845924615859985
reported O 0 0.023176901042461395
, O 0 0.009191574528813362
was O 0 0.01624705269932747
2988 O 0 0.1692104935646057
A O 0 0.028269411996006966
or O 0 0.022319655865430832
C O 0 0.08641430735588074
that O 0 0.01060638576745987
introduces O 0 0.04642713442444801
a O 0 0.016028501093387604
new O 0 0.01650814525783062
restriction O 0 0.04023199528455734
site O 0 0.024069497361779213
for O 0 0.01572570390999317
Eco0109 O 0 0.16942046582698822
I O 0 0.04476955160498619
. O 0 0.022904599085450172

All O 0 0.016365746036171913
the O 0 0.021264085546135902
4003delTC O 0 0.33099499344825745
alleles O 0 0.14393477141857147
showed O 0 0.0319766104221344
the O 0 0.011662069708108902
same O 0 0.020431479439139366
haplotype O 1 0.9138615131378174
for O 0 0.009677991271018982
these O 0 0.008603078313171864
five O 0 0.02097008377313614
polymorphic O 0 0.2390296459197998
markers O 0 0.10474955290555954
. O 0 0.03691906854510307

Fourteen O 0 0.11323391646146774
microsatellite O 0 0.3364872634410858
polymorphisms O 0 0.13168887794017792
were O 0 0.011820810846984386
selected O 0 0.014444749802350998
based O 0 0.011442904360592365
on O 0 0.006612867116928101
their O 0 0.009469874203205109
high O 0 0.034195225685834885
heterozygosity O 0 0.4239308834075928
and O 0 0.010172990150749683
their O 0 0.009584189392626286
location O 0 0.024864817038178444
within O 0 0.02538806013762951
10q23 O 1 0.7793790698051453
- O 0 0.12402406334877014
q25 O 0 0.22423328459262848
near O 0 0.08571428805589676
COL17A1 O 1 0.9876574277877808
. O 0 0.03568265214562416

Three O 0 0.027154967188835144
families O 0 0.042658258229494095
shared O 0 0.0616314522922039
microsatellite O 1 0.6674048900604248
polymorphisms O 0 0.16845770180225372
covering O 0 0.05399934947490692
at O 0 0.022519947960972786
most O 0 0.013792627491056919
19 O 0 0.027877936139702797
cM O 0 0.047214459627866745
, O 0 0.01119568943977356
whereas O 0 0.019732072949409485
the O 0 0.008157158270478249
others O 0 0.013609038665890694
shared O 0 0.021604513749480247
smaller O 0 0.02066636271774769
regions O 0 0.025819770991802216
consistent O 0 0.02743518352508545
with O 0 0.011334008537232876
cross O 0 0.03454688936471939
- O 0 0.04384756460785866
over O 0 0.011398166418075562
events O 0 0.016675710678100586
during O 0 0.01735834777355194
passage O 0 0.02256442978978157
of O 0 0.007849457673728466
this O 0 0.011927490122616291
mutation O 0 0.09102243930101395
through O 0 0.016064714640378952
several O 0 0.01201566867530346
generations O 0 0.04256885126233101
. O 0 0.027416115626692772

These O 0 0.0186686459928751
results O 0 0.03375804051756859
indicate O 0 0.03566144034266472
that O 0 0.013453654013574123
4003delTC O 0 0.14820295572280884
occurs O 0 0.03334110230207443
on O 0 0.007153340615332127
a O 0 0.01379024051129818
single O 0 0.026313843205571175
ancestral O 0 0.0769365206360817
allele O 0 0.15036018192768097
. O 0 0.021151889115571976
. O 0 0.028177406638860703

The O 0 0.06089258939027786
haptoglobin O 1 0.9947718977928162
- O 0 0.16523632407188416
gene O 0 0.15009844303131104
deletion O 0 0.15200315415859222
responsible O 0 0.04722196236252785
for O 0 0.023218343034386635
anhaptoglobinemia B-Disease 1 0.5659083127975464
. O 0 0.03605802729725838

We O 0 0.020150015130639076
have O 0 0.010999944061040878
found O 0 0.017316143959760666
an O 0 0.01820444129407406
allelic O 0 0.22544237971305847
deletion O 0 0.11257670074701309
of O 0 0.013027464970946312
the O 0 0.023089231923222542
haptoglobin O 1 0.9884186387062073
( O 0 0.05413873866200447
Hp O 0 0.2987334728240967
) O 0 0.031054243445396423
gene O 0 0.04850941523909569
from O 0 0.01063369121402502
an O 0 0.009446877054870129
individual O 0 0.017254991456866264
with O 0 0.021069590002298355
anhaptoglobinemia B-Disease 1 0.9226254820823669
. O 0 0.03152680769562721

The O 0 0.040141742676496506
Hp O 0 0.4526825547218323
gene O 0 0.10401999950408936
cluster O 0 0.07514053583145142
consists O 0 0.022768860682845116
of O 0 0.01225588284432888
coding O 0 0.07959439605474472
regions O 0 0.023357557132840157
of O 0 0.008499214425683022
the O 0 0.014640619978308678
alpha O 0 0.06954856216907501
chain O 0 0.05605738237500191
and O 0 0.014781950041651726
beta O 0 0.06226184591650963
chain O 0 0.04746193438768387
of O 0 0.009666685946285725
the O 0 0.02214978262782097
haptoglobin O 1 0.991692066192627
gene O 0 0.11555386334657669
( O 0 0.041894879192113876
Hp O 0 0.13270486891269684
) O 0 0.014720837585628033
and O 0 0.005600367672741413
of O 0 0.005192126147449017
the O 0 0.01180277206003666
alpha O 0 0.06736180186271667
chain O 0 0.05483703687787056
and O 0 0.01343581173568964
beta O 0 0.06543363630771637
chain O 0 0.04482278600335121
of O 0 0.010334314778447151
the O 0 0.02159639075398445
haptoglobin O 1 0.9992225170135498
- O 0 0.1091870442032814
related O 0 0.05505787953734398
gene O 0 0.11168574541807175
( O 0 0.054677799344062805
Hpr O 1 0.9960171580314636
) O 0 0.02077655680477619
, O 0 0.009563331492245197
in O 0 0.00916434358805418
tandem O 0 0.05871139466762543
from O 0 0.011361547745764256
the O 0 0.011487878859043121
5 O 0 0.025412138551473618
side O 0 0.03547205775976181
. O 0 0.023781966418027878

Southern O 0 0.08009588718414307
blot O 0 0.3998648524284363
and O 0 0.024751683697104454
PCR O 0 0.1557360142469406
analyses O 0 0.03884550556540489
have O 0 0.009285262785851955
indicated O 0 0.018923640251159668
that O 0 0.005205788183957338
the O 0 0.007736947387456894
individual O 0 0.01616014912724495
with O 0 0.014614200219511986
anhaptoglobinemia B-Disease 1 0.5815685987472534
was O 0 0.022795166820287704
homozygous O 0 0.07506094872951508
for O 0 0.009225059300661087
the O 0 0.013243443332612514
gene O 0 0.0773700624704361
deletion O 0 0.09009318798780441
and O 0 0.00892530009150505
that O 0 0.007607319857925177
the O 0 0.013991397805511951
gene O 0 0.0878213495016098
deletion O 0 0.10464590042829514
was O 0 0.015283043496310711
included O 0 0.013583894819021225
at O 0 0.01528076734393835
least O 0 0.0111832981929183
from O 0 0.009309510700404644
the O 0 0.012106439098715782
promoter O 0 0.10449578613042831
region O 0 0.03618842735886574
of O 0 0.012999976985156536
Hp O 0 0.13190148770809174
to O 0 0.021268224343657494
Hpr O 1 0.9777058959007263
alpha O 0 0.06577993184328079
but O 0 0.010858389548957348
not O 0 0.010117804631590843
to O 0 0.01915563829243183
Hpr O 1 0.9897547364234924
beta O 0 0.12654763460159302
( O 0 0.050929270684719086
Hpdel O 1 0.857745349407196
) O 0 0.029967494308948517
. O 0 0.022511549293994904

In O 0 0.02041294425725937
addition O 0 0.02039080113172531
, O 0 0.009558802470564842
we O 0 0.0076811243779957294
found O 0 0.011663059704005718
seven O 0 0.013530761934816837
individuals O 0 0.015590174123644829
with O 0 0.011659432202577591
hypohaptoglobinemia B-Disease 0 0.3397848904132843
in O 0 0.009760860353708267
three O 0 0.008962757885456085
families O 0 0.019338076934218407
, O 0 0.008382466621696949
and O 0 0.007299418561160564
the O 0 0.010926422663033009
genotypes O 0 0.11088979989290237
of O 0 0.006462151184678078
six O 0 0.009006019681692123
of O 0 0.005203526932746172
the O 0 0.007856825366616249
seven O 0 0.012646329589188099
individuals O 0 0.01179533638060093
were O 0 0.006080258637666702
found O 0 0.01066972129046917
to O 0 0.00867148395627737
be O 0 0.01602872647345066
Hp2 O 1 0.9988493919372559
/ O 1 0.9951371550559998
Hpdel O 1 0.93153977394104
. O 0 0.03337792307138443

The O 0 0.041018757969141006
phenotypes O 0 0.16781482100486755
and O 0 0.021482661366462708
genotypes O 0 0.14275972545146942
in O 0 0.010175203904509544
one O 0 0.007303894497454166
of O 0 0.005224381573498249
these O 0 0.0052490620873868465
three O 0 0.007283282931894064
families O 0 0.01883547008037567
showed O 0 0.02239484339952469
the O 0 0.009283779188990593
father O 0 0.01843523420393467
to O 0 0.008791614323854446
be O 0 0.014153418131172657
hypohaptoglobinemic B-Disease 1 0.7544663548469543
( O 0 0.042703334242105484
Hp2 O 1 0.7806434035301208
) O 0 0.025894099846482277
and O 0 0.01950186677277088
Hp2 O 1 0.9976286292076111
/ O 1 0.985007107257843
Hpdel O 1 0.5244024991989136
, O 0 0.010491807945072651
the O 0 0.008574509993195534
mother O 0 0.02442772500216961
to O 0 0.008780130185186863
be O 0 0.01167289074510336
Hp2 O 1 0.9161708950996399
- O 0 0.07500164210796356
1 O 0 0.032320983707904816
and O 0 0.022006558254361153
Hp1 O 1 0.9988648891448975
/ O 1 0.9931829571723938
Hp2 O 1 0.6298549771308899
, O 0 0.00957859680056572
one O 0 0.005849040113389492
of O 0 0.00449523376300931
the O 0 0.007494201418012381
two O 0 0.0072973910719156265
children O 0 0.018478451296687126
to O 0 0.010870488360524178
be O 0 0.015879513695836067
hypohaptoglobinemic B-Disease 1 0.7809791564941406
( O 0 0.04540674388408661
Hp2 O 1 0.654148519039154
) O 0 0.027781901881098747
and O 0 0.020639875903725624
Hp2 O 1 0.9994269609451294
/ O 1 0.9968066215515137
Hpdel O 1 0.7157004475593567
, O 0 0.009761085733771324
and O 0 0.006042505614459515
the O 0 0.005924612749367952
other O 0 0.006064769811928272
child O 0 0.026523349806666374
to O 0 0.008909707888960838
be O 0 0.011890895664691925
Hp1 O 1 0.8971498012542725
and O 0 0.022838514298200607
Hp1 O 1 0.9990969896316528
/ O 1 0.995902955532074
Hpdel O 1 0.8429749608039856
, O 0 0.015401853248476982
showing O 0 0.02871824987232685
an O 0 0.01873578131198883
anomalous O 0 0.135664701461792
inheritance O 0 0.06712622940540314
of O 0 0.018415894359350204
Hp O 1 0.8052330017089844
phenotypes O 0 0.11550094187259674
in O 0 0.011875912547111511
the O 0 0.01285169180482626
child O 0 0.049250394105911255
with O 0 0.023249903693795204
Hp1 O 1 0.9756935238838196
. O 0 0.03315185010433197

The O 0 0.058074913918972015
Hp2 O 1 0.9985120892524719
/ O 1 0.9951851963996887
Hpdel O 1 0.74507075548172
individuals O 0 0.022413432598114014
had O 0 0.01363668218255043
an O 0 0.011638877913355827
extremely O 0 0.03389083966612816
low O 0 0.03396447002887726
level O 0 0.023410076275467873
of O 0 0.013578400015830994
Hp O 0 0.47467368841171265
( O 0 0.04408075287938118
mean O 0 0.058231890201568604
+ O 1 0.9814842939376831
/ O 1 0.9861946105957031
- O 0 0.1297975480556488
SD O 0 0.27716541290283203
= O 0 0.15964052081108093
0 O 0 0.0799281969666481
. O 0 0.039425529539585114
049 O 1 0.9980108141899109
+ O 1 0.9499766230583191
/ O 1 0.9332000613212585
- O 0 0.1055554524064064
0 O 0 0.07197944819927216
. O 0 0.032644305378198624
043 O 1 0.9864046573638916
mg O 1 0.9983193278312683
/ O 1 0.9930064678192139
ml O 1 0.7038970589637756
; O 0 0.040706392377614975
n O 0 0.0892016589641571
= O 0 0.10365235805511475
6 O 0 0.03391658514738083
) O 0 0.018192065879702568
, O 0 0.009881027042865753
compared O 0 0.016139397397637367
with O 0 0.00846945121884346
the O 0 0.01075710728764534
level O 0 0.024977317079901695
( O 0 0.02043142542243004
1 O 0 0.018316542729735374
. O 0 0.012876639142632484
64 O 0 0.05226816609501839
+ O 1 0.8867914080619812
/ O 1 0.9561827778816223
- O 0 0.07523404061794281
1 O 0 0.03349356725811958
. O 0 0.02521183155477047
07 O 1 0.8950872421264648
mg O 1 0.9977468848228455
/ O 1 0.9907659292221069
ml O 0 0.23515751957893372
) O 0 0.024526122957468033
obtained O 0 0.018936553969979286
from O 0 0.016144001856446266
52 O 0 0.04815922677516937
healthy O 0 0.08604159206151962
volunteers O 0 0.06614485383033752
having O 0 0.04675973951816559
phenotype O 1 0.9893079400062561
Hp2 O 1 0.7854474782943726
, O 0 0.01887248456478119
whereas O 0 0.03636008873581886
the O 0 0.021134551614522934
serum O 1 0.9858832955360413
Hp O 0 0.10147617757320404
level O 0 0.01972728595137596
of O 0 0.005935225170105696
an O 0 0.008885798044502735
individual O 0 0.01744779571890831
with O 0 0.021815752610564232
Hp1 O 1 0.9995146989822388
/ O 1 0.9939950108528137
Hpdel O 1 0.7690148949623108
was O 0 0.029283085837960243
0 O 0 0.05867559090256691
. O 0 0.025051048025488853

50 O 0 0.11131482571363449
mg O 1 0.9985393285751343
/ O 1 0.9965025186538696
ml O 0 0.20709876716136932
, O 0 0.013200181536376476
which O 0 0.008753369562327862
was O 0 0.010304030030965805
approximately O 0 0.014608515426516533
half O 0 0.012096177786588669
the O 0 0.008747166022658348
level O 0 0.020333759486675262
of O 0 0.009973668493330479
Hp O 0 0.0893535166978836
in O 0 0.013797610066831112
control O 0 0.0424974262714386
sera O 0 0.33474525809288025
from O 0 0.017662927508354187
the O 0 0.02365758642554283
Hp1 O 1 0.9872056245803833
phenotype O 1 0.9246557354927063
( O 0 0.034899864345788956
1 O 0 0.02372041530907154
. O 0 0.013964544981718063
26 O 0 0.04249104857444763
+ O 1 0.7758134007453918
/ O 1 0.7934204936027527
- O 0 0.07708553224802017
0 O 0 0.05184043198823929
. O 0 0.017016500234603882
33 O 0 0.07004246860742569
mg O 1 0.9971786737442017
/ O 1 0.9932979941368103
ml O 1 0.6754604578018188
; O 0 0.044187046587467194
n O 0 0.08769353479146957
= O 0 0.10104655474424362
9 O 0 0.032273322343826294
) O 0 0.018491996452212334
, O 0 0.009457162581384182
showing O 0 0.026508070528507233
a O 0 0.027269715443253517
gene O 0 0.11090685427188873
- O 0 0.13369272649288177
dosage O 1 0.9871789216995239
effect O 0 0.07208584249019623
. O 0 0.03241166099905968

The O 0 0.022858841344714165
other O 0 0.020115088671445847
allele O 0 0.18629072606563568
( O 0 0.05003371462225914
Hp2 O 0 0.34507107734680176
) O 0 0.019443416967988014
of O 0 0.009163948707282543
individuals O 0 0.02062058076262474
with O 0 0.0242864228785038
Hp2 O 1 0.9997386336326599
/ O 1 0.9985664486885071
Hpdel O 1 0.8069536089897156
was O 0 0.016588447615504265
found O 0 0.012162777595221996
to O 0 0.006125494372099638
have O 0 0.006364890839904547
, O 0 0.006497903726994991
in O 0 0.007086037192493677
all O 0 0.00802301149815321
exons O 0 0.07160650193691254
, O 0 0.014548974111676216
no O 0 0.01839584670960903
mutation O 0 0.09395348280668259
, O 0 0.013462093658745289
by O 0 0.013336041942238808
DNA O 0 0.06760141253471375
sequencing O 0 0.08349527418613434
. O 0 0.03390698879957199

On O 0 0.0137582216411829
the O 0 0.008286830969154835
basis O 0 0.008068239316344261
of O 0 0.005109742283821106
the O 0 0.007100891321897507
present O 0 0.014165624976158142
study O 0 0.01712229661643505
, O 0 0.007566570304334164
the O 0 0.010280690155923367
mechanism O 0 0.04466773942112923
of O 0 0.012514195404946804
anhaptoglobinemia B-Disease 0 0.14215227961540222
and O 0 0.008529252372682095
the O 0 0.010670899413526058
mechanism O 0 0.0455719493329525
of O 0 0.012689784169197083
anomalous O 0 0.292019248008728
inheritance O 0 0.07443269342184067
of O 0 0.016684038564562798
Hp O 1 0.975074291229248
phenotypes O 0 0.13732966780662537
were O 0 0.013400878757238388
well O 0 0.015559050254523754
explained O 0 0.03634214773774147
. O 0 0.02428223006427288

However O 0 0.020849181339144707
, O 0 0.009661626070737839
the O 0 0.011887186206877232
mechanism O 0 0.047935850918293
of O 0 0.01695704460144043
hypohaptoglobinemia B-Disease 1 0.8500467538833618
remains O 0 0.05165925249457359
unknown O 0 0.06632471829652786

ATM O 0 0.29526540637016296
mutations O 0 0.15530604124069214
and O 0 0.02378757856786251
phenotypes O 0 0.4356182813644409
in O 0 0.04041212052106857
ataxia B-Disease 1 1.0
- I-Disease 1 0.9988483190536499
telangiectasia I-Disease 1 0.9999867677688599
families O 0 0.034911856055259705
in O 0 0.010901161469519138
the O 0 0.01188386045396328
British O 0 0.03741900622844696
Isles O 0 0.10565032064914703
: O 0 0.022977417334914207
expression O 0 0.032223060727119446
of O 0 0.011149301193654537
mutant O 0 0.10474758595228195
ATM O 0 0.09609571099281311
and O 0 0.0098592359572649
the O 0 0.013052902184426785
risk O 1 0.9405595660209656
of O 0 0.022317834198474884
leukemia B-Disease 1 1.0
, O 1 0.9561057686805725
lymphoma B-Disease 1 1.0
, O 0 0.030048003420233727
and O 0 0.032894738018512726
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.040595877915620804

We O 0 0.01931338757276535
report O 0 0.015434346161782742
the O 0 0.011287989094853401
spectrum O 0 0.050591181963682175
of O 0 0.014148016460239887
59 O 0 0.0791962742805481
ATM O 0 0.17278997600078583
mutations O 0 0.12355732917785645
observed O 0 0.05114108324050903
in O 0 0.030005749315023422
ataxia B-Disease 1 1.0
- I-Disease 1 0.9989407658576965
telangiectasia I-Disease 1 0.999997615814209
( O 0 0.06958577036857605
A B-Disease 1 0.9907839298248291
- I-Disease 1 0.9989765882492065
T I-Disease 1 0.9999969005584717
) O 0 0.037362974137067795
patients O 1 0.9981764554977417
in O 0 0.009758067317306995
the O 0 0.011099395342171192
British O 0 0.03591937571763992
Isles O 0 0.11774957925081253
. O 0 0.029559900984168053

Of O 0 0.03132016584277153
51 O 0 0.09907861799001694
ATM O 0 0.21326854825019836
mutations O 0 0.11960835754871368
identified O 0 0.031837593764066696
in O 0 0.010640432126820087
families O 0 0.021166378632187843
native O 0 0.015394100919365883
to O 0 0.008196328766644001
the O 0 0.01097618043422699
British O 0 0.03131962567567825
Isles O 0 0.08007194101810455
, O 0 0.012014809995889664
11 O 0 0.01953200064599514
were O 0 0.011582935228943825
founder O 0 0.05203606188297272
mutations O 0 0.08147399127483368
, O 0 0.010155320167541504
and O 0 0.007225378416478634
2 O 0 0.013565963134169579
of O 0 0.005900934338569641
these O 0 0.006853574886918068
11 O 0 0.02141561359167099
conferred O 0 0.05015958473086357
a O 0 0.030623454600572586
milder O 1 0.9972979426383972
clinical O 1 0.9995352029800415
phenotype O 1 0.9143174290657043
with O 0 0.011875851079821587
respect O 0 0.015553325414657593
to O 0 0.01075525302439928
both O 0 0.01995009556412697
cerebellar B-Disease 1 0.9999982118606567
degeneration I-Disease 1 0.9999990463256836
and O 0 0.02220146544277668
cellular O 0 0.07693096995353699
features O 0 0.034485824406147
. O 0 0.025992747396230698

We O 0 0.01628141663968563
report O 0 0.014894058927893639
, O 0 0.007501479238271713
in O 0 0.00734416488558054
two O 0 0.009745008312165737
A B-Disease 0 0.274139940738678
- I-Disease 1 0.9234817624092102
T I-Disease 1 0.9999088048934937
families O 0 0.030181169509887695
, O 0 0.013602294027805328
an O 0 0.020885026082396507
ATM O 0 0.17548780143260956
mutation O 0 0.1728897988796234
( O 0 0.06170503795146942
7271T O 1 0.9901100993156433
- O 1 0.802972137928009
- O 0 0.22143633663654327
> O 0 0.4363844096660614
G O 0 0.2382284700870514
) O 0 0.020581509917974472
that O 0 0.007981491275131702
may O 0 0.01173581462353468
be O 0 0.005778210237622261
associated O 0 0.011196323670446873
with O 0 0.006919011007994413
an O 0 0.010865711607038975
increased O 0 0.03203066065907478
risk O 1 0.9901813864707947
of O 0 0.02317299135029316
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.014840423129498959
both O 0 0.016898958012461662
homozygotes O 1 0.9994668364524841
and O 0 0.02434995025396347
heterozygotes O 1 0.9963647723197937
( O 0 0.03732096031308174
relative O 0 0.04867922142148018
risk O 0 0.08494225144386292
12 O 0 0.021133728325366974
. O 0 0.011863837949931622
7 O 0 0.03140423074364662
; O 0 0.027876248583197594
P O 1 0.9770475625991821
= O 0 0.1212335079908371
. O 0 0.025477882474660873
0025 O 1 0.9940363168716431
) O 0 0.0215164665132761
, O 0 0.008364587090909481
although O 0 0.00828912016004324
there O 0 0.006509679835289717
is O 0 0.0071822283789515495
a O 0 0.012608921155333519
less O 0 0.020915405824780464
severe O 1 0.9999849796295166
A B-Disease 1 0.9963059425354004
- I-Disease 1 0.9992269277572632
T I-Disease 1 0.9999951124191284
phenotype O 1 0.5075436234474182
in O 0 0.011247677728533745
terms O 0 0.009601075202226639
of O 0 0.005707860924303532
the O 0 0.009958021342754364
degree O 0 0.03374570980668068
of O 0 0.019125744700431824
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 0.9999998807907104
. O 0 0.04190373420715332

This O 0 0.037033356726169586
mutation O 0 0.17387470602989197
( O 0 0.06204061955213547
7271T O 1 0.9866123199462891
- O 1 0.7416586875915527
- O 0 0.20829984545707703
> O 0 0.3178434371948242
G O 0 0.16653233766555786
) O 0 0.020190352573990822
also O 0 0.010847149416804314
allows O 0 0.019797656685113907
expression O 0 0.02203483320772648
of O 0 0.007873781956732273
full O 0 0.024260682985186577
- O 0 0.06473732739686966
length O 0 0.05167724937200546
ATM O 0 0.13143068552017212
protein O 0 0.04556012153625488
at O 0 0.014725062996149063
a O 0 0.012905259616672993
level O 0 0.021328715607523918
comparable O 0 0.031312741339206696
with O 0 0.008513436652719975
that O 0 0.006537300534546375
in O 0 0.012126222252845764
unaffected O 0 0.45786285400390625
individuals O 0 0.028180809691548347
. O 0 0.02569452114403248

In O 0 0.017841141670942307
addition O 0 0.017501872032880783
, O 0 0.009590556845068932
we O 0 0.006528564728796482
have O 0 0.007113544270396233
studied O 0 0.01848006434738636
18 O 0 0.022374939173460007
A B-Disease 1 0.9732242226600647
- I-Disease 1 0.9996596574783325
T I-Disease 1 0.9999996423721313
patients O 1 0.9998148083686829
, O 0 0.010483628138899803
in O 0 0.008874517865478992
15 O 0 0.0156205203384161
families O 0 0.019178101792931557
, O 0 0.01072615198791027
who O 0 0.025361433625221252
developed O 1 0.9779638051986694
leukemia B-Disease 1 1.0
, O 1 0.8315680027008057
lymphoma B-Disease 1 1.0
, O 0 0.04737450182437897
preleukemic O 1 0.9999722242355347
T O 1 0.9999964237213135
- O 1 0.6932882070541382
cell O 0 0.11629946529865265
proliferation O 0 0.13552707433700562
, O 0 0.026370301842689514
or O 1 0.8902735710144043
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.02120993472635746
mostly O 0 0.016677485778927803
in O 0 0.015016129240393639
childhood O 1 0.7721489667892456
. O 0 0.029169443994760513

A O 0 0.03494920954108238
wide O 0 0.02563716471195221
variety O 0 0.019679652526974678
of O 0 0.01575915887951851
ATM O 0 0.38719362020492554
mutation O 0 0.145564004778862
types O 0 0.03979484364390373
, O 0 0.01412627100944519
including O 0 0.021832160651683807
missense O 0 0.21346260607242584
mutations O 0 0.10613881051540375
and O 0 0.012432686053216457
in O 0 0.015238428488373756
- O 0 0.07636230438947678
frame O 0 0.0647338256239891
deletions O 0 0.06957326084375381
, O 0 0.01145285926759243
were O 0 0.007592143025249243
seen O 0 0.01727619767189026
in O 0 0.009196195751428604
these O 0 0.012566203251481056
patients O 1 0.9999001026153564
. O 0 0.027768857777118683

We O 0 0.01939719170331955
also O 0 0.010928577743470669
show O 0 0.01588793657720089
that O 0 0.006073076277971268
25 O 0 0.013624013401567936
% O 0 0.012156115844845772
of O 0 0.005572193767875433
all O 0 0.009174996055662632
A B-Disease 1 0.9546259045600891
- I-Disease 1 0.9994732737541199
T I-Disease 1 0.9999992847442627
patients O 1 0.9998615980148315
carried O 0 0.021645938977599144
in O 0 0.013708868995308876
- O 0 0.08058439195156097
frame O 0 0.081638403236866
deletions O 0 0.11344422399997711
or O 0 0.03852946683764458
missense O 1 0.539158821105957
mutations O 0 0.09744720160961151
, O 0 0.00946889165788889
many O 0 0.0054831840097904205
of O 0 0.004623573739081621
which O 0 0.0070813982747495174
were O 0 0.005770648829638958
also O 0 0.008175017312169075
associated O 0 0.014623019844293594
with O 0 0.010555224493145943
expression O 0 0.03350576385855675
of O 0 0.015353688970208168
mutant O 0 0.13487231731414795
ATM O 0 0.1829911321401596
protein O 0 0.10082465410232544
. O 0 0.03304630145430565

The O 0 0.04710284247994423
DMPK O 1 0.9867097735404968
gene O 0 0.1098271906375885
of O 0 0.02303105965256691
severely O 1 0.9998694658279419
affected O 1 0.9998750686645508
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999996423721313
is O 0 0.03467557579278946
hypermethylated O 1 0.9942236542701721
proximal O 1 0.9909186363220215
to O 0 0.010725180618464947
the O 0 0.010825401172041893
largely O 0 0.024263089522719383
expanded O 0 0.04684922471642494
CTG O 1 0.9977052807807922
repeat O 0 0.12636834383010864
. O 0 0.038479965180158615

Using O 0 0.061858415603637695
methylation O 0 0.15600411593914032
- O 0 0.10365994274616241
sensitive O 0 0.06370557099580765
restriction O 0 0.06177075207233429
enzymes O 0 0.05924691632390022
, O 0 0.013504563830792904
we O 0 0.010798543691635132
characterized O 0 0.044761620461940765
the O 0 0.013509722426533699
methylation O 0 0.08020146936178207
pattern O 0 0.042004361748695374
on O 0 0.007787040900439024
the O 0 0.009423283860087395
5 O 0 0.01759670488536358
side O 0 0.017250405624508858
of O 0 0.008960784412920475
the O 0 0.019909687340259552
CTG O 1 0.9972578883171082
repeat O 0 0.07207177579402924
in O 0 0.0126401511952281
the O 0 0.01753208041191101
DMPK O 1 0.9909259080886841
gene O 0 0.0636763796210289
of O 0 0.009740973822772503
normal O 0 0.030930090695619583
individuals O 0 0.01611158810555935
and O 0 0.008680605329573154
of O 0 0.012099530547857285
patients O 1 0.9999991655349731
affected O 1 0.8344604969024658
with O 0 0.08947936445474625
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.024925298988819122
showing O 0 0.03373907133936882
expansions O 0 0.04567869380116463
of O 0 0.008570724166929722
the O 0 0.017587319016456604
repetitive O 0 0.32308220863342285
sequence O 0 0.056034550070762634
. O 0 0.03276918828487396

The O 0 0.04197198152542114
gene O 0 0.10456924140453339
segment O 0 0.08297092467546463
analyzed O 0 0.04765491187572479
corresponds O 0 0.04104634374380112
to O 0 0.011771051213145256
the O 0 0.0209654550999403
genomic O 0 0.16431069374084473
SacI O 1 0.9940462112426758
- O 0 0.1453145295381546
HindIII O 0 0.28670641779899597
fragment O 0 0.11707791686058044
carrying O 0 0.05499903857707977
exons O 0 0.12504233419895172
11 O 0 0.04603061452507973
- O 0 0.0781748816370964
15 O 0 0.03637746721506119
. O 0 0.029354194179177284

There O 0 0.022775355726480484
is O 0 0.022459611296653748
constitutive O 0 0.1516009271144867
methylation O 0 0.11168177425861359
in O 0 0.026396270841360092
intron O 1 0.8815207481384277
12 O 0 0.03443382307887077
at O 0 0.023689759895205498
restriction O 0 0.03504759445786476
sites O 0 0.01570264622569084
of O 0 0.011725930497050285
SacII O 1 0.6060114502906799
and O 0 0.020821046084165573
HhaI O 1 0.6129149794578552
, O 0 0.022322028875350952
localized O 0 0.1136244460940361
1 O 0 0.02834543213248253
, O 0 0.015382355079054832
159 O 0 0.09008150547742844
- O 0 0.07801800966262817
1 O 0 0.033665917813777924
, O 0 0.018626965582370758
232 O 0 0.09942243993282318
bp O 0 0.09973455965518951
upstream O 0 0.0512409545481205
of O 0 0.010580037720501423
the O 0 0.020167047157883644
CTG O 1 0.9995512366294861
repeat O 0 0.09138830751180649
, O 0 0.014205100014805794
whereas O 0 0.026832185685634613
most O 0 0.008314685896039009
, O 0 0.007586285937577486
if O 0 0.007885162718594074
not O 0 0.004762629978358746
all O 0 0.003955587279051542
, O 0 0.004325283225625753
of O 0 0.0034856810234487057
the O 0 0.005274679511785507
other O 0 0.005945260636508465
sites O 0 0.012003205716609955
of O 0 0.010722772218286991
SacII O 1 0.9762756824493408
, O 0 0.02177196927368641
HhaI O 1 0.725597620010376
, O 0 0.013229207135736942
and O 0 0.011388510465621948
HpaII O 0 0.1760873794555664
in O 0 0.009572523646056652
this O 0 0.008534843102097511
region O 0 0.025521880015730858
are O 0 0.01135502103716135
unmethylated O 1 0.8992202281951904
, O 0 0.012037493288516998
in O 0 0.00942355114966631
normal O 0 0.027275310829281807
individuals O 0 0.012608376331627369
and O 0 0.005473332479596138
most O 0 0.0054640015587210655
of O 0 0.006448768544942141
the O 0 0.017213696613907814
patients O 1 0.9999659061431885
. O 0 0.033294424414634705

In O 0 0.0180000439286232
a O 0 0.015691641718149185
number O 0 0.00879430491477251
of O 0 0.008430792950093746
young O 0 0.03333232179284096
and O 0 0.016486257314682007
severely O 1 0.9995920062065125
affected O 1 0.9840072989463806
patients O 1 0.9999909400939941
, O 0 0.011232400313019753
however O 0 0.009375772438943386
, O 0 0.008313149213790894
complete O 0 0.01901439018547535
methylation O 0 0.049235645681619644
of O 0 0.007212590891867876
these O 0 0.007399497553706169
restriction O 0 0.030639227479696274
sites O 0 0.015609512105584145
was O 0 0.010238435119390488
found O 0 0.01236043218523264
in O 0 0.008305221796035767
the O 0 0.01696031168103218
mutated O 0 0.15689557790756226
allele O 0 0.1917533278465271
. O 0 0.03813290596008301

In O 0 0.01575797237455845
most O 0 0.0077201989479362965
of O 0 0.006962526589632034
these O 0 0.009477786719799042
patients O 1 0.9999638795852661
, O 0 0.009977379813790321
the O 0 0.012046490795910358
onset O 1 0.9999463558197021
of O 0 0.01229393482208252
the O 0 0.024675382301211357
disease O 1 1.0
was O 0 0.4721084535121918
congenital O 1 1.0
. O 0 0.03566629812121391

Preliminary O 0 0.06541401147842407
in O 0 0.03203997388482094
vivo O 0 0.40061429142951965
footprinting O 1 0.994929313659668
data O 0 0.023056568577885628
gave O 0 0.02103704772889614
evidence O 0 0.015417746268212795
for O 0 0.012910605408251286
protein O 0 0.06952011585235596
- O 0 0.07359009236097336
DNA O 0 0.06643704324960709
contact O 0 0.04465398192405701
in O 0 0.0123258912935853
normal O 0 0.04439437761902809
genes O 0 0.04897615686058998
at O 0 0.024986328557133675
an O 0 0.02057465724647045
Sp1 O 1 0.9924964904785156
consensus O 0 0.04139157012104988
binding O 0 0.04489583522081375
site O 0 0.024944623932242393
upstream O 0 0.038856010884046555
of O 0 0.008490010164678097
the O 0 0.018114887177944183
CTG O 1 0.9991324543952942
repeat O 0 0.06807994842529297
and O 0 0.007687200326472521
for O 0 0.006231377366930246
a O 0 0.013585786335170269
significant O 0 0.017978167161345482
reduction O 0 0.03602948784828186
of O 0 0.006386133376508951
this O 0 0.007390179205685854
interaction O 0 0.02525007538497448
in O 0 0.011212796904146671
cells O 0 0.05205095559358597
with O 0 0.014284860342741013
a O 0 0.031793855130672455
hypermethylated O 1 0.9922194480895996
DMPK O 1 0.9990664124488831
gene O 0 0.09937985986471176
. O 0 0.017733750864863396
. O 0 0.02565194107592106

The O 0 0.07781220972537994
hemochromatosis B-Disease 1 0.9999997615814209
gene O 0 0.14437681436538696
product O 0 0.04314417392015457
complexes O 0 0.06810745596885681
with O 0 0.011509212665259838
the O 0 0.02190742827951908
transferrin O 1 0.9917001128196716
receptor O 0 0.17441555857658386
and O 0 0.018025025725364685
lowers O 0 0.3806687295436859
its O 0 0.01794363558292389
affinity O 0 0.08185555785894394
for O 0 0.019079485908150673
ligand O 0 0.13618960976600647
binding O 0 0.06811495870351791
. O 0 0.032137226313352585

We O 0 0.026582583785057068
recently O 0 0.03508907929062843
reported O 0 0.027729429304599762
the O 0 0.014680351130664349
positional O 0 0.0787733644247055
cloning O 0 0.04636487364768982
of O 0 0.00939176045358181
a O 0 0.01756412535905838
candidate O 0 0.03603262081742287
gene O 0 0.0811467245221138
for O 0 0.029583076015114784
hereditary B-Disease 1 0.9999992847442627
hemochromatosis I-Disease 1 1.0
called O 0 0.10691886395215988
HFE O 1 0.9999364614486694
. O 0 0.043081872165203094

The O 0 0.03402058035135269
gene O 0 0.08634912967681885
product O 0 0.02573753148317337
, O 0 0.009524927474558353
a O 0 0.01199078094214201
member O 0 0.011981915682554245
of O 0 0.006532381754368544
the O 0 0.01171787641942501
major O 0 0.03412016108632088
histocompatibility O 1 0.9997864365577698
complex O 0 0.05403197184205055
class O 0 0.06386269629001617
I O 0 0.11175625026226044
- O 0 0.04959320276975632
like O 0 0.016426190733909607
family O 0 0.020253071561455727
, O 0 0.009079213254153728
was O 0 0.009826050139963627
found O 0 0.009711667895317078
to O 0 0.0067179156467318535
have O 0 0.009490633383393288
a O 0 0.025003086775541306
mutation O 0 0.13111664354801178
, O 0 0.031239710748195648
Cys O 1 0.9999737739562988
- O 0 0.2255394011735916
282 O 1 0.6027159094810486
- O 1 0.6338459849357605
- O 0 0.18996840715408325
> O 0 0.45403924584388733
Tyr O 1 0.9896873831748962
( O 0 0.06441085040569305
C282Y O 0 0.15500405430793762
) O 0 0.021266469731926918
, O 0 0.010302643291652203
in O 0 0.010880018584430218
85 O 0 0.0472446046769619
% O 0 0.022837022319436073
of O 0 0.016146229580044746
patient O 1 0.9969515800476074
chromosomes O 0 0.10465201735496521
. O 0 0.034446053206920624

This O 0 0.03631608933210373
mutation O 0 0.16132479906082153
eliminates O 0 0.10613866150379181
the O 0 0.01549904141575098
ability O 0 0.03134699538350105
of O 0 0.013210160657763481
HFE O 1 0.9988458156585693
to O 0 0.015289977192878723
associate O 0 0.03453340381383896
with O 0 0.020747516304254532
beta2 O 1 0.9941202998161316
- O 0 0.14863529801368713
microglobulin O 1 0.8267151713371277
( O 0 0.050516121089458466
beta2m O 0 0.45923924446105957
) O 0 0.024530570954084396
and O 0 0.014273430220782757
prevents O 0 0.22666947543621063
cell O 0 0.1054723933339119
- O 0 0.08010207116603851
surface O 0 0.05780386924743652
expression O 0 0.0541093535721302
. O 0 0.029137246310710907

A O 0 0.04464675858616829
second O 0 0.03820226341485977
mutation O 0 0.11437775194644928
that O 0 0.010492714121937752
has O 0 0.012942531146109104
no O 0 0.013900548219680786
effect O 0 0.028208546340465546
on O 0 0.015764880925416946
beta2m O 1 0.9524794816970825
association O 0 0.05149686336517334
, O 0 0.019818516448140144
H63D O 1 0.9923783540725708
, O 0 0.012130667455494404
was O 0 0.011411096900701523
found O 0 0.011245249770581722
in O 0 0.005866664927452803
eight O 0 0.01038515754044056
out O 0 0.007677280344069004
of O 0 0.007381049450486898
nine O 0 0.026823025196790695
patients O 1 0.998867392539978
heterozygous O 0 0.1015160083770752
for O 0 0.01422416977584362
the O 0 0.02062036283314228
C282Y O 0 0.2020685076713562
mutant O 0 0.1443697214126587
. O 0 0.039323996752500534

In O 0 0.01999247446656227
this O 0 0.009125357493758202
report O 0 0.012894203886389732
, O 0 0.007772824261337519
we O 0 0.007213909178972244
demonstrate O 0 0.025230295956134796
in O 0 0.014454548247158527
cultured O 0 0.12086959928274155
293 O 1 0.6096972823143005
cells O 0 0.16242952644824982
overexpressing O 1 0.9777172803878784
wild O 0 0.08886303752660751
- O 0 0.10541140288114548
type O 0 0.07688315957784653
or O 0 0.03181103244423866
mutant O 0 0.15359385311603546
HFE O 1 0.9961526989936829
proteins O 0 0.03782527521252632
that O 0 0.007237969897687435
both O 0 0.0070577943697571754
the O 0 0.011115108616650105
wild O 0 0.050080761313438416
- O 0 0.08613445609807968
type O 0 0.06674253940582275
and O 0 0.02435792237520218
H63D O 1 0.9994913339614868
HFE O 1 0.9992551207542419
proteins O 0 0.05625966191291809
form O 0 0.03287484496831894
stable O 0 0.0746232196688652
complexes O 0 0.07454896718263626
with O 0 0.014404406771063805
the O 0 0.02490038052201271
transferrin O 1 0.9969053864479065
receptor O 0 0.37357762455940247
( O 0 0.05640528351068497
TfR O 1 0.9995263814926147
) O 0 0.0356295220553875
. O 0 0.027417268604040146

The O 0 0.04749101400375366
C282Y O 0 0.2608828842639923
mutation O 0 0.15618711709976196
nearly O 0 0.04405920207500458
completely O 0 0.039296165108680725
prevents O 0 0.059914883226156235
the O 0 0.01325346902012825
association O 0 0.029732516035437584
of O 0 0.009550039656460285
the O 0 0.019521402195096016
mutant O 0 0.15891079604625702
HFE O 1 0.9987087249755859
protein O 0 0.07847407460212708
with O 0 0.017537107691168785
the O 0 0.027721844613552094
TfR O 1 0.9997770190238953
. O 0 0.04007032886147499

Studies O 0 0.0442519374191761
on O 0 0.01783689670264721
cell O 0 0.09064386039972305
- O 0 0.08667165786027908
associated O 0 0.04943852126598358
transferrin O 0 0.33347243070602417
at O 0 0.029641257598996162
37 O 0 0.04597954824566841
degrees O 0 0.05079945549368858
C O 0 0.09538334608078003
suggest O 0 0.024077463895082474
that O 0 0.008656682446599007
the O 0 0.019783928990364075
overexpressed O 1 0.7091989517211914
wild O 0 0.07347256690263748
- O 0 0.11729831993579865
type O 0 0.14086408913135529
HFE O 1 0.9987623691558838
protein O 0 0.09902004897594452
decreases O 0 0.07398003339767456
the O 0 0.013845783658325672
affinity O 0 0.06354663521051407
of O 0 0.010571706108748913
the O 0 0.01918274722993374
TfR O 1 0.9992220401763916
for O 0 0.02678745985031128
transferrin O 1 0.9790405035018921
. O 0 0.04251248389482498

The O 0 0.0547848641872406
overexpressed O 1 0.9267205595970154
H63D O 1 0.9930813908576965
protein O 0 0.06511812657117844
does O 0 0.015280173160135746
not O 0 0.005211169831454754
have O 0 0.006297175772488117
this O 0 0.007216696161776781
effect O 0 0.023564942181110382
, O 0 0.008174186572432518
providing O 0 0.01542507391422987
the O 0 0.006662310566753149
first O 0 0.009196109138429165
direct O 0 0.01602897420525551
evidence O 0 0.012859969399869442
for O 0 0.00747497845441103
a O 0 0.015105409547686577
functional O 0 0.039341095834970474
consequence O 0 0.03663720190525055
of O 0 0.008603419177234173
the O 0 0.0211100522428751
H63D O 1 0.9995531439781189
mutation O 0 0.256960928440094
. O 0 0.03769836947321892

Addition O 0 0.03366100415587425
of O 0 0.018166813999414444
soluble O 0 0.13825726509094238
wild O 0 0.08053693920373917
- O 0 0.22631534934043884
type O 1 0.8339480757713318
HFE O 1 0.9999903440475464
/ O 1 0.9989145994186401
beta2m O 1 0.9787838459014893
heterodimers O 1 0.866787314414978
to O 0 0.026840629056096077
cultured O 0 0.1253373622894287
cells O 0 0.07406553626060486
also O 0 0.013969928957521915
decreased O 0 0.040815021842718124
the O 0 0.012334438972175121
apparent O 0 0.05798039212822914
affinity O 0 0.058507710695266724
of O 0 0.0077646938152611256
the O 0 0.013314544223248959
TfR O 1 0.996025800704956
for O 0 0.010266702622175217
its O 0 0.013504886999726295
ligand O 0 0.10404358059167862
under O 0 0.020360946655273438
steady O 0 0.06606082618236542
- O 0 0.05318024754524231
state O 0 0.015456026419997215
conditions O 0 0.029435375705361366
, O 0 0.00833392608910799
both O 0 0.007061805110424757
in O 0 0.011951104737818241
293 O 0 0.17569947242736816
cells O 0 0.06845313310623169
and O 0 0.013415930792689323
in O 0 0.020374765619635582
HeLa O 1 0.9974392652511597
cells O 0 0.1240118145942688
. O 0 0.03210075944662094

Furthermore O 0 0.06174831464886665
, O 0 0.01667936146259308
at O 0 0.02004406787455082
4 O 0 0.027494113892316818
degrees O 0 0.044716399163007736
C O 0 0.07425656914710999
, O 0 0.010178128257393837
the O 0 0.011289632879197598
added O 0 0.02372652105987072
soluble O 0 0.11214695125818253
complex O 0 0.049211736768484116
of O 0 0.029566915705800056
HFE O 1 0.999984622001648
/ O 1 0.9979495406150818
beta2m O 1 0.7731854915618896
inhibited O 0 0.17698314785957336
binding O 0 0.05272122099995613
of O 0 0.016415083780884743
transferrin O 1 0.7108525633811951
to O 0 0.029804280027747154
HeLa O 1 0.9970219731330872
cell O 0 0.1403072625398636
TfR O 1 0.9929285645484924
in O 0 0.019274193793535233
a O 0 0.029538581147789955
concentration O 0 0.12776724994182587
- O 0 0.0846899226307869
dependent O 0 0.07619157433509827
manner O 0 0.045260511338710785
. O 0 0.027349282056093216

Scatchard O 0 0.22454313933849335
plots O 0 0.0454707033932209
of O 0 0.009604834020137787
these O 0 0.006625723093748093
data O 0 0.011176513507962227
indicate O 0 0.01792551763355732
that O 0 0.006125341169536114
the O 0 0.00948962103575468
added O 0 0.02586524561047554
heterodimer O 1 0.960343062877655
substantially O 0 0.05746966972947121
reduced O 0 0.03325027972459793
the O 0 0.015208989381790161
affinity O 0 0.07464978098869324
of O 0 0.02025028131902218
TfR O 1 0.999570906162262
for O 0 0.02851971425116062
transferrin O 1 0.9831226468086243
. O 0 0.038068678230047226

These O 0 0.016924144700169563
results O 0 0.025347361341118813
establish O 0 0.030205588787794113
a O 0 0.02043788880109787
molecular O 0 0.056563884019851685
link O 0 0.05173106864094734
between O 0 0.02415820024907589
HFE O 1 0.9982690811157227
and O 0 0.0133667578920722
a O 0 0.018139585852622986
key O 0 0.027665432542562485
protein O 0 0.04437291622161865
involved O 0 0.021852413192391396
in O 0 0.01341676153242588
iron O 0 0.07733864337205887
transport O 0 0.03516756370663643
, O 0 0.012366208247840405
the O 0 0.017556795850396156
TfR O 1 0.9997422099113464
, O 0 0.013001213781535625
and O 0 0.007104459218680859
raise O 0 0.020203568041324615
the O 0 0.008687345311045647
possibility O 0 0.020047469064593315
that O 0 0.007023535203188658
alterations O 0 0.027764109894633293
in O 0 0.00733018247410655
this O 0 0.008204693906009197
regulatory O 0 0.05539226904511452
mechanism O 0 0.049596142023801804
may O 0 0.014169154688715935
play O 0 0.00854181032627821
a O 0 0.009017945267260075
role O 0 0.01321684941649437
in O 0 0.007693979423493147
the O 0 0.01479651965200901
pathogenesis O 1 0.999967098236084
of O 0 0.025637833401560783
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
. O 0 0.029743975028395653
. O 0 0.03066309355199337

Genomic O 0 0.13948577642440796
organization O 0 0.03954820707440376
of O 0 0.01311119832098484
the O 0 0.02929193526506424
UBE3A O 1 0.99997878074646
/ O 1 0.9997456669807434
E6 O 1 0.9998812675476074
- O 0 0.13501374423503876
AP O 0 0.11036096513271332
gene O 0 0.07376159727573395
and O 0 0.0155534278601408
related O 0 0.038320351392030716
pseudogenes O 0 0.16180308163166046
. O 0 0.03515497222542763

The O 0 0.059886857867240906
UBE3A O 1 0.9685863852500916
gene O 0 0.12362830340862274
encodes O 0 0.09561020135879517
the O 0 0.03136525675654411
E6 O 1 0.9987421631813049
- O 0 0.1233745738863945
AP O 0 0.12448737770318985
ubiquitin O 0 0.18994316458702087
- O 0 0.11668775975704193
protein O 0 0.09404365718364716
ligase O 0 0.0904153510928154
and O 0 0.011070960201323032
has O 0 0.01262154895812273
recently O 0 0.021116141229867935
been O 0 0.009175303392112255
shown O 0 0.016636168584227562
to O 0 0.008466404862701893
be O 0 0.010608813725411892
mutated O 0 0.47523176670074463
in O 0 0.3925777077674866
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999997615814209
who O 0 0.035308822989463806
lack O 0 0.06865095347166061
15q11 O 1 0.9977431297302246
- O 0 0.15451042354106903
q13 O 1 0.5219595432281494
deletions O 0 0.12636591494083405
or O 0 0.039484672248363495
chromosome O 0 0.17351609468460083
15 O 0 0.05413660407066345
paternal O 0 0.49546992778778076
uniparental B-Disease 1 0.99994957447052
disomy I-Disease 1 0.9789205193519592
. O 0 0.04200035333633423

Previous O 0 0.08053741604089737
UBE3A O 1 0.9510729312896729
cDNA O 0 0.158601775765419
analysis O 0 0.03435099869966507
has O 0 0.014901107177138329
shown O 0 0.021795816719532013
a O 0 0.018832337111234665
coding O 0 0.07337789982557297
region O 0 0.026740945875644684
of O 0 0.010732964612543583
approximately O 0 0.03296627476811409
2 O 0 0.03216545283794403
. O 0 0.025196494534611702

6 O 0 0.06711671501398087
kb O 0 0.1126401275396347
and O 0 0.015938295051455498
a O 0 0.022027863189578056
3 O 0 0.038375940173864365
- O 0 0.09441669285297394
untranslated O 0 0.1853812336921692
region O 0 0.07623329013586044
( O 0 0.0546705387532711
UTR O 0 0.40852904319763184
) O 0 0.031441476196050644
of O 0 0.017833955585956573
< O 0 0.1557154506444931
50 O 0 0.03896167874336243
bp O 0 0.08660886436700821
, O 0 0.014957395382225513
whereas O 0 0.031427960842847824
Northern O 0 0.024855362251400948
analysis O 0 0.02536899782717228
has O 0 0.017114602029323578
indicated O 0 0.041715797036886215
mRNA O 0 0.048345908522605896
sizes O 0 0.02619270607829094
of O 0 0.012863263487815857
5 O 0 0.03519664332270622
- O 0 0.0787578895688057
8 O 0 0.05189983919262886
kb O 0 0.16746214032173157
. O 0 0.03931042179465294

We O 0 0.01998509094119072
have O 0 0.012305491603910923
analyzed O 0 0.039422407746315
additional O 0 0.031248314306139946
cDNA O 0 0.1273898482322693
clones O 0 0.08073905855417252
and O 0 0.009720724076032639
provide O 0 0.014985001645982265
evidence O 0 0.012930827215313911
for O 0 0.00752152968198061
an O 0 0.009996755979955196
additional O 0 0.026011550799012184
0 O 0 0.05733589082956314
. O 0 0.025729451328516006

5 O 0 0.05643727630376816
kb O 0 0.11106666177511215
of O 0 0.01714080385863781
5 O 0 0.04108339920639992
- O 0 0.09802678227424622
UTR O 0 0.3208635449409485
and O 0 0.025542832911014557
> O 0 0.12794040143489838
2 O 0 0.0354086309671402
kb O 0 0.09919693320989609
of O 0 0.018819697201251984
3 O 0 0.048496443778276443
- O 0 0.11227608472108841
UTR O 0 0.4033222794532776
. O 0 0.0370781272649765

We O 0 0.01709778979420662
have O 0 0.00930401124060154
established O 0 0.014429640024900436
the O 0 0.012890355661511421
genomic O 0 0.08451154828071594
organization O 0 0.02806408330798149
of O 0 0.013795856386423111
UBE3A O 1 0.9958760142326355
and O 0 0.01153783593326807
the O 0 0.01110947597771883
sequence O 0 0.03251662850379944
of O 0 0.020009644329547882
intron O 1 0.9940057992935181
- O 0 0.13833196461200714
exon O 0 0.18519432842731476
borders O 0 0.06552178412675858
. O 0 0.03501687943935394

We O 0 0.019647222012281418
have O 0 0.009735745377838612
also O 0 0.010568009689450264
mapped O 0 0.03374463692307472
two O 0 0.010513398796319962
highly O 0 0.035130009055137634
homologous O 0 0.12626367807388306
processed O 0 0.047645069658756256
pseudogenes O 0 0.1350117027759552
, O 0 0.02610117383301258
UBE3AP1 O 1 0.9588634371757507
and O 0 0.018436601385474205
UBE3AP2 O 1 0.9102272391319275
, O 0 0.012290970422327518
to O 0 0.00979575514793396
chromosomes O 0 0.04827488958835602
2 O 0 0.01979316771030426
and O 0 0.008760165423154831
21 O 0 0.018985051661729813
, O 0 0.008380905725061893
respectively O 0 0.015513798221945763
, O 0 0.007510335650295019
and O 0 0.007032128982245922
determined O 0 0.021294016391038895
their O 0 0.01078153494745493
genomic O 0 0.09471611678600311
organization O 0 0.04651769623160362
. O 0 0.028300799429416656

These O 0 0.01663765124976635
results O 0 0.02218496799468994
will O 0 0.008761672303080559
form O 0 0.011012941598892212
the O 0 0.006342075765132904
basis O 0 0.008922562934458256
for O 0 0.007290851324796677
studies O 0 0.020567573606967926
of O 0 0.010146787390112877
mutation O 0 0.12027620524168015
and O 0 0.018774576485157013
imprinting O 0 0.22446013987064362
of O 0 0.02687978558242321
UBE3A O 1 0.9990310668945312
. O 0 0.0442425012588501

Mutation O 0 0.2502523362636566
spectrum O 0 0.10279414057731628
and O 0 0.025702528655529022
genotype O 1 0.9955809712409973
- O 0 0.16217972338199615
phenotype O 1 0.6825127601623535
analyses O 0 0.07766559720039368
in O 0 0.033354733139276505
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.032378435134887695
Bannayan B-Disease 1 0.9999979734420776
- I-Disease 1 0.999956488609314
Zonana I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
, O 0 0.027023253962397575
two O 0 0.03227229416370392
hamartoma B-Disease 1 0.9999995231628418
syndromes I-Disease 1 0.9999996423721313
with O 0 0.05950362607836723
germline O 1 0.9987087249755859
PTEN O 1 0.9999061822891235
mutation O 0 0.35763439536094666
. O 0 0.04374709725379944

The O 0 0.07977539300918579
tumour B-Disease 1 0.9999991655349731
suppressor O 1 0.9969197511672974
gene O 0 0.21901148557662964
PTEN O 1 0.9989683628082275
, O 0 0.016067784279584885
which O 0 0.011602216400206089
maps O 0 0.021853314712643623
to O 0 0.01829458773136139
10q23 O 0 0.1483704298734665
. O 0 0.03307520970702171

3 O 0 0.03921611234545708
and O 0 0.017206888645887375
encodes O 0 0.07567916065454483
a O 0 0.036758843809366226
403 O 0 0.1467784196138382
amino O 0 0.1020539253950119
acid O 0 0.15970754623413086
dual O 0 0.10464107990264893
specificity O 0 0.16790129244327545
phosphatase O 1 0.9337124228477478
( O 0 0.0685405358672142
protein O 0 0.11813836544752121
tyrosine O 0 0.2144758701324463
phosphatase O 1 0.9739624261856079
; O 0 0.04314228519797325
PTPase O 1 0.7952969670295715
) O 0 0.02335061877965927
, O 0 0.01044448558241129
was O 0 0.011934641748666763
shown O 0 0.01743663288652897
recently O 0 0.01653270423412323
to O 0 0.006493204738944769
play O 0 0.008924768306314945
a O 0 0.012518344447016716
broad O 0 0.030204815790057182
role O 0 0.023919938132166862
in O 0 0.013908819295465946
human O 0 0.04608072713017464
malignancy B-Disease 1 0.999983549118042
. O 0 0.04007711261510849

Somatic O 1 0.8471323847770691
PTEN O 1 0.9989802241325378
deletions O 0 0.1516631543636322
and O 0 0.02715703658759594
mutations O 0 0.09555267542600632
were O 0 0.013680800795555115
observed O 0 0.029352784156799316
in O 0 0.017081890255212784
sporadic B-Disease 1 0.9372451901435852
breast I-Disease 1 0.9999998807907104
, I-Disease 0 0.03146862983703613
brain I-Disease 1 0.999982476234436
, I-Disease 0 0.03623487427830696
prostate I-Disease 1 1.0
and I-Disease 1 0.5271735787391663
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.22929373383522034
lines O 0 0.01815209910273552
and O 0 0.006046728231012821
in O 0 0.006918424740433693
several O 0 0.0102846072986722
primary O 0 0.04909524694085121
tumours B-Disease 1 0.9999960660934448
such O 0 0.015744319185614586
as O 0 0.026551615446805954
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9989389777183533
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9488286972045898
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.04697458818554878

In O 0 0.023482734337449074
addition O 0 0.030902903527021408
, O 0 0.027108360081911087
PTEN O 1 0.9992103576660156
was O 0 0.019628426060080528
identified O 0 0.021345246583223343
as O 0 0.010311730206012726
the O 0 0.016612127423286438
susceptibility O 1 0.9395931959152222
gene O 0 0.06913715600967407
for O 0 0.014330900274217129
two O 0 0.031005486845970154
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.04821324348449707
CD B-Disease 0 0.09419920295476913
; O 0 0.03856683522462845
MIM O 1 0.9997028708457947
158350 O 1 0.6423063278198242
) O 0 0.02882726676762104
and O 0 0.019130943343043327
Bannayan B-Disease 1 0.9973015785217285
- I-Disease 0 0.2922890782356262
Zonana I-Disease 1 0.9908912777900696
( I-Disease 0 0.07270018756389618
BZS I-Disease 1 0.9951180219650269
) I-Disease 0 0.04063970223069191
or I-Disease 0 0.039466243237257004
Ruvalcaba I-Disease 1 0.9999831914901733
- I-Disease 1 0.9610046744346619
Riley I-Disease 1 0.997946560382843
- I-Disease 1 0.9897593259811401
Smith I-Disease 1 0.9968061447143555
syndrome I-Disease 1 1.0
( O 0 0.09450695663690567
MIM O 1 0.9999732971191406
153480 O 1 0.920686662197113
) O 0 0.03680438920855522
. O 0 0.027409328147768974

Constitutive O 0 0.23822028934955597
DNA O 0 0.08729740977287292
from O 0 0.02129530906677246
37 O 0 0.043069664388895035
CD B-Disease 0 0.04876123368740082
families O 0 0.021042516455054283
and O 0 0.010553768835961819
seven O 0 0.025487145408988
BZS B-Disease 1 0.9947476983070374
families O 0 0.03398367390036583
was O 0 0.025774311274290085
screened O 0 0.08392893522977829
for O 0 0.03188089653849602
germline O 1 0.9926522374153137
PTEN O 1 0.9997149109840393
mutations O 0 0.202177032828331
. O 0 0.041649673134088516

PTEN O 1 0.9992678761482239
mutations O 0 0.15755167603492737
were O 0 0.014045365154743195
identified O 0 0.02157331258058548
in O 0 0.009331388399004936
30 O 0 0.015043702907860279
of O 0 0.009461612440645695
37 O 0 0.03990869224071503
( O 0 0.02697186917066574
81 O 0 0.059795912355184555
% O 0 0.02623051591217518
) O 0 0.021701067686080933
CD B-Disease 0 0.04746954143047333
families O 0 0.02156917005777359
, O 0 0.010884878225624561
including O 0 0.01689782366156578
missense O 0 0.14705117046833038
and O 0 0.020265478640794754
nonsense O 0 0.09298104792833328
point O 0 0.03695168346166611
mutations O 0 0.10102056711912155
, O 0 0.018846677616238594
deletions O 0 0.08586423099040985
, O 0 0.02011389471590519
insertions O 0 0.11838586628437042
, O 0 0.021063249558210373
a O 0 0.034885864704847336
deletion O 0 0.3084987699985504
/ O 1 0.9687568545341492
insertion O 0 0.12557995319366455
and O 0 0.023559946566820145
splice O 0 0.1933322548866272
site O 0 0.060483526438474655
mutations O 0 0.1370820850133896
. O 0 0.038383886218070984

These O 0 0.025787869468331337
mutations O 0 0.08548131585121155
were O 0 0.011450765654444695
scattered O 0 0.022815698757767677
over O 0 0.008654194884002209
the O 0 0.00893399491906166
entire O 0 0.02387593872845173
length O 0 0.029290741309523582
of O 0 0.017080042511224747
PTEN O 1 0.9997530579566956
, O 0 0.011072928085923195
with O 0 0.006903717294335365
the O 0 0.007574681658297777
exception O 0 0.019454699009656906
of O 0 0.0054762037470936775
the O 0 0.007564723026007414
first O 0 0.010662717744708061
, O 0 0.009375018998980522
fourth O 0 0.020933499559760094
and O 0 0.010733571834862232
last O 0 0.02743939869105816
exons O 0 0.11814530938863754
. O 0 0.03257136419415474

A O 0 0.05580733343958855
hot O 0 0.09515009820461273
spot O 0 0.05994395911693573
for O 0 0.027316130697727203
PTEN O 1 0.9989672899246216
mutation O 0 0.13985610008239746
in O 0 0.017099104821681976
CD B-Disease 0 0.04836241900920868
was O 0 0.016505388543009758
identified O 0 0.022912010550498962
in O 0 0.013482575304806232
exon O 0 0.10523168742656708
5 O 0 0.02368789166212082
that O 0 0.0077893612906336784
contains O 0 0.013353012502193451
the O 0 0.01442761905491352
PTPase O 1 0.7206199765205383
core O 0 0.05042275786399841
motif O 0 0.07392771542072296
, O 0 0.010164706036448479
with O 0 0.008950905874371529
13 O 0 0.017936090007424355
of O 0 0.009036905132234097
30 O 0 0.02334219217300415
( O 0 0.024275317788124084
43 O 0 0.040172554552555084
% O 0 0.028630170971155167
) O 0 0.02740296721458435
CD B-Disease 0 0.07186300307512283
mutations O 0 0.0886373370885849
identified O 0 0.024252327159047127
in O 0 0.010970084927976131
this O 0 0.01174143049865961
exon O 0 0.13767099380493164
. O 0 0.0354384109377861

Seven O 0 0.02709406055510044
of O 0 0.013924341648817062
30 O 0 0.028212303295731544
( O 0 0.02742869406938553
23 O 0 0.02830103039741516
% O 0 0.023790709674358368
) O 0 0.01281210407614708
were O 0 0.006300479639321566
within O 0 0.0087643563747406
the O 0 0.010606685653328896
core O 0 0.038962990045547485
motif O 0 0.058838989585638046
, O 0 0.009389977902173996
the O 0 0.008152901194989681
majority O 0 0.01891818642616272
( O 0 0.016520537436008453
five O 0 0.007899872958660126
of O 0 0.005901924334466457
seven O 0 0.013587524183094501
) O 0 0.012164302170276642
of O 0 0.006376656703650951
which O 0 0.00986505951732397
were O 0 0.016247624531388283
missense O 0 0.40204545855522156
mutations O 0 0.11985836923122406
, O 0 0.015829939395189285
possibly O 0 0.03145739808678627
pointing O 0 0.029813699424266815
to O 0 0.008081546984612942
the O 0 0.00970919243991375
functional O 0 0.030184561386704445
significance O 0 0.01825244165956974
of O 0 0.007188188377767801
this O 0 0.009332076646387577
region O 0 0.03470498323440552
. O 0 0.02733789198100567

Germline O 1 0.9972909092903137
PTEN O 1 0.999567449092865
mutations O 0 0.14577096700668335
were O 0 0.011990753933787346
identified O 0 0.017961077392101288
in O 0 0.007219600025564432
four O 0 0.007682407274842262
of O 0 0.006844743154942989
seven O 0 0.019754281267523766
( O 0 0.031568679958581924
57 O 0 0.05443175509572029
% O 0 0.03127134591341019
) O 0 0.03617461025714874
BZS B-Disease 1 0.9966913461685181
families O 0 0.04006340354681015
studied O 0 0.04053148627281189
. O 0 0.024038715288043022

Interestingly O 0 0.12130140513181686
, O 0 0.017015932127833366
none O 0 0.02050863765180111
of O 0 0.007743063382804394
these O 0 0.010846171528100967
mutations O 0 0.08340959995985031
was O 0 0.01689760386943817
observed O 0 0.02167854830622673
in O 0 0.010290068574249744
the O 0 0.018222106620669365
PTPase O 1 0.807097315788269
core O 0 0.06721041351556778
motif O 0 0.11416307836771011
. O 0 0.03279680013656616

It O 0 0.017464546486735344
is O 0 0.011564393527805805
also O 0 0.009768135845661163
worthy O 0 0.0334780216217041
of O 0 0.007283803541213274
note O 0 0.0234488844871521
that O 0 0.0064747529104352
a O 0 0.013506024144589901
single O 0 0.027698097750544548
nonsense O 0 0.08050056546926498
point O 0 0.0336763970553875
mutation O 0 0.1257130205631256
, O 0 0.022292841225862503
R233X O 0 0.12602558732032776
, O 0 0.012902156449854374
was O 0 0.015773002058267593
observed O 0 0.022247254848480225
in O 0 0.008044508285820484
the O 0 0.015219277702271938
germline O 1 0.5134521126747131
DNA O 0 0.052773792296648026
from O 0 0.011035350151360035
two O 0 0.00980769656598568
unrelated O 0 0.04663021117448807
CD B-Disease 0 0.05897734686732292
families O 0 0.024594899266958237
and O 0 0.011197716929018497
one O 0 0.020875072106719017
BZS B-Disease 1 0.9987931251525879
family O 0 0.04534570500254631
. O 0 0.02845003828406334

Genotype O 1 0.9966754913330078
- O 1 0.5750547647476196
phenotype O 1 0.8070633411407471
studies O 0 0.03925859183073044
were O 0 0.007346215657889843
not O 0 0.0064631314016878605
performed O 0 0.014283176511526108
on O 0 0.005537847522646189
this O 0 0.006451213266700506
small O 0 0.014912198297679424
group O 0 0.02506018988788128
of O 0 0.015579909086227417
BZS B-Disease 1 0.9984777569770813
families O 0 0.0497124046087265
. O 0 0.031772494316101074

However O 0 0.031789228320121765
, O 0 0.029226820915937424
genotype O 1 0.9889482259750366
- O 0 0.14730404317378998
phenotype O 1 0.5945097208023071
analysis O 0 0.05068871006369591
inthe O 0 0.1690102219581604
group O 0 0.03022182360291481
of O 0 0.010956351645290852
CD B-Disease 0 0.051529817283153534
families O 0 0.025755634531378746
revealed O 0 0.0268405694514513
two O 0 0.008214276283979416
possible O 0 0.020908985286951065
associations O 0 0.03074641153216362
worthy O 0 0.04082215577363968
of O 0 0.008426185697317123
follow O 0 0.02652006968855858
- O 0 0.048248689621686935
up O 0 0.013768822886049747
in O 0 0.011521896347403526
independent O 0 0.021987974643707275
analyses O 0 0.05073997750878334
. O 0 0.02495553530752659

The O 0 0.01737585850059986
first O 0 0.015155889093875885
was O 0 0.01372693944722414
an O 0 0.010772040113806725
association O 0 0.028158899396657944
noted O 0 0.015034252777695656
in O 0 0.006520173046737909
the O 0 0.007453045342117548
group O 0 0.019391121342778206
of O 0 0.00876091979444027
CD B-Disease 0 0.054869841784238815
families O 0 0.0325312465429306
with O 0 0.035816602408885956
breast B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 0 0.04036010801792145

A O 0 0.05466997250914574
correlation O 0 0.07662145048379898
was O 0 0.018016580492258072
observed O 0 0.022422784939408302
between O 0 0.011150320991873741
the O 0 0.01238457765430212
presence O 0 0.049205757677555084
/ O 1 0.831697404384613
absence O 0 0.03702239319682121
of O 0 0.010595123283565044
a O 0 0.03347962349653244
PTEN O 1 0.9998902082443237
mutation O 0 0.1258312314748764
and O 0 0.009013790637254715
the O 0 0.010540477931499481
type O 0 0.05204186961054802
of O 0 0.017594512552022934
breast O 1 0.9999986886978149
involvement O 0 0.40246620774269104
( O 0 0.0411747507750988
unaffected O 1 0.979473888874054
versus O 1 0.9740910530090332
benign O 1 0.999993085861206
versus O 1 0.9973188042640686
malignant O 1 0.9999995231628418
) O 0 0.04347608983516693
. O 0 0.0283889751881361

Specifically O 0 0.04259060323238373
and O 0 0.009939013049006462
more O 0 0.007488987408578396
directly O 0 0.014978092163801193
, O 0 0.009072446264326572
an O 0 0.00952005572617054
association O 0 0.02977132983505726
was O 0 0.011706771329045296
also O 0 0.007968640886247158
observed O 0 0.014410542324185371
between O 0 0.007252532988786697
the O 0 0.008193410001695156
presence O 0 0.02217404544353485
of O 0 0.010845014825463295
a O 0 0.038222283124923706
PTEN O 1 0.9999927282333374
mutation O 1 0.9928969740867615
and O 0 0.1709109991788864
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.03697139769792557

Secondly O 0 0.09195276349782944
, O 0 0.015185561962425709
there O 0 0.008364681154489517
appeared O 0 0.014786976389586926
to O 0 0.006858048960566521
be O 0 0.007033638656139374
an O 0 0.012709153816103935
interdependent O 0 0.1228686198592186
association O 0 0.04443991929292679
between O 0 0.020570121705532074
mutations O 0 0.09788021445274353
upstream O 0 0.04828498512506485
and O 0 0.009112362749874592
within O 0 0.010728307068347931
the O 0 0.014475458301603794
PTPase O 1 0.8428027629852295
core O 0 0.051788702607154846
motif O 0 0.07469921559095383
, O 0 0.012469807639718056
the O 0 0.01219969429075718
core O 0 0.03856615349650383
motif O 0 0.060329992324113846
containing O 0 0.01660969667136669
the O 0 0.010885104537010193
majority O 0 0.024422964081168175
of O 0 0.018244659528136253
missense O 0 0.25477278232574463
mutations O 0 0.10506380349397659
, O 0 0.011446313932538033
and O 0 0.006711986847221851
the O 0 0.0081979064270854
involvement O 0 0.03424522653222084
of O 0 0.006035987753421068
all O 0 0.007908664643764496
major O 0 0.024840541183948517
organ O 0 0.2297944724559784
systems O 0 0.04580923542380333
( O 0 0.026862025260925293
central O 0 0.033036451786756516
nervous O 1 0.9999513626098633
system O 0 0.04549429565668106
, O 0 0.02485233172774315
thyroid O 1 1.0
, O 0 0.054998647421598434
breast O 1 1.0
, O 0 0.036760855466127396
skin O 1 0.9999998807907104
and O 0 0.0324212871491909
gastrointestinal O 1 1.0
tract O 1 0.9999932050704956
) O 0 0.03882572799921036
. O 0 0.025966638699173927

However O 0 0.02032092958688736
, O 0 0.010460878722369671
these O 0 0.006715745199471712
observations O 0 0.019608566537499428
would O 0 0.007947769947350025
need O 0 0.011122563853859901
to O 0 0.006231226492673159
be O 0 0.006434285081923008
confirmed O 0 0.016559956595301628
by O 0 0.00761397136375308
studying O 0 0.015163698233664036
a O 0 0.010363362729549408
larger O 0 0.011723891831934452
number O 0 0.00712987594306469
of O 0 0.007800551131367683
CD B-Disease 0 0.054747190326452255
families O 0 0.036676835268735886
. O 0 0.025806181132793427

Molecular O 0 0.17089678347110748
defects O 1 0.976095974445343
leading O 0 0.031477026641368866
to O 0 0.012991183437407017
human O 0 0.03067955933511257
complement B-Disease 0 0.0943388044834137
component I-Disease 1 0.9980892539024353
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.016263386234641075
an O 0 0.014529447071254253
African O 0 0.048887934535741806
- O 0 0.06568638235330582
American O 0 0.03657243028283119
family O 0 0.04424390196800232
. O 0 0.029653025791049004

Complement B-Disease 0 0.21076683700084686
component I-Disease 1 0.9984496831893921
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.07339583337306976
C6D B-Disease 1 0.9995381832122803
) O 0 0.03132755309343338
was O 0 0.022163329645991325
diagnosed O 1 0.9999932050704956
in O 0 0.010928834788501263
a O 0 0.014856591820716858
16 O 0 0.02141815423965454
- O 0 0.048887766897678375
year O 0 0.024252580478787422
- O 0 0.06839021295309067
old O 0 0.04041482135653496
African O 0 0.06314542889595032
- O 0 0.07802138477563858
American O 0 0.035409606993198395
male O 0 0.07466936856508255
with O 0 0.051330506801605225
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.05581645295023918

The O 0 0.036702241748571396
patients O 1 0.9995500445365906
father O 0 0.029217392206192017
and O 0 0.00823749229311943
two O 0 0.008745139464735985
brothers O 0 0.03415723145008087
also O 0 0.012930704280734062
had O 0 0.021215153858065605
C6D B-Disease 1 0.9976720213890076
, O 0 0.010465153492987156
but O 0 0.0073944199830293655
gave O 0 0.016011174768209457
no O 0 0.009998021647334099
history O 0 0.017542170360684395
of O 0 0.017154915258288383
meningitis B-Disease 1 1.0
or O 0 0.025685841217637062
other O 0 0.017685487866401672
neisserial B-Disease 1 0.9997891783714294
infection I-Disease 1 0.9999978542327881
. O 0 0.03836267441511154

By O 0 0.027194375172257423
using O 0 0.03130793944001198
exon O 0 0.16393955051898956
- O 0 0.09337807446718216
specific O 0 0.04586939513683319
polymerase O 0 0.20560064911842346
chain O 0 0.11319088935852051
reaction O 0 0.09999292343854904
( O 0 0.05176585912704468
PCR O 0 0.22560590505599976
) O 0 0.0437181256711483
/ O 0 0.3549966812133789
single O 0 0.04454886168241501
- O 0 0.10142479091882706
strand O 0 0.12774558365345
conformation O 0 0.1383904218673706
polymorphism O 0 0.10459284484386444
as O 0 0.0149959372356534
a O 0 0.021042633801698685
screening O 0 0.07814192771911621
step O 0 0.03213702514767647
and O 0 0.013726677745580673
nucleotide O 0 0.07499991357326508
sequencing O 0 0.055911771953105927
of O 0 0.010722164995968342
target O 0 0.03444518893957138
exons O 0 0.07716795802116394
, O 0 0.011188375763595104
we O 0 0.008243836462497711
determined O 0 0.017108019441366196
that O 0 0.0070254080928862095
the O 0 0.01135756354779005
proband O 0 0.1465357542037964
was O 0 0.018296411260962486
a O 0 0.022937411442399025
compound O 0 0.08403906971216202
heterozygote O 1 0.6281984448432922
for O 0 0.0186106339097023
two O 0 0.02690916135907173
C6 O 1 0.9997673630714417
gene O 0 0.16050417721271515
mutations O 0 0.1624220311641693
. O 0 0.03953094780445099

The O 0 0.021084733307361603
first O 0 0.020250748842954636
, O 0 0.017474785447120667
1195delC O 0 0.10593397170305252
located O 0 0.025206254795193672
in O 0 0.013656385242938995
exon O 0 0.10424063354730606
7 O 0 0.025243235751986504
, O 0 0.01067842822521925
is O 0 0.010714617557823658
a O 0 0.01743912696838379
novel O 0 0.03394533321261406
mutation O 0 0.0978735089302063
, O 0 0.011133267544209957
while O 0 0.010526592843234539
the O 0 0.009241020306944847
second O 0 0.01971760205924511
, O 0 0.015678713098168373
1936delG O 0 0.11285453289747238
in O 0 0.015691904351115227
exon O 0 0.1070864200592041
12 O 0 0.023387789726257324
, O 0 0.010390225797891617
has O 0 0.009940946474671364
been O 0 0.008577225729823112
described O 0 0.017833029851317406
before O 0 0.010898527689278126
to O 0 0.011750624515116215
cause O 0 0.06389335542917252
C6D B-Disease 1 0.783156156539917
in O 0 0.011508495546877384
an O 0 0.013793768361210823
unrelated O 0 0.05131484568119049
African O 0 0.054555494338274
- O 0 0.0699205994606018
American O 0 0.030557753518223763
individual O 0 0.032027069479227066
. O 0 0.030435308814048767

Both O 0 0.04334868863224983
mutations O 0 0.13446290791034698
result O 0 0.04025643691420555
in O 0 0.02544516697525978
premature O 1 0.9956969022750854
termination O 1 0.9679570198059082
codons O 0 0.15219838917255402
and O 0 0.03386956453323364
C6 O 1 0.9991708993911743
null O 0 0.14483895897865295
alleles O 0 0.20771238207817078
. O 0 0.045920249074697495

Allele O 0 0.26477253437042236
- O 0 0.11881386488676071
specific O 0 0.0440792478621006
PCR O 0 0.15497197210788727
indicated O 0 0.03225996717810631
that O 0 0.007446716073900461
the O 0 0.012737683951854706
probands O 0 0.13992224633693695
two O 0 0.013772263191640377
brothers O 0 0.045530691742897034
also O 0 0.01736825704574585
inherited O 0 0.09055251628160477
the O 0 0.02363794669508934
1195delC O 1 0.8578978776931763
mutation O 0 0.12732847034931183
from O 0 0.01440106425434351
their O 0 0.013232406228780746
heterozygous O 0 0.10234384983778
mother O 0 0.037664055824279785
and O 0 0.011201335117220879
the O 0 0.017066853120923042
1936delG O 1 0.7851055860519409
mutation O 0 0.1191687360405922
from O 0 0.015932396054267883
their O 0 0.014803769998252392
homozygous O 0 0.10892908275127411
father O 0 0.03964332118630409
. O 0 0.01657770201563835
. O 0 0.02527519129216671

PAX6 O 1 0.9984751343727112
mutations O 0 0.24080491065979004
reviewed O 0 0.07491274178028107
. O 0 0.03838479518890381

Mutations O 0 0.18872186541557312
in O 0 0.035016704350709915
PAX6 O 1 0.9985862970352173
are O 0 0.01319788210093975
responsible O 0 0.023684386163949966
for O 0 0.00912644062191248
human O 0 0.028067098930478096
aniridia B-Disease 1 0.9996978044509888
and O 0 0.00822887197136879
have O 0 0.006816809996962547
also O 0 0.00648229056969285
been O 0 0.007513993885368109
found O 0 0.01299226377159357
in O 0 0.012640555389225483
patients O 1 0.9999831914901733
with O 0 0.021742066368460655
Peters B-Disease 1 0.9999862909317017
anomaly I-Disease 1 0.9999686479568481
, O 0 0.020161902531981468
with O 0 0.039356254041194916
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.022080738097429276
with O 0 0.022672688588500023
autosomal B-Disease 1 0.9999924898147583
dominant I-Disease 1 0.9994207620620728
keratitis I-Disease 1 1.0
, O 0 0.016950741410255432
and O 0 0.010910109616816044
with O 0 0.02114308811724186
isolated B-Disease 1 0.9224036335945129
foveal I-Disease 1 0.999992847442627
hypoplasia I-Disease 1 0.9999982118606567
. O 0 0.05086557939648628

No O 0 0.039227306842803955
locus O 0 0.114390067756176
other O 0 0.013038923032581806
than O 0 0.01842564530670643
chromosome O 0 0.1370980143547058
11p13 O 0 0.14548638463020325
has O 0 0.01629747822880745
been O 0 0.015319705940783024
implicated O 0 0.09305828809738159
in O 0 0.019664451479911804
aniridia B-Disease 1 0.9996539354324341
, O 0 0.015008106827735901
and O 0 0.01482397224754095
PAX6 O 1 0.9998835325241089
is O 0 0.016362063586711884
clearly O 0 0.01889204792678356
the O 0 0.008229728788137436
major O 0 0.014314811676740646
, O 0 0.00801900029182434
if O 0 0.008118363097310066
not O 0 0.006223574746400118
only O 0 0.009102228097617626
, O 0 0.014272457920014858
gene O 0 0.07037120312452316
responsible O 0 0.042317379266023636
. O 0 0.030873743817210197

Twenty O 0 0.07282988727092743
- O 0 0.06888949126005173
eight O 0 0.02240201085805893
percent O 0 0.023825159296393394
of O 0 0.012449911795556545
identified O 0 0.06020193174481392
PAX6 O 1 0.9998230338096619
mutations O 0 0.14463001489639282
are O 0 0.022263625636696815
C O 1 0.9949520826339722
- O 0 0.4711017608642578
T O 1 0.9832966327667236
changes O 0 0.03013267181813717
at O 0 0.033580996096134186
CpG O 1 0.8898256421089172
dinucleotides O 0 0.19352437555789948
, O 0 0.016028307378292084
20 O 0 0.01763392984867096
% O 0 0.018665699288249016
are O 0 0.009863589890301228
splicing O 0 0.09236498922109604
errors O 0 0.03737187385559082
, O 0 0.008360362611711025
and O 0 0.005930361337959766
more O 0 0.00614682212471962
than O 0 0.009405949153006077
30 O 0 0.01866278611123562
% O 0 0.022013526409864426
are O 0 0.011157956905663013
deletion O 0 0.11251509189605713
or O 0 0.03010907955467701
insertion O 0 0.13046257197856903
events O 0 0.039497967809438705
. O 0 0.029995661228895187

There O 0 0.022265447303652763
is O 0 0.01373185496777296
a O 0 0.02036837860941887
noticeably O 0 0.08600564301013947
elevated O 0 0.08772577345371246
level O 0 0.02581135928630829
of O 0 0.010843142867088318
mutation O 0 0.08255098015069962
in O 0 0.011024249717593193
the O 0 0.012615162879228592
paired O 0 0.07556097954511642
domain O 0 0.03744249418377876
compared O 0 0.021440787240862846
with O 0 0.00742585863918066
the O 0 0.008172117173671722
rest O 0 0.01612410880625248
of O 0 0.006676089949905872
the O 0 0.013476109132170677
gene O 0 0.08698417991399765
. O 0 0.0283079631626606

Increased O 0 0.07832919806241989
mutation O 0 0.1227487176656723
in O 0 0.014122233726084232
the O 0 0.01703340746462345
homeodomain O 1 0.6613057851791382
is O 0 0.01594957709312439
accounted O 0 0.024970611557364464
for O 0 0.007393146865069866
by O 0 0.010139992460608482
the O 0 0.021223774179816246
hypermutable O 1 0.9754119515419006
CpG O 1 0.9747057557106018
dinucleotide O 0 0.2917814552783966
in O 0 0.036395780742168427
codon O 0 0.15444165468215942
240 O 0 0.09755416959524155
. O 0 0.03854074329137802

Very O 0 0.030117757618427277
nearly O 0 0.02299230359494686
all O 0 0.012103076092898846
mutations O 0 0.08367053419351578
appear O 0 0.020597515627741814
to O 0 0.013374431990087032
cause O 0 0.05860156565904617
loss O 0 0.0359189473092556
of O 0 0.007744631264358759
function O 0 0.01789715141057968
of O 0 0.005906106438487768
the O 0 0.014623066410422325
mutant O 0 0.10326746851205826
allele O 0 0.12196607887744904
, O 0 0.012251258827745914
and O 0 0.006466481368988752
more O 0 0.0062233866192400455
than O 0 0.009604960680007935
80 O 0 0.02688472718000412
% O 0 0.019306359812617302
of O 0 0.011486520059406757
exonic O 1 0.7497612833976746
substitutions O 0 0.0662010982632637
result O 0 0.027281608432531357
in O 0 0.01878209412097931
nonsense O 0 0.10132801532745361
codons O 0 0.1250259131193161
. O 0 0.030414748936891556

In O 0 0.02759578451514244
a O 0 0.028005460277199745
gene O 0 0.061038386076688766
with O 0 0.010225441306829453
such O 0 0.01092479471117258
extraordinarily O 0 0.07618390768766403
high O 0 0.03316458314657211
sequence O 0 0.03452077507972717
conservation O 0 0.03514477238059044
throughout O 0 0.015346940606832504
evolution O 0 0.024445755407214165
, O 0 0.00958928745239973
there O 0 0.009245849214494228
are O 0 0.01060556061565876
presumed O 0 0.09472837299108505
undiscovered O 1 0.8545802235603333
missense O 1 0.6758648753166199
mutations O 0 0.12796087563037872
, O 0 0.012217963114380836
these O 0 0.006913750898092985
are O 0 0.007852217182517052
hypothesized O 0 0.04917413368821144
to O 0 0.007455193903297186
exist O 0 0.010282524861395359
in O 0 0.007212050724774599
as O 0 0.011049007996916771
- O 0 0.05726029351353645
yet O 0 0.0308615043759346
unidentified O 0 0.08558255434036255
phenotypes O 0 0.16833537817001343
. O 0 0.022283213213086128
. O 0 0.028717288747429848

Genetic O 0 0.16628716886043549
heterogeneity O 0 0.15861867368221283
and O 0 0.024257037788629532
penetrance O 0 0.4665988087654114
analysis O 0 0.025684718042612076
of O 0 0.009473597630858421
the O 0 0.018480125814676285
BRCA1 O 1 0.9977220892906189
and O 0 0.03014921024441719
BRCA2 O 1 0.9998736381530762
genes O 0 0.10783078521490097
in O 0 0.042702820152044296
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.04826945438981056
. O 0 0.02917497046291828

The O 0 0.21438491344451904
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9929734468460083
Consortium O 0 0.32011303305625916
. O 0 0.027605697512626648

The O 0 0.023957328870892525
contribution O 0 0.044942937791347504
of O 0 0.01871596649289131
BRCA1 O 1 0.9990590214729309
and O 0 0.02565249614417553
BRCA2 O 1 0.9999607801437378
to O 0 0.03825249522924423
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.029765836894512177
assessed O 0 0.05140163004398346
by O 0 0.017415031790733337
linkage O 0 0.11858313530683517
and O 0 0.017330877482891083
mutation O 0 0.11722961813211441
analysis O 0 0.027666620910167694
in O 0 0.012466883286833763
237 O 0 0.06928747147321701
families O 0 0.02157384529709816
, O 0 0.007406522054225206
each O 0 0.006439929828047752
with O 0 0.007575993426144123
at O 0 0.011201423592865467
least O 0 0.010870878584682941
four O 0 0.01037499401718378
cases O 0 0.02398393675684929
of O 0 0.01917463168501854
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.011181404814124107
collected O 0 0.012117292732000351
by O 0 0.014063997194170952
the O 0 0.03458435460925102
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9902538657188416
Consortium O 0 0.14654994010925293
. O 0 0.034473683685064316

Families O 0 0.04156263917684555
were O 0 0.009882328100502491
included O 0 0.011668127961456776
without O 0 0.011335253715515137
regard O 0 0.018903756514191628
to O 0 0.007567551918327808
the O 0 0.010348828509449959
occurrence O 0 0.07131601870059967
of O 0 0.019236139953136444
ovarian B-Disease 1 1.0
or I-Disease 0 0.025621401146054268
other I-Disease 0 0.01847364753484726
cancers I-Disease 1 0.9999856948852539
. O 0 0.03074270859360695

Overall O 0 0.10837952792644501
, O 0 0.03252124413847923
disease O 1 0.9999955892562866
was O 0 0.01807378977537155
linked O 0 0.04718795418739319
to O 0 0.016116999089717865
BRCA1 O 1 0.9739907383918762
in O 0 0.01469477266073227
an O 0 0.013001465238630772
estimated O 0 0.030008094385266304
52 O 0 0.038632962852716446
% O 0 0.01874655671417713
of O 0 0.008211146108806133
families O 0 0.020788729190826416
, O 0 0.011955087073147297
to O 0 0.015006577596068382
BRCA2 O 1 0.9842373728752136
in O 0 0.015303220599889755
32 O 0 0.02714398130774498
% O 0 0.016317687928676605
of O 0 0.007011659909039736
families O 0 0.017405634745955467
, O 0 0.008895790204405785
and O 0 0.006163980346173048
to O 0 0.008443603292107582
neither O 0 0.03163638338446617
gene O 0 0.056363243609666824
in O 0 0.014021175913512707
16 O 0 0.02357723005115986
% O 0 0.023661937564611435
( O 0 0.025386760011315346
95 O 0 0.039052460342645645
% O 0 0.027060655876994133
confidence O 0 0.05548328533768654
interval O 0 0.11173930764198303
[ O 0 0.10515688359737396
CI O 1 0.9998346567153931
] O 0 0.09469670057296753
6 O 0 0.03384116291999817
% O 0 0.028119947761297226
- O 0 0.06169693544507027
28 O 0 0.03269325941801071
% O 0 0.02862478792667389
) O 0 0.019412213936448097
, O 0 0.011934281326830387
suggesting O 0 0.042171087116003036
other O 0 0.01693863794207573
predisposition O 1 0.9828116297721863
genes O 0 0.08572851866483688
. O 0 0.03380643576383591

The O 0 0.024969015270471573
majority O 0 0.03178764507174492
( O 0 0.030716484412550926
81 O 0 0.057602256536483765
% O 0 0.021518684923648834
) O 0 0.012586524710059166
of O 0 0.006804038304835558
the O 0 0.03200027719140053
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.02722257561981678
were O 0 0.00790428463369608
due O 0 0.018906136974692345
to O 0 0.013476982712745667
BRCA1 O 1 0.9987419247627258
, O 0 0.010549882426857948
with O 0 0.00787694938480854
most O 0 0.009774958714842796
others O 0 0.01763598807156086
( O 0 0.022615261375904083
14 O 0 0.024781975895166397
% O 0 0.021978717297315598
) O 0 0.017302511259913445
due O 0 0.020110100507736206
to O 0 0.02020026184618473
BRCA2 O 1 0.9984281063079834
. O 0 0.03570070490241051

Conversely O 0 0.10253294557332993
, O 0 0.01133526861667633
the O 0 0.007635754067450762
majority O 0 0.01494628470391035
of O 0 0.007771264761686325
families O 0 0.019269339740276337
with O 0 0.012219793163239956
male B-Disease 0 0.050398774445056915
and I-Disease 0 0.017203697934746742
female I-Disease 1 0.9834336042404175
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 0.009454965591430664
due O 0 0.020927634090185165
to O 0 0.01919914409518242
BRCA2 O 1 0.9987315535545349
( O 0 0.04325195774435997
76 O 0 0.07712845504283905
% O 0 0.03191826120018959
) O 0 0.02727566473186016
. O 0 0.02598728984594345

The O 0 0.025786731392145157
largest O 0 0.044276200234889984
proportion O 0 0.05235551297664642
( O 0 0.03625786677002907
67 O 0 0.05703786388039589
% O 0 0.026430046185851097
) O 0 0.015257665887475014
of O 0 0.006918027997016907
families O 0 0.018133649602532387
due O 0 0.01491718553006649
to O 0 0.007292714901268482
other O 0 0.007312342524528503
genes O 0 0.0373825803399086
was O 0 0.014283020980656147
found O 0 0.012367361225187778
in O 0 0.0070153954438865185
families O 0 0.015377046540379524
with O 0 0.007350041996687651
four O 0 0.008002384565770626
or O 0 0.011290574446320534
five O 0 0.011735820211470127
cases O 0 0.021305469796061516
of O 0 0.01424153707921505
female O 1 0.9685893058776855
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
only O 0 0.020482812076807022
. O 0 0.0251663438975811

These O 0 0.015050875954329967
estimates O 0 0.023315604776144028
were O 0 0.00821908749639988
not O 0 0.00914628803730011
substantially O 0 0.04385416582226753
affected O 0 0.034412045031785965
either O 0 0.013687843456864357
by O 0 0.007836556062102318
changing O 0 0.023315664380788803
the O 0 0.013481777161359787
assumed O 0 0.06395179778337479
penetrance O 1 0.8796908855438232
model O 0 0.04202482849359512
for O 0 0.020096320658922195
BRCA1 O 1 0.9909226298332214
or O 0 0.018182871863245964
by O 0 0.009976249188184738
including O 0 0.012022849172353745
or O 0 0.021807506680488586
excluding O 0 0.06604775041341782
BRCA1 O 1 0.9993683695793152
mutation O 0 0.18767568469047546
data O 0 0.029949937015771866
. O 0 0.026994330808520317

Among O 0 0.022549444809556007
those O 0 0.012511331588029861
families O 0 0.024695461615920067
with O 0 0.021039163693785667
disease O 1 0.9999991655349731
due O 0 0.025335460901260376
to O 0 0.013314167968928814
BRCA1 O 1 0.9986143112182617
that O 0 0.009364250116050243
were O 0 0.009096261113882065
tested O 0 0.03753531351685524
by O 0 0.007313491776585579
one O 0 0.007146110758185387
of O 0 0.005916655994951725
the O 0 0.012481492012739182
standard O 0 0.03724423050880432
screening O 0 0.06927637755870819
methods O 0 0.026372047141194344
, O 0 0.0166177898645401
mutations O 0 0.0744815543293953
were O 0 0.010216077789664268
detected O 0 0.049100589007139206
in O 0 0.00982353650033474
the O 0 0.014338147826492786
coding O 0 0.10408692061901093
sequence O 0 0.045152269303798676
or O 0 0.02300970070064068
splice O 0 0.11579165607690811
sites O 0 0.019815485924482346
in O 0 0.009080620482563972
an O 0 0.012283967807888985
estimated O 0 0.033051468431949615
63 O 0 0.06435194611549377
% O 0 0.030243899673223495
( O 0 0.02986748330295086
95 O 0 0.049867551773786545
% O 0 0.04377833008766174
CI O 1 0.9998213648796082
51 O 0 0.06828244030475616
% O 0 0.04030081257224083
- O 0 0.08494888246059418
77 O 0 0.07740212976932526
% O 0 0.038308609277009964
) O 0 0.029294563457369804
. O 0 0.024675898253917694

The O 0 0.023817965760827065
estimated O 0 0.03914518654346466
sensitivity O 0 0.06652505695819855
was O 0 0.01551132183521986
identical O 0 0.022362874820828438
for O 0 0.008693523705005646
direct O 0 0.022742509841918945
sequencing O 0 0.04409721493721008
and O 0 0.008627807721495628
other O 0 0.00919354148209095
techniques O 0 0.04107561334967613
. O 0 0.024657530710101128

The O 0 0.03956576809287071
penetrance O 1 0.6441682577133179
of O 0 0.028369193896651268
BRCA2 O 1 0.997495174407959
was O 0 0.02313133515417576
estimated O 0 0.02460319921374321
by O 0 0.012282336130738258
maximizing O 0 0.0744049996137619
the O 0 0.023881424218416214
LOD O 1 0.9962913990020752
score O 0 0.033542003482580185
in O 0 0.02325013093650341
BRCA2 O 1 0.999972939491272
- O 0 0.3032214045524597
mutation O 0 0.16628991067409515
families O 0 0.02911413088440895
, O 0 0.009558523073792458
over O 0 0.009138563647866249
all O 0 0.00840613804757595
possible O 0 0.029535653069615364
penetrance O 0 0.4914897382259369
functions O 0 0.03154482692480087
. O 0 0.027679264545440674

The O 0 0.024916069582104683
estimated O 0 0.04963921383023262
cumulative O 1 0.5411674380302429
risk O 1 0.9734067320823669
of O 0 0.02873089909553528
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
reached O 0 0.037995003163814545
28 O 0 0.03135998547077179
% O 0 0.02596202865242958
( O 0 0.030250810086727142
95 O 0 0.05050573870539665
% O 0 0.040542684495449066
CI O 1 0.9997134804725647
9 O 0 0.0405157245695591
% O 0 0.033844757825136185
- O 0 0.06113487854599953
44 O 0 0.03967117518186569
% O 0 0.025430936366319656
) O 0 0.016082262620329857
by O 0 0.00948740728199482
age O 0 0.026398468762636185
50 O 0 0.02175019681453705
years O 0 0.011943787336349487
and O 0 0.012257014401257038
84 O 0 0.06321118772029877
% O 0 0.030001245439052582
( O 0 0.03056734800338745
95 O 0 0.0501982644200325
% O 0 0.041619084775447845
CI O 1 0.9996035695075989
43 O 0 0.05148788541555405
% O 0 0.03507430478930473
- O 0 0.061896197497844696
95 O 0 0.050581060349941254
% O 0 0.026371445506811142
) O 0 0.015808388590812683
by O 0 0.010490338318049908
age O 0 0.03020024113357067
70 O 0 0.03791694715619087
years O 0 0.021270975470542908
. O 0 0.02659272588789463

The O 0 0.04303768277168274
corresponding O 1 0.9307906031608582
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9671655893325806
were O 0 0.019382866099476814
0 O 0 0.058629922568798065
. O 0 0.026858022436499596

4 O 0 0.05577290803194046
% O 0 0.03599477931857109
( O 0 0.03305114060640335
95 O 0 0.053919438272714615
% O 0 0.04572112858295441
CI O 1 0.999822199344635
0 O 0 0.06659716367721558
% O 0 0.03492121025919914
- O 0 0.06312993168830872
1 O 0 0.027174323797225952
% O 0 0.02526511251926422
) O 0 0.015979938209056854
by O 0 0.00950988195836544
age O 0 0.02182738669216633
50 O 0 0.02032713033258915
years O 0 0.01263266708701849
and O 0 0.00928515661507845
27 O 0 0.026935700327157974
% O 0 0.02538675256073475
( O 0 0.02485169842839241
95 O 0 0.05096625164151192
% O 0 0.046185288578271866
CI O 1 0.9997871518135071
0 O 0 0.059196338057518005
% O 0 0.03183036670088768
- O 0 0.05883884057402611
47 O 0 0.05058472231030464
% O 0 0.025869259610772133
) O 0 0.017197391018271446
by O 0 0.010594313964247704
age O 0 0.028891615569591522
70 O 0 0.0335717648267746
years O 0 0.0207605492323637
. O 0 0.02507815510034561

The O 0 0.03492517024278641
lifetime O 1 0.8066742420196533
risk O 1 0.995800793170929
of O 0 0.028299540281295776
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
appears O 0 0.03515980392694473
similar O 0 0.013095097616314888
to O 0 0.006567446514964104
the O 0 0.011682819575071335
risk O 1 0.6655961871147156
in O 0 0.020424561575055122
BRCA1 O 1 0.9999594688415527
carriers O 0 0.2192353755235672
, O 0 0.012075591832399368
but O 0 0.006537634879350662
there O 0 0.006029465701431036
was O 0 0.008151822723448277
some O 0 0.006211517844349146
suggestion O 0 0.027257997542619705
of O 0 0.008432547561824322
a O 0 0.01999014988541603
lower O 0 0.04973207786679268
risk O 1 0.7750946879386902
in O 0 0.026308119297027588
BRCA2 O 1 0.9998462200164795
carriers O 0 0.42733460664749146
< O 0 0.1910775899887085
50 O 0 0.030388209968805313
years O 0 0.013201099820435047
of O 0 0.010690489783883095
age O 0 0.03575189411640167
. O 0 0.02690235897898674

Eye B-Disease 1 0.998895525932312
movement I-Disease 0 0.09299593418836594
abnormalities I-Disease 1 0.9794707894325256
correlate O 0 0.1124858409166336
with O 0 0.026838228106498718
genotype O 1 0.7497777342796326
in O 0 0.034531112760305405
autosomal O 1 0.9996511936187744
dominant O 1 0.9958795309066772
cerebellar B-Disease 1 0.9999997615814209
ataxia I-Disease 1 0.9999997615814209
type I-Disease 1 0.9982990622520447
I I-Disease 0 0.07899871468544006
. O 0 0.020548373460769653

We O 0 0.030302520841360092
compared O 0 0.04671483486890793
horizontal O 0 0.10922253876924515
eye O 1 0.8571314215660095
movements O 0 0.05097321793437004
( O 0 0.03566022217273712
visually O 0 0.08802220970392227
guided O 0 0.10487417876720428
saccades O 1 0.9994444251060486
, O 0 0.02437346614897251
antisaccades O 0 0.15387016534805298
, O 0 0.013654695823788643
and O 0 0.01161803025752306
smooth O 0 0.05071522668004036
pursuit O 0 0.07588973641395569
) O 0 0.018561268225312233
in O 0 0.010721134021878242
control O 0 0.03439221531152725
subjects O 0 0.042022183537483215
( O 0 0.037729594856500626
n O 0 0.07698170095682144
= O 0 0.09062385559082031
14 O 0 0.02433805912733078
) O 0 0.01721150241792202
and O 0 0.011526997201144695
patients O 1 0.9965066313743591
with O 0 0.007591274566948414
three O 0 0.008877672255039215
forms O 0 0.02006722241640091
of O 0 0.014892869628965855
autosomal O 1 0.9998899698257446
dominant O 1 0.9899145364761353
cerebellar B-Disease 1 0.9999985694885254
ataxias I-Disease 1 0.9999284744262695
type I-Disease 1 0.9856104254722595
I I-Disease 1 0.838656485080719
spinocerebellar B-Disease 1 0.9999817609786987
ataxias I-Disease 1 0.7605827450752258
1 I-Disease 0 0.02716352790594101
and I-Disease 0 0.012680288404226303
2 I-Disease 0 0.029435014352202415
( O 0 0.033610641956329346
SCA1 B-Disease 1 0.9596981406211853
, O 0 0.023181399330496788
n O 0 0.07428868114948273
= O 0 0.10233332216739655
11 O 0 0.03432523459196091
; O 0 0.027684880420565605
SCA2 B-Disease 1 0.7791571021080017
, O 0 0.022177159786224365
n O 0 0.07340157777070999
= O 0 0.08570867776870728
10 O 0 0.021609000861644745
) O 0 0.02313535287976265
and O 0 0.02070087566971779
SCA3 B-Disease 1 0.9999903440475464
/ O 1 0.9995123147964478
Machado B-Disease 1 0.9887056946754456
- I-Disease 1 0.6712539792060852
Joseph I-Disease 0 0.15187464654445648
disease I-Disease 1 0.999996542930603
( O 0 0.07304741442203522
MJD B-Disease 1 0.9999507665634155
) O 0 0.03694701939821243
( O 0 0.03930222615599632
n O 0 0.07820231467485428
= O 0 0.09685128182172775
16 O 0 0.03287043422460556
) O 0 0.027125872671604156
. O 0 0.024783067405223846

In O 0 0.044930312782526016
SCA1 B-Disease 1 0.8689844012260437
, O 0 0.03911888971924782
saccade O 1 0.7237151265144348
amplitude O 0 0.1088256984949112
was O 0 0.02552494779229164
significantly O 0 0.0422048456966877
increased O 0 0.025982003659009933
, O 0 0.012570002116262913
resulting O 0 0.035254865884780884
in O 0 0.017698226496577263
hypermetria B-Disease 1 0.8519698977470398
. O 0 0.033792003989219666

The O 0 0.031915511935949326
smooth O 0 0.07824292033910751
pursuit O 0 0.09594893455505371
gain O 0 0.04993400722742081
was O 0 0.02608589641749859
decreased O 0 0.0803971067070961
. O 0 0.027417756617069244

In O 0 0.04420742765069008
SCA2 B-Disease 1 0.957424521446228
, O 0 0.03876592963933945
saccade O 1 0.9358509182929993
velocity O 0 0.10207672417163849
was O 0 0.03134394809603691
markedly O 0 0.10074812173843384
decreased O 0 0.08952196687459946
. O 0 0.030598705634474754

The O 0 0.02078096568584442
percentage O 0 0.029098354279994965
of O 0 0.010729325003921986
errors O 0 0.03601602464914322
in O 0 0.014879919588565826
antisaccades O 1 0.6104263067245483
was O 0 0.018049292266368866
greatly O 0 0.031077641993761063
increased O 0 0.018648281693458557
and O 0 0.008835387416183949
was O 0 0.016886502504348755
significantly O 0 0.043230630457401276
correlated O 0 0.0786941796541214
with O 0 0.01594989001750946
age O 0 0.04331456869840622
at O 0 0.05303959175944328
disease O 1 1.0
onset O 1 0.9999949932098389
. O 0 0.04434574395418167

In O 0 0.01945469155907631
addition O 0 0.019458692520856857
, O 0 0.011404713615775108
a O 0 0.01903686858713627
correlation O 0 0.053339678794145584
between O 0 0.016715532168745995
smooth O 0 0.04791983217000961
pursuit O 0 0.0591057613492012
gain O 0 0.022148404270410538
and O 0 0.005870715249329805
the O 0 0.006464723963290453
number O 0 0.007544601336121559
of O 0 0.013590745627880096
trinucleotide O 1 0.9974963068962097
repeats O 0 0.09689486026763916
was O 0 0.023525942116975784
found O 0 0.027606897056102753
. O 0 0.02588820271193981

In O 0 0.045046985149383545
SCA3 B-Disease 1 0.9999606609344482
, O 0 0.03564115986227989
gaze B-Disease 1 0.9867123365402222
- I-Disease 0 0.3379947543144226
evoked I-Disease 1 0.5365460515022278
nystagmus I-Disease 1 0.9995433688163757
was O 0 0.02609858103096485
often O 0 0.017098864540457726
present O 0 0.01426777709275484
as O 0 0.011341460049152374
was O 0 0.023668238893151283
saccade O 1 0.9888426065444946
hypometria O 0 0.29068779945373535
and O 0 0.016727322712540627
smooth O 0 0.06520199030637741
pursuit O 0 0.08965619653463364
gain O 0 0.04921139031648636
was O 0 0.02835315465927124
markedly O 0 0.10142296552658081
decreased O 0 0.09721367061138153
. O 0 0.029036100953817368

Three O 0 0.023316234350204468
major O 0 0.03317022696137428
criteria O 0 0.04196914657950401
, O 0 0.023419475182890892
saccade O 1 0.9032505750656128
amplitude O 0 0.11857389658689499
, O 0 0.02961505763232708
saccade O 1 0.7447986006736755
velocity O 0 0.07503899931907654
, O 0 0.010208828374743462
and O 0 0.008080223575234413
presence O 0 0.026252295821905136
of O 0 0.015309588983654976
gaze B-Disease 1 0.9909268617630005
- I-Disease 0 0.27813756465911865
evoked I-Disease 1 0.7512370944023132
nystagmus I-Disease 1 0.999249279499054
, O 0 0.01973477005958557
permitted O 0 0.023884788155555725
the O 0 0.0146329365670681
correct O 0 0.04627344384789467
assignment O 0 0.04695688560605049
of O 0 0.010543105192482471
90 O 0 0.032134149223566055
% O 0 0.0161509420722723
of O 0 0.008008095435798168
the O 0 0.016061753034591675
SCA1 B-Disease 1 0.985131561756134
, O 0 0.013586437329649925
90 O 0 0.025631070137023926
% O 0 0.014591538347303867
of O 0 0.006326334550976753
the O 0 0.013852100819349289
SCA2 B-Disease 1 0.9772529006004333
, O 0 0.012192759662866592
and O 0 0.009319741278886795
93 O 0 0.051476992666721344
% O 0 0.01627441495656967
of O 0 0.007411859929561615
the O 0 0.01489449292421341
patients O 1 0.9999386072158813
with O 0 0.01790918968617916
SCA3 B-Disease 1 0.9999321699142456
to O 0 0.009924164041876793
their O 0 0.00999183114618063
genetically O 0 0.05218903347849846
confirmed O 0 0.05760785564780235
patient O 1 0.9993725419044495
group O 0 0.026214923709630966
and O 0 0.008008493110537529
, O 0 0.007859840989112854
therefore O 0 0.012804712168872356
, O 0 0.009680474177002907
may O 0 0.018463153392076492
help O 0 0.03680863603949547
orient O 0 0.1122971847653389
diagnoses O 1 0.9963895678520203
of O 0 0.02003403566777706
SCA1 B-Disease 1 0.9983593821525574
, O 0 0.02399471029639244
SCA2 B-Disease 1 0.9954506754875183
, O 0 0.01584763638675213
and O 0 0.014013480395078659
SCA3 B-Disease 1 0.9999195337295532
at O 0 0.025247981771826744
early O 0 0.027977459132671356
clinical O 1 0.8979461789131165
stages O 0 0.041841596364974976
of O 0 0.009877821430563927
the O 0 0.019574284553527832
diseases O 1 0.9999961853027344
. O 0 0.019212696701288223
. O 0 0.022780831903219223

Genetic O 0 0.09673473984003067
basis O 0 0.0191439650952816
and O 0 0.01307639665901661
molecular O 0 0.06138509884476662
mechanism O 0 0.07613076269626617
for O 0 0.03748251870274544
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.058122627437114716

Ventricular B-Disease 1 0.9999996423721313
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.8748579025268555
more O 0 0.011229969561100006
than O 0 0.012019848451018333
300 O 0 0.02998538129031658
, O 0 0.01452094316482544
000 O 0 0.07168960571289062
sudden O 1 0.8418117761611938
deaths O 0 0.05405907332897186
each O 0 0.009834414348006248
year O 0 0.012231874279677868
in O 0 0.00808323547244072
the O 0 0.013257409445941448
USA O 0 0.09360139071941376
alone O 0 0.0478607714176178
. O 0 0.02473221905529499

In O 0 0.02746471017599106
approximately O 0 0.03240310028195381
5 O 0 0.034038569778203964
- O 0 0.05474763736128807
12 O 0 0.023417813703417778
% O 0 0.015237155370414257
of O 0 0.006012434605509043
these O 0 0.006409947294741869
cases O 0 0.015670739114284515
, O 0 0.00781940296292305
there O 0 0.006964616943150759
are O 0 0.007369368337094784
no O 0 0.02132120169699192
demonstrable O 1 0.9991716146469116
cardiac O 1 0.9999994039535522
or O 0 0.031678423285484314
non O 1 0.805234968662262
- O 1 0.9994134902954102
cardiac O 1 0.9999997615814209
causes O 0 0.4545556902885437
to O 0 0.00902960542589426
account O 0 0.012182249687612057
for O 0 0.006527200806885958
the O 0 0.008876530453562737
episode O 0 0.029243525117635727
, O 0 0.007321104872971773
which O 0 0.006574119441211224
is O 0 0.008896437473595142
therefore O 0 0.013052362948656082
classified O 0 0.03295338153839111
as O 0 0.02914309687912464
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.8561906814575195
IVF B-Disease 1 0.9999984502792358
) O 0 0.03557437285780907
. O 0 0.02571193501353264

A O 0 0.040259551256895065
distinct O 0 0.042943499982357025
group O 0 0.03682566434144974
of O 0 0.019710034132003784
IVF B-Disease 1 1.0
patients O 1 0.9999831914901733
has O 0 0.014070029370486736
been O 0 0.009095513261854649
found O 0 0.009507493115961552
to O 0 0.0051254210993647575
present O 0 0.0079796789214015
with O 0 0.009029747918248177
a O 0 0.019894354045391083
characteristic O 0 0.07981932908296585
electrocardiographic O 1 0.9906054139137268
pattern O 0 0.08850453048944473
. O 0 0.030719852074980736

Because O 0 0.023658448830246925
of O 0 0.006649705581367016
the O 0 0.009088355116546154
small O 0 0.012936476618051529
size O 0 0.016668306663632393
of O 0 0.006900575943291187
most O 0 0.011083036661148071
pedigrees O 0 0.07487544417381287
and O 0 0.009164118207991123
the O 0 0.012487887404859066
high O 0 0.040804021060466766
incidence O 1 0.9993696808815002
of O 0 0.017233680933713913
sudden B-Disease 1 0.9974104762077332
death I-Disease 0 0.03413617983460426
, O 0 0.0116591090336442
however O 0 0.012137160636484623
, O 0 0.012617876753211021
molecular O 0 0.054722025990486145
genetic O 0 0.05368700996041298
studies O 0 0.02727556973695755
of O 0 0.015522786416113377
IVF B-Disease 1 0.9999940395355225
have O 0 0.010453300550580025
not O 0 0.007624987047165632
yet O 0 0.013255313970148563
been O 0 0.011155979707837105
done O 0 0.02060890570282936
. O 0 0.019632410258054733

Because O 0 0.10681500285863876
IVF B-Disease 1 0.9999992847442627
causes O 1 0.9999566078186035
cardiac O 1 0.9999997615814209
rhythm O 1 0.9943234920501709
disturbance O 1 0.9911960363388062
, O 0 0.01474003680050373
we O 0 0.011344111524522305
investigated O 0 0.041900165379047394
whether O 0 0.02455413155257702
malfunction O 1 0.9468554258346558
of O 0 0.013945725746452808
ion O 0 0.10125729441642761
channels O 0 0.03867683187127113
could O 0 0.021347811445593834
cause O 0 0.0590030662715435
the O 0 0.02098533697426319
disorder O 1 0.9999903440475464
by O 0 0.01429781224578619
studying O 0 0.031900785863399506
mutations O 0 0.08443106710910797
in O 0 0.013915255665779114
the O 0 0.026256021112203598
cardiac O 1 0.9999978542327881
sodium O 0 0.2762179374694824
channel O 0 0.08632182329893112
gene O 0 0.12330961972475052
SCN5A O 1 0.8882216811180115
. O 0 0.04114089533686638

We O 0 0.01810457929968834
have O 0 0.010027259588241577
now O 0 0.014634966850280762
identified O 0 0.026328369975090027
a O 0 0.027767598628997803
missense O 0 0.1841939091682434
mutation O 0 0.14202792942523956
, O 0 0.01815629005432129
a O 0 0.03112500160932541
splice O 1 0.5067816376686096
- O 0 0.14343029260635376
donor O 0 0.3334018886089325
mutation O 0 0.13589772582054138
, O 0 0.013978958129882812
and O 0 0.011462830007076263
a O 0 0.02986706979572773
frameshift O 1 0.968427836894989
mutation O 0 0.12546402215957642
in O 0 0.014529051259160042
the O 0 0.015085249207913876
coding O 0 0.0846804678440094
region O 0 0.03001881204545498
of O 0 0.01354204397648573
SCN5A O 1 0.9813118577003479
in O 0 0.015281866304576397
three O 0 0.022668296471238136
IVF B-Disease 1 0.99994957447052
families O 0 0.05229632928967476
. O 0 0.032738830894231796

We O 0 0.0204353965818882
show O 0 0.022841444239020348
that O 0 0.012256493791937828
sodium O 0 0.08626944571733475
channels O 0 0.027069704607129097
with O 0 0.011056591756641865
the O 0 0.021365614607930183
missense O 0 0.28909042477607727
mutation O 0 0.2160126119852066
recover O 0 0.2143125832080841
from O 0 0.025674426928162575
inactivation O 0 0.334134042263031
more O 0 0.011512890458106995
rapidly O 0 0.03150339424610138
than O 0 0.012375483289361
normal O 0 0.02801422029733658
and O 0 0.007921518757939339
that O 0 0.008639585226774216
the O 0 0.01918257586658001
frameshift O 1 0.9976983666419983
mutation O 0 0.34808585047721863
causes O 0 0.12864772975444794
the O 0 0.021811386570334435
sodium O 0 0.0993909016251564
channel O 0 0.032287269830703735
to O 0 0.008842852897942066
be O 0 0.009186104871332645
non O 0 0.03777380660176277
- O 0 0.06956201046705246
functional O 0 0.07215383648872375
. O 0 0.03355727344751358

Our O 0 0.033945482224226
results O 0 0.03403199836611748
indicate O 0 0.03483885899186134
that O 0 0.015991734340786934
mutations O 0 0.11261911690235138
in O 0 0.0336848609149456
cardiac O 1 0.9999983310699463
ion O 0 0.3872976303100586
- O 0 0.08876306563615799
channel O 0 0.05276209115982056
genes O 0 0.0508270300924778
contribute O 0 0.03378395363688469
to O 0 0.009392781183123589
the O 0 0.011479143984615803
risk O 0 0.06283698230981827
of O 0 0.014036729000508785
developing O 0 0.08467333018779755
IVF B-Disease 1 0.999993085861206
. O 0 0.020613858476281166
. O 0 0.025165895000100136

Molecular O 0 0.15243268013000488
heterogeneity O 0 0.17041680216789246
in O 0 0.03639485687017441
mucopolysaccharidosis B-Disease 1 0.9976524710655212
IVA I-Disease 1 0.99866783618927
in O 0 0.015823068097233772
Australia O 0 0.01901186816394329
and O 0 0.01003155019134283
Northern O 0 0.022436928004026413
Ireland O 0 0.02886928990483284
: O 0 0.017719659954309464
nine O 0 0.022633152082562447
novel O 0 0.037452805787324905
mutations O 0 0.0881490558385849
including O 0 0.017180154100060463
T312S O 0 0.12564115226268768
, O 0 0.01132258027791977
a O 0 0.014866946265101433
common O 0 0.029278412461280823
allele O 0 0.11736717820167542
that O 0 0.014391903765499592
confers O 0 0.3269730806350708
a O 0 0.042569003999233246
mild O 1 0.9998452663421631
phenotype O 1 0.9959413409233093
. O 0 0.04520723223686218

Mucopolysaccharidosis B-Disease 1 0.9983977675437927
IVA I-Disease 1 0.9999252557754517
( O 0 0.08414053171873093
MPS B-Disease 1 0.9937180280685425
IVA I-Disease 1 0.9999921321868896
) O 0 0.029439454898238182
is O 0 0.018144113942980766
an O 0 0.025098513811826706
autosomal B-Disease 1 0.9999847412109375
recessive I-Disease 1 0.9999980926513672
lysosomal I-Disease 1 0.9999997615814209
storage I-Disease 1 0.9999536275863647
disorder I-Disease 1 1.0
caused O 0 0.36714935302734375
by O 0 0.013553112745285034
a O 0 0.030707549303770065
genetic B-Disease 1 0.8102850317955017
defect I-Disease 1 0.9998370409011841
in O 0 0.025943554937839508
N O 0 0.206425279378891
- O 0 0.12176047265529633
acetylgalactosamine O 1 0.9878435134887695
- O 0 0.1372532993555069
6 O 0 0.07744250446557999
- O 1 0.733960747718811
sulfate O 1 0.999731719493866
sulfatase O 1 0.9998892545700073
( O 0 0.08550696820020676
GALNS O 1 0.9898644089698792
) O 0 0.04209943488240242
. O 0 0.027504608035087585

Previous O 0 0.04094189032912254
studies O 0 0.031180715188384056
of O 0 0.013966738246381283
patients O 1 0.9993584752082825
from O 0 0.01435661781579256
a O 0 0.016845831647515297
British O 0 0.03358772397041321
- O 0 0.06082158908247948
Irish O 0 0.040152277797460556
population O 0 0.0229507926851511
showed O 0 0.022648965939879417
that O 0 0.007936138659715652
the O 0 0.015566809102892876
I113F O 1 0.6740525960922241
mutation O 0 0.11200401186943054
is O 0 0.012183683924376965
the O 0 0.008298926055431366
most O 0 0.008152337744832039
common O 0 0.02326902374625206
single O 0 0.03467436507344246
mutation O 0 0.15070734918117523
among O 0 0.03084487095475197
MPS B-Disease 1 0.9999276399612427
IVA I-Disease 1 1.0
patients O 1 0.9999914169311523
and O 0 0.0187932550907135
produces O 0 0.06179853901267052
a O 0 0.0385383665561676
severe O 1 0.9999921321868896
clinical O 1 0.99994957447052
phenotype O 1 0.9980478286743164
. O 0 0.043675199151039124

We O 0 0.0278288796544075
studied O 0 0.04109552130103111
mutations O 0 0.08367528021335602
in O 0 0.014504588209092617
the O 0 0.024092212319374084
GALNS O 1 0.9943641424179077
gene O 0 0.08277105540037155
from O 0 0.019390257075428963
23 O 0 0.029035575687885284
additional O 0 0.035992082208395004
MPS B-Disease 1 0.9979592561721802
IVA I-Disease 1 0.9999997615814209
patients O 1 0.9999550580978394
( O 0 0.029519056901335716
15 O 0 0.015851810574531555
from O 0 0.010882913134992123
Australia O 0 0.01796194352209568
, O 0 0.01010903064161539
8 O 0 0.018210651353001595
from O 0 0.011482628993690014
Northern O 0 0.023420346900820732
Ireland O 0 0.02641161158680916
) O 0 0.014972043223679066
, O 0 0.007001991383731365
with O 0 0.008080820553004742
various O 0 0.012678509578108788
clinical O 1 0.9993895292282104
phenotypes O 1 0.9920687675476074
( O 0 0.05614069476723671
severe O 1 0.9999116659164429
, O 0 0.014159300364553928
16 O 0 0.020597610622644424
cases O 0 0.025019947439432144
; O 0 0.018003154546022415
intermediate O 0 0.0473172701895237
, O 0 0.013011760078370571
4 O 0 0.024141741916537285
cases O 0 0.027964260429143906
; O 0 0.02225015126168728
mild O 1 0.999455988407135
, O 0 0.014878842979669571
3 O 0 0.027091212570667267
cases O 0 0.029930686578154564
) O 0 0.02701812982559204
. O 0 0.02452767640352249

We O 0 0.021197021007537842
found O 0 0.01664256490767002
two O 0 0.010870149359107018
common O 0 0.030778665095567703
mutations O 0 0.07809208333492279
that O 0 0.00911538116633892
together O 0 0.011252781376242638
accounted O 0 0.028246838599443436
for O 0 0.009464098140597343
32 O 0 0.02578658238053322
% O 0 0.01481909304857254
of O 0 0.007142681162804365
the O 0 0.01135209295898676
44 O 0 0.039444271475076675
unrelated O 0 0.06428184360265732
alleles O 0 0.12258679419755936
in O 0 0.01587495394051075
these O 0 0.015303364023566246
patients O 1 0.9998923540115356
. O 0 0.02812095172703266

One O 0 0.025908494368195534
is O 0 0.017230579629540443
the O 0 0.019380513578653336
T312S O 0 0.379871129989624
mutation O 0 0.1261012852191925
, O 0 0.014758328907191753
a O 0 0.020152011886239052
novel O 0 0.041210614144802094
mutation O 0 0.1143166646361351
found O 0 0.02025376260280609
exclusively O 0 0.02230045385658741
in O 0 0.020380482077598572
milder O 1 0.9996682405471802
patients O 1 0.9999867677688599
. O 0 0.0322401225566864

The O 0 0.015181474387645721
other O 0 0.0077626146376132965
is O 0 0.008744520135223866
the O 0 0.00916893407702446
previously O 0 0.0182420015335083
described O 0 0.03286070004105568
I113F O 0 0.12321735173463821
that O 0 0.011165720410645008
produces O 0 0.046585675328969955
a O 0 0.0340689942240715
severe O 1 0.9999434947967529
phenotype O 1 0.9983084201812744
. O 0 0.04394206032156944

The O 0 0.03771912679076195
I113F O 0 0.1693284660577774
and O 0 0.02642975002527237
T312S O 0 0.2629067301750183
mutations O 0 0.1208266019821167
accounted O 0 0.047838930040597916
for O 0 0.014542438089847565
8 O 0 0.025385845452547073
( O 0 0.0225352980196476
18 O 0 0.01962384767830372
% O 0 0.0205971822142601
) O 0 0.01658337004482746
and O 0 0.009869580157101154
6 O 0 0.028774263337254524
( O 0 0.023345017805695534
14 O 0 0.02029545046389103
% O 0 0.021306810900568962
) O 0 0.01385464146733284
of O 0 0.008828241378068924
44 O 0 0.040942732244729996
unrelated O 0 0.06549293547868729
alleles O 0 0.14986129105091095
, O 0 0.01974518410861492
respectively O 0 0.03698354959487915
. O 0 0.02751924656331539

The O 0 0.030605921521782875
relatively O 0 0.04339544102549553
high O 0 0.053284015506505966
residual O 0 0.4490381181240082
GALNS O 1 0.9923602938652039
activity O 0 0.04606223106384277
seen O 0 0.021852780133485794
when O 0 0.014960094355046749
the O 0 0.02011084370315075
T312S O 0 0.1774912178516388
mutant O 0 0.13611163198947906
cDNA O 0 0.15693016350269318
is O 0 0.03304776921868324
overexpressed O 0 0.16766603291034698
in O 0 0.02112683653831482
mutant O 0 0.11620330065488815
cells O 0 0.07209105044603348
provides O 0 0.030494650825858116
an O 0 0.012492304667830467
explanation O 0 0.026752503588795662
for O 0 0.009401170536875725
the O 0 0.01791011169552803
mild O 1 0.9999340772628784
phenotype O 1 0.9978068470954895
in O 0 0.022685300558805466
patients O 1 0.9997872710227966
with O 0 0.013860148377716541
this O 0 0.01692386530339718
mutation O 0 0.1490209847688675
. O 0 0.028742225840687752

The O 0 0.021382931619882584
distribution O 0 0.023740680888295174
and O 0 0.009892410598695278
relative O 0 0.028113625943660736
frequencies O 0 0.02593923918902874
of O 0 0.0070964619517326355
the O 0 0.014409411698579788
I113F O 0 0.16375944018363953
and O 0 0.021516814827919006
T312S O 0 0.35640960931777954
mutations O 0 0.09294956177473068
in O 0 0.01415091659873724
Australia O 0 0.024321025237441063
corresponded O 0 0.03586490452289581
to O 0 0.007887028157711029
those O 0 0.008150957524776459
observed O 0 0.01872977986931801
in O 0 0.00859469547867775
Northern O 0 0.017930472269654274
Ireland O 0 0.019106190651655197
and O 0 0.006147288717329502
are O 0 0.004644622560590506
unique O 0 0.011805424466729164
to O 0 0.005697038024663925
these O 0 0.004713561851531267
two O 0 0.007966719567775726
populations O 0 0.03506999835371971
, O 0 0.011756948195397854
suggesting O 0 0.029397886246442795
that O 0 0.008439954370260239
both O 0 0.013316523283720016
mutations O 0 0.06995449960231781
were O 0 0.010013229213654995
probably O 0 0.01962912641465664
introduced O 0 0.014796970412135124
to O 0 0.007676278240978718
Australia O 0 0.01435976941138506
by O 0 0.010304627940058708
Irish O 0 0.029435886070132256
migrants O 0 0.03187117725610733
during O 0 0.01745731569826603
the O 0 0.011830350384116173
19th O 0 0.030439281836152077
century O 0 0.03085741214454174
. O 0 0.03138000890612602

Haplotype O 1 0.8078802227973938
analysis O 0 0.04162505269050598
using O 0 0.022570574656128883
6 O 0 0.039772287011146545
RFLPs O 0 0.20302900671958923
provides O 0 0.02804538980126381
additional O 0 0.015145352110266685
data O 0 0.01041463203728199
that O 0 0.007555471267551184
the O 0 0.015775807201862335
I113F O 0 0.31056708097457886
mutation O 0 0.14143691956996918
originated O 0 0.0455983467400074
from O 0 0.01458998117595911
a O 0 0.017913702875375748
common O 0 0.03480107709765434
ancestor O 0 0.08301372826099396
. O 0 0.034243714064359665

The O 0 0.02292119339108467
other O 0 0.012485513463616371
9 O 0 0.03574647381901741
novel O 0 0.04185379296541214
mutations O 0 0.09149321913719177
identified O 0 0.024589378386735916
in O 0 0.009312893263995647
these O 0 0.008638201281428337
23 O 0 0.0274958498775959
patients O 1 0.9991099238395691
were O 0 0.006166323088109493
each O 0 0.006829599384218454
limited O 0 0.014208192005753517
to O 0 0.007195794489234686
a O 0 0.012423744425177574
single O 0 0.02608434297144413
family O 0 0.03541509062051773
. O 0 0.024476179853081703

These O 0 0.0139223113656044
data O 0 0.012841773219406605
provide O 0 0.014536631293594837
further O 0 0.010311691090464592
evidence O 0 0.01295563392341137
for O 0 0.009416559711098671
extensive O 0 0.042421042919158936
allelic O 1 0.5309072136878967
heterogeneity O 0 0.15155534446239471
in O 0 0.026541078463196754
MPS B-Disease 1 0.9875093102455139
IVA I-Disease 1 0.9999934434890747
in O 0 0.021702894940972328
British O 0 0.04740414023399353
- O 0 0.11430340260267258
Irish O 0 0.06813935935497284
patients O 1 0.9996083378791809
and O 0 0.01035739853978157
provide O 0 0.014153684489428997
evidence O 0 0.010092601180076599
for O 0 0.005802141036838293
their O 0 0.0088926637545228
transmission O 0 0.053365860134363174
to O 0 0.008282569237053394
Australia O 0 0.017174456268548965
by O 0 0.009880205616354942
British O 0 0.036098334938287735
- O 0 0.06763531267642975
Irish O 0 0.0460524782538414
migrants O 0 0.04529627040028572
. O 0 0.01721976324915886
. O 0 0.025882378220558167

Identification O 0 0.055940501391887665
of O 0 0.017761338502168655
constitutional O 0 0.052207425236701965
WT1 O 1 0.9998468160629272
mutations O 0 0.147189661860466
, O 0 0.015333862043917179
in O 0 0.014971965923905373
patients O 1 0.9999796152114868
with O 0 0.022808639332652092
isolated O 1 0.9983099699020386
diffuse B-Disease 1 0.9999995231628418
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.020417554304003716
and O 0 0.010569201782345772
analysis O 0 0.023574266582727432
of O 0 0.018144674599170685
genotype O 1 0.999422550201416
/ O 1 0.9989780187606812
phenotype O 1 0.8659403324127197
correlations O 0 0.07165981084108353
by O 0 0.01013385970145464
use O 0 0.011648524552583694
of O 0 0.008656330406665802
a O 0 0.02622326835989952
computerized O 0 0.14642079174518585
mutation O 0 0.15822124481201172
database O 0 0.05350164324045181
. O 0 0.029603244736790657

Constitutional O 0 0.05903678759932518
mutations O 0 0.09251268953084946
of O 0 0.013708522543311119
the O 0 0.024769732728600502
WT1 O 1 0.9995757937431335
gene O 0 0.09833595156669617
, O 0 0.017692862078547478
encoding O 0 0.04938886687159538
a O 0 0.03972318768501282
zinc O 1 0.995721697807312
- O 0 0.1303936243057251
finger O 0 0.1899862140417099
transcription O 0 0.12361672520637512
factor O 0 0.06479853391647339
involved O 0 0.029787221923470497
in O 0 0.022032450884580612
renal O 1 1.0
and O 0 0.02510843425989151
gonadal O 1 0.9999780654907227
development O 0 0.026660770177841187
, O 0 0.008605013601481915
are O 0 0.005334453657269478
found O 0 0.010359822772443295
in O 0 0.008503555320203304
most O 0 0.01262408122420311
patients O 1 0.9999496936798096
with O 0 0.025446351617574692
Denys B-Disease 1 0.9999964237213135
- I-Disease 1 0.9997305274009705
Drash I-Disease 1 0.9999972581863403
syndrome I-Disease 1 1.0
( O 0 0.4544426500797272
DDS B-Disease 1 1.0
) O 0 0.02836957946419716
, O 0 0.015304629690945148
or O 0 0.03998112305998802
diffuse B-Disease 1 0.9999986886978149
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9387117624282837
DMS B-Disease 1 0.9999986886978149
) O 0 0.026422807946801186
associated O 0 0.02385539934039116
with O 0 0.017443547025322914
pseudohermaphroditism B-Disease 1 0.9999442100524902
and O 0 0.024459324777126312
/ O 1 0.999784529209137
or O 0 0.06734508275985718
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999972581863403
( O 0 0.09092780947685242
WT B-Disease 1 0.9999769926071167
) O 0 0.04386988654732704
. O 0 0.029398085549473763

Most O 0 0.04228467121720314
mutations O 0 0.1525799185037613
in O 0 0.043948814272880554
DDS B-Disease 1 1.0
patients O 1 0.9999879598617554
lie O 0 0.061293452978134155
in O 0 0.01939438469707966
exon O 0 0.12765470147132874
8 O 0 0.041342537850141525
or O 0 0.025111332535743713
exon O 0 0.12186766415834427
9 O 0 0.04290272295475006
, O 0 0.02028670161962509
encoding O 0 0.08112264424562454
zinc O 1 0.7221238613128662
finger O 0 0.14783404767513275
2 O 0 0.044499725103378296
or O 0 0.0375397652387619
zinc O 1 0.9857963919639587
finger O 0 0.11825747787952423
3 O 0 0.024369170889258385
, O 0 0.008775055408477783
respectively O 0 0.015326951630413532
, O 0 0.007420016918331385
with O 0 0.00849900208413601
a O 0 0.019610406830906868
hot O 0 0.06819155812263489
spot O 0 0.055329591035842896
( O 0 0.03914710879325867
R394W O 0 0.1354953497648239
) O 0 0.022937271744012833
in O 0 0.014123309403657913
exon O 0 0.12414294481277466
9 O 0 0.0438658632338047
. O 0 0.024882720783352852

We O 0 0.02187071181833744
analyzed O 0 0.03497987240552902
a O 0 0.016928447410464287
series O 0 0.01826886087656021
of O 0 0.009962186217308044
24 O 0 0.03301040828227997
patients O 1 0.999076247215271
, O 0 0.012676062062382698
10 O 0 0.013913986273109913
with O 0 0.01615898683667183
isolated B-Disease 0 0.33142462372779846
DMS I-Disease 1 0.9999980926513672
( O 0 0.0668526440858841
IDMS B-Disease 1 0.9999818801879883
) O 0 0.026465019211173058
, O 0 0.00955800898373127
10 O 0 0.016610026359558105
with O 0 0.016104860231280327
DDS B-Disease 1 0.9999992847442627
, O 0 0.013561970554292202
and O 0 0.009548299014568329
4 O 0 0.023883648216724396
with O 0 0.02051614224910736
urogenital B-Disease 1 0.9999977350234985
abnormalities I-Disease 1 0.9998977184295654
and O 0 0.03051007352769375
/ O 1 0.9998075366020203
or O 0 0.04727813974022865
WT B-Disease 1 0.9999914169311523
. O 0 0.03784520551562309

We O 0 0.03489202633500099
report O 0 0.05196293070912361
WT1 O 1 0.9974476099014282
heterozygous O 0 0.20913967490196228
mutations O 0 0.13523845374584198
in O 0 0.01899433322250843
16 O 0 0.035855308175086975
patients O 1 0.999285876750946
, O 0 0.011112305335700512
4 O 0 0.015080232173204422
of O 0 0.0070813787169754505
whom O 0 0.024278195574879646
presented O 0 0.023187749087810516
with O 0 0.024688944220542908
IDMS B-Disease 1 0.9999830722808838
. O 0 0.03528309613466263

One O 0 0.029273422434926033
male O 0 0.046491943299770355
and O 0 0.012048277072608471
two O 0 0.015982361510396004
female O 0 0.09314007312059402
IDMS B-Disease 1 0.9999995231628418
patients O 1 0.9999945163726807
with O 0 0.04178766533732414
WT1 O 1 0.9999935626983643
mutations O 1 0.8321976661682129
underwent O 1 0.9993413090705872
normal O 0 0.10351239144802094
puberty O 1 0.9929036498069763
. O 0 0.03171693906188011

Two O 0 0.035534605383872986
mutations O 0 0.12630902230739594
associated O 0 0.038666848093271255
with O 0 0.020877160131931305
IDMS B-Disease 1 0.9999457597732544
are O 0 0.00751181086525321
different O 0 0.0059733097441494465
from O 0 0.007336691487580538
those O 0 0.009793851524591446
described O 0 0.03065679967403412
in O 0 0.02812841162085533
DDS B-Disease 1 1.0
patients O 1 0.9999949932098389
. O 0 0.03413468226790428

No O 0 0.07465239614248276
WT1 O 1 0.9994305968284607
mutations O 0 0.13612961769104004
were O 0 0.014910257421433926
detected O 0 0.05359354615211487
in O 0 0.00863900501281023
the O 0 0.009596233256161213
six O 0 0.016914214938879013
other O 0 0.02121230587363243
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9999936819076538
, O 0 0.01959042437374592
suggesting O 0 0.05176198482513428
genetic O 0 0.07254713773727417
heterogeneity O 0 0.09830465167760849
of O 0 0.01174248568713665
this O 0 0.018720511347055435
disease O 1 0.999998927116394
. O 0 0.03203321620821953

We O 0 0.03637764975428581
analyzed O 0 0.10519697517156601
genotype O 1 0.99544358253479
/ O 1 0.9973762035369873
phenotype O 1 0.9211307764053345
correlations O 0 0.08771708607673645
, O 0 0.009515538811683655
on O 0 0.005155072547495365
the O 0 0.005386976525187492
basis O 0 0.006924130953848362
of O 0 0.00494356919080019
the O 0 0.00733551662415266
constitution O 0 0.013564348220825195
of O 0 0.009695447050035
a O 0 0.030742937698960304
WT1 O 1 0.9996867179870605
mutation O 0 0.1578814834356308
database O 0 0.04090791568160057
of O 0 0.016065023839473724
84 O 0 0.2311345636844635
germ O 1 0.9999327659606934
- O 0 0.1116967499256134
line O 0 0.04737532511353493
mutations O 0 0.09334736317396164
, O 0 0.009807816706597805
to O 0 0.00952721294015646
compare O 0 0.03259798139333725
the O 0 0.008732368238270283
distribution O 0 0.015332854352891445
and O 0 0.008687594905495644
type O 0 0.03861955553293228
of O 0 0.010386570356786251
mutations O 0 0.07568810135126114
, O 0 0.00835594441741705
according O 0 0.007364054676145315
to O 0 0.006023490335792303
the O 0 0.010045157745480537
different O 0 0.016183190047740936
symptoms O 1 0.9999979734420776
. O 0 0.032717227935791016

This O 0 0.019845696166157722
demonstrated O 0 0.05224310979247093
( O 0 0.027502812445163727
1 O 0 0.021345555782318115
) O 0 0.014219277538359165
the O 0 0.01082687173038721
association O 0 0.038409072905778885
between O 0 0.02036987990140915
mutations O 0 0.09037154167890549
in O 0 0.01531137153506279
exons O 0 0.08853526413440704
8 O 0 0.02559087797999382
and O 0 0.011090962216258049
9 O 0 0.028280023485422134
and O 0 0.019959483295679092
DMS B-Disease 1 0.9999938011169434
; O 0 0.024590030312538147
( O 0 0.02462899312376976
2 O 0 0.024409323930740356
) O 0 0.017886819317936897
among O 0 0.020132962614297867
patients O 1 0.9998419284820557
with O 0 0.024417227134108543
DMS B-Disease 1 0.9999915361404419
, O 0 0.012762797996401787
a O 0 0.015297861769795418
higher O 0 0.026948517188429832
frequency O 0 0.04103795439004898
of O 0 0.01320849359035492
exon O 0 0.13795039057731628
8 O 0 0.049211859703063965
mutations O 0 0.09965138137340546
among O 0 0.022663244977593422
46 O 0 0.051377035677433014
, O 0 0.028301574289798737
XY O 1 0.9999936819076538
patients O 1 0.9994261264801025
with O 0 0.021499741822481155
female O 0 0.05746188014745712
phenotype O 1 0.6213634014129639
than O 0 0.01606965996325016
among O 0 0.018580256029963493
46 O 0 0.04682009294629097
, O 0 0.024933448061347008
XY O 1 0.9999973773956299
patients O 1 0.9999288320541382
with O 0 0.01714469864964485
sexual O 0 0.04694666340947151
ambiguity O 0 0.06238416209816933
or O 0 0.026599083095788956
male O 0 0.10328608751296997
phenotype O 1 0.9972733855247498
; O 0 0.02122214064002037
and O 0 0.011657866649329662
( O 0 0.02274167351424694
3 O 0 0.02446061186492443
) O 0 0.017371032387018204
statistically O 0 0.030599821358919144
significant O 0 0.016203662380576134
evidence O 0 0.014492230489850044
that O 0 0.011976086534559727
mutations O 0 0.07757379859685898
in O 0 0.01545749232172966
exons O 0 0.09527426213026047
8 O 0 0.029729269444942474
and O 0 0.012688793241977692
9 O 0 0.036636997014284134
preferentially O 0 0.11299257725477219
affect O 0 0.047579050064086914
amino O 0 0.057798415422439575
acids O 0 0.04278719052672386
with O 0 0.00949255283921957
different O 0 0.008600995875895023
functions O 0 0.015722079202532768
. O 0 0.013657336123287678
. O 0 0.022263381630182266

The O 0 0.06209685280919075
185delAG O 1 0.9282060265541077
BRCA1 O 1 0.9985730648040771
mutation O 0 0.22821462154388428
originated O 0 0.0600304901599884
before O 0 0.01720542274415493
the O 0 0.01387752778828144
dispersion O 0 0.0702209621667862
of O 0 0.0077720084227621555
Jews O 0 0.015566838905215263
in O 0 0.0077504380606114864
the O 0 0.009229633025825024
diaspora O 0 0.036427129060029984
and O 0 0.007796581368893385
is O 0 0.008272383362054825
not O 0 0.007399167865514755
limited O 0 0.019276639446616173
to O 0 0.01673325151205063
Ashkenazim O 0 0.38385501503944397
. O 0 0.03497570753097534

The O 0 0.04660937190055847
185delAG O 0 0.4973302185535431
mutation O 0 0.18005156517028809
in O 0 0.029795540496706963
BRCA1 O 1 0.9969435334205627
is O 0 0.029370859265327454
detected O 0 0.06924262642860413
in O 0 0.014809543266892433
Ashkenazi O 0 0.09358500689268112
Jews O 0 0.018423907458782196
both O 0 0.009858383797109127
in O 0 0.018757512792944908
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9842400550842285
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.010750679299235344
in O 0 0.006756378337740898
the O 0 0.008087610825896263
general O 0 0.014751847833395004
population O 0 0.02439194545149803
. O 0 0.022800181061029434

All O 0 0.029884086921811104
tested O 0 0.12207670509815216
Ashkenazi O 0 0.42562544345855713
mutation O 0 0.19758570194244385
carriers O 0 0.07926245778799057
share O 0 0.02741491049528122
the O 0 0.011608002707362175
same O 0 0.02140429988503456
allelic O 1 0.5875710844993591
pattern O 0 0.06435564160346985
at O 0 0.023786606267094612
the O 0 0.02325700968503952
BRCA1 O 1 0.9957796335220337
locus O 0 0.19629555940628052
. O 0 0.039951201528310776

Our O 0 0.02330579236149788
previous O 0 0.024423537775874138
study O 0 0.0257498137652874
showed O 0 0.024682004004716873
that O 0 0.008529809303581715
this O 0 0.013023187406361103
Ashkenazi O 0 0.41732797026634216
mutation O 0 0.14534792304039001
also O 0 0.017440933734178543
occurs O 0 0.03477253392338753
in O 0 0.008760427124798298
Iraqi O 0 0.02297586016356945
Jews O 0 0.018287677317857742
with O 0 0.010450937785208225
a O 0 0.020065946504473686
similar O 0 0.03637111559510231
allelic O 1 0.9445288181304932
pattern O 0 0.10446547716856003
. O 0 0.03166193887591362

We O 0 0.01817578449845314
extended O 0 0.025897610932588577
our O 0 0.013926167972385883
analysis O 0 0.016176743432879448
to O 0 0.007730649784207344
other O 0 0.00919943768531084
non O 0 0.04672601819038391
- O 0 0.10317017138004303
Ashkenazi O 0 0.1828756332397461
subsets O 0 0.11222393065690994
354 O 0 0.11532150208950043
of O 0 0.016219381242990494
Moroccan O 0 0.0728110820055008
origin O 0 0.03057940863072872
, O 0 0.016776960343122482
200 O 0 0.043235693126916885
Yemenites O 0 0.3151278495788574
and O 0 0.014741143211722374
150 O 0 0.03473325073719025
Iranian O 0 0.0309279877692461
Jews O 0 0.03744177147746086
. O 0 0.027840247377753258

Heteroduplex O 0 0.27545708417892456
analysis O 0 0.04179218411445618
complemented O 0 0.058060355484485626
by O 0 0.013247831724584103
direct O 0 0.032548606395721436
DNA O 0 0.06129644438624382
sequencing O 0 0.06056816875934601
of O 0 0.01682407781481743
abnormally O 0 0.36759090423583984
migrating O 0 0.08703944087028503
bands O 0 0.04821125045418739
were O 0 0.013823911547660828
employed O 0 0.04311361536383629
. O 0 0.02778518758714199

Four O 0 0.021026473492383957
of O 0 0.012647401541471481
Moroccan O 0 0.06587089598178864
origin O 0 0.03186262026429176
( O 0 0.025914456695318222
1 O 0 0.020107289776206017
. O 0 0.00960248801857233
1 O 0 0.019416317343711853
% O 0 0.019495606422424316
) O 0 0.013078642077744007
and O 0 0.006145566701889038
none O 0 0.01382733229547739
of O 0 0.006081757601350546
the O 0 0.013381159864366055
Yemenites O 1 0.9662420153617859
or O 0 0.020038176327943802
Iranians O 0 0.027616022154688835
was O 0 0.01230327133089304
a O 0 0.012998826801776886
carrier O 0 0.0575050413608551
of O 0 0.010277324356138706
the O 0 0.022783000022172928
185delAG O 1 0.8253461718559265
mutation O 0 0.1956578493118286
. O 0 0.03907238319516182

BRCA1 O 1 0.9984530210494995
allelic O 1 0.8280946016311646
patterns O 0 0.05682920664548874
were O 0 0.010407008230686188
determined O 0 0.019221458584070206
for O 0 0.005903393961489201
four O 0 0.006558443419635296
of O 0 0.005081199109554291
these O 0 0.0051361084915697575
individuals O 0 0.012316728010773659
and O 0 0.006124717649072409
for O 0 0.007924419827759266
12 O 0 0.016405677422881126
additional O 0 0.020857712253928185
non O 0 0.05330636724829674
- O 0 0.12465471774339676
Ashkenazi O 0 0.4784112572669983
185delAG O 1 0.9481009840965271
mutation O 0 0.3742433488368988
carriers O 0 0.21420049667358398
who O 0 0.03765091300010681
had O 1 0.8504168391227722
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04578733816742897

Six O 0 0.04591280594468117
non O 0 0.06724518537521362
- O 0 0.09574975818395615
Ashkenazi O 0 0.14618396759033203
individuals O 0 0.026134232059121132
shared O 0 0.025307515636086464
the O 0 0.016083847731351852
common O 0 0.04062550887465477
Ashkenazi O 1 0.9688134789466858
haplotype O 1 0.9946409463882446
, O 0 0.013912579044699669
four O 0 0.009070826694369316
had O 0 0.012545275501906872
a O 0 0.014731036499142647
closely O 0 0.021338827908039093
related O 0 0.028829490765929222
pattern O 0 0.04580477252602577
, O 0 0.009163902141153812
and O 0 0.006485902704298496
the O 0 0.011381339281797409
rest O 0 0.031426914036273956
( O 0 0.034837473183870316
n O 0 0.07626069337129593
= O 0 0.09213626384735107
6 O 0 0.028711337596178055
) O 0 0.016706131398677826
displayed O 0 0.022624358534812927
a O 0 0.024047525599598885
distinct O 0 0.06520894169807434
BRCA1 O 1 0.9995619654655457
allelic O 1 0.9740314483642578
pattern O 0 0.11601781845092773
. O 0 0.03634520620107651

We O 0 0.020512616261839867
conclude O 0 0.046456098556518555
that O 0 0.010292943567037582
the O 0 0.021324260160326958
185delAG O 1 0.9872564077377319
BRCA1 O 1 0.9996128678321838
mutation O 0 0.34855619072914124
occurs O 0 0.05408211797475815
in O 0 0.010965708643198013
some O 0 0.011656707152724266
non O 0 0.048022087663412094
- O 0 0.10489572584629059
Ashkenazi O 0 0.18602345883846283
populations O 0 0.06608821451663971
at O 0 0.027388012036681175
rates O 0 0.04061310365796089
comparable O 0 0.03217720612883568
with O 0 0.009626052342355251
that O 0 0.00725325383245945
of O 0 0.012877795845270157
Ashkenazim O 1 0.9575936198234558
. O 0 0.03909595310688019

The O 0 0.02323891595005989
majority O 0 0.02732471004128456
of O 0 0.015244053676724434
Jewish O 0 0.057809825986623764
185delAG O 1 0.9581981301307678
mutation O 0 0.1904645711183548
carriers O 0 0.07456161081790924
have O 0 0.012087054550647736
a O 0 0.01997947506606579
common O 0 0.038184262812137604
allelic O 1 0.9600149989128113
pattern O 0 0.06516019254922867
, O 0 0.011230901814997196
supporting O 0 0.021345794200897217
the O 0 0.013993581756949425
founder O 0 0.05485795438289642
effect O 0 0.03941255807876587
notion O 0 0.030721787363290787
, O 0 0.00987331848591566
but O 0 0.009875340387225151
dating O 0 0.025690792128443718
the O 0 0.013497533276677132
mutations O 0 0.07827345281839371
origin O 0 0.017591167241334915
to O 0 0.009269204922020435
an O 0 0.009954401291906834
earlier O 0 0.016840774565935135
date O 0 0.0143289715051651
than O 0 0.009641662240028381
currently O 0 0.019544854760169983
estimated O 0 0.03515312448143959
. O 0 0.0285495538264513

However O 0 0.02366534247994423
, O 0 0.010034404695034027
the O 0 0.010417875833809376
different O 0 0.012605812400579453
allelic O 0 0.48162397742271423
pattern O 0 0.06611048430204391
at O 0 0.024352239444851875
the O 0 0.020554382354021072
BRCA1 O 1 0.9973210692405701
locus O 0 0.13263845443725586
even O 0 0.014786755666136742
in O 0 0.00868639349937439
some O 0 0.010880541987717152
Jewish O 0 0.046047065407037735
mutation O 0 0.2665851414203644
carriers O 0 0.11368080973625183
, O 0 0.016032259911298752
might O 0 0.021600907668471336
suggest O 0 0.018647100776433945
that O 0 0.006801276467740536
the O 0 0.014549506828188896
mutation O 0 0.11725717037916183
arose O 0 0.04762674495577812
independently O 0 0.02717200294137001
. O 0 0.015283817425370216
. O 0 0.025056755170226097

Crystal O 0 0.10442136228084564
structure O 0 0.031047185882925987
of O 0 0.013280290178954601
the O 0 0.03258691728115082
hemochromatosis B-Disease 1 1.0
protein O 0 0.1312488168478012
HFE O 1 0.9990880489349365
and O 0 0.015150267630815506
characterization O 0 0.04761587828397751
of O 0 0.007305789738893509
its O 0 0.011212890967726707
interaction O 0 0.04188608378171921
with O 0 0.026672454550862312
transferrin O 1 0.9914683103561401
receptor O 0 0.22660687565803528
. O 0 0.03443385288119316

HFE O 1 0.9939968585968018
is O 0 0.038075853139162064
an O 0 0.03635924309492111
MHC O 1 0.9997699856758118
- O 0 0.09784581512212753
related O 0 0.04388474300503731
protein O 0 0.04736989364027977
that O 0 0.007762599736452103
is O 0 0.01219378225505352
mutated O 0 0.07260510325431824
in O 0 0.010593133978545666
the O 0 0.01603563129901886
iron B-Disease 1 0.9999737739562988
- I-Disease 1 0.9999773502349854
overload I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.05782316252589226

HFE O 1 0.9890508651733398
binds O 0 0.1838454008102417
to O 0 0.041993647813797
transferrin O 1 0.9779078364372253
receptor O 0 0.2881340980529785
( O 0 0.06414032727479935
TfR O 1 0.9987389445304871
) O 0 0.025893304497003555
and O 0 0.011288350448012352
reduces O 0 0.06611987203359604
its O 0 0.014802740886807442
affinity O 0 0.06631199270486832
for O 0 0.015316072851419449
iron O 0 0.4239095449447632
- O 0 0.08177777379751205
loaded O 0 0.07330140471458435
transferrin O 1 0.8974478244781494
, O 0 0.029500169679522514
implicating O 0 0.24583859741687775
HFE O 1 0.9991934895515442
in O 0 0.033122435212135315
iron O 1 0.7854440808296204
metabolism O 0 0.4782041609287262
. O 0 0.038907647132873535

The O 0 0.030873285606503487
2 O 0 0.03776465728878975
. O 0 0.028827272355556488

6 O 0 0.054577745497226715
A O 0 0.03581254929304123
crystal O 0 0.06621439754962921
structure O 0 0.02664664201438427
of O 0 0.016678767278790474
HFE O 1 0.9998010993003845
reveals O 0 0.0638270229101181
the O 0 0.014374610036611557
locations O 0 0.02605426497757435
of O 0 0.022731676697731018
hemochromatosis B-Disease 1 1.0
mutations O 0 0.13832184672355652
and O 0 0.01269584335386753
a O 0 0.02004263922572136
patch O 1 0.9959506988525391
of O 0 0.013648821040987968
histidines O 1 0.6331354379653931
that O 0 0.008062876760959625
could O 0 0.008891948498785496
be O 0 0.006767054554075003
involved O 0 0.017364472150802612
in O 0 0.015440382994711399
pH O 1 0.9927841424942017
- O 0 0.09294811636209488
dependent O 0 0.07426775246858597
interactions O 0 0.05374973267316818
. O 0 0.030907729640603065

We O 0 0.022732358425855637
also O 0 0.012470100075006485
demonstrate O 0 0.028617307543754578
that O 0 0.016298212110996246
soluble O 0 0.2748767137527466
TfR O 1 0.9995636343955994
and O 0 0.0298945102840662
HFE O 1 0.9996504783630371
bind O 0 0.11090653389692307
tightly O 0 0.05057431012392044
at O 0 0.016626249998807907
the O 0 0.009963597171008587
basic O 0 0.02605476602911949
pH O 0 0.11069190502166748
of O 0 0.009255067445337772
the O 0 0.014434299431741238
cell O 0 0.06155405566096306
surface O 0 0.02960948832333088
, O 0 0.008960030041635036
but O 0 0.007022480946034193
not O 0 0.006115291267633438
at O 0 0.01283741183578968
the O 0 0.014506224542856216
acidic O 0 0.4982669949531555
pH O 0 0.3353561460971832
of O 0 0.022720277309417725
intracellular O 0 0.20111984014511108
vesicles O 0 0.25092920660972595
. O 0 0.04309982806444168

TfR O 1 0.9996311664581299
HFE O 1 0.9993533492088318
stoichiometry O 0 0.28521454334259033
( O 0 0.03784501552581787
2 O 0 0.027555003762245178
1 O 0 0.025570014491677284
) O 0 0.01949741505086422
differs O 0 0.049132682383060455
from O 0 0.03241516277194023
TfR O 1 0.9998301267623901
transferrin O 1 0.9971402883529663
stoichiometry O 0 0.21217064559459686
( O 0 0.040946345776319504
2 O 0 0.02708696387708187
2 O 0 0.024339383468031883
) O 0 0.017044272273778915
, O 0 0.010662888176739216
implying O 0 0.04311800003051758
a O 0 0.01242045033723116
different O 0 0.008793859742581844
mode O 0 0.03624805063009262
of O 0 0.009422152303159237
binding O 0 0.03577399253845215
for O 0 0.019457992166280746
HFE O 1 0.9987825751304626
and O 0 0.023447725921869278
transferrin O 1 0.9137365818023682
to O 0 0.0237905140966177
TfR O 1 0.9990218877792358
, O 0 0.016630956903100014
consistent O 0 0.027781330049037933
with O 0 0.01039343886077404
our O 0 0.015023402869701385
demonstration O 0 0.046040937304496765
that O 0 0.019457191228866577
HFE O 1 0.9993057250976562
, O 0 0.028127891942858696
transferrin O 1 0.9819292426109314
, O 0 0.015119305811822414
and O 0 0.016429485753178596
TfR O 1 0.9993857145309448
form O 0 0.0313483327627182
a O 0 0.025952426716685295
ternary O 0 0.10005468875169754
complex O 0 0.05103674530982971
. O 0 0.02830512635409832

Identification O 0 0.049047622829675674
of O 0 0.012046637944877148
three O 0 0.015580544248223305
novel O 0 0.038769517093896866
mutations O 0 0.08164864778518677
and O 0 0.011064290069043636
a O 0 0.015619009733200073
high O 0 0.02676892839372158
frequency O 0 0.03462770953774452
of O 0 0.008357373997569084
the O 0 0.0184369795024395
Arg778Leu O 1 0.9906448125839233
mutation O 0 0.13498875498771667
in O 0 0.017675185576081276
Korean O 0 0.10661870986223221
patients O 1 0.9999798536300659
with O 0 0.028758591040968895
Wilson B-Disease 1 0.9994438290596008
disease I-Disease 1 0.9999995231628418
. O 0 0.03630676120519638

Four O 0 0.06028951331973076
mutations O 0 0.22865402698516846
- O 0 0.21640120446681976
- O 0 0.13816551864147186
R778L O 0 0.21035079658031464
, O 0 0.03145483508706093
A874V O 0 0.15115134418010712
, O 0 0.022004032507538795
L1083F O 0 0.11258313059806824
, O 0 0.013671789318323135
and O 0 0.015287491492927074
2304delC O 1 0.928804337978363
- O 0 0.08445511013269424
- O 0 0.05102793499827385
in O 0 0.012080223299562931
the O 0 0.013793250545859337
copper O 0 0.08858181536197662
- O 0 0.07873063534498215
transporting O 0 0.07651940733194351
enzyme O 0 0.11730459332466125
, O 0 0.030209209769964218
P O 1 0.9923018217086792
- O 0 0.12908916175365448
type O 0 0.14081650972366333
ATPase O 1 0.9910564422607422
( O 0 0.06497334688901901
ATP7B O 1 0.979688823223114
) O 0 0.021229835227131844
, O 0 0.008367648348212242
were O 0 0.006835727486759424
identified O 0 0.018171265721321106
in O 0 0.011361537501215935
Korean O 0 0.07635658234357834
Patients O 1 0.9999693632125854
with O 0 0.027139555662870407
Wilson B-Disease 1 0.9983850717544556
disease I-Disease 1 0.9999990463256836
. O 0 0.03280801326036453

Arg778Leu O 0 0.29962781071662903
, O 0 0.017099279910326004
the O 0 0.011957255192101002
most O 0 0.013871459290385246
frequently O 0 0.0282191950827837
reported O 0 0.0347636416554451
mutation O 0 0.08518718183040619
of O 0 0.009066062048077583
this O 0 0.010886168107390404
enzyme O 0 0.06350916624069214
, O 0 0.009972406551241875
was O 0 0.01041385531425476
found O 0 0.01043590810149908
in O 0 0.00682491110637784
six O 0 0.00959770567715168
of O 0 0.007079494185745716
eight O 0 0.02092103287577629
unrelated O 0 0.08609702438116074
patients O 1 0.9998260140419006
studied O 0 0.02905750833451748
, O 0 0.011439570225775242
an O 0 0.017504684627056122
allele O 0 0.12071862071752548
frequency O 0 0.049513135105371475
of O 0 0.013192940503358841
37 O 0 0.05352747067809105
. O 0 0.027439139783382416

5 O 0 0.047571320086717606
% O 0 0.02736593969166279
, O 0 0.010030990466475487
which O 0 0.008140124380588531
is O 0 0.010202214121818542
considerably O 0 0.029690228402614594
higher O 0 0.016536511480808258
than O 0 0.007508356589823961
those O 0 0.005705810151994228
in O 0 0.005957563873380423
other O 0 0.007697190623730421
Asian O 0 0.0472291074693203
populations O 0 0.06167716160416603
. O 0 0.03133556619286537

The O 0 0.028735190629959106
novel O 0 0.04468277096748352
single O 0 0.049421340227127075
nucleotide O 0 0.12230360507965088
deletion O 0 0.14259453117847443
, O 0 0.02439226396381855
2304delC O 0 0.14937308430671692
, O 0 0.012112955562770367
was O 0 0.012134508229792118
found O 0 0.011766625568270683
in O 0 0.008108784444630146
one O 0 0.017089586704969406
patient O 1 0.9987326264381409
. O 0 0.02781720831990242

Since O 0 0.04193299636244774
a O 0 0.039323870092630386
mutation O 0 0.15589359402656555
at O 0 0.04829370230436325
cDNA O 0 0.2015039473772049
nucleotide O 0 0.20694874227046967
2302 O 1 0.9935668110847473
( O 0 0.06178416311740875
2302insC O 0 0.18285644054412842
) O 0 0.02064385637640953
had O 0 0.013009635731577873
been O 0 0.009208274073898792
previously O 0 0.014662167057394981
described O 0 0.019238989800214767
, O 0 0.007254592142999172
this O 0 0.0056726159527897835
region O 0 0.01647522859275341
of O 0 0.007773876190185547
the O 0 0.018942924216389656
ATP7B O 1 0.9998433589935303
gene O 0 0.09397429972887039
may O 0 0.024328412488102913
be O 0 0.012939070351421833
susceptible O 0 0.21156369149684906
to O 0 0.02098282426595688
gene O 0 0.11886975914239883
rearrangements O 0 0.42491766810417175
causing O 1 0.9729282855987549
Wilson B-Disease 1 0.9966384172439575
disease I-Disease 1 0.9999978542327881
. O 0 0.04011450335383415

Disruption O 0 0.15077559649944305
of O 0 0.019453303888440132
splicing O 0 0.11583356559276581
regulated O 0 0.06092187762260437
by O 0 0.015348648652434349
a O 0 0.03223028779029846
CUG O 1 0.9945275187492371
- O 0 0.11281997710466385
binding O 0 0.08121536672115326
protein O 0 0.09414408355951309
in O 0 0.0478578545153141
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.05657283589243889

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9973776340484619
DM B-Disease 1 1.0
) O 0 0.034323789179325104
is O 0 0.014746462926268578
caused O 0 0.04459741339087486
by O 0 0.011191373690962791
a O 0 0.023710059002041817
CTG O 1 0.989461362361908
expansion O 0 0.03434253856539726
in O 0 0.009882393293082714
the O 0 0.012579492293298244
3 O 0 0.03114650771021843
untranslated O 0 0.10735666006803513
region O 0 0.02992008626461029
of O 0 0.011232977733016014
the O 0 0.03453312814235687
DM B-Disease 1 1.0
gene O 0 0.1507171392440796
. O 0 0.0381048209965229

One O 0 0.029463134706020355
model O 0 0.04854443296790123
of O 0 0.03533555939793587
DM B-Disease 1 1.0
pathogenesis O 1 0.9999747276306152
suggests O 0 0.06086517497897148
that O 0 0.01650390401482582
RNAs O 0 0.10150236636400223
from O 0 0.010950184427201748
the O 0 0.010099302046000957
expanded O 0 0.0242311954498291
allele O 0 0.09492938220500946
create O 0 0.023395130410790443
a O 0 0.015952181071043015
gain O 0 0.037061095237731934
- O 0 0.05084560811519623
of O 0 0.01451661717146635
- O 0 0.07592085003852844
function O 0 0.051536738872528076
mutation O 0 0.09951617568731308
by O 0 0.011241729371249676
the O 0 0.012381277047097683
inappropriate O 0 0.051339633762836456
binding O 0 0.027379970997571945
of O 0 0.007192051038146019
proteins O 0 0.02366388961672783
to O 0 0.010834764689207077
the O 0 0.017854973673820496
CUG O 1 0.9950892329216003
repeats O 0 0.1207505464553833
. O 0 0.03535390645265579

Data O 0 0.026080438867211342
presented O 0 0.021624067798256874
here O 0 0.01356306578963995
indicate O 0 0.02112935297191143
that O 0 0.006273828446865082
the O 0 0.01169344037771225
conserved O 0 0.05946167930960655
heterogeneous O 0 0.1276301145553589
nuclear O 0 0.07709704339504242
ribonucleoprotein O 1 0.9955507516860962
, O 0 0.029182666912674904
CUG O 1 0.9816675186157227
- O 0 0.10621745139360428
binding O 0 0.07476511597633362
protein O 0 0.08958495408296585
( O 0 0.049082860350608826
CUG O 1 0.9991963505744934
- O 0 0.11554179340600967
BP O 0 0.14459143579006195
) O 0 0.022423747926950455
, O 0 0.011365095153450966
may O 0 0.020707862451672554
mediate O 0 0.08086145669221878
the O 0 0.020831191912293434
trans O 1 0.7303110361099243
- O 0 0.08234325796365738
dominant O 0 0.06389614939689636
effect O 0 0.03558618575334549
of O 0 0.008972259238362312
the O 0 0.017506390810012817
RNA O 0 0.10669318586587906
. O 0 0.03170831501483917

CUG O 1 0.9964371919631958
- O 0 0.1347029209136963
BP O 0 0.13621987402439117
was O 0 0.019431741908192635
found O 0 0.014953294768929482
to O 0 0.008960581384599209
bind O 0 0.04516199976205826
to O 0 0.008972716517746449
the O 0 0.0147557919844985
human O 0 0.06496906280517578
cardiac O 1 0.9999998807907104
troponin O 1 0.9999992847442627
T O 1 0.9997519850730896
( O 0 0.04556063935160637
cTNT O 1 0.6971458196640015
) O 0 0.030550766736268997
pre O 0 0.09463805705308914
- O 0 0.09510872513055801
messenger O 0 0.11962562054395676
RNA O 0 0.07704800367355347
and O 0 0.012059196829795837
regulate O 0 0.048708800226449966
its O 0 0.01666358672082424
alternative O 0 0.06029154360294342
splicing O 0 0.1382572203874588
. O 0 0.03649230673909187

Splicing O 0 0.17007723450660706
of O 0 0.024353336542844772
cTNT O 0 0.2639249563217163
was O 0 0.03272489458322525
disrupted O 0 0.12324626743793488
in O 0 0.044770773500204086
DM B-Disease 1 1.0
striated O 1 0.9999935626983643
muscle O 1 0.9998173117637634
and O 0 0.012544560246169567
in O 0 0.013183768838644028
normal O 0 0.05102357640862465
cells O 0 0.07370921224355698
expressing O 0 0.04715556651353836
transcripts O 0 0.04234375059604645
that O 0 0.013410376384854317
contain O 0 0.040363065898418427
CUG O 1 0.9470945000648499
repeats O 0 0.11072035133838654
. O 0 0.030944455415010452

Altered O 0 0.09305905550718307
expression O 0 0.05246489495038986
of O 0 0.016793856397271156
genes O 0 0.06785855442285538
regulated O 0 0.08460982143878937
posttranscriptionally O 0 0.30177077651023865
by O 0 0.030390288680791855
CUG O 1 0.9985162615776062
- O 0 0.12382720410823822
BP O 0 0.1715783029794693
therefore O 0 0.03226453810930252
may O 0 0.02394605241715908
contribute O 0 0.04983830451965332
to O 0 0.033569589257240295
DM B-Disease 1 1.0
pathogenesis O 1 0.9999338388442993
. O 0 0.026351725682616234
. O 0 0.028539657592773438

Identification O 0 0.04324241355061531
of O 0 0.012537144124507904
a O 0 0.024386409670114517
novel O 0 0.048744261264801025
nonsense O 0 0.10408169031143188
mutation O 0 0.11756400763988495
and O 0 0.012317627668380737
a O 0 0.02292291820049286
missense O 0 0.15023961663246155
substitution O 0 0.060876645147800446
in O 0 0.011434643529355526
the O 0 0.01956081949174404
vasopressin O 1 0.999247670173645
- O 0 0.18897682428359985
neurophysin O 1 0.9766096472740173
II O 0 0.12117309123277664
gene O 0 0.05870573967695236
in O 0 0.01034033577889204
two O 0 0.010667949914932251
Spanish O 0 0.04431719705462456
kindreds O 1 0.7466236352920532
with O 0 0.040451258420944214
familial B-Disease 1 0.9999983310699463
neurohypophyseal I-Disease 1 0.9999977350234985
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
. O 0 0.05573664978146553

Familial B-Disease 1 0.9999948740005493
neurohypophyseal I-Disease 1 0.9999947547912598
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
( O 0 0.14466360211372375
FNDI B-Disease 1 0.9999927282333374
) O 0 0.023514119908213615
is O 0 0.01320554781705141
an O 0 0.021333256736397743
autosomal B-Disease 1 0.9999961853027344
dominant I-Disease 1 0.9999552965164185
disease I-Disease 1 1.0
caused O 1 0.9994460940361023
by O 0 0.030588658526539803
deficiency O 1 1.0
in O 0 0.019413523375988007
the O 0 0.027323948219418526
antidiuretic O 1 0.9999102354049683
hormone O 1 0.9986608028411865
arginine O 1 0.8843598961830139
vasopressin O 1 0.9910892248153687
( O 0 0.06686875969171524
AVP O 1 0.9975493550300598
) O 0 0.02598421834409237
encoded O 0 0.021677831187844276
by O 0 0.011944896541535854
the O 0 0.02143821120262146
AVP O 1 0.9999097585678101
- O 0 0.15127769112586975
neurophysin O 1 0.9584744572639465
II O 1 0.8244485855102539
( O 0 0.06875183433294296
AVP O 1 0.9999629259109497
- O 0 0.2273532748222351
NPII O 1 0.9716547131538391
) O 0 0.04394764080643654
gene O 0 0.07406637072563171
on O 0 0.021879184991121292
chromosome O 0 0.17925871908664703
20p13 O 0 0.1975308358669281
. O 0 0.03865959867835045

In O 0 0.017722731456160545
this O 0 0.011454435996711254
study O 0 0.02344564162194729
, O 0 0.010902883484959602
we O 0 0.00908785779029131
analyzed O 0 0.025998137891292572
two O 0 0.008905354887247086
families O 0 0.0238242968916893
with O 0 0.019806724041700363
FNDI B-Disease 1 0.9982469081878662
using O 0 0.025162899866700172
direct O 0 0.03525093197822571
automated O 0 0.07356550544500351
fluorescent O 0 0.10086841136217117
, O 0 0.01862308755517006
solid O 0 0.04562637209892273
phase O 0 0.062106095254421234
, O 0 0.014655107632279396
single O 0 0.030472837388515472
- O 0 0.07649780809879303
stranded O 0 0.1254226565361023
DNA O 0 0.07262363284826279
sequencing O 0 0.06643743067979813
of O 0 0.019455423578619957
PCR O 0 0.3696845471858978
- O 0 0.1447862684726715
amplified O 0 0.18645739555358887
AVP O 1 0.9997543692588806
- O 0 0.1731758415699005
NPII O 1 0.9687106609344482
DNA O 0 0.10544541478157043
. O 0 0.03325764834880829

In O 0 0.014372759498655796
one O 0 0.008533414453268051
of O 0 0.006373494863510132
the O 0 0.010234865359961987
families O 0 0.024108272045850754
, O 0 0.012242808938026428
affected O 0 0.03819200396537781
individuals O 0 0.017272578552365303
presented O 0 0.02149580605328083
a O 0 0.01861906610429287
novel O 0 0.03840462863445282
nonsense O 0 0.09100615978240967
mutation O 0 0.11712580174207687
in O 0 0.019043803215026855
exon O 0 0.1031111553311348
3 O 0 0.022809786722064018
of O 0 0.008974352851510048
the O 0 0.013293838128447533
gene O 0 0.05612443387508392
, O 0 0.009959486313164234
consisting O 0 0.01627504639327526
in O 0 0.009765156544744968
a O 0 0.024584120139479637
G O 0 0.323688268661499
to O 0 0.018989993259310722
T O 1 0.9707740545272827
transition O 0 0.05804426968097687
at O 0 0.0356871634721756
nucleotide O 0 0.11298259347677231
2101 O 0 0.3377225697040558
, O 0 0.016269169747829437
which O 0 0.013181175105273724
produces O 0 0.042869001626968384
a O 0 0.02165989950299263
stop O 0 0.0411049909889698
signal O 0 0.049961645156145096
in O 0 0.01870453916490078
codon O 0 0.14076337218284607
82 O 0 0.10991137474775314
( O 0 0.05989792197942734
Glu O 1 0.99528568983078
) O 0 0.030756574124097824
of O 0 0.017808618023991585
NPII O 1 0.9772626757621765
. O 0 0.03884986788034439

The O 0 0.05310644581913948
premature O 1 0.9818196296691895
termination O 1 0.5976431965827942
eliminates O 0 0.09571170806884766
part O 0 0.016476061195135117
of O 0 0.008641636930406094
the O 0 0.016681019216775894
C O 1 0.6612874865531921
- O 0 0.07728812843561172
terminal O 0 0.08300510793924332
domain O 0 0.03683841601014137
of O 0 0.012693165801465511
NPII O 1 0.9256428480148315
, O 0 0.010622450150549412
including O 0 0.00967101939022541
a O 0 0.021440736949443817
cysteine O 0 0.11123093217611313
residue O 0 0.08936037868261337
in O 0 0.01229988131672144
position O 0 0.019052481278777122
85 O 0 0.040301963686943054
, O 0 0.008533488027751446
which O 0 0.006257059518247843
could O 0 0.007883796468377113
be O 0 0.005405515432357788
involved O 0 0.013171316124498844
in O 0 0.006765344180166721
the O 0 0.010157338343560696
correct O 0 0.04606905207037926
folding O 0 0.06842553615570068
of O 0 0.01335230190306902
the O 0 0.026488808915019035
prohormone O 1 0.9961736798286438
. O 0 0.04025024548172951

In O 0 0.017013661563396454
the O 0 0.011959993280470371
second O 0 0.01809350959956646
family O 0 0.023250209167599678
, O 0 0.012464712373912334
a O 0 0.024636896327137947
G279A O 0 0.14291273057460785
substitution O 0 0.06908184289932251
at O 0 0.021749863401055336
position O 0 0.020613258704543114
- O 0 0.04631109908223152
1 O 0 0.016651136800646782
of O 0 0.00820619985461235
the O 0 0.013831662945449352
signal O 0 0.06256195157766342
peptide O 0 0.09630706906318665
was O 0 0.018414687365293503
observed O 0 0.02090778760612011
in O 0 0.008493113331496716
all O 0 0.008075027726590633
affected O 0 0.04427361115813255
individuals O 0 0.027445783838629723
. O 0 0.02393471635878086

This O 0 0.04878120496869087
missense O 0 0.2470954805612564
mutation O 0 0.1541009247303009
, O 0 0.018874462693929672
which O 0 0.016227614134550095
replaces O 0 0.3870311677455902
Ala O 1 0.9705367088317871
with O 0 0.03050421178340912
Thr O 1 0.9998723268508911
, O 0 0.018857579678297043
is O 0 0.01595240645110607
frequent O 0 0.05393602326512337
among O 0 0.031283386051654816
FNDI B-Disease 1 0.9999998807907104
patients O 1 0.9999620914459229
and O 0 0.0112457862123847
is O 0 0.009639258496463299
thought O 0 0.017086781561374664
to O 0 0.007959072478115559
reduce O 0 0.028542615473270416
the O 0 0.01148184947669506
efficiency O 0 0.03831351548433304
of O 0 0.014377070590853691
cleavage O 1 0.6046487092971802
by O 0 0.02423027530312538
signal O 0 0.08414484560489655
peptidases O 1 0.5126447677612305
. O 0 0.01989784836769104
. O 0 0.02333189733326435

Genetic O 0 0.13799326121807098
heterogeneity O 0 0.1484960913658142
of O 0 0.027488339692354202
Saethre B-Disease 1 0.9999749660491943
- I-Disease 1 0.9997546076774597
Chotzen I-Disease 1 0.9999961853027344
syndrome I-Disease 1 1.0
, O 0 0.018068062141537666
due O 0 0.020335981622338295
to O 0 0.012460650876164436
TWIST O 0 0.15813766419887543
and O 0 0.024991216138005257
FGFR O 1 0.9980050921440125
mutations O 0 0.16577526926994324
. O 0 0.03431585431098938

Thirty O 0 0.08744927495718002
- O 0 0.06615226715803146
two O 0 0.018406493589282036
unrelated O 0 0.07978042215108871
patients O 1 0.9977582693099976
with O 0 0.012061663903295994
features O 0 0.020031513646245003
of O 0 0.014064797200262547
Saethre B-Disease 1 0.9999839067459106
- I-Disease 1 0.9993979930877686
Chotzen I-Disease 1 0.9999935626983643
syndrome I-Disease 1 1.0
, O 0 0.018108367919921875
a O 0 0.02047835662961006
common O 0 0.04476002976298332
autosomal B-Disease 1 0.9999067783355713
dominant I-Disease 1 0.7597088813781738
condition I-Disease 1 0.9991866946220398
of O 0 0.0197021272033453
craniosynostosis B-Disease 1 0.9999998807907104
and O 0 0.03575020655989647
limb B-Disease 1 0.9999992847442627
anomalies I-Disease 1 0.9911682605743408
, O 0 0.011406143195927143
were O 0 0.009360862895846367
screened O 0 0.053560905158519745
for O 0 0.013882408849895
mutations O 0 0.08845808357000351
in O 0 0.01774713397026062
TWIST O 0 0.1525336652994156
, O 0 0.019358661025762558
FGFR2 O 1 0.9943403005599976
, O 0 0.01628873497247696
and O 0 0.016244905069470406
FGFR3 O 1 0.9935546517372131
. O 0 0.030597209930419922

Nine O 0 0.037248268723487854
novel O 0 0.029795920476317406
and O 0 0.012283679097890854
three O 0 0.020619714632630348
recurrent O 1 0.999415397644043
TWIST O 1 0.9002976417541504
mutations O 0 0.10458655655384064
were O 0 0.011324713937938213
found O 0 0.014765465632081032
in O 0 0.010462725535035133
12 O 0 0.02166425622999668
families O 0 0.031316522508859634
. O 0 0.02454473450779915

Seven O 0 0.03668907657265663
families O 0 0.024769267067313194
were O 0 0.009541640989482403
found O 0 0.011960827745497227
to O 0 0.007798329461365938
have O 0 0.008966942317783833
the O 0 0.01921764202415943
FGFR3 O 1 0.998977541923523
P250R O 1 0.882281482219696
mutation O 0 0.12112243473529816
, O 0 0.011565795168280602
and O 0 0.006982182618230581
one O 0 0.008558116853237152
individual O 0 0.012871481478214264
was O 0 0.010867448523640633
found O 0 0.0104147307574749
to O 0 0.006321117747575045
have O 0 0.00811747182160616
an O 0 0.017345650121569633
FGFR2 O 1 0.998904824256897
VV269 O 1 0.8389222025871277
- O 0 0.11815383285284042
270 O 0 0.14712001383304596
deletion O 0 0.18663723766803741
. O 0 0.03804798796772957

To O 0 0.019931213930249214
date O 0 0.0181745495647192
, O 0 0.011203917674720287
our O 0 0.016704658046364784
detection O 0 0.0723213255405426
rate O 0 0.028808657079935074
for O 0 0.012434250675141811
TWIST O 0 0.20982690155506134
or O 0 0.030866820365190506
FGFR O 1 0.9979967474937439
mutations O 0 0.09972886741161346
is O 0 0.016431307420134544
68 O 0 0.046386703848838806
% O 0 0.018625270575284958
in O 0 0.009143289178609848
our O 0 0.023800259456038475
Saethre B-Disease 1 0.9999802112579346
- I-Disease 1 0.9998925924301147
Chotzen I-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
patients O 1 0.9999957084655762
, O 0 0.01241082139313221
including O 0 0.008093374781310558
our O 0 0.012336576357483864
five O 0 0.01945296674966812
patients O 1 0.999935507774353
elsewhere O 0 0.03124854527413845
reported O 0 0.03097379207611084
with O 0 0.02037336863577366
TWIST O 1 0.7590705156326294
mutations O 0 0.15585023164749146
. O 0 0.03680751845240593

More O 0 0.017111338675022125
than O 0 0.015037387609481812
35 O 0 0.030093347653746605
different O 0 0.013568069785833359
TWIST O 0 0.2806251645088196
mutations O 0 0.09273353964090347
are O 0 0.008335699327290058
now O 0 0.010701054707169533
known O 0 0.012534688226878643
in O 0 0.006595529615879059
the O 0 0.009649893268942833
literature O 0 0.021906698122620583
. O 0 0.024635158479213715

The O 0 0.022350216284394264
most O 0 0.015586609952151775
common O 0 0.0314551442861557
phenotypic O 0 0.08071038126945496
features O 0 0.02056966908276081
, O 0 0.007846249267458916
present O 0 0.008412228897213936
in O 0 0.005956651642918587
more O 0 0.005230898503214121
than O 0 0.006988831330090761
a O 0 0.009932469576597214
third O 0 0.016201375052332878
of O 0 0.008544904179871082
our O 0 0.02044975943863392
patients O 1 0.9998776912689209
with O 0 0.020385796204209328
TWIST O 1 0.9871562719345093
mutations O 0 0.11293648928403854
, O 0 0.016035888344049454
are O 0 0.013553132303059101
coronal B-Disease 1 0.8347011208534241
synostosis I-Disease 1 0.792011022567749
, O 0 0.025084184482693672
brachycephaly B-Disease 1 0.871932327747345
, O 0 0.02206452749669552
low B-Disease 0 0.093616783618927
frontal I-Disease 1 0.9999575614929199
hairline I-Disease 1 0.9999992847442627
, O 0 0.050167374312877655
facial B-Disease 1 0.9999943971633911
asymmetry I-Disease 1 0.9987106323242188
, O 0 0.034450411796569824
ptosis B-Disease 1 0.9999995231628418
, O 0 0.03260064497590065
hypertelorism B-Disease 1 0.9999370574951172
, O 0 0.01815808191895485
broad B-Disease 0 0.046270035207271576
great I-Disease 0 0.02995241805911064
toes I-Disease 1 0.9015047550201416
, O 0 0.01705116592347622
and O 0 0.01586024835705757
clinodactyly B-Disease 1 0.8687593936920166
. O 0 0.03435920551419258

Significant O 0 0.06482535600662231
intra O 0 0.15649083256721497
- O 0 0.09920284897089005
and O 0 0.025127708911895752
interfamilial O 1 0.6853801608085632
phenotypic O 0 0.14424702525138855
variability O 0 0.11289975047111511
is O 0 0.013261849991977215
present O 0 0.01331661269068718
for O 0 0.01024638582020998
either O 0 0.02583589218556881
TWIST O 1 0.8978786468505859
mutations O 0 0.1467551440000534
or O 0 0.04550142586231232
FGFR O 1 0.9994587302207947
mutations O 0 0.16623228788375854
. O 0 0.039376720786094666

The O 0 0.024370519444346428
overlap O 0 0.05112847313284874
in O 0 0.016233326867222786
clinical O 1 0.6919123530387878
features O 0 0.015971288084983826
and O 0 0.005948982201516628
the O 0 0.00778974499553442
presence O 0 0.0203325767070055
, O 0 0.006269032135605812
in O 0 0.005997958593070507
the O 0 0.007607702165842056
same O 0 0.013273038901388645
genes O 0 0.036248579621315
, O 0 0.009918514639139175
of O 0 0.008744512684643269
mutations O 0 0.06345081329345703
for O 0 0.007805460598319769
more O 0 0.0070490045472979546
than O 0 0.009505042806267738
one O 0 0.015459662303328514
craniosynostotic B-Disease 1 0.9986825585365295
condition I-Disease 1 0.9946396946907043
- O 0 0.049706507474184036
such O 0 0.010556583292782307
as O 0 0.01727215014398098
Saethre B-Disease 1 0.9970045685768127
- I-Disease 0 0.10230781883001328
Chotzen I-Disease 1 0.6595783233642578
, I-Disease 0 0.02263559028506279
Crouzon I-Disease 1 0.9319659471511841
, I-Disease 0 0.01934780366718769
and I-Disease 0 0.02607407420873642
Pfeiffer I-Disease 1 0.9999980926513672
syndromes I-Disease 1 0.9999997615814209
- O 0 0.07234769314527512
support O 0 0.023676032200455666
the O 0 0.015478085726499557
hypothesis O 0 0.05642043426632881
that O 0 0.014306334778666496
TWIST O 0 0.10477379709482193
and O 0 0.014239154756069183
FGFRs O 0 0.2700521945953369
are O 0 0.0070366389118134975
components O 0 0.014924971386790276
of O 0 0.005554326809942722
the O 0 0.010430315509438515
same O 0 0.01860017515718937
molecular O 0 0.0674733892083168
pathway O 0 0.09033595770597458
involved O 0 0.019493451341986656
in O 0 0.007647169288247824
the O 0 0.010985160246491432
modulation O 0 0.11252554506063461
of O 0 0.019343925639986992
craniofacial O 1 0.9999997615814209
and O 0 0.02567204087972641
limb O 1 0.9999144077301025
development O 0 0.02393096312880516
in O 0 0.011295175179839134
humans O 0 0.03702561929821968
. O 0 0.015672532841563225
. O 0 0.026363680139183998

Mutation O 0 0.19447137415409088
analysis O 0 0.041530806571245193
of O 0 0.024395404383540154
UBE3A O 1 0.9999924898147583
in O 1 0.9094755053520203
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999997615814209
. O 0 0.03322308510541916

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.061060935258865356
AS B-Disease 0 0.034357503056526184
) O 0 0.021639587357640266
is O 0 0.015211276710033417
caused O 0 0.056067515164613724
by O 0 0.02526831440627575
chromosome O 0 0.2119646966457367
15q11 O 1 0.9134289622306824
- O 0 0.12420384585857391
q13 O 0 0.19173623621463776
deletions O 0 0.09515064209699631
of O 0 0.01901874877512455
maternal O 0 0.09621473401784897
origin O 0 0.02481764182448387
, O 0 0.012104148045182228
by O 0 0.018347492441534996
paternal O 1 0.5464291572570801
uniparental B-Disease 1 0.9999845027923584
disomy I-Disease 1 0.9978265166282654
( O 0 0.08227194845676422
UPD B-Disease 1 0.9999914169311523
) O 0 0.03240659460425377
15 O 0 0.020383670926094055
, O 0 0.010809481143951416
by O 0 0.017443368211388588
imprinting O 1 0.9955477714538574
defects O 1 0.9966950416564941
, O 0 0.012638169340789318
and O 0 0.008605842478573322
by O 0 0.012880106456577778
mutations O 0 0.08369618654251099
in O 0 0.014053156599402428
the O 0 0.022292345762252808
UBE3A O 1 0.9996160268783569
gene O 0 0.12653860449790955
. O 0 0.03321296349167824

UBE3A O 1 0.8658140897750854
encodes O 0 0.1469704955816269
a O 0 0.0540090948343277
ubiquitin O 0 0.20385290682315826
- O 0 0.12741053104400635
protein O 0 0.1002100333571434
ligase O 0 0.10490446537733078
and O 0 0.017020806670188904
shows O 0 0.035290155559778214
brain O 1 0.9949989318847656
- O 0 0.08195804059505463
specific O 0 0.03865540027618408
imprinting O 0 0.2662773132324219
. O 0 0.039802584797143936

Here O 0 0.02974151074886322
we O 0 0.022067079320549965
describe O 0 0.07557196915149689
UBE3A O 1 0.9982256293296814
coding O 0 0.22210438549518585
- O 0 0.1328289657831192
region O 0 0.08771208673715591
mutations O 0 0.156830832362175
detected O 0 0.10408944636583328
by O 0 0.02138480544090271
SSCP O 1 0.9417704343795776
analysis O 0 0.026802854612469673
in O 0 0.010504612699151039
13 O 0 0.019900107756257057
AS B-Disease 0 0.01768306829035282
individuals O 0 0.014909136109054089
or O 0 0.015741445124149323
families O 0 0.02950098179280758
. O 0 0.024069519713521004

Two O 0 0.0229237899184227
identical O 0 0.05480153486132622
de O 0 0.08794095367193222
novo O 0 0.17073865234851837
5 O 0 0.049262575805187225
- O 0 0.09321007132530212
bp O 0 0.12736108899116516
duplications O 0 0.11064061522483826
in O 0 0.02175304852426052
exon O 0 0.11742448806762695
16 O 0 0.025749189779162407
were O 0 0.010690807364881039
found O 0 0.024269940331578255
. O 0 0.02421259880065918

Among O 0 0.02040223777294159
the O 0 0.01200801320374012
other O 0 0.009191148914396763
11 O 0 0.023504219949245453
unique O 0 0.03269821032881737
mutations O 0 0.09025805443525314
, O 0 0.01187566015869379
8 O 0 0.019637251272797585
were O 0 0.007939179427921772
small O 0 0.019557088613510132
deletions O 0 0.08362860977649689
or O 0 0.030419601127505302
insertions O 0 0.12189497798681259
predicted O 0 0.04549773037433624
to O 0 0.01758163422346115
cause O 0 0.07878027856349945
frameshifts O 1 0.79744553565979
, O 0 0.015794048085808754
1 O 0 0.019654324278235435
was O 0 0.014827336184680462
a O 0 0.021806078031659126
mutation O 0 0.08928404748439789
to O 0 0.011087923310697079
a O 0 0.01968425139784813
stop O 0 0.048711538314819336
codon O 0 0.09918351471424103
, O 0 0.015161974355578423
1 O 0 0.023830851539969444
was O 0 0.02164365164935589
a O 0 0.03589324280619621
missense O 0 0.21541354060173035
mutation O 0 0.1364089697599411
, O 0 0.012666183523833752
and O 0 0.008842814713716507
1 O 0 0.01962880976498127
was O 0 0.014100700616836548
predicted O 0 0.03068741038441658
to O 0 0.013330151326954365
cause O 0 0.052392397075891495
insertion O 0 0.08134829252958298
of O 0 0.009949872270226479
an O 0 0.016398895531892776
isoleucine O 0 0.12248428165912628
in O 0 0.01122361235320568
the O 0 0.01342780515551567
hect O 0 0.12825962901115417
domain O 0 0.030772270634770393
of O 0 0.00874327216297388
the O 0 0.01880292221903801
UBE3A O 1 0.9989690780639648
protein O 0 0.057509586215019226
, O 0 0.008886124938726425
which O 0 0.0074745723977684975
functions O 0 0.012482673861086369
in O 0 0.014233815483748913
E2 O 1 0.9872149229049683
binding O 0 0.04677513241767883
and O 0 0.015751022845506668
ubiquitin O 0 0.10500829666852951
transfer O 0 0.03321489319205284
. O 0 0.027831537649035454

Eight O 0 0.023154543712735176
of O 0 0.00791582465171814
the O 0 0.010547742247581482
cases O 0 0.02507602982223034
were O 0 0.014564432203769684
familial O 1 0.9997851252555847
, O 0 0.010446278378367424
and O 0 0.0075497375801205635
five O 0 0.010191751644015312
were O 0 0.01144092995673418
sporadic O 0 0.07505764812231064
. O 0 0.032218657433986664

In O 0 0.02068166807293892
two O 0 0.018931467086076736
familial O 1 0.999894380569458
cases O 0 0.028986195102334023
and O 0 0.00857505202293396
one O 0 0.01186154130846262
sporadic O 0 0.05833769962191582
case O 0 0.02834164723753929
, O 0 0.02245553955435753
mosaicism O 1 0.9985694885253906
for O 0 0.03087964840233326
UBE3A O 1 0.9997110962867737
mutations O 0 0.13167694211006165
was O 0 0.02078114077448845
detected O 0 0.05006195977330208
in O 0 0.008074494078755379
the O 0 0.007969923317432404
mother O 0 0.022508472204208374
of O 0 0.00598289305344224
three O 0 0.00860194768756628
AS B-Disease 0 0.02219574898481369
sons O 0 0.033710308372974396
, O 0 0.007820149883627892
in O 0 0.0071978215128183365
the O 0 0.010722124949097633
maternal O 0 0.09729533642530441
grandfather O 0 0.03683902695775032
of O 0 0.007225639186799526
two O 0 0.007461783476173878
AS B-Disease 0 0.01675371080636978
first O 0 0.01332937367260456
cousins O 0 0.04656994715332985
, O 0 0.009260235354304314
and O 0 0.005715095903724432
in O 0 0.006368236616253853
the O 0 0.008516229689121246
mother O 0 0.024405188858509064
of O 0 0.006719246041029692
an O 0 0.012443493120372295
AS B-Disease 0 0.027426226064562798
daughter O 0 0.07174862176179886
. O 0 0.028382280841469765

The O 0 0.023644274100661278
frequencies O 0 0.038381095975637436
with O 0 0.011079388670623302
which O 0 0.012364285998046398
we O 0 0.018146254122257233
detected O 0 0.09369825571775436
mutations O 0 0.08642424643039703
were O 0 0.010258051566779613
5 O 0 0.02450883388519287
( O 0 0.021154802292585373
14 O 0 0.0200920682400465
% O 0 0.01998448744416237
) O 0 0.013286033645272255
of O 0 0.007358434144407511
35 O 0 0.02429463155567646
in O 0 0.011493041180074215
sporadic O 0 0.06694962829351425
cases O 0 0.028075607493519783
and O 0 0.011602315120398998
8 O 0 0.028925541788339615
( O 0 0.025386007502675056
80 O 0 0.03229743614792824
% O 0 0.020062364637851715
) O 0 0.013683811761438847
of O 0 0.007112371269613504
10 O 0 0.015762366354465485
in O 0 0.014845995232462883
familial O 1 0.9999589920043945
cases O 0 0.03596476465463638
. O 0 0.015045256353914738
. O 0 0.022188179194927216

The O 0 0.07495259493589401
hemochromatosis B-Disease 1 1.0
845 O 1 0.9996616840362549
G O 1 0.9990215301513672
- O 0 0.33022570610046387
- O 0 0.11511751264333725
> O 0 0.11799316108226776
A O 0 0.031826842576265335
and O 0 0.015788525342941284
187 O 0 0.10517045855522156
C O 1 0.970270574092865
- O 0 0.493789404630661
- O 0 0.20969446003437042
> O 1 0.7721322178840637
G O 1 0.8421077132225037
mutations O 0 0.1589609831571579
: O 0 0.040193211287260056
prevalence O 1 0.7684420943260193
in O 0 0.02166699431836605
non O 0 0.06181653216481209
- O 0 0.1277221143245697
Caucasian O 1 0.9142706394195557
populations O 0 0.1012759804725647
. O 0 0.03712247312068939

Hemochromatosis B-Disease 1 0.9999992847442627
, O 0 0.02811472862958908
the O 0 0.02590712159872055
inherited B-Disease 1 0.9999992847442627
disorder I-Disease 1 1.0
of I-Disease 0 0.02247464470565319
iron I-Disease 1 0.9977329969406128
metabolism I-Disease 1 0.9666492342948914
, O 0 0.017599929124116898
leads O 0 0.048111848533153534
, O 0 0.013556658290326595
if O 0 0.017729181796312332
untreated O 1 0.9995858073234558
, O 0 0.01199132390320301
to O 0 0.01229004468768835
progressive O 1 0.8922556042671204
iron B-Disease 1 0.9993064403533936
overload I-Disease 1 0.9998725652694702
and O 0 0.025984277948737144
premature B-Disease 1 0.9915845394134521
death I-Disease 0 0.06297425180673599
. O 0 0.03347000107169151

The O 0 0.0730690285563469
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.15870024263858795
, O 0 0.033087216317653656
HFE O 1 0.9996732473373413
, O 0 0.01870541088283062
recently O 0 0.02630145661532879
has O 0 0.011382906697690487
been O 0 0.010729118250310421
identified O 0 0.017805757001042366
, O 0 0.007897384464740753
and O 0 0.008086709305644035
characterization O 0 0.0414903461933136
of O 0 0.00801070500165224
this O 0 0.010644347406923771
gene O 0 0.04995621740818024
has O 0 0.013170636259019375
shown O 0 0.014638192020356655
that O 0 0.005389463156461716
it O 0 0.006273721344769001
contains O 0 0.012101422064006329
two O 0 0.011273246258497238
mutations O 0 0.07844266295433044
that O 0 0.010230576619505882
result O 0 0.022654883563518524
in O 0 0.015514888800680637
amino O 0 0.07602941244840622
acid O 0 0.15553715825080872
substitutions O 0 0.09800116717815399
- O 0 0.1215822771191597
cDNA O 0 0.20662562549114227
nucleotides O 0 0.1693728268146515
845 O 1 0.9277241826057434
G O 1 0.9881783127784729
- O 0 0.17452876269817352
- O 0 0.14196018874645233
> O 0 0.15134097635746002
A O 0 0.04690197482705116
( O 0 0.04165805131196976
C282Y O 0 0.1435244232416153
) O 0 0.023577218875288963
and O 0 0.01494100783020258
187 O 0 0.10648937523365021
C O 1 0.9650576114654541
- O 0 0.4904496967792511
- O 0 0.1958373486995697
> O 0 0.3525967001914978
G O 0 0.29638296365737915
( O 0 0.05748621001839638
H63D O 1 0.9703118801116943
) O 0 0.03960396721959114
. O 0 0.02488504722714424

Although O 0 0.06819961220026016
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 0.02088259905576706
common O 0 0.027844920754432678
in O 0 0.0161283016204834
Caucasians O 1 0.9289264678955078
, O 0 0.02638753317296505
affecting O 0 0.10421176254749298
> O 1 0.7697004675865173
= O 0 0.1339636743068695
1 O 0 0.03991859778761864
/ O 0 0.11624167859554291
300 O 0 0.0321878045797348
individuals O 0 0.015372585505247116
of O 0 0.006941969972103834
northern O 0 0.01850585639476776
European O 0 0.017637629061937332
origin O 0 0.015009347349405289
, O 0 0.008171995170414448
it O 0 0.005592692643404007
has O 0 0.007165135815739632
not O 0 0.005785068497061729
been O 0 0.007795637007802725
recognized O 0 0.017406072467565536
in O 0 0.008881594985723495
other O 0 0.009789305739104748
populations O 0 0.05166343227028847
. O 0 0.024988234043121338

The O 0 0.021955493837594986
present O 0 0.02108137682080269
study O 0 0.027896706014871597
used O 0 0.02154410444200039
PCR O 0 0.12655311822891235
and O 0 0.016418779268860817
restriction O 0 0.06439131498336792
- O 0 0.10353127866983414
enzyme O 0 0.14140735566616058
digestion O 0 0.13559143245220184
to O 0 0.013293362222611904
analyze O 0 0.03309197723865509
the O 0 0.01202545315027237
frequency O 0 0.03407444432377815
of O 0 0.009183721616864204
the O 0 0.020200416445732117
845 O 1 0.9980436563491821
G O 1 0.9958562254905701
- O 0 0.15158748626708984
- O 0 0.11749093234539032
> O 0 0.12664422392845154
A O 0 0.029646502807736397
and O 0 0.01767539419233799
187 O 0 0.10731431096792221
C O 1 0.8404585719108582
- O 0 0.30429744720458984
- O 0 0.18721342086791992
> O 0 0.40620532631874084
G O 0 0.4460548460483551
mutations O 0 0.131968691945076
in O 0 0.02972433902323246
HLA O 1 0.9997703433036804
- O 0 0.10516449064016342
typed O 0 0.06885222345590591
samples O 0 0.0492117814719677
from O 0 0.020207559689879417
non O 0 0.05438999459147453
- O 0 0.10981415957212448
Caucasian O 1 0.5076067447662354
populations O 0 0.06593280285596848
, O 0 0.015699101611971855
comprising O 0 0.02981153316795826
Australian O 0 0.03841569647192955
Aboriginal O 0 0.06251288205385208
, O 0 0.01306704431772232
Chinese O 0 0.016145484521985054
, O 0 0.010334232822060585
and O 0 0.012056573294103146
Pacific O 0 0.06017026677727699
Islanders O 0 0.10328067094087601
. O 0 0.031583018600940704

Results O 0 0.04712916165590286
showed O 0 0.029029719531536102
that O 0 0.00867069698870182
the O 0 0.018101705238223076
845 O 1 0.9992094039916992
G O 1 0.999626874923706
- O 1 0.6450043320655823
- O 0 0.13982082903385162
> O 0 0.16408070921897888
A O 0 0.04567868262529373
mutation O 0 0.10409492999315262
was O 0 0.013649463653564453
present O 0 0.012424557469785213
in O 0 0.008321309462189674
these O 0 0.009425785392522812
populations O 0 0.051910314708948135
( O 0 0.03979452699422836
allele O 0 0.14054663479328156
frequency O 0 0.06521794945001602
0 O 0 0.043238259851932526
. O 0 0.012014067731797695
32 O 0 0.028514284640550613
% O 0 0.023311641067266464
) O 0 0.016549676656723022
, O 0 0.008271954022347927
and O 0 0.007178890518844128
, O 0 0.008337986655533314
furthermore O 0 0.022066999226808548
, O 0 0.008191519416868687
it O 0 0.006936358287930489
was O 0 0.01092908252030611
always O 0 0.015275007113814354
seen O 0 0.015343721024692059
in O 0 0.009514743462204933
conjunction O 0 0.05374738574028015
with O 0 0.028870223090052605
HLA O 1 0.9998666048049927
haplotypes O 1 0.5733085870742798
common O 0 0.04297700151801109
in O 0 0.018148818984627724
Caucasians O 0 0.42420074343681335
, O 0 0.017849909141659737
suggesting O 0 0.04653172940015793
that O 0 0.018656205385923386
845 O 1 0.9985034465789795
G O 1 0.9995521903038025
- O 1 0.8600314259529114
- O 0 0.1426270753145218
> O 0 0.1368277221918106
A O 0 0.02906954474747181
may O 0 0.016837941482663155
have O 0 0.006857250351458788
been O 0 0.007824220694601536
introduced O 0 0.013263510540127754
into O 0 0.010691992938518524
these O 0 0.007799960672855377
populations O 0 0.041706934571266174
by O 0 0.022406652569770813
Caucasian O 1 0.9880018830299377
admixture O 1 0.9809070229530334
. O 0 0.043257661163806915

187 O 0 0.20947682857513428
C O 1 0.9858464598655701
- O 1 0.8181396126747131
- O 0 0.21607105433940887
> O 0 0.2223799228668213
G O 0 0.13640406727790833
was O 0 0.018469303846359253
present O 0 0.016768358647823334
at O 0 0.01752426289021969
an O 0 0.016167307272553444
allele O 0 0.12042614072561264
frequency O 0 0.05022216588258743
of O 0 0.010771725326776505
2 O 0 0.032985854893922806
. O 0 0.02641335502266884

68 O 0 0.09478336572647095
% O 0 0.024565162137150764
in O 0 0.00879706908017397
the O 0 0.009691309183835983
two O 0 0.010403295047581196
populations O 0 0.04749142751097679
analyzed O 0 0.049484021961688995
( O 0 0.028109600767493248
Australian O 0 0.034976713359355927
Aboriginal O 0 0.04702690616250038
and O 0 0.009963060729205608
Chinese O 0 0.01969803124666214
) O 0 0.026859821751713753
. O 0 0.02251702919602394

In O 0 0.017109494656324387
the O 0 0.013589332811534405
Australian O 0 0.03750722482800484
Aboriginal O 0 0.06763089448213577
samples O 0 0.04970281571149826
, O 0 0.022220967337489128
187 O 0 0.11046039313077927
C O 1 0.9024232625961304
- O 0 0.32444140315055847
- O 0 0.16012753546237946
> O 0 0.20244327187538147
G O 0 0.13177207112312317
was O 0 0.017634637653827667
found O 0 0.012063617818057537
to O 0 0.007049138192087412
be O 0 0.00834769755601883
associated O 0 0.022296931594610214
with O 0 0.02529742754995823
HLA O 1 0.9999914169311523
haplotypes O 1 0.9688205122947693
common O 0 0.03695470467209816
in O 0 0.016584651544690132
Caucasians O 1 0.9829620718955994
, O 0 0.016516633331775665
suggesting O 0 0.02928847260773182
that O 0 0.006877553183585405
it O 0 0.0059036314487457275
was O 0 0.0094684399664402
introduced O 0 0.014116738922894001
by O 0 0.011108433827757835
recent O 0 0.03806142508983612
admixture O 1 0.6240187287330627
. O 0 0.03746328502893448

In O 0 0.014100673608481884
the O 0 0.013208159245550632
Chinese O 0 0.01818220131099224
samples O 0 0.041838884353637695
analyzed O 0 0.04276006668806076
, O 0 0.018623527139425278
187 O 0 0.10875394195318222
C O 1 0.9664247035980225
- O 0 0.3620162308216095
- O 0 0.15177130699157715
> O 0 0.2075941115617752
G O 0 0.13407790660858154
was O 0 0.017404930666089058
present O 0 0.014532123692333698
in O 0 0.009266183711588383
association O 0 0.025128236040472984
with O 0 0.009610558860003948
a O 0 0.015849644318223
wide O 0 0.024112984538078308
variety O 0 0.021623892709612846
of O 0 0.019897500053048134
HLA O 1 0.9999698400497437
haplotypes O 1 0.9418531060218811
, O 0 0.018815770745277405
showing O 0 0.034314729273319244
this O 0 0.012916958890855312
mutation O 0 0.08476927131414413
to O 0 0.009096295572817326
be O 0 0.009031172841787338
widespread O 0 0.023958200588822365
and O 0 0.009138084948062897
likely O 0 0.019509650766849518
to O 0 0.01043888833373785
predate O 0 0.06619562953710556
the O 0 0.01181232463568449
more O 0 0.01146320253610611
genetically O 0 0.05282099172472954
restricted O 0 0.06331321597099304
845 O 1 0.9987240433692932
G O 1 0.9989805817604065
- O 1 0.6485742330551147
- O 0 0.1465042680501938
> O 0 0.18997828662395477
A O 0 0.06095525249838829
mutation O 0 0.17109137773513794
. O 0 0.03595966473221779

Genotype O 1 0.9943668246269226
- O 0 0.2908761203289032
phenotype O 1 0.8755839467048645
correlations O 0 0.14786826074123383
in O 0 0.046734120696783066
attenuated B-Disease 1 0.9999837875366211
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999969005584717
. O 0 0.06428166478872299

Germ O 1 0.9997827410697937
- O 0 0.1275322139263153
line O 0 0.05740189179778099
mutations O 0 0.09335087239742279
of O 0 0.013251197524368763
the O 0 0.030053386464715004
tumor B-Disease 1 0.9999871253967285
suppressor O 1 0.996466875076294
APC O 1 0.9803217053413391
are O 0 0.0161751601845026
implicated O 0 0.2382492870092392
in O 0 0.0330660417675972
attenuated B-Disease 1 0.9999923706054688
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999996423721313
( O 1 0.5630984902381897
AAPC B-Disease 1 0.9999996423721313
) O 0 0.028939764946699142
, O 0 0.01180938072502613
a O 0 0.01892249844968319
variant O 0 0.10862230509519577
of O 0 0.03011704795062542
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9694085121154785
FAP B-Disease 1 0.9999991655349731
) O 0 0.04141389951109886
. O 0 0.028109341859817505

AAPC B-Disease 1 0.9999368190765381
is O 0 0.02423475868999958
recognized O 0 0.02417658641934395
by O 0 0.009614173322916031
the O 0 0.014913155697286129
occurrence O 0 0.07924190163612366
of O 0 0.019658798351883888
< O 1 0.8113483786582947
100 O 0 0.06100478023290634
colonic B-Disease 1 0.9996401071548462
adenomas I-Disease 1 0.999913215637207
and O 0 0.012705085799098015
a O 0 0.018560830503702164
later O 0 0.02788357064127922
onset O 1 0.9999940395355225
of O 0 0.05815580114722252
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0577680841088295
age O 0 0.05717858299612999
> O 0 0.16673968732357025
40 O 0 0.03014066256582737
years O 0 0.02002534084022045
) O 0 0.024586180225014687
. O 0 0.023136883974075317

The O 0 0.019403165206313133
aim O 0 0.03679337352514267
of O 0 0.007174041587859392
this O 0 0.00765094393864274
study O 0 0.01854640059173107
was O 0 0.012292775325477123
to O 0 0.013909786008298397
assess O 0 0.10316633433103561
genotype O 1 0.9908692836761475
- O 0 0.15223544836044312
phenotype O 1 0.6524730324745178
correlations O 0 0.12972460687160492
in O 0 0.03751900792121887
AAPC B-Disease 1 0.9999974966049194
families O 0 0.05849236622452736
. O 0 0.0361907035112381

By O 0 0.04433552175760269
protein O 0 0.10595560818910599
- O 0 0.11093728244304657
truncation O 0 0.18625174462795258
test O 0 0.07516277581453323
( O 0 0.04536822438240051
PTT O 0 0.1456109583377838
) O 0 0.029807748273015022
assay O 0 0.07254255563020706
, O 0 0.009454349987208843
the O 0 0.00955300871282816
entire O 0 0.03371162712574005
coding O 0 0.08746122568845749
region O 0 0.030226944014430046
of O 0 0.009748120792210102
the O 0 0.019385287538170815
APC B-Disease 1 0.9970561265945435
gene O 0 0.08057117462158203
was O 0 0.021420741453766823
screened O 0 0.05734501779079437
in O 0 0.01216124277561903
affected O 0 0.03980901837348938
individuals O 0 0.022046448662877083
from O 0 0.018898310139775276
11 O 0 0.05378611385822296
AAPC B-Disease 1 0.9999997615814209
kindreds O 1 0.9886367917060852
, O 0 0.014437630772590637
and O 0 0.0077146808616817
their O 0 0.010228954255580902
phenotypic O 0 0.07540582120418549
differences O 0 0.029178082942962646
were O 0 0.015166298486292362
examined O 0 0.07554386556148529
. O 0 0.03241267427802086

Five O 0 0.038631685078144073
novel O 0 0.07516874372959137
germ O 1 0.9987014532089233
- O 0 0.1459522694349289
line O 0 0.07638300210237503
APC B-Disease 1 0.9925751686096191
mutations O 0 0.11729095876216888
were O 0 0.012405123561620712
identified O 0 0.02453564666211605
in O 0 0.012042053043842316
seven O 0 0.02656589075922966
kindreds O 1 0.8918085694313049
. O 0 0.036854248493909836

Mutations O 0 0.13790109753608704
were O 0 0.014756678603589535
located O 0 0.01883789710700512
in O 0 0.007463305722922087
three O 0 0.00702388072386384
different O 0 0.0059630186296999454
regions O 0 0.017004970461130142
of O 0 0.00799716729670763
the O 0 0.020245399326086044
APC B-Disease 1 0.9982752799987793
gene O 0 0.10680107772350311
( O 0 0.03168584406375885
1 O 0 0.02351653017103672
) O 0 0.015369655564427376
at O 0 0.011305329389870167
the O 0 0.008369832299649715
5 O 0 0.02167348936200142
end O 0 0.023554731160402298
spanning O 0 0.052672792226076126
exons O 0 0.09441069513559341
4 O 0 0.027741527184844017
and O 0 0.009284700267016888
5 O 0 0.02121191844344139
, O 0 0.01271179411560297
( O 0 0.02217477187514305
2 O 0 0.022391462698578835
) O 0 0.0186186321079731
within O 0 0.016596203669905663
exon O 0 0.09464488923549652
9 O 0 0.027952702715992928
, O 0 0.010371014475822449
and O 0 0.009398985654115677
( O 0 0.020481426268815994
3 O 0 0.019938871264457703
) O 0 0.01266217790544033
at O 0 0.011147871613502502
the O 0 0.009354396723210812
3 O 0 0.028078651055693626
distal O 1 0.7352055907249451
end O 0 0.01855376735329628
of O 0 0.009601160883903503
the O 0 0.016537124291062355
gene O 0 0.08357689529657364
. O 0 0.028077183291316032

Variability O 0 0.12814991176128387
in O 0 0.012160693295300007
the O 0 0.009557070210576057
number O 0 0.012277211993932724
of O 0 0.027985122054815292
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
was O 0 0.021248411387205124
most O 0 0.01110334973782301
apparent O 0 0.03683590143918991
in O 0 0.009706532582640648
individuals O 0 0.017390063032507896
with O 0 0.013620840385556221
mutations O 0 0.07501891255378723
in O 0 0.012153282761573792
region O 0 0.030736317858099937
1 O 0 0.018596122041344643
, O 0 0.009281174279749393
and O 0 0.01262674480676651
upper O 1 0.999823272228241
- O 1 0.9989755153656006
gastrointestinal O 1 0.9999998807907104
manifestations O 1 0.9463648200035095
were O 0 0.009981035254895687
more O 0 0.012209328822791576
severe O 1 0.9983866214752197
in O 0 0.009285573847591877
them O 0 0.009727759286761284
. O 0 0.021450860425829887

In O 0 0.02303292788565159
individuals O 0 0.02586623653769493
with O 0 0.01739232987165451
mutations O 0 0.07824746519327164
in O 0 0.0120638906955719
either O 0 0.017618322744965553
region O 0 0.0314699225127697
2 O 0 0.02472461387515068
or O 0 0.017019953578710556
region O 0 0.025845235213637352
3 O 0 0.017678571864962578
, O 0 0.007197964005172253
the O 0 0.008167644962668419
average O 0 0.021276693791151047
number O 0 0.009066866710782051
of O 0 0.012048522010445595
adenomas B-Disease 1 0.9999762773513794
tended O 0 0.04904000088572502
to O 0 0.008365970104932785
be O 0 0.0069825006648898125
lower O 0 0.01897241920232773
than O 0 0.0069741010665893555
those O 0 0.00612662686035037
in O 0 0.007473970763385296
individuals O 0 0.01585308276116848
with O 0 0.012931185774505138
mutations O 0 0.07394535094499588
in O 0 0.011806637048721313
region O 0 0.028667643666267395
1 O 0 0.019605468958616257
, O 0 0.00909348949790001
although O 0 0.013090063817799091
age O 0 0.026787325739860535
at O 0 0.024019144475460052
diagnosis O 1 0.9999740123748779
was O 0 0.01941682957112789
similar O 0 0.021837640553712845
. O 0 0.02312582917511463

In O 0 0.02753204107284546
all O 0 0.027523817494511604
AAPC B-Disease 1 0.9999979734420776
kindreds O 1 0.8727561235427856
, O 0 0.015773054212331772
a O 0 0.018146373331546783
predominance O 0 0.08989161252975464
of O 0 0.012026485055685043
right O 0 0.19106361269950867
- O 1 0.9989908337593079
sided O 1 0.9999911785125732
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.31310173869132996
rectal B-Disease 1 1.0
polyp I-Disease 1 0.9999997615814209
sparing O 1 0.9710524082183838
was O 0 0.03314889967441559
observed O 0 0.04736793413758278
. O 0 0.025337502360343933

No O 0 0.063934825360775
desmoid B-Disease 1 0.9996812343597412
tumors I-Disease 1 0.9999934434890747
were O 0 0.012953597120940685
found O 0 0.015634700655937195
in O 0 0.010058995336294174
these O 0 0.013527718372642994
kindreds O 1 0.8920861482620239
. O 0 0.04309948906302452

Our O 0 0.028947148472070694
data O 0 0.019474364817142487
suggest O 0 0.022605344653129578
that O 0 0.00697954511269927
, O 0 0.009054006077349186
in O 0 0.01627982035279274
AAPC B-Disease 1 0.9999996423721313
families O 0 0.02790534682571888
, O 0 0.009317592717707157
the O 0 0.00873778946697712
location O 0 0.014407629147171974
of O 0 0.0068197185173630714
the O 0 0.0206744447350502
APC B-Disease 1 0.999485969543457
mutation O 0 0.44848373532295227
may O 0 0.03513351455330849
partially O 0 0.07072225213050842
predict O 0 0.056221362203359604
specific O 0 0.023787345737218857
phenotypic O 0 0.10317014902830124
expression O 0 0.06109559163451195
. O 0 0.028556756675243378

This O 0 0.014939560554921627
should O 0 0.01187985111027956
help O 0 0.015575594268739223
in O 0 0.006546014454215765
the O 0 0.007463030982762575
design O 0 0.022191915661096573
of O 0 0.012215610593557358
tailored O 1 0.654394268989563
clinical O 1 0.9998438358306885
- O 0 0.10842004418373108
management O 0 0.06426304578781128
protocols O 0 0.04286590963602066
in O 0 0.00927785225212574
this O 0 0.009735488332808018
subset O 0 0.06570596992969513
of O 0 0.022815557196736336
FAP B-Disease 1 1.0
patients O 1 0.9999821186065674
. O 0 0.01892201043665409
. O 0 0.0265518669039011

Wilms B-Disease 1 0.9999940395355225
' I-Disease 1 0.5617630481719971
tumor I-Disease 1 0.9989420771598816
1 O 0 0.03404846414923668
and O 0 0.01770704798400402
Dax O 1 0.9991187453269958
- O 0 0.08946466445922852
1 O 0 0.041730016469955444
modulate O 0 0.15506558120250702
the O 0 0.02872231788933277
orphan O 1 0.9904166460037231
nuclear O 0 0.1262538880109787
receptor O 1 0.632605791091919
SF O 1 0.9994437098503113
- O 0 0.08171571791172028
1 O 0 0.024327414110302925
in O 0 0.012774549424648285
sex O 0 0.051143746823072433
- O 0 0.06127867102622986
specific O 0 0.028687553480267525
gene O 0 0.09420070052146912
expression O 0 0.06075810268521309
. O 0 0.026317618787288666

Products O 0 0.052875787019729614
of O 0 0.02726883441209793
steroidogenic O 1 0.9977420568466187
factor O 0 0.09550327807664871
1 O 0 0.046573009341955185
( O 0 0.052581265568733215
SF O 1 0.9998582601547241
- O 0 0.08520811051130295
1 O 0 0.0353279747068882
) O 0 0.029063403606414795
and O 0 0.029986998066306114
Wilms B-Disease 1 0.9999960660934448
tumor I-Disease 1 0.9998250603675842
1 O 0 0.06060830503702164
( O 0 0.05846889317035675
WT1 O 1 0.9997456669807434
) O 0 0.031860969960689545
genes O 0 0.03982970863580704
are O 0 0.007904517464339733
essential O 0 0.02066856063902378
for O 0 0.014212500303983688
mammalian O 0 0.12701280415058136
gonadogenesis O 0 0.20651115477085114
prior O 0 0.029017789289355278
to O 0 0.013278908096253872
sexual O 0 0.04465010389685631
differentiation O 0 0.09426014125347137
. O 0 0.028076492249965668

In O 0 0.0300886370241642
males O 0 0.07055284082889557
, O 0 0.027927912771701813
SF O 1 0.9999619722366333
- O 0 0.08419575542211533
1 O 0 0.030483467504382133
participates O 0 0.05798802152276039
in O 0 0.013235775753855705
sexual O 0 0.03443819656968117
development O 0 0.019602004438638687
by O 0 0.011637719348073006
regulating O 0 0.05568063259124756
expression O 0 0.03459741175174713
of O 0 0.010463614016771317
the O 0 0.02424827218055725
polypeptide O 1 0.5501916408538818
hormone O 1 0.9988008737564087
Mullerian O 1 0.9997909665107727
inhibiting O 1 0.9718952775001526
substance O 1 0.9845423698425293
( O 0 0.07396119087934494
MIS O 1 0.9988717436790466
) O 0 0.04009978100657463
. O 0 0.02624540403485298

Here O 0 0.022433241829276085
, O 0 0.010853668674826622
we O 0 0.009360425174236298
show O 0 0.01964993216097355
that O 0 0.018794095143675804
WT1 O 1 0.999885082244873
- O 0 0.3512194752693176
KTS O 1 0.9984163045883179
isoforms O 0 0.11256689578294754
associate O 0 0.04869590699672699
and O 0 0.018484951928257942
synergize O 1 0.9723514318466187
with O 0 0.04010652005672455
SF O 1 0.9998528957366943
- O 0 0.08116736263036728
1 O 0 0.025950219482183456
to O 0 0.014664915390312672
promote O 0 0.04760916531085968
MIS O 1 0.9935684204101562
expression O 0 0.06876587867736816
. O 0 0.029535897076129913

In O 0 0.026952173560857773
contrast O 0 0.06634112447500229
, O 0 0.040552519261837006
WT1 O 1 0.9998148083686829
missense O 1 0.6416236162185669
mutations O 0 0.13011592626571655
, O 0 0.014932838268578053
associated O 0 0.021586451679468155
with O 0 0.015147436410188675
male B-Disease 0 0.07738787680864334
pseudohermaphroditism I-Disease 1 0.9995841383934021
in O 0 0.03195475414395332
Denys B-Disease 1 0.9999898672103882
- I-Disease 1 0.9996073842048645
Drash I-Disease 1 0.999994158744812
syndrome I-Disease 1 1.0
, O 0 0.024466345086693764
fail O 0 0.06444916874170303
to O 0 0.018526805564761162
synergize O 1 0.988125205039978
with O 0 0.03752448409795761
SF O 1 0.9999241828918457
- O 0 0.1046699807047844
1 O 0 0.047692086547613144
. O 0 0.02884836122393608

Additionally O 0 0.05440714210271835
, O 0 0.016263889148831367
the O 0 0.01621417887508869
X O 1 0.6081095337867737
- O 0 0.07682022452354431
linked O 0 0.05863939970731735
, O 0 0.015706898644566536
candidate O 0 0.03850426897406578
dosage O 1 0.9993884563446045
- O 0 0.09057679027318954
sensitive O 0 0.05299988016486168
sex O 0 0.06964227557182312
- O 0 0.11841928213834763
reversal O 0 0.1678365021944046
gene O 0 0.10147102177143097
, O 0 0.02666153945028782
Dax O 1 0.9968301653862
- O 0 0.08622027933597565
1 O 0 0.03614583984017372
, O 0 0.02611500769853592
antagonizes O 1 0.9402680397033691
synergy O 0 0.2763615548610687
between O 0 0.04287497699260712
SF O 1 0.9999159574508667
- O 0 0.09527956694364548
1 O 0 0.03611727058887482
and O 0 0.021981319412589073
WT1 O 1 0.9989380240440369
, O 0 0.01562565378844738
most O 0 0.009462247602641582
likely O 0 0.016607873141765594
through O 0 0.009934109635651112
a O 0 0.013464880175888538
direct O 0 0.023459959775209427
interaction O 0 0.04086122289299965
with O 0 0.02440578117966652
SF O 1 0.9999653100967407
- O 0 0.09763605147600174
1 O 0 0.04006488621234894
. O 0 0.029655657708644867

We O 0 0.025551745668053627
propose O 0 0.06498023867607117
that O 0 0.02135009691119194
WT1 O 1 0.9989802241325378
and O 0 0.02638656087219715
Dax O 1 0.9993854761123657
- O 0 0.08657775074243546
1 O 0 0.037406787276268005
functionally O 0 0.09111879765987396
oppose O 0 0.032331664115190506
each O 0 0.009114248678088188
other O 0 0.007822629064321518
in O 0 0.01380231324583292
testis O 1 0.9522410035133362
development O 0 0.029074721038341522
by O 0 0.025184690952301025
modulating O 1 0.9888352751731873
SF O 1 0.9999291896820068
- O 0 0.13267531991004944
1 O 0 0.058263882994651794
- O 0 0.12012802809476852
mediated O 0 0.23527686297893524
transactivation O 1 0.6495723724365234
. O 0 0.027826422825455666
. O 0 0.03098651021718979

A O 0 0.06030520051717758
mouse O 0 0.12821762263774872
model O 0 0.05124259740114212
for O 0 0.035164836794137955
Prader B-Disease 1 1.0
- I-Disease 1 0.9999940395355225
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9997757077217102
- O 1 0.5009328722953796
centre O 0 0.0933779925107956
mutations O 0 0.14972910284996033
. O 0 0.033484168350696564

Imprinting O 0 0.2471708357334137
in O 0 0.021200837567448616
the O 0 0.022166995331645012
15q11 O 1 0.5686323642730713
- O 0 0.10180721431970596
q13 O 0 0.1719430685043335
region O 0 0.05124257877469063
involves O 0 0.055858761072158813
an O 0 0.02929835580289364
imprinting O 1 0.5561397075653076
centre O 0 0.09201232343912125
( O 0 0.05513500049710274
IC O 1 0.9973645806312561
) O 0 0.0232995618134737
, O 0 0.009829280897974968
mapping O 0 0.03133537247776985
in O 0 0.008408130146563053
part O 0 0.011419238522648811
to O 0 0.0073019759729504585
the O 0 0.01162504032254219
promoter O 0 0.08474992960691452
and O 0 0.010107920505106449
first O 0 0.015247131697833538
exon O 0 0.10201632976531982
of O 0 0.01978016272187233
SNRPN O 1 0.9893898367881775
. O 0 0.03604240342974663

Deletion O 0 0.17726993560791016
of O 0 0.019423771649599075
this O 0 0.026929104700684547
IC O 1 0.989535391330719
abolishes O 0 0.3320101797580719
local O 0 0.036729782819747925
paternally O 0 0.17533043026924133
derived O 0 0.059140194207429886
gene O 0 0.08391714096069336
expression O 0 0.03725193068385124
and O 0 0.011162529699504375
results O 0 0.02857353538274765
in O 0 0.03035302832722664
Prader B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9107390642166138
PWS B-Disease 1 1.0
) O 0 0.05381852388381958
. O 0 0.02812054567039013

We O 0 0.02011006884276867
have O 0 0.010866571217775345
created O 0 0.018814966082572937
two O 0 0.013859632425010204
deletion O 0 0.15151187777519226
mutations O 0 0.12930727005004883
in O 0 0.023320427164435387
mice O 0 0.11938537657260895
to O 0 0.018502462655305862
understand O 0 0.05749177932739258
PWS B-Disease 1 0.9999998807907104
and O 0 0.011703770607709885
the O 0 0.010045778937637806
mechanism O 0 0.03952452540397644
of O 0 0.009956633672118187
this O 0 0.016660846769809723
IC O 1 0.9924072623252869
. O 0 0.032297633588314056

Mice O 1 0.8065361380577087
harbouring O 1 0.8326436877250671
an O 0 0.03978802636265755
intragenic O 1 0.8259985446929932
deletion O 0 0.1429537534713745
in O 0 0.02572808787226677
Snrpn O 0 0.44433802366256714
are O 0 0.019186364486813545
phenotypically O 0 0.2580588161945343
normal O 0 0.04991074651479721
, O 0 0.014252635650336742
suggesting O 0 0.03699514642357826
that O 0 0.014064790681004524
mutations O 0 0.07868415862321854
of O 0 0.01313499640673399
SNRPN O 1 0.9182906746864319
are O 0 0.007886759005486965
not O 0 0.007814306765794754
sufficient O 0 0.025446197018027306
to O 0 0.022933779284358025
induce O 1 0.9857556223869324
PWS B-Disease 1 0.9999997615814209
. O 0 0.050858546048402786

Mice O 0 0.17358385026454926
with O 0 0.018379895016551018
a O 0 0.022319115698337555
larger O 0 0.03275055065751076
deletion O 0 0.11169663071632385
involving O 0 0.03501996770501137
both O 0 0.015126721002161503
Snrpn O 0 0.40577876567840576
and O 0 0.014331908896565437
the O 0 0.022957155480980873
putative O 1 0.9978284239768982
PWS O 1 1.0
- O 1 0.9808254837989807
IC O 1 0.9960881471633911
lack O 0 0.0409974530339241
expression O 0 0.03257521614432335
of O 0 0.00854548905044794
the O 0 0.017592107877135277
imprinted O 0 0.1720835417509079
genes O 0 0.10994482040405273
Zfp127 O 1 0.8757876753807068
( O 0 0.05441637709736824
mouse O 0 0.14038784801959991
homologue O 0 0.183311328291893
of O 0 0.02473827823996544
ZNF127 O 1 0.9817195534706116
) O 0 0.03230300545692444
, O 0 0.02243041805922985
Ndn O 1 0.9992414712905884
and O 0 0.022759700194001198
Ipw O 0 0.3672398626804352
, O 0 0.01312278863042593
and O 0 0.010503789409995079
manifest O 0 0.042694125324487686
several O 0 0.013546834699809551
phenotypes O 0 0.13837367296218872
common O 0 0.041701193898916245
to O 0 0.03514872491359711
PWS B-Disease 1 1.0
infants O 1 0.9996705055236816
. O 0 0.043504662811756134

These O 0 0.013738532550632954
data O 0 0.013444758020341396
demonstrate O 0 0.02013162337243557
that O 0 0.004935166798532009
both O 0 0.004668314475566149
the O 0 0.006492063868790865
position O 0 0.011432702653110027
of O 0 0.006323421373963356
the O 0 0.011828744783997536
IC O 1 0.9918397665023804
and O 0 0.007269298657774925
its O 0 0.007597451563924551
role O 0 0.014881912618875504
in O 0 0.0076666902750730515
the O 0 0.009911727160215378
coordinate O 0 0.051780037581920624
expression O 0 0.03074861876666546
of O 0 0.010283761657774448
genes O 0 0.04011944308876991
is O 0 0.015531226061284542
conserved O 0 0.03798416256904602
between O 0 0.017138032242655754
mouse O 0 0.07819528877735138
and O 0 0.009674355387687683
human O 0 0.01613335683941841
, O 0 0.0077550821006298065
and O 0 0.007675024215131998
indicate O 0 0.0202555600553751
that O 0 0.005994636099785566
the O 0 0.011200559325516224
mouse O 0 0.07776740938425064
is O 0 0.012551714666187763
a O 0 0.013751992024481297
suitable O 0 0.031415048986673355
model O 0 0.02613409236073494
system O 0 0.01685747504234314
in O 0 0.005773167125880718
which O 0 0.006508754100650549
to O 0 0.006633591838181019
investigate O 0 0.025758670642971992
the O 0 0.011271758936345577
molecular O 0 0.048549726605415344
mechanisms O 0 0.04023955389857292
of O 0 0.011726295575499535
imprinting O 0 0.1352594941854477
in O 0 0.01114233210682869
this O 0 0.006816547829657793
region O 0 0.017912941053509712
of O 0 0.007032835390418768
the O 0 0.012411551550030708
genome O 0 0.0647667646408081
. O 0 0.01560517493635416
. O 0 0.02352689579129219

Mutations O 0 0.12769795954227448
of O 0 0.014100859872996807
the O 0 0.020710084587335587
ATM O 0 0.17819909751415253
gene O 0 0.09735992550849915
detected O 0 0.08161530643701553
in O 0 0.01998027227818966
Japanese O 1 0.8113736510276794
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999830722808838
telangiectasia I-Disease 1 1.0
patients O 1 0.9999974966049194
: O 0 0.027115890756249428
possible O 0 0.021978480741381645
preponderance O 0 0.09396565705537796
of O 0 0.007844709791243076
the O 0 0.009569472633302212
two O 0 0.013504537753760815
founder O 0 0.07799152284860611
mutations O 0 0.1521904468536377
4612del165 O 0 0.18137426674365997
and O 0 0.02657405473291874
7883del5 O 0 0.18638409674167633
. O 0 0.03802535682916641

The O 0 0.03512880951166153
ATM O 0 0.16303135454654694
( O 0 0.04431577026844025
A O 1 0.8051513433456421
- O 1 0.9872491955757141
T O 1 0.999966025352478
, O 0 0.02540098875761032
mutated O 0 0.13395710289478302
) O 0 0.03307501599192619
gene O 0 0.0611431747674942
on O 0 0.015075021423399448
human O 0 0.04251750558614731
chromosome O 0 0.18156510591506958
11q22 O 0 0.21387910842895508
. O 0 0.03614635393023491

3 O 0 0.04357423260807991
has O 0 0.015873031690716743
recently O 0 0.022727064788341522
been O 0 0.010390393435955048
identified O 0 0.015121295116841793
as O 0 0.006996790878474712
the O 0 0.010039403103291988
gene O 0 0.04734625294804573
responsible O 0 0.02062920108437538
for O 0 0.007182643283158541
the O 0 0.013238085433840752
human O 0 0.07094382494688034
recessive B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999585151672363
telangiectasia I-Disease 1 0.9999991655349731
( O 0 0.08630762994289398
A B-Disease 1 0.9894864559173584
- I-Disease 1 0.9914064407348633
T I-Disease 1 0.9999575614929199
) O 0 0.030743416398763657
. O 0 0.02583981491625309

In O 0 0.014695415273308754
order O 0 0.010999873280525208
to O 0 0.008010606281459332
define O 0 0.02386259101331234
the O 0 0.011129447259008884
types O 0 0.02901206724345684
of O 0 0.01780223846435547
disease O 1 0.9999998807907104
- O 1 0.8313558101654053
causing O 1 0.5851801633834839
ATM O 0 0.22397677600383759
mutations O 0 0.09400219470262527
in O 0 0.0135572524741292
Japanese O 0 0.04442884027957916
A B-Disease 1 0.9894864559173584
- I-Disease 1 0.999861478805542
T I-Disease 1 0.9999995231628418
patients O 1 0.9998155236244202
as O 0 0.009312630631029606
well O 0 0.0073465914465487
as O 0 0.005523766856640577
to O 0 0.006657698191702366
look O 0 0.018693866208195686
for O 0 0.01122364867478609
possible O 0 0.0359194315969944
mutational O 1 0.9914008975028992
hotspots O 0 0.27523016929626465
, O 0 0.025887053459882736
reverse O 0 0.08780865371227264
- O 0 0.10021937638521194
transcribed O 0 0.09633936733007431
RNA O 0 0.0981365293264389
derived O 0 0.037045788019895554
from O 0 0.015713442116975784
ten O 0 0.02370149828493595
patients O 1 0.9910500049591064
belonging O 0 0.02857610210776329
to O 0 0.008606006391346455
eight O 0 0.01648239977657795
unrelated O 0 0.04304609075188637
Japanese O 0 0.044265128672122955
A B-Disease 1 0.9059858322143555
- I-Disease 1 0.9867636561393738
T I-Disease 1 0.9999654293060303
families O 0 0.03113262541592121
was O 0 0.01757378876209259
analyzed O 0 0.03523537889122963
for O 0 0.012621834874153137
mutations O 0 0.07222849130630493
by O 0 0.010792016051709652
the O 0 0.02024669758975506
restriction O 0 0.0837821215391159
endonuclease O 1 0.7557247877120972
fingerprinting O 0 0.13778164982795715
method O 0 0.05413985624909401
. O 0 0.028255321085453033

As O 0 0.020348021760582924
has O 0 0.014925925061106682
been O 0 0.013231025077402592
reported O 0 0.02275073155760765
by O 0 0.010795703157782555
others O 0 0.020292384549975395
, O 0 0.015536806546151638
mutations O 0 0.07114118337631226
that O 0 0.011649996042251587
lead O 0 0.02615569718182087
to O 0 0.016277644783258438
exon O 0 0.13879600167274475
skipping O 0 0.13603736460208893
or O 0 0.04584862291812897
premature O 1 0.7578717470169067
protein O 0 0.08330144733190536
truncation O 0 0.11004187166690826
were O 0 0.01184198446571827
also O 0 0.012149812653660774
predominant O 0 0.04552854970097542
in O 0 0.013017862103879452
our O 0 0.022367706522345543
mutants O 0 0.12255141884088516
. O 0 0.031185872852802277

Six O 0 0.03516129404306412
different O 0 0.017708584666252136
mutations O 0 0.07729838788509369
were O 0 0.00910319946706295
identified O 0 0.016668276861310005
on O 0 0.006993704009801149
12 O 0 0.012233540415763855
of O 0 0.0059698461554944515
the O 0 0.01209743320941925
16 O 0 0.03509417548775673
alleles O 0 0.16191497445106506
examined O 0 0.0909983292222023
. O 0 0.03489483892917633

Four O 0 0.02455737814307213
were O 0 0.015404331497848034
deletions O 0 0.07759194076061249
involving O 0 0.034272853285074234
a O 0 0.019829142838716507
loss O 0 0.03748725354671478
of O 0 0.009444530121982098
a O 0 0.02251489646732807
single O 0 0.04431037977337837
exon O 0 0.1607176661491394
exon O 0 0.16125281155109406
7 O 0 0.04373323544859886
, O 0 0.018403219059109688
exon O 0 0.11592686921358109
16 O 0 0.03236301615834236
, O 0 0.01927957497537136
exon O 0 0.1256999969482422
33 O 0 0.05145188421010971
or O 0 0.027691734954714775
exon O 0 0.1455041468143463
35 O 0 0.056134339421987534
. O 0 0.031347986310720444

The O 0 0.019866961985826492
others O 0 0.019509509205818176
were O 0 0.01116055715829134
minute O 0 0.04311198368668556
deletions O 0 0.09146210551261902
, O 0 0.021353770047426224
4649delA O 0 0.12394078820943832
in O 0 0.019121438264846802
exon O 0 0.13340890407562256
33 O 0 0.04809099808335304
and O 0 0.016649512574076653
7883del5 O 0 0.1288672834634781
in O 0 0.023468373343348503
exon O 0 0.144536554813385
55 O 0 0.07138393074274063
. O 0 0.03251954913139343

The O 0 0.046053696423769
mutations O 0 0.17126189172267914
4612del165 O 0 0.16928841173648834
and O 0 0.020508477464318275
7883del5 O 0 0.11284810304641724
were O 0 0.008905241265892982
found O 0 0.010737652890384197
in O 0 0.00524834543466568
more O 0 0.00538532854989171
than O 0 0.006758055649697781
two O 0 0.008859163150191307
unrelated O 0 0.043475523591041565
families O 0 0.03240644186735153
; O 0 0.0204654298722744
44 O 0 0.03146529197692871
% O 0 0.02310440130531788
( O 0 0.019678382202982903
7 O 0 0.015781227499246597
of O 0 0.0064359065145254135
16 O 0 0.016973786056041718
) O 0 0.01099955104291439
of O 0 0.0057659512385725975
the O 0 0.012175227515399456
mutant O 0 0.09206975996494293
alleles O 0 0.1123289167881012
had O 0 0.015061786398291588
one O 0 0.007596320006996393
of O 0 0.005269333254545927
the O 0 0.009383158758282661
two O 0 0.01473493967205286
mutations O 0 0.11052386462688446
. O 0 0.031197115778923035

The O 0 0.04727035388350487
4612del165 O 0 0.39642152190208435
mutations O 0 0.1044851541519165
in O 0 0.011630585417151451
three O 0 0.007840627804398537
different O 0 0.0069056302309036255
families O 0 0.013670251704752445
were O 0 0.00528300553560257
all O 0 0.005176642443984747
ascribed O 0 0.03547130525112152
to O 0 0.008218166418373585
the O 0 0.010568085126578808
same O 0 0.02687971666455269
T O 1 0.9999896287918091
- O 1 0.598117470741272
- O 0 0.12239354103803635
> O 0 0.13973386585712433
A O 0 0.036072224378585815
substitution O 0 0.058610767126083374
at O 0 0.022465920075774193
the O 0 0.01776561513543129
splice O 0 0.17305606603622437
donor O 0 0.12548305094242096
site O 0 0.03480665013194084
in O 0 0.019897345453500748
intron O 1 0.8923824429512024
33 O 0 0.07664893567562103
. O 0 0.03402756154537201

Microsatellite O 1 0.736173689365387
genotyping O 0 0.23466935753822327
around O 0 0.03356938809156418
the O 0 0.022403361275792122
ATM O 0 0.14460992813110352
locus O 0 0.11068369448184967
also O 0 0.01565975323319435
indicated O 0 0.02748260833323002
that O 0 0.0070961457677185535
a O 0 0.01574891060590744
common O 0 0.03524041175842285
haplotype O 1 0.9868282079696655
was O 0 0.016926396638154984
shared O 0 0.018888985738158226
by O 0 0.008620535023510456
the O 0 0.013240939937531948
mutant O 0 0.11228206753730774
alleles O 0 0.12997369468212128
in O 0 0.01749594509601593
both O 0 0.02075674943625927
mutations O 0 0.12339920550584793
. O 0 0.034265268594026566

This O 0 0.018825270235538483
suggests O 0 0.027579290792346
that O 0 0.00616412004455924
these O 0 0.006007671821862459
two O 0 0.010781831108033657
founder O 0 0.06478790193796158
mutations O 0 0.10562282800674438
may O 0 0.020869404077529907
be O 0 0.009856974706053734
predominant O 0 0.05091118440032005
among O 0 0.020533328875899315
Japanese O 0 0.04640522599220276
ATM O 0 0.16713176667690277
mutant O 0 0.16047827899456024
alleles O 0 0.20855966210365295
. O 0 0.04988029599189758

W474C O 0 0.3135012090206146
amino O 0 0.1545218974351883
acid O 0 0.23177553713321686
substitution O 0 0.1216648519039154
affects O 0 0.10630955547094345
early O 0 0.021179107949137688
processing O 0 0.018076134845614433
of O 0 0.006827911362051964
the O 0 0.0133220748975873
alpha O 0 0.07691661268472672
- O 0 0.0736689567565918
subunit O 0 0.096547931432724
of O 0 0.018078098073601723
beta O 0 0.09822890907526016
- O 0 0.087668776512146
hexosaminidase O 0 0.1423283964395523
A O 0 0.026512881740927696
and O 0 0.01035928912460804
is O 0 0.013044188730418682
associated O 0 0.0230112187564373
with O 0 0.023438971489667892
subacute O 1 0.9999992847442627
G B-Disease 1 0.992957592010498
( I-Disease 0 0.05211752653121948
M2 I-Disease 1 0.9451075196266174
) I-Disease 0 0.045633431524038315
gangliosidosis I-Disease 1 0.5415196418762207
. O 0 0.029561098664999008

Mutations O 0 0.1594151258468628
in O 0 0.020340517163276672
the O 0 0.030089549720287323
HEXA O 1 0.9994339346885681
gene O 0 0.09733770042657852
, O 0 0.016768483445048332
encoding O 0 0.03422177582979202
the O 0 0.0173511765897274
alpha O 0 0.08258935064077377
- O 0 0.07733094692230225
subunit O 0 0.09963708370923996
of O 0 0.019503086805343628
beta O 0 0.09336846321821213
- O 0 0.09967414289712906
hexosaminidase O 0 0.17687319219112396
A O 0 0.042185187339782715
( O 0 0.03396710008382797
Hex O 0 0.09353163838386536
A O 0 0.02874714322388172
) O 0 0.01594163104891777
, O 0 0.00891921203583479
that O 0 0.00872976053506136
abolish O 0 0.0611485056579113
Hex O 0 0.09444258362054825
A O 0 0.04097330942749977
enzyme O 0 0.14156019687652588
activity O 0 0.11279024928808212
cause O 1 0.999962568283081
Tay B-Disease 1 1.0
- I-Disease 1 0.9999703168869019
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
( O 0 0.11333140730857849
TSD B-Disease 1 0.9999973773956299
) O 0 0.026745568960905075
, O 0 0.01266508735716343
the O 0 0.021522942930459976
fatal O 1 0.9999581575393677
infantile B-Disease 1 0.9999581575393677
form I-Disease 0 0.03337724506855011
of I-Disease 0 0.02100091241300106
G I-Disease 1 0.9602915644645691
( I-Disease 0 0.047731973230838776
M2 I-Disease 1 0.9602568745613098
) I-Disease 0 0.03873410448431969
gangliosidosis I-Disease 0 0.4184841215610504
, I-Disease 0 0.017196375876665115
Type I-Disease 0 0.0608624629676342
1 I-Disease 0 0.031731411814689636
. O 0 0.026617800816893578

Less O 0 0.0689019188284874
severe O 1 0.9999146461486816
, O 0 0.0410345122218132
subacute O 1 1.0
( O 0 0.3346811532974243
juvenile O 1 0.9999433755874634
- O 1 0.9941516518592834
onset O 1 0.9999842643737793
) O 0 0.03512638434767723
and O 0 0.024172790348529816
chronic O 1 1.0
( O 0 0.051506515592336655
adult O 0 0.17548391222953796
- O 1 0.9456462860107422
onset O 1 0.9998331069946289
) O 0 0.030314955860376358
variants O 0 0.03981228172779083
are O 0 0.008997716009616852
characterized O 0 0.04394296556711197
by O 0 0.00875571183860302
a O 0 0.01495868805795908
broad O 0 0.040328558534383774
spectrum O 0 0.05342087894678116
of O 0 0.013273724354803562
clinical O 1 0.9992617964744568
manifestations O 0 0.23726625740528107
and O 0 0.008348488248884678
are O 0 0.006406955886632204
associated O 0 0.01741967350244522
with O 0 0.013743806630373001
residual O 0 0.11047559231519699
levels O 0 0.04288536682724953
of O 0 0.011945245787501335
Hex O 0 0.10200101882219315
A O 0 0.04235382005572319
enzyme O 0 0.10782002657651901
activity O 0 0.047276098281145096
. O 0 0.027899473905563354

We O 0 0.027617020532488823
identified O 0 0.04032014682888985
a O 0 0.039865851402282715
1422 O 1 0.9997475743293762
G O 1 0.9991724491119385
- O 0 0.46167701482772827
- O 0 0.17767933011054993
> O 0 0.22912174463272095
C O 0 0.17734089493751526
( O 0 0.058307841420173645
amino O 0 0.10563743859529495
acid O 0 0.18302881717681885
W474C O 0 0.17944228649139404
) O 0 0.0261833555996418
substitution O 0 0.03934018313884735
in O 0 0.007183611858636141
the O 0 0.007036482449620962
first O 0 0.00950654223561287
position O 0 0.013349343091249466
of O 0 0.010587377473711967
exon O 0 0.10250036418437958
13 O 0 0.028088506311178207
of O 0 0.014906896278262138
HEXA O 1 0.9924443364143372
of O 0 0.01492159441113472
a O 0 0.022927826270461082
non O 0 0.05134110525250435
- O 0 0.08256367594003677
Jewish O 0 0.06180154159665108
proband O 1 0.6860151886940002
who O 0 0.041339341551065445
manifested O 0 0.16379575431346893
a O 0 0.053697939962148666
subacute O 1 0.9999914169311523
variant O 0 0.1650659739971161
of O 0 0.02651127055287361
G B-Disease 1 0.9312335848808289
( I-Disease 0 0.048985760658979416
M2 I-Disease 1 0.8981726169586182
) I-Disease 0 0.043379347771406174
gangliosidosis I-Disease 0 0.41336891055107117
. O 0 0.03453778475522995

On O 0 0.015798991546034813
the O 0 0.016669277101755142
second O 0 0.037214890122413635
maternally O 0 0.29037773609161377
inherited O 1 0.6059267520904541
allele O 0 0.15509741008281708
, O 0 0.016926756128668785
we O 0 0.009860879741609097
identified O 0 0.019066685810685158
the O 0 0.014185469597578049
common O 1 0.5686278939247131
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9562138915061951
causing O 0 0.37410688400268555
4 O 0 0.04476543143391609
- O 0 0.0905173048377037
bp O 0 0.1485438495874405
insertion O 0 0.16020458936691284
, O 0 0.03443329781293869
+ O 1 0.5173304080963135
TATC O 1 0.9948996901512146
1278 O 1 0.9630764722824097
, O 0 0.01946314610540867
in O 0 0.01606813818216324
exon O 0 0.13867096602916718
11 O 0 0.0412173829972744
. O 0 0.026613036170601845

Pulse O 1 0.9300063252449036
- O 0 0.13110069930553436
chase O 0 0.12415435165166855
analysis O 0 0.03754877299070358
using O 0 0.035261090844869614
proband O 1 0.820809543132782
fibroblasts O 1 0.5543968081474304
revealed O 0 0.03884616866707802
that O 0 0.008827690035104752
the O 0 0.014970693737268448
W474C O 0 0.24781674146652222
- O 0 0.07348071038722992
containing O 0 0.04133836179971695
alpha O 0 0.09820134192705154
- O 0 0.1153288260102272
subunit O 0 0.1515662670135498
precursor O 0 0.10510310530662537
was O 0 0.0293163750320673
normally O 0 0.049352340400218964
synthesized O 0 0.07807496935129166
, O 0 0.011277264915406704
but O 0 0.008789605461061
not O 0 0.010994582436978817
phosphorylated O 0 0.09416869282722473
or O 0 0.0254648607224226
secreted O 0 0.07618394494056702
, O 0 0.010901695117354393
and O 0 0.0083283307030797
the O 0 0.015505561605095863
mature O 0 0.09641536325216293
lysosomal O 1 0.993735134601593
alpha O 0 0.1255790889263153
- O 0 0.10355935990810394
subunit O 0 0.11935292184352875
was O 0 0.025242576375603676
not O 0 0.016258688643574715
detected O 0 0.08486444503068924
. O 0 0.027797270566225052

When O 0 0.0356992743909359
the O 0 0.022693516686558723
W474C O 0 0.18216392397880554
- O 0 0.07944867759943008
containing O 0 0.043188389390707016
alpha O 0 0.09037651866674423
- O 0 0.09938549995422363
subunit O 0 0.12999749183654785
was O 0 0.035890497267246246
transiently O 1 0.7407578229904175
co O 0 0.11034765839576721
- O 0 0.06576245278120041
expressed O 0 0.02531229890882969
with O 0 0.012143462896347046
the O 0 0.015429056249558926
beta O 0 0.07826821506023407
- O 0 0.07388803362846375
subunit O 0 0.08023045212030411
to O 0 0.01392295304685831
produce O 0 0.026827223598957062
Hex O 0 0.09037639945745468
A O 0 0.037484198808670044
( O 0 0.0418437160551548
alphabeta O 0 0.30083659291267395
) O 0 0.02526176907122135
in O 0 0.01908946968615055
COS O 1 0.9999221563339233
- O 0 0.09187871217727661
7 O 0 0.037670403718948364
cells O 0 0.05380736291408539
, O 0 0.011228042654693127
the O 0 0.013262193650007248
mature O 0 0.06687978655099869
alpha O 0 0.08079651743173599
- O 0 0.07747596502304077
subunit O 0 0.0871039405465126
was O 0 0.01795080117881298
present O 0 0.01332203857600689
, O 0 0.007227499969303608
but O 0 0.006109943147748709
its O 0 0.007347453851252794
level O 0 0.02135179005563259
was O 0 0.011340240016579628
much O 0 0.012815505266189575
lower O 0 0.023629695177078247
than O 0 0.00760916993021965
that O 0 0.0060843294486403465
from O 0 0.011779861524701118
normal O 0 0.04462816193699837
alpha O 0 0.0857672467827797
- O 0 0.09316273033618927
subunit O 0 0.15068165957927704
transfections O 0 0.17805203795433044
, O 0 0.015507609583437443
although O 0 0.013746300712227821
higher O 0 0.0182962566614151
than O 0 0.0076265097595751286
in O 0 0.008548404090106487
those O 0 0.013110902160406113
cells O 0 0.075729139149189
transfected O 0 0.29823875427246094
with O 0 0.01680007018148899
an O 0 0.019338097423315048
alpha O 0 0.08951647579669952
- O 0 0.09704633802175522
subunit O 0 0.11961300671100616
associated O 0 0.03636140748858452
with O 0 0.03419209271669388
infantile O 1 0.9999936819076538
TSD B-Disease 1 0.9999710321426392
. O 0 0.059706639498472214

Furthermore O 0 0.060998231172561646
, O 0 0.012095211073756218
the O 0 0.012395617552101612
precursor O 0 0.06169046089053154
level O 0 0.02445247769355774
of O 0 0.00753262871876359
the O 0 0.019152063876390457
W474C O 0 0.1903379261493683
alpha O 0 0.10599789768457413
- O 0 0.0804208442568779
subunit O 0 0.09446199983358383
was O 0 0.01901155151426792
found O 0 0.014686932787299156
to O 0 0.010378172621130943
accumulate O 0 0.0546882227063179
in O 0 0.009795358404517174
comparison O 0 0.02056540548801422
to O 0 0.008238077163696289
the O 0 0.012831078842282295
normal O 0 0.05833030492067337
alpha O 0 0.09223105013370514
- O 0 0.10187345743179321
subunit O 0 0.15671919286251068
precursor O 0 0.1341097503900528
levels O 0 0.07421630620956421
. O 0 0.03290138021111488

We O 0 0.021692901849746704
conclude O 0 0.04688212275505066
that O 0 0.010261359624564648
the O 0 0.01995045877993107
1422 O 1 0.9999059438705444
G O 1 0.9995835423469543
- O 1 0.754055917263031
- O 0 0.1873083859682083
> O 0 0.3190881907939911
C O 0 0.19701731204986572
mutation O 0 0.11974596977233887
is O 0 0.015258505940437317
the O 0 0.01120919082313776
cause O 0 0.04238855466246605
of O 0 0.013356694020330906
Hex B-Disease 0 0.1253827065229416
A I-Disease 0 0.06576687097549438
enzyme I-Disease 1 0.9998527765274048
deficiency I-Disease 1 1.0
in O 0 0.019022395834326744
the O 0 0.020462412387132645
proband O 1 0.9587611556053162
. O 0 0.03734854608774185

The O 0 0.03756963461637497
resulting O 0 0.08219083398580551
W474C O 0 0.22426262497901917
substitution O 0 0.09603597968816757
clearly O 0 0.040967412292957306
interferes O 0 0.11690446734428406
with O 0 0.02033321000635624
alpha O 0 0.08287334442138672
- O 0 0.08596187829971313
subunit O 0 0.10588326305150986
processing O 0 0.0310713741928339
, O 0 0.0100239934399724
but O 0 0.007958455011248589
because O 0 0.010225203819572926
the O 0 0.011118746362626553
base O 0 0.0366194061934948
substitution O 0 0.07147745788097382
falls O 0 0.06359951943159103
at O 0 0.012796360068023205
the O 0 0.00733544398099184
first O 0 0.010021155700087547
position O 0 0.015580217353999615
of O 0 0.012336826883256435
exon O 0 0.11900199949741364
13 O 0 0.03941762074828148
, O 0 0.02365669421851635
aberrant O 0 0.16468778252601624
splicing O 0 0.11054830253124237
may O 0 0.023238101974129677
also O 0 0.011332286521792412
contribute O 0 0.03402070328593254
to O 0 0.013938580639660358
Hex B-Disease 0 0.1212494745850563
A I-Disease 0 0.06078128144145012
deficiency I-Disease 1 0.9999996423721313
in O 0 0.015827301889657974
this O 0 0.01382426917552948
proband O 1 0.7864400148391724
. O 0 0.01584744267165661
. O 0 0.020893177017569542

Two O 0 0.03608100488781929
frequent O 0 0.10987821221351624
missense O 0 0.3860715925693512
mutations O 0 0.19642505049705505
in O 0 0.04321283474564552
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 0.04916969686746597

Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
is O 0 0.03877521678805351
an O 0 0.048183027654886246
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9990414977073669
by O 0 0.02228875271975994
early O 0 0.05759397894144058
childhood O 1 0.9999954700469971
deafness B-Disease 1 1.0
and O 0 0.04429700970649719
goiter B-Disease 1 1.0
. O 0 0.047467511147260666

A O 0 0.03615967929363251
century O 0 0.02272963523864746
after O 0 0.018425412476062775
its O 0 0.011808156035840511
recognition O 0 0.026601547375321388
as O 0 0.014207263477146626
a O 0 0.03730899468064308
syndrome O 1 1.0
by O 0 0.02453433908522129
Vaughan O 1 0.5195633172988892
Pendred O 1 0.9596430063247681
, O 0 0.01759599708020687
the O 0 0.028572196140885353
disease O 1 0.9999972581863403
gene O 0 0.14642852544784546
( O 0 0.053996492177248
PDS O 1 0.9998008608818054
) O 0 0.023802444338798523
was O 0 0.017640793696045876
mapped O 0 0.05054338276386261
to O 0 0.02211369201540947
chromosome O 0 0.1690746545791626
7q22 O 1 0.7579478025436401
- O 0 0.1451192945241928
q31 O 0 0.20874112844467163
. O 0 0.042355507612228394

1 O 0 0.033836521208286285
and O 0 0.011102516204118729
, O 0 0.010266735218465328
recently O 0 0.020830655470490456
, O 0 0.008597861044108868
found O 0 0.011525769717991352
to O 0 0.007545522879809141
encode O 0 0.03640350326895714
a O 0 0.03507096320390701
putative O 0 0.2543138265609741
sulfate O 1 0.9995666146278381
transporter O 1 0.9519085884094238
. O 0 0.04233004152774811

We O 0 0.03176286071538925
performed O 0 0.04525889828801155
mutation O 0 0.10713236033916473
analysis O 0 0.021967435255646706
of O 0 0.009415943175554276
the O 0 0.020647889003157616
PDS B-Disease 1 0.9999452829360962
gene O 0 0.10174597054719925
in O 0 0.02496381662786007
patients O 1 0.9993576407432556
from O 0 0.01934804394841194
14 O 0 0.035303905606269836
Pendred B-Disease 1 0.9316688776016235
families O 0 0.03287900611758232
originating O 0 0.040121205151081085
from O 0 0.011301524005830288
seven O 0 0.012894591316580772
countries O 0 0.010806718841195107
and O 0 0.008619976229965687
identified O 0 0.023723041638731956
all O 0 0.01332168746739626
mutations O 0 0.11147841811180115
. O 0 0.03017001785337925

The O 0 0.034613803029060364
mutations O 0 0.10516943037509918
include O 0 0.016758369281888008
three O 0 0.012628087773919106
single O 0 0.032492198050022125
base O 0 0.04095767065882683
deletions O 0 0.0816652923822403
, O 0 0.016035133972764015
one O 0 0.019048381596803665
splice O 0 0.16292838752269745
site O 0 0.047680921852588654
mutation O 0 0.1285809427499771
and O 0 0.01917031966149807
10 O 0 0.04147486016154289
missense O 0 0.23534420132637024
mutations O 0 0.16149233281612396
. O 0 0.036809056997299194

One O 0 0.05753130093216896
missense O 0 0.29604318737983704
mutation O 0 0.2277410328388214
( O 0 0.05936483293771744
L236P O 0 0.172429621219635
) O 0 0.01947733759880066
was O 0 0.012633772566914558
found O 0 0.011874278075993061
in O 0 0.00805717334151268
a O 0 0.0167889054864645
homozygous O 0 0.0719161406159401
state O 0 0.01077287271618843
in O 0 0.008616949431598186
two O 0 0.012567728757858276
consanguineous O 1 0.7211729884147644
families O 0 0.026039257645606995
and O 0 0.008253323845565319
in O 0 0.008209025487303734
a O 0 0.014999297447502613
heterozygous O 0 0.06431623548269272
state O 0 0.00938983540982008
in O 0 0.007741143461316824
five O 0 0.011502319946885109
additional O 0 0.024520697072148323
non O 0 0.058691829442977905
- O 0 0.12065429985523224
consanguineous O 1 0.9479749798774719
families O 0 0.05330134928226471
. O 0 0.03221491351723671

Another O 0 0.09368006885051727
missense O 0 0.42117395997047424
mutation O 0 0.2436959445476532
( O 0 0.061100468039512634
T416P O 0 0.22628071904182434
) O 0 0.02040308341383934
was O 0 0.012536488473415375
found O 0 0.012126520276069641
in O 0 0.007654685061424971
a O 0 0.013968531973659992
homozygous O 0 0.06806381791830063
state O 0 0.010090887546539307
in O 0 0.007373974192887545
one O 0 0.008865932002663612
family O 0 0.015383010730147362
and O 0 0.0070293801836669445
in O 0 0.008380135521292686
a O 0 0.017359534278512
heterozygous O 0 0.077617347240448
state O 0 0.010674696415662766
in O 0 0.00807472225278616
four O 0 0.013356555253267288
families O 0 0.030194517225027084
. O 0 0.02832680195569992

Pendred B-Disease 1 0.9989321827888489
patients O 1 0.9988922476768494
in O 0 0.014645387418568134
three O 0 0.01452814880758524
non O 0 0.05207652226090431
- O 0 0.12446865439414978
consanguineous O 1 0.9200891256332397
families O 0 0.032805055379867554
were O 0 0.009705607779324055
shown O 0 0.018126223236322403
to O 0 0.009174671955406666
be O 0 0.01240965723991394
compound O 0 0.0797644779086113
heterozygotes O 1 0.7083328366279602
for O 0 0.017659222707152367
L236P O 0 0.1335199624300003
and O 0 0.020863907411694527
T416P O 0 0.1807939112186432
. O 0 0.031858544796705246

In O 0 0.01730111613869667
total O 0 0.01804945431649685
, O 0 0.00912414863705635
one O 0 0.008681676350533962
or O 0 0.009636891074478626
both O 0 0.006341709289699793
of O 0 0.006473997607827187
these O 0 0.009475691244006157
mutations O 0 0.06298907846212387
were O 0 0.0071127149276435375
found O 0 0.010003158822655678
in O 0 0.006199984345585108
nine O 0 0.009787600487470627
of O 0 0.005272268783301115
the O 0 0.009914478287100792
14 O 0 0.022148003801703453
families O 0 0.02997630089521408
analyzed O 0 0.05797604098916054
. O 0 0.02802279405295849

The O 0 0.020410383120179176
identification O 0 0.026359843090176582
of O 0 0.008332228288054466
two O 0 0.014489587396383286
frequent O 0 0.08347713202238083
PDS B-Disease 1 0.9999229907989502
mutations O 0 0.10852083563804626
will O 0 0.013322771526873112
facilitate O 0 0.029852358624339104
the O 0 0.018969561904668808
molecular O 0 0.09585530310869217
diagnosis O 1 0.9999948740005493
of O 0 0.03570164367556572
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.05157152935862541

Insertional O 1 0.7252622842788696
mutation O 0 0.19253656268119812
by O 0 0.03214007243514061
transposable O 1 0.6888355016708374
element O 0 0.06894072145223618
, O 0 0.023268288001418114
L1 O 1 0.9858065247535706
, O 0 0.011675840243697166
in O 0 0.011816299520432949
the O 0 0.026271885260939598
DMD B-Disease 1 1.0
gene O 0 0.09048484265804291
results O 0 0.026110773906111717
in O 0 0.013392018154263496
X B-Disease 1 0.9773312211036682
- I-Disease 1 0.518092155456543
linked I-Disease 1 0.8836272954940796
dilated I-Disease 1 0.9999990463256836
cardiomyopathy I-Disease 1 1.0
. O 0 0.058726321905851364

X B-Disease 1 0.9796120524406433
- I-Disease 1 0.6449710130691528
linked I-Disease 1 0.9319656491279602
dilated I-Disease 1 0.9999958276748657
cardiomyopathy I-Disease 1 1.0
( O 0 0.08849464356899261
XLDCM B-Disease 1 0.9995429515838623
) O 0 0.022097837179899216
is O 0 0.011178189888596535
a O 0 0.021302059292793274
clinical O 1 0.9927318692207336
phenotype O 1 0.8664315342903137
of O 0 0.01669529266655445
dystrophinopathy B-Disease 1 0.6182828545570374
which O 0 0.011972679756581783
is O 0 0.014517326839268208
characterized O 0 0.05761091038584709
by O 0 0.018083805218338966
preferential O 1 0.9990624785423279
myocardial B-Disease 1 0.9999998807907104
involvement I-Disease 0 0.15766243636608124
without O 0 0.017800597473978996
any O 0 0.015025017783045769
overt O 0 0.11485586315393448
clinical O 1 0.998788058757782
signs O 0 0.06529749184846878
of O 0 0.023898513987660408
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.05782794579863548

To O 0 0.018960874527692795
date O 0 0.01637290231883526
, O 0 0.009562568739056587
several O 0 0.012461951933801174
mutations O 0 0.07375136762857437
in O 0 0.01737888716161251
the O 0 0.03621308505535126
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9517266154289246
, O 0 0.044944338500499725
DMD O 1 1.0
, O 0 0.014573289081454277
have O 0 0.0078004696406424046
been O 0 0.009048262611031532
identified O 0 0.020639508962631226
in O 0 0.013925493694841862
patients O 1 0.9999523162841797
with O 0 0.015792667865753174
XLDCM B-Disease 1 0.999329686164856
, O 0 0.010701356455683708
but O 0 0.008253457024693489
a O 0 0.016426943242549896
pathogenic O 0 0.0913798063993454
correlation O 0 0.05561951547861099
of O 0 0.010676059871912003
these O 0 0.014489438384771347
cardiospecific O 1 0.9844127297401428
mutations O 0 0.1445850133895874
in O 0 0.029038695618510246
DMD O 1 1.0
with O 0 0.019555816426873207
the O 0 0.02326269820332527
XLDCM B-Disease 1 0.9996904134750366
phenotype O 1 0.9688754677772522
has O 0 0.0186400655657053
remained O 0 0.021068599075078964
to O 0 0.009417152032256126
be O 0 0.014395779930055141
elucidated O 0 0.12659354507923126
. O 0 0.032921988517045975

We O 0 0.020044513046741486
report O 0 0.01479561347514391
here O 0 0.008076016791164875
the O 0 0.0062980204820632935
identification O 0 0.01781735196709633
of O 0 0.006609391421079636
a O 0 0.017091212794184685
unique O 0 0.03998229652643204
de O 0 0.09455423802137375
novo O 0 0.2331382930278778
L1 O 1 0.97381591796875
insertion O 0 0.1310524046421051
in O 0 0.01470789685845375
the O 0 0.020063048228621483
muscle O 1 0.9984424710273743
exon O 0 0.14605742692947388
1 O 0 0.03980812430381775
in O 0 0.02676275186240673
DMD O 1 0.9999998807907104
in O 0 0.019206348806619644
three O 0 0.022240111604332924
XLDCM B-Disease 1 0.9999563694000244
patients O 1 0.9997583031654358
from O 0 0.01386911142617464
two O 0 0.010558467358350754
unrelated O 0 0.047283533960580826
Japanese O 0 0.036990225315093994
families O 0 0.03945520520210266
. O 0 0.02921544760465622

The O 0 0.03594920039176941
insertion O 0 0.12112035602331161
was O 0 0.02216639369726181
a O 0 0.020071929320693016
5 O 0 0.030554963275790215
- O 0 0.06389221549034119
truncated O 0 0.08229348808526993
form O 0 0.023296035826206207
of O 0 0.012390423566102982
human O 0 0.03575838729739189
L1 O 1 0.9699260592460632
inversely O 0 0.0994749590754509
integrated O 0 0.04710647463798523
in O 0 0.011093849316239357
the O 0 0.012963147833943367
5 O 0 0.037869758903980255
- O 0 0.0768536850810051
untranslated O 0 0.13391783833503723
region O 0 0.03701651841402054
in O 0 0.014172371476888657
the O 0 0.02157871052622795
muscle O 1 0.998176097869873
exon O 0 0.14428329467773438
1 O 0 0.02695678174495697
, O 0 0.011284858919680119
which O 0 0.009519086219370365
affected O 0 0.03520907834172249
the O 0 0.015766184777021408
transcription O 0 0.06222064420580864
or O 0 0.013335634022951126
the O 0 0.010251155123114586
stability O 0 0.028182892128825188
of O 0 0.008103693835437298
the O 0 0.015326851047575474
muscle O 1 0.9987362027168274
form O 0 0.02495047263801098
of O 0 0.014186409302055836
dystrophin O 1 0.9994156360626221
transcripts O 0 0.04647120460867882
but O 0 0.008182266727089882
not O 0 0.004846333991736174
that O 0 0.004217986948788166
of O 0 0.006452436093240976
the O 0 0.018439242616295815
brain O 1 0.9997190833091736
or O 0 0.04272756353020668
Purkinje O 1 0.9999650716781616
cell O 0 0.08442340046167374
form O 0 0.019982486963272095
, O 0 0.009807974100112915
probably O 0 0.017277320846915245
due O 0 0.010746440850198269
to O 0 0.005316939204931259
its O 0 0.007207958493381739
unique O 0 0.019401898607611656
site O 0 0.01599247381091118
of O 0 0.00872895959764719
integration O 0 0.043760184198617935
. O 0 0.030569061636924744

We O 0 0.024309268221259117
speculate O 0 0.04671249911189079
that O 0 0.007083485368639231
this O 0 0.009033668786287308
insertion O 0 0.06689905375242233
of O 0 0.010666148737072945
an O 0 0.01920875906944275
L1 O 1 0.98977130651474
sequence O 0 0.057049740105867386
in O 0 0.03023340553045273
DMD O 1 0.9999998807907104
is O 0 0.018178734928369522
responsible O 0 0.01975921355187893
for O 0 0.005631527863442898
some O 0 0.00485467491671443
of O 0 0.0045403665862977505
the O 0 0.008203011006116867
population O 0 0.017757337540388107
of O 0 0.009505177848041058
Japanese O 0 0.043981876224279404
patients O 1 0.9999206066131592
with O 0 0.02212066948413849
XLDCM B-Disease 1 0.9995321035385132
. O 0 0.01949794590473175
. O 0 0.025027289986610413

Severe O 1 0.9999773502349854
early O 0 0.10070526599884033
- O 1 0.9995591044425964
onset O 1 0.9999996423721313
obesity B-Disease 1 1.0
, O 0 0.20278184115886688
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.025391338393092155
red O 1 0.9960086345672607
hair O 1 0.999962568283081
pigmentation O 1 0.9999991655349731
caused O 1 0.9106895327568054
by O 0 0.03540802374482155
POMC O 1 0.999975323677063
mutations O 0 0.1395609825849533
in O 0 0.020479723811149597
humans O 0 0.04892983287572861
. O 0 0.02844564989209175

Sequential O 0 0.12410812079906464
cleavage O 0 0.15470699965953827
of O 0 0.012690799310803413
the O 0 0.018200818449258804
precursor O 0 0.10478701442480087
protein O 0 0.07890283316373825
pre O 0 0.10420072078704834
- O 0 0.0992099791765213
pro O 0 0.07910764217376709
- O 0 0.13440996408462524
opiomelanocortin O 1 0.6949604153633118
( O 0 0.08075118809938431
POMC O 1 0.9968690276145935
) O 0 0.041510943323373795
generates O 0 0.07245072722434998
the O 0 0.031326260417699814
melanocortin O 1 0.99491286277771
peptides O 0 0.21889401972293854
adrenocorticotrophin O 1 0.8131300210952759
( O 0 0.07243037968873978
ACTH O 1 0.9998373985290527
) O 0 0.04307973384857178
, O 0 0.03020656108856201
melanocyte O 1 0.9997593760490417
- O 0 0.20112694799900055
stimulating O 1 0.6849639415740967
hormones O 1 0.5672706961631775
( O 0 0.0816422626376152
MSH O 1 0.9999581575393677
) O 0 0.037218619138002396
alpha O 0 0.06136053055524826
, O 0 0.01526790950447321
beta O 0 0.058160293847322464
and O 0 0.013964926823973656
gamma O 0 0.07136154174804688
as O 0 0.00938404444605112
well O 0 0.00896825734525919
as O 0 0.009615752846002579
the O 0 0.022586453706026077
opioid O 1 0.9984660148620605
- O 0 0.18645530939102173
receptor O 0 0.2855641841888428
ligand O 0 0.3342486321926117
beta O 0 0.15770940482616425
- O 0 0.18435010313987732
endorphin O 1 0.986578106880188
. O 0 0.050701599568128586

While O 0 0.023498957976698875
a O 0 0.016856083646416664
few O 0 0.012909847311675549
cases O 0 0.02193421870470047
of O 0 0.01630735769867897
isolated O 1 0.9984304308891296
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.014579014852643013
been O 0 0.016770167276263237
reported O 0 0.038611073046922684
( O 0 0.05048803612589836
OMIM O 1 0.9999860525131226
201400 O 1 0.8666064143180847
) O 0 0.021364739164710045
, O 0 0.011412043124437332
an O 0 0.021340036764740944
inherited O 1 0.9996998310089111
POMC O 1 0.9999997615814209
defect O 1 0.9997946619987488
has O 0 0.016371259465813637
not O 0 0.0071238563396036625
been O 0 0.010650440119206905
described O 0 0.023710323497653008
so O 0 0.01563958078622818
far O 0 0.021503210067749023
. O 0 0.02185874432325363

Recent O 0 0.04609539359807968
studies O 0 0.034478429704904556
in O 0 0.014230898581445217
animal O 0 0.04160035029053688
models O 0 0.03844699263572693
elucidated O 0 0.09021357446908951
a O 0 0.016639117151498795
central O 0 0.01692592166364193
role O 0 0.018995294347405434
of O 0 0.01356241013854742
alpha O 0 0.09282932430505753
- O 0 0.13706335425376892
MSH O 1 0.9995275735855103
in O 0 0.013467807322740555
the O 0 0.012056108564138412
regulation O 0 0.03482763096690178
of O 0 0.0099470354616642
food O 0 0.03248584270477295
intake O 0 0.10256132483482361
by O 0 0.013252007775008678
activation O 0 0.07843396067619324
of O 0 0.010651801712810993
the O 0 0.022951651364564896
brain O 1 0.9994373917579651
melanocortin O 1 0.9999583959579468
- O 0 0.13676582276821136
4 O 0 0.05640995129942894
- O 0 0.126516655087471
receptor O 0 0.2506963908672333
( O 0 0.08418123424053192
MC4 O 1 0.999994158744812
- O 0 0.18841493129730225
R O 0 0.19141624867916107
; O 0 0.04165545850992203
refs O 0 0.1700010448694229
3 O 0 0.039771903306245804
- O 0 0.06607913970947266
5 O 0 0.02658405900001526
) O 0 0.01462310180068016
and O 0 0.0068470025435090065
the O 0 0.012991707772016525
linkage O 0 0.0913110226392746
of O 0 0.01472220104187727
human O 0 0.04326542094349861
obesity B-Disease 1 0.9999778270721436
to O 0 0.023510005325078964
chromosome O 0 0.11089712381362915
2 O 0 0.02268240414559841
in O 0 0.010477709583938122
close O 0 0.022379186004400253
proximity O 0 0.03510831668972969
to O 0 0.011546464636921883
the O 0 0.021838894113898277
POMC O 1 0.9998995065689087
locus O 0 0.13139136135578156
, O 0 0.01284939143806696
led O 0 0.017349468544125557
to O 0 0.006170643027871847
the O 0 0.006775091867893934
proposal O 0 0.015913140028715134
of O 0 0.006122171878814697
an O 0 0.011454053223133087
association O 0 0.03457440435886383
of O 0 0.01590310037136078
POMC O 1 0.9999901056289673
with O 0 0.023446394130587578
human O 0 0.053056925535202026
obesity B-Disease 1 0.9999982118606567
. O 0 0.03676963597536087

The O 0 0.024595007300376892
dual O 0 0.05674813315272331
role O 0 0.03119487501680851
of O 0 0.01875838078558445
alpha O 0 0.10921389609575272
- O 0 0.14447420835494995
MSH O 1 0.9994681477546692
in O 0 0.025253675878047943
regulating O 0 0.07966824620962143
food O 0 0.04844864830374718
intake O 0 0.13820785284042358
and O 0 0.019726334139704704
influencing O 0 0.1093878448009491
hair O 1 0.999546229839325
pigmentation O 1 0.999971866607666
predicts O 0 0.08988978713750839
that O 0 0.010324366390705109
the O 0 0.0152721107006073
phenotype O 1 0.8497190475463867
associated O 0 0.02372240461409092
with O 0 0.012220995500683784
a O 0 0.027173252776265144
defect O 1 0.9898725748062134
in O 0 0.02821389026939869
POMC O 1 0.9999415874481201
function O 0 0.038858916610479355
would O 0 0.013297151774168015
include O 0 0.027095837518572807
obesity B-Disease 1 0.9999971389770508
, O 0 0.020595913752913475
alteration O 0 0.07880419492721558
in O 0 0.01985246129333973
pigmentation O 1 0.9999977350234985
and O 0 0.04931247979402542
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04278247803449631

The O 0 0.023457692936062813
observation O 0 0.061322927474975586
of O 0 0.01128147542476654
these O 0 0.012902205809950829
symptoms O 1 0.9999853372573853
in O 0 0.010663552209734917
two O 0 0.01189102977514267
probands O 1 0.9299011826515198
prompted O 0 0.05384035408496857
us O 0 0.023602614179253578
to O 0 0.009346961975097656
search O 0 0.020640118047595024
for O 0 0.011946950107812881
mutations O 0 0.0792168378829956
within O 0 0.01753661409020424
their O 0 0.02328837662935257
POMC O 1 0.9998143315315247
genes O 0 0.1096859723329544
. O 0 0.03695952147245407

Patient O 1 0.997775137424469
1 O 0 0.030947905033826828
was O 0 0.014241625554859638
found O 0 0.01055056881159544
to O 0 0.005745856091380119
be O 0 0.007410751190036535
a O 0 0.020026568323373795
compound O 0 0.0780821442604065
heterozygote O 0 0.4854173958301544
for O 0 0.011761846952140331
two O 0 0.01346068736165762
mutations O 0 0.08182607591152191
in O 0 0.01865890808403492
exon O 0 0.1427791863679886
3 O 0 0.04542871564626694
( O 0 0.03676912933588028
G7013T O 0 0.16277764737606049
, O 0 0.020473409444093704
C7133delta O 0 0.27753207087516785
) O 0 0.019423160701990128
which O 0 0.009885202161967754
interfere O 0 0.03932086378335953
with O 0 0.01095697283744812
appropriate O 0 0.029684871435165405
synthesis O 0 0.05428675562143326
of O 0 0.016461851075291634
ACTH O 1 0.9982439279556274
and O 0 0.024630803614854813
alpha O 0 0.12481853365898132
- O 1 0.5216080546379089
MSH O 1 0.9999010562896729
. O 0 0.0506807379424572

Patient O 1 0.9955474138259888
2 O 0 0.03798111528158188
was O 0 0.022055907174944878
homozygous O 0 0.08204465359449387
for O 0 0.012343468144536018
a O 0 0.024631913751363754
mutation O 0 0.11416486650705338
in O 0 0.019181564450263977
exon O 0 0.1415197253227234
2 O 0 0.045879434794187546
( O 0 0.04485398903489113
C3804A O 0 0.15606234967708588
) O 0 0.034897010773420334
which O 0 0.027536500245332718
abolishes O 1 0.9511402249336243
POMC O 1 0.9967702627182007
translation O 0 0.05471529811620712
. O 0 0.029571495950222015

These O 0 0.01842104084789753
findings O 0 0.02564368210732937
represent O 0 0.011554433964192867
the O 0 0.007597771007567644
first O 0 0.008734581060707569
examples O 0 0.01404754351824522
of O 0 0.008170557208359241
a O 0 0.025773899629712105
genetic B-Disease 1 0.9259663820266724
defect I-Disease 1 0.9997325539588928
within O 0 0.02285197377204895
the O 0 0.0248683113604784
POMC O 1 0.9999788999557495
gene O 0 0.07875271886587143
and O 0 0.011183924041688442
define O 0 0.03200622275471687
a O 0 0.019997654482722282
new O 0 0.03521477058529854
monogenic B-Disease 1 0.9999990463256836
endocrine I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999997615814209
resulting O 0 0.05646384507417679
in O 0 0.01782500557601452
early O 0 0.04151371866464615
- O 1 0.9996600151062012
onset O 1 0.9999997615814209
obesity B-Disease 1 1.0
, O 0 0.2019951045513153
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.023970892652869225
red O 1 0.9953990578651428
hair O 1 0.9998363256454468
pigmentation O 1 0.999972939491272
. O 0 0.023167941719293594
. O 0 0.026097625494003296

A O 0 0.05295749753713608
European O 0 0.05207757651805878
multicenter O 1 0.9873113632202148
study O 0 0.04733390733599663
of O 0 0.029137417674064636
phenylalanine B-Disease 1 0.9999266862869263
hydroxylase I-Disease 1 0.999996542930603
deficiency I-Disease 1 1.0
: O 0 0.043206892907619476
classification O 0 0.06765618920326233
of O 0 0.014857380650937557
105 O 0 0.0743199959397316
mutations O 0 0.07714497298002243
and O 0 0.007694431114941835
a O 0 0.010425400920212269
general O 0 0.012696990743279457
system O 0 0.023661388084292412
for O 0 0.015263192355632782
genotype O 1 0.9858618974685669
- O 0 0.06959512829780579
based O 0 0.028550194576382637
prediction O 0 0.0667189434170723
of O 0 0.020554276183247566
metabolic O 1 0.9955736398696899
phenotype O 1 0.984226644039154
. O 0 0.04009062796831131

Phenylketonuria B-Disease 1 0.9999923706054688
( O 0 0.15022818744182587
PKU B-Disease 1 0.9999992847442627
) O 0 0.03984495624899864
and O 0 0.020985940471291542
mild B-Disease 1 0.999990701675415
hyperphenylalaninemia I-Disease 1 0.9999970197677612
( O 0 0.35773858428001404
MHP B-Disease 1 0.9999998807907104
) O 0 0.03819669410586357
are O 0 0.02046298235654831
allelic B-Disease 1 0.9999074935913086
disorders I-Disease 1 0.9999998807907104
caused O 0 0.3238130807876587
by O 0 0.017319122329354286
mutations O 0 0.07976484298706055
in O 0 0.012278946116566658
the O 0 0.018330873921513557
gene O 0 0.10377536714076996
encoding O 0 0.10488530993461609
phenylalanine O 1 0.5430704951286316
hydroxylase O 1 0.9880460500717163
( O 0 0.10579615831375122
PAH O 1 0.9999932050704956
) O 0 0.0508500412106514
. O 0 0.037792105227708817

Previous O 0 0.04297678917646408
studies O 0 0.03089802898466587
have O 0 0.009733309969305992
suggested O 0 0.015922192484140396
that O 0 0.006296154577285051
the O 0 0.010775602422654629
highly O 0 0.040061105042696
variable O 0 0.12773288786411285
metabolic O 1 0.9975879192352295
phenotypes O 1 0.9727292656898499
of O 0 0.0555584691464901
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.6322616934776306
with O 0 0.048908986151218414
PAH O 1 0.9999992847442627
genotypes O 1 0.9628094434738159
. O 0 0.048611242324113846

We O 0 0.029003478586673737
identified O 0 0.037607621401548386
both O 0 0.01947180926799774
causative O 1 0.9058897495269775
mutations O 0 0.14930470287799835
in O 0 0.027383994311094284
686 O 1 0.9997937083244324
patients O 1 0.9998766183853149
from O 0 0.01406965870410204
seven O 0 0.01703079789876938
European O 0 0.02529539354145527
centers O 0 0.04918920621275902
. O 0 0.025981586426496506

On O 0 0.01263272576034069
the O 0 0.008615490980446339
basis O 0 0.009090469218790531
of O 0 0.006268740631639957
the O 0 0.011217989027500153
phenotypic O 0 0.0817914679646492
characteristics O 0 0.03921831399202347
of O 0 0.015512960031628609
297 O 0 0.45332252979278564
functionally O 1 0.7041622996330261
hemizygous O 1 0.9987469911575317
patients O 1 0.9996318817138672
, O 0 0.014481664635241032
105 O 0 0.041745781898498535
of O 0 0.008393841795623302
the O 0 0.013879852369427681
mutations O 0 0.06988697499036789
were O 0 0.007983298972249031
assigned O 0 0.020335612818598747
to O 0 0.0068732332438230515
one O 0 0.006010137964040041
of O 0 0.005908541847020388
four O 0 0.015218563377857208
arbitrary O 0 0.046720027923583984
phenotype O 1 0.5140925049781799
categories O 0 0.04975520446896553
. O 0 0.030912235379219055

We O 0 0.023475004360079765
proposed O 0 0.025324871763586998
and O 0 0.012870118953287601
tested O 0 0.055999528616666794
a O 0 0.01751718670129776
simple O 0 0.019782615825533867
model O 0 0.022584743797779083
for O 0 0.010418824851512909
correlation O 0 0.056800477206707
between O 0 0.02060484141111374
genotype O 0 0.3898853361606598
and O 0 0.01792706362903118
phenotypic O 0 0.09484584629535675
outcome O 0 0.053290534764528275
. O 0 0.02988569624722004

The O 0 0.037739746272563934
observed O 0 0.07487504184246063
phenotype O 1 0.833326518535614
matched O 0 0.060946639627218246
the O 0 0.01896507665514946
predicted O 0 0.061528801918029785
phenotype O 0 0.24239923059940338
in O 0 0.01674431562423706
79 O 0 0.05786532908678055
% O 0 0.015750175341963768
of O 0 0.00577566958963871
the O 0 0.009522009640932083
cases O 0 0.018000507727265358
, O 0 0.007406658958643675
and O 0 0.005173391662538052
in O 0 0.0060572149232029915
only O 0 0.0070988480001688
5 O 0 0.014556911773979664
of O 0 0.009915677830576897
184 O 0 0.1234227642416954
patients O 1 0.9994949102401733
was O 0 0.017152518033981323
the O 0 0.014798971824347973
observed O 0 0.0422019399702549
phenotype O 0 0.21192392706871033
more O 0 0.01051370706409216
than O 0 0.00964591559022665
one O 0 0.011956269852817059
category O 0 0.029643865302205086
away O 0 0.017574792727828026
from O 0 0.00955730490386486
that O 0 0.007882350124418736
expected O 0 0.01998475380241871
. O 0 0.022710399702191353

Among O 0 0.022230345755815506
the O 0 0.0125754838809371
seven O 0 0.01805122010409832
contributing O 0 0.042052753269672394
centers O 0 0.03164634481072426
, O 0 0.008750076405704021
the O 0 0.0089707151055336
proportion O 0 0.030936753377318382
of O 0 0.011922119185328484
patients O 1 0.999698281288147
for O 0 0.009918833151459694
whom O 0 0.021148445084691048
the O 0 0.0133827468380332
observed O 0 0.04611531272530556
phenotype O 1 0.9270181655883789
did O 0 0.015598217025399208
not O 0 0.007907500490546227
match O 0 0.01995520293712616
the O 0 0.013184064999222755
predicted O 0 0.054959673434495926
phenotype O 0 0.21508504450321198
was O 0 0.024304000660777092
4 O 0 0.030260616913437843
% O 0 0.02936684712767601
- O 0 0.06714959442615509
23 O 0 0.03612414374947548
% O 0 0.03894386067986488
( O 0 0.051128361374139786
P O 1 0.994793713092804
< O 1 0.527102530002594
. O 0 0.02695615589618683
0001 O 1 0.9438951015472412
) O 0 0.02249341644346714
, O 0 0.011111377738416195
suggesting O 0 0.0267750583589077
that O 0 0.007285131141543388
differences O 0 0.011976764537394047
in O 0 0.007365964353084564
methods O 0 0.016330014914274216
used O 0 0.013561728410422802
for O 0 0.015984760597348213
mutation O 0 0.26096785068511963
detection O 0 0.2487354874610901
or O 0 0.04115572199225426
phenotype O 1 0.9986055493354797
classification O 1 0.5262933969497681
may O 0 0.02043946459889412
account O 0 0.012967309914529324
for O 0 0.006109694018959999
a O 0 0.01239477563649416
considerable O 0 0.02674183063209057
proportion O 0 0.035767391324043274
of O 0 0.019463779404759407
genotype O 1 0.999593198299408
- O 1 0.7184962034225464
phenotype O 1 0.9845297336578369
inconsistencies O 0 0.0940968468785286
. O 0 0.03655955567955971

Our O 0 0.027129409834742546
data O 0 0.01796143315732479
indicate O 0 0.025133492425084114
that O 0 0.009640168398618698
the O 0 0.028751052916049957
PAH O 1 0.9999998807907104
- O 0 0.22633664309978485
mutation O 0 0.21246455609798431
genotype O 0 0.23394431173801422
is O 0 0.017043080180883408
the O 0 0.012181210331618786
main O 0 0.026644838973879814
determinant O 0 0.10198637843132019
of O 0 0.023518603295087814
metabolic O 1 0.9971855282783508
phenotype O 1 0.9837057590484619
in O 0 0.01943489909172058
most O 0 0.018978005275130272
patients O 1 0.9999992847442627
with O 1 0.801789402961731
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.04563755542039871

In O 0 0.018889984115958214
the O 0 0.013399181887507439
present O 0 0.016393525525927544
study O 0 0.018062548711895943
, O 0 0.00781505648046732
the O 0 0.010457385331392288
classification O 0 0.06133111193776131
of O 0 0.015300712548196316
105 O 1 0.9391708970069885
PAH O 1 0.9999997615814209
mutations O 0 0.14441467821598053
may O 0 0.020493825897574425
allow O 0 0.012070643715560436
the O 0 0.009282854385674
prediction O 0 0.038800690323114395
of O 0 0.00782383605837822
the O 0 0.016642237082123756
biochemical O 0 0.13544391095638275
phenotype O 1 0.8190579414367676
in O 0 0.02500724606215954
> O 0 0.11319059133529663
10 O 0 0.020772205665707588
, O 0 0.014808444306254387
000 O 0 0.06950923055410385
genotypes O 0 0.18365925550460815
, O 0 0.012900942005217075
which O 0 0.009157746098935604
may O 0 0.012703458778560162
be O 0 0.0057265907526016235
useful O 0 0.011126959696412086
for O 0 0.005607581697404385
the O 0 0.009930283762514591
management O 0 0.04087131842970848
of O 0 0.014637057669460773
hyperphenylalaninemia B-Disease 1 0.9998527765274048
in O 0 0.02906102128326893
newborns O 1 0.9944319128990173
. O 0 0.037851665169000626

Somatic O 0 0.25303179025650024
instability O 0 0.10673163831233978
of O 0 0.013405556790530682
the O 0 0.021852245554327965
CTG O 1 0.9987248778343201
repeat O 0 0.09902092069387436
in O 0 0.02175246924161911
mice O 0 0.13778021931648254
transgenic O 0 0.08289428800344467
for O 0 0.019209230318665504
the O 0 0.037410661578178406
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.07173339277505875
is O 0 0.02006099931895733
age O 0 0.030411148443818092
dependent O 0 0.04026332497596741
but O 0 0.01028062216937542
not O 0 0.008731567300856113
correlated O 0 0.05098358169198036
to O 0 0.00921383872628212
the O 0 0.013163622468709946
relative O 0 0.05746975913643837
intertissue O 1 0.7201110124588013
transcription O 0 0.11002647131681442
levels O 0 0.05782506242394447
and O 0 0.027492213994264603
proliferative O 1 0.9999674558639526
capacities O 0 0.08952721953392029
. O 0 0.03543395921587944

A O 0 0.0723474845290184
( O 0 0.061380498111248016
CTG O 1 0.993841290473938
) O 0 0.035534899681806564
nexpansion O 0 0.10930974036455154
in O 0 0.012007191777229309
the O 0 0.014798290096223354
3 O 0 0.039505477994680405
- O 0 0.08674990385770798
untranslated O 0 0.1654549241065979
region O 0 0.06422635912895203
( O 0 0.05273369327187538
UTR O 0 0.41067883372306824
) O 0 0.020045842975378036
of O 0 0.01203944906592369
the O 0 0.03336751088500023
DM O 1 0.9999997615814209
protein O 0 0.17969375848770142
kinase O 1 0.5238303542137146
gene O 0 0.11525234580039978
( O 0 0.04598366841673851
DMPK O 1 0.9834379553794861
) O 0 0.021265361458063126
is O 0 0.012022112496197224
responsible O 0 0.027894044294953346
for O 0 0.0219388697296381
causing O 1 0.9999034404754639
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.997767448425293
DM B-Disease 1 1.0
) O 0 0.048718929290771484
. O 0 0.029328320175409317

Major O 0 0.06240981072187424
instability O 0 0.10327701270580292
, O 0 0.013226130977272987
with O 0 0.009073929861187935
very O 0 0.012383364140987396
large O 0 0.014468166045844555
expansions O 0 0.042323239147663116
between O 0 0.012271767482161522
generations O 0 0.02745097130537033
and O 0 0.01116885431110859
high O 0 0.028613822534680367
levels O 0 0.03940102458000183
of O 0 0.019341174513101578
somatic O 0 0.38293716311454773
mosaicism O 1 0.9970349073410034
, O 0 0.017945557832717896
is O 0 0.015160972252488136
observed O 0 0.029908670112490654
in O 0 0.018017103895545006
patients O 1 0.9999451637268066
. O 0 0.025207562372088432

There O 0 0.018178097903728485
is O 0 0.012285430915653706
a O 0 0.016119133681058884
good O 0 0.024888118728995323
correlation O 0 0.06034007668495178
between O 0 0.021029580384492874
repeat O 0 0.07106457650661469
size O 0 0.031006144359707832
( O 0 0.02227691374719143
at O 0 0.01572679542005062
least O 0 0.014879598282277584
in O 0 0.013057307340204716
leucocytes O 1 0.9418616890907288
) O 0 0.02740575186908245
, O 0 0.018374264240264893
clinical O 1 0.999653697013855
severity O 1 0.9983108043670654
and O 0 0.011146199889481068
age O 0 0.028976548463106155
of O 0 0.018402090296149254
onset O 1 0.999855637550354
. O 0 0.04178084433078766

The O 0 0.05280351638793945
trinucleotide O 1 0.9973351359367371
repeat O 0 0.3417755663394928
instability O 0 0.13879486918449402
mechanisms O 0 0.06226314976811409
involved O 0 0.031172793358564377
in O 0 0.022244419902563095
DM B-Disease 1 1.0
and O 0 0.011870776303112507
other O 0 0.009810229763388634
human O 0 0.04052240774035454
genetic B-Disease 1 0.9999054670333862
diseases I-Disease 1 0.9999998807907104
are O 0 0.013311575166881084
unknown O 0 0.040620896965265274
. O 0 0.027211584150791168

We O 0 0.030644290149211884
studied O 0 0.049355510622262955
somatic O 0 0.16062386333942413
instability O 0 0.100578173995018
by O 0 0.018308062106370926
measuring O 0 0.05533500015735626
the O 0 0.02534029632806778
CTG O 1 0.9988023042678833
repeat O 0 0.0944758877158165
length O 0 0.03261168301105499
at O 0 0.014504287391901016
several O 0 0.00824685487896204
ages O 0 0.02926219254732132
in O 0 0.00802092719823122
various O 0 0.010122768580913544
tissues O 0 0.0697772353887558
of O 0 0.013445460237562656
transgenic O 0 0.11304635554552078
mice O 0 0.12844859063625336
carrying O 0 0.03932666406035423
a O 0 0.029772844165563583
( O 0 0.05255283787846565
CTG O 1 0.9985650181770325
) O 0 0.04496216028928757
55expansion O 0 0.17649124562740326
surrounded O 0 0.04975685477256775
by O 0 0.014157542958855629
45 O 0 0.03601305931806564
kb O 0 0.08686685562133789
of O 0 0.011076430790126324
the O 0 0.017718108370900154
human O 0 0.057407304644584656
DM B-Disease 1 0.9999998807907104
region O 0 0.04390868544578552
, O 0 0.013469315133988857
using O 0 0.01749238930642605
small O 0 0.027411678805947304
- O 0 0.09124995023012161
pool O 0 0.14560209214687347
PCR O 0 0.21690700948238373
. O 0 0.03924883157014847

These O 0 0.02526441030204296
mice O 0 0.10162126272916794
have O 0 0.011670096777379513
been O 0 0.010668654926121235
shown O 0 0.01771502196788788
to O 0 0.0083870654925704
reproduce O 0 0.03832317516207695
the O 0 0.01609206758439541
intergenerational O 0 0.2624392509460449
and O 0 0.02084675431251526
somatic O 0 0.14835608005523682
instability O 0 0.07384513318538666
of O 0 0.009694535285234451
the O 0 0.01703592576086521
55 O 0 0.07548917084932327
CTG O 1 0.9996919631958008
repeat O 0 0.12041535973548889
suggesting O 0 0.04824448749423027
that O 0 0.01048014685511589
surrounding O 0 0.02745804190635681
sequences O 0 0.02619302086532116
and O 0 0.007966048084199429
the O 0 0.011806837283074856
chromatin O 0 0.07309477776288986
environment O 0 0.022782284766435623
are O 0 0.007058917544782162
involved O 0 0.018339267000555992
in O 0 0.014331108890473843
instability O 0 0.17477142810821533
mechanisms O 0 0.07537344843149185
. O 0 0.029199302196502686

As O 0 0.02026798017323017
observed O 0 0.023240098729729652
in O 0 0.006333247292786837
some O 0 0.005507155321538448
of O 0 0.005355500150471926
the O 0 0.01232855673879385
tissues O 1 0.696998119354248
of O 0 0.0318845771253109
DM B-Disease 1 1.0
patients O 1 0.9999957084655762
, O 0 0.013215581886470318
there O 0 0.008372151292860508
is O 0 0.008914248086512089
a O 0 0.012626219540834427
tendency O 0 0.04251392185688019
for O 0 0.011131702922284603
repeat O 0 0.06143902242183685
length O 0 0.0318339504301548
and O 0 0.01709439419209957
somatic O 0 0.18283243477344513
mosaicism O 1 0.9947599768638611
to O 0 0.012605455704033375
increase O 0 0.015781782567501068
with O 0 0.0065979366190731525
the O 0 0.007845938205718994
age O 0 0.01601291075348854
of O 0 0.006687337066978216
the O 0 0.017596011981368065
mouse O 0 0.12858319282531738
. O 0 0.03465661033987999

Furthermore O 0 0.06224943324923515
, O 0 0.016422292217612267
we O 0 0.01041737012565136
observed O 0 0.02438088320195675
no O 0 0.01353116799145937
correlation O 0 0.04209872707724571
between O 0 0.012876300141215324
the O 0 0.018840523436665535
somatic O 0 0.22130154073238373
mutation O 0 0.1733464002609253
rate O 0 0.04548031836748123
and O 0 0.019251858815550804
tissue O 1 0.9899420738220215
proliferation O 0 0.10342132300138474
capacity O 0 0.04111916199326515
. O 0 0.030522774904966354

The O 0 0.04620892181992531
somatic O 0 0.2553216814994812
mutation O 0 0.18411576747894287
rates O 0 0.048864979296922684
in O 0 0.011559173464775085
different O 0 0.011854344047605991
tissues O 0 0.058481376618146896
were O 0 0.007967759855091572
also O 0 0.008554023690521717
not O 0 0.00836930237710476
correlated O 0 0.04520085081458092
to O 0 0.00750341173261404
the O 0 0.01050325483083725
relative O 0 0.04195288568735123
inter O 0 0.20357157289981842
- O 0 0.1696954220533371
tissue O 0 0.35981377959251404
difference O 0 0.03384483605623245
in O 0 0.013214267790317535
transcriptional O 0 0.09045635908842087
levels O 0 0.026782041415572166
of O 0 0.006330765783786774
the O 0 0.008365686051547527
three O 0 0.01413655560463667
genes O 0 0.06776801496744156
( O 0 0.0486215278506279
DMAHP O 1 0.9972797632217407
, O 0 0.022982589900493622
DMPK O 1 0.933902382850647
and O 0 0.014873286709189415
59 O 0 0.04928228631615639
) O 0 0.019536083564162254
surrounding O 0 0.023357685655355453
the O 0 0.015151619911193848
repeat O 0 0.07470956444740295
. O 0 0.016305169090628624
. O 0 0.0237138569355011

A O 0 0.06848113983869553
novel O 0 0.07696818560361862
missense O 0 0.29779109358787537
mutation O 0 0.17947310209274292
in O 0 0.029642175883054733
patients O 1 0.9999203681945801
from O 0 0.01914779469370842
a O 0 0.031872108578681946
retinoblastoma B-Disease 1 0.9999717473983765
pedigree O 0 0.34644025564193726
showing O 0 0.03733526170253754
only O 0 0.01802987977862358
mild O 1 0.9859252572059631
expression O 0 0.033683452755212784
of O 0 0.010952993296086788
the O 0 0.026205290108919144
tumor B-Disease 1 0.9999892711639404
phenotype O 1 0.9949867725372314
. O 0 0.041442595422267914

We O 0 0.01940137706696987
have O 0 0.01054469682276249
used O 0 0.01503419503569603
single O 0 0.03377285227179527
strand O 0 0.12133371084928513
conformation O 0 0.13472911715507507
polymorphism O 0 0.10541995614767075
analysis O 0 0.025059258565306664
to O 0 0.0091682318598032
study O 0 0.017852047458291054
the O 0 0.010273759253323078
27 O 0 0.029930833727121353
exons O 0 0.06712788343429565
of O 0 0.010372552089393139
the O 0 0.02422904223203659
RB1 O 1 0.9999862909317017
gene O 0 0.07359613478183746
in O 0 0.012309635058045387
individuals O 0 0.015308394096791744
from O 0 0.009512605145573616
a O 0 0.015388146974146366
family O 0 0.029698926955461502
showing O 0 0.04598265141248703
mild O 1 0.9975957274436951
expression O 0 0.035845644772052765
of O 0 0.009485434740781784
the O 0 0.024323875084519386
retinoblastoma B-Disease 1 0.9999819993972778
phenotype O 1 0.9942284822463989
. O 0 0.04065285623073578

In O 0 0.020125312730669975
this O 0 0.012869052588939667
family O 0 0.02995726466178894
affected O 0 0.0455455482006073
individuals O 0 0.025990532711148262
developed O 0 0.06095019727945328
unilateral B-Disease 1 0.9845422506332397
tumors I-Disease 1 0.9999994039535522
and O 0 0.011895343661308289
, O 0 0.008837692439556122
as O 0 0.007175937760621309
a O 0 0.012824383564293385
result O 0 0.018414825201034546
of O 0 0.011392074637115002
linkage O 0 0.12634903192520142
analysis O 0 0.036751653999090195
, O 0 0.02271801047027111
unaffected O 1 0.8628820776939392
mutation O 0 0.2338833063840866
carriers O 0 0.07822605222463608
were O 0 0.011288425885140896
also O 0 0.010534267872571945
identified O 0 0.020867500454187393
within O 0 0.012256643734872341
the O 0 0.014312281273305416
pedigree O 0 0.13155464828014374
. O 0 0.029487090185284615

A O 0 0.04342421144247055
single O 0 0.03769400343298912
band O 0 0.0524308905005455
shift O 0 0.05165944620966911
using O 0 0.02646804414689541
SSCP O 1 0.6695913076400757
was O 0 0.01677103154361248
identified O 0 0.021768750622868538
in O 0 0.011936058290302753
exon O 0 0.10256124287843704
21 O 0 0.024341443553566933
which O 0 0.009403559379279613
resulted O 0 0.02468605525791645
in O 0 0.011849675327539444
a O 0 0.025844354182481766
missense O 0 0.19775354862213135
mutation O 0 0.1507069617509842
converting O 0 0.06833736598491669
a O 0 0.0579434335231781
cys O 1 0.9999877214431763
- O 1 0.9815009832382202
- O 1 0.5066314935684204
> O 1 0.5555707216262817
arg O 1 0.8494288921356201
at O 0 0.037204500287771225
nucleotide O 0 0.07481078803539276
position O 0 0.025165796279907227
28 O 0 0.021588746458292007
in O 0 0.009713446721434593
the O 0 0.01782352849841118
exon O 0 0.1508266031742096
. O 0 0.03442217782139778

The O 0 0.04031932353973389
mutation O 0 0.16350215673446655
destroyed O 0 0.05935157835483551
an O 0 0.028694065287709236
NdeI O 1 0.6240046620368958
restriction O 0 0.09457047283649445
enzyme O 0 0.12676475942134857
site O 0 0.04246900975704193
. O 0 0.026092898100614548

Analysis O 0 0.03279759734869003
of O 0 0.008264955133199692
all O 0 0.006982552818953991
family O 0 0.018033113330602646
members O 0 0.013704783283174038
demonstrated O 0 0.027160977944731712
that O 0 0.008846367709338665
the O 0 0.017799902707338333
missense O 1 0.6964734792709351
mutation O 1 0.8407681584358215
co O 1 0.8758386969566345
- O 0 0.11046337336301804
segregated O 0 0.11732824146747589
with O 0 0.0265390295535326
patients O 1 0.9999967813491821
with O 0 0.028140543028712273
tumors B-Disease 1 0.9999997615814209
or O 0 0.018563155084848404
who O 0 0.01180482842028141
, O 0 0.006478901486843824
as O 0 0.005756697617471218
a O 0 0.010696412064135075
result O 0 0.015449278987944126
of O 0 0.009043880738317966
linkage O 0 0.11325263977050781
analysis O 0 0.022017834708094597
had O 0 0.012699466198682785
been O 0 0.010754356160759926
predicted O 0 0.02278953790664673
to O 0 0.009089025668799877
carry O 0 0.019624412059783936
the O 0 0.021145880222320557
predisposing O 1 0.687994122505188
mutation O 0 0.20384249091148376
. O 0 0.03978952020406723

These O 0 0.014643673785030842
observations O 0 0.028899971395730972
point O 0 0.013301520608365536
to O 0 0.007743378635495901
another O 0 0.013525347225368023
region O 0 0.020743535831570625
of O 0 0.008600402623414993
the O 0 0.023011310026049614
RB1 O 1 0.9999936819076538
gene O 0 0.10295803844928741
where O 0 0.023312987759709358
mutations O 0 0.07766912132501602
only O 0 0.009855452924966812
modify O 0 0.0343221053481102
the O 0 0.009390238672494888
function O 0 0.018565092235803604
of O 0 0.006614123471081257
the O 0 0.012637835927307606
gene O 0 0.055241908878088
and O 0 0.010228114202618599
raise O 0 0.026885824277997017
important O 0 0.011283667758107185
questions O 0 0.017332827672362328
for O 0 0.011128833517432213
genetic O 0 0.07889196276664734
counseling O 1 0.9369909167289734
in O 0 0.008711844682693481
families O 0 0.01714469864964485
with O 0 0.00895204022526741
these O 0 0.00922142993658781
distinctive O 0 0.06943941116333008
phenotypes O 0 0.4290652275085449
. O 0 0.01904870755970478
. O 0 0.024611826986074448

Maternal B-Disease 1 0.9298922419548035
disomy I-Disease 1 0.9967503547668457
and O 0 0.06224087253212929
Prader B-Disease 1 1.0
- I-Disease 1 0.9999914169311523
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.07252740859985352
with O 0 0.027555610984563828
gamete O 1 0.9958544969558716
complementation O 1 0.9993300437927246
in O 0 0.014816028997302055
a O 0 0.016328055411577225
case O 0 0.02175915613770485
of O 0 0.01657804287970066
familial O 1 0.9997757077217102
translocation O 1 0.8496720194816589
( O 0 0.03873337432742119
3 O 0 0.026680614799261093
; O 0 0.018345801159739494
15 O 0 0.023351214826107025
) O 0 0.027309859171509743
( O 0 0.043167583644390106
p25 O 1 0.9836294054985046
; O 0 0.034916169941425323
q11 O 0 0.12090706080198288
. O 0 0.014902890659868717
2 O 0 0.026201430708169937
) O 0 0.023140039294958115
. O 0 0.02036779187619686

Maternal B-Disease 1 0.9731566309928894
uniparental I-Disease 1 0.9999312162399292
disomy I-Disease 1 0.997379720211029
( I-Disease 0 0.09074258804321289
UPD I-Disease 1 0.9999833106994629
) I-Disease 0 0.03258931636810303
for I-Disease 0 0.01604601740837097
chromosome I-Disease 0 0.10157911479473114
15 I-Disease 0 0.020118512213230133
is O 0 0.01022931095212698
responsible O 0 0.01656840555369854
for O 0 0.00634086225181818
an O 0 0.009617428295314312
estimated O 0 0.022750873118638992
30 O 0 0.01760443113744259
% O 0 0.01485478412359953
of O 0 0.008174823597073555
cases O 0 0.02809164859354496
of O 0 0.0310149434953928
Prader B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9683625102043152
PWS B-Disease 1 1.0
) O 0 0.04928926005959511
. O 0 0.029769182205200195

We O 0 0.016154905781149864
report O 0 0.013414427638053894
on O 0 0.007686192635446787
an O 0 0.01091207005083561
unusual O 0 0.02419114299118519
case O 0 0.018854210153222084
of O 0 0.011254891753196716
maternal B-Disease 0 0.2805216312408447
disomy I-Disease 1 0.8809719681739807
15 I-Disease 0 0.028263235464692116
in O 0 0.020816100761294365
PWS B-Disease 1 0.9999998807907104
that O 0 0.01095836702734232
is O 0 0.00911284051835537
most O 0 0.007802122738212347
consistent O 0 0.023023081943392754
with O 0 0.01187822874635458
adjacent O 0 0.036184657365083694
- O 0 0.06743481010198593
1 O 0 0.031130148097872734
segregation O 0 0.06282980740070343
of O 0 0.011867220513522625
a O 0 0.03019658289849758
paternal O 0 0.19812241196632385
t O 1 0.9645805358886719
( O 0 0.033507321029901505
3 O 0 0.029266970232129097
; O 0 0.0208511333912611
15 O 0 0.025956325232982635
) O 0 0.029405757784843445
( O 0 0.04472428560256958
p25 O 1 0.9838693737983704
; O 0 0.03205735236406326
q11 O 0 0.11787354201078415
. O 0 0.01299052219837904
2 O 0 0.022393671795725822
) O 0 0.015050988644361496
with O 0 0.012387294322252274
simultaneous O 0 0.06042144075036049
maternal O 0 0.3609654903411865
meiotic O 1 0.988825261592865
nondisjunction O 1 0.5376691222190857
for O 0 0.029701687395572662
chromosome O 0 0.15263986587524414
15 O 0 0.04053447023034096
. O 0 0.029286369681358337

The O 0 0.05274941772222519
patient O 1 0.9976288676261902
( O 0 0.05622316896915436
J O 1 0.9974072575569153
. O 0 0.02164681814610958
B O 0 0.08061289042234421
. O 0 0.01080984715372324
) O 0 0.012034794315695763
, O 0 0.006712816655635834
a O 0 0.01434776745736599
17 O 0 0.026096871122717857
- O 0 0.055863894522190094
year O 0 0.024652400985360146
- O 0 0.07075008004903793
old O 0 0.03817051649093628
white O 0 0.056514788419008255
male O 0 0.06603594869375229
with O 0 0.03039262443780899
PWS B-Disease 1 1.0
, O 0 0.017512183636426926
was O 0 0.012785451486706734
found O 0 0.011592530645430088
to O 0 0.006832970771938562
have O 0 0.009023749269545078
47 O 0 0.03579634800553322
chromosomes O 0 0.05135606974363327
with O 0 0.013237089850008488
a O 0 0.023819634690880775
supernumerary O 0 0.15686295926570892
, O 0 0.02709413878619671
paternal O 0 0.22003807127475739
der O 1 0.7892993688583374
( O 0 0.027462050318717957
15 O 0 0.0178206916898489
) O 0 0.014340413734316826
consisting O 0 0.013252681121230125
of O 0 0.00685304356738925
the O 0 0.012289673089981079
short O 0 0.03232968598604202
arm O 0 0.08459562063217163
and O 0 0.010651174932718277
the O 0 0.014586374163627625
proximal O 1 0.998177170753479
long O 0 0.04474865272641182
arm O 0 0.24966242909431458
of O 0 0.015041003935039043
chromosome O 0 0.11064689606428146
15 O 0 0.021084122359752655
, O 0 0.01175178773701191
and O 0 0.017636887729167938
distal O 1 0.998653769493103
chromosome O 1 0.6422261595726013
arm O 1 0.9943285584449768
3p O 1 0.9973468780517578
. O 0 0.04667948558926582

The O 0 0.04337218776345253
t O 1 0.8976062536239624
( O 0 0.031951386481523514
3 O 0 0.02458830364048481
; O 0 0.015281506814062595
15 O 0 0.017618728801608086
) O 0 0.014401726424694061
was O 0 0.010133147239685059
present O 0 0.008210753090679646
in O 0 0.005520917009562254
the O 0 0.007425633724778891
balanced O 0 0.02866019494831562
state O 0 0.009413914754986763
in O 0 0.009052928537130356
the O 0 0.01555315125733614
patients O 1 0.9998966455459595
father O 0 0.024104546755552292
and O 0 0.008847497403621674
a O 0 0.018322216346859932
sister O 0 0.0508975088596344
. O 0 0.02459486946463585

Fluorescent O 0 0.20478811860084534
in O 0 0.03814837709069252
situ O 0 0.1847083568572998
hybridization O 0 0.11364659667015076
analysis O 0 0.03072740137577057
demonstrated O 0 0.03350866585969925
that O 0 0.010395850986242294
the O 0 0.023194028064608574
PWS B-Disease 1 0.9999998807907104
critical O 0 0.05273676663637161
region O 0 0.0319790281355381
resided O 0 0.04589473828673363
on O 0 0.0092464005574584
the O 0 0.015631098300218582
derivative O 0 0.10136322677135468
chromosome O 0 0.1086258515715599
3 O 0 0.016988765448331833
and O 0 0.006411948706954718
that O 0 0.005798050202429295
there O 0 0.007137637585401535
was O 0 0.010869990102946758
no O 0 0.01360263954848051
deletion O 0 0.07313109934329987
of O 0 0.009867403656244278
the O 0 0.022415366023778915
PWS B-Disease 1 0.9999998807907104
region O 0 0.032271843403577805
on O 0 0.007663980592042208
the O 0 0.010105662979185581
normal O 0 0.029260555282235146
pair O 0 0.027478104457259178
of O 0 0.011379697360098362
15s O 0 0.2079363316297531
present O 0 0.022768892347812653
in O 0 0.019444860517978668
J O 1 0.9989334940910339
. O 0 0.03513973951339722

B O 0 0.2494717538356781
. O 0 0.04372812435030937

Methylation O 0 0.14994727075099945
analysis O 0 0.03744520992040634
at O 0 0.029162423685193062
exon O 0 0.1028425395488739
alpha O 0 0.04827319085597992
of O 0 0.007848644629120827
the O 0 0.011871996335685253
small O 0 0.02398514375090599
nuclear O 0 0.07034200429916382
ribonucleoprotein O 1 0.9987474679946899
- O 0 0.11375221610069275
associated O 0 0.06039512902498245
polypeptide O 0 0.18038801848888397
N O 0 0.13389840722084045
( O 0 0.052823539823293686
SNRPN O 1 0.9800059795379639
) O 0 0.03615051135420799
gene O 0 0.07051163911819458
showed O 0 0.03582203760743141
a O 0 0.02254028618335724
pattern O 0 0.05149221792817116
characteristic O 0 0.03288379684090614
of O 0 0.0060983337461948395
only O 0 0.008454256691038609
the O 0 0.01410362496972084
maternal O 0 0.12947285175323486
chromosome O 0 0.1270437091588974
15 O 0 0.02921929396688938
in O 0 0.02016100473701954
J O 1 0.998238205909729
. O 0 0.03378893807530403

B O 0 0.23654964566230774
. O 0 0.04603143036365509

Maternal B-Disease 1 0.7180408835411072
disomy I-Disease 1 0.6283578872680664
was O 0 0.029157688841223717
confirmed O 0 0.03967636078596115
by O 0 0.022868528962135315
polymerase O 0 0.1752006858587265
chain O 0 0.09572209417819977
reaction O 0 0.06494630128145218
analysis O 0 0.02729012444615364
of O 0 0.013083991594612598
microsatellite O 0 0.21956698596477509
repeats O 0 0.08747583627700806
at O 0 0.02504350244998932
the O 0 0.01888737641274929
gamma O 0 0.16679514944553375
- O 0 0.1472119837999344
aminobutyric O 1 0.6755011081695557
acid O 0 0.33493572473526
receptor O 0 0.27653682231903076
beta3 O 0 0.27730441093444824
subunit O 0 0.1835935413837433
( O 0 0.06518189609050751
GABRB3 O 1 0.9752107858657837
) O 0 0.04535257816314697
locus O 0 0.1534220427274704
. O 0 0.03711961582303047

A O 0 0.06717230379581451
niece O 0 0.16178594529628754
( O 0 0.051540400832891464
B O 0 0.1610291749238968
. O 0 0.018119459971785545
B O 0 0.08284236490726471
. O 0 0.010522132739424706
) O 0 0.014276484027504921
with O 0 0.010445351712405682
45 O 0 0.026718420907855034
chromosomes O 0 0.047641485929489136
and O 0 0.00966651365160942
the O 0 0.013377219438552856
derivative O 0 0.08190629631280899
3 O 0 0.024252254515886307
but O 0 0.009543470107018948
without O 0 0.011601440608501434
the O 0 0.01607542112469673
der O 1 0.7879824042320251
( O 0 0.02866356633603573
15 O 0 0.022512102499604225
) O 0 0.018738623708486557
demonstrated O 0 0.040428176522254944
a O 0 0.028789035975933075
phenotype O 1 0.7042125463485718
consistent O 0 0.03461816906929016
with O 0 0.009748147800564766
that O 0 0.007806303445249796
reported O 0 0.02065015397965908
for O 0 0.012687322683632374
haploinsufficiency O 0 0.15934516489505768
of O 0 0.019808879122138023
distal O 1 0.9910282492637634
3 O 0 0.05609719827771187
p O 0 0.1531914323568344
. O 0 0.03290533646941185

Uniparental B-Disease 1 0.999991774559021
disomy I-Disease 1 0.9980655312538147
associated O 0 0.049848105758428574
with O 0 0.020252637565135956
unbalanced O 0 0.15614745020866394
segregation O 0 0.07783511281013489
of O 0 0.013750983402132988
non O 0 0.06059669330716133
- O 0 0.14351408183574677
Robertsonian O 1 0.9768596291542053
translocations O 0 0.18579407036304474
has O 0 0.01952529512345791
been O 0 0.014942719601094723
reported O 0 0.024507177993655205
previously O 0 0.014048176817595959
but O 0 0.007155101280659437
has O 0 0.007646521553397179
not O 0 0.004741042386740446
, O 0 0.005621150601655245
to O 0 0.005163040943443775
our O 0 0.008863224647939205
knowledge O 0 0.014730080962181091
, O 0 0.0068157934583723545
been O 0 0.007978912442922592
observed O 0 0.01680110953748226
in O 0 0.0066063362173736095
a O 0 0.014531577005982399
case O 0 0.02607317827641964
of O 0 0.023265304043889046
PWS B-Disease 1 1.0
. O 0 0.0442170649766922

Furthermore O 0 0.06490358710289001
, O 0 0.014209375716745853
our O 0 0.011433246545493603
findings O 0 0.021069005131721497
are O 0 0.006775848567485809
best O 0 0.01465055625885725
interpreted O 0 0.020925626158714294
as O 0 0.01208470854908228
true O 0 0.04008903726935387
gamete O 1 0.9651950001716614
complementation O 1 0.9996753931045532
resulting O 0 0.06021524593234062
in O 0 0.024449029937386513
maternal B-Disease 1 0.9912163019180298
UPD I-Disease 1 0.9999978542327881
15 I-Disease 0 0.060427431017160416
and O 0 0.04387243092060089
PWS B-Disease 1 0.9999992847442627

Schwartz B-Disease 1 0.9987602233886719
- I-Disease 1 0.9956745505332947
Jampel I-Disease 1 0.999976396560669
syndrome I-Disease 1 1.0
type I-Disease 0 0.11949892342090607
2 I-Disease 0 0.03146825358271599
and O 0 0.019339820370078087
Stuve B-Disease 1 0.9999876022338867
- I-Disease 1 0.9997394680976868
Wiedemann I-Disease 1 0.9999979734420776
syndrome I-Disease 1 1.0
: O 0 0.02489645779132843
a O 0 0.014998269267380238
case O 0 0.017033608630299568
for O 0 0.009600095450878143
" O 0 0.017433971166610718
lumping O 0 0.1152738556265831
" O 0 0.028896600008010864
. O 0 0.02363600954413414

Recent O 0 0.04613852873444557
studies O 0 0.033320073038339615
demonstrated O 0 0.03132350742816925
the O 0 0.010128489695489407
existence O 0 0.019241610541939735
of O 0 0.008315919898450375
a O 0 0.02020035684108734
genetically O 0 0.041793838143348694
distinct O 0 0.032389406114816666
, O 0 0.014789018779993057
usually O 0 0.025154776871204376
lethal O 0 0.0720076709985733
form O 0 0.015189362689852715
of O 0 0.007291310466825962
the O 0 0.018231011927127838
Schwartz B-Disease 1 0.9998559951782227
- I-Disease 1 0.9975916147232056
Jampel I-Disease 1 0.9999892711639404
syndrome I-Disease 1 1.0
( O 1 0.5058632493019104
SJS B-Disease 1 0.9999995231628418
) O 0 0.0302641149610281
of O 0 0.01969345659017563
myotonia B-Disease 1 0.9999991655349731
and O 0 0.03454380854964256
skeletal B-Disease 1 0.9999978542327881
dysplasia I-Disease 1 1.0
, O 0 0.017414312809705734
which O 0 0.011329665780067444
we O 0 0.013655833899974823
called O 0 0.04752035439014435
SJS B-Disease 1 0.9999978542327881
type I-Disease 0 0.0962684378027916
2 I-Disease 0 0.03961597755551338
. O 0 0.02782524563372135

This O 0 0.044501885771751404
disorder O 1 0.9999788999557495
is O 0 0.020926272496581078
reminiscent O 0 0.05516056716442108
of O 0 0.010623583570122719
another O 0 0.025047417730093002
rare O 0 0.05605555698275566
condition O 1 0.9381872415542603
, O 0 0.014008808881044388
the O 0 0.018221313133835793
Stuve B-Disease 1 0.9999909400939941
- I-Disease 1 0.9998117089271545
Wiedemann I-Disease 1 0.9999986886978149
syndrome I-Disease 1 1.0
( O 0 0.1015741303563118
SWS B-Disease 1 0.9999825954437256
) O 0 0.02595740556716919
, O 0 0.009867743588984013
which O 0 0.010014652274549007
comprises O 0 0.03413905203342438
campomelia B-Disease 0 0.41842028498649597
at O 0 0.029165666550397873
birth O 0 0.05048501864075661
with O 0 0.02776378206908703
skeletal B-Disease 1 0.9999977350234985
dysplasia I-Disease 1 1.0
, O 0 0.03340451791882515
contractures B-Disease 1 0.9999933242797852
, O 0 0.013654341921210289
and O 0 0.008771220222115517
early B-Disease 0 0.021702835336327553
death I-Disease 0 0.036241643130779266
. O 0 0.02290683053433895

To O 0 0.020645305514335632
test O 0 0.0334310382604599
for O 0 0.011967930942773819
possible O 0 0.02651357091963291
nosologic O 0 0.2543337047100067
identity O 0 0.029949378222227097
between O 0 0.01545361801981926
these O 0 0.014969048090279102
disorders O 1 0.9999994039535522
, O 0 0.011710865423083305
we O 0 0.007478644605726004
reviewed O 0 0.01601448841392994
the O 0 0.0070440396666526794
literature O 0 0.012594242580235004
and O 0 0.007166118826717138
obtained O 0 0.011967252939939499
a O 0 0.01266585011035204
follow O 0 0.021738272160291672
- O 0 0.03655474632978439
up O 0 0.010102085769176483
of O 0 0.005493584088981152
the O 0 0.007506256923079491
only O 0 0.007619828451424837
two O 0 0.00915196817368269
surviving O 0 0.06176570802927017
patients O 1 0.9995459914207458
, O 0 0.01123099122196436
one O 0 0.012593911029398441
with O 0 0.026467863470315933
SJS B-Disease 1 0.9999995231628418
type I-Disease 0 0.0760616585612297
2 I-Disease 0 0.02413560263812542
at O 0 0.015041123144328594
age O 0 0.020605461671948433
10 O 0 0.011174806393682957
years O 0 0.009633238427340984
and O 0 0.00815765280276537
another O 0 0.016775231808423996
with O 0 0.017654625698924065
SWS B-Disease 1 0.9998296499252319
at O 0 0.026190783828496933
age O 0 0.029602712020277977
7 O 0 0.025058923289179802
years O 0 0.017098991200327873
. O 0 0.025338632985949516

Patients O 1 0.9998888969421387
reported O 0 0.04270956292748451
as O 0 0.01375529170036316
having O 0 0.03061884082853794
either O 0 0.04871351644396782
neonatal O 1 1.0
SJS B-Disease 1 0.9999998807907104
or O 0 0.05020071938633919
SWS B-Disease 1 0.9999291896820068
presented O 0 0.026095658540725708
a O 0 0.019107965752482414
combination O 0 0.043769147247076035
of O 0 0.010728409513831139
a O 0 0.02569449134171009
severe O 1 0.9999816417694092
, O 0 0.03425222635269165
prenatal O 1 0.9999998807907104
- O 1 0.9999896287918091
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.054695598781108856
with O 0 0.03240089491009712
congenital B-Disease 1 1.0
joint I-Disease 1 0.9999226331710815
contractures I-Disease 1 1.0
, O 0 0.3197343647480011
respiratory O 1 1.0
and O 0 0.015481822192668915
feeding O 0 0.07313238829374313
difficulties O 0 0.15080605447292328
, O 0 0.01261591725051403
tendency O 0 0.06704990565776825
to O 0 0.020855598151683807
hyperthermia B-Disease 1 0.9999990463256836
, O 0 0.013713609427213669
and O 0 0.011817212216556072
frequent O 0 0.05234628543257713
death O 0 0.03758708015084267
in O 0 0.015895362943410873
infancy O 0 0.46643877029418945
) O 0 0.01615716889500618
with O 0 0.01005549170076847
a O 0 0.02103930152952671
distinct O 0 0.06123718246817589
campomelic B-Disease 1 0.9995725750923157
- I-Disease 1 0.9841894507408142
metaphyseal I-Disease 1 0.9996322393417358
skeletal I-Disease 1 0.9999897480010986
dysplasia I-Disease 1 0.9999998807907104
. O 0 0.0505787692964077

The O 0 0.02284081093966961
similarity O 0 0.040473371744155884
of O 0 0.009734348393976688
the O 0 0.01573125459253788
clinical O 1 0.9945698380470276
and O 0 0.017092078924179077
radiographic O 1 0.9990814924240112
findings O 0 0.039195284247398376
is O 0 0.010866592638194561
so O 0 0.009637719951570034
extensive O 0 0.02067144773900509
that O 0 0.008853319101035595
these O 0 0.010865362361073494
disorders O 1 0.999991774559021
appear O 0 0.018428267911076546
to O 0 0.0062042283825576305
be O 0 0.005714056082069874
a O 0 0.011277956888079643
single O 0 0.02607334777712822
entity O 0 0.05047731474041939
. O 0 0.028190990909934044

The O 0 0.025463031604886055
follow O 0 0.03589235246181488
- O 0 0.05350560322403908
up O 0 0.018375804647803307
observation O 0 0.0419352650642395
of O 0 0.006670741364359856
an O 0 0.010039185173809528
identical O 0 0.021032899618148804
and O 0 0.008529768325388432
unique O 0 0.02241857536137104
pattern O 0 0.050369780510663986
of O 0 0.016262762248516083
progressive O 1 0.9997712969779968
bone B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
in O 0 0.01266511157155037
the O 0 0.010055048391222954
two O 0 0.013374644331634045
patients O 1 0.9999628067016602
( O 0 0.021759968250989914
one O 0 0.012223714031279087
with O 0 0.02477492392063141
SJS B-Disease 1 0.9999995231628418
type I-Disease 0 0.0664280354976654
2 I-Disease 0 0.02045021578669548
, O 0 0.00858532264828682
one O 0 0.010786082595586777
with O 0 0.02095346711575985
SWS B-Disease 1 0.9999178647994995
) O 0 0.03406042233109474
surviving O 0 0.05951874703168869
beyond O 0 0.0493462011218071
infancy O 0 0.29691046476364136
adds O 0 0.046735215932130814
to O 0 0.00851218868046999
the O 0 0.008114133961498737
evidence O 0 0.012914118357002735
in O 0 0.00846659392118454
favor O 0 0.018106229603290558
of O 0 0.009619930759072304
identity O 0 0.03753535449504852
. O 0 0.026059886440634727

The O 0 0.03541237488389015
hypothesis O 0 0.08764761686325073
that O 0 0.026457002386450768
SWS B-Disease 1 0.9999231100082397
and O 0 0.044205911457538605
SJS B-Disease 1 0.999998927116394
type I-Disease 0 0.0717146173119545
2 I-Disease 0 0.019183753058314323
are O 0 0.005861024837940931
the O 0 0.01125325821340084
same O 0 0.02290513925254345
disorder O 1 0.9999979734420776
should O 0 0.014219684526324272
be O 0 0.008507481776177883
testable O 0 0.05433942750096321
by O 0 0.01237392146140337
molecular O 0 0.04626859724521637
methods O 0 0.026966312900185585
. O 0 0.013214250095188618
. O 0 0.01922687329351902

A O 0 0.06582965701818466
mouse O 0 0.13395781815052032
model O 0 0.05632506683468819
of O 0 0.029417654499411583
severe O 1 0.9999996423721313
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.19240815937519073
defects O 1 0.9998435974121094
in O 0 0.028135521337389946
hemostasis O 1 0.9999977350234985
and O 0 0.041028618812561035
thrombosis B-Disease 1 1.0
. O 0 0.04151003435254097

von B-Disease 1 0.9868742823600769
Willebrand I-Disease 1 0.9999737739562988
factor I-Disease 0 0.2354760468006134
( I-Disease 0 0.0937686413526535
vWf I-Disease 1 0.999991774559021
) I-Disease 1 0.9960046410560608
deficiency I-Disease 1 1.0
causes O 1 0.9999997615814209
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.023803185671567917
humans O 0 0.055569157004356384
. O 0 0.026917798444628716

We O 0 0.02151024341583252
generated O 0 0.03165673837065697
a O 0 0.024398306384682655
mouse O 0 0.08818764984607697
model O 0 0.028561048209667206
for O 0 0.010473745875060558
this O 0 0.014399582520127296
disease O 1 0.9998785257339478
by O 0 0.013965634629130363
using O 0 0.02412719652056694
gene O 0 0.08767060935497284
targeting O 0 0.07354984432458878
. O 0 0.033295758068561554

vWf B-Disease 1 0.9993622899055481
- I-Disease 1 0.9640740752220154
deficient I-Disease 1 0.99842369556427
mice O 0 0.23800379037857056
appeared O 0 0.042668960988521576
normal O 0 0.041962578892707825
at O 0 0.020901598036289215
birth O 0 0.03575432673096657
; O 0 0.012452514842152596
they O 0 0.006738392636179924
were O 0 0.007961874827742577
viable O 0 0.041730646044015884
and O 0 0.016178878024220467
fertile O 0 0.09951978921890259
. O 0 0.03262864425778389

Neither O 0 0.11195198446512222
vWf O 1 0.980217695236206
nor O 0 0.1064356341958046
vWf O 1 0.9951127171516418
propolypeptide O 1 0.9887977242469788
( O 0 0.092188261449337
von B-Disease 1 0.9988922476768494
Willebrand I-Disease 1 0.9999990463256836
antigen O 1 0.9998657703399658
II O 1 0.8777373433113098
) O 0 0.022370146587491035
were O 0 0.011521066538989544
detectable O 0 0.09609836339950562
in O 0 0.018006956204771996
plasma O 0 0.10721239447593689
, O 0 0.025272149592638016
platelets O 1 0.9609704613685608
, O 0 0.020044533535838127
or O 0 0.028802508488297462
endothelial O 1 0.9988228678703308
cells O 0 0.0628705695271492
of O 0 0.00954784918576479
the O 0 0.01887650415301323
homozygous O 0 0.15312626957893372
mutant O 0 0.17761766910552979
mice O 0 0.21408267319202423
. O 0 0.045978836715221405

The O 0 0.04485223442316055
mutant O 0 0.18899883329868317
mice O 1 0.6077666282653809
exhibited O 0 0.27723637223243713
defects O 1 0.9962843060493469
in O 0 0.02107379212975502
hemostasis O 1 0.99983811378479
with O 0 0.014435648918151855
a O 0 0.02387482486665249
highly O 0 0.05822984129190445
prolonged O 1 0.9999792575836182
bleeding O 1 0.9999990463256836
time O 0 0.02230185829102993
and O 0 0.0168465543538332
spontaneous O 0 0.22634191811084747
bleeding O 1 0.9999582767486572
events O 0 0.025180507451295853
in O 0 0.010176246054470539
approximately O 0 0.019273653626441956
10 O 0 0.01473294012248516
% O 0 0.019698454067111015
of O 0 0.013719810172915459
neonates O 1 0.9978209733963013
. O 0 0.036954279989004135

As O 0 0.016867181286215782
in O 0 0.01075070071965456
the O 0 0.013016287237405777
human O 0 0.04014364257454872
disease O 1 0.9999971389770508
, O 0 0.013484327122569084
the O 0 0.014089766889810562
factor O 0 0.06585537642240524
VIII O 1 0.9586023092269897
level O 0 0.026045246049761772
in O 0 0.01081931497901678
these O 0 0.011016681790351868
mice O 0 0.0913463905453682
was O 0 0.01805010251700878
reduced O 0 0.027490917593240738
strongly O 0 0.020559018477797508
as O 0 0.006966767366975546
a O 0 0.010720133781433105
result O 0 0.012327900156378746
of O 0 0.005558007396757603
the O 0 0.00864950381219387
lack O 0 0.022322556003928185
of O 0 0.009626185521483421
protection O 0 0.03400587663054466
provided O 0 0.028295911848545074
by O 0 0.021619638428092003
vWf O 1 0.986357569694519
. O 0 0.04008207842707634

Defective O 1 0.9999144077301025
thrombosis B-Disease 1 0.9999997615814209
in O 0 0.04169422388076782
mutant O 0 0.1426422894001007
mice O 0 0.13243937492370605
was O 0 0.018895655870437622
also O 0 0.009207373484969139
evident O 0 0.02539954148232937
in O 0 0.006720162462443113
an O 0 0.008664559572935104
in O 0 0.012599592097103596
vivo O 0 0.13117626309394836
model O 0 0.04209505021572113
of O 0 0.02351575344800949
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999736547470093
. O 0 0.03199527785181999

In O 0 0.01597757637500763
this O 0 0.010580597445368767
model O 0 0.030772732570767403
, O 0 0.013632460497319698
the O 0 0.020459843799471855
exteriorized O 1 0.7872933149337769
mesentery O 1 0.9467796683311462
was O 0 0.040414582937955856
superfused O 1 0.7900460362434387
with O 0 0.028679583221673965
ferric O 1 0.9999681711196899
chloride O 1 0.9715201258659363
and O 0 0.012630199082195759
the O 0 0.015452172607183456
accumulation O 0 0.09961899369955063
of O 0 0.02237532287836075
fluorescently O 1 0.985114336013794
labeled O 0 0.11872593313455582
platelets O 1 0.850039005279541
was O 0 0.02749769017100334
observed O 0 0.03279757872223854
by O 0 0.019437123090028763
intravital O 0 0.47584351897239685
microscopy O 0 0.14731325209140778
. O 0 0.03453157842159271

We O 0 0.022332174703478813
conclude O 0 0.04621172696352005
that O 0 0.008411482907831669
these O 0 0.009867260232567787
mice O 0 0.09735627472400665
very O 0 0.02216341719031334
closely O 0 0.037411198019981384
mimic O 1 0.9992341995239258
severe O 1 0.9999973773956299
human O 1 0.9507694840431213
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.010812969878315926
will O 0 0.006986118387430906
be O 0 0.005670542363077402
very O 0 0.007950583472847939
useful O 0 0.012596674263477325
for O 0 0.006281163543462753
investigating O 0 0.024487478658556938
the O 0 0.0077700805850327015
role O 0 0.01730044186115265
of O 0 0.012444734573364258
vWf O 1 0.7798113822937012
in O 0 0.015950707718729973
normal O 0 0.04356733337044716
physiology O 0 0.29754534363746643
and O 0 0.01244912575930357
in O 0 0.017894702032208443
disease O 1 0.9999994039535522
models O 0 0.03934919461607933
. O 0 0.01424673292785883
. O 0 0.021856946870684624

Oral O 1 0.6380195021629333
contraceptives O 1 0.7186560034751892
and O 0 0.013213865458965302
the O 0 0.014122527092695236
risk O 1 0.9742344617843628
of O 0 0.023892490193247795
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04379383847117424

Hereditary B-Disease 1 0.9999991655349731
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999332427978516
Study O 0 0.04423990100622177
Group O 0 0.04263194650411606
. O 0 0.024499282240867615

BACKGROUND O 0 0.09241049736738205
Women O 0 0.039707936346530914
with O 0 0.016346968710422516
mutations O 0 0.07016550004482269
in O 0 0.010746227577328682
either O 0 0.016123414039611816
the O 0 0.016288811340928078
BRCA1 O 1 0.9986597299575806
or O 0 0.02581753395497799
the O 0 0.023182736709713936
BRCA2 O 1 0.999288022518158
gene O 0 0.08005853742361069
have O 0 0.011496265418827534
a O 0 0.016062680631875992
high O 0 0.03196725249290466
lifetime O 1 0.9104084372520447
risk O 1 0.9987704157829285
of O 0 0.04545953497290611
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04121541976928711

Oral O 1 0.8991149663925171
contraceptives O 1 0.9965887069702148
protect O 0 0.4243427515029907
against O 1 0.9196785688400269
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.01352036464959383
general O 0 0.013006188906729221
, O 0 0.007731589954346418
but O 0 0.005679181776940823
it O 0 0.005714381113648415
is O 0 0.007114802952855825
not O 0 0.00607528118416667
known O 0 0.011737030930817127
whether O 0 0.009487949311733246
they O 0 0.005346601828932762
also O 0 0.007772397715598345
protect O 0 0.024653606116771698
against O 0 0.018470467999577522
hereditary B-Disease 1 0.9940198659896851
forms I-Disease 0 0.04064783453941345
of I-Disease 0 0.056566838175058365
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04329151287674904

METHODS O 0 0.06820151209831238
We O 0 0.023344898596405983
enrolled O 0 0.08325465023517609
207 O 0 0.3986300230026245
women O 0 0.04957665503025055
with O 0 0.032518237829208374
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.015224503353238106
161 O 0 0.044171445071697235
of O 0 0.0062723951414227486
their O 0 0.007475109770894051
sisters O 0 0.028884436935186386
as O 0 0.008102865889668465
controls O 0 0.023341376334428787
in O 0 0.007151193451136351
a O 0 0.014452320523560047
case O 0 0.022468026727437973
- O 0 0.056062906980514526
control O 0 0.03829753398895264
study O 0 0.034874867647886276
. O 0 0.024265682324767113

All O 0 0.01485530100762844
the O 0 0.017746146768331528
patients O 1 0.9987196922302246
carried O 0 0.02930363267660141
a O 0 0.031359970569610596
pathogenic O 0 0.15766793489456177
mutation O 0 0.12941981852054596
in O 0 0.0180239025503397
either O 0 0.035226527601480484
BRCA1 O 1 0.9967317581176758
( O 0 0.04735888913273811
179 O 0 0.0911710187792778
women O 0 0.03962972015142441
) O 0 0.029795551672577858
or O 0 0.0331585556268692
BRCA2 O 1 0.9993213415145874
( O 0 0.04119193181395531
28 O 0 0.03001815266907215
women O 0 0.03437437117099762
) O 0 0.025369802489876747
. O 0 0.02255820482969284

The O 0 0.024613836780190468
control O 0 0.038646575063467026
women O 0 0.029308924451470375
were O 0 0.010827310383319855
enrolled O 0 0.047310732305049896
regardless O 0 0.024021603167057037
of O 0 0.006463535595685244
whether O 0 0.012437527999281883
or O 0 0.010703286156058311
not O 0 0.0062676239758729935
they O 0 0.006086134351789951
had O 0 0.01395723968744278
either O 0 0.026930727064609528
mutation O 0 0.1432580202817917
. O 0 0.029438655823469162

Lifetime O 0 0.1260439157485962
histories O 0 0.07469835877418518
of O 0 0.01950441673398018
oral O 1 0.9482712745666504
- O 0 0.24462677538394928
contraceptive O 1 0.9836408495903015
use O 0 0.01592704840004444
were O 0 0.006441709119826555
obtained O 0 0.012784415856003761
by O 0 0.008966045454144478
interview O 0 0.028108034282922745
or O 0 0.011973400600254536
by O 0 0.00774921290576458
written O 0 0.011657173745334148
questionnaire O 0 0.044334739446640015
and O 0 0.007369522470980883
were O 0 0.007535709533840418
compared O 0 0.022869490087032318
between O 0 0.01782616600394249
patients O 1 0.9999343156814575
and O 0 0.010473774746060371
control O 0 0.025702686980366707
women O 0 0.02350248582661152
, O 0 0.010805835947394371
after O 0 0.01569022797048092
adjustment O 0 0.03942613676190376
for O 0 0.006964735221117735
year O 0 0.010671907104551792
of O 0 0.007990009151399136
birth O 0 0.03905206546187401
and O 0 0.014390184544026852
parity O 0 0.09338054060935974
. O 0 0.032595857977867126

RESULTS O 0 0.057199060916900635
The O 0 0.020853105932474136
adjusted O 0 0.06782738119363785
odds O 0 0.09533723443746567
ratio O 0 0.09638644754886627
for O 0 0.0580454096198082
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0248207189142704
with O 0 0.00795879028737545
any O 0 0.008130582049489021
past O 0 0.01128566823899746
use O 0 0.010112730786204338
of O 0 0.009782287292182446
oral O 0 0.2407931536436081
contraceptives O 1 0.8680970072746277
was O 0 0.026835737749934196
0 O 0 0.05513754487037659
. O 0 0.024323342368006706

5 O 0 0.05264325067400932
( O 0 0.03179679065942764
95 O 0 0.04624802619218826
percent O 0 0.03249114379286766
confidence O 0 0.04067309573292732
interval O 0 0.06399444490671158
, O 0 0.01589721068739891
0 O 0 0.03523978590965271
. O 0 0.008525289595127106
3 O 0 0.017634466290473938
to O 0 0.011358163319528103
0 O 0 0.035739004611968994
. O 0 0.010526006110012531
8 O 0 0.02476694993674755
) O 0 0.021803727373480797
. O 0 0.023201126605272293

The O 0 0.040555838495492935
risk O 1 0.5104846954345703
decreased O 0 0.05974370241165161
with O 0 0.012770143337547779
increasing O 0 0.025974782183766365
duration O 0 0.05477890744805336
of O 0 0.00944312009960413
use O 0 0.020227758213877678
( O 0 0.03612552955746651
P O 0 0.4969634413719177
for O 0 0.014827970415353775
trend O 0 0.05487874522805214
, O 0 0.02603471651673317
< O 0 0.14969170093536377
0 O 0 0.05435197055339813
. O 0 0.020410584285855293
001 O 0 0.18989792466163635
) O 0 0.02274555340409279
; O 0 0.01166853029280901
use O 0 0.008416145108640194
for O 0 0.006242691073566675
six O 0 0.012235325761139393
or O 0 0.010156610049307346
more O 0 0.006408729124814272
years O 0 0.010362649336457253
was O 0 0.012374481186270714
associated O 0 0.015049159526824951
with O 0 0.008294720202684402
a O 0 0.016274163499474525
60 O 0 0.029109572991728783
percent O 0 0.02823900245130062
reduction O 0 0.06646416336297989
in O 0 0.019901340827345848
risk O 1 0.7614511847496033
. O 0 0.028659630566835403

Oral O 1 0.9730720520019531
- O 1 0.500210165977478
contraceptive O 1 0.9979608058929443
use O 0 0.030987700447440147
protected O 0 0.06592731922864914
against O 1 0.510025143623352
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.011590235866606236
for O 0 0.008647504262626171
carriers O 0 0.052900154143571854
of O 0 0.010961980558931828
the O 0 0.023335181176662445
BRCA1 O 1 0.9995703101158142
mutation O 0 0.47956568002700806
( O 0 0.05199183523654938
odds O 0 0.0879475399851799
ratio O 0 0.06155742332339287
, O 0 0.01648099347949028
0 O 0 0.0390205942094326
. O 0 0.010733025148510933
5 O 0 0.01922626420855522
; O 0 0.014236880466341972
95 O 0 0.03369961678981781
percent O 0 0.024890022352337837
confidence O 0 0.04100406914949417
interval O 0 0.06288650631904602
, O 0 0.014150949195027351
0 O 0 0.03252844884991646
. O 0 0.008385971188545227
3 O 0 0.01448815781623125
to O 0 0.010745532810688019
0 O 0 0.03481290861964226
. O 0 0.010780544020235538
9 O 0 0.022478491067886353
) O 0 0.010753600858151913
and O 0 0.005751396995037794
for O 0 0.008335656486451626
carriers O 0 0.044222332537174225
of O 0 0.01108129695057869
the O 0 0.027780024334788322
BRCA2 O 1 0.9996947050094604
mutation O 0 0.2837387025356293
( O 0 0.04766938090324402
odds O 0 0.08193809539079666
ratio O 0 0.06772780418395996
, O 0 0.01571696624159813
0 O 0 0.03746076300740242
. O 0 0.009913580492138863
4 O 0 0.021089330315589905
; O 0 0.015530548989772797
95 O 0 0.03672399744391441
percent O 0 0.028237665072083473
confidence O 0 0.046543654054403305
interval O 0 0.06886828690767288
, O 0 0.01582612842321396
0 O 0 0.03381555899977684
. O 0 0.008601979352533817
2 O 0 0.016151729971170425
to O 0 0.00971921905875206
1 O 0 0.019572168588638306
. O 0 0.012674451805651188
1 O 0 0.02394411899149418
) O 0 0.02495039999485016
. O 0 0.024647753685712814

CONCLUSIONS O 0 0.10029900074005127
Oral O 1 0.8747534155845642
- O 0 0.17387200891971588
contraceptive O 1 0.9969484210014343
use O 0 0.02370862476527691
may O 0 0.02151191048324108
reduce O 0 0.03591282293200493
the O 0 0.016508344560861588
risk O 1 0.9985654950141907
of O 0 0.03330310806632042
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.01581345498561859
women O 0 0.025435928255319595
with O 0 0.01587483286857605
pathogenic O 0 0.15333132445812225
mutations O 0 0.11247751116752625
in O 0 0.015518400818109512
the O 0 0.025692826136946678
BRCA1 O 1 0.9995331764221191
or O 0 0.06897911429405212
BRCA2 O 1 0.9995905756950378
gene O 0 0.2553711533546448

A O 0 0.04669402167201042
Japanese O 0 0.04158397391438484
family O 0 0.03299500048160553
with O 0 0.025372644886374474
adrenoleukodystrophy B-Disease 1 0.9999991655349731
with O 0 0.022024787962436676
a O 0 0.037251632660627365
codon O 0 0.17753104865550995
291 O 0 0.18772542476654053
deletion O 0 0.17248857021331787
: O 0 0.03219640254974365
a O 0 0.025148095563054085
clinical O 1 0.9704871773719788
, O 0 0.020230792462825775
biochemical O 0 0.0967508852481842
, O 0 0.020890699699521065
pathological O 1 0.8593721389770508
, O 0 0.012991048395633698
and O 0 0.011220824904739857
genetic O 0 0.06008325517177582
report O 0 0.024446936324238777
. O 0 0.023302936926484108

We O 0 0.017472077161073685
report O 0 0.014943968504667282
a O 0 0.015726543962955475
Japanese O 0 0.027943748980760574
family O 0 0.030451368540525436
with O 0 0.03268995136022568
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9097471833229065
ALD B-Disease 1 1.0
) O 0 0.02398936077952385
with O 0 0.009052800014615059
a O 0 0.012524275109171867
three O 0 0.011840388178825378
base O 0 0.03812514245510101
pair O 0 0.060260191559791565
deletion O 0 0.16539564728736877
( O 0 0.057367097586393356
delGAG O 1 0.7437742352485657
291 O 0 0.13479097187519073
) O 0 0.022716287523508072
in O 0 0.015353860333561897
the O 0 0.03253398835659027
ALD B-Disease 1 1.0
gene O 0 0.1630776971578598
. O 0 0.03752574324607849

A O 0 0.03963632881641388
variety O 0 0.022583981975913048
of O 0 0.012678497470915318
phenotypes O 0 0.11545352637767792
were O 0 0.011614132672548294
observed O 0 0.02395140938460827
within O 0 0.011497033759951591
this O 0 0.009706367738544941
family O 0 0.03427734598517418
. O 0 0.02440212480723858

While O 0 0.02938210219144821
the O 0 0.026336027309298515
proband O 1 0.9844004511833191
( O 0 0.052683088928461075
patient O 1 0.9977996945381165
1 O 0 0.026286771520972252
) O 0 0.01451457105576992
was O 0 0.010894899256527424
classified O 0 0.019061338156461716
as O 0 0.007688869256526232
having O 0 0.0176108218729496
a O 0 0.017134319990873337
rare O 0 0.04313001036643982
intermediate O 0 0.054716482758522034
type O 0 0.042954426258802414
of O 0 0.011330947279930115
adult O 0 0.07152438163757324
cerebral O 1 0.9999923706054688
and O 0 0.025034723803400993
cerebello O 1 0.9999711513519287
- O 1 0.9909886717796326
brain O 1 0.9984443783760071
stem O 0 0.07774614542722702
forms O 0 0.024271124973893166
, O 0 0.010434150695800781
his O 0 0.014686890877783298
younger O 0 0.04921925067901611
brother O 0 0.05616658553481102
( O 0 0.041060563176870346
patient O 1 0.9985252022743225
2 O 0 0.028928933665156364
) O 0 0.017221828922629356
and O 0 0.011903676204383373
nephew O 0 0.10164234042167664
( O 0 0.044219378381967545
patient O 1 0.9941294193267822
3 O 0 0.028613770380616188
) O 0 0.01589375175535679
had O 0 0.015380779281258583
a O 0 0.028509847819805145
childhood O 1 0.999882698059082
ALD B-Disease 1 1.0
type O 1 0.5874537229537964
. O 0 0.0318741537630558

Another O 0 0.0725388377904892
nephew O 0 0.15063759684562683
( O 0 0.056237634271383286
patient O 1 0.9893143177032471
4 O 0 0.030106205493211746
) O 0 0.015174455009400845
of O 0 0.010690519586205482
patient O 1 0.9915783405303955
1 O 0 0.019715238362550735
was O 0 0.011762067675590515
classified O 0 0.022842833772301674
as O 0 0.008138388395309448
having O 0 0.017993967980146408
an O 0 0.015919780358672142
adolescent O 1 0.9750319123268127
form O 0 0.04063820466399193
. O 0 0.0314362607896328

The O 0 0.03783779963850975
tau O 0 0.13023047149181366
level O 0 0.03334483504295349
in O 0 0.01543841790407896
the O 0 0.023912934586405754
cerebrospinal O 1 0.9997482895851135
fluid O 1 0.9204760789871216
( O 0 0.06664849072694778
CSF O 1 0.9994809031486511
) O 0 0.027308426797389984
in O 0 0.015546800568699837
patient O 1 0.9232703447341919
1 O 0 0.018069753423333168
was O 0 0.009364685043692589
as O 0 0.006349056959152222
high O 0 0.014171432703733444
as O 0 0.006526848301291466
that O 0 0.006047227419912815
of O 0 0.01265366654843092
patients O 1 0.9999988079071045
with O 0 0.22719885408878326
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.06244014948606491
AD B-Disease 0 0.2685129642486572
) O 0 0.032625529915094376
. O 0 0.02203608863055706

His O 0 0.06187546253204346
brain O 1 0.9331209659576416
magnetic O 0 0.0993615984916687
resonance O 0 0.12837378680706024
image O 0 0.07558682560920715
( O 0 0.050640903413295746
MRI O 1 0.9995074272155762
) O 0 0.028431981801986694
showed O 0 0.03723043575882912
abnormalities B-Disease 1 0.739772379398346
in I-Disease 0 0.008664371445775032
the I-Disease 0 0.011122668161988258
bilateral I-Disease 0 0.04904542490839958
cerebellar I-Disease 1 0.9999778270721436
hemispheres I-Disease 1 0.6678491830825806
and O 0 0.024120014160871506
brain O 1 0.9995754361152649
stem O 0 0.07517877966165543
, O 0 0.009414705447852612
but O 0 0.006344846915453672
not O 0 0.005355785135179758
in O 0 0.007410354446619749
the O 0 0.016509460285305977
cerebral O 1 0.9999991655349731
white O 0 0.062045272439718246
matter O 0 0.016732333227992058
, O 0 0.009480517357587814
where O 0 0.012099210172891617
marked O 0 0.02586984634399414
reductions O 0 0.041632138192653656
of O 0 0.009393011219799519
the O 0 0.022248748689889908
cerebral O 1 0.9999980926513672
blood O 1 0.9866132140159607
flow O 0 0.05676215514540672
and O 0 0.019628698006272316
oxygen O 1 0.7488616108894348
metabolism O 0 0.1194087341427803
were O 0 0.011539086699485779
clearly O 0 0.027125393971800804
demonstrated O 0 0.04315456748008728
by O 0 0.020141595974564552
positron O 0 0.29047891497612
emission O 0 0.1748075932264328
tomography O 0 0.26250603795051575
( O 0 0.05764194205403328
PET O 1 0.7407727241516113
) O 0 0.03359770029783249
. O 0 0.02706778235733509

In O 0 0.04071762412786484
patients O 1 0.9984661340713501
2 O 0 0.020705366507172585
and O 0 0.009800372645258904
3 O 0 0.017910348251461983
, O 0 0.008399606682360172
the O 0 0.01107159722596407
autopsy O 1 0.6084313988685608
findings O 0 0.04078591242432594
showed O 0 0.039864107966423035
massive O 0 0.08977443724870682
demyelination B-Disease 1 0.9999927282333374
of I-Disease 0 0.014302973635494709
the I-Disease 0 0.021396681666374207
cerebral I-Disease 1 0.999998927116394
white I-Disease 0 0.038366783410310745
matter I-Disease 0 0.01458044070750475
with O 0 0.010886569507420063
sparing O 0 0.0703805610537529
of O 0 0.009366046637296677
the O 0 0.01820872537791729
U O 1 0.9966192245483398
- O 0 0.09760893881320953
fibers O 0 0.17686116695404053
, O 0 0.011437781155109406
compatible O 0 0.022308005020022392
with O 0 0.0071104043163359165
the O 0 0.009282429702579975
findings O 0 0.02931874990463257
of O 0 0.015724292024970055
childhood O 1 0.9998708963394165
ALD B-Disease 1 1.0
. O 0 0.05184610188007355

Oleic O 1 0.5767399668693542
and O 0 0.051931463181972504
erucic O 1 0.992486834526062
acids O 0 0.12717309594154358
( O 0 0.0517333522439003
Lorenzos O 0 0.3688933253288269
Oil O 0 0.040808405727148056
) O 0 0.019114261493086815
were O 0 0.00907190702855587
administered O 0 0.05785325914621353
to O 0 0.01626753807067871
patients O 1 0.9991002082824707
1 O 0 0.019604191184043884
and O 0 0.008604558184742928
4 O 0 0.016929959878325462
, O 0 0.0077919866889715195
but O 0 0.008335470221936703
sufficient O 0 0.02716858498752117
effectiveness O 0 0.059555403888225555
was O 0 0.012690046802163124
not O 0 0.007960804738104343
obtained O 0 0.020840534940361977
. O 0 0.02347906306385994

The O 0 0.021681735292077065
findings O 0 0.028243815526366234
in O 0 0.00811326876282692
this O 0 0.007791411131620407
family O 0 0.021363701671361923
suggest O 0 0.026856210082769394
that O 0 0.00873108021914959
delGAG291 O 0 0.10311056673526764
is O 0 0.009210196323692799
part O 0 0.010744909755885601
of O 0 0.006326358765363693
the O 0 0.012422217056155205
cause O 0 0.05008959397673607
of O 0 0.014538940042257309
Japanese O 0 0.1263255625963211
ALD B-Disease 1 1.0
with O 0 0.029959676787257195
phenotypic O 0 0.12162107974290848
variations O 0 0.06142519414424896
. O 0 0.03122529946267605

Moreover O 0 0.06476256996393204
, O 0 0.011323978193104267
although O 0 0.010188932530581951
the O 0 0.008634825237095356
scale O 0 0.02111375704407692
of O 0 0.006037003360688686
the O 0 0.00904128234833479
study O 0 0.02052278257906437
is O 0 0.0111758504062891
limited O 0 0.017384465783834457
, O 0 0.006389210466295481
there O 0 0.006095245014876127
is O 0 0.007740966975688934
a O 0 0.011416050605475903
possibility O 0 0.022367000579833984
that O 0 0.01249548327177763
PET O 1 0.5185702443122864
can O 0 0.02092304825782776
detect O 0 0.0763922706246376
an O 0 0.024061135947704315
insidious B-Disease 1 0.9997698664665222
lesion I-Disease 1 0.9999942779541016
which O 0 0.016423145309090614
is O 0 0.02011791430413723
undetectable O 1 0.7111549973487854
by O 0 0.022526847198605537
computed O 0 0.1189434751868248
tomogram O 1 0.9479703903198242
( O 0 0.06724383682012558
CT O 1 0.9999922513961792
) O 0 0.03203151747584343
or O 0 0.022239921614527702
MRI O 1 0.9956454038619995
analysis O 0 0.022742902860045433
, O 0 0.006615743972361088
and O 0 0.005266215186566114
that O 0 0.005120978690683842
the O 0 0.008240757510066032
higher O 0 0.02119920402765274
level O 0 0.022628262639045715
of O 0 0.01036171056330204
tau O 0 0.0902884379029274
reflects O 0 0.029577551409602165
the O 0 0.009184537455439568
process O 0 0.014368126168847084
of O 0 0.014710853807628155
neuronal B-Disease 1 0.9983441829681396
degeneration I-Disease 1 0.9999995231628418
in O 0 0.0433853454887867
ALD B-Disease 1 1.0
. O 0 0.044327836483716965

Lorenzos O 1 0.6767262816429138
Oil O 0 0.04616009443998337
should O 0 0.014257806353271008
be O 0 0.00573548162356019
given O 0 0.00770934671163559
in O 0 0.005335764493793249
the O 0 0.008241990581154823
early O 0 0.01960047334432602
stage O 0 0.05109183117747307
. O 0 0.014460147358477116
. O 0 0.024321317672729492

Nonsense O 0 0.17301461100578308
mutation O 0 0.1564236432313919
in O 0 0.021703684702515602
exon O 0 0.12087541818618774
4 O 0 0.02802184224128723
of O 0 0.011675289832055569
human O 0 0.03350502997636795
complement O 0 0.09132625162601471
C9 O 1 0.9998819828033447
gene O 0 0.08477304130792618
is O 0 0.011822503060102463
the O 0 0.01102618221193552
major O 0 0.0221285130828619
cause O 0 0.04064691439270973
of O 0 0.010559133253991604
Japanese O 0 0.05227019637823105
complement B-Disease 1 0.7329450249671936
C9 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
. O 0 0.046214617788791656

Deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.017232365906238556
the I-Disease 0 0.014827531762421131
ninth I-Disease 0 0.05792186036705971
component I-Disease 0 0.03910871595144272
of I-Disease 0 0.01023380272090435
human I-Disease 0 0.026609845459461212
complement I-Disease 0 0.07290613651275635
( O 0 0.045835044234991074
C9 O 1 0.9997798800468445
) O 0 0.022149112075567245
is O 0 0.00883184652775526
the O 0 0.008059441111981869
most O 0 0.012095746584236622
common O 0 0.04450163617730141
complement B-Disease 1 0.9998778104782104
deficiency I-Disease 1 1.0
in O 0 0.015708189457654953
Japan O 0 0.022917285561561584
but O 0 0.009974242188036442
is O 0 0.00931961927562952
rare O 0 0.022539177909493446
in O 0 0.007879296317696571
other O 0 0.006701278500258923
countries O 0 0.01521320454776287
. O 0 0.024574892595410347

We O 0 0.01846371777355671
studied O 0 0.020890669897198677
the O 0 0.01121676154434681
molecular O 0 0.03836798667907715
basis O 0 0.016551757231354713
of O 0 0.01749698631465435
C9 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
in O 0 0.016395602375268936
four O 0 0.016946151852607727
Japanese O 0 0.0781330093741417
C9 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9988605976104736
deficient I-Disease 1 0.9999921321868896
patients O 1 0.999984622001648
who O 0 0.0282053854316473
had O 0 0.03212786093354225
suffered O 1 0.9999990463256836
from O 0 0.2771819233894348
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.05337802320718765

Direct O 0 0.06246499717235565
sequencing O 0 0.08166728913784027
of O 0 0.023094307631254196
amplified O 0 0.1653740555047989
C9 O 1 0.9922770261764526
cDNA O 0 0.14864392578601837
and O 0 0.017754927277565002
DNA O 0 0.05262507125735283
revealed O 0 0.033169347792863846
a O 0 0.0240363497287035
nonsense O 0 0.09092725813388824
substitution O 0 0.09822314977645874
( O 0 0.04705628380179405
CGA O 1 0.9949437975883484
- O 1 0.6508674025535583
- O 0 0.20185455679893494
> O 0 0.38825398683547974
TGA O 1 0.985313892364502
) O 0 0.04021546617150307
at O 0 0.03287521377205849
codon O 0 0.10640979558229446
95 O 0 0.04538002610206604
in O 0 0.014997909776866436
exon O 0 0.09449446946382523
4 O 0 0.02232467010617256
in O 0 0.008409064263105392
the O 0 0.011877523735165596
four O 0 0.026157986372709274
C9 B-Disease 1 0.9999935626983643
- I-Disease 1 0.577695906162262
deficient I-Disease 1 0.9917857050895691
individuals O 0 0.04261869937181473
. O 0 0.030833739787340164

An O 0 0.05065983161330223
allele O 0 0.208138570189476
- O 0 0.1140974685549736
specific O 0 0.05234023928642273
polymerase O 0 0.18650279939174652
chain O 0 0.09996803104877472
reaction O 0 0.07528815418481827
system O 0 0.031083887442946434
designed O 0 0.028735026717185974
to O 0 0.012354506179690361
detect O 0 0.0558772049844265
exclusively O 0 0.015673194080591202
only O 0 0.006585677154362202
one O 0 0.006232587620615959
of O 0 0.005584610626101494
the O 0 0.010465466417372227
normal O 0 0.03604211285710335
and O 0 0.01519775390625
mutant O 0 0.10503967106342316
alleles O 0 0.128051295876503
indicated O 0 0.033312149345874786
that O 0 0.0061283172108232975
all O 0 0.004879160318523645
the O 0 0.008494716137647629
four O 0 0.014716391451656818
patients O 1 0.9992792010307312
were O 0 0.01112933736294508
homozygous O 0 0.0660279169678688
for O 0 0.008746041916310787
the O 0 0.014627204276621342
mutation O 0 0.10062011331319809
in O 0 0.01729341596364975
exon O 0 0.1153893992304802
4 O 0 0.02353265881538391
and O 0 0.007307069376111031
that O 0 0.0060226283967494965
the O 0 0.00871203001588583
parents O 0 0.025812696665525436
of O 0 0.011948025785386562
patient O 1 0.9947196245193481
2 O 0 0.025904657319188118
were O 0 0.01407158188521862
heterozygous O 0 0.11797928065061569
. O 0 0.029671471565961838

The O 0 0.02990209124982357
common O 0 0.050691962242126465
mutation O 0 0.15057174861431122
at O 0 0.03953054919838905
codon O 0 0.1212691068649292
95 O 0 0.04847855493426323
in O 0 0.017466478049755096
exon O 0 0.12388846278190613
4 O 0 0.03005122020840645
might O 0 0.01751956157386303
be O 0 0.006614837795495987
responsible O 0 0.015193428844213486
for O 0 0.0067899832502007484
most O 0 0.011426744051277637
Japanese O 0 0.16015207767486572
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.025989551097154617
. O 0 0.02683013305068016

BRCA1 O 1 0.8972988128662109
required O 0 0.0395500622689724
for O 0 0.019381456077098846
transcription O 0 0.10688215494155884
- O 0 0.09847802668809891
coupled O 0 0.10567111521959305
repair O 1 0.840475857257843
of O 0 0.023233244195580482
oxidative O 1 0.8771503567695618
DNA O 0 0.11931152641773224
damage O 0 0.11946430057287216
. O 0 0.03295047953724861

The O 0 0.05492808297276497
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9114486575126648
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.99982750415802
gene O 0 0.22619618475437164
BRCA1 O 1 0.9934554696083069
encodes O 0 0.11359499394893646
a O 0 0.04434284195303917
zinc O 1 0.9633732438087463
finger O 0 0.13937094807624817
protein O 0 0.055925153195858
of O 0 0.01208699680864811
unknown O 0 0.03417643904685974
function O 0 0.0366312600672245
. O 0 0.023012157529592514

Association O 0 0.05958294868469238
of O 0 0.01256610732525587
the O 0 0.021829310804605484
BRCA1 O 1 0.991754412651062
protein O 0 0.0579291470348835
with O 0 0.011189642362296581
the O 0 0.015329370275139809
DNA O 0 0.08583087474107742
repair O 1 0.955851674079895
protein O 0 0.10267027467489243
Rad51 O 1 0.9957197308540344
and O 0 0.011490263044834137
changes O 0 0.013303924351930618
in O 0 0.007268224842846394
the O 0 0.010826723650097847
phosphorylation O 0 0.05702891945838928
and O 0 0.01373296044766903
cellular O 0 0.059066712856292725
localization O 0 0.05457073450088501
of O 0 0.008443598635494709
the O 0 0.013390417210757732
protein O 0 0.05614522844552994
after O 0 0.027026280760765076
exposure O 1 0.7702340483665466
to O 0 0.017146145924925804
DNA O 0 0.07511518895626068
- O 0 0.08387038111686707
damaging O 0 0.08640041202306747
agents O 0 0.03566329926252365
are O 0 0.00736148189753294
consistent O 0 0.02192707173526287
with O 0 0.007292369846254587
a O 0 0.012785498052835464
role O 0 0.019337905570864677
for O 0 0.013024413958191872
BRCA1 O 1 0.998275876045227
in O 0 0.02017858251929283
DNA O 0 0.0916447788476944
repair O 1 0.9485631585121155
. O 0 0.02949373424053192

Here O 0 0.024134986102581024
, O 0 0.011437878012657166
it O 0 0.008612525649368763
is O 0 0.009008309803903103
shown O 0 0.02018273063004017
that O 0 0.012800612486898899
mouse O 0 0.1386553794145584
embryonic O 0 0.14751598238945007
stem O 0 0.14947271347045898
cells O 0 0.13463079929351807
deficient B-Disease 1 0.9951661825180054
in I-Disease 0 0.023948626592755318
BRCA1 I-Disease 1 0.9990131855010986
are O 0 0.013539732433855534
defective O 0 0.11602545529603958
in O 0 0.008827499113976955
the O 0 0.00764719070866704
ability O 0 0.020164957270026207
to O 0 0.007401938550174236
carry O 0 0.017500387504696846
out O 0 0.018288979306817055
transcription O 0 0.08968767523765564
- O 0 0.09043215960264206
coupled O 0 0.10624632239341736
repair O 1 0.785067081451416
of O 0 0.01975046470761299
oxidative O 1 0.9329934120178223
DNA O 0 0.09464550018310547
damage O 0 0.07523258775472641
, O 0 0.011157989501953125
and O 0 0.00815507210791111
are O 0 0.011525345966219902
hypersensitive O 1 0.9305375218391418
to O 0 0.03155221790075302
ionizing O 1 0.9724809527397156
radiation O 1 0.9424076676368713
and O 0 0.025411536917090416
hydrogen O 0 0.12012717127799988
peroxide O 0 0.4558197259902954
. O 0 0.03572814539074898

These O 0 0.01773924008011818
results O 0 0.032939571887254715
suggest O 0 0.03353374823927879
that O 0 0.01750875450670719
BRCA1 O 1 0.9889217615127563
participates O 0 0.08196412771940231
, O 0 0.012257780879735947
directly O 0 0.016134262084960938
or O 0 0.016156796365976334
indirectly O 0 0.04442446678876877
, O 0 0.011142143048346043
in O 0 0.015534975565969944
transcription O 0 0.0948362722992897
- O 0 0.09932221472263336
coupled O 0 0.12225007265806198
repair O 1 0.8125428557395935
of O 0 0.022984281182289124
oxidative O 1 0.8776485919952393
DNA O 0 0.10517238825559616
damage O 0 0.08577434718608856
. O 0 0.01584898866713047
. O 0 0.021433385089039803

Truncation O 0 0.3136495351791382
mutations O 0 0.1353953331708908
in O 0 0.015578052029013634
the O 0 0.01949312351644039
transactivation O 1 0.7992429733276367
region O 0 0.04467879608273506
of O 0 0.01799333468079567
PAX6 O 1 0.9998977184295654
result O 0 0.031606853008270264
in O 0 0.014425897970795631
dominant O 0 0.07180611044168472
- O 0 0.09770188480615616
negative O 0 0.0844837948679924
mutants O 0 0.1299968957901001
. O 0 0.03628382831811905

PAX6 O 1 0.9917661547660828
is O 0 0.03079824335873127
a O 0 0.030349381268024445
transcription O 0 0.07688137143850327
factor O 0 0.03732013702392578
with O 0 0.010319016873836517
two O 0 0.013030451722443104
DNA O 0 0.07821892201900482
- O 0 0.079273521900177
binding O 0 0.05859542265534401
domains O 0 0.07009262591600418
( O 0 0.03799772262573242
paired O 0 0.09313477575778961
box O 0 0.05495154857635498
and O 0 0.020212728530168533
homeobox O 1 0.9865309596061707
) O 0 0.020962223410606384
and O 0 0.010186365805566311
a O 0 0.02522982656955719
proline O 1 0.8171354532241821
- O 0 0.13147881627082825
serine O 0 0.24625173211097717
- O 0 0.14723189175128937
threonine O 0 0.2612043619155884
( O 0 0.0708441287279129
PST O 1 0.9992387294769287
) O 0 0.03676627576351166
- O 0 0.07238959521055222
rich O 0 0.07172814011573792
transactivation O 0 0.27249059081077576
domain O 0 0.07220408320426941
. O 0 0.03403138741850853

PAX6 O 1 0.9997450709342957
regulates O 1 0.6693340539932251
eye O 1 0.9745845794677734
development O 0 0.0299060121178627
in O 0 0.013815788552165031
animals O 0 0.027725962921977043
ranging O 0 0.029088763520121574
from O 0 0.017802471294999123
jellyfish O 0 0.09680362045764923
to O 0 0.016378039494156837
Drosophila O 0 0.07558990269899368
to O 0 0.015328953042626381
humans O 0 0.04478593170642853
. O 0 0.02761969529092312

Heterozygous O 0 0.24815215170383453
mutations O 0 0.13036495447158813
in O 0 0.015002382919192314
the O 0 0.016717344522476196
human O 0 0.044867418706417084
PAX6 O 1 0.9999574422836304
gene O 0 0.09126173704862595
result O 0 0.021008221432566643
in O 0 0.008665034547448158
various O 0 0.01108460407704115
phenotypes O 0 0.11899799108505249
, O 0 0.01425691694021225
including O 0 0.019083837047219276
aniridia B-Disease 1 0.9999403953552246
, O 0 0.028905637562274933
Peters B-Disease 1 0.9997103810310364
anomaly I-Disease 1 0.9997977614402771
, O 0 0.03190365061163902
autosomal B-Disease 1 0.9999244213104248
dominant I-Disease 1 0.9947463870048523
keratitis I-Disease 1 0.9999998807907104
, O 0 0.02466905303299427
and O 0 0.02591881714761257
familial B-Disease 1 0.9999969005584717
foveal I-Disease 1 0.9999898672103882
dysplasia I-Disease 1 1.0
. O 0 0.046009473502635956

It O 0 0.017686722800135612
is O 0 0.013196391984820366
believed O 0 0.02207539603114128
that O 0 0.009051840752363205
the O 0 0.015016794204711914
mutated O 0 0.1372782588005066
allele O 0 0.15649017691612244
of O 0 0.02589677833020687
PAX6 O 1 0.9994557499885559
produces O 0 0.06898742914199829
an O 0 0.02506730891764164
inactive O 0 0.1138961985707283
protein O 0 0.062443140894174576
and O 0 0.01636393554508686
aniridia B-Disease 1 0.99985671043396
is O 0 0.022687213495373726
caused O 0 0.05538227781653404
due O 0 0.023977981880307198
to O 0 0.018336864188313484
genetic O 0 0.09388647973537445
haploinsufficiency O 1 0.7516917586326599
. O 0 0.03840241581201553

However O 0 0.024479858577251434
, O 0 0.0145308468490839
several O 0 0.015084893442690372
truncation O 0 0.1632174402475357
mutations O 0 0.08959805965423584
have O 0 0.010387314483523369
been O 0 0.010395512916147709
found O 0 0.011126886121928692
to O 0 0.008939103223383427
occur O 0 0.023056255653500557
in O 0 0.008317893370985985
the O 0 0.015436303801834583
C O 1 0.8274215459823608
- O 0 0.06951291114091873
terminal O 0 0.07365845143795013
half O 0 0.02183346636593342
of O 0 0.01602451503276825
PAX6 O 1 0.9999446868896484
in O 0 0.02725050039589405
patients O 1 0.9999332427978516
with O 0 0.021053576841950417
Aniridia B-Disease 1 0.999808132648468
resulting O 0 0.04664229974150658
in O 0 0.015573220327496529
mutant O 0 0.08812503516674042
proteins O 0 0.03578472509980202
that O 0 0.009489897638559341
retain O 0 0.029619969427585602
the O 0 0.015219221822917461
DNA O 0 0.07124496251344681
- O 0 0.06755014508962631
binding O 0 0.0459408275783062
domains O 0 0.043367695063352585
but O 0 0.009969544596970081
have O 0 0.007907036691904068
lost O 0 0.019079921767115593
most O 0 0.006410424131900072
of O 0 0.006659938022494316
the O 0 0.014610793441534042
transactivation O 1 0.8976292014122009
domain O 0 0.06459131836891174
. O 0 0.0313640832901001

It O 0 0.01631874404847622
is O 0 0.01070914976298809
not O 0 0.007100844755768776
clear O 0 0.01491750031709671
whether O 0 0.012766276486217976
such O 0 0.010506412014365196
mutants O 0 0.0950406864285469
really O 0 0.03521915152668953
behave O 0 0.04601970687508583
as O 0 0.010757791809737682
loss O 0 0.05768820270895958
- O 0 0.053249292075634
of O 0 0.014579898677766323
- O 0 0.0696016252040863
function O 0 0.04340458661317825
mutants O 0 0.08164715021848679
as O 0 0.012754983268678188
predicted O 0 0.039872005581855774
by O 0 0.018391361460089684
haploinsufficiency O 0 0.32097309827804565
. O 0 0.03491194546222687

Contrary O 0 0.04288798198103905
to O 0 0.009897137992084026
this O 0 0.00900014117360115
theory O 0 0.016658008098602295
, O 0 0.007953796535730362
our O 0 0.009989670477807522
data O 0 0.011280008591711521
showed O 0 0.01703445427119732
that O 0 0.006135710049420595
these O 0 0.0069285910576581955
mutants O 0 0.07275316119194031
are O 0 0.011178609915077686
dominant O 0 0.05921283736824989
- O 0 0.07977147400379181
negative O 0 0.054365452378988266
in O 0 0.02367071993649006
transient O 1 0.9909591674804688
transfection O 1 0.9940643906593323
assays O 0 0.10022268444299698
when O 0 0.016844691708683968
they O 0 0.007348343729972839
are O 0 0.008804972283542156
coexpressed O 0 0.19808416068553925
with O 0 0.01589762419462204
wild O 0 0.053486499935388565
- O 0 0.13280120491981506
type O 0 0.1838797926902771
PAX6 O 1 0.9995920062065125
. O 0 0.04752225801348686

We O 0 0.01606306992471218
found O 0 0.013654678128659725
that O 0 0.006579238921403885
the O 0 0.012567965313792229
dominant O 0 0.07730347663164139
- O 0 0.09179753810167313
negative O 0 0.07454034686088562
effects O 0 0.08064258843660355
result O 0 0.020746121183037758
from O 0 0.010846341028809547
the O 0 0.011087928898632526
enhanced O 0 0.056046683341264725
DNA O 0 0.055992595851421356
binding O 0 0.032467156648635864
ability O 0 0.02308555133640766
of O 0 0.007798152044415474
these O 0 0.011305030435323715
mutants O 0 0.1098482683300972
. O 0 0.032261501997709274

Kinetic O 0 0.11679856479167938
studies O 0 0.03818659484386444
of O 0 0.01228498574346304
binding O 0 0.037759795784950256
and O 0 0.014317858032882214
dissociation O 0 0.15969136357307434
revealed O 0 0.029456712305545807
that O 0 0.007659138645976782
various O 0 0.010235154069960117
truncation O 0 0.11858434230089188
mutants O 0 0.08790139108896255
have O 0 0.014467508532106876
3 O 0 0.030253635719418526
- O 0 0.06561458855867386
5 O 0 0.036048781126737595
- O 0 0.0751686617732048
fold O 0 0.06658170372247696
higher O 0 0.035808250308036804
affinity O 0 0.06399127840995789
to O 0 0.010087463073432446
various O 0 0.013158914633095264
DNA O 0 0.06768230348825455
- O 0 0.06384032964706421
binding O 0 0.04215957224369049
sites O 0 0.021349480375647545
when O 0 0.013322502374649048
compared O 0 0.01735350862145424
with O 0 0.008343664929270744
the O 0 0.013437519781291485
wild O 0 0.05605555698275566
- O 0 0.14208365976810455
type O 0 0.32245251536369324
PAX6 O 1 0.9997703433036804
. O 0 0.04782278835773468

These O 0 0.015528857707977295
results O 0 0.02048092894256115
provide O 0 0.016653673723340034
a O 0 0.012232732959091663
new O 0 0.01598493941128254
insight O 0 0.04695773497223854
into O 0 0.0088875163346529
the O 0 0.007701431401073933
role O 0 0.021402044221758842
of O 0 0.01559141743928194
mutant O 0 0.14617104828357697
PAX6 O 1 0.9998534917831421
in O 0 0.035826798528432846
causing O 1 0.7237197756767273
aniridia B-Disease 1 0.999617338180542
. O 0 0.021520916372537613
. O 0 0.02357717603445053

Reversal O 1 0.6598633527755737
of O 0 0.039683640003204346
severe O 1 0.9999998807907104
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.022911183536052704
excellent O 0 0.06105167791247368
neuropsychologic O 1 0.6946092247962952
outcome O 0 0.025867318734526634
in O 0 0.00967880617827177
very B-Disease 0 0.016020547598600388
- I-Disease 0 0.0663820207118988
long I-Disease 0 0.046306438744068146
- I-Disease 0 0.11954367905855179
chain I-Disease 0 0.140926331281662
acyl I-Disease 1 0.9928594827651978
- I-Disease 0 0.20631635189056396
coenzyme I-Disease 1 0.8115744590759277
A I-Disease 0 0.19297076761722565
dehydrogenase I-Disease 1 0.999980092048645
deficiency I-Disease 1 0.9999998807907104
. O 0 0.05468723550438881

Very B-Disease 0 0.04432990029454231
- I-Disease 0 0.09341034293174744
long I-Disease 0 0.06170862540602684
- I-Disease 0 0.1188560351729393
chain I-Disease 0 0.12907065451145172
acyl I-Disease 1 0.9743309020996094
- I-Disease 0 0.14708131551742554
coenzyme I-Disease 0 0.2477092742919922
A I-Disease 0 0.09154863655567169
dehydrogenase I-Disease 1 0.9945883750915527
( I-Disease 0 0.06991392374038696
VLCAD I-Disease 1 0.9999749660491943
) I-Disease 0 0.11966270208358765
deficiency I-Disease 1 1.0
is O 0 0.018296565860509872
a O 0 0.02714018151164055
disorder O 1 0.9999964237213135
of O 0 0.0213836207985878
fatty O 1 0.9131560921669006
acid O 1 0.8661753535270691
beta O 0 0.11120818555355072
oxidation O 0 0.09374592453241348
that O 0 0.011774946004152298
reportedly O 0 0.03451135754585266
has O 0 0.01416448038071394
high O 0 0.026861194521188736
rates O 0 0.03321485221385956
of O 0 0.013713913038372993
morbidity O 1 0.9958757758140564
and O 0 0.021705765277147293
mortality O 1 0.6118640303611755
. O 0 0.03484664484858513

We O 0 0.022934695705771446
describe O 0 0.02896066941320896
the O 0 0.010217947885394096
outcome O 0 0.023826738819479942
of O 0 0.008683337830007076
a O 0 0.018212895840406418
5 O 0 0.031002389267086983
- O 0 0.059448812156915665
year O 0 0.02795526012778282
- O 0 0.07489278167486191
old O 0 0.0475793331861496
girl O 0 0.18340358138084412
with O 0 0.038107581436634064
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0262648593634367
was O 0 0.014336301945149899
first O 0 0.011792637407779694
seen O 0 0.0188984964042902
at O 0 0.015216834843158722
5 O 0 0.016815287992358208
months O 0 0.013041267171502113
of O 0 0.007519426289945841
age O 0 0.029849296435713768
with O 0 0.03044087253510952
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.961510419845581
hepatomegaly B-Disease 1 1.0
, O 0 0.4444805383682251
encephalopathy B-Disease 1 1.0
, O 0 0.019954737275838852
and O 0 0.018677497282624245
hypotonia B-Disease 1 0.9999347925186157
. O 0 0.030048003420233727

Biochemical O 0 0.2857828438282013
studies O 0 0.0877443253993988
indicated O 1 0.993129551410675
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.3183410167694092
by O 0 0.012575933709740639
a O 0 0.021867627277970314
stable O 0 0.06665776669979095
yet O 0 0.031860824674367905
inactive O 0 0.14151932299137115
enzyme O 0 0.13336601853370667
. O 0 0.03421419858932495

Molecular O 0 0.11844529211521149
genetic O 0 0.07955259829759598
analysis O 0 0.02567516639828682
of O 0 0.011242068372666836
her O 0 0.03414219990372658
VLCAD O 1 0.9988808035850525
gene O 0 0.10369516164064407
revealed O 0 0.0444701686501503
a O 0 0.030102035030722618
T1372C O 0 0.44343724846839905
( O 0 0.05012669786810875
F458L O 0 0.2226981669664383
) O 0 0.04654235020279884
missense O 0 0.19598378241062164
mutation O 0 0.14196550846099854
and O 0 0.019061347469687462
a O 0 0.03964163735508919
1668 O 1 0.994317352771759
ACAG O 1 0.9973658919334412
1669 O 1 0.8634956479072571
splice O 0 0.25894856452941895
site O 0 0.07160758972167969
mutation O 0 0.17181657254695892
. O 0 0.03492569178342819

After O 0 0.054170526564121246
initial O 0 0.0712682232260704
treatment O 1 0.9986820816993713
with O 0 0.024941008538007736
intravenous O 1 0.9996596574783325
glucose O 1 0.5284408926963806
and O 0 0.022526320070028305
carnitine O 1 0.9999452829360962
, O 0 0.014675543643534184
the O 0 0.014635654166340828
patient O 1 0.9823886752128601
has O 0 0.015451006591320038
thrived O 0 0.04966291785240173
on O 0 0.010170848108828068
a O 0 0.02098025009036064
low O 0 0.06574255973100662
- O 0 0.10282264649868011
fat O 0 0.0996905118227005
diet O 0 0.0934620276093483
supplemented O 0 0.05941253900527954
with O 0 0.021851345896720886
medium O 0 0.06779640167951584
- O 0 0.10134129971265793
chain O 0 0.1184428408741951
triglyceride O 0 0.3710156977176666
oil O 0 0.04744701832532883
and O 0 0.021945059299468994
carnitine O 1 0.9990070462226868
and O 0 0.02187071181833744
avoidance O 1 0.9351370930671692
of O 0 0.017937684431672096
fasting O 0 0.13349831104278564
. O 0 0.028175270184874535

Her O 0 0.12376133352518082
ventricular O 1 0.9999979734420776
hypertrophy O 1 0.9999963045120239
resolved O 0 0.05872026085853577
significantly O 0 0.044042155146598816
over O 0 0.013247083872556686
1 O 0 0.02007487416267395
year O 0 0.015385591425001621
, O 0 0.011729435063898563
and O 0 0.014024643227458
cognitively O 1 0.9321644902229309
, O 0 0.011842731386423111
she O 0 0.012956658378243446
is O 0 0.007171034347265959
in O 0 0.00669964449480176
the O 0 0.009357432834804058
superior O 0 0.038560349494218826
range O 0 0.024723924696445465
for O 0 0.011653818190097809
age O 0 0.03616252914071083
. O 0 0.02505667135119438

Clinical O 1 0.9524766802787781
recognition O 0 0.05860108509659767
of O 0 0.033242207020521164
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.017390470951795578
important O 0 0.010004173032939434
because O 0 0.009469857439398766
it O 0 0.005808861926198006
is O 0 0.00584094924852252
one O 0 0.0047582113184034824
of O 0 0.0042538149282336235
the O 0 0.009448269382119179
few O 0 0.017004380002617836
directly O 0 0.03754844889044762
treatable O 1 0.9999996423721313
causes O 1 0.9986573457717896
of O 0 0.024565305560827255
cardiomyopathy B-Disease 1 1.0
in O 0 0.017958790063858032
children O 0 0.02862422540783882
. O 0 0.013171602040529251
. O 0 0.021219981834292412

Cloning O 0 0.08510149270296097
of O 0 0.011318245902657509
a O 0 0.015887361019849777
novel O 0 0.02019738033413887
member O 0 0.01263817586004734
of O 0 0.006444972008466721
the O 0 0.013709772378206253
low O 0 0.06339683383703232
- O 0 0.12219592183828354
density O 0 0.12629710137844086
lipoprotein O 1 0.9993324875831604
receptor O 0 0.3075736463069916
family O 0 0.053051989525556564
. O 0 0.03077356331050396

A O 0 0.059106823056936264
gene O 0 0.09427503496408463
encoding O 0 0.053355224430561066
a O 0 0.023943018168210983
novel O 0 0.05185076594352722
transmembrane O 0 0.1599898636341095
protein O 0 0.06807983666658401
was O 0 0.01825304888188839
identified O 0 0.023810654878616333
by O 0 0.011724459938704967
DNA O 0 0.04890267178416252
sequence O 0 0.02729133889079094
analysis O 0 0.021790971979498863
within O 0 0.01489394810050726
the O 0 0.019686469808220863
insulin B-Disease 1 0.9997627139091492
- I-Disease 1 0.9369975328445435
dependent I-Disease 1 0.9906976819038391
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.09003553539514542
IDDM B-Disease 1 0.9990102052688599
) O 0 0.04628027230501175
locus O 0 0.1663578450679779
IDDM4 O 1 0.7079519033432007
on O 0 0.02491043321788311
chromosome O 0 0.1702105700969696
11q13 O 0 0.20233872532844543
. O 0 0.03439146652817726

Based O 0 0.02718958631157875
on O 0 0.012325780466198921
its O 0 0.01748925819993019
chromosomal O 0 0.12283848226070404
position O 0 0.021331267431378365
, O 0 0.010325442999601364
this O 0 0.009834173135459423
gene O 0 0.047015268355607986
is O 0 0.009636071510612965
a O 0 0.010782415978610516
candidate O 0 0.018895337358117104
for O 0 0.013416207395493984
conferring O 0 0.13043434917926788
susceptibility O 1 0.996605634689331
to O 0 0.03642915189266205
diabetes B-Disease 1 0.9999998807907104
. O 0 0.038697969168424606

The O 0 0.038980741053819656
gene O 0 0.09774570912122726
, O 0 0.021942337974905968
termed O 0 0.09239742159843445
low O 0 0.08470559865236282
- O 0 0.13160370290279388
density O 0 0.14269669353961945
lipoprotein O 1 0.9970605969429016
receptor O 0 0.25223565101623535
related O 0 0.05305824428796768
protein O 0 0.07124600559473038
5 O 0 0.03915861248970032
( O 0 0.04034331813454628
LRP5 O 1 0.9699632525444031
) O 0 0.027154792100191116
, O 0 0.01317683421075344
encodes O 0 0.05105726793408394
a O 0 0.02291136048734188
protein O 0 0.0499507375061512
of O 0 0.018117211759090424
1615 O 0 0.1534307450056076
amino O 0 0.06677134335041046
acids O 0 0.044979240745306015
that O 0 0.01011990662664175
contains O 0 0.01827928051352501
conserved O 0 0.04122139513492584
modules O 0 0.038166243582963943
which O 0 0.009036977775394917
are O 0 0.006031017750501633
characteristic O 0 0.0265449620783329
of O 0 0.006680511869490147
the O 0 0.013018878176808357
low O 0 0.06463252007961273
- O 0 0.13549913465976715
density O 0 0.13573028147220612
lipoprotein O 1 0.9998200535774231
( O 0 0.09149442613124847
LDL O 1 0.9999572038650513
) O 0 0.06022085249423981
receptor O 0 0.1802409142255783
family O 0 0.04834499955177307
. O 0 0.02675214223563671

These O 0 0.01854780875146389
modules O 0 0.04810182377696037
include O 0 0.020131003111600876
a O 0 0.026812689378857613
putative O 0 0.12843714654445648
signal O 0 0.07679838687181473
peptide O 0 0.10200949013233185
for O 0 0.013157639652490616
protein O 0 0.03949150815606117
export O 0 0.01750793494284153
, O 0 0.012545032426714897
four O 0 0.02564634568989277
epidermal O 1 0.999893307685852
growth O 0 0.06371321529150009
factor O 0 0.08253524452447891
( O 0 0.0529753714799881
EGF O 1 0.999527096748352
) O 0 0.03633703663945198
repeats O 0 0.06329181045293808
with O 0 0.016354497522115707
associated O 0 0.033162593841552734
spacer O 0 0.21592791378498077
domains O 0 0.06108420714735985
, O 0 0.01679953560233116
three O 0 0.03146106004714966
LDL O 1 0.9999945163726807
- O 0 0.3526802659034729
receptor O 0 0.26023903489112854
( O 0 0.06233443692326546
LDLR O 1 0.9612835049629211
) O 0 0.0335385799407959
repeats O 0 0.05698871240019798
, O 0 0.011633513495326042
a O 0 0.01840195618569851
single O 0 0.03147260844707489
transmembrane O 0 0.12370802462100983
spanning O 0 0.04772958531975746
domain O 0 0.03246748819947243
, O 0 0.009634152986109257
and O 0 0.008500243537127972
a O 0 0.018929164856672287
cytoplasmic O 0 0.12160851061344147
domain O 0 0.06502728164196014
. O 0 0.03171181678771973

The O 0 0.02952725999057293
encoded O 0 0.04228871315717697
protein O 0 0.050409264862537384
has O 0 0.011826894246041775
a O 0 0.013640645891427994
unique O 0 0.021680692210793495
organization O 0 0.030077612027525902
of O 0 0.018795209005475044
EGF O 1 0.9994078874588013
and O 0 0.0281897634267807
LDLR O 1 0.9974923133850098
repeats O 0 0.08835099637508392
; O 0 0.020328087732195854
therefore O 0 0.017028436064720154
, O 0 0.015381942503154278
LRP5 O 1 0.9935178756713867
likely O 0 0.030057543888688087
represents O 0 0.025463439524173737
a O 0 0.012053596787154675
new O 0 0.01260655838996172
category O 0 0.0236575398594141
of O 0 0.007369158789515495
the O 0 0.017278820276260376
LDLR O 1 0.9973227381706238
family O 0 0.042856305837631226
. O 0 0.030160190537571907

Both O 0 0.02315857633948326
human O 0 0.03165987879037857
and O 0 0.02228088676929474
mouse O 0 0.2745722234249115
LRP5 O 1 0.9987303614616394
cDNAs O 1 0.805038332939148
have O 0 0.012013755738735199
been O 0 0.012506112456321716
isolated O 0 0.04196314513683319
and O 0 0.008592590689659119
the O 0 0.011256515048444271
encoded O 0 0.035338908433914185
mature O 0 0.058053869754076004
proteins O 0 0.033015985041856766
are O 0 0.009395048022270203
95 O 0 0.03359748050570488
% O 0 0.021558381617069244
identical O 0 0.028721971437335014
, O 0 0.01287404540926218
indicating O 0 0.03132978826761246
a O 0 0.014657992869615555
high O 0 0.023164138197898865
degree O 0 0.022639324888586998
of O 0 0.009306020103394985
evolutionary O 0 0.03903163596987724
conservation O 0 0.04369839280843735
. O 0 0.01664598472416401
. O 0 0.02483760379254818

The O 0 0.04729826748371124
APC B-Disease 1 0.8674799799919128
variants O 0 0.11199532449245453
I1307K O 0 0.1666109710931778
and O 0 0.018810078501701355
E1317Q O 0 0.133930504322052
are O 0 0.011228646151721478
associated O 0 0.028236016631126404
with O 0 0.06296346336603165
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.01528996229171753
but O 0 0.0073180836625397205
not O 0 0.006733042653650045
always O 0 0.012060253880918026
with O 0 0.006875720340758562
a O 0 0.013166830874979496
family O 0 0.024457894265651703
history O 0 0.020901070907711983
. O 0 0.022930828854441643

Classical O 0 0.22967387735843658
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9438865780830383
FAP B-Disease 1 0.9999984502792358
) O 0 0.027478156611323357
is O 0 0.012505576014518738
a O 0 0.018110917881131172
high O 0 0.043068982660770416
- O 1 0.8178122043609619
penetrance O 1 0.9997894167900085
autosomal B-Disease 1 0.9999911785125732
dominant I-Disease 1 0.9996598958969116
disease I-Disease 1 0.9999998807907104
that O 0 0.019670667126774788
predisposes O 1 0.9996304512023926
to O 0 0.011365372687578201
hundreds O 0 0.019300557672977448
or O 0 0.015545296482741833
thousands O 0 0.024902135133743286
of O 0 0.030646173283457756
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.32183268666267395
carcinoma I-Disease 1 1.0
and O 0 0.012085049413144588
that O 0 0.009228690527379513
results O 0 0.023314286023378372
from O 0 0.019460754469037056
truncating O 1 0.7173628807067871
mutations O 0 0.09995408356189728
in O 0 0.016162613406777382
the O 0 0.022173015400767326
APC B-Disease 1 0.9975277781486511
gene O 0 0.1159641370177269
. O 0 0.03464236110448837

A O 0 0.059103019535541534
variant O 0 0.11939454823732376
of O 0 0.028012439608573914
FAP B-Disease 1 0.9999977350234985
is O 0 0.07690775394439697
attenuated B-Disease 1 0.9999880790710449
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999977350234985
, O 0 0.026026178151369095
which O 0 0.012827624566853046
results O 0 0.025631878525018692
from O 0 0.01978575624525547
germ O 1 0.9998799562454224
- O 0 0.08686593919992447
line O 0 0.03649665042757988
mutations O 0 0.06980433315038681
in O 0 0.00966048426926136
the O 0 0.010180875658988953
5 O 0 0.018627388402819633
and O 0 0.008844185620546341
3 O 0 0.01917993277311325
regions O 0 0.018971195444464684
of O 0 0.009080445393919945
the O 0 0.02233876660466194
APC B-Disease 1 0.9965618252754211
gene O 0 0.12379778921604156
. O 0 0.03467061370611191

Attenuated B-Disease 1 0.999985933303833
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.999998927116394
have O 0 0.017132915556430817
" O 0 0.019506197422742844
multiple O 0 0.04567014053463936
" O 0 0.41369739174842834
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.040228817611932755
typically O 0 0.024836767464876175
fewer O 0 0.019464535638689995
than O 0 0.00895597878843546
100 O 0 0.02043994516134262
) O 0 0.014511268585920334
without O 0 0.011783871799707413
the O 0 0.017865188419818878
florid O 1 0.870819628238678
phenotype O 0 0.40066230297088623
of O 0 0.022306209430098534
classical O 0 0.07839490473270416
FAP B-Disease 1 0.9999868869781494
. O 0 0.0431990846991539

Another O 0 0.04058396816253662
group O 0 0.03197487071156502
of O 0 0.013894856907427311
patients O 1 0.9998906850814819
with O 0 0.01835605688393116
multiple O 0 0.05529394745826721
adenomas B-Disease 1 0.9999959468841553
has O 0 0.021826613694429398
no O 0 0.01845310814678669
mutations O 0 0.06973055750131607
in O 0 0.01240527629852295
the O 0 0.018197979778051376
APC B-Disease 1 0.9992247819900513
gene O 0 0.07543978840112686
, O 0 0.012464194558560848
and O 0 0.00829760730266571
their O 0 0.013247283175587654
phenotype O 1 0.9692427515983582
probably O 0 0.036409005522727966
results O 0 0.02382274903357029
from O 0 0.013645381666719913
variation O 0 0.03424900770187378
at O 0 0.017407575622200966
a O 0 0.019757676869630814
locus O 0 0.10729996860027313
, O 0 0.014015382155776024
or O 0 0.019288653507828712
loci O 0 0.10566384345293045
, O 0 0.01137385331094265
elsewhere O 0 0.018775632604956627
in O 0 0.008843191899359226
the O 0 0.014403636567294598
genome O 0 0.09316503256559372
. O 0 0.036188893020153046

Recently O 0 0.0539572611451149
, O 0 0.014385114423930645
however O 0 0.011838211677968502
, O 0 0.01028966624289751
a O 0 0.02419324219226837
missense O 0 0.17067097127437592
variant O 0 0.10968076437711716
of O 0 0.024168163537979126
APC B-Disease 1 0.9936887621879578
( O 0 0.05281170457601547
I1307K O 0 0.24711517989635468
) O 0 0.022585568949580193
was O 0 0.015291226096451283
described O 0 0.01996540278196335
that O 0 0.009692810475826263
confers O 0 0.07963202148675919
an O 0 0.016082391142845154
increased O 0 0.03997617959976196
risk O 1 0.9990371465682983
of O 0 0.04437779262661934
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.01601587049663067
including O 0 0.013163498602807522
multiple O 0 0.05040726438164711
adenomas B-Disease 1 0.9999887943267822
, O 0 0.014963649213314056
in O 0 0.017317840829491615
Ashkenazim O 1 0.9448094367980957
. O 0 0.0378466472029686

We O 0 0.016950219869613647
have O 0 0.00905916653573513
studied O 0 0.017356453463435173
a O 0 0.01233465876430273
set O 0 0.010165962390601635
of O 0 0.009831544943153858
164 O 0 0.12788569927215576
patients O 1 0.9999555349349976
with O 0 0.02265121228992939
multiple O 1 0.9710158705711365
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.05099134147167206
/ I-Disease 1 0.9999880790710449
or I-Disease 0 0.0937112420797348
carcinoma I-Disease 1 1.0
and O 0 0.022537818178534508
analyzed O 0 0.08655642718076706
codons O 0 0.1822374314069748
1263 O 1 0.9950692653656006
- O 0 0.17689833045005798
1377 O 1 0.7959436178207397
( O 0 0.07622789591550827
exon O 0 0.20719024538993835
15G O 0 0.23238743841648102
) O 0 0.020347412675619125
of O 0 0.009650562889873981
the O 0 0.018775220960378647
APC B-Disease 1 0.9821820855140686
gene O 0 0.09661050885915756
for O 0 0.02713150903582573
germ O 1 0.9997171759605408
- O 0 0.10111577063798904
line O 0 0.045208632946014404
variants O 0 0.0843905657529831
. O 0 0.03844454884529114

Three O 0 0.040406666696071625
patients O 1 0.997490644454956
with O 0 0.016993703320622444
the O 0 0.0213197972625494
I1307K O 0 0.3275302052497864
allele O 0 0.13983187079429626
were O 0 0.015316633507609367
detected O 0 0.057873379439115524
, O 0 0.010279380716383457
each O 0 0.010163141414523125
of O 0 0.012773371301591396
Ashkenazi O 0 0.1456928700208664
descent O 0 0.09573403745889664
. O 0 0.03382973000407219

Four O 0 0.041729141026735306
patients O 1 0.9989674091339111
had O 0 0.02258361130952835
a O 0 0.030022572726011276
germ O 1 0.9998468160629272
- O 0 0.10374755412340164
line O 0 0.0573703795671463
E1317Q O 0 0.4139385521411896
missense O 0 0.21536056697368622
variant O 0 0.11461375653743744
of O 0 0.016724515706300735
APC O 1 0.984093964099884
that O 0 0.009326355531811714
was O 0 0.009558398276567459
not O 0 0.006195258814841509
present O 0 0.00995173305273056
in O 0 0.008033822290599346
controls O 0 0.029661977663636208
; O 0 0.010709251277148724
one O 0 0.005634198430925608
of O 0 0.004483180586248636
these O 0 0.005460157059133053
individuals O 0 0.012649568729102612
had O 0 0.011995415203273296
an O 0 0.01195090264081955
unusually O 0 0.04626767709851265
large O 0 0.014078207314014435
number O 0 0.010938270948827267
of O 0 0.013025663793087006
metaplastic B-Disease 1 0.9973371624946594
polyps I-Disease 1 0.9976498484611511
of I-Disease 0 0.01344837062060833
the I-Disease 0 0.019343048334121704
colorectum I-Disease 1 0.9551816582679749
. O 0 0.03852140158414841

There O 0 0.016895117238163948
is O 0 0.011206262744963169
increasing O 0 0.016712207347154617
evidence O 0 0.01175669301301241
that O 0 0.006441605277359486
there O 0 0.011465764604508877
exist O 0 0.025887751951813698
germ O 1 0.9992187023162842
- O 0 0.06897956877946854
line O 0 0.03166884556412697
variants O 0 0.031536124646663666
of O 0 0.009216969832777977
the O 0 0.019595911726355553
APC B-Disease 1 0.9966546297073364
gene O 0 0.0886831134557724
that O 0 0.014710466377437115
predispose O 0 0.11787047237157822
to O 0 0.008631143718957901
the O 0 0.008463175036013126
development O 0 0.016789646819233894
of O 0 0.014357151463627815
multiple O 1 0.9918540716171265
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.5050904750823975
carcinoma I-Disease 1 1.0
, O 0 0.014391268603503704
but O 0 0.009383583441376686
without O 0 0.010138021782040596
the O 0 0.016030320897698402
florid O 1 0.9506188631057739
phenotype O 1 0.6640779972076416
of O 0 0.0174204483628273
classical O 0 0.05839699134230614
FAP B-Disease 1 0.999992847442627
, O 0 0.013544884510338306
and O 0 0.008797085843980312
possibly O 0 0.02269143797457218
with O 0 0.010013632476329803
importance O 0 0.024118781089782715
for O 0 0.19373132288455963
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9963298439979553
in O 0 0.009145528078079224
the O 0 0.009141267277300358
general O 0 0.014160498976707458
population O 0 0.018032614141702652
. O 0 0.014254223555326462
. O 0 0.022949233651161194

Genomic O 0 0.1336696892976761
structure O 0 0.026327354833483696
of O 0 0.009842910803854465
the O 0 0.02031356282532215
human O 1 0.7776632905006409
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9627846479415894
CLD B-Disease 1 0.9999998807907104
) O 0 0.0508267804980278
gene O 0 0.09763181209564209
. O 0 0.029984407126903534

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9429234266281128
CLD B-Disease 1 0.9999998807907104
) O 0 0.03160285949707031
is O 0 0.016500337049365044
caused O 0 0.046910032629966736
by O 0 0.013582219369709492
mutations O 0 0.06737850606441498
in O 0 0.011156757362186909
a O 0 0.019220300018787384
gene O 0 0.0572936125099659
which O 0 0.013824600726366043
encodes O 0 0.07063768804073334
an O 0 0.034003011882305145
intestinal O 1 0.9999983310699463
anion O 1 0.9974837303161621
transporter O 1 0.9588540196418762
. O 0 0.047249987721443176

We O 0 0.02039911225438118
report O 0 0.014873916283249855
here O 0 0.009492279030382633
the O 0 0.009815617464482784
complete O 0 0.023712918162345886
genomic O 0 0.06684130430221558
organization O 0 0.01950255036354065
of O 0 0.007377182599157095
the O 0 0.013583255000412464
human O 0 0.049190010875463486
CLD B-Disease 1 0.9999958276748657
gene O 0 0.09186431020498276
which O 0 0.015314017422497272
spans O 0 0.05828997120261192
approximately O 0 0.032278671860694885
39kb O 0 0.14534005522727966
, O 0 0.013509976677596569
and O 0 0.009669691324234009
comprises O 0 0.03231213986873627
21 O 0 0.03719897195696831
exons O 0 0.11808115243911743
. O 0 0.03552692010998726

All O 0 0.0337519608438015
exon O 0 0.21946150064468384
/ O 1 0.5014651417732239
intron O 0 0.24188947677612305
boundaries O 0 0.02582586742937565
conform O 0 0.03870562091469765
to O 0 0.012227991595864296
the O 0 0.025176746770739555
GT O 1 0.9999656677246094
/ O 1 0.9997947812080383
AG O 1 0.9995198249816895
rule O 0 0.050472915172576904
. O 0 0.0331583209335804

An O 0 0.025168024003505707
analysis O 0 0.021109264343976974
of O 0 0.009523240849375725
the O 0 0.01589723490178585
putative O 0 0.1198691874742508
promoter O 0 0.14374138414859772
region O 0 0.03656638413667679
sequence O 0 0.0322396419942379
shows O 0 0.021168949082493782
a O 0 0.0218585766851902
putative O 0 0.1406543254852295
TATA O 1 0.9947311878204346
box O 0 0.05331755802035332
and O 0 0.01636551506817341
predicts O 0 0.08417747169733047
multiple O 0 0.0487205870449543
transcription O 0 0.10276692360639572
factor O 0 0.06367465853691101
binding O 0 0.048649873584508896
sites O 0 0.027427755296230316
. O 0 0.02509736828505993

The O 0 0.03014500066637993
genomic O 0 0.11107544600963593
structure O 0 0.02524206042289734
was O 0 0.014628070406615734
determined O 0 0.022636087611317635
using O 0 0.015577270649373531
DNA O 0 0.03798454627394676
from O 0 0.009692471474409103
several O 0 0.0069656651467084885
sources O 0 0.011679735966026783
including O 0 0.00875069759786129
multiple O 0 0.028294945135712624
large O 0 0.025312095880508423
- O 0 0.0874524638056755
insert O 0 0.13650162518024445
libaries O 0 0.1697510927915573
and O 0 0.021086769178509712
genomic O 0 0.11804183572530746
DNA O 0 0.07701375335454941
from O 0 0.028879819437861443
Finnish O 1 0.9049957990646362
CLD B-Disease 1 0.9999998807907104
patients O 1 0.999947190284729
and O 0 0.01642211340367794
controls O 0 0.056685421615839005
. O 0 0.027661502361297607

Exon O 0 0.27333539724349976
- O 0 0.10348014533519745
specific O 0 0.03914686664938927
primers O 0 0.13224035501480103
developed O 0 0.03514164686203003
in O 0 0.008861683309078217
this O 0 0.00655817287042737
study O 0 0.01898031309247017
will O 0 0.012772684916853905
facilitate O 0 0.044390998780727386
mutation O 0 0.1609925478696823
screening O 0 0.09162495285272598
studies O 0 0.025769326835870743
of O 0 0.012017384171485901
patients O 1 0.999980092048645
with O 0 0.014560982584953308
the O 0 0.024748990312218666
disease O 1 0.9999992847442627
. O 0 0.03316047042608261

Genomic O 0 0.1712169647216797
sequencing O 0 0.08101910352706909
of O 0 0.01693316176533699
a O 0 0.04475756362080574
BAC O 1 0.9999041557312012
clone O 1 0.9881322979927063
H O 1 0.9998486042022705
_ O 0 0.05478135868906975
RG364P16 O 0 0.13522541522979736
revealed O 0 0.029299505054950714
the O 0 0.009112169034779072
presence O 0 0.018207773566246033
of O 0 0.006703866180032492
another O 0 0.01598726399242878
, O 0 0.013183316215872765
highly O 0 0.03539074957370758
homologous O 0 0.1322832703590393
gene O 0 0.08051816374063492
3 O 0 0.021630888804793358
of O 0 0.009276783093810081
the O 0 0.02409130521118641
CLD B-Disease 1 0.999998927116394
gene O 0 0.08897500485181808
, O 0 0.012760341167449951
with O 0 0.009780648164451122
a O 0 0.016308467835187912
similar O 0 0.021990828216075897
genomic O 0 0.08903578668832779
structure O 0 0.024798089638352394
, O 0 0.011920354329049587
recently O 0 0.023076456040143967
identified O 0 0.020097117871046066
as O 0 0.010970789939165115
the O 0 0.025400081649422646
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
gene O 1 0.7257360816001892
( O 0 0.051209017634391785
PDS B-Disease 1 0.9999735355377197
) O 0 0.025548255071043968
. O 0 0.013367223553359509
. O 0 0.022136863321065903

The O 0 0.044211484491825104
APCI1307K O 1 0.9970490336418152
allele O 0 0.22168917953968048
and O 0 0.035660337656736374
cancer B-Disease 1 0.9999997615814209
risk O 1 0.5550363659858704
in O 0 0.009853479452431202
a O 0 0.016831083223223686
community O 0 0.0265771746635437
- O 0 0.04455912113189697
based O 0 0.018651338294148445
study O 0 0.021920090541243553
of O 0 0.012170398607850075
Ashkenazi O 0 0.1338803917169571
Jews O 0 0.039511822164058685
. O 0 0.02788667567074299

Mutations O 0 0.1808033585548401
in O 0 0.031825173646211624
APC O 1 0.9110381603240967
are O 0 0.017982017248868942
classically O 1 0.9653440117835999
associated O 0 0.037133246660232544
with O 0 0.036817215383052826
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9794129133224487
FAP B-Disease 1 0.9999994039535522
) O 0 0.02567509561777115
, O 0 0.012621489353477955
a O 0 0.022908594459295273
highly O 0 0.06567329168319702
penetrant O 1 0.9999988079071045
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999834299087524
disorder I-Disease 1 1.0
characterized O 1 0.9955867528915405
by O 0 0.020735284313559532
multiple O 1 0.7558176517486572
intestinal O 1 1.0
polyps B-Disease 1 0.9999911785125732
and O 0 0.014749512076377869
, O 0 0.014211272820830345
without O 0 0.019022729247808456
surgical O 1 0.9999864101409912
intervention O 0 0.21170590817928314
, O 0 0.008358418010175228
the O 0 0.008278155699372292
development O 0 0.02392200380563736
of O 0 0.029379764571785927
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.10296767950057983
CRC B-Disease 1 0.999806821346283
) O 0 0.03274689242243767
. O 0 0.02668164297938347

APC B-Disease 1 0.9416197538375854
is O 0 0.0354168564081192
a O 0 0.05358132719993591
tumour O 1 0.9999998807907104
- O 1 0.9540895223617554
suppressor O 1 0.9533758163452148
gene O 0 0.0977725088596344
, O 0 0.015584691427648067
and O 0 0.018046729266643524
somatic O 0 0.24113324284553528
loss O 0 0.17138603329658508
occurs O 0 0.07134555280208588
in O 0 0.026008307933807373
tumours B-Disease 1 0.9999985694885254
. O 0 0.03561367467045784

The O 0 0.055364593863487244
germline O 1 0.9990381002426147
T O 1 0.9997201561927795
- O 0 0.07810135930776596
to O 0 0.017494050785899162
- O 0 0.06032834202051163
A O 0 0.037336062639951706
transversion O 0 0.14730428159236908
responsible O 0 0.027249205857515335
for O 0 0.010187361389398575
the O 0 0.02001342363655567
APC O 1 0.9786449670791626
I1307K O 0 0.23655222356319427
allele O 0 0.17422136664390564
converts O 0 0.0625792071223259
the O 0 0.022316625341773033
wild O 0 0.06145629286766052
- O 0 0.08401114493608475
type O 0 0.06110652908682823
sequence O 0 0.028263291344046593
to O 0 0.012763982638716698
a O 0 0.02583436667919159
homopolymer O 1 0.9969639182090759
tract O 1 0.999805748462677
( O 0 0.05533198267221451
A8 O 1 0.9997653365135193
) O 0 0.02127058431506157
that O 0 0.00878418143838644
is O 0 0.014207462780177593
genetically O 0 0.05321761220693588
unstable O 1 0.8323280215263367
and O 0 0.02009125053882599
prone O 1 0.630959153175354
to O 0 0.024368830025196075
somatic O 0 0.242402121424675
mutation O 0 0.19526530802249908
. O 0 0.0440775603055954

The O 0 0.04490455612540245
I1307K O 0 0.2066706418991089
allele O 0 0.15492472052574158
was O 0 0.024683263152837753
found O 0 0.019858907908201218
in O 0 0.012839574366807938
6 O 0 0.031744688749313354
. O 0 0.022629672661423683

1 O 0 0.04249333590269089
% O 0 0.028874114155769348
of O 0 0.01682264357805252
unselected O 1 0.6416769623756409
Ashkenazi O 0 0.15851247310638428
Jews O 0 0.02820548042654991
and O 0 0.01138682384043932
higher O 0 0.02891037054359913
proportions O 0 0.062057338654994965
of O 0 0.01320936530828476
Ashkenazim O 1 0.637208878993988
with O 0 0.016529742628335953
family O 0 0.024813387542963028
or O 0 0.015425805933773518
personal O 0 0.024999378249049187
histories O 0 0.05794163793325424
of O 0 0.01916583441197872
CRC B-Disease 1 0.9993757605552673
( O 0 0.046353600919246674
ref O 0 0.16524061560630798
. O 0 0.016120199114084244
2 O 0 0.03159545734524727
) O 0 0.02922399342060089
. O 0 0.024669930338859558

To O 0 0.01899837702512741
evaluate O 0 0.04572102427482605
the O 0 0.01156605128198862
role O 0 0.019373031333088875
of O 0 0.01225906889885664
I1307K O 1 0.6654614806175232
in O 0 0.027505338191986084
cancer B-Disease 1 0.9999980926513672
, O 0 0.015822280198335648
we O 0 0.01734706200659275
genotyped O 0 0.23005591332912445
5 O 0 0.03500847890973091
, O 0 0.025790991261601448
081 O 1 0.9904153347015381
Ashkenazi O 0 0.1568242311477661
volunteers O 0 0.05909762904047966
in O 0 0.011699503287672997
a O 0 0.016668198630213737
community O 0 0.028847146779298782
survey O 0 0.03792990744113922
. O 0 0.026707444339990616

Risk O 1 0.697790801525116
of O 0 0.024559034034609795
developing O 1 0.9495965838432312
colorectal B-Disease 1 1.0
, I-Disease 0 0.0390222929418087
breast I-Disease 1 0.9999988079071045
and I-Disease 0 0.01383040752261877
other I-Disease 0 0.014501554891467094
cancers I-Disease 1 0.9996808767318726
were O 0 0.01103504654020071
compared O 0 0.025549324229359627
between O 0 0.020785342901945114
genotyped O 1 0.9918516278266907
I1307K O 1 0.6993299722671509
carriers O 0 0.0699225589632988
and O 0 0.013375230133533478
non O 0 0.04359322041273117
- O 0 0.06816643476486206
carriers O 0 0.05639221519231796
and O 0 0.008759545162320137
their O 0 0.00770547054708004
first O 0 0.014461478218436241
- O 0 0.06407174468040466
degree O 0 0.04782786965370178
relatives O 0 0.050174281001091
. O 0 0.028304118663072586

Sperm O 0 0.14840516448020935
DNA O 0 0.0774666965007782
analysis O 0 0.02712300419807434
in O 0 0.014177543111145496
a O 0 0.04760918766260147
Friedreich B-Disease 1 0.9999872446060181
ataxia I-Disease 1 0.9999936819076538
premutation O 1 0.9967808723449707
carrier O 0 0.3754141628742218
suggests O 0 0.04602772369980812
both O 0 0.015804514288902283
meiotic O 1 0.9016735553741455
and O 0 0.017920464277267456
mitotic O 0 0.13816840946674347
expansion O 0 0.031774044036865234
in O 0 0.010541427880525589
the O 0 0.017965469509363174
FRDA B-Disease 1 0.9983710646629333
gene O 0 0.12117332965135574
. O 0 0.03093387931585312

Friedreich B-Disease 1 0.9999837875366211
ataxia I-Disease 1 0.9999886751174927
is O 0 0.03258929401636124
usually O 0 0.02811010740697384
caused O 0 0.04118351265788078
by O 0 0.00895754899829626
an O 0 0.009025881998240948
expansion O 0 0.023598359897732735
of O 0 0.008865327574312687
a O 0 0.02919105440378189
GAA O 0 0.36610233783721924
trinucleotide O 1 0.9876129031181335
repeat O 0 0.10018890351057053
in O 0 0.023242216557264328
intron O 0 0.30450940132141113
1 O 0 0.024618731811642647
of O 0 0.010151433758437634
the O 0 0.022743241861462593
FRDA B-Disease 1 0.9941853880882263
gene O 0 0.10945992171764374
. O 0 0.03067852184176445

Occasionally O 0 0.05320555344223976
, O 0 0.01294019166380167
a O 0 0.015798568725585938
fully O 0 0.02838577888906002
expanded O 0 0.032333213835954666
allele O 0 0.10806718468666077
has O 0 0.015718000009655952
been O 0 0.01113532017916441
found O 0 0.01268410962074995
to O 0 0.009275425225496292
arise O 0 0.0323917493224144
from O 0 0.01152825728058815
a O 0 0.018190134316682816
premutation O 0 0.1129116415977478
of O 0 0.01026021596044302
100 O 0 0.02499646320939064
or O 0 0.020232144743204117
less O 0 0.03195308893918991
triplet O 1 0.5095056891441345
repeats O 0 0.1239251121878624
. O 0 0.034985870122909546

We O 0 0.02023673988878727
have O 0 0.01143276784569025
examined O 0 0.04149243235588074
the O 0 0.01557718776166439
sperm O 0 0.08032413572072983
DNA O 0 0.04421865567564964
of O 0 0.009490382857620716
a O 0 0.027597948908805847
premutation O 1 0.900800347328186
carrier O 0 0.14765413105487823
. O 0 0.0361514650285244

This O 0 0.03840872272849083
mans O 0 0.1548188477754593
leucocyte O 1 0.5413222908973694
DNA O 0 0.07438237965106964
showed O 0 0.030792536213994026
one O 0 0.015685588121414185
normal O 0 0.04297192394733429
allele O 0 0.1093437671661377
and O 0 0.011272384785115719
one O 0 0.012659727595746517
allele O 0 0.0916384682059288
of O 0 0.011295611038804054
approximately O 0 0.030717279762029648
100 O 0 0.03871791437268257
repeats O 0 0.09772217273712158
. O 0 0.028997978195548058

His O 0 0.03755075857043266
sperm O 0 0.09642114490270615
showed O 0 0.030602484941482544
an O 0 0.013437987305223942
expanded O 0 0.028315981850028038
allele O 0 0.09144217520952225
in O 0 0.012574560008943081
a O 0 0.017149006947875023
tight O 0 0.03778533264994621
range O 0 0.02614080347120762
centering O 0 0.050310369580984116
on O 0 0.009395292960107327
a O 0 0.014144877903163433
size O 0 0.020109141245484352
of O 0 0.011977790854871273
approximately O 0 0.044554051011800766
320 O 0 0.1420954018831253
trinucleotide O 1 0.9785770177841187
repeats O 0 0.15283827483654022
. O 0 0.04512614756822586

His O 0 0.03903496637940407
affected O 0 0.06995169073343277
son O 0 0.06584636121988297
has O 0 0.022447559982538223
repeat O 0 0.06899883598089218
sizes O 0 0.0324879065155983
of O 0 0.012933371588587761
1040 O 1 0.7802174687385559
and O 0 0.01700248382985592
540 O 0 0.12972237169742584
. O 0 0.030777666717767715

These O 0 0.016629226505756378
data O 0 0.01680534891784191
suggest O 0 0.02456764690577984
that O 0 0.009419224224984646
expansion O 0 0.031830232590436935
occurs O 0 0.03236991539597511
in O 0 0.00712461955845356
two O 0 0.007780934683978558
stages O 0 0.03556639701128006
, O 0 0.007811519782990217
the O 0 0.007403392810374498
first O 0 0.011509071104228497
during O 0 0.021186482161283493
meiosis O 0 0.0909627228975296
followed O 0 0.02129684016108513
by O 0 0.009673257358372211
a O 0 0.016828859224915504
second O 0 0.028365684673190117
mitotic O 0 0.18708088994026184
expansion O 0 0.055908530950546265
. O 0 0.03126688301563263

We O 0 0.017892133444547653
also O 0 0.010103588923811913
show O 0 0.013603728264570236
that O 0 0.005124599207192659
in O 0 0.006477010902017355
all O 0 0.007631441578269005
informative O 0 0.04818961024284363
carrier O 0 0.07396847009658813
father O 0 0.0313802994787693
to O 0 0.0142393559217453
affected O 0 0.052337296307086945
child O 0 0.055069927126169205
transmissions O 0 0.06052806228399277
, O 0 0.008864155039191246
with O 0 0.006785894278436899
the O 0 0.008164627477526665
notable O 0 0.016561243683099747
exception O 0 0.02258933335542679
of O 0 0.008531520143151283
the O 0 0.016028206795454025
premutation O 1 0.7735182046890259
carrier O 0 0.07878429442644119
, O 0 0.010983864776790142
the O 0 0.011886301450431347
expansion O 0 0.0360109768807888
size O 0 0.035577185451984406
decreases O 0 0.0764780044555664
. O 0 0.01638110727071762
. O 0 0.02598905935883522

The O 0 0.04644966125488281
R496H O 0 0.21906252205371857
mutation O 0 0.1417650282382965
of O 0 0.01770968548953533
arylsulfatase O 1 0.5506039261817932
A O 0 0.03005143068730831
does O 0 0.02095928229391575
not O 0 0.017412535846233368
cause O 1 0.9641814231872559
metachromatic B-Disease 1 0.9999812841415405
leukodystrophy I-Disease 1 0.9999997615814209
. O 0 0.050669144839048386

Deficiency B-Disease 1 0.9999990463256836
of I-Disease 0 0.032433055341243744
arylsulfatase I-Disease 1 0.8321536183357239
A I-Disease 0 0.0557018481194973
( O 0 0.058207299560308456
ARSA O 1 0.9998537302017212
) O 0 0.049071718007326126
enzyme O 0 0.14251333475112915
activity O 0 0.08217119425535202
causes O 1 0.9954208731651306
metachromatic B-Disease 1 0.9999920129776001
leukodystrophy I-Disease 1 1.0
( O 0 0.4534032940864563
MLD B-Disease 1 0.9999996423721313
) O 0 0.04936017096042633
. O 0 0.03300577774643898

A O 0 0.0363524854183197
number O 0 0.01441649068146944
of O 0 0.019637035205960274
ARSA O 1 0.999943733215332
gene O 0 0.1507924497127533
mutations O 0 0.1237160935997963
responsible O 0 0.03874794393777847
for O 0 0.022235073149204254
MLD B-Disease 1 0.9999992847442627
have O 0 0.014684406109154224
been O 0 0.012614385224878788
identified O 0 0.030394986271858215
. O 0 0.022377843037247658

Recently O 0 0.0566769577562809
, O 0 0.01769401505589485
the O 0 0.02046954818069935
R496H O 0 0.183183491230011
mutation O 0 0.1376613974571228
of O 0 0.02050880156457424
ARSA O 1 0.9990624785423279
was O 0 0.01747409999370575
proposed O 0 0.015082739293575287
to O 0 0.00774001982063055
be O 0 0.007816435769200325
a O 0 0.017219753935933113
cause O 0 0.05442451313138008
of O 0 0.023730410262942314
MLD B-Disease 1 0.9999998807907104
( O 0 0.05795017257332802
Draghia O 1 0.9914217591285706
et O 0 0.10583222657442093
al O 0 0.05729307234287262
. O 0 0.011982057243585587
, O 0 0.012344934977591038
1997 O 0 0.037022270262241364
) O 0 0.026052111759781837
. O 0 0.022706931456923485

We O 0 0.020419787615537643
have O 0 0.012840237468481064
investigated O 0 0.04596903175115585
the O 0 0.021163420751690865
R496H O 0 0.44157594442367554
mutation O 0 0.12702198326587677
and O 0 0.011213916353881359
found O 0 0.01734478585422039
this O 0 0.012234022840857506
mutation O 0 0.1027032807469368
at O 0 0.019893255084753036
a O 0 0.015627942979335785
relatively O 0 0.022385001182556152
high O 0 0.024141618981957436
frequency O 0 0.03216646611690521
in O 0 0.007723882328718901
an O 0 0.0099569633603096
African O 0 0.03429697826504707
American O 0 0.027602534741163254
population O 0 0.032628245651721954
( O 0 0.03873639181256294
f O 0 0.11161855608224869
= O 0 0.11014115065336227
0 O 0 0.052809473127126694
. O 0 0.014787755906581879
09 O 0 0.08683941513299942
, O 0 0.02225347049534321
n O 0 0.07797350734472275
= O 0 0.10316696763038635
61 O 0 0.06241010129451752
subjects O 0 0.03752485290169716
) O 0 0.025142770260572433
. O 0 0.02403232641518116

The O 0 0.06534579396247864
ARSA O 1 0.9991106390953064
enzyme O 0 0.14362485706806183
activity O 0 0.036874089390039444
in O 0 0.009587693028151989
subjects O 0 0.01840103045105934
with O 0 0.007527736481279135
and O 0 0.0068924641236662865
without O 0 0.011006648652255535
the O 0 0.01606275513768196
R496H O 1 0.8601269125938416
mutation O 0 0.12004967778921127
was O 0 0.017092855647206306
determined O 0 0.021268783137202263
and O 0 0.006825981196016073
found O 0 0.010422076098620892
to O 0 0.007137599866837263
be O 0 0.009298057295382023
normal O 0 0.03914695978164673
. O 0 0.02402830496430397

It O 0 0.01953938417136669
is O 0 0.013850120827555656
therefore O 0 0.01606813073158264
concluded O 0 0.030678479000926018
that O 0 0.009166066534817219
the O 0 0.018210576847195625
R496H O 1 0.7877031564712524
mutation O 0 0.15014517307281494
of O 0 0.025119008496403694
ARSA O 1 0.9999308586120605
does O 0 0.025541041046380997
not O 0 0.00976433977484703
negatively O 0 0.03981485217809677
influence O 0 0.017570098862051964
the O 0 0.010540681891143322
activity O 0 0.029096830636262894
of O 0 0.013033989816904068
ARSA O 1 0.9999089241027832
and O 0 0.008770623244345188
is O 0 0.00918962899595499
not O 0 0.007114405278116465
a O 0 0.01697511225938797
cause O 0 0.061652857810258865
of O 0 0.028603874146938324
MLD B-Disease 1 0.9999994039535522

Down O 0 0.0638178214430809
- O 0 0.08183087408542633
regulation O 0 0.06025342643260956
of O 0 0.024376923218369484
transmembrane O 1 0.664376437664032
carbonic O 1 0.9990105628967285
anhydrases O 1 0.9982448816299438
in O 0 0.059820156544446945
renal B-Disease 1 1.0
cell I-Disease 1 0.9999504089355469
carcinoma I-Disease 1 1.0
cell O 0 0.13198105990886688
lines O 0 0.03203040733933449
by O 0 0.015749560669064522
wild O 0 0.057227179408073425
- O 0 0.1507839411497116
type O 0 0.34705260396003723
von B-Disease 1 0.9909330606460571
Hippel I-Disease 1 0.9995090961456299
- I-Disease 1 0.7281012535095215
Lindau I-Disease 1 0.9982411861419678
transgenes O 1 0.8330116271972656
. O 0 0.05669471621513367

To O 0 0.029579032212495804
discover O 0 0.09334259480237961
genes O 0 0.059927236288785934
involved O 0 0.033637307584285736
in O 0 0.02384771965444088
von B-Disease 1 0.9919598698616028
Hippel I-Disease 1 0.9998412132263184
- I-Disease 1 0.8050696849822998
Lindau I-Disease 1 0.9993748068809509
( O 0 0.09620393812656403
VHL B-Disease 1 0.99997878074646
) O 0 0.045190855860710144
- O 0 0.10795605182647705
mediated O 1 0.8085455894470215
carcinogenesis O 1 0.9992746710777283
, O 0 0.018531648442149162
we O 0 0.01624043844640255
used O 0 0.037221379578113556
renal B-Disease 1 1.0
cell I-Disease 1 0.9998223185539246
carcinoma I-Disease 1 1.0
cell O 0 0.14631271362304688
lines O 0 0.05224970728158951
stably O 0 0.18134014308452606
transfected O 1 0.839451253414154
with O 0 0.02548913285136223
wild O 0 0.06318602710962296
- O 0 0.3798809349536896
type O 1 0.92247474193573
VHL O 1 0.9999854564666748
- O 0 0.15932758152484894
expressing O 0 0.13282166421413422
transgenes O 0 0.4572611153125763
. O 0 0.049493372440338135

Large O 0 0.05136758089065552
- O 0 0.09780149161815643
scale O 0 0.0769796296954155
RNA O 0 0.11217384785413742
differential O 0 0.07788147777318954
display O 0 0.030347418040037155
technology O 0 0.02570071816444397
applied O 0 0.014942662790417671
to O 0 0.007106124889105558
these O 0 0.007723275106400251
cell O 0 0.049271732568740845
lines O 0 0.024727270007133484
identified O 0 0.02256595529615879
several O 0 0.012380448170006275
differentially O 0 0.11400303244590759
expressed O 0 0.03343535587191582
genes O 0 0.03945797309279442
, O 0 0.010028140619397163
including O 0 0.011517439037561417
an O 0 0.023527609184384346
alpha O 0 0.13956451416015625
carbonic O 1 0.9981916546821594
anhydrase O 1 0.9982383251190186
gene O 0 0.11437664180994034
, O 0 0.025930194184184074
termed O 0 0.1182674914598465
CA12 O 1 0.9965674877166748
. O 0 0.03633001074194908

The O 0 0.03849884495139122
deduced O 0 0.10110912472009659
protein O 0 0.06193338334560394
sequence O 0 0.030644390732049942
was O 0 0.015795830637216568
classified O 0 0.026353567838668823
as O 0 0.007683617994189262
a O 0 0.013475030660629272
one O 0 0.015146908350288868
- O 0 0.06359568238258362
pass O 0 0.04952557384967804
transmembrane O 0 0.1610625684261322
CA O 0 0.07251410186290741
possessing O 0 0.037469297647476196
an O 0 0.018380217254161835
apparently O 0 0.05344964936375618
intact O 0 0.07402346283197403
catalytic O 0 0.10683327168226242
domain O 0 0.03547856584191322
in O 0 0.011874177493155003
the O 0 0.018437214195728302
extracellular O 0 0.11504559218883514
CA O 0 0.10550031810998917
module O 0 0.10507684201002121
. O 0 0.032587457448244095

Reintroduced O 0 0.18204715847969055
wild O 0 0.10337875783443451
- O 0 0.17498157918453217
type O 0 0.3583163321018219
VHL B-Disease 1 0.9997206330299377
strongly O 0 0.06236441805958748
inhibited O 0 0.1320277452468872
the O 0 0.016630802303552628
overexpression O 0 0.11991794407367706
of O 0 0.011428876779973507
the O 0 0.01950031705200672
CA12 O 1 0.992352306842804
gene O 0 0.06889956444501877
in O 0 0.014270580373704433
the O 0 0.024303477257490158
parental O 1 0.9999561309814453
renal B-Disease 1 1.0
cell I-Disease 1 0.9999865293502808
carcinoma I-Disease 1 1.0
cell O 1 0.518163800239563
lines O 0 0.047714557498693466
. O 0 0.029212674126029015

Similar O 0 0.038310516625642776
results O 0 0.025896409526467323
were O 0 0.008862814866006374
obtained O 0 0.01908419467508793
with O 0 0.022796589881181717
CA9 O 1 0.9998477697372437
, O 0 0.020374299958348274
encoding O 0 0.05190904811024666
another O 0 0.03375525772571564
transmembrane O 0 0.1524186134338379
CA O 0 0.06075263395905495
with O 0 0.012035009451210499
an O 0 0.015586046501994133
intact O 0 0.07416435331106186
catalytic O 0 0.13408753275871277
domain O 0 0.06036585569381714
. O 0 0.026448672637343407

Although O 0 0.023662984371185303
both O 0 0.011477109044790268
domains O 0 0.03506423160433769
of O 0 0.009965009056031704
the O 0 0.022042617201805115
VHL B-Disease 1 0.9998975992202759
protein O 0 0.07699576765298843
contribute O 0 0.03909928351640701
to O 0 0.009879599325358868
regulation O 0 0.033732667565345764
of O 0 0.014672772958874702
CA12 O 1 0.9973461627960205
expression O 0 0.04375266283750534
, O 0 0.010131492279469967
the O 0 0.013839724473655224
elongin O 0 0.1810527741909027
binding O 0 0.055405810475349426
domain O 0 0.04549987241625786
alone O 0 0.038057006895542145
could O 0 0.021819304674863815
effectively O 0 0.05601710453629494
regulate O 0 0.12581412494182587
CA9 O 1 0.9998791217803955
expression O 0 0.08380137383937836
. O 0 0.03033834509551525

We O 0 0.03574817627668381
mapped O 0 0.10132607817649841
CA12 O 1 0.8519458174705505
and O 0 0.035309139639139175
CA9 O 1 0.9997023940086365
loci O 0 0.19713427126407623
to O 0 0.031047262251377106
chromosome O 0 0.16409286856651306
bands O 0 0.08043909817934036
15q22 O 0 0.1649317890405655
and O 0 0.02298492006957531
17q21 O 0 0.1675121784210205
. O 0 0.033378083258867264

2 O 0 0.043595634400844574
respectively O 0 0.027775296941399574
, O 0 0.01581585966050625
regions O 0 0.03970583528280258
prone O 0 0.16475671529769897
to O 0 0.01755562610924244
amplification O 0 0.09612567722797394
in O 0 0.010535569861531258
some O 0 0.011826680973172188
human O 0 0.0408642515540123
cancers B-Disease 1 0.9999724626541138
. O 0 0.032002050429582596

Additional O 0 0.04496152698993683
experiments O 0 0.04711049422621727
are O 0 0.007273202762007713
needed O 0 0.01792936399579048
to O 0 0.007771279197186232
define O 0 0.0217265821993351
the O 0 0.009387422353029251
role O 0 0.02035071887075901
of O 0 0.013905718922615051
CA O 1 0.8242130279541016
IX O 1 0.9872195720672607
and O 0 0.020206419751048088
CA O 1 0.5141870379447937
XII O 1 0.9455198049545288
enzymes O 0 0.05025362968444824
in O 0 0.009269283153116703
the O 0 0.01111941784620285
regulation O 0 0.03648993372917175
of O 0 0.012327109463512897
pH O 0 0.14501936733722687
in O 0 0.01282600685954094
the O 0 0.017869532108306885
extracellular O 0 0.1253947913646698
microenvironment O 1 0.5978084802627563
and O 0 0.010980582796037197
its O 0 0.011648217216134071
potential O 0 0.02961188368499279
impact O 0 0.04062868654727936
on O 0 0.021255886182188988
cancer B-Disease 1 0.9999996423721313
cell O 0 0.2048628181219101
growth O 0 0.04623332992196083
. O 0 0.02384660765528679

A O 0 0.05733601376414299
gene O 0 0.09307124465703964
encoding O 0 0.059263452887535095
a O 0 0.03456076607108116
transmembrane O 0 0.16318602859973907
protein O 0 0.07347744703292847
is O 0 0.02094932086765766
mutated O 0 0.10314039885997772
in O 0 0.023648887872695923
patients O 1 0.9999972581863403
with O 0 0.1241711750626564
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.5518555045127869
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9971455931663513
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.04470817372202873
. O 0 0.025582164525985718

Wolfram B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 1 0.6925225853919983
WFS B-Disease 1 0.9999997615814209
; O 0 0.07085731625556946
OMIM O 1 0.9999746084213257
222300 O 1 0.6383639574050903
) O 0 0.027745625004172325
is O 0 0.017075911164283752
an O 0 0.027798334136605263
autosomal B-Disease 1 0.999995231628418
recessive I-Disease 1 0.9999997615814209
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 0.03679575026035309
by O 0 0.015733232721686363
young O 0 0.17834098637104034
- O 1 0.9541049599647522
onset O 1 0.9999631643295288
non O 1 0.6204940676689148
- O 1 0.9971422553062439
immune O 1 0.9999973773956299
insulin B-Disease 1 0.9999855756759644
- I-Disease 1 0.9961313009262085
dependent I-Disease 1 0.9978241920471191
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.041667863726615906
progressive O 1 0.999397873878479
optic B-Disease 1 0.9999996423721313
atrophy I-Disease 1 0.9999861717224121
. O 0 0.044793449342250824

Linkage O 0 0.168422132730484
to O 0 0.02457088977098465
markers O 0 0.07200485467910767
on O 0 0.023095501586794853
chromosome O 0 0.2132241576910019
4p O 1 0.992523729801178
was O 0 0.022013653069734573
confirmed O 0 0.024190198630094528
in O 0 0.009016252122819424
five O 0 0.01529015600681305
families O 0 0.031903624534606934
. O 0 0.02887345477938652

On O 0 0.012892982922494411
the O 0 0.009661991149187088
basis O 0 0.015434098429977894
of O 0 0.01580161601305008
meiotic O 1 0.9998266100883484
recombinants O 1 0.9996572732925415
and O 0 0.03548699989914894
disease O 1 0.9999998807907104
- O 0 0.11790800839662552
associated O 0 0.04603194817900658
haplotypes O 1 0.5124420523643494
, O 0 0.01713518053293228
the O 0 0.025446776300668716
WFS B-Disease 1 0.9999854564666748
gene O 0 0.09639383852481842
was O 0 0.022766370326280594
localized O 0 0.08157598972320557
to O 0 0.015923790633678436
a O 0 0.04336879402399063
BAC O 1 0.9999594688415527
/ O 1 0.997680127620697
P1 O 1 0.9937487840652466
contig O 0 0.13416455686092377
of O 0 0.011619431897997856
less O 0 0.014501628465950489
than O 0 0.012184654362499714
250 O 0 0.053321368992328644
kb O 0 0.13130998611450195
. O 0 0.033324841409921646

Mutations O 0 0.1498064547777176
in O 0 0.020031262189149857
a O 0 0.02578386291861534
novel O 0 0.05750169977545738
gene O 0 0.11835070699453354
( O 0 0.052712082862854004
WFS1 O 1 0.8431175947189331
) O 0 0.03251245617866516
encoding O 0 0.04784863442182541
a O 0 0.03288126364350319
putative O 0 0.16219650208950043
transmembrane O 0 0.17088869214057922
protein O 0 0.054385386407375336
were O 0 0.008353155106306076
found O 0 0.010923836380243301
in O 0 0.0072313593700528145
all O 0 0.007010888773947954
affected O 0 0.03390007093548775
individuals O 0 0.019064605236053467
in O 0 0.01276283897459507
six O 0 0.029881296679377556
WFS B-Disease 1 0.9999990463256836
families O 0 0.029800226911902428
, O 0 0.010330482386052608
and O 0 0.007256371434777975
these O 0 0.009000600315630436
mutations O 0 0.06167862191796303
were O 0 0.007944196462631226
associated O 0 0.016011526808142662
with O 0 0.011823238804936409
the O 0 0.0263065155595541
disease O 1 0.9999997615814209
phenotype O 1 0.9993817806243896
. O 0 0.0357622355222702

WFS1 O 1 0.9849648475646973
appears O 0 0.04154554381966591
to O 0 0.011051492765545845
function O 0 0.020884908735752106
in O 0 0.010431443341076374
survival O 0 0.07862960547208786
of O 0 0.01648605801165104
islet O 1 0.6358838677406311
beta O 0 0.4679509699344635
- O 0 0.1195504367351532
cells O 0 0.0887724831700325
and O 0 0.019788263365626335
neurons O 0 0.12748797237873077
. O 0 0.01687425933778286
. O 0 0.025054944679141045

Stable O 0 0.10818784683942795
interaction O 0 0.04004799947142601
between O 0 0.011576849967241287
the O 0 0.00880033802241087
products O 0 0.01585443690419197
of O 0 0.00851420033723116
the O 0 0.01841200701892376
BRCA1 O 1 0.9994587302207947
and O 0 0.03676474466919899
BRCA2 O 1 0.9999889135360718
tumor B-Disease 1 0.9999761581420898
suppressor O 1 0.899182140827179
genes O 0 0.07961113750934601
in O 0 0.02297550067305565
mitotic O 0 0.2539902925491333
and O 0 0.02553411014378071
meiotic O 1 0.9966230392456055
cells O 0 0.12068381905555725
. O 0 0.03213256224989891

BRCA1 O 1 0.9936816692352295
and O 0 0.03674057871103287
BRCA2 O 1 0.9934073686599731
account O 0 0.021775756031274796
for O 0 0.008054726757109165
most O 0 0.008154119364917278
cases O 0 0.018364539369940758
of O 0 0.010736924596130848
familial O 1 0.9999747276306152
, O 0 0.02064349129796028
early O 0 0.05886465311050415
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 0 0.058247700333595276
/ I-Disease 1 0.9999992847442627
or I-Disease 1 0.9967238306999207
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.015178524889051914
encode O 0 0.03879105672240257
products O 0 0.02041974849998951
that O 0 0.007512436714023352
each O 0 0.01124431099742651
interact O 0 0.043155644088983536
with O 0 0.019438717514276505
hRAD51 O 0 0.20189374685287476
. O 0 0.03474661707878113

Results O 0 0.04263022914528847
presented O 0 0.025183627381920815
here O 0 0.014838694594800472
show O 0 0.022793827578425407
that O 0 0.012914817780256271
BRCA1 O 1 0.9975353479385376
and O 0 0.022695958614349365
BRCA2 O 1 0.9992067217826843
coexist O 0 0.06987328827381134
in O 0 0.014022626914083958
a O 0 0.02281522937119007
biochemical O 0 0.0875597670674324
complex O 0 0.03473878279328346
and O 0 0.013754462823271751
colocalize O 0 0.21963095664978027
in O 0 0.021152039989829063
subnuclear O 1 0.9439137578010559
foci O 0 0.3507167100906372
in O 0 0.021272623911499977
somatic O 0 0.13992951810359955
cells O 0 0.05869534984230995
and O 0 0.00803493894636631
on O 0 0.007579988334327936
the O 0 0.012212181463837624
axial O 0 0.11965540051460266
elements O 0 0.022478973492980003
of O 0 0.012854170985519886
developing O 0 0.07375074177980423
synaptonemal O 1 0.981547474861145
complexes O 0 0.15595810115337372
. O 0 0.0383525975048542

Like O 0 0.0673435851931572
BRCA1 O 1 0.988719642162323
and O 0 0.038720861077308655
RAD51 O 1 0.9998418092727661
, O 0 0.04011097922921181
BRCA2 O 1 0.9965697526931763
relocates O 0 0.30845406651496887
to O 0 0.041143327951431274
PCNA O 1 0.999129593372345
+ O 0 0.2380153238773346
replication O 0 0.13228951394557953
sites O 0 0.027073461562395096
following O 0 0.024261904880404472
exposure O 1 0.6303873062133789
of O 0 0.01666511781513691
S O 1 0.996049702167511
phase O 0 0.09221555292606354
cells O 0 0.07484719902276993
to O 0 0.02236943691968918
hydroxyurea O 1 0.9995911717414856
or O 0 0.059652265161275864
UV O 1 0.9999037981033325
irradiation O 0 0.28302687406539917
. O 0 0.038601696491241455

Thus O 0 0.049404326826334
, O 0 0.028774939477443695
BRCA1 O 1 0.9936515092849731
and O 0 0.025964634492993355
BRCA2 O 1 0.9960609078407288
participate O 0 0.03224290907382965
, O 0 0.010406178422272205
together O 0 0.008892351761460304
, O 0 0.008041775785386562
in O 0 0.009647992439568043
a O 0 0.023080315440893173
pathway O 0 0.14981259405612946
( O 0 0.035740189254283905
s O 0 0.10197140276432037
) O 0 0.01863100193440914
associated O 0 0.013104524463415146
with O 0 0.007807082496583462
the O 0 0.012366638518869877
activation O 0 0.0782015398144722
of O 0 0.011760140769183636
double O 0 0.06479856371879578
- O 0 0.09325829148292542
strand O 0 0.11080370843410492
break O 0 0.05564431846141815
repair O 1 0.932708740234375
and O 0 0.021730156615376472
/ O 1 0.9270714521408081
or O 0 0.028502358123660088
homologous O 0 0.16997693479061127
recombination O 0 0.20304447412490845
. O 0 0.04061859846115112

Dysfunction O 1 0.9999154806137085
of O 0 0.016381921246647835
this O 0 0.01572929136455059
pathway O 0 0.11958201229572296
may O 0 0.016997065395116806
be O 0 0.006098954938352108
a O 0 0.010134276002645493
general O 0 0.013962903060019016
phenomenon O 0 0.03701505810022354
in O 0 0.006319153122603893
the O 0 0.006821537856012583
majority O 0 0.013407336547970772
of O 0 0.007316424045711756
cases O 0 0.02127121575176716
of O 0 0.015321683138608932
hereditary B-Disease 1 0.9999988079071045
breast I-Disease 1 1.0
and I-Disease 0 0.17079941928386688
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9995338916778564
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.019918596372008324
. O 0 0.02427787333726883

A O 0 0.06630446016788483
novel O 0 0.0705919936299324
Arg362Ser O 1 0.6101106405258179
mutation O 0 0.13838331401348114
in O 0 0.017156898975372314
the O 0 0.02342395856976509
sterol O 1 0.9843571782112122
27 O 0 0.06969352811574936
- O 0 0.149708092212677
hydroxylase O 1 0.7978944182395935
gene O 0 0.13005580008029938
( O 0 0.059511035680770874
CYP27 O 1 0.9897951483726501
) O 0 0.02495354413986206
: O 0 0.013337427750229836
its O 0 0.010865475051105022
effects O 0 0.0547356940805912
on O 0 0.014907777309417725
pre O 0 0.08826296776533127
- O 0 0.09443061053752899
mRNA O 0 0.09510460495948792
splicing O 0 0.11857551336288452
and O 0 0.023265330120921135
enzyme O 0 0.12699617445468903
activity O 0 0.05814702436327934
. O 0 0.02917860448360443

A O 0 0.046908434480428696
novel O 0 0.050276871770620346
C O 0 0.08716562390327454
to O 0 0.014002257026731968
A O 0 0.029039178043603897
mutation O 0 0.09128249436616898
in O 0 0.013130919076502323
the O 0 0.021165044978260994
sterol O 1 0.9698277711868286
27 O 0 0.06945943832397461
- O 0 0.1510520726442337
hydroxylase O 1 0.8641750812530518
gene O 0 0.12690883874893188
( O 0 0.0554281510412693
CYP27 O 1 0.9813032746315002
) O 0 0.02392852120101452
was O 0 0.016826225444674492
identified O 0 0.02516609989106655
by O 0 0.01672961376607418
sequencing O 0 0.09320370852947235
amplified O 0 0.16173680126667023
CYP27 O 1 0.9401073455810547
gene O 0 0.0949593186378479
products O 0 0.026637524366378784
from O 0 0.01607373170554638
a O 0 0.026734545826911926
patient O 1 0.9962422847747803
with O 0 0.03144966438412666
cerebrotendinous B-Disease 1 0.999955415725708
xanthomatosis I-Disease 1 0.9999306201934814
( O 0 0.0804077684879303
CTX B-Disease 1 0.9999911785125732
) O 0 0.04356198012828827
. O 0 0.03006548434495926

The O 0 0.03923835605382919
mutation O 0 0.1573173701763153
changed O 0 0.04291187599301338
the O 0 0.02549864538013935
adrenodoxin O 1 0.6694539785385132
cofactor O 0 0.2901996970176697
binding O 0 0.09051695466041565
residue O 0 0.15054315328598022
362Arg O 0 0.17366543412208557
to O 0 0.02970549277961254
362Ser O 0 0.2175235152244568
( O 0 0.060849953442811966
CGT O 1 0.9865517616271973
362Arg O 1 0.5909945368766785
to O 0 0.04112320765852928
AGT O 1 0.9999971389770508
362Ser O 1 0.7411314845085144
) O 0 0.02420790307223797
, O 0 0.008930008858442307
and O 0 0.007777341641485691
was O 0 0.014568804763257504
responsible O 0 0.029745502397418022
for O 0 0.01796388067305088
deficiency O 1 0.9999996423721313
in O 0 0.016828196123242378
the O 0 0.023736942559480667
sterol O 1 0.9960408210754395
27 O 0 0.06631847470998764
- O 0 0.12652835249900818
hydroxylase O 1 0.6768734455108643
activity O 0 0.04310905560851097
, O 0 0.010808460414409637
as O 0 0.008850006386637688
confirmed O 0 0.023349139839410782
by O 0 0.009024081751704216
expression O 0 0.02840595878660679
of O 0 0.012360583059489727
mutant O 0 0.10216597467660904
cDNA O 0 0.13697388768196106
into O 0 0.036593690514564514
COS O 1 0.9996826648712158
- O 0 0.11662513017654419
1 O 0 0.054379504173994064
cells O 0 0.0938229113817215
. O 0 0.030588161200284958

Quantitative O 0 0.09783671051263809
analysis O 0 0.034314047545194626
showed O 0 0.0214059017598629
that O 0 0.005878521129488945
the O 0 0.009683404117822647
expression O 0 0.031804006546735764
of O 0 0.014927229844033718
CYP27 O 1 0.9884005784988403
gene O 0 0.08644042909145355
mRNA O 0 0.05177973583340645
in O 0 0.01154241617769003
the O 0 0.014195702038705349
patient O 1 0.9730913639068604
represented O 0 0.02839990146458149
52 O 0 0.055670857429504395
. O 0 0.030148372054100037

5 O 0 0.04093937203288078
% O 0 0.018378255888819695
of O 0 0.00736585957929492
the O 0 0.012325972318649292
normal O 0 0.043503452092409134
level O 0 0.03765987604856491
. O 0 0.02321814000606537

As O 0 0.0215721745043993
the O 0 0.02397887036204338
mutation O 0 0.13474170863628387
occurred O 0 0.055149149149656296
at O 0 0.021877266466617584
the O 0 0.018629658967256546
penultimate O 0 0.15473245084285736
nucleotide O 0 0.09139192849397659
of O 0 0.01741049438714981
exon O 0 0.14087465405464172
6 O 0 0.045665010809898376
( O 0 0.032850269228219986
- O 0 0.052508484572172165
2 O 0 0.023010700941085815
position O 0 0.01680777594447136
of O 0 0.012857923284173012
exon O 0 0.13958294689655304
6 O 0 0.057059068232774734
- O 0 0.11757827550172806
intron O 1 0.6049911379814148
6 O 0 0.06422587484121323
splice O 0 0.1651061326265335
site O 0 0.03190131485462189
) O 0 0.01487442571669817
of O 0 0.006975127849727869
the O 0 0.012802766636013985
gene O 0 0.06277728080749512
, O 0 0.01178177259862423
we O 0 0.011373884975910187
hypothesized O 0 0.06375537067651749
that O 0 0.009867493063211441
the O 0 0.018057381734251976
mutation O 0 0.15031568706035614
may O 0 0.030828090384602547
partially O 0 0.0595441572368145
affect O 0 0.03856084868311882
the O 0 0.016914183273911476
normal O 0 0.05182892084121704
splicing O 0 0.10474346578121185
efficiency O 0 0.050331637263298035
in O 0 0.01568327657878399
exon O 0 0.1099378764629364
6 O 0 0.03417353332042694
and O 0 0.015655415132641792
cause O 0 0.06184457987546921
alternative O 0 0.05393487215042114
splicing O 0 0.09897509962320328
elsewhere O 0 0.029378622770309448
, O 0 0.009910537861287594
which O 0 0.008050616830587387
resulted O 0 0.026343192905187607
in O 0 0.012073243968188763
decreased O 0 0.06698711961507797
transcript O 0 0.05188019946217537
in O 0 0.010718080215156078
the O 0 0.016967562958598137
patient O 1 0.9989783763885498
. O 0 0.02689131535589695

Transfection O 1 0.8239025473594666
of O 0 0.023877499625086784
constructed O 0 0.04916738346219063
minigenes O 0 0.25117284059524536
, O 0 0.01145553681999445
with O 0 0.008405176922678947
or O 0 0.011730876751244068
without O 0 0.010668860748410225
the O 0 0.013707439415156841
mutation O 0 0.10336368530988693
, O 0 0.016156163066625595
into O 0 0.027186913415789604
COS O 1 0.9999852180480957
- O 0 0.1033371165394783
1 O 0 0.040378667414188385
cells O 0 0.06457263976335526
confirmed O 0 0.025097357109189034
that O 0 0.007214625831693411
the O 0 0.013991384766995907
mutant O 0 0.11413617432117462
minigene O 0 0.2054232358932495
was O 0 0.021636702120304108
responsible O 0 0.02511836774647236
for O 0 0.010865557007491589
a O 0 0.020583288744091988
mRNA O 0 0.058178290724754333
species O 0 0.03212482109665871
alternatively O 0 0.08233155310153961
spliced O 0 0.11159319430589676
at O 0 0.02932710386812687
an O 0 0.022872362285852432
activated O 0 0.1508963704109192
cryptic O 0 0.13627591729164124
5 O 0 0.05166137218475342
splice O 0 0.16471557319164276
site O 0 0.04706981033086777
88 O 0 0.09146218746900558
bp O 0 0.10445207357406616
upstream O 0 0.05056752637028694
from O 0 0.00998957734555006
the O 0 0.010129446163773537
3 O 0 0.020868752151727676
end O 0 0.0198617335408926
of O 0 0.013304324820637703
exon O 0 0.1336982697248459
6 O 0 0.049951810389757156
. O 0 0.027916446328163147

Our O 0 0.02560148760676384
data O 0 0.017240434885025024
suggest O 0 0.020041784271597862
that O 0 0.0059793489053845406
the O 0 0.009861567988991737
C O 0 0.06969527900218964
to O 0 0.010898832231760025
A O 0 0.026695216074585915
mutation O 0 0.09994744509458542
at O 0 0.018025491386651993
the O 0 0.017580671235919
penultimate O 0 0.14016884565353394
nucleotide O 0 0.08567143231630325
of O 0 0.014344282448291779
exon O 0 0.10622651875019073
6 O 0 0.02475878782570362
of O 0 0.00844842754304409
the O 0 0.018837757408618927
CYP27 O 1 0.9986104965209961
gene O 0 0.07033665478229523
not O 0 0.01096721924841404
only O 0 0.01239058654755354
causes O 1 0.6918968558311462
the O 0 0.025348646566271782
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.0173589326441288
the I-Disease 0 0.023347876965999603
sterol I-Disease 1 0.9964175224304199
27 I-Disease 0 0.061232831329107285
- I-Disease 0 0.1147322729229927
hydroxylase I-Disease 1 0.5367468595504761
activity I-Disease 0 0.040821608155965805
, O 0 0.010831744410097599
but O 0 0.009363047778606415
also O 0 0.010152796283364296
partially O 0 0.050559766590595245
leads O 0 0.04360239580273628
to O 0 0.01354299858212471
alternative O 0 0.04186101257801056
pre O 0 0.09159082174301147
- O 0 0.08672080934047699
mRNA O 0 0.07469023019075394
splicing O 0 0.0848269984126091
of O 0 0.012273628264665604
the O 0 0.02014749124646187
gene O 0 0.10600384324789047
. O 0 0.03228223696351051

To O 0 0.01809888333082199
our O 0 0.01365935243666172
knowledge O 0 0.016662077978253365
, O 0 0.006980199832469225
this O 0 0.005102242808789015
is O 0 0.006118293851613998
the O 0 0.005438235588371754
first O 0 0.00964988861232996
report O 0 0.013403375633060932
regarding O 0 0.01856159046292305
effects O 0 0.053532883524894714
on O 0 0.012399504892528057
pre O 0 0.0864405483007431
- O 0 0.08818034827709198
mRNA O 0 0.07464995980262756
splicing O 0 0.08601547032594681
of O 0 0.012605348601937294
a O 0 0.02521562948822975
mutation O 0 0.11066514998674393
at O 0 0.02176845446228981
the O 0 0.013509297743439674
- O 0 0.0496293306350708
2 O 0 0.020797112956643105
position O 0 0.013788197189569473
of O 0 0.008654076606035233
a O 0 0.023264080286026
5 O 0 0.04180920496582985
splice O 0 0.1604643315076828
site O 0 0.043088361620903015
. O 0 0.03177254647016525

ATM O 1 0.5945851802825928
germline O 1 0.5080334544181824
mutations O 0 0.14856958389282227
in O 0 0.0268414206802845
classical O 0 0.10674543678760529
ataxia B-Disease 1 1.0
- I-Disease 1 0.999935507774353
telangiectasia I-Disease 1 0.9999997615814209
patients O 1 0.9999459981918335
in O 0 0.012498653493821621
the O 0 0.012695442885160446
Dutch O 0 0.04874037951231003
population O 0 0.029301568865776062
. O 0 0.02551242895424366

Germline O 1 0.9603946208953857
mutations O 0 0.140420064330101
in O 0 0.017814557999372482
the O 0 0.019469238817691803
ATM O 0 0.1332682967185974
gene O 0 0.0530409961938858
are O 0 0.0068944161757826805
responsible O 0 0.017715848982334137
for O 0 0.00942945946007967
the O 0 0.025860300287604332
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999855756759644
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.16438379883766174
A B-Disease 1 0.9965858459472656
- I-Disease 1 0.998054027557373
T I-Disease 1 0.9999821186065674
) O 0 0.03795981407165527
. O 0 0.026233570650219917

In O 0 0.020599855110049248
our O 0 0.01632257178425789
study O 0 0.02095198631286621
, O 0 0.008132309652864933
we O 0 0.00740656815469265
have O 0 0.007060648407787085
determined O 0 0.022766394540667534
the O 0 0.017354102805256844
ATM O 0 0.13744789361953735
mutation O 0 0.13008257746696472
spectrum O 0 0.0520167239010334
in O 0 0.011856053955852985
19 O 0 0.026095837354660034
classical O 0 0.036852169781923294
A B-Disease 1 0.9901963472366333
- I-Disease 1 0.9998751878738403
T I-Disease 1 0.9999998807907104
patients O 1 0.9999481439590454
, O 0 0.011185896582901478
including O 0 0.007882649078965187
some O 0 0.010659447871148586
immigrant O 0 0.05210384726524353
populations O 0 0.04084182158112526
, O 0 0.008723169565200806
as O 0 0.006151653826236725
well O 0 0.007334704045206308
as O 0 0.006334786769002676
12 O 0 0.012234934605658054
of O 0 0.007376906927675009
Dutch O 0 0.03264524042606354
ethnic O 0 0.02231709472835064
origin O 0 0.03776012361049652
. O 0 0.03150900453329086

Both O 0 0.02046569064259529
the O 0 0.02111147902905941
protein O 0 0.08142548054456711
truncation O 0 0.158519446849823
test O 0 0.07082125544548035
( O 0 0.04584065452218056
PTT O 0 0.133982852101326
) O 0 0.021088581532239914
and O 0 0.009911250323057175
the O 0 0.017828285694122314
restriction O 0 0.07708887755870819
endonuclease O 1 0.8336594104766846
fingerprinting O 0 0.16986717283725739
( O 0 0.05690378323197365
REF O 1 0.8330352306365967
) O 0 0.026084113866090775
method O 0 0.023507189005613327
were O 0 0.007171881850808859
used O 0 0.009652805514633656
and O 0 0.007758502382785082
compared O 0 0.01650359481573105
for O 0 0.006440561264753342
their O 0 0.010531431064009666
detection O 0 0.082950659096241
efficiency O 0 0.04548513889312744
, O 0 0.01420555543154478
identifying O 0 0.04749634116888046
76 O 0 0.06222493574023247
% O 0 0.02210697904229164
and O 0 0.009162974543869495
60 O 0 0.022059312090277672
% O 0 0.01411269698292017
of O 0 0.007123465184122324
the O 0 0.016190357506275177
mutations O 0 0.09641234576702118
, O 0 0.01693805120885372
respectively O 0 0.029339246451854706
. O 0 0.02489282377064228

Most O 0 0.03543298318982124
patients O 1 0.9990824460983276
were O 0 0.010075542144477367
found O 0 0.012322686612606049
to O 0 0.0085035040974617
be O 0 0.013473117724061012
compound O 0 0.09802308678627014
heterozygote O 1 0.9827021360397339
. O 0 0.03841537609696388

Seventeen O 0 0.11597763001918793
mutations O 0 0.11525397002696991
were O 0 0.012559700757265091
distinct O 0 0.02494472824037075
, O 0 0.007370177190750837
of O 0 0.005737428553402424
which O 0 0.007021310739219189
10 O 0 0.011341736651957035
were O 0 0.005968835204839706
not O 0 0.007187169976532459
reported O 0 0.023903561756014824
previously O 0 0.022489143535494804
. O 0 0.021632835268974304

Mutations O 0 0.16168643534183502
are O 0 0.014912624843418598
small O 0 0.02387872524559498
deletions O 0 0.08782970160245895
or O 0 0.026842856779694557
point O 0 0.03503879904747009
mutations O 0 0.12145616859197617
frequently O 0 0.04838564246892929
affecting O 0 0.07821066677570343
splice O 0 0.1812104731798172
sites O 0 0.03915111720561981
. O 0 0.028655827045440674

Moreover O 0 0.061466000974178314
, O 0 0.01349647156894207
a O 0 0.017232269048690796
16 O 0 0.02738036774098873
. O 0 0.025484517216682434

7 O 0 0.0863674134016037
- O 0 0.12572602927684784
kb O 0 0.1844792515039444
genomic O 0 0.1448223888874054
deletion O 0 0.10914088040590286
of O 0 0.010542050935328007
the O 0 0.011923062615096569
3 O 0 0.019679391756653786
end O 0 0.014634800143539906
of O 0 0.006661499850451946
the O 0 0.010978851467370987
gene O 0 0.054927483201026917
, O 0 0.009297355078160763
most O 0 0.00815307442098856
likely O 0 0.01812147907912731
a O 0 0.011598820798099041
result O 0 0.01603376492857933
of O 0 0.008686055429279804
recombination O 0 0.08641920983791351
between O 0 0.01160496287047863
two O 0 0.009722073562443256
LINE O 0 0.02754659205675125
elements O 0 0.017847934737801552
, O 0 0.010990077629685402
was O 0 0.015247275121510029
identified O 0 0.030146658420562744
. O 0 0.021079078316688538

The O 0 0.021129336208105087
most O 0 0.014673275873064995
frequently O 0 0.03164355456829071
found O 0 0.026923445984721184
mutation O 0 0.10294195264577866
, O 0 0.010369062423706055
identified O 0 0.017166463658213615
in O 0 0.006515257526189089
three O 0 0.010341447778046131
unrelated O 0 0.041260574012994766
Turkish O 0 0.04351617023348808
A B-Disease 1 0.901691198348999
- I-Disease 1 0.9697688221931458
T I-Disease 1 0.9999386072158813
individuals O 0 0.025476038455963135
, O 0 0.009913693182170391
was O 0 0.011495452374219894
previously O 0 0.014089316129684448
described O 0 0.016196008771657944
to O 0 0.006364870350807905
be O 0 0.005873863585293293
a O 0 0.013364739716053009
Turkish O 0 0.03424772247672081
A B-Disease 1 0.7719611525535583
- I-Disease 1 0.9842841625213623
T I-Disease 1 0.9999798536300659
founder O 0 0.11731113493442535
mutation O 0 0.17435970902442932
. O 0 0.03285801783204079

The O 0 0.020657561719417572
presence O 0 0.02818242274224758
of O 0 0.010272637940943241
a O 0 0.02578451670706272
founder O 0 0.07564867287874222
mutation O 0 0.11811366677284241
among O 0 0.019654689356684685
relatively O 0 0.02307235077023506
small O 0 0.014865750446915627
ethnic O 0 0.01570354588329792
population O 0 0.018361316993832588
groups O 0 0.012623801827430725
in O 0 0.008516817353665829
Western O 0 0.022451288998126984
Europe O 0 0.020517457276582718
could O 0 0.012909944169223309
indicate O 0 0.023758109658956528
a O 0 0.01464130636304617
high O 0 0.02832920476794243
carrier O 0 0.07118643075227737
frequency O 0 0.04001274332404137
in O 0 0.010019216686487198
such O 0 0.010293381288647652
communities O 0 0.0304043460637331
. O 0 0.026249412447214127

In O 0 0.03241634741425514
patients O 1 0.9983102083206177
of O 0 0.010073957964777946
Dutch O 0 0.034207653254270554
ethnic O 0 0.018534481525421143
origin O 0 0.02002059668302536
, O 0 0.009130929596722126
however O 0 0.008813745342195034
, O 0 0.007698083762079477
no O 0 0.01024242676794529
significant O 0 0.02040293999016285
founder O 0 0.04948560521006584
effect O 0 0.03166282922029495
could O 0 0.013267031870782375
be O 0 0.010270467959344387
identified O 0 0.03009706363081932
. O 0 0.02160743810236454

The O 0 0.034537382423877716
observed O 0 0.06087448447942734
genetic O 0 0.08808965981006622
heterogeneity O 0 0.10333803296089172
including O 0 0.012670275755226612
the O 0 0.011253162287175655
relative O 0 0.03161092475056648
high O 0 0.027850022539496422
percentage O 0 0.03309912979602814
of O 0 0.015949394553899765
splice O 1 0.6231242418289185
- O 0 0.09665964543819427
site O 0 0.045918744057416916
mutations O 0 0.09526240825653076
had O 0 0.020698489621281624
no O 0 0.014493394643068314
reflection O 0 0.04112783446907997
on O 0 0.009174758568406105
the O 0 0.01899338886141777
phenotype O 1 0.952257513999939
. O 0 0.037482935935258865

All O 0 0.03167498856782913
patients O 1 0.9996029734611511
manifested O 0 0.30100172758102417
classical O 0 0.04942915588617325
A B-Disease 1 0.8353301286697388
- I-Disease 1 0.9643486738204956
T I-Disease 1 0.9998027682304382
and O 0 0.015789035707712173
increased O 0 0.0391014888882637
cellular O 0 0.10286436975002289
radioresistant O 0 0.4812820255756378
DNA O 0 0.10534188151359558
synthesis O 0 0.09135691821575165
. O 0 0.027304179966449738

Determination O 0 0.057347219437360764
of O 0 0.009902887046337128
the O 0 0.012738896533846855
genomic O 0 0.08303171396255493
structure O 0 0.022390052676200867
of O 0 0.008382802829146385
the O 0 0.018382444977760315
COL4A4 O 1 0.9990180730819702
gene O 0 0.05947486683726311
and O 0 0.00911606103181839
of O 0 0.011743316426873207
novel O 0 0.05586433783173561
mutations O 1 0.774185836315155
causing O 1 0.9983327984809875
autosomal B-Disease 1 0.9999995231628418
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.05606723576784134

Autosomal B-Disease 1 0.9999929666519165
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.036029018461704254
a O 0 0.0341397300362587
progressive O 1 0.9660020470619202
hematuric B-Disease 1 0.9999505281448364
glomerulonephritis I-Disease 1 0.9999998807907104
characterized O 1 0.9036378860473633
by O 0 0.03281752020120621
glomerular B-Disease 1 0.9999939203262329
basement I-Disease 1 0.9996750354766846
membrane I-Disease 1 0.872970461845398
abnormalities I-Disease 1 0.9975499510765076
and O 0 0.01338078361004591
associated O 0 0.022772300988435745
with O 0 0.0145494369789958
mutations O 0 0.08126000314950943
in O 0 0.011190708726644516
either O 0 0.014137819409370422
the O 0 0.014151968993246555
COL4A3 O 1 0.9971610307693481
or O 0 0.019590139389038086
the O 0 0.0196713674813509
COL4A4 O 1 0.9989816546440125
gene O 0 0.07409252226352692
, O 0 0.012602392584085464
which O 0 0.009244365617632866
encode O 0 0.02969624660909176
the O 0 0.01624097302556038
alpha3 O 0 0.2649146616458893
and O 0 0.0227945726364851
alpha4 O 1 0.9963966012001038
type O 1 0.9195859432220459
IV O 1 0.9999648332595825
collagen O 1 0.999812662601471
chains O 0 0.07379632443189621
, O 0 0.018731173127889633
respectively O 0 0.03339315950870514
. O 0 0.023224152624607086

To O 0 0.023310260847210884
date O 0 0.024434588849544525
, O 0 0.019864017143845558
mutation O 0 0.12303552031517029
screening O 0 0.06397789716720581
in O 0 0.00892777368426323
the O 0 0.008259824477136135
two O 0 0.009330429136753082
genes O 0 0.038983412086963654
has O 0 0.014430291019380093
been O 0 0.012984824366867542
hampered O 0 0.2770116627216339
by O 0 0.008507982827723026
the O 0 0.009390411898493767
lack O 0 0.024237006902694702
of O 0 0.010739294812083244
genomic O 0 0.0927024781703949
structure O 0 0.029381971806287766
information O 0 0.01894977129995823
. O 0 0.023954171687364578

We O 0 0.018392736092209816
report O 0 0.014731512404978275
here O 0 0.009190852753818035
the O 0 0.008820009417831898
complete O 0 0.019533812999725342
characterization O 0 0.03939497470855713
of O 0 0.0071734171360731125
the O 0 0.009869682602584362
48 O 0 0.036550071090459824
exons O 0 0.06446115672588348
of O 0 0.011391247622668743
the O 0 0.021639063954353333
COL4A4 O 1 0.9962942004203796
gene O 0 0.08607687801122665
, O 0 0.013855723664164543
a O 0 0.019427331164479256
comprehensive O 0 0.05408012866973877
gene O 0 0.076644666492939
screen O 0 0.033686209470033646
, O 0 0.008978091180324554
and O 0 0.007627411745488644
the O 0 0.011203061789274216
subsequent O 0 0.03118005208671093
detection O 0 0.06127911061048508
of O 0 0.008836640045046806
10 O 0 0.019542207941412926
novel O 0 0.032320454716682434
mutations O 0 0.0814327597618103
in O 0 0.014166363514959812
eight O 0 0.03836612030863762
patients O 1 0.9999998807907104
diagnosed O 1 1.0
with O 0 0.0662546381354332
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.057889800518751144

Furthermore O 0 0.0659625232219696
, O 0 0.01546186301857233
we O 0 0.010223490186035633
identified O 0 0.022087639197707176
a O 0 0.023158513009548187
glycine O 0 0.12511785328388214
to O 0 0.017445050179958344
alanine O 0 0.14213822782039642
substitution O 0 0.055247992277145386
in O 0 0.012141328305006027
the O 0 0.018180685117840767
collagenous O 1 0.9989849925041199
domain O 0 0.04345623403787613
that O 0 0.00882774032652378
is O 0 0.014235226437449455
apparently O 0 0.03940976411104202
silent O 0 0.04915410280227661
in O 0 0.010901634581387043
the O 0 0.015494284220039845
heterozygous O 0 0.12234070152044296
carriers O 0 0.07361974567174911
, O 0 0.012729130685329437
in O 0 0.011712344363331795
11 O 0 0.02899077534675598
. O 0 0.02432318404316902

5 O 0 0.04298603534698486
% O 0 0.018935687839984894
of O 0 0.007079689297825098
all O 0 0.007642470300197601
control O 0 0.024116812273859978
individuals O 0 0.01460958644747734
, O 0 0.0070288535207509995
and O 0 0.004786761477589607
in O 0 0.006276343949139118
one O 0 0.009249047376215458
control O 0 0.02805088274180889
individual O 0 0.020983528345823288
homozygous O 0 0.07332050800323486
for O 0 0.011737871915102005
this O 0 0.014927607960999012
glycine O 0 0.16583286225795746
substitution O 0 0.09964457899332047
. O 0 0.03480890020728111

There O 0 0.02028753235936165
has O 0 0.012580256909132004
been O 0 0.009371140971779823
no O 0 0.008858873508870602
previous O 0 0.015233886428177357
finding O 0 0.019327782094478607
of O 0 0.007952510379254818
a O 0 0.021349480375647545
glycine O 0 0.14593032002449036
substitution O 0 0.06141500174999237
that O 0 0.008724859915673733
is O 0 0.008926590904593468
not O 0 0.0066728489473462105
associated O 0 0.01259549893438816
with O 0 0.008336511440575123
any O 0 0.01194305531680584
obvious O 0 0.05309372395277023
phenotype O 1 0.7384815216064453
in O 0 0.020552577450871468
homozygous O 0 0.12094434350728989
individuals O 0 0.03680787235498428
. O 0 0.027948152273893356

Founder O 0 0.18228158354759216
BRCA1 O 1 0.9949207901954651
and O 0 0.04121329262852669
BRCA2 O 1 0.9987969398498535
mutations O 0 0.14563554525375366
in O 0 0.019241319969296455
French O 0 0.056224651634693146
Canadian O 1 0.8490306735038757
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9077301025390625
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.05490424856543541
. O 0 0.03184247761964798

We O 0 0.01920080929994583
have O 0 0.01178242638707161
identified O 0 0.025104207918047905
four O 0 0.014567524194717407
mutations O 0 0.05678309127688408
in O 0 0.00803743302822113
each O 0 0.007283352315425873
of O 0 0.008412698283791542
the O 0 0.028093859553337097
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9522765278816223
susceptibility O 1 0.9903044104576111
genes O 0 0.08506058156490326
, O 0 0.02527427487075329
BRCA1 O 1 0.9939008951187134
and O 0 0.026611264795064926
BRCA2 O 1 0.9980953335762024
, O 0 0.016608577221632004
in O 0 0.01393057405948639
French O 0 0.04622868075966835
Canadian O 1 0.9838347434997559
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9336999654769897
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.041804276406764984
from O 0 0.0189018826931715
Quebec O 0 0.07358073443174362
. O 0 0.030073633417487144

To O 0 0.02618739753961563
identify O 0 0.04855667054653168
founder O 0 0.07335572689771652
effects O 0 0.08166082203388214
, O 0 0.015227627009153366
we O 0 0.013679500669240952
examined O 0 0.05156909301877022
independently O 0 0.03501857444643974
ascertained O 0 0.09748416393995285
French O 0 0.0550740584731102
Canadian O 0 0.08784452825784683
cancer B-Disease 1 0.9999959468841553
families O 0 0.01878971792757511
for O 0 0.005729309283196926
the O 0 0.0065460833720862865
distribution O 0 0.014102290384471416
of O 0 0.005937009584158659
these O 0 0.007904755882918835
eight O 0 0.02596885710954666
mutations O 0 0.12403963506221771
. O 0 0.03203262761235237

Mutations O 0 0.1447816640138626
were O 0 0.01291881874203682
found O 0 0.01572907529771328
in O 0 0.008923600427806377
41 O 0 0.031278595328330994
of O 0 0.01154341734945774
97 O 0 0.07379458099603653
families O 0 0.03900184854865074
. O 0 0.028562556952238083

Six O 0 0.031017351895570755
of O 0 0.01340686995536089
eight O 0 0.027872847393155098
mutations O 0 0.0792565792798996
were O 0 0.012794902548193932
observed O 0 0.028042083606123924
at O 0 0.017321478575468063
least O 0 0.019312649965286255
twice O 0 0.035174403339624405
. O 0 0.025517063215374947

The O 0 0.05581246316432953
BRCA1 O 1 0.9982848763465881
C4446T O 1 0.8960522413253784
mutation O 0 0.15016204118728638
was O 0 0.016204649582505226
the O 0 0.010478890500962734
most O 0 0.013296152465045452
common O 0 0.03667578101158142
mutation O 0 0.12807904183864594
found O 0 0.02095680870115757
, O 0 0.011520832777023315
followed O 0 0.019184134900569916
by O 0 0.011275319382548332
the O 0 0.024896465241909027
BRCA2 O 1 0.9997171759605408
8765delAG O 1 0.9831331372261047
mutation O 0 0.24944373965263367
. O 0 0.0411754809319973

Together O 0 0.026829438284039497
, O 0 0.014394257217645645
these O 0 0.011563178151845932
mutations O 0 0.06942236423492432
were O 0 0.007449264172464609
found O 0 0.01176641508936882
in O 0 0.008171391673386097
28 O 0 0.017343314364552498
of O 0 0.007225652690976858
41 O 0 0.036667224019765854
families O 0 0.019916456192731857
identified O 0 0.020775457844138145
to O 0 0.008567507378757
have O 0 0.010460751131176949
a O 0 0.028202304616570473
mutation O 0 0.159623384475708
. O 0 0.03453103080391884

The O 0 0.024881817400455475
odds O 0 0.06776003539562225
of O 0 0.012888827361166477
detection O 0 0.056341417133808136
of O 0 0.005680975504219532
any O 0 0.006577188149094582
of O 0 0.005466764327138662
the O 0 0.010419911704957485
four O 0 0.025947965681552887
BRCA1 O 1 0.9985696077346802
mutations O 0 0.13526995480060577
was O 0 0.02599654346704483
18 O 0 0.029500488191843033
. O 0 0.02392462268471718

7x O 1 0.9920594692230225
greater O 0 0.04194994270801544
if O 0 0.013167091645300388
one O 0 0.009611349552869797
or O 0 0.011335808783769608
more O 0 0.008176478557288647
cases O 0 0.026450911536812782
of O 0 0.027170635759830475
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.009533447213470936
also O 0 0.007403140421956778
present O 0 0.00932437926530838
in O 0 0.006229434162378311
the O 0 0.009911222383379936
family O 0 0.0308048315346241
. O 0 0.024967946112155914

The O 0 0.02672615833580494
odds O 0 0.06461719423532486
of O 0 0.01237298920750618
detection O 0 0.052702855318784714
of O 0 0.0062599158845841885
any O 0 0.006236966233700514
of O 0 0.005303847137838602
the O 0 0.011550133116543293
four O 0 0.029261542484164238
BRCA2 O 1 0.9991318583488464
mutations O 0 0.1444849818944931
was O 0 0.028488945215940475
5 O 0 0.0314926914870739
. O 0 0.02522732876241207

3x O 0 0.4999884068965912
greater O 0 0.032946985214948654
if O 0 0.011781644076108932
there O 0 0.008090289309620857
were O 0 0.005660337395966053
at O 0 0.010491407476365566
least O 0 0.010448073968291283
five O 0 0.010246106423437595
cases O 0 0.021259935572743416
of O 0 0.019615668803453445
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 0.011389208026230335
the O 0 0.013497773557901382
family O 0 0.03506208956241608
. O 0 0.02499607764184475

Interestingly O 0 0.09895030409097672
, O 0 0.013577659614384174
the O 0 0.009901952929794788
presence O 0 0.0253001619130373
of O 0 0.01259379182010889
a O 0 0.057342130690813065
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.06419364362955093
< O 0 0.4018099904060364
36 O 0 0.02679029479622841
years O 0 0.011792737059295177
of O 0 0.008574606850743294
age O 0 0.022234734147787094
was O 0 0.014234752394258976
strongly O 0 0.02501099184155464
predictive O 0 0.05795207619667053
of O 0 0.00593126006424427
the O 0 0.007549334317445755
presence O 0 0.01653192937374115
of O 0 0.004511938896030188
any O 0 0.005485826637595892
of O 0 0.005470729898661375
the O 0 0.010991736315190792
eight O 0 0.02868071384727955
mutations O 0 0.12339331954717636
screened O 0 0.11127962917089462
. O 0 0.03412792831659317

Carriers O 0 0.08851401507854462
of O 0 0.011910049244761467
the O 0 0.013686580583453178
same O 0 0.02163248136639595
mutation O 0 0.10061899572610855
, O 0 0.012563114054501057
from O 0 0.010094011202454567
different O 0 0.008199780248105526
families O 0 0.019921621307730675
, O 0 0.010800470598042011
shared O 0 0.02511453814804554
similar O 0 0.028418870642781258
haplotypes O 1 0.9070457816123962
, O 0 0.016500744968652725
indicating O 0 0.03019927628338337
that O 0 0.007607702165842056
the O 0 0.01307632029056549
mutant O 0 0.1025119423866272
alleles O 0 0.11169317364692688
were O 0 0.010731496848165989
likely O 0 0.01687619835138321
to O 0 0.006382783874869347
be O 0 0.006063671782612801
identical O 0 0.01780950091779232
by O 0 0.008698089979588985
descent O 0 0.03488016128540039
for O 0 0.00933173205703497
a O 0 0.01898343674838543
mutation O 0 0.08464166522026062
in O 0 0.00926431454718113
the O 0 0.011282859370112419
founder O 0 0.05249971151351929
population O 0 0.031587596982717514
. O 0 0.025326132774353027

The O 0 0.02057652920484543
identification O 0 0.030473018065094948
of O 0 0.0127525944262743
common O 0 0.04636823385953903
BRCA1 O 1 0.9995482563972473
and O 0 0.032724715769290924
BRCA2 O 1 0.9997748732566833
mutations O 0 0.13023406267166138
will O 0 0.015124120749533176
facilitate O 0 0.04062194377183914
carrier O 0 0.10582461208105087
detection O 0 0.07309401780366898
in O 0 0.013578873127698898
French O 0 0.043867938220500946
Canadian O 1 0.9836423397064209
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.936894953250885
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.057089462876319885
. O 0 0.02991282008588314

Are O 0 0.028337428346276283
Dp71 O 0 0.3989681303501129
and O 0 0.034549396485090256
Dp140 O 1 0.9791768193244934
brain O 1 0.9979698061943054
dystrophin O 1 0.9900829195976257
isoforms O 0 0.10136597603559494
related O 0 0.03680263087153435
to O 0 0.022568928077816963
cognitive B-Disease 1 0.9633278846740723
impairment I-Disease 1 0.9999892711639404
in O 0 0.049304574728012085
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9138704538345337

Molecular O 0 0.10598542541265488
study O 0 0.038707833737134933
and O 0 0.018576044589281082
neuropsychological O 0 0.39635393023490906
analysis O 0 0.025101488456130028
were O 0 0.008946017362177372
performed O 0 0.022858070209622383
concurrently O 0 0.020212842151522636
on O 0 0.010863753035664558
49 O 0 0.062370628118515015
patients O 1 0.999975323677063
with O 0 0.04846819490194321
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9960237741470337
DMD B-Disease 1 1.0
) O 0 0.020026689395308495
in O 0 0.006639458239078522
order O 0 0.007431910838931799
to O 0 0.006365799345076084
find O 0 0.017856262624263763
a O 0 0.014913367107510567
molecular O 0 0.038402874022722244
explanation O 0 0.026281407102942467
for O 0 0.00846068188548088
the O 0 0.013820849359035492
cognitive B-Disease 1 0.7931759357452393
impairment I-Disease 1 0.9998251795768738
observed O 0 0.035752154886722565
in O 0 0.01461015548557043
most O 0 0.03223452344536781
DMD B-Disease 1 1.0
patients O 1 0.9999970197677612
. O 0 0.03583519533276558

Complete O 0 0.04599418118596077
analysis O 0 0.023677045479416847
of O 0 0.011062797158956528
the O 0 0.024017969146370888
dystrophin O 1 0.9985635876655579
gene O 0 0.0871872678399086
was O 0 0.017095770686864853
performed O 0 0.02022942341864109
to O 0 0.007379893213510513
define O 0 0.0241656806319952
the O 0 0.011042073369026184
localization O 0 0.055729493498802185
of O 0 0.01163301058113575
deletions O 0 0.06973840296268463
and O 0 0.016133688390254974
duplications O 0 0.07697079330682755
in O 0 0.01153577584773302
relation O 0 0.022938363254070282
to O 0 0.008421589620411396
the O 0 0.012942183762788773
different O 0 0.025027859956026077
DMD B-Disease 1 1.0
promoters O 1 0.949308454990387
. O 0 0.03648475185036659

Qualitative O 0 0.07884759455919266
analysis O 0 0.02778620645403862
of O 0 0.008039722219109535
the O 0 0.016283279284834862
Dp71 O 1 0.9470179080963135
transcript O 0 0.06167568266391754
and O 0 0.010526795871555805
testing O 0 0.02948777936398983
for O 0 0.006593868136405945
the O 0 0.007945485413074493
specific O 0 0.013828475959599018
first O 0 0.01426256075501442
exon O 0 0.09392041712999344
of O 0 0.013059279881417751
Dp140 O 0 0.10327529907226562
were O 0 0.010121081955730915
also O 0 0.009206412360072136
carried O 0 0.016598328948020935
out O 0 0.015420787036418915
. O 0 0.02382873184978962

Neuropsychological O 1 0.8754706978797913
analysis O 0 0.05222979187965393
assessed O 0 0.07467084378004074
verbal O 0 0.0823911502957344
and O 0 0.02111896127462387
visuospatial O 1 0.9968357682228088
intelligence O 0 0.04539250582456589
, O 0 0.01697375252842903
verbal O 0 0.07350917160511017
memory O 0 0.044941648840904236
, O 0 0.009522674605250359
and O 0 0.008801818825304508
reading O 0 0.025721527636051178
skills O 0 0.04526996612548828
. O 0 0.02451309747993946

Comparison O 0 0.048411913216114044
of O 0 0.014883163385093212
molecular O 0 0.05380236357450485
and O 0 0.01749591901898384
psychometric O 1 0.5460197925567627
findings O 0 0.044420886784791946
demonstrated O 0 0.042817290872335434
that O 0 0.012205511331558228
deletions O 0 0.07022011280059814
and O 0 0.013578744605183601
duplications O 0 0.0693451538681984
that O 0 0.008199557662010193
were O 0 0.009229240007698536
localized O 0 0.06533395498991013
in O 0 0.009550982154905796
the O 0 0.012758509255945683
distal O 1 0.9206244945526123
part O 0 0.016384417191147804
of O 0 0.007689706049859524
the O 0 0.013217334635555744
gene O 0 0.0678129568696022
seemed O 0 0.032099105417728424
to O 0 0.009622285142540932
be O 0 0.01117289811372757
preferentially O 0 0.08803713321685791
associated O 0 0.02947860397398472
with O 0 0.023159267380833626
cognitive B-Disease 1 0.8893753886222839
impairment I-Disease 1 0.9998832941055298
. O 0 0.039179809391498566

Two O 0 0.031226133927702904
altered O 0 0.0828658789396286
Dp71 O 0 0.2617921531200409
transcripts O 0 0.04707932844758034
and O 0 0.009608816355466843
two O 0 0.011089879088103771
deleted O 0 0.06607750803232193
Dp140 O 0 0.1515495628118515
DNA O 0 0.06448854506015778
sequences O 0 0.029472995549440384
were O 0 0.007969407364726067
found O 0 0.011603599414229393
in O 0 0.009240146726369858
four O 0 0.017492519691586494
patients O 1 0.9999871253967285
with O 0 0.03368943929672241
severe O 1 0.9999998807907104
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999998807907104
. O 0 0.04077167063951492

These O 0 0.020204316824674606
findings O 0 0.03547094762325287
suggest O 0 0.025661882013082504
that O 0 0.007409646175801754
some O 0 0.008793278597295284
sequences O 0 0.025077026337385178
located O 0 0.020169543102383614
in O 0 0.008523416705429554
the O 0 0.011631561443209648
distal O 1 0.816608726978302
part O 0 0.01565948687493801
of O 0 0.0071456232108175755
the O 0 0.012315677478909492
gene O 0 0.05172846093773842
and O 0 0.00789668969810009
, O 0 0.006935465149581432
in O 0 0.007464083842933178
particular O 0 0.017179662361741066
, O 0 0.012014615349471569
some O 0 0.0196821391582489
DMD B-Disease 1 1.0
isoforms O 0 0.07478445023298264
expressed O 0 0.02140972390770912
in O 0 0.009923502802848816
the O 0 0.016652777791023254
brain O 1 0.9996672868728638
may O 0 0.01428874209523201
be O 0 0.0058622807264328
related O 0 0.013472103513777256
to O 0 0.007662603631615639
the O 0 0.014625590294599533
cognitive B-Disease 1 0.992881178855896
impairment I-Disease 1 0.9999855756759644
associated O 0 0.03719291836023331
with O 0 0.028699539601802826
DMD B-Disease 1 1.0
. O 0 0.02562367357313633
. O 0 0.028392741456627846

I1307K O 1 0.6773784756660461
APC O 1 0.9217734932899475
and O 0 0.031037751585245132
hMLH1 O 0 0.21894510090351105
mutations O 0 0.10537964105606079
in O 0 0.013505733571946621
a O 0 0.018306702375411987
non O 0 0.038258787244558334
- O 0 0.05613758787512779
Jewish O 0 0.0310734361410141
family O 0 0.023300819098949432
with O 0 0.0159870944917202
hereditary B-Disease 1 0.9999699592590332
non I-Disease 1 0.999836802482605
- I-Disease 1 0.9999986886978149
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.05247489735484123

We O 0 0.022749051451683044
describe O 0 0.038432929664850235
a O 0 0.01876872405409813
French O 0 0.03650929778814316
Canadian O 0 0.054838646203279495
hereditary B-Disease 1 0.9997383952140808
non I-Disease 1 0.9990717172622681
- I-Disease 1 0.9999984502792358
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9444368481636047
HNPCC B-Disease 1 0.9999997615814209
) O 0 0.043617792427539825
kindred O 1 0.9811702370643616
which O 0 0.012880840338766575
carries O 0 0.028549401089549065
a O 0 0.021514199674129486
novel O 0 0.05042070150375366
truncating O 1 0.653774082660675
mutation O 0 0.1735742837190628
in O 0 0.028295621275901794
hMLH1 O 0 0.3585427403450012
. O 0 0.03239038959145546

Interestingly O 0 0.11184147745370865
, O 0 0.02034623548388481
the O 0 0.022091789171099663
I1307K O 1 0.6048113703727722
APC O 1 0.957633376121521
polymorphism O 0 0.12169160693883896
, O 0 0.01391303725540638
associated O 0 0.016036836430430412
with O 0 0.008312287740409374
an O 0 0.012481768615543842
increased O 0 0.034804996103048325
risk O 1 0.9995347261428833
of O 0 0.04748215898871422
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.014181435108184814
is O 0 0.009798919782042503
also O 0 0.006138130556792021
present O 0 0.008400020189583302
in O 0 0.007733217906206846
this O 0 0.009405571967363358
family O 0 0.02941695973277092
. O 0 0.02500416897237301

The O 0 0.04028751701116562
I1307K O 0 0.17285706102848053
polymorphism O 0 0.10834427922964096
has O 0 0.01711389794945717
previously O 0 0.015065913088619709
only O 0 0.007389710750430822
been O 0 0.0077370242215693
identified O 0 0.014853116124868393
in O 0 0.0067204805091023445
individuals O 0 0.013460320420563221
of O 0 0.009847741574048996
self O 0 0.06013813614845276
- O 0 0.08430743962526321
reported O 0 0.05569843575358391
Ashkenazi O 0 0.15704527497291565
Jewish O 0 0.055218201130628586
origins O 0 0.08119945228099823
. O 0 0.03702174872159958

In O 0 0.018340708687901497
addition O 0 0.01796667091548443
, O 0 0.007870708592236042
in O 0 0.006152709014713764
this O 0 0.0074627585709095
family O 0 0.019537627696990967
, O 0 0.00835977029055357
there O 0 0.007553808391094208
appears O 0 0.016576159745454788
to O 0 0.006011278368532658
be O 0 0.0060723451897501945
no O 0 0.009699752554297447
relationship O 0 0.01956937089562416
between O 0 0.00985007919371128
the O 0 0.01446084026247263
I1307K O 0 0.3079516291618347
polymorphism O 0 0.08504404127597809
and O 0 0.008126700296998024
the O 0 0.010010077618062496
presence O 0 0.025011444464325905
or O 0 0.01591729186475277
absence O 0 0.039142727851867676
of O 0 0.01755489595234394
cancer B-Disease 1 0.9999995231628418
. O 0 0.017482556402683258
. O 0 0.023205211386084557

Identification O 0 0.04743228852748871
of O 0 0.011863374151289463
a O 0 0.022104738280177116
novel O 0 0.04058535769581795
mutation O 0 0.09435892850160599
of O 0 0.009746347554028034
the O 0 0.014739508740603924
CPO O 0 0.45977652072906494
gene O 0 0.060166213661432266
in O 0 0.010583891533315182
a O 0 0.01729399897158146
Japanese O 0 0.04654312506318092
hereditary B-Disease 1 0.9927623867988586
coproporphyria I-Disease 1 0.9819199442863464
family O 0 0.0511065237224102
. O 0 0.03366430476307869

Hereditary B-Disease 1 0.9955776929855347
coproporphyria I-Disease 1 0.9949459433555603
( O 0 0.076004259288311
HCP B-Disease 1 0.9997109770774841
) O 0 0.025812312960624695
is O 0 0.013506348244845867
an O 0 0.022020647302269936
autosomal B-Disease 1 0.9999758005142212
dominant I-Disease 1 0.9995917677879333
disease I-Disease 1 1.0
characterized O 1 0.8907133936882019
by O 0 0.021510625258088112
a O 0 0.04422063007950783
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.0249046441167593
coproporphyrinogen I-Disease 1 0.9976528286933899
oxidase I-Disease 1 0.9723988771438599
( O 0 0.05205108970403671
CPO O 1 0.6895437240600586
) O 0 0.030918316915631294
caused O 0 0.047561660408973694
by O 0 0.01137713436037302
a O 0 0.02273683063685894
mutation O 0 0.09481710940599442
in O 0 0.01278616115450859
the O 0 0.017074167728424072
CPO O 1 0.7399600744247437
gene O 0 0.108222596347332
. O 0 0.03410844877362251

Only O 0 0.02578495815396309
11 O 0 0.03278426453471184
mutations O 0 0.06872821599245071
of O 0 0.0075969877652823925
the O 0 0.013941150158643723
gene O 0 0.05653062462806702
have O 0 0.009736710228025913
been O 0 0.01171006541699171
reported O 0 0.029912259429693222
in O 0 0.0251639224588871
HCP B-Disease 1 0.9999983310699463
patients O 1 0.999962329864502
. O 0 0.03281880170106888

We O 0 0.0205109603703022
report O 0 0.02226141467690468
another O 0 0.024278100579977036
mutation O 0 0.08992661535739899
in O 0 0.010911025106906891
a O 0 0.015993192791938782
Japanese O 0 0.03380937501788139
family O 0 0.03495243564248085
. O 0 0.028697723522782326

Polymerase O 0 0.346528559923172
chain O 0 0.15085633099079132
reaction O 0 0.11797808855772018
- O 0 0.08886644244194031
single O 0 0.049154382199048996
strand O 0 0.13725894689559937
conformational O 0 0.15268182754516602
polymorphism O 0 0.11602745205163956
and O 0 0.014761768281459808
direct O 0 0.02494029887020588
sequence O 0 0.034415118396282196
analyses O 0 0.043396998196840286
demonstrated O 0 0.04255540668964386
a O 0 0.02434193156659603
C O 0 0.09134111553430557
to O 0 0.019323792308568954
T O 1 0.8450778722763062
substitution O 0 0.061534758657217026
in O 0 0.017257973551750183
exon O 0 0.10243572294712067
1 O 0 0.020844656974077225
of O 0 0.00867373961955309
the O 0 0.018007917329669
CPO O 0 0.23794354498386383
gene O 0 0.08213933557271957
at O 0 0.024773886427283287
nucleotide O 0 0.0647205039858818
position O 0 0.021749742329120636
85 O 0 0.04354805871844292
, O 0 0.009984842501580715
which O 0 0.00796571746468544
lies O 0 0.022494062781333923
in O 0 0.008070369251072407
the O 0 0.01487467810511589
putative O 0 0.11980316787958145
presequence O 0 0.14877304434776306
for O 0 0.01638648472726345
targeting O 0 0.050126127898693085
to O 0 0.017684778198599815
mitochondria O 0 0.11188770085573196
. O 0 0.029687585309147835

This O 0 0.034952562302351
mutation O 0 0.13505956530570984
changes O 0 0.026362279430031776
the O 0 0.016738133504986763
codon O 0 0.09491512179374695
for O 0 0.014030620455741882
glutamine O 0 0.11760439723730087
to O 0 0.01608663983643055
a O 0 0.03128594905138016
termination O 0 0.15926183760166168
codon O 0 0.15095210075378418
at O 0 0.04067741334438324
amino O 0 0.08422714471817017
acid O 0 0.133767232298851
position O 0 0.03370674327015877
29 O 0 0.04210839793086052
. O 0 0.02736799605190754

MaeI O 1 0.507187008857727
restriction O 0 0.07422485202550888
analysis O 0 0.02948806993663311
showed O 0 0.02249172143638134
two O 0 0.007537521421909332
other O 0 0.008399689570069313
carriers O 0 0.04823080450296402
in O 0 0.008800104260444641
the O 0 0.012885963544249535
family O 0 0.03767683729529381
. O 0 0.028418119996786118

The O 0 0.054115716367959976
C O 1 0.9899129867553711
- O 1 0.7939419746398926
T O 1 0.9951386451721191
mutation O 0 0.13395433127880096
is O 0 0.016830815002322197
located O 0 0.021713770925998688
within O 0 0.01124449260532856
a O 0 0.01619652844965458
recently O 0 0.03292902559041977
proposed O 0 0.03238433972001076
putative O 0 0.1147388145327568
alternative O 0 0.05693700909614563
translation O 0 0.04877934232354164
initiation O 0 0.1323791742324829
codon O 0 0.17767688632011414
( O 0 0.0649636909365654
TIC O 1 0.9999427795410156
- O 0 0.09508942067623138
1 O 0 0.03330932930111885
) O 0 0.01676158420741558
, O 0 0.009875918738543987
supporting O 0 0.024239933118224144
that O 0 0.015815110877156258
TIC O 1 0.9999891519546509
- O 0 0.06660513579845428
1 O 0 0.020369837060570717
is O 0 0.010093583725392818
the O 0 0.010928320698440075
real O 0 0.04172743856906891
TIC O 1 0.9999102354049683
rather O 0 0.023102324455976486
than O 0 0.02208094298839569
TIC O 1 0.9999921321868896
- O 0 0.08243099600076675
2 O 0 0.030309496447443962
. O 0 0.016572430729866028
. O 0 0.024061787873506546

Human B-Disease 0 0.06080920249223709
complement I-Disease 0 0.11298594623804092
factor I-Disease 1 0.98667311668396
H I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
associated O 0 0.08709079772233963
with O 1 0.730800986289978
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.06359611451625824

This O 0 0.020864741876721382
study O 0 0.02422427199780941
reports O 0 0.015189210884273052
on O 0 0.008085889741778374
six O 0 0.014079040847718716
cases O 0 0.023843204602599144
of O 0 0.014842947013676167
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.01131763681769371
the I-Disease 0 0.010734068229794502
human I-Disease 0 0.02558739483356476
complement I-Disease 0 0.06285744160413742
regulatory I-Disease 0 0.09500619769096375
protein I-Disease 0 0.09994258731603622
Factor I-Disease 0 0.11970209330320358
H I-Disease 1 0.9996657371520996
( O 0 0.06114712357521057
FH O 1 0.9998970031738281
) O 0 0.01754452846944332
in O 0 0.0069532087072730064
the O 0 0.007660297676920891
context O 0 0.018236367031931877
of O 0 0.010133630596101284
an O 0 0.09973761439323425
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.041964784264564514

Five O 0 0.020559212192893028
of O 0 0.008057218976318836
the O 0 0.00921689998358488
cases O 0 0.02064884454011917
were O 0 0.008104636333882809
observed O 0 0.020330846309661865
in O 0 0.009258919395506382
children O 0 0.02718101628124714
presenting O 0 0.0562870055437088
with O 0 0.1567428708076477
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9959893822669983
HUS B-Disease 1 1.0
) O 0 0.039976365864276886
. O 0 0.02439299039542675

Two O 0 0.01355381403118372
of O 0 0.008250459097325802
the O 0 0.013662566430866718
children O 0 0.037447553128004074
exhibited O 0 0.06691557914018631
a O 0 0.041202232241630554
homozygous O 1 0.9954540729522705
deficiency O 1 1.0
characterized O 0 0.09894336014986038
by O 0 0.010248031467199326
the O 0 0.008376341313123703
absence O 0 0.02466273307800293
of O 0 0.006262138020247221
the O 0 0.011462727561593056
150 O 0 0.046752892434597015
- O 0 0.09352277964353561
kD O 1 0.6195594072341919
form O 0 0.026146097108721733
of O 0 0.015132725238800049
Factor O 0 0.07685825973749161
H O 1 0.9974690675735474
and O 0 0.009786435402929783
the O 0 0.01037870068103075
presence O 0 0.023881858214735985
, O 0 0.010486279614269733
upon O 0 0.014147997833788395
immunoblotting O 0 0.10216379910707474
, O 0 0.008762204088270664
of O 0 0.00682615302503109
the O 0 0.014653411693871021
42 O 0 0.060382820665836334
- O 0 0.17488670349121094
kD O 1 0.997470498085022
Factor O 0 0.18389753997325897
H O 1 0.999683141708374
- O 0 0.0867692157626152
like O 0 0.028772670775651932
protein O 0 0.0593850277364254
1 O 0 0.039355311542749405
( O 0 0.04773252457380295
FHL O 1 0.9999322891235352
- O 0 0.08292624354362488
1 O 0 0.02758786641061306
) O 0 0.015316396951675415
and O 0 0.009091369807720184
other O 0 0.01592378504574299
FH O 1 0.9999971389770508
- O 0 0.10859256237745285
related O 0 0.05184001848101616
protein O 0 0.09110274910926819
( O 0 0.04998745396733284
FHR O 1 0.9578872919082642
) O 0 0.033003680408000946
bands O 0 0.05560657009482384
. O 0 0.030148034915328026

Southern O 0 0.08362998068332672
blot O 0 0.20582692325115204
and O 0 0.023852907121181488
PCR O 0 0.13502563536167145
analysis O 0 0.02150290459394455
of O 0 0.00796001497656107
DNA O 0 0.03687349334359169
of O 0 0.007836364209651947
one O 0 0.014417695812880993
patient O 1 0.9992768168449402
with O 0 0.028404399752616882
homozygous O 1 0.9985791444778442
deficiency O 1 1.0
ruled O 0 0.043377332389354706
out O 0 0.009728126227855682
the O 0 0.007539576850831509
presence O 0 0.019399046897888184
of O 0 0.0066166711039841175
a O 0 0.011958945542573929
large O 0 0.018077386543154716
deletion O 0 0.08447793126106262
of O 0 0.01160215213894844
the O 0 0.024662692099809647
FH O 1 0.999992847442627
gene O 0 0.07216360419988632
as O 0 0.01000379491597414
the O 0 0.01157284528017044
underlying O 0 0.43400055170059204
defect O 1 0.9991154074668884
for O 0 0.014910977333784103
the O 0 0.026795346289873123
deficiency O 1 1.0
. O 0 0.036686971783638

The O 0 0.016861720010638237
other O 0 0.008143505081534386
four O 0 0.011886968277394772
children O 0 0.023428458720445633
presented O 0 0.022172564640641212
with O 0 0.02290349453687668
heterozygous O 1 0.9886569380760193
deficiency O 1 1.0
and O 0 0.01644003950059414
exhibited O 0 0.048322439193725586
a O 0 0.021593159064650536
normal O 0 0.05191044509410858
immunoblotting O 1 0.9108743667602539
pattern O 0 0.0495774932205677
of O 0 0.008976457640528679
proteins O 0 0.025699228048324585
of O 0 0.009412615559995174
the O 0 0.022003578022122383
FH O 1 0.9999934434890747
family O 0 0.050984859466552734
. O 0 0.02979089319705963

Factor B-Disease 1 0.9929510354995728
H I-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9999998807907104
is O 0 0.01688605733215809
the O 0 0.011467051692306995
only O 0 0.018228009343147278
complement B-Disease 1 0.9989815354347229
deficiency I-Disease 1 1.0
associated O 0 0.04505288228392601
with O 0 0.03133681043982506
HUS B-Disease 1 0.9999992847442627
. O 0 0.039209481328725815

These O 0 0.016023095697164536
observations O 0 0.030531644821166992
suggest O 0 0.0246410109102726
a O 0 0.014540020376443863
role O 0 0.021959034726023674
for O 0 0.020280936732888222
FH O 1 0.9999973773956299
and O 0 0.02520320937037468
/ O 1 0.9965680837631226
or O 0 0.03922130540013313
FH O 1 0.9999898672103882
receptors O 0 0.1158851608633995
in O 0 0.012461659498512745
the O 0 0.018916945904493332
pathogenesis O 1 0.9999353885650635
of O 0 0.03296888619661331
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.02619938552379608
. O 0 0.030606232583522797

Further O 0 0.025128783658146858
evidence O 0 0.016753986477851868
for O 0 0.007652805652469397
a O 0 0.01407250203192234
major O 0 0.021324941888451576
ancient O 0 0.037869591265916824
mutation O 1 0.9808639883995056
underlying O 1 0.9998524188995361
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.0503426231443882
linkage O 1 0.9901264905929565
disequilibrium O 1 0.9975234866142273
studies O 0 0.032649751752614975
in O 0 0.008803832344710827
the O 0 0.010367623530328274
Japanese O 0 0.03003670647740364
population O 0 0.027670957148075104
. O 0 0.02623598463833332

The O 0 0.10681235790252686
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9955202341079712
DM B-Disease 1 1.0
) O 0 0.04933922365307808
mutation O 0 0.11867918819189072
is O 0 0.017520321533083916
an O 0 0.020289085805416107
unstable O 1 0.9599573016166687
( O 0 0.061848994344472885
CTG O 1 0.9994080066680908
) O 0 0.04019298031926155
n O 0 0.07298534363508224
repeat O 0 0.06942085921764374
, O 0 0.011383057571947575
present O 0 0.012936598621308804
at O 0 0.01280951127409935
a O 0 0.012054131366312504
copy O 0 0.020795723423361778
number O 0 0.00855900626629591
of O 0 0.00978602934628725
5 O 0 0.032065730541944504
- O 0 0.06400632858276367
37 O 0 0.04719818755984306
repeats O 0 0.060635361820459366
on O 0 0.013148576952517033
normal O 0 0.04041236266493797
chromosomes O 0 0.054184768348932266
but O 0 0.01372764352709055
amplified O 0 0.06062448397278786
to O 0 0.01208834070712328
50 O 0 0.030441435053944588
- O 0 0.06585220992565155
3000 O 0 0.11444935202598572
copies O 0 0.03517098352313042
on O 0 0.03509664535522461
DM B-Disease 1 0.9999973773956299
chromosomes O 0 0.13277772068977356
. O 0 0.04303336516022682

Previous O 0 0.04090771824121475
findings O 0 0.03955240175127983
in O 0 0.01705348491668701
Caucasian O 0 0.31404608488082886
populations O 0 0.05274353176355362
of O 0 0.015339427627623081
a O 0 0.046849846839904785
DM B-Disease 1 1.0
founder O 0 0.12945528328418732
chromosome O 0 0.12238407880067825
raise O 0 0.032350584864616394
a O 0 0.01601567678153515
question O 0 0.015710977837443352
about O 0 0.009532304480671883
the O 0 0.011450079269707203
molecular O 0 0.041844192892313004
events O 0 0.017976906150579453
involved O 0 0.015621379017829895
in O 0 0.008294343948364258
the O 0 0.01267084851861
expansion O 0 0.05225033313035965
mutation O 0 0.1550212800502777
. O 0 0.03386760130524635

To O 0 0.021283244714140892
investigate O 0 0.04400881752371788
whether O 0 0.019938932731747627
a O 0 0.020523197948932648
founder O 0 0.06271074712276459
chromosome O 0 0.10173799097537994
for O 0 0.015570608898997307
the O 0 0.030338667333126068
DM B-Disease 1 1.0
mutation O 0 0.1801765114068985
exists O 0 0.0337478369474411
in O 0 0.00867734756320715
the O 0 0.009423894807696342
Japanese O 0 0.025954030454158783
population O 0 0.020786847919225693
, O 0 0.013364549726247787
we O 0 0.014333917759358883
genotyped O 0 0.1593395322561264
families O 0 0.032782744616270065
using O 0 0.03169606253504753
polymorphic O 0 0.19773361086845398
markers O 0 0.08500683307647705
near O 0 0.035129472613334656
the O 0 0.017196079716086388
( O 0 0.042693931609392166
CTG O 1 0.9984526634216309
) O 0 0.038802992552518845
n O 0 0.07047198712825775
repeat O 0 0.07613471895456314
region O 0 0.035311829298734665
and O 0 0.014964612200856209
constructed O 0 0.056040920317173004
haplotypes O 0 0.41462624073028564
. O 0 0.03657333925366402

Six O 0 0.031117381528019905
different O 0 0.0190334040671587
haplotypes O 0 0.15695692598819733
were O 0 0.013325060717761517
found O 0 0.025444505736231804
and O 0 0.026635639369487762
DM B-Disease 1 1.0
alleles O 0 0.17813104391098022
were O 0 0.019920654594898224
always O 0 0.038724444806575775
haplotype O 1 0.9125487208366394
A O 0 0.03871828690171242
. O 0 0.028738418594002724

To O 0 0.018373319879174232
find O 0 0.018473809584975243
an O 0 0.00952234212309122
origin O 0 0.013195238076150417
of O 0 0.006915460340678692
the O 0 0.015175417996942997
( O 0 0.047066427767276764
CTG O 1 0.9973204731941223
) O 0 0.0414830818772316
n O 0 0.07869209349155426
repeat O 0 0.0898498147726059
mutation O 0 0.10061924904584885
and O 0 0.009223229251801968
to O 0 0.007541803177446127
investigate O 0 0.02670716680586338
the O 0 0.011449799872934818
mechanism O 0 0.03558387607336044
of O 0 0.007001073099672794
the O 0 0.011435549706220627
expansion O 0 0.042012181133031845
mutation O 0 0.09197072684764862
in O 0 0.009864268824458122
the O 0 0.010787923820316792
Japanese O 0 0.024887267500162125
population O 0 0.016822120174765587
we O 0 0.009386628866195679
have O 0 0.009244644083082676
studied O 0 0.02877102605998516
90 O 0 0.04382176324725151
Japanese O 0 0.0703289806842804
DM B-Disease 1 0.9999995231628418
families O 0 0.04996977001428604
comprising O 0 0.04511725530028343
190 O 0 0.07951513677835464
affected O 0 0.05003031715750694
and O 0 0.01713496446609497
130 O 0 0.06350218504667282
unaffected O 0 0.13455204665660858
members O 0 0.028544070199131966
. O 0 0.0291843693703413

The O 0 0.023875780403614044
results O 0 0.02897750400006771
suggest O 0 0.02443346008658409
that O 0 0.007558997720479965
a O 0 0.012821154668927193
few O 0 0.013461771421134472
common O 0 0.02590344287455082
ancestral O 0 0.07182301580905914
mutations O 0 0.09615086019039154
in O 0 0.01188104972243309
both O 0 0.0142960911616683
Caucasian O 1 0.9419339895248413
and O 0 0.012255454435944557
Japanese O 0 0.02788310870528221
populations O 0 0.036066118627786636
have O 0 0.009999347850680351
originated O 0 0.027912069112062454
by O 0 0.008427660912275314
expansion O 0 0.02033999375998974
of O 0 0.0072570317424833775
an O 0 0.015176385641098022
ancestral O 0 0.08327852189540863
n O 0 0.09225232899188995
= O 0 0.11008397489786148
5 O 0 0.03574717044830322
repeat O 0 0.06532098352909088
to O 0 0.019963841885328293
n O 0 0.08065053820610046
= O 0 0.10819023847579956
19 O 0 0.040083348751068115
- O 0 0.06234460696578026
37 O 0 0.043423399329185486
copies O 0 0.025181498378515244
. O 0 0.02746948041021824

These O 0 0.01456189900636673
data O 0 0.015406039543449879
support O 0 0.02710392326116562
multistep O 0 0.1384727954864502
models O 0 0.037928711622953415
of O 0 0.016007075086236
triplet O 1 0.8941081762313843
repeat O 0 0.09502334147691727
expansion O 0 0.030977658927440643
that O 0 0.007606190163642168
have O 0 0.00663973530754447
been O 0 0.008116465993225574
proposed O 0 0.015058561228215694
for O 0 0.009613674134016037
both O 0 0.024268105626106262
DM B-Disease 1 1.0
and O 0 0.031832292675971985
Friedreichs B-Disease 1 0.9997954964637756
ataxia I-Disease 1 0.999985933303833
. O 0 0.024323411285877228
. O 0 0.026993291452527046

The O 0 0.028944889083504677
molecular O 0 0.06228705123066902
basis O 0 0.025671470910310745
of O 0 0.026762496680021286
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.011801498010754585
the O 0 0.010274170897901058
western O 0 0.02635096199810505
Cape O 0 0.061031728982925415
, O 0 0.013282520696520805
South O 0 0.026997648179531097
Africa O 0 0.047955017536878586
. O 0 0.027953388169407845

Deficiency B-Disease 1 0.9999992847442627
of I-Disease 0 0.014677896164357662
the I-Disease 0 0.015518452040851116
sixth I-Disease 0 0.04549523815512657
component I-Disease 0 0.04411982372403145
of I-Disease 0 0.009637155570089817
human I-Disease 0 0.027707865461707115
complement I-Disease 0 0.07822959125041962
( O 0 0.05257582291960716
C6 O 1 0.9999642372131348
) O 0 0.018699344247579575
has O 0 0.009582343511283398
been O 0 0.008419523946940899
reported O 0 0.015750711783766747
in O 0 0.005806337110698223
a O 0 0.010071895085275173
number O 0 0.00639301398769021
of O 0 0.006234932690858841
families O 0 0.017999570816755295
from O 0 0.008981234394013882
the O 0 0.010287397541105747
western O 0 0.026524655520915985
Cape O 0 0.07418704777956009
, O 0 0.01343171764165163
South O 0 0.03038645349442959
Africa O 0 0.04803837463259697
. O 0 0.027667734771966934

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
is O 0 0.025263527408242226
endemic O 0 0.07368747889995575
in O 0 0.010102811269462109
the O 0 0.009969882667064667
Cape O 0 0.048976171761751175
and O 0 0.00782452430576086
almost O 0 0.011747611686587334
all O 0 0.0075190309435129166
pedigrees O 0 0.08211029320955276
of O 0 0.01504930667579174
total O 0 0.07057829946279526
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.0757630467414856
C6Q0 O 1 0.9996317625045776
) O 0 0.021268311887979507
have O 0 0.009206611663103104
been O 0 0.01273807417601347
ascertained O 0 0.06575815379619598
because O 0 0.01589227467775345
of O 0 0.018156571313738823
recurrent O 1 0.999998927116394
disease O 1 0.9999998807907104
. O 0 0.04020651802420616

We O 0 0.019530342891812325
have O 0 0.011936384253203869
sequenced O 0 0.0566057413816452
the O 0 0.01348454225808382
expressed O 0 0.028448674827814102
exons O 0 0.07327087968587875
of O 0 0.011115118861198425
the O 0 0.02429765835404396
C6 O 1 0.9998983144760132
gene O 0 0.07076030969619751
from O 0 0.011363700963556767
selected O 0 0.016461163759231567
cases O 0 0.0184367373585701
and O 0 0.006558405235409737
have O 0 0.0072821867652237415
found O 0 0.011773614212870598
three O 0 0.01082750502973795
molecular O 0 0.07387257367372513
defects O 1 0.9879002571105957
leading O 0 0.032922714948654175
to O 0 0.01712588220834732
total O 0 0.04747195169329643
deficiency O 1 1.0
879delG O 1 0.9470582008361816
, O 0 0.01206175982952118
which O 0 0.007043412420898676
is O 0 0.007313387468457222
the O 0 0.009185605682432652
common O 0 0.02986243925988674
defect O 1 0.9921156764030457
in O 0 0.01043408177793026
the O 0 0.012336350977420807
Cape O 0 0.0637655109167099
and O 0 0.013911199755966663
hitherto O 0 0.08436238020658493
unreported O 0 0.08431999385356903
, O 0 0.013952028937637806
and O 0 0.013022867031395435
1195delC O 0 0.13752330839633942
and O 0 0.013723384588956833
1936delG O 0 0.13150149583816528
, O 0 0.010644398629665375
which O 0 0.006640879437327385
have O 0 0.006210493855178356
been O 0 0.008106122724711895
previously O 0 0.012001807801425457
reported O 0 0.019608337432146072
in O 0 0.010269948281347752
African O 0 0.045857012271881104
- O 0 0.07026848942041397
Americans O 0 0.045738063752651215
. O 0 0.03238895162940025

We O 0 0.017652135342359543
also O 0 0.010528321377933025
show O 0 0.016102558001875877
that O 0 0.007129315752536058
the O 0 0.01255939994007349
879delG O 0 0.330183744430542
and O 0 0.019667919725179672
1195delC O 1 0.9964784979820251
defects O 1 0.993172824382782
are O 0 0.009721463546156883
associated O 0 0.022916799411177635
with O 0 0.020409289747476578
characteristic O 1 0.6975919008255005
C6 O 1 0.9999990463256836
/ O 1 0.9996271133422852
C7 O 1 0.9994254112243652
region O 0 0.0755297988653183
DNA O 0 0.10587700456380844
marker O 0 0.13175958395004272
haplotypes O 1 0.6787000298500061
, O 0 0.016007471829652786
although O 0 0.014288057573139668
small O 0 0.017470546066761017
variations O 0 0.028534607961773872
were O 0 0.011134129017591476
observed O 0 0.03385057672858238
. O 0 0.024460166692733765

The O 0 0.0459638312458992
1936delG O 1 0.9820641279220581
defect O 1 0.9848736524581909
was O 0 0.023985236883163452
observed O 0 0.025996532291173935
only O 0 0.008159998804330826
once O 0 0.012214861810207367
in O 0 0.0062758587300777435
the O 0 0.010053260251879692
Cape O 0 0.05251721292734146
, O 0 0.010370789095759392
but O 0 0.0071426331996917725
its O 0 0.011359100230038166
associated O 0 0.03395861014723778
haplotype O 1 0.968643844127655
could O 0 0.019133614376187325
be O 0 0.011592049151659012
deduced O 0 0.07149800658226013
. O 0 0.02927083522081375

The O 0 0.01967228762805462
data O 0 0.015992188826203346
from O 0 0.009430515579879284
the O 0 0.013501388020813465
haplotypes O 1 0.7453793287277222
indicate O 0 0.02667754329741001
that O 0 0.00635048933327198
these O 0 0.005234169773757458
three O 0 0.010903916321694851
molecular O 0 0.0655466616153717
defects O 1 0.9453021287918091
account O 0 0.01920315995812416
for O 0 0.008629325777292252
the O 0 0.012985631823539734
defects O 1 0.910165011882782
in O 0 0.007488359231501818
all O 0 0.006319135427474976
the O 0 0.012873154133558273
38 O 0 0.04665305092930794
unrelated O 0 0.07357686012983322
C6Q0 O 1 0.9963313937187195
individuals O 0 0.02200028859078884
we O 0 0.007410698104649782
have O 0 0.006269953213632107
studied O 0 0.015241519547998905
from O 0 0.007724327966570854
the O 0 0.01314014196395874
Cape O 0 0.08402402698993683
. O 0 0.0272467490285635

We O 0 0.015682656317949295
have O 0 0.009297064505517483
also O 0 0.010024352930486202
observed O 0 0.02231971174478531
the O 0 0.01692390628159046
879delG O 1 0.9197798371315002
defect O 1 0.8441224694252014
in O 0 0.013232007622718811
two O 0 0.01682714745402336
Dutch O 1 0.5724590420722961
C6 B-Disease 1 1.0
- I-Disease 1 0.9967911839485168
deficient I-Disease 1 0.999981164932251
kindreds O 1 0.9809716939926147
, O 0 0.018168918788433075
but O 0 0.010969268158078194
the O 0 0.016537543386220932
879delG O 1 0.9771474003791809
defect O 1 0.9501783847808838
in O 0 0.010501649230718613
the O 0 0.01170879602432251
Cape O 0 0.08793917298316956
probably O 0 0.0264121126383543
did O 0 0.01157939713448286
not O 0 0.006276718340814114
come O 0 0.009845741093158722
from O 0 0.007173335645347834
The O 0 0.010027998127043247
Netherlands O 0 0.0289639662951231
. O 0 0.0128508685156703
. O 0 0.024267762899398804

Complement B-Disease 1 0.9942061901092529
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.03345072269439697
seven O 0 0.02027471363544464
further O 0 0.022749770432710648
molecular O 0 0.07925070822238922
defects O 1 0.9423738718032837
and O 0 0.010603914968669415
their O 0 0.010751145891845226
associated O 0 0.038124747574329376
marker O 0 0.12953545153141022
haplotypes O 1 0.6931513547897339
. O 0 0.037777408957481384

Seven O 0 0.03350188955664635
further O 0 0.02002684772014618
molecular O 0 0.051619336009025574
bases O 0 0.03904515877366066
of O 0 0.030570177361369133
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.016686400398612022
described O 0 0.0344996452331543
. O 0 0.02304426021873951

All O 0 0.014799723401665688
these O 0 0.008292735554277897
new O 0 0.020960839465260506
molecular O 0 0.07826078683137894
defects O 1 0.9680444002151489
involve O 0 0.04581362009048462
single O 0 0.036907218396663666
- O 0 0.07464590668678284
nucleotide O 0 0.09051134437322617
events O 0 0.025622542947530746
, O 0 0.014053422026336193
deletions O 0 0.06959205120801926
and O 0 0.012454455718398094
substitutions O 0 0.03691279515624046
, O 0 0.007693920750170946
some O 0 0.005767006892710924
of O 0 0.007205335423350334
which O 0 0.014754432253539562
alter O 0 0.08007128536701202
splice O 0 0.14674432575702667
sites O 0 0.022807277739048004
, O 0 0.011667589657008648
and O 0 0.01166048739105463
others O 0 0.023804491385817528
codons O 0 0.10132297873497009
. O 0 0.029666392132639885

They O 0 0.014332947321236134
are O 0 0.007926947437226772
distributed O 0 0.01790294423699379
along O 0 0.016209667548537254
the O 0 0.02260686457157135
C7 O 1 0.9997714161872864
gene O 0 0.07883836328983307
, O 0 0.010598838329315186
but O 0 0.007083776406943798
predominantly O 0 0.01895851455628872
towards O 0 0.016702760010957718
the O 0 0.010302322916686535
3 O 0 0.027722125872969627
end O 0 0.031226834282279015
. O 0 0.02854827605187893

All O 0 0.01290537416934967
were O 0 0.008465408347547054
found O 0 0.015330635942518711
in O 0 0.01381068304181099
compound O 0 0.08431403338909149
heterozygous O 0 0.1405448466539383
individuals O 0 0.038820408284664154
. O 0 0.03309278562664986

The O 0 0.06904520094394684
C6 O 1 0.9999774694442749
/ O 1 0.9992864727973938
C7 O 1 0.999643087387085
marker O 0 0.1936427652835846
haplotypes O 1 0.6141261458396912
associated O 0 0.033842504024505615
with O 0 0.016623876988887787
most O 0 0.024906370788812637
C7 B-Disease 1 0.9999921321868896
defects I-Disease 1 0.9953988194465637
are O 0 0.01166500523686409
tabulated O 0 0.0474417507648468
. O 0 0.015485236421227455
. O 0 0.02338612638413906

A O 0 0.0647481381893158
genome O 0 0.10748729854822159
- O 0 0.07492037117481232
wide O 0 0.031527079641819
search O 0 0.03480713441967964
for O 0 0.020030468702316284
chromosomal O 0 0.2965545058250427
loci O 0 0.2842218279838562
linked O 0 0.07590408623218536
to O 0 0.023361660540103912
mental O 1 0.9999951124191284
health O 1 0.9995179176330566
wellness O 1 0.9996976852416992
in O 0 0.015594104304909706
relatives O 0 0.035878632217645645
at O 0 0.017619801685214043
high O 0 0.03344397619366646
risk O 1 0.971348226070404
for O 0 0.036402419209480286
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
among O 0 0.016387837007641792
the O 0 0.010875376872718334
Old O 0 0.03124631568789482
Order O 0 0.022504113614559174
Amish O 0 0.1364685297012329
. O 0 0.032266709953546524

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999994039535522
disorder I-Disease 1 1.0
( O 1 0.9273350834846497
BPAD B-Disease 1 1.0
; O 1 0.9928447604179382
manic B-Disease 1 1.0
- I-Disease 1 0.9999934434890747
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999992847442627
) O 0 0.03133596479892731
is O 0 0.014017247594892979
characterized O 0 0.04085322842001915
by O 0 0.010840438306331635
episodes O 0 0.03396201133728027
of O 0 0.018309030681848526
mania B-Disease 1 0.9999970197677612
and O 0 0.027624282985925674
/ O 1 0.9997888207435608
or O 0 0.04445430636405945
hypomania B-Disease 1 0.9999971389770508
interspersed O 0 0.06952530145645142
with O 0 0.01582222245633602
periods O 0 0.04561557620763779
of O 0 0.019733600318431854
depression B-Disease 1 0.9999605417251587
. O 0 0.0359484888613224

Compelling O 0 0.06443014740943909
evidence O 0 0.02280507981777191
supports O 0 0.0326150543987751
a O 0 0.017161455005407333
significant O 0 0.024630893021821976
genetic O 0 0.06362717598676682
component O 0 0.04247572273015976
in O 0 0.01033876370638609
the O 0 0.018035275861620903
susceptibility O 1 0.8890706300735474
to O 0 0.02004544995725155
develop O 0 0.08255446702241898
BPAD B-Disease 1 0.9999338388442993
. O 0 0.04243214428424835

To O 0 0.020577356219291687
date O 0 0.02299734205007553
, O 0 0.011043752543628216
however O 0 0.01249377615749836
, O 0 0.01485829520970583
linkage O 0 0.1083725169301033
studies O 0 0.02527136728167534
have O 0 0.008780610747635365
attempted O 0 0.023193035274744034
only O 0 0.00839831680059433
to O 0 0.012129809707403183
identify O 0 0.04759751632809639
chromosomal O 0 0.4435323178768158
loci O 0 0.16307759284973145
that O 0 0.01507572177797556
cause O 0 0.045895081013441086
or O 0 0.012872881256043911
increase O 0 0.01862923614680767
the O 0 0.011618566699326038
risk O 0 0.07551297545433044
of O 0 0.013572040013968945
developing O 0 0.0925687849521637
BPAD B-Disease 1 0.9999711513519287
. O 0 0.039283107966184616

To O 0 0.01858857087790966
determine O 0 0.024441273882985115
whether O 0 0.01354570034891367
there O 0 0.007741795852780342
could O 0 0.010453098453581333
be O 0 0.009881982579827309
protective O 1 0.9721141457557678
alleles O 0 0.1213175356388092
that O 0 0.012680956162512302
prevent O 0 0.03643391653895378
or O 0 0.01619960367679596
reduce O 0 0.036679044365882874
the O 0 0.015086068771779537
risk O 0 0.09480267018079758
of O 0 0.012465092353522778
developing O 0 0.0668451339006424
BPAD B-Disease 1 0.9999916553497314
, O 0 0.011715414002537727
similar O 0 0.012228666804730892
to O 0 0.0074121542274951935
what O 0 0.010090621188282967
is O 0 0.00974707119166851
observed O 0 0.017807891592383385
in O 0 0.007376173045486212
other O 0 0.01232871226966381
genetic B-Disease 1 0.9999126195907593
disorders I-Disease 1 1.0
, O 0 0.013507017865777016
we O 0 0.009146330878138542
used O 0 0.019590813666582108
mental O 1 0.999997615814209
health O 1 0.9997368454933167
wellness O 1 0.9999598264694214
( O 0 0.025680875405669212
absence O 0 0.03139800205826759
of O 0 0.01049152109771967
any O 0 0.022947555407881737
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
) O 0 0.01792943850159645
as O 0 0.007223905064165592
the O 0 0.012594303116202354
phenotype O 0 0.37578701972961426
in O 0 0.013456889428198338
our O 0 0.01757640764117241
genome O 0 0.085439532995224
- O 0 0.08126845955848694
wide O 0 0.04970626160502434
linkage O 0 0.14528007805347443
scan O 0 0.10231596231460571
of O 0 0.009276608005166054
several O 0 0.009887938387691975
large O 0 0.019332172349095345
multigeneration O 0 0.39283472299575806
Old O 0 0.03606564551591873
Order O 0 0.027987172827124596
Amish O 0 0.13818693161010742
pedigrees O 0 0.1523725390434265
exhibiting O 0 0.08068437874317169
an O 0 0.019986020401120186
extremely O 0 0.04783042520284653
high O 0 0.04883168265223503
incidence O 1 0.9953755140304565
of O 0 0.024726426228880882
BPAD B-Disease 1 0.9999687671661377
. O 0 0.04066487401723862

We O 0 0.019337384030222893
have O 0 0.009742675349116325
found O 0 0.012984073720872402
strong O 0 0.01632436364889145
evidence O 0 0.01145439874380827
for O 0 0.00742828194051981
a O 0 0.0193893201649189
locus O 0 0.11980324983596802
on O 0 0.02402045950293541
chromosome O 0 0.2113836258649826
4p O 1 0.9872848391532898
at O 0 0.046500105410814285
D4S2949 O 0 0.16416391730308533
( O 0 0.04140010103583336
maximum O 0 0.06101803109049797
GENEHUNTER O 1 0.9919708967208862
- O 0 0.11959367990493774
PLUS O 0 0.1111823096871376
nonparametric O 0 0.21832866966724396
linkage O 0 0.17477284371852875
score O 0 0.05468598008155823
= O 0 0.1100245863199234
4 O 0 0.034300390630960464
. O 0 0.018300076946616173
05 O 0 0.12695634365081787
, O 0 0.024978339672088623
P O 0 0.38888078927993774
= O 0 0.08958776295185089
5 O 0 0.023639526218175888
. O 0 0.010122266598045826
22 O 0 0.02552144229412079
x O 0 0.059121593832969666
10 O 0 0.023093555122613907
( O 0 0.030839424580335617
- O 0 0.06880109757184982
4 O 0 0.035928744822740555
) O 0 0.026351867243647575
; O 0 0.027728337794542313
SIBPAL O 1 0.9212762117385864
Pempirical O 0 0.25769373774528503
value O 0 0.03994828090071678
< O 0 0.1522877812385559
3 O 0 0.03678116947412491
x O 0 0.06710731983184814
10 O 0 0.027337228879332542
( O 0 0.03461358696222305
- O 0 0.06466639786958694
5 O 0 0.03328395634889603
) O 0 0.019425487145781517
) O 0 0.01460094004869461
and O 0 0.009760035201907158
suggestive O 0 0.06841005384922028
evidence O 0 0.01460697129368782
for O 0 0.008710602298378944
a O 0 0.019823601469397545
locus O 0 0.11402673274278641
on O 0 0.025136208161711693
chromosome O 0 0.22954370081424713
4q O 1 0.9991723299026489
at O 0 0.045947808772325516
D4S397 O 0 0.17135486006736755
( O 0 0.037490364164114
maximum O 0 0.059521500021219254
GENEHUNTER O 1 0.9930840730667114
- O 0 0.10944746434688568
PLUS O 0 0.11149822175502777
nonparametric O 0 0.22693441808223724
linkage O 0 0.17453375458717346
score O 0 0.049529366195201874
= O 0 0.09106198698282242
3 O 0 0.028063209727406502
. O 0 0.011664609424769878
29 O 0 0.0318802185356617
, O 0 0.02378757856786251
P O 0 0.45707568526268005
= O 0 0.09970713406801224
2 O 0 0.02708672732114792
. O 0 0.013664738275110722
57 O 0 0.050914522260427475
x O 0 0.06747259199619293
10 O 0 0.023734817281365395
( O 0 0.031160300597548485
- O 0 0.06597859412431717
3 O 0 0.03269780054688454
) O 0 0.027712849900126457
; O 0 0.029402563348412514
SIBPAL O 1 0.8660610914230347
Pempirical O 0 0.20742864906787872
value O 0 0.041776854544878006
< O 0 0.14626944065093994
1 O 0 0.032269127666950226
x O 0 0.06501602381467819
10 O 0 0.02303468808531761
( O 0 0.029170740395784378
- O 0 0.05594354495406151
3 O 0 0.029189947992563248
) O 0 0.016606980934739113
) O 0 0.011683843098580837
that O 0 0.005325292702764273
are O 0 0.007386920507997274
linked O 0 0.04270009323954582
to O 0 0.016965655609965324
mental O 1 0.9999921321868896
health O 1 0.9991015195846558
wellness O 1 0.9996610879898071
. O 0 0.03635295107960701

These O 0 0.016661711037158966
findings O 0 0.028825802728533745
are O 0 0.006626186892390251
consistent O 0 0.020110879093408585
with O 0 0.0077902465127408504
the O 0 0.0117033077403903
hypothesis O 0 0.049617890268564224
that O 0 0.010539433918893337
certain O 0 0.015481836162507534
alleles O 0 0.11424532532691956
could O 0 0.02132834494113922
prevent O 0 0.04130923002958298
or O 0 0.016299832612276077
modify O 0 0.05125845968723297
the O 0 0.017755066975951195
clinical O 1 0.9906524419784546
manifestations O 1 0.5065399408340454
of O 0 0.018047794699668884
BPAD B-Disease 1 0.9999943971633911
and O 0 0.011790437623858452
perhaps O 0 0.021152442321181297
other O 0 0.009813281707465649
related O 0 0.08311869949102402
affective B-Disease 1 0.9999982118606567
disorders I-Disease 1 0.9999998807907104
. O 0 0.03722110018134117

Segregation O 1 0.5168159604072571
distortion O 1 0.6567873358726501
in O 0 0.0631309375166893
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.06669002771377563

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9926481246948242
DM B-Disease 1 1.0
) O 0 0.03708944469690323
is O 0 0.0179826058447361
an O 0 0.024378251284360886
autosomal B-Disease 1 0.999966025352478
dominant I-Disease 1 0.9988667964935303
disease I-Disease 1 0.9999995231628418
which O 0 0.010941150598227978
, O 0 0.007661326788365841
in O 0 0.0077270325273275375
the O 0 0.012357929721474648
typical O 0 0.049088746309280396
pedigree O 0 0.09716786444187164
, O 0 0.012214943766593933
shows O 0 0.015488488599658012
a O 0 0.012939497828483582
three O 0 0.013883904553949833
generation O 0 0.06652557104825974
anticipation O 0 0.10357242822647095
cascade O 0 0.22614003717899323
. O 0 0.04091504216194153

This O 0 0.01845467835664749
results O 0 0.030046354979276657
in O 0 0.025564493611454964
infertility B-Disease 1 0.9999998807907104
and O 1 0.5656175017356873
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.6507193446159363
CDM B-Disease 1 0.9999936819076538
) O 0 0.018052376806735992
with O 0 0.008206192404031754
the O 0 0.010811577551066875
disappearance O 0 0.05872977897524834
of O 0 0.0239796694368124
DM B-Disease 1 1.0
in O 0 0.01936117559671402
that O 0 0.015288756228983402
pedigree O 0 0.12608858942985535
. O 0 0.03210138902068138

The O 0 0.0224000196903944
concept O 0 0.03105216845870018
of O 0 0.0167227890342474
segregation O 0 0.1330462247133255
distortion O 0 0.10673703998327255
, O 0 0.012210087850689888
where O 0 0.012771951034665108
there O 0 0.007892200723290443
is O 0 0.011148858815431595
preferential O 0 0.0737157016992569
transmission O 0 0.05851888284087181
of O 0 0.008052094839513302
the O 0 0.011601017788052559
larger O 0 0.030053164809942245
allele O 0 0.1362806111574173
at O 0 0.030947282910346985
the O 0 0.03194081783294678
DM B-Disease 1 1.0
locus O 0 0.1444142609834671
, O 0 0.014077055267989635
has O 0 0.01078531052917242
been O 0 0.008999596349895
put O 0 0.016188839450478554
forward O 0 0.013817399740219116
to O 0 0.011022512800991535
explain O 0 0.034178320318460464
partially O 0 0.047475989907979965
the O 0 0.016942115500569344
maintenance O 0 0.1946185976266861
of O 0 0.025426149368286133
DM B-Disease 1 0.9999998807907104
in O 0 0.01597914844751358
the O 0 0.01420389860868454
population O 0 0.03124718926846981
. O 0 0.026210013777017593

In O 0 0.021732334047555923
a O 0 0.02098352089524269
survey O 0 0.036685824394226074
of O 0 0.018387412652373314
DM B-Disease 1 0.9999998807907104
in O 0 0.01421775296330452
Northern O 0 0.025105126202106476
Ireland O 0 0.029058467596769333
, O 0 0.015590516850352287
59 O 0 0.05555075407028198
pedigrees O 0 0.10746660083532333
were O 0 0.019496574997901917
ascertained O 0 0.10345900803804398
. O 0 0.03031396120786667

Sibships O 0 0.2188175916671753
where O 0 0.01824948564171791
the O 0 0.00930401124060154
status O 0 0.01570437103509903
of O 0 0.004466085694730282
all O 0 0.003923304378986359
the O 0 0.0068070609122514725
members O 0 0.010561436414718628
had O 0 0.011963476426899433
been O 0 0.010851308703422546
identified O 0 0.016800057142972946
were O 0 0.006203175988048315
examined O 0 0.027905186638236046
to O 0 0.006987669970840216
determine O 0 0.01469477266073227
the O 0 0.011691004037857056
transmission O 0 0.059890229254961014
of O 0 0.01129974890500307
the O 0 0.023929135873913765
DM B-Disease 1 1.0
expansion O 0 0.048122964799404144
from O 0 0.016552384942770004
affected O 0 0.04313147813081741
parents O 0 0.02411085180938244
to O 0 0.009363153949379921
their O 0 0.012234577909111977
offspring O 0 0.08414965867996216
. O 0 0.031489066779613495

Where O 0 0.027245091274380684
the O 0 0.02062244899570942
transmitting O 0 0.11815750598907471
parent O 0 0.09797459840774536
was O 0 0.021739408373832703
male O 0 0.049965664744377136
, O 0 0.018117355182766914
58 O 0 0.055012401193380356
. O 0 0.025564786046743393

3 O 0 0.04058254882693291
% O 0 0.020972101017832756
of O 0 0.007461801636964083
the O 0 0.011865240521728992
offspring O 0 0.055929265916347504
were O 0 0.00967011135071516
affected O 0 0.03246691823005676
, O 0 0.007701183669269085
and O 0 0.00560393463820219
in O 0 0.0050169019959867
the O 0 0.006961654871702194
case O 0 0.014053805731236935
of O 0 0.006084236782044172
a O 0 0.017894519492983818
female O 0 0.04972374066710472
transmitting O 0 0.13134713470935822
parent O 0 0.11118777841329575
, O 0 0.022716660052537918
68 O 0 0.07654707878828049
. O 0 0.028165576979517937

7 O 0 0.04893774539232254
% O 0 0.028695793822407722
were O 0 0.013713777996599674
affected O 0 0.05078219249844551
. O 0 0.026142222806811333

Studies O 0 0.05451307073235512
on O 0 0.019520776346325874
meiotic O 1 0.9213494062423706
drive O 0 0.07152720540761948
in O 0 0.03371141850948334
DM B-Disease 1 0.9999998807907104
have O 0 0.01671781949698925
shown O 0 0.023101549595594406
increased O 0 0.023515911772847176
transmission O 0 0.049978628754615784
of O 0 0.006204057950526476
the O 0 0.009646572172641754
larger O 0 0.028949635103344917
allele O 0 0.12571360170841217
at O 0 0.029260244220495224
the O 0 0.02710055373609066
DM B-Disease 1 0.9999997615814209
locus O 0 0.14770931005477905
in O 0 0.02571439929306507
non O 0 0.165933296084404
- O 1 0.9983905553817749
DM O 1 1.0
heterozygotes O 1 0.9935106635093689
for O 0 0.03711622580885887
CTGn O 1 0.9168376326560974
. O 0 0.04019884392619133

This O 0 0.019283033907413483
study O 0 0.027838213369250298
provides O 0 0.026907633990049362
further O 0 0.01250354666262865
evidence O 0 0.012646770104765892
that O 0 0.008637850172817707
the O 0 0.020319251343607903
DM B-Disease 1 1.0
expansion O 0 0.05435555428266525
tends O 0 0.04931113123893738
to O 0 0.011637000367045403
be O 0 0.013956877402961254
transmitted O 0 0.08872758597135544
preferentially O 0 0.14018328487873077
. O 0 0.036995045840740204

Diagnosis O 1 0.9999873638153076
of O 0 0.054144781082868576
hemochromatosis B-Disease 1 1.0
. O 0 0.04938722774386406

If O 0 0.06377798318862915
untreated O 1 0.9999949932098389
, O 0 0.1529701054096222
hemochromatosis B-Disease 1 1.0
can O 0 0.0751318410038948
cause O 1 0.9994526505470276
serious O 1 0.99957674741745
illness O 1 0.9999990463256836
and O 0 0.012276079505681992
early B-Disease 0 0.01959899440407753
death I-Disease 0 0.027835968881845474
, O 0 0.009729762561619282
but O 0 0.008425365202128887
the O 0 0.015150615014135838
disease O 1 0.9999985694885254
is O 0 0.01327458769083023
still O 0 0.016564100980758667
substantially O 0 0.045923277735710144
under O 0 0.030028464272618294
- O 1 0.9954290390014648
diagnosed O 1 0.9999992847442627
. O 0 0.04367423802614212

The O 0 0.024973219260573387
cornerstone O 0 0.06360843777656555
of O 0 0.01311778835952282
screening O 0 0.06604483723640442
and O 0 0.012431644834578037
case O 0 0.02249494008719921
detection O 0 0.06811005622148514
is O 0 0.01107227522879839
the O 0 0.013041114434599876
measurement O 0 0.0549456849694252
of O 0 0.02156091295182705
serum O 1 0.9961814880371094
transferrin O 1 0.9932324886322021
saturation O 0 0.16809983551502228
and O 0 0.014458590187132359
the O 0 0.0219343900680542
serum O 1 0.9962129592895508
ferritin O 1 0.9446436762809753
level O 0 0.05651291087269783
. O 0 0.03447724133729935

Once O 0 0.044178932905197144
the O 0 0.025742294266819954
diagnosis O 1 0.9999661445617676
is O 0 0.022026101127266884
suspected O 0 0.056090421974658966
, O 0 0.01559608057141304
physicians O 1 0.5440581440925598
must O 0 0.01924746297299862
use O 0 0.025836708024144173
serum O 1 0.9951121211051941
ferritin O 1 0.9798046350479126
levels O 0 0.06808388233184814
and O 0 0.025859249755740166
hepatic O 1 0.9999990463256836
iron O 1 0.8271826505661011
stores O 0 0.03682929649949074
on O 0 0.025775043293833733
liver O 1 0.999998927116394
biopsy O 1 0.9999407529830933
specimens O 0 0.04829677939414978
to O 0 0.014058959670364857
assess O 0 0.09244087338447571
patients O 1 0.9985644221305847
for O 0 0.007251262199133635
the O 0 0.010477952659130096
presence O 0 0.026955487206578255
of O 0 0.01508383173495531
iron B-Disease 1 0.9971492886543274
overload I-Disease 1 0.9994480013847351
. O 0 0.03600667417049408

Liver O 1 0.9999988079071045
biopsy O 1 0.9999017715454102
is O 0 0.016502926126122475
also O 0 0.008565313182771206
used O 0 0.008029426448047161
to O 0 0.006448691710829735
establish O 0 0.018013054504990578
the O 0 0.010260561481118202
presence O 0 0.02874654345214367
or O 0 0.014004389755427837
absence O 0 0.032536957412958145
of O 0 0.015195404179394245
cirrhosis B-Disease 1 0.9999980926513672
, O 0 0.014420948922634125
which O 0 0.010728267952799797
can O 0 0.018418997526168823
affect O 0 0.06566084921360016
prognosis O 1 0.9999978542327881
and O 0 0.017922814935445786
management O 0 0.16855193674564362
. O 0 0.02563013881444931

A O 0 0.05658934637904167
DNA O 0 0.08499080687761307
- O 0 0.06127677112817764
based O 0 0.022656869143247604
test O 0 0.032391179352998734
for O 0 0.012353861704468727
the O 0 0.02187316305935383
HFE O 1 0.9988628625869751
gene O 0 0.08198660612106323
is O 0 0.014345306903123856
commercially O 0 0.026811296120285988
available O 0 0.012454853393137455
, O 0 0.006955672055482864
but O 0 0.0052671898156404495
its O 0 0.00649984972551465
place O 0 0.010130210779607296
in O 0 0.008399853482842445
the O 0 0.017016427591443062
diagnosis O 1 0.9999974966049194
of O 0 0.025211717933416367
hemochromatosis B-Disease 1 1.0
is O 0 0.020308025181293488
still O 0 0.01594942808151245
being O 0 0.01547841913998127
evaluated O 0 0.0663817897439003
. O 0 0.024239584803581238

Currently O 0 0.026931963860988617
, O 0 0.008986154571175575
the O 0 0.007684716489166021
most O 0 0.007531915791332722
useful O 0 0.01727316901087761
role O 0 0.014220734126865864
for O 0 0.006495748646557331
this O 0 0.0066553084179759026
test O 0 0.022350048646330833
is O 0 0.007377891335636377
in O 0 0.00709242420271039
the O 0 0.010287231765687466
detection O 0 0.06978297978639603
of O 0 0.016097700223326683
hemochromatosis B-Disease 1 1.0
in O 0 0.011400875635445118
the O 0 0.008722913451492786
family O 0 0.0173924770206213
members O 0 0.010059383697807789
of O 0 0.00973004661500454
patients O 1 0.9998984336853027
with O 0 0.009786980226635933
a O 0 0.01501532457768917
proven O 0 0.04404088482260704
case O 0 0.01324914675205946
of O 0 0.0071211387403309345
the O 0 0.020530203357338905
disease O 1 0.9999991655349731
. O 0 0.03250954672694206

It O 0 0.01890658773481846
is O 0 0.013674085028469563
crucial O 0 0.02925199642777443
to O 0 0.024454912170767784
diagnose O 1 0.9999997615814209
hemochromatosis B-Disease 1 1.0
before O 1 0.5876116156578064
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999502897262573
because O 0 0.2088945508003235
phlebotomy O 1 0.9999998807907104
therapy O 1 0.9999998807907104
can O 0 0.08972864598035812
avert O 1 0.9999909400939941
serious O 1 0.9999997615814209
chronic O 1 1.0
disease O 1 1.0
and O 0 0.010788901709020138
can O 0 0.010321492329239845
even O 0 0.010239570401608944
lead O 0 0.018598880618810654
to O 0 0.009642382152378559
normal O 0 0.03339630365371704
life O 0 0.02363845519721508
expectancy O 0 0.08261032402515411
. O 0 0.017496764659881592
. O 0 0.023938536643981934

Prevalence O 1 0.9350513219833374
of O 0 0.01897823065519333
the O 0 0.0266337338835001
I1307K O 1 0.9651297926902771
APC B-Disease 1 0.9958083629608154
gene O 0 0.133677676320076
variant O 0 0.09308412671089172
in O 0 0.012637450359761715
Israeli O 0 0.025737401098012924
Jews O 0 0.016586465761065483
of O 0 0.007395750377327204
differing O 0 0.023678744211792946
ethnic O 0 0.020251043140888214
origin O 0 0.023441830649971962
and O 0 0.016458848491311073
risk O 1 0.9992672801017761
for O 0 0.13834181427955627
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.040668074041604996

BACKGROUND O 0 0.11199551075696945
& O 0 0.083469919860363
AIMS O 0 0.07357650250196457
Israeli O 0 0.03040207549929619
Jews O 0 0.018371693789958954
of O 0 0.007228834088891745
European O 0 0.022655874490737915
birth O 0 0.04310546815395355
, O 0 0.012893724255263805
i O 0 0.02057167887687683
. O 0 0.012792373076081276
e O 0 0.042969729751348495
. O 0 0.011273713782429695
, O 0 0.012992288917303085
Ashkenazim O 0 0.21554751694202423
, O 0 0.009316598996520042
have O 0 0.008030318655073643
the O 0 0.014350215904414654
highest O 1 0.9995129108428955
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999480247497559
of O 0 0.009075427427887917
any O 0 0.009741769172251225
Israeli O 0 0.023568857461214066
ethnic O 0 0.020902074873447418
group O 0 0.03781811520457268
. O 0 0.02679002471268177

The O 0 0.05390175059437752
I1307K O 1 0.6521012187004089
APC B-Disease 1 0.9861903190612793
gene O 0 0.13034579157829285
variant O 0 0.10983072221279144
was O 0 0.01911492459475994
found O 0 0.015830431133508682
in O 0 0.011922119185328484
6 O 0 0.03199451044201851
. O 0 0.025216039270162582

1 O 0 0.03861360624432564
% O 0 0.02228545770049095
of O 0 0.007522334344685078
American O 0 0.017228497192263603
Jews O 0 0.017201591283082962
, O 0 0.010759962722659111
28 O 0 0.020897608250379562
% O 0 0.015870902687311172
of O 0 0.009662989526987076
their O 0 0.02651659958064556
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.1032777652144432
, O 0 0.008530470542609692
but O 0 0.006053455173969269
not O 0 0.005262753926217556
in O 0 0.008727573789656162
non O 0 0.03626115620136261
- O 0 0.06636593490839005
Jews O 0 0.03371846303343773
. O 0 0.027240203693509102

We O 0 0.028878167271614075
assessed O 0 0.06208445131778717
the O 0 0.022151896730065346
I1307K O 1 0.9495310187339783
prevalence O 1 0.9615634083747864
in O 0 0.01393771544098854
Israeli O 0 0.026537803933024406
Jews O 0 0.01676430180668831
of O 0 0.006918479688465595
differing O 0 0.02306591533124447
ethnic O 0 0.01661645993590355
origin O 0 0.020056067034602165
and O 0 0.014941665343940258
risk O 1 0.9997567534446716
for O 0 0.17426516115665436
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04311404749751091

METHODS O 0 0.08230739831924438
DNA O 0 0.078395776450634
samples O 0 0.04240856319665909
from O 0 0.01518236007541418
500 O 0 0.04076896607875824
unrelated O 0 0.04091159999370575
Jews O 0 0.016095902770757675
of O 0 0.006614982150495052
European O 0 0.017062805593013763
or O 0 0.01610809564590454
non O 0 0.03658061474561691
- O 0 0.04973803833127022
European O 0 0.01979750767350197
origin O 0 0.016423232853412628
, O 0 0.007912852801382542
with O 0 0.008103413507342339
or O 0 0.011527040973305702
without O 0 0.00979556143283844
a O 0 0.013267068192362785
personal O 0 0.02012305147945881
and O 0 0.013946926221251488
/ O 1 0.9876883625984192
or O 0 0.01378771010786295
family O 0 0.02022898755967617
history O 0 0.014317662455141544
of O 0 0.012723606079816818
neoplasia B-Disease 1 0.9999966621398926
, O 0 0.012325344607234001
were O 0 0.0088048055768013
examined O 0 0.03472571820020676
for O 0 0.008455655537545681
the O 0 0.014689245261251926
I1307K O 0 0.1496681272983551
variant O 0 0.08120927214622498
by O 0 0.012793350033462048
the O 0 0.019817236810922623
allele O 0 0.17927753925323486
- O 0 0.09291471540927887
specific O 0 0.0479644276201725
oligonucleotide O 0 0.4002465605735779
( O 0 0.04904845356941223
ASO O 1 0.9824771285057068
) O 0 0.034851834177970886
method O 0 0.04249003902077675
. O 0 0.027877628803253174

RESULTS O 0 0.054361630231142044
In O 0 0.013009562157094479
persons O 0 0.023329779505729675
at O 0 0.02094564400613308
average O 0 0.047433510422706604
risk O 1 0.9992511868476868
for O 0 0.06587103009223938
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.025555843487381935
I1307K O 1 0.6074681282043457
was O 0 0.01581650599837303
found O 0 0.015250825323164463
in O 0 0.011228078976273537
5 O 0 0.027748871594667435
. O 0 0.023007694631814957

0 O 0 0.07435841113328934
% O 0 0.022382088005542755
of O 0 0.010094622150063515
120 O 0 0.027985576540231705
European O 0 0.018044348806142807
and O 0 0.010894221253693104
1 O 0 0.02839828096330166
. O 0 0.02251504547894001

6 O 0 0.05071743577718735
% O 0 0.02435190975666046
of O 0 0.011712604202330112
188 O 0 0.08757921308279037
non O 0 0.051308173686265945
- O 0 0.06682971119880676
European O 0 0.037838537245988846
Jews O 0 0.041060347110033035
( O 0 0.04953206330537796
P O 1 0.9599639177322388
= O 0 0.11258310824632645
0 O 0 0.05346576124429703
. O 0 0.01602434366941452
08 O 0 0.08626497536897659
) O 0 0.029747840017080307
. O 0 0.027879055589437485

It O 0 0.02493681013584137
occurred O 0 0.037905655801296234
in O 0 0.013999616727232933
15 O 0 0.02428547292947769
. O 0 0.023519951850175858

4 O 0 0.05276486650109291
% O 0 0.027852684259414673
of O 0 0.012753525748848915
52 O 0 0.06222805380821228
Ashkenazi O 0 0.15563315153121948
Israelis O 0 0.06560390442609787
with O 0 0.03110937774181366
familial O 1 0.9999996423721313
cancer B-Disease 1 1.0
( O 0 0.0792362168431282
P O 1 0.9976578950881958
= O 0 0.12501534819602966
0 O 0 0.05819564685225487
. O 0 0.019920669496059418
02 O 1 0.8719443678855896
) O 0 0.017705349251627922
and O 0 0.0076844473369419575
was O 0 0.011852656491100788
not O 0 0.010198941454291344
detected O 0 0.049468994140625
in O 0 0.010705598630011082
51 O 0 0.04380258545279503
non O 0 0.03894001618027687
- O 0 0.050907865166664124
European O 0 0.026795241981744766
Jews O 0 0.026226909831166267
at O 0 0.0269740279763937
increased O 0 0.07950589060783386
cancer B-Disease 1 0.9999997615814209
risk O 1 0.992188572883606
. O 0 0.03143065422773361

Colorectal B-Disease 1 0.9999996423721313
neoplasia I-Disease 1 0.9999958276748657
occurred O 0 0.08103746920824051
personally O 0 0.050393614917993546
or O 0 0.010872221551835537
in O 0 0.006124150939285755
the O 0 0.006783002056181431
families O 0 0.014326300472021103
of O 0 0.005798138212412596
13 O 0 0.015171020291745663
of O 0 0.008646776899695396
20 O 0 0.030288081616163254
Ashkenazi O 0 0.2032039910554886
I1307K O 1 0.6009895205497742
carriers O 0 0.07970435917377472
, O 0 0.01223924569785595
8 O 0 0.01646181382238865
of O 0 0.007017793133854866
whom O 0 0.01953810267150402
also O 0 0.008061610162258148
had O 0 0.009519584476947784
a O 0 0.011194951832294464
personal O 0 0.0168149471282959
or O 0 0.01269105076789856
family O 0 0.018210474401712418
history O 0 0.01537424698472023
of O 0 0.015649333596229553
noncolonic O 1 0.9992169141769409
neoplasia B-Disease 1 0.99998939037323
. O 0 0.043982550501823425

CONCLUSIONS O 0 0.08556272834539413
The O 0 0.038622207939624786
I1307K O 1 0.8942347764968872
APC O 1 0.9934800863265991
variant O 0 0.13422611355781555
may O 0 0.02520175091922283
represent O 0 0.018550235778093338
a O 0 0.029886746779084206
susceptibility O 1 0.9846397638320923
gene O 0 0.09674232453107834
for O 0 0.02320747636258602
colorectal B-Disease 1 1.0
, I-Disease 0 0.016005638986825943
or I-Disease 0 0.012116800993680954
other I-Disease 0 0.008126764558255672
, I-Disease 0 0.015017624013125896
cancers I-Disease 1 0.9998149275779724
in O 0 0.016231542453169823
Ashkenazi O 0 0.13422323763370514
Jews O 0 0.021030141040682793
, O 0 0.010353987105190754
and O 0 0.008351891301572323
partially O 0 0.04955563694238663
explains O 0 0.03839508444070816
the O 0 0.012702669948339462
higher O 0 0.04231790453195572
incidence O 1 0.9999730587005615
of O 0 0.054974138736724854
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.018358919769525528
European O 0 0.031005166471004486
Israelis O 0 0.058845050632953644
. O 0 0.027324844151735306

Systematic O 0 0.11170036345720291
analysis O 0 0.04429451748728752
of O 0 0.023649713024497032
coproporphyrinogen O 1 0.99471515417099
oxidase O 1 0.9923213124275208
gene O 0 0.18795576691627502
defects O 1 0.9922550916671753
in O 0 0.02270340360701084
hereditary B-Disease 1 0.9960038065910339
coproporphyria I-Disease 1 0.9677122831344604
and O 0 0.028130987659096718
mutation O 0 0.2184189260005951
update O 0 0.1076245978474617
. O 0 0.03144615888595581

Hereditary B-Disease 1 0.9970831274986267
coproporphyria I-Disease 1 0.997495710849762
( O 0 0.06732304394245148
HC B-Disease 1 0.999994158744812
) O 0 0.025804491713643074
is O 0 0.016564086079597473
an O 0 0.03075975365936756
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.0415513776242733
autosomal O 1 0.9999732971191406
dominant O 1 0.9038052558898926
inheritance O 1 0.9633699059486389
caused O 1 0.8562568426132202
by O 0 0.022093867883086205
deficient B-Disease 1 0.9975860118865967
activity I-Disease 0 0.03977387025952339
of I-Disease 0 0.016422076150774956
coproporphyrinogen I-Disease 1 0.9980078339576721
III I-Disease 1 0.9771917462348938
oxidase I-Disease 1 0.8965150713920593
( O 0 0.05005055293440819
CPO O 0 0.1664818525314331
) O 0 0.031614117324352264
. O 0 0.024590419605374336

Clinical O 1 0.9977891445159912
manifestations O 0 0.27047061920166016
of O 0 0.011731435544788837
the O 0 0.019232990220189095
disease O 1 0.9999992847442627
are O 0 0.012174366973340511
characterized O 1 0.6294874548912048
by O 0 0.01921193301677704
acute O 1 0.9999998807907104
attacks O 0 0.15421487390995026
of O 0 0.02643449790775776
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.035326771438121796
precipitated O 1 0.9724360704421997
by O 0 0.01916210725903511
drugs O 0 0.18569983541965485
, O 0 0.01882418803870678
fasting O 0 0.2771990895271301
, O 0 0.026708614081144333
cyclical O 1 0.9984946250915527
hormonal O 1 0.9989757537841797
changes O 0 0.03587981313467026
, O 0 0.020597711205482483
or O 0 0.29192113876342773
infectious B-Disease 1 1.0
diseases I-Disease 1 0.9999995231628418
. O 0 0.039082881063222885

Skin O 1 0.9999998807907104
photosensitivity O 1 0.9999970197677612
may O 0 0.029962671920657158
also O 0 0.00996914878487587
be O 0 0.00759169040247798
present O 0 0.016871104016900063
. O 0 0.023430896922945976

The O 0 0.02057606913149357
seven O 0 0.026847831904888153
exons O 0 0.08650290220975876
, O 0 0.01836783066391945
the O 0 0.023993922397494316
exon O 0 0.21438266336917877
/ O 1 0.9115614891052246
intron O 0 0.2752017676830292
boundaries O 0 0.01895085535943508
and O 0 0.008058849722146988
part O 0 0.013823170214891434
of O 0 0.009481270797550678
3 O 0 0.032310955226421356
noncoding O 0 0.13685671985149384
sequence O 0 0.029248228296637535
of O 0 0.008386281318962574
the O 0 0.016429118812084198
CPO O 0 0.33005356788635254
gene O 0 0.06780216842889786
were O 0 0.01212524063885212
systematically O 0 0.057752229273319244
analyzed O 0 0.0361800454556942
by O 0 0.011988234706223011
an O 0 0.01844152994453907
exon O 0 0.14338934421539307
- O 0 0.0840216726064682
by O 0 0.0258653424680233
- O 0 0.1270074099302292
exon O 0 0.2551535367965698
denaturing O 1 0.8698292374610901
gradient O 1 0.632298469543457
gel O 1 0.9920016527175903
electrophoresis O 1 0.83412104845047
( O 0 0.07003845274448395
DGGE O 1 0.9900218844413757
) O 0 0.030498981475830078
strategy O 0 0.038830820471048355
followed O 0 0.019689658656716347
by O 0 0.009471435099840164
direct O 0 0.02291269414126873
sequencing O 0 0.04818516597151756
in O 0 0.011341684497892857
seven O 0 0.025133229792118073
unrelated O 0 0.08656588196754456
heterozygous O 1 0.7395502924919128
HC B-Disease 1 0.9999997615814209
patients O 1 0.9999779462814331
from O 0 0.020926160737872124
France O 0 0.03846537321805954
, O 0 0.016254067420959473
Holland O 0 0.06844482570886612
, O 0 0.011395152658224106
and O 0 0.010626590810716152
Czech O 0 0.043113358318805695
Republic O 0 0.03176706284284592
. O 0 0.02891826443374157

Seven O 0 0.0418618805706501
novel O 0 0.051201507449150085
mutations O 0 0.09161660075187683
and O 0 0.011417725123465061
two O 0 0.01035065483301878
new O 0 0.024472206830978394
polymorphisms O 0 0.1288905143737793
were O 0 0.020717117935419083
detected O 0 0.08983348309993744
. O 0 0.02980266511440277

Among O 0 0.031913504004478455
these O 0 0.015711981803178787
mutations O 0 0.08073366433382034
two O 0 0.013954199850559235
are O 0 0.017075741663575172
missense O 0 0.17712664604187012
( O 0 0.046794354915618896
G197W O 0 0.3567758798599243
, O 0 0.021383831277489662
W427R O 0 0.13916553556919098
) O 0 0.019764533266425133
, O 0 0.008155588991940022
two O 0 0.007423582021147013
are O 0 0.009248515591025352
nonsense O 0 0.08046624809503555
( O 0 0.039137519896030426
Q306X O 0 0.19704563915729523
, O 0 0.02483263611793518
Q385X O 0 0.13586406409740448
) O 0 0.01819322630763054
, O 0 0.007149331737309694
two O 0 0.006356419529765844
are O 0 0.00744049483910203
small O 0 0.02314925380051136
deletions O 0 0.10878869146108627
( O 0 0.0479704923927784
662de14bp O 0 0.3296692669391632
; O 0 0.03475983813405037
1168del3bp O 0 0.17708472907543182
removing O 0 0.059061963111162186
a O 0 0.03191448375582695
glycine O 0 0.13981515169143677
at O 0 0.024660561233758926
position O 0 0.025784673169255257
390 O 0 0.09096811711788177
) O 0 0.01849251613020897
, O 0 0.0074348486959934235
and O 0 0.006400991231203079
one O 0 0.008621642366051674
is O 0 0.011479824781417847
a O 0 0.028087420389056206
splicing O 0 0.1528499275445938
mutation O 0 0.19525526463985443
( O 0 0.07251386344432831
IVS1 O 1 0.99940025806427
- O 1 0.6762897968292236
15c O 1 0.9974886178970337
- O 1 0.8116922974586487
- O 0 0.20863492786884308
> O 0 0.2478664219379425
g O 0 0.12826280295848846
) O 0 0.022151106968522072
which O 0 0.013224476017057896
creates O 0 0.04195987805724144
a O 0 0.01917611062526703
new O 0 0.029091626405715942
acceptor O 0 0.20757240056991577
splice O 0 0.19146831333637238
site O 0 0.04775865748524666
. O 0 0.026938389986753464

The O 0 0.03356779366731644
pathological O 0 0.11199946701526642
significance O 0 0.022962534800171852
of O 0 0.008205686695873737
the O 0 0.013583522289991379
point O 0 0.030821090564131737
mutations O 0 0.128168523311615
G197W O 0 0.16768141090869904
, O 0 0.020484037697315216
W427R O 0 0.1068200021982193
, O 0 0.008794665336608887
and O 0 0.0061643426306545734
the O 0 0.007878459058701992
in O 0 0.01498614251613617
- O 0 0.08772693574428558
frame O 0 0.09272463619709015
deletion O 0 0.18579459190368652
390delGly O 0 0.16448672115802765
were O 0 0.014320173300802708
assessed O 0 0.03505382686853409
by O 0 0.007793924305588007
their O 0 0.007236058358103037
respective O 0 0.019921528175473213
expression O 0 0.030322400853037834
in O 0 0.009841112419962883
a O 0 0.01680196076631546
prokaryotic O 0 0.057186517864465714
system O 0 0.028297409415245056
using O 0 0.017449380829930305
site O 0 0.03454168885946274
- O 0 0.0679415762424469
directed O 0 0.05050794407725334
mutagenesis O 0 0.19876331090927124
. O 0 0.03979332745075226

These O 0 0.025577016174793243
mutations O 0 0.0986824706196785
resulted O 0 0.032949984073638916
in O 0 0.008480366319417953
the O 0 0.009420221671462059
absence O 0 0.027479544281959534
or O 0 0.012107939459383488
a O 0 0.013098456896841526
dramatic O 0 0.040335897356271744
decrease O 0 0.048365287482738495
of O 0 0.014253995381295681
CPO O 1 0.6251201629638672
activity O 0 0.05853695794939995
. O 0 0.028748029842972755

The O 0 0.023844294250011444
two O 0 0.01899503543972969
polymorphisms O 0 0.12140346318483353
were O 0 0.017986714839935303
localized O 0 0.09611805528402328
in O 0 0.019194193184375763
noncoding O 0 0.12339190393686295
part O 0 0.01644240692257881
of O 0 0.007939504459500313
the O 0 0.015485427342355251
gene O 0 0.06926717609167099
1 O 0 0.02691251039505005
) O 0 0.022389894351363182
a O 0 0.029814595356583595
C O 1 0.8196908831596375
/ O 1 0.9041640758514404
G O 0 0.1378297209739685
polymorphism O 0 0.08279639482498169
in O 0 0.011670933105051517
the O 0 0.016887089237570763
promotor O 1 0.9653028249740601
region O 0 0.04324294626712799
, O 0 0.0183752179145813
142 O 0 0.09738529473543167
bp O 0 0.11343560367822647
upstream O 0 0.06257939338684082
from O 0 0.01386281382292509
the O 0 0.016595248132944107
transcriptional O 0 0.12287263572216034
initiation O 0 0.09862635284662247
site O 0 0.045538708567619324
( O 0 0.04509800672531128
- O 0 0.12388008832931519
142C O 1 0.9498104453086853
/ O 1 0.9808070063591003
G O 0 0.16271263360977173
) O 0 0.020402558147907257
, O 0 0.010170569643378258
and O 0 0.009966720826923847
2 O 0 0.02414054609835148
) O 0 0.016946133226156235
a O 0 0.022113410755991936
6 O 0 0.04089384526014328
bp O 0 0.13157877326011658
deletion O 0 0.14425846934318542
polymorphism O 0 0.10272688418626785
in O 0 0.014678812585771084
the O 0 0.013435590080916882
3 O 0 0.031892407685518265
noncoding O 0 0.1222200021147728
part O 0 0.01703314669430256
of O 0 0.00815627258270979
the O 0 0.018754614517092705
CPO O 1 0.6719489693641663
gene O 0 0.09072932600975037
, O 0 0.024959836155176163
574 O 0 0.22363397479057312
bp O 0 0.11612822115421295
downstream O 0 0.04850614815950394
of O 0 0.007703593000769615
the O 0 0.010150427930057049
last O 0 0.016179606318473816
base O 0 0.022142460569739342
of O 0 0.007352888584136963
the O 0 0.015797292813658714
normal O 0 0.07784067094326019
termination O 1 0.8188130855560303
codon O 0 0.2095462679862976
( O 0 0.07121369987726212
+ O 0 0.25158432126045227
574 O 1 0.6353724598884583
delATTCTT O 1 0.504162073135376
) O 0 0.04355752840638161
. O 0 0.030728984624147415

Five O 0 0.054975613951683044
intragenic O 1 0.9050619006156921
dimorphisms O 0 0.19660866260528564
are O 0 0.011104421690106392
now O 0 0.01384479459375143
well O 0 0.011729368008673191
characterized O 0 0.03874439373612404
and O 0 0.007131081540137529
the O 0 0.009875462390482426
high O 0 0.02746059186756611
degree O 0 0.028820496052503586
of O 0 0.013007014989852905
allelic O 1 0.9386572241783142
heterogeneity O 0 0.1545831561088562
in O 0 0.024426253512501717
HC B-Disease 1 0.9999856948852539
is O 0 0.017790118232369423
demonstrated O 0 0.030115311965346336
with O 0 0.008678796701133251
seven O 0 0.013396328315138817
new O 0 0.012366964481770992
different O 0 0.010618602856993675
mutations O 0 0.05967430770397186
making O 0 0.012633927166461945
a O 0 0.012239702045917511
total O 0 0.015004525892436504
of O 0 0.010877853259444237
nineteen O 0 0.07089085131883621
CPO O 1 0.9938744902610779
gene B-Disease 0 0.21166634559631348
defects I-Disease 1 0.9967150688171387
reported O 0 0.03731830418109894
so O 0 0.013713468797504902
far O 0 0.01596374250948429
. O 0 0.01156827062368393
. O 0 0.019700756296515465

Coincidence O 0 0.07940439879894257
of O 0 0.010466832667589188
two O 0 0.012203549966216087
novel O 0 0.038869135081768036
arylsulfatase O 0 0.17854507267475128
A O 0 0.044708725064992905
alleles O 0 0.156826451420784
and O 0 0.028857581317424774
mutation O 0 0.21188051998615265
459 O 1 0.982506275177002
+ O 1 0.9222376346588135
1G O 1 0.9849810600280762
> O 0 0.1310570389032364
A O 0 0.025356410071253777
within O 0 0.013789097778499126
a O 0 0.015417718328535557
family O 0 0.027185998857021332
with O 0 0.02599136158823967
metachromatic B-Disease 1 0.9999933242797852
leukodystrophy I-Disease 1 0.9999997615814209
: O 0 0.039522506296634674
molecular O 0 0.050964269787073135
basis O 0 0.014377299696207047
of O 0 0.01327864732593298
phenotypic O 0 0.12678295373916626
heterogeneity O 0 0.1775360256433487
. O 0 0.039984215050935745

In O 0 0.021048234775662422
a O 0 0.017422882840037346
family O 0 0.021394066512584686
with O 0 0.010906734503805637
three O 0 0.010941822081804276
siblings O 0 0.05040057748556137
, O 0 0.01159122958779335
one O 0 0.010729816742241383
developed O 0 0.03347805142402649
classical O 0 0.04672287404537201
late O 0 0.06081894785165787
infantile O 1 0.9999978542327881
metachromatic B-Disease 1 0.9999915361404419
leukodystrophy I-Disease 1 0.9999998807907104
( O 1 0.6395660638809204
MLD B-Disease 1 0.9999998807907104
) O 0 0.04092321917414665
, O 0 0.02057665027678013
fatal O 1 0.9991180300712585
at O 0 0.02460664138197899
age O 0 0.02841232717037201
5 O 0 0.019864650443196297
years O 0 0.011620461009442806
, O 0 0.010480928234755993
with O 0 0.017356591299176216
deficient O 1 0.9984286427497864
arylsulfatase O 1 0.9753325581550598
A O 0 0.050150759518146515
( O 0 0.055648695677518845
ARSA O 1 0.9997567534446716
) O 0 0.027485007420182228
activity O 0 0.02826962061226368
and O 0 0.011207785457372665
increased O 0 0.03967966511845589
galactosylsulfatide O 1 0.9921330809593201
( O 0 0.07186022400856018
GS O 1 0.999994158744812
) O 0 0.059868231415748596
excretion O 0 0.19079039990901947
. O 0 0.03674466535449028

The O 0 0.019139045849442482
two O 0 0.011671660467982292
other O 0 0.010868468321859837
siblings O 0 0.0619448721408844
, O 0 0.017972072586417198
apparently O 0 0.04580437019467354
healthy O 0 0.06807214766740799
at O 0 0.021909503266215324
12 O 0 0.022511625662446022
( O 0 0.02731289155781269
1 O 0 0.03512541577219963
/ O 0 0.14223787188529968
2 O 0 0.022135552018880844
) O 0 0.014131731353700161
and O 0 0.0071755703538656235
15 O 0 0.01434127613902092
years O 0 0.010256726294755936
, O 0 0.008844553492963314
respectively O 0 0.014945273287594318
, O 0 0.007494752295315266
and O 0 0.006124377250671387
their O 0 0.007892261259257793
father O 0 0.024175187572836876
, O 0 0.013553780503571033
apparently O 0 0.0396457277238369
healthy O 0 0.05227458104491234
as O 0 0.008858769200742245
well O 0 0.010300475172698498
, O 0 0.011821272782981396
presented O 0 0.03486374393105507
ARSA O 1 0.9999014139175415
and O 0 0.026880228891968727
GS O 1 0.9998900890350342
values O 0 0.023527782410383224
within O 0 0.009969047270715237
the O 0 0.010165113024413586
range O 0 0.0329359695315361
of O 0 0.02660873904824257
MLD B-Disease 1 1.0
patients O 1 0.9999847412109375
. O 0 0.0393076054751873

Mutation O 0 0.3607860207557678
screening O 0 0.11153961718082428
and O 0 0.015440694987773895
sequence O 0 0.03174813464283943
analysis O 0 0.026412764564156532
disclosed O 0 0.03852224722504616
the O 0 0.010948334820568562
involvement O 0 0.03522234037518501
of O 0 0.0077218725346028805
three O 0 0.011305873282253742
different O 0 0.01988855190575123
ARSA O 1 0.9998564720153809
mutations O 0 0.10751665383577347
being O 0 0.013597836717963219
the O 0 0.010736387223005295
molecular O 0 0.03988698124885559
basis O 0 0.0144876129925251
of O 0 0.015169374644756317
intrafamilial O 1 0.6307719349861145
phenotypic O 0 0.15497756004333496
heterogeneity O 0 0.1857435405254364
. O 0 0.040322959423065186

The O 0 0.03773889318108559
late O 0 0.06580241769552231
infantile O 1 0.999998927116394
patient O 1 0.9999675750732422
inherited O 1 0.6452929377555847
from O 0 0.014560818672180176
his O 0 0.014266536571085453
mother O 0 0.03219912573695183
the O 0 0.014773702248930931
frequent O 0 0.07384343445301056
0 O 0 0.08135690540075302
- O 0 0.10651589184999466
type O 0 0.1288222074508667
mutation O 0 0.2203081250190735
459 O 1 0.9766117930412292
+ O 1 0.9151043891906738
1G O 1 0.9927131533622742
> O 0 0.1319054216146469
A O 0 0.022936983034014702
, O 0 0.008259063586592674
and O 0 0.006291576661169529
from O 0 0.008169895969331264
his O 0 0.011123927310109138
father O 0 0.019112374633550644
a O 0 0.01523001678287983
novel O 0 0.02449657768011093
, O 0 0.013202193193137646
single O 0 0.036899369210004807
basepair O 1 0.5259060859680176
microdeletion O 0 0.16762948036193848
of O 0 0.01861199550330639
guanine O 0 0.12579123675823212
at O 0 0.030471300706267357
nucleotide O 0 0.0802159532904625
7 O 0 0.030157003551721573
in O 0 0.016360925510525703
exon O 0 0.1340000331401825
1 O 0 0.04020222648978233
( O 0 0.039014771580696106
7delG O 0 0.17701436579227448
) O 0 0.033105358481407166
. O 0 0.02662631683051586

The O 0 0.025818124413490295
two O 0 0.02390313148498535
clinically O 1 0.9677176475524902
unaffected O 0 0.3654811382293701
siblings O 0 0.07320621609687805
carried O 0 0.028830356895923615
the O 0 0.02269921265542507
maternal O 0 0.4087725579738617
mutation O 1 0.6077442169189453
459 O 1 0.9941605925559998
+ O 1 0.9750154614448547
1G O 1 0.9896066784858704
> O 0 0.1448616087436676
A O 0 0.0242772214114666
and O 0 0.007816754281520844
, O 0 0.006335901096463203
on O 0 0.006850226782262325
their O 0 0.011186815798282623
paternal O 0 0.10358993709087372
allele O 0 0.12477792054414749
, O 0 0.015258777886629105
a O 0 0.019603149965405464
novel O 0 0.034824538975954056
cytosine O 0 0.11872673034667969
to O 0 0.020707398653030396
thymidine O 0 0.20520015060901642
transition O 0 0.07034797966480255
at O 0 0.04234156385064125
nucleotide O 0 0.13330356776714325
2435 O 1 0.707477331161499
in O 0 0.026001807302236557
exon O 0 0.13622626662254333
8 O 0 0.03390810638666153
, O 0 0.01349404826760292
resulting O 0 0.029652468860149384
in O 0 0.012234542518854141
substitution O 0 0.05444788932800293
of O 0 0.017996100708842278
alanine O 0 0.20741881430149078
464 O 0 0.2070780247449875
by O 0 0.033608876168727875
valine O 0 0.2819503843784332
( O 0 0.05978991836309433
A464V O 0 0.20769891142845154
) O 0 0.037035346031188965
. O 0 0.027830200269818306

The O 0 0.03365422040224075
fathers O 0 0.08982687443494797
genotype O 0 0.2194492369890213
thus O 0 0.03346375375986099
was O 0 0.03457661718130112
7delG O 1 0.9930068254470825
/ O 1 0.9872354865074158
A464V O 0 0.2083485722541809
. O 0 0.038453325629234314

Mutation O 0 0.3942289352416992
A464V O 0 0.18612590432167053
was O 0 0.02161734364926815
not O 0 0.008952615782618523
found O 0 0.013052467256784439
in O 0 0.0123219545930624
18 O 0 0.03408566862344742
unrelated O 1 0.8962214589118958
MLD B-Disease 1 1.0
patients O 1 0.999962568283081
and O 0 0.016102133318781853
50 O 0 0.030130796134471893
controls O 0 0.048251502215862274
. O 0 0.029613317921757698

A464V O 0 0.22153890132904053
, O 0 0.022661857306957245
although O 0 0.02138402871787548
clearly O 0 0.039067305624485016
modifying O 0 0.1290760040283203
ARSA O 1 0.9999667406082153
and O 0 0.0340423621237278
GS O 1 0.9999996423721313
levels O 0 0.05951362103223801
, O 0 0.01449255645275116
apparently O 0 0.04108094051480293
bears O 0 0.03904598578810692
little O 0 0.023302052170038223
significance O 0 0.023050427436828613
for O 0 0.012453916482627392
clinical O 1 0.9856427311897278
manifestation O 1 0.8293408155441284
of O 0 0.026039961725473404
MLD B-Disease 1 0.9999998807907104
, O 0 0.025445038452744484
mimicking O 0 0.11494911462068558
the O 0 0.027263954281806946
frequent O 0 0.1297098845243454
ARSA O 1 0.999874472618103
pseudodeficiency O 1 0.9571210741996765
allele O 0 0.2176809012889862
. O 0 0.04094044119119644

Our O 0 0.030025117099285126
results O 0 0.023337505757808685
demonstrate O 0 0.021859923377633095
that O 0 0.006894235964864492
in O 0 0.008286349475383759
certain O 0 0.02160787023603916
genetic O 0 0.1093418300151825
conditions O 1 0.9596521258354187
MLD B-Disease 1 1.0
- O 1 0.5703853368759155
like O 0 0.04857216775417328
ARSA O 1 0.9999488592147827
and O 0 0.03349834680557251
GS O 1 0.9999755620956421
values O 0 0.028565894812345505
need O 0 0.018775098025798798
not O 0 0.0072143771685659885
be O 0 0.008377688005566597
paralleled O 0 0.0650201290845871
by O 0 0.024530626833438873
clinical O 1 0.9999929666519165
disease O 1 0.9999996423721313
, O 0 0.012604719027876854
a O 0 0.013368260115385056
finding O 0 0.02142336033284664
with O 0 0.01373366266489029
serious O 0 0.4934540092945099
diagnostic O 1 0.9775814414024353
and O 0 0.02351578138768673
prognostic O 1 0.9996480941772461
implications O 0 0.09731175005435944
. O 0 0.03520932048559189

Moreover O 0 0.07815206050872803
, O 0 0.02272060140967369
further O 0 0.038633041083812714
ARSA O 1 0.9990947246551514
alleles O 0 0.1927587389945984
functionally O 0 0.11480508744716644
similar O 0 0.02952120080590248
to O 0 0.01783577911555767
A464V O 0 0.17390333116054535
might O 0 0.024689123034477234
exist O 0 0.012715031392872334
which O 0 0.007342197932302952
, O 0 0.00688042351976037
together O 0 0.010501143522560596
with O 0 0.016290858387947083
0 O 0 0.06532809883356094
- O 0 0.09277242422103882
type O 0 0.09810282289981842
mutations O 0 0.11931844055652618
, O 0 0.019168542698025703
may O 0 0.02969532646238804
cause O 1 0.8099682331085205
pathological O 1 0.9997808337211609
ARSA O 1 0.9999949932098389
and O 0 0.034248773008584976
GS O 1 0.9999992847442627
levels O 0 0.05474558845162392
, O 0 0.010708052664995193
but O 0 0.010178710334002972
not O 0 0.012442433275282383
clinical O 1 0.9995951056480408
outbreak O 1 0.9944841265678406
of O 0 0.00959235429763794
the O 0 0.017841599881649017
disease O 1 0.9999997615814209
. O 0 0.0185136366635561
. O 0 0.025138529017567635

Human O 1 0.6438672542572021
MLH1 O 1 0.9999997615814209
deficiency O 1 1.0
predisposes O 1 0.9999313354492188
to O 0 0.05538048595190048
hematological B-Disease 1 0.9999953508377075
malignancy I-Disease 1 0.999996542930603
and O 0 0.0493583157658577
neurofibromatosis B-Disease 1 0.9999996423721313
type I-Disease 0 0.13573797047138214
1 I-Disease 0 0.03607688844203949
. O 0 0.025076447054743767

Heterozygous O 1 0.6414787769317627
germ O 1 0.9997342228889465
- O 0 0.12874794006347656
line O 0 0.05123121663928032
mutations O 0 0.08812625706195831
in O 0 0.012938760221004486
the O 0 0.01656888611614704
DNA O 0 0.08936185389757156
mismatch O 1 0.9845921397209167
repair O 1 0.8682836294174194
genes O 0 0.06749328225851059
lead O 0 0.04189802333712578
to O 0 0.026278521865606308
hereditary B-Disease 1 0.9999738931655884
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.047348249703645706

The O 0 0.05493473634123802
disease O 1 0.9999996423721313
susceptibility O 1 0.9838305711746216
of O 0 0.011341170407831669
individuals O 0 0.018743859604001045
who O 0 0.018482547253370285
constitutionally O 0 0.0440092571079731
lack O 0 0.02560037188231945
both O 0 0.01289092656224966
wild O 0 0.048175789415836334
- O 0 0.10746479779481888
type O 0 0.09570372849702835
alleles O 0 0.14689837396144867
is O 0 0.024963224306702614
unknown O 0 0.041155483573675156
. O 0 0.0270150788128376

We O 0 0.018938612192869186
have O 0 0.00931429211050272
identified O 0 0.019778983667492867
three O 0 0.010446318425238132
offspring O 0 0.04607890546321869
in O 0 0.011266249231994152
a O 0 0.030084803700447083
hereditary B-Disease 1 0.9999979734420776
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.06489500403404236
who O 0 0.03175056725740433
developed O 0 0.2800205945968628
hematological B-Disease 1 0.9999986886978149
malignancy I-Disease 1 0.9999964237213135
at O 0 0.023415669798851013
a O 0 0.013831447809934616
very O 0 0.012797576375305653
early O 0 0.01678743213415146
age O 0 0.021106775850057602
, O 0 0.006224701181054115
and O 0 0.0054985154420137405
at O 0 0.01038356963545084
least O 0 0.007846788503229618
two O 0 0.0047631883062422276
of O 0 0.0049201687797904015
them O 0 0.00709941191598773
displayed O 0 0.02846280112862587
signs O 0 0.0425289161503315
of O 0 0.023551534861326218
neurofibromatosis B-Disease 1 0.9999994039535522
type I-Disease 0 0.19260479509830475
1 I-Disease 0 0.04818973317742348
( O 0 0.05187974497675896
NF1 B-Disease 1 0.999782383441925
) O 0 0.03373252972960472
. O 0 0.026526782661676407

DNA O 0 0.09984402358531952
sequence O 0 0.043165720999240875
analysis O 0 0.029263535514473915
and O 0 0.015819281339645386
allele O 0 0.15714256465435028
- O 0 0.07711164653301239
specific O 0 0.03185334429144859
amplification O 0 0.10808722674846649
in O 0 0.01117502711713314
two O 0 0.011836070567369461
siblings O 0 0.07448749989271164
revealed O 0 0.05601352080702782
a O 0 0.04364356771111488
homozygous O 0 0.19862590730190277
MLH1 O 1 0.9996079802513123
mutation O 1 0.5536137223243713
( O 0 0.07532655447721481
C676T O 1 0.9923245906829834
- O 1 0.8282172679901123
- O 0 0.2511041462421417
> O 0 0.3795260787010193
Arg226Stop O 1 0.5908415913581848
) O 0 0.040863435715436935
. O 0 0.02873671054840088

Thus O 0 0.03776075318455696
, O 0 0.015905242413282394
a O 0 0.027899926528334618
homozygous O 0 0.1839751899242401
germ O 1 0.9997492432594299
- O 0 0.13763974606990814
line O 0 0.07838763296604156
MLH1 O 1 0.9998928308486938
mutation O 0 0.25561416149139404
and O 0 0.028314022347331047
consequent O 1 0.9993278980255127
mismatch O 1 0.999995231628418
repair O 1 0.9999991655349731
deficiency O 1 1.0
results O 0 0.03689296916127205
in O 0 0.012790116481482983
a O 0 0.030177149921655655
mutator O 1 0.999927282333374
phenotype O 1 0.9990001320838928
characterized O 1 0.9403202533721924
by O 0 0.035844337195158005
leukemia B-Disease 1 1.0
and O 0 0.04205259308218956
/ O 1 0.999997615814209
or O 1 0.8796008229255676
lymphoma B-Disease 1 1.0
associated O 0 0.04949045926332474
with O 0 0.03204871341586113
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.09259939193725586
1 I-Disease 0 0.026110194623470306
. O 0 0.014776547439396381
. O 0 0.0212080180644989

Missense O 0 0.42565688490867615
mutations O 0 0.11844348907470703
in O 0 0.012067459523677826
the O 0 0.008660833351314068
most O 0 0.008964383974671364
ancient O 0 0.01844272017478943
residues O 0 0.040836066007614136
of O 0 0.008556606248021126
the O 0 0.02159639075398445
PAX6 O 1 0.9995483756065369
paired O 0 0.11340362578630447
domain O 0 0.05248156189918518
underlie O 0 0.11774731427431107
a O 0 0.020872395485639572
spectrum O 0 0.05420415475964546
of O 0 0.016553664579987526
human O 1 0.5102772116661072
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999996423721313
malformations I-Disease 1 0.9999971389770508
. O 0 0.039309464395046234

Mutations O 0 0.11928103119134903
of O 0 0.011294982396066189
the O 0 0.01596181094646454
human O 0 0.05001325160264969
PAX6 O 1 0.9999929666519165
gene O 0 0.47043973207473755
underlie O 1 0.9995338916778564
aniridia B-Disease 1 0.9999922513961792
( O 0 0.43234771490097046
congenital B-Disease 1 0.9999998807907104
absence I-Disease 0 0.044816914945840836
of I-Disease 0 0.008960656821727753
the I-Disease 0 0.015687545761466026
iris I-Disease 1 0.9866277575492859
) O 0 0.018610747531056404
, O 0 0.008669402450323105
a O 0 0.017486700788140297
rare O 0 0.046378377825021744
dominant O 0 0.17172929644584656
malformation B-Disease 1 0.9999761581420898
of I-Disease 0 0.012041179463267326
the I-Disease 0 0.020305832847952843
eye I-Disease 1 0.9987673759460449
. O 0 0.02946695312857628

The O 0 0.03147219493985176
spectrum O 0 0.07717011868953705
of O 0 0.029054416343569756
PAX6 O 1 0.9999579191207886
mutations O 0 0.18359361588954926
in O 0 0.03400183469057083
aniridia B-Disease 1 0.999994158744812
patients O 1 0.9999104738235474
is O 0 0.01610635779798031
highly O 0 0.026623709127306938
biased O 0 0.04475235193967819
, O 0 0.008844621479511261
with O 0 0.010584111325442791
92 O 0 0.04819970950484276
% O 0 0.01628062315285206
of O 0 0.006390875671058893
all O 0 0.008833545260131359
reported O 0 0.03874872624874115
mutations O 0 0.09594414383172989
leading O 0 0.02776692993938923
to O 0 0.01696617342531681
premature O 0 0.2913561463356018
truncation O 0 0.11049669235944748
of O 0 0.013524893671274185
the O 0 0.020339667797088623
protein O 0 0.07038462162017822
( O 0 0.03901492804288864
nonsense O 0 0.07796597480773926
, O 0 0.01726381666958332
splicing O 0 0.10121408849954605
, O 0 0.018731098622083664
insertions O 0 0.10746476799249649
and O 0 0.01905430480837822
deletions O 0 0.08210896700620651
) O 0 0.01854950748383999
and O 0 0.009337429888546467
just O 0 0.013896842487156391
2 O 0 0.016736233606934547
% O 0 0.017120642587542534
leading O 0 0.01643485203385353
to O 0 0.00917371828109026
substitution O 0 0.03624418377876282
of O 0 0.008146101608872414
one O 0 0.013319569639861584
amino O 0 0.0630461648106575
acid O 0 0.09795728325843811
by O 0 0.017610831186175346
another O 0 0.03039376065135002
( O 0 0.04304852709174156
missense O 0 0.17912809550762177
) O 0 0.033734142780303955
. O 0 0.02732352912425995

The O 0 0.026253754273056984
extraordinary O 0 0.047510407865047455
conservation O 0 0.034218356013298035
of O 0 0.009941894561052322
the O 0 0.01962072215974331
PAX6 O 1 0.9995842576026917
protein O 0 0.06777635216712952
at O 0 0.019290370866656303
the O 0 0.017392931506037712
amino O 0 0.07401049137115479
acid O 0 0.12070541828870773
level O 0 0.03506998345255852
amongst O 0 0.03871338814496994
vertebrates O 0 0.07759413868188858
predicts O 0 0.09819924086332321
that O 0 0.020955383777618408
pathological O 1 0.9870052337646484
missense O 1 0.8136110305786133
mutations O 0 0.1252390742301941
should O 0 0.01449157577008009
in O 0 0.00848217960447073
fact O 0 0.012305323034524918
be O 0 0.0064758723601698875
common O 0 0.016179939731955528
even O 0 0.009672855958342552
though O 0 0.009124369360506535
they O 0 0.005233488976955414
are O 0 0.006673534866422415
hardly O 0 0.03293824940919876
ever O 0 0.01938418298959732
seen O 0 0.02306566946208477
in O 0 0.02089875377714634
aniridia B-Disease 1 0.999995231628418
patients O 1 0.999958872795105
. O 0 0.03611250966787338

This O 0 0.018752554431557655
indicates O 0 0.03403569757938385
that O 0 0.0066228825598955154
there O 0 0.00734282610937953
is O 0 0.00967880617827177
a O 0 0.01793590560555458
heavy O 0 0.07726980745792389
ascertainment O 1 0.999010443687439
bias O 0 0.06698701530694962
in O 0 0.009258298203349113
the O 0 0.00877912063151598
selection O 0 0.020265938714146614
of O 0 0.014627672731876373
patients O 1 0.9999587535858154
for O 0 0.024018073454499245
PAX6 O 1 0.9999865293502808
mutation O 0 0.14776545763015747
analysis O 0 0.02195572853088379
and O 0 0.00700403144583106
that O 0 0.007112334482371807
the O 0 0.01642264612019062
missing O 0 0.09736820310354233
PAX6 O 1 0.9999566078186035
missense O 1 0.9007532596588135
mutations O 0 0.1890256255865097
frequently O 0 0.05537906289100647
may O 0 0.043056052178144455
underlie O 1 0.8232356309890747
phenotypes O 0 0.1817111372947693
distinct O 0 0.042695410549640656
from O 0 0.025878706946969032
textbook O 0 0.12563477456569672
aniridia B-Disease 1 0.9986516833305359
. O 0 0.0414821095764637

Here O 0 0.022554945200681686
we O 0 0.009929683990776539
present O 0 0.01383927557617426
four O 0 0.019017530605196953
novel O 0 0.06320362538099289
PAX6 O 1 0.9998666048049927
missense O 1 0.5028423070907593
mutations O 0 0.10509750247001648
, O 0 0.010530596598982811
two O 0 0.006528493016958237
in O 0 0.01062842644751072
association O 0 0.04016784206032753
with O 0 0.024185150861740112
atypical O 1 0.9998862743377686
phenotypes O 1 0.9842556118965149
ectopia B-Disease 1 0.99722820520401
pupillae I-Disease 1 0.9896861910820007
( O 0 0.044239502400159836
displaced B-Disease 0 0.07520671933889389
pupils I-Disease 0 0.08531616628170013
) O 0 0.03590256720781326
and O 0 0.028550321236252785
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.999993085861206
( O 0 0.0554276704788208
searching B-Disease 0 0.07329044491052628
gaze I-Disease 0 0.37311840057373047
) O 0 0.01735595613718033
, O 0 0.006774578243494034
and O 0 0.005060427822172642
two O 0 0.005129760596901178
in O 0 0.008004659786820412
association O 0 0.027078457176685333
with O 0 0.010337011888623238
more O 0 0.01612260565161705
recognizable O 0 0.11172986030578613
aniridia B-Disease 1 0.9993667006492615
phenotypes O 0 0.2786784768104553
. O 0 0.044089674949645996

Strikingly O 0 0.11598628014326096
, O 0 0.014757497236132622
all O 0 0.008012797683477402
four O 0 0.01699810102581978
mutations O 0 0.08337055146694183
are O 0 0.009904940612614155
located O 0 0.02044154517352581
within O 0 0.013411322608590126
the O 0 0.021011553704738617
PAX6 O 1 0.9997186064720154
paired O 0 0.11640116572380066
domain O 0 0.04879046604037285
and O 0 0.015424828045070171
affect O 0 0.047115206718444824
amino O 0 0.054870977997779846
acids O 0 0.04491728916764259
which O 0 0.009799021296203136
are O 0 0.006838726345449686
highly O 0 0.023016875609755516
conserved O 0 0.028479671105742455
in O 0 0.008121688850224018
all O 0 0.00798720121383667
known O 0 0.02617206797003746
paired O 0 0.0837845504283905
domain O 0 0.05669863149523735
proteins O 0 0.053572796285152435
. O 0 0.03024321049451828

Our O 0 0.024903278797864914
results O 0 0.02407807856798172
support O 0 0.015819357708096504
the O 0 0.010292641818523407
hypothesis O 0 0.037620335817337036
that O 0 0.00688747875392437
the O 0 0.008084543980658054
under O 0 0.014414139091968536
- O 0 0.045104313641786575
representation O 0 0.022872239351272583
of O 0 0.01728254370391369
missense O 0 0.4636264741420746
mutations O 0 0.14971137046813965
is O 0 0.023865921422839165
caused O 0 0.06252408772706985
by O 0 0.021663768216967583
ascertainment O 1 0.9990350008010864
bias O 0 0.09123443067073822
and O 0 0.010879834182560444
suggest O 0 0.018229693174362183
that O 0 0.006579023785889149
a O 0 0.012067410163581371
substantial O 0 0.02913106046617031
burden O 0 0.29889339208602905
of O 0 0.021644869819283485
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9983940720558167
related I-Disease 1 0.6853892803192139
disease I-Disease 1 0.9999991655349731
remains O 0 0.020643820986151695
to O 0 0.0083571532741189
be O 0 0.009305207058787346
uncovered O 0 0.04752592742443085
. O 0 0.014664191752672195
. O 0 0.02359762415289879

The O 0 0.03255151957273483
chromosomal O 0 0.14728164672851562
order O 0 0.019263342022895813
of O 0 0.011809887364506721
genes O 0 0.05188390240073204
controlling O 0 0.06267482042312622
the O 0 0.016232337802648544
major O 0 0.037902988493442535
histocompatibility O 1 0.9998012185096741
complex O 0 0.05014768987894058
, O 0 0.02138908952474594
properdin O 1 0.978297233581543
factor O 0 0.07810898870229721
B O 0 0.3549198508262634
, O 0 0.014348031021654606
and O 0 0.016615524888038635
deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.008292371407151222
the I-Disease 0 0.008767008781433105
second I-Disease 0 0.01670486107468605
component I-Disease 0 0.03961906209588051
of I-Disease 0 0.012212825939059258
complement I-Disease 0 0.06617333739995956
. O 0 0.02729458175599575

The O 0 0.025123773142695427
relationship O 0 0.032273951917886734
of O 0 0.008387407287955284
the O 0 0.01624656654894352
genes O 0 0.0649811178445816
coding O 0 0.10923989117145538
for O 0 0.022609028965234756
HLA O 1 0.9974859952926636
to O 0 0.014136960729956627
those O 0 0.013026067055761814
coding O 0 0.0858965516090393
for O 0 0.02156050130724907
properdin O 1 0.8315173983573914
Factor O 0 0.09886033833026886
B O 1 0.5053084492683411
allotypes O 1 0.6234087347984314
and O 0 0.01293895486742258
for O 0 0.01668260060250759
deficiency B-Disease 1 0.9999986886978149
of I-Disease 0 0.010161270387470722
the I-Disease 0 0.009358073584735394
second I-Disease 0 0.01885901764035225
component I-Disease 0 0.040972404181957245
of I-Disease 0 0.010629869997501373
complement I-Disease 0 0.07080448418855667
( O 0 0.05090605840086937
C2 O 1 0.99998939037323
) O 0 0.023732412606477737
was O 0 0.01355027686804533
studied O 0 0.01742079295217991
in O 0 0.008111745119094849
families O 0 0.018595661967992783
of O 0 0.012995792552828789
patients O 1 0.9999929666519165
with O 0 0.031057970598340034
connective O 1 0.9999995231628418
tissue O 1 0.9999992847442627
disorders O 1 1.0
. O 0 0.036747802048921585

Patients O 1 0.9994460940361023
were O 0 0.011001148261129856
selected O 0 0.01639760285615921
because O 0 0.011235137470066547
they O 0 0.0073137166909873486
were O 0 0.009125741198658943
heterozygous O 0 0.09028500318527222
or O 0 0.02788299135863781
homozygous O 0 0.12993831932544708
for O 0 0.04658738523721695
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05804170295596123

12 O 0 0.035552531480789185
families O 0 0.028101826086640358
with O 0 0.015082457102835178
15 O 0 0.03353869915008545
matings O 0 0.17663002014160156
informative O 0 0.08285153657197952
for O 0 0.04000319540500641
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.022669775411486626
found O 0 0.027586445212364197
. O 0 0.028574394062161446

Of O 0 0.02633928507566452
57 O 0 0.08279364556074142
informative O 0 0.08525268733501434
meioses O 0 0.1567685753107071
, O 0 0.012216439470648766
two O 0 0.008576934225857258
crossovers O 0 0.05030752718448639
were O 0 0.00817901361733675
noted O 0 0.015816276893019676
between O 0 0.014426094479858875
the O 0 0.03278785198926926
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.10416272282600403
and O 0 0.015319373458623886
the O 0 0.025460289791226387
HLA O 1 0.9999966621398926
- O 0 0.2643249034881592
B O 0 0.25841695070266724
gene O 0 0.06507328152656555
, O 0 0.011201762594282627
with O 0 0.010328941978514194
a O 0 0.018959371373057365
recombinant O 0 0.11073293536901474
fraction O 0 0.05085291713476181
of O 0 0.01678287796676159
0 O 0 0.06053592637181282
. O 0 0.026661908254027367

035 O 1 0.9507958292961121
. O 0 0.06558135151863098

A O 0 0.07319212704896927
lod O 0 0.45434334874153137
score O 0 0.02307741530239582
of O 0 0.007791411131620407
13 O 0 0.01595694199204445
was O 0 0.01279655285179615
calculated O 0 0.02446862868964672
for O 0 0.014460568316280842
linkage O 0 0.44451361894607544
between O 0 0.049003005027770996
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.05214044824242592
HLA O 1 0.999998927116394
- O 0 0.1307261437177658
B O 0 0.11162503808736801
at O 0 0.019673461094498634
a O 0 0.016496893018484116
maximum O 0 0.03264344111084938
likelihood O 0 0.04507848247885704
value O 0 0.010503439232707024
of O 0 0.005879363045096397
the O 0 0.012584676034748554
recombinant O 0 0.10851866751909256
fraction O 0 0.047887153923511505
of O 0 0.01462594699114561
0 O 0 0.06283599138259888
. O 0 0.02607814222574234

04 O 1 0.8977823257446289
. O 0 0.0460473895072937

18 O 0 0.038563501089811325
families O 0 0.02689938060939312
with O 0 0.014377880841493607
21 O 0 0.033285871148109436
informative O 0 0.05994752049446106
matings O 0 0.12186910957098007
for O 0 0.012653154321014881
both O 0 0.019882438704371452
properdin O 1 0.6420012712478638
Factor O 0 0.09926252067089081
B O 0 0.2494785040616989
allotype O 1 0.7525920867919922
and O 0 0.030429741367697716
HLA O 1 0.9999880790710449
- O 0 0.14281900227069855
B O 0 0.12133049964904785
were O 0 0.01485078688710928
found O 0 0.02235017903149128
. O 0 0.0245220847427845

Of O 0 0.028820360079407692
72 O 0 0.08742880076169968
informative O 0 0.08878275752067566
meioses O 0 0.15471884608268738
, O 0 0.015687545761466026
three O 0 0.012000293470919132
recombinants O 0 0.11403157562017441
were O 0 0.008958346210420132
found O 0 0.012620550580322742
, O 0 0.008681424893438816
giving O 0 0.02069057524204254
a O 0 0.019075484946370125
recombinant O 0 0.09573592990636826
fraction O 0 0.04140085726976395
of O 0 0.013831019401550293
0 O 0 0.06376217305660248
. O 0 0.028226831927895546

042 O 1 0.5410781502723694
. O 0 0.05247761309146881

A O 0 0.06866176426410675
lod O 1 0.5118017196655273
score O 0 0.0260508693754673
of O 0 0.010176231153309345
16 O 0 0.023053204640746117
between O 0 0.02624419517815113
HLA O 1 0.9999585151672363
- O 0 0.12698474526405334
B O 0 0.1278606802225113
and O 0 0.02351962774991989
Factor O 0 0.08421114087104797
B O 0 0.19614176452159882
allotypes O 0 0.14836816489696503
was O 0 0.02094857394695282
calculated O 0 0.030639462172985077
at O 0 0.017403611913323402
a O 0 0.015129080973565578
maximum O 0 0.030317269265651703
likelihood O 0 0.04178202897310257
value O 0 0.010328025557100773
of O 0 0.0066989269107580185
the O 0 0.012837296351790428
recombinant O 0 0.10573843866586685
fraction O 0 0.04184411093592644
of O 0 0.013542667962610722
0 O 0 0.05922849476337433
. O 0 0.02593238838016987

04 O 1 0.86229008436203
. O 0 0.05461408197879791

A O 0 0.053968727588653564
crossover O 0 0.07460694760084152
was O 0 0.02108732983469963
shown O 0 0.017908336594700813
to O 0 0.007462101522833109
have O 0 0.009400824084877968
occurred O 0 0.028024323284626007
between O 0 0.012967212125658989
genes O 0 0.040826860815286636
for O 0 0.013357950374484062
Factor O 0 0.06789906322956085
B O 0 0.479534775018692
and O 0 0.028280457481741905
HLA O 1 0.9999933242797852
- O 0 0.17416509985923767
D O 1 0.5803784728050232
, O 0 0.012327689677476883
in O 0 0.011752916499972343
which O 0 0.021294131875038147
HLA O 1 0.9999921321868896
- O 0 0.46726173162460327
D O 1 0.9841423630714417
segregared O 1 0.7753412127494812
with O 0 0.03268905356526375
HLA O 1 0.9999631643295288
- O 0 0.07957641035318375
A O 0 0.031517695635557175
and O 0 0.020345427095890045
B O 0 0.14523924887180328
. O 0 0.03088580071926117

These O 0 0.01897285133600235
studies O 0 0.027530929073691368
suggest O 0 0.019446607679128647
that O 0 0.007008376531302929
the O 0 0.010028560645878315
genes O 0 0.04184543341398239
for O 0 0.015512288548052311
Factor O 0 0.08427563309669495
B O 1 0.9740351438522339
and O 0 0.03345155343413353
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.013423731550574303
located O 0 0.02127181924879551
outside O 0 0.013133774511516094
those O 0 0.00816715694963932
for O 0 0.012427951209247112
HLA O 1 0.9999390840530396
, O 0 0.00875537283718586
that O 0 0.005015830975025892
the O 0 0.0058360169641673565
order O 0 0.008879097178578377
of O 0 0.011040481738746166
genese O 1 0.924692690372467
is O 0 0.03352406248450279
HLA O 1 0.9999693632125854
- O 0 0.06737292557954788
A O 0 0.02992778643965721
, O 0 0.019310055300593376
- O 0 0.08122172206640244
B O 0 0.13156245648860931
, O 0 0.024477558210492134
- O 0 0.10118186473846436
D O 1 0.6235154867172241
, O 0 0.027076460421085358
Factor O 0 0.0924680307507515
B O 1 0.7855921983718872
allotype O 1 0.9973020553588867
, O 0 0.15849554538726807
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.015481537207961082
that O 0 0.00789528526365757
the O 0 0.01443225797265768
genes O 0 0.06793788820505142
coding O 0 0.136948823928833
for O 0 0.04561164602637291
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.029452435672283173
Factor O 0 0.09412519633769989
B O 0 0.20108452439308167
allotypes O 0 0.12610670924186707
are O 0 0.010098930448293686
approximately O 0 0.02427794225513935
3 O 0 0.03229185566306114
- O 0 0.07496965676546097
- O 0 0.08204211294651031
5 O 0 0.03950471431016922
centimorgans O 0 0.11911730468273163
from O 0 0.017423957586288452
the O 0 0.024124983698129654
HLA O 1 0.9999580383300781
- O 0 0.0895547941327095
A O 0 0.040341075509786606
and O 0 0.025328626856207848
HLA O 1 0.9999924898147583
- O 0 0.17767618596553802
B O 0 0.3146393597126007
loci O 0 0.12918835878372192
, O 0 0.011341378092765808
and O 0 0.006506633013486862
that O 0 0.006291771307587624
the O 0 0.010405810549855232
apparent O 0 0.0477479062974453
lack O 0 0.026228686794638634
of O 0 0.0101753706112504
recombinants O 1 0.5703135132789612
between O 0 0.013449307531118393
the O 0 0.014375914819538593
Factor O 0 0.08382310718297958
B O 1 0.9484579563140869
gene O 0 0.10779924690723419
and O 0 0.034599803388118744
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.20179766416549683
suggests O 0 0.03575943037867546
that O 0 0.006927068345248699
these O 0 0.005044509191066027
two O 0 0.008304287679493427
genes O 0 0.03970484808087349
lie O 0 0.033948998898267746
in O 0 0.010526562109589577
close O 0 0.020944461226463318
proximity O 0 0.03407111391425133
to O 0 0.007868482731282711
one O 0 0.010889526456594467
another O 0 0.021138424053788185
. O 0 0.024402853101491928

Distribution O 0 0.043471988290548325
of O 0 0.01787845604121685
emerin O 0 0.45785030722618103
and O 0 0.019937755540013313
lamins O 1 0.9819600582122803
in O 0 0.013151981867849827
the O 0 0.013854446820914745
heart O 1 0.9810612201690674
and O 0 0.010269924998283386
implications O 0 0.04264051839709282
for O 0 0.016338180750608444
Emery B-Disease 1 0.9997957348823547
- I-Disease 1 0.9983097314834595
Dreifuss I-Disease 1 0.9999972581863403
muscular I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
. O 0 0.0547872819006443

Emerin O 0 0.2088063806295395
is O 0 0.022973889485001564
a O 0 0.024272145703434944
nuclear O 0 0.053076762706041336
membrane O 0 0.07598757743835449
protein O 0 0.046502482146024704
which O 0 0.009595131501555443
is O 0 0.01157336961477995
missing O 0 0.030521618202328682
or O 0 0.01837472803890705
defective O 1 0.9213224649429321
in O 0 0.023006770759820938
Emery B-Disease 1 0.9998199343681335
- I-Disease 1 0.9984258413314819
Dreifuss I-Disease 1 0.9999986886978149
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 0.3045523762702942
EDMD B-Disease 1 0.9999951124191284
) O 0 0.0400376059114933
. O 0 0.026363931596279144

It O 0 0.014902268536388874
is O 0 0.00914403609931469
one O 0 0.006429281085729599
member O 0 0.009382001124322414
of O 0 0.005470460280776024
a O 0 0.01216916088014841
family O 0 0.022598866373300552
of O 0 0.014630683697760105
lamina O 1 0.9999878406524658
- O 0 0.0779409408569336
associated O 0 0.02818453125655651
proteins O 0 0.032669827342033386
which O 0 0.013676072470843792
includes O 0 0.029096629470586777
LAP1 O 1 0.9745878577232361
, O 0 0.02483777143061161
LAP2 O 1 0.950801432132721
and O 0 0.028455205261707306
lamin O 1 0.9926077127456665
B O 1 0.9057500958442688
receptor O 1 0.61416095495224
( O 0 0.06779734790325165
LBR O 1 0.999980092048645
) O 0 0.039551738649606705
. O 0 0.02769210748374462

A O 0 0.0424412377178669
panel O 0 0.04371437802910805
of O 0 0.015103282406926155
16 O 0 0.05291951820254326
monoclonal O 1 0.9209308624267578
antibodies O 1 0.750217080116272
( O 0 0.06802093237638474
mAbs O 1 0.9912645816802979
) O 0 0.023747019469738007
has O 0 0.011965032666921616
been O 0 0.009819799102842808
mapped O 0 0.02904578112065792
to O 0 0.007547787390649319
six O 0 0.011640951037406921
specific O 0 0.013488400727510452
sites O 0 0.01662401854991913
throughout O 0 0.01378802303224802
the O 0 0.015882031992077827
emerin O 1 0.5685721039772034
molecule O 0 0.11767657846212387
using O 0 0.0392439179122448
phage O 1 0.9980258941650391
- O 0 0.09814721345901489
displayed O 0 0.05314793065190315
peptide O 0 0.10551182925701141
libraries O 0 0.02787189558148384
and O 0 0.008150256238877773
has O 0 0.010313823819160461
been O 0 0.009306354448199272
used O 0 0.010693605989217758
to O 0 0.012411878444254398
localize O 0 0.16110922396183014
emerin O 0 0.17596407234668732
in O 0 0.013582922518253326
human O 0 0.023303978145122528
and O 0 0.020309142768383026
rabbit O 1 0.9992460012435913
heart O 1 0.9991036057472229
. O 0 0.03431321680545807

Several O 0 0.039233382791280746
mAbs O 0 0.4507458209991455
against O 0 0.029399501159787178
different O 0 0.022269047796726227
emerin O 1 0.8102924823760986
epitopes O 0 0.418413907289505
did O 0 0.022317834198474884
not O 0 0.010788815096020699
recognize O 0 0.04282401502132416
intercalated O 1 0.7872540950775146
discs O 0 0.04764683544635773
in O 0 0.010642148554325104
the O 0 0.015341279096901417
heart O 1 0.9961066842079163
, O 0 0.011906256899237633
though O 0 0.012012578547000885
they O 0 0.008050726726651192
recognized O 0 0.035435210913419724
cardiomyocyte O 1 0.7315585613250732
nuclei O 0 0.08855187147855759
strongly O 0 0.023105314001441002
, O 0 0.00900246761739254
both O 0 0.007360917516052723
at O 0 0.013193853199481964
the O 0 0.01146712712943554
rim O 0 0.08178067207336426
and O 0 0.01215028204023838
in O 0 0.016247861087322235
intranuclear O 1 0.7341464757919312
spots O 0 0.061596859246492386
or O 0 0.02265486866235733
channels O 0 0.04309358820319176
. O 0 0.027450984343886375

A O 0 0.10949794948101044
polyclonal O 1 0.9729764461517334
rabbit O 1 0.9673742651939392
antiserum O 1 0.9610949754714966
against O 0 0.04147518798708916
emerin O 0 0.48817962408065796
did O 0 0.023583268746733665
recognize O 0 0.03408172354102135
both O 0 0.01268921047449112
nuclear O 0 0.04624428600072861
membrane O 0 0.068997822701931
and O 0 0.01758561283349991
intercalated O 1 0.7279590368270874
discs O 0 0.05815151706337929
but O 0 0.012544861063361168
, O 0 0.011243214830756187
after O 0 0.0221061110496521
affinity O 0 0.08324054628610611
purification O 0 0.07777828723192215
against O 0 0.017046546563506126
a O 0 0.022060099989175797
pure O 0 0.062068525701761246
- O 0 0.09573519229888916
emerin O 0 0.1648823320865631
band O 0 0.04381057992577553
on O 0 0.010055766440927982
a O 0 0.01890910044312477
western O 0 0.03480874001979828
blot O 0 0.48714619874954224
, O 0 0.014925230294466019
it O 0 0.011788835749030113
stained O 0 0.3438946604728699
only O 0 0.009220384992659092
the O 0 0.01126192044466734
nuclear O 0 0.04557924345135689
membrane O 0 0.09032859653234482
. O 0 0.03244674950838089

These O 0 0.016937360167503357
results O 0 0.022252723574638367
would O 0 0.008226444013416767
not O 0 0.005861124023795128
be O 0 0.006319242529571056
expected O 0 0.016289452090859413
if O 0 0.017369836568832397
immunostaining O 0 0.3324376940727234
at O 0 0.030702535063028336
intercalated O 1 0.6723605990409851
discs O 0 0.04308861866593361
were O 0 0.007180654443800449
due O 0 0.0121747562661767
to O 0 0.006660019513219595
a O 0 0.01009091455489397
product O 0 0.015470472164452076
of O 0 0.007273006718605757
the O 0 0.015083787962794304
emerin O 1 0.9667425751686096
gene O 0 0.07134563475847244
and O 0 0.011410052888095379
, O 0 0.010395189747214317
therefore O 0 0.01210751198232174
, O 0 0.00792924128472805
cast O 0 0.013113320805132389
some O 0 0.00739669194445014
doubt O 0 0.022198224440217018
upon O 0 0.011306710541248322
the O 0 0.013528252951800823
hypothesis O 0 0.07389827817678452
that O 0 0.02666960097849369
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999052286148071
in O 0 0.02267734706401825
EDMD B-Disease 1 0.9999946355819702
are O 0 0.011840303428471088
caused O 0 0.041607413440942764
by O 0 0.010448625311255455
absence O 0 0.033628154546022415
of O 0 0.01564311981201172
emerin O 1 0.9039291739463806
from O 0 0.028032273054122925
intercalated O 1 0.9471427798271179
discs O 0 0.08967689424753189
. O 0 0.03515971079468727

Although O 0 0.04964261129498482
emerin O 0 0.16246746480464935
was O 0 0.020639432594180107
abundant O 0 0.026042742654681206
in O 0 0.007965467870235443
the O 0 0.01237478293478489
membranes O 0 0.06978687644004822
of O 0 0.015132575295865536
cardiomyocyte O 1 0.896062970161438
nuclei O 0 0.07643039524555206
, O 0 0.010256546549499035
it O 0 0.007997795008122921
was O 0 0.012955449521541595
absent O 0 0.037060968577861786
from O 0 0.011085942387580872
many O 0 0.009700817987322807
non O 0 0.05131232738494873
- O 0 0.3641844391822815
myocyte O 1 0.9995068311691284
cells O 0 0.07442092895507812
in O 0 0.012504570186138153
the O 0 0.017659330740571022
heart O 1 0.9989655017852783
. O 0 0.03504573181271553

This O 0 0.015719622373580933
distribution O 0 0.02291209064424038
of O 0 0.011955227702856064
emerin O 0 0.17263786494731903
was O 0 0.015438302420079708
similar O 0 0.012239096686244011
to O 0 0.006632661912590265
that O 0 0.006935724522918463
of O 0 0.010218231938779354
lamin O 1 0.7117063999176025
A O 0 0.024404481053352356
, O 0 0.011067685671150684
a O 0 0.01594797521829605
candidate O 0 0.02638905495405197
gene O 0 0.04916572943329811
for O 0 0.009143751114606857
an O 0 0.017269590869545937
autosomal O 1 0.9938222169876099
form O 0 0.03697348013520241
of O 0 0.02422025240957737
EDMD B-Disease 1 0.9999843835830688
. O 0 0.037992894649505615

In O 0 0.030781468376517296
contrast O 0 0.059908296912908554
, O 0 0.037730805575847626
lamin O 1 0.9986054301261902
B1 O 1 0.9999892711639404
was O 0 0.03776407241821289
absent O 0 0.07145320624113083
from O 0 0.02379530854523182
cardiomyocyte O 1 0.7092965841293335
nuclei O 0 0.0833083763718605
, O 0 0.014746754430234432
showing O 0 0.03251810371875763
that O 0 0.020408518612384796
lamin O 1 0.9993650317192078
B1 O 1 0.9999786615371704
is O 0 0.01854865439236164
not O 0 0.009131562896072865
essential O 0 0.018856065347790718
for O 0 0.011186430230736732
localization O 0 0.05831655114889145
of O 0 0.01366184651851654
emerin O 0 0.1191321462392807
to O 0 0.012760292738676071
the O 0 0.016751157119870186
nuclear O 0 0.06446412205696106
lamina O 1 0.9978531002998352
. O 0 0.034912820905447006

Lamin O 1 0.9975892305374146
B1 O 1 0.9999502897262573
is O 0 0.027522701770067215
also O 0 0.014469228684902191
almost O 0 0.0171626266092062
completely O 0 0.03474196791648865
absent O 0 0.062462881207466125
from O 0 0.027093248441815376
skeletal O 1 0.9999630451202393
muscle O 1 0.9999017715454102
nuclei O 0 0.14301642775535583
. O 0 0.030415620654821396

In O 0 0.038878098130226135
EDMD B-Disease 1 0.9992788434028625
, O 0 0.012086735107004642
the O 0 0.008672468364238739
additional O 0 0.016728609800338745
absence O 0 0.037686992436647415
of O 0 0.018815476447343826
lamin O 1 0.9999192953109741
B1 O 1 0.999998927116394
from O 0 0.0325809083878994
heart O 1 0.9995716214179993
and O 0 0.024163171648979187
skeletal O 1 0.9999738931655884
muscle O 1 0.9999465942382812
nuclei O 0 0.08821619302034378
which O 0 0.011958213523030281
already O 0 0.022247280925512314
lack O 0 0.03790195286273956
emerin O 1 0.9701668620109558
may O 0 0.01871452108025551
offer O 0 0.01904340647161007
an O 0 0.01122818049043417
alternative O 0 0.03005262278020382
explanation O 0 0.027109183371067047
of O 0 0.008359864354133606
why O 0 0.021286780014634132
these O 0 0.01007871050387621
tissues O 0 0.0675148069858551
are O 0 0.009316290728747845
particularly O 0 0.021329782903194427
affected O 0 0.04317399486899376
. O 0 0.014080801978707314
. O 0 0.023490970954298973

Genetic O 0 0.12091609090566635
mapping O 0 0.05522150918841362
of O 0 0.014051650650799274
the O 0 0.02423195168375969
copper B-Disease 1 0.7741385102272034
toxicosis I-Disease 1 0.9997759461402893
locus O 0 0.17605891823768616
in O 0 0.03334880992770195
Bedlington O 1 0.9979377388954163
terriers O 0 0.23122204840183258
to O 0 0.028054537251591682
dog O 0 0.12396806478500366
chromosome O 0 0.1180095225572586
10 O 0 0.01739366725087166
, O 0 0.008288293145596981
in O 0 0.00783775094896555
a O 0 0.015771055594086647
region O 0 0.037990715354681015
syntenic O 0 0.23117265105247498
to O 0 0.015003482811152935
human O 0 0.03137650340795517
chromosome O 0 0.15024803578853607
region O 0 0.0681924819946289
2p13 O 1 0.9707311391830444
- O 0 0.1586574763059616
p16 O 1 0.9278712868690491
. O 0 0.038658350706100464

Abnormal O 1 0.9999241828918457
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 1 0.9943467974662781
accumulation I-Disease 0 0.2568078339099884
is O 0 0.014629115350544453
recognized O 0 0.02025056630373001
as O 0 0.010392168536782265
an O 0 0.021011868491768837
inherited B-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
in O 0 0.016506092622876167
man O 0 0.03870444744825363
, O 0 0.01651415228843689
mouse O 0 0.1095210388302803
, O 0 0.024053635075688362
rat O 1 0.8956003189086914
and O 0 0.020477933809161186
dog O 0 0.11552523076534271
. O 0 0.03142322599887848

The O 0 0.02300404943525791
major O 0 0.02912348136305809
cause O 0 0.0802018791437149
of O 0 0.023112237453460693
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9951015114784241
accumulation I-Disease 0 0.38504886627197266
in O 0 0.014372490346431732
man O 0 0.02780659683048725
is O 0 0.012796036899089813
a O 0 0.025472482666373253
dysfunctional O 1 0.9978420734405518
ATP7B O 1 0.9995974898338318
gene O 0 0.11149116605520248
, O 0 0.027235500514507294
causing O 1 0.9936417937278748
Wilson B-Disease 1 0.9995622038841248
disease I-Disease 1 0.9999998807907104
( O 0 0.2778913676738739
WD B-Disease 1 0.9999971389770508
) O 0 0.044721685349941254
. O 0 0.027866942808032036

Mutations O 0 0.15416382253170013
in O 0 0.019050253555178642
the O 0 0.020131275057792664
ATP7B O 1 0.9970241189002991
genes O 0 0.04678548127412796
have O 0 0.0088625717908144
also O 0 0.007015455048531294
been O 0 0.00980215985327959
demonstrated O 0 0.03132161498069763
in O 0 0.012754635885357857
mouse O 0 0.09984511137008667
and O 0 0.02149621583521366
rat O 1 0.9583425521850586
. O 0 0.03222654387354851

The O 0 0.041821692138910294
ATP7B O 1 0.9934750199317932
gene O 0 0.08346231281757355
has O 0 0.016158685088157654
been O 0 0.011616142466664314
excluded O 0 0.028257885947823524
in O 0 0.007753679994493723
the O 0 0.009760371409356594
much O 0 0.019751885905861855
rarer O 1 0.8575771450996399
human O 0 0.04691691696643829
copper B-Disease 1 0.9999819993972778
overload I-Disease 1 0.9999997615814209
disease O 1 0.9999998807907104
non B-Disease 0 0.12237341701984406
- I-Disease 0 0.11387262493371964
Indian I-Disease 0 0.06317948549985886
childhood I-Disease 1 0.9998787641525269
cirrhosis I-Disease 1 0.9999990463256836
, O 0 0.025153454393148422
indicating O 0 0.06755802780389786
genetic O 0 0.09844996780157089
heterogeneity O 0 0.1789095550775528
. O 0 0.03631185367703438

By O 0 0.024340005591511726
investigating O 0 0.046581000089645386
the O 0 0.021711602807044983
common O 0 0.06483420729637146
autosomal O 1 0.9999649524688721
recessive O 1 0.9999932050704956
copper B-Disease 1 0.9999326467514038
toxicosis I-Disease 1 0.9999996423721313
( O 0 0.0947132259607315
CT B-Disease 1 0.999990701675415
) O 0 0.030999241396784782
in O 0 0.020376821979880333
Bedlington O 1 0.9994897842407227
terriers O 1 0.643534779548645
, O 0 0.01354940328747034
we O 0 0.008021313697099686
have O 0 0.006699955556541681
identified O 0 0.015257659368216991
a O 0 0.013441362418234348
new O 0 0.017200076952576637
locus O 0 0.09862175583839417
involved O 0 0.031397219747304916
in O 0 0.02440178394317627
progressive O 1 0.9999703168869019
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.03783862665295601

We O 0 0.0251011960208416
examined O 0 0.04758584126830101
whether O 0 0.01947684958577156
the O 0 0.026273777708411217
WD B-Disease 1 0.9999902248382568
gene O 0 0.14000064134597778
ATP7B O 1 0.9689263701438904
was O 0 0.025008156895637512
also O 0 0.016227204352617264
causative O 0 0.4441019892692566
for O 0 0.01977831870317459
CT B-Disease 1 0.9998983144760132
by O 0 0.013116493821144104
investigating O 0 0.03926480934023857
the O 0 0.021475480869412422
chromosomal O 1 0.9096029996871948
co O 0 0.3229907155036926
- O 0 0.0954011008143425
localization O 0 0.08878225833177567
of O 0 0.019030334427952766
ATP7B O 1 0.9878215193748474
and O 0 0.016861308366060257
C04107 O 0 0.12279261648654938
, O 0 0.016186073422431946
using O 0 0.0238944198936224
fluorescence O 0 0.14203132688999176
in O 0 0.027801472693681717
situ O 0 0.17787037789821625
hybridization O 0 0.12499908357858658
( O 0 0.03954208642244339
FISH O 0 0.0531943179666996
) O 0 0.03032967820763588
. O 0 0.024329237639904022

C04107 O 0 0.1908520758152008
is O 0 0.025213532149791718
an O 0 0.021298181265592575
anonymous O 0 0.08155807852745056
microsatellite O 0 0.3721756637096405
marker O 0 0.11164078861474991
closely O 0 0.03998195007443428
linked O 0 0.06923657655715942
to O 0 0.02670111320912838
CT B-Disease 1 0.9999690055847168
. O 0 0.03362337872385979

However O 0 0.03553589805960655
, O 0 0.033066168427467346
BAC O 1 0.9988633394241333
clones O 0 0.1316661834716797
containing O 0 0.048911917954683304
ATP7B O 1 0.9022718071937561
and O 0 0.020873814821243286
C04107 O 0 0.1377859115600586
mapped O 0 0.04831940308213234
to O 0 0.012227743864059448
the O 0 0.020286252722144127
canine O 1 0.9625124931335449
chromosome O 0 0.1798313856124878
regions O 0 0.05801933631300926
CFA22q11 O 1 0.8968680500984192
and O 0 0.018942909315228462
CFA10q26 O 1 0.7804322838783264
, O 0 0.01291849184781313
respectively O 0 0.018331438302993774
, O 0 0.01111973263323307
demonstrating O 0 0.04114583879709244
that O 0 0.018071794882416725
WD B-Disease 1 0.9999337196350098
cannot O 0 0.027911419048905373
be O 0 0.010810837149620056
homologous O 0 0.10069629549980164
to O 0 0.028146235272288322
CT B-Disease 1 0.9999281167984009
. O 0 0.03461643308401108

The O 0 0.03380674496293068
copper O 0 0.09162818640470505
transport O 0 0.06471507996320724
genes O 0 0.08921293914318085
CTR1 O 1 0.9550400972366333
and O 0 0.021253876388072968
CTR2 O 1 0.8614913821220398
were O 0 0.010938591323792934
also O 0 0.011892911978065968
excluded O 0 0.034440506249666214
as O 0 0.009641452692449093
candidate O 0 0.023937445133924484
genes O 0 0.045203130692243576
for O 0 0.01818849891424179
CT B-Disease 1 0.99994957447052
since O 0 0.015920041128993034
they O 0 0.007958552800118923
both O 0 0.009922130964696407
mapped O 0 0.048385705798864365
to O 0 0.019225921481847763
canine O 1 0.9806272387504578
chromosome O 0 0.188534677028656
region O 0 0.07989560812711716
CFA11q22 O 1 0.9571471214294434
. O 0 0.03666186332702637

2 O 0 0.06625089049339294
- O 0 0.09089627861976624
22 O 0 0.048152197152376175
. O 0 0.0327971912920475

5 O 0 0.07692259550094604
. O 0 0.03601491078734398

A O 0 0.05807749181985855
transcribed O 0 0.088919498026371
sequence O 0 0.036617130041122437
identified O 0 0.02639603801071644
from O 0 0.01227828860282898
the O 0 0.018842754885554314
C04107 O 1 0.6466847062110901
- O 0 0.08759267628192902
containing O 0 0.04760056734085083
BAC O 1 0.9941007494926453
was O 0 0.019438544288277626
found O 0 0.012555320747196674
to O 0 0.007372536230832338
be O 0 0.008169274777173996
homologous O 0 0.06751774251461029
to O 0 0.01091809757053852
a O 0 0.02119501680135727
gene O 0 0.05935484170913696
expressed O 0 0.026399031281471252
from O 0 0.0165408942848444
human O 0 0.03501211479306221
chromosome O 0 0.21157367527484894
2p13 O 1 0.9883989095687866
- O 0 0.12901636958122253
p16 O 1 0.5322911739349365
, O 0 0.017270013689994812
a O 0 0.016976872459053993
region O 0 0.033027831465005875
devoid O 0 0.05364101380109787
of O 0 0.010147783905267715
any O 0 0.014474492520093918
positional O 0 0.08409935981035233
candidate O 0 0.04202844947576523
genes O 0 0.07570864260196686
. O 0 0.03184400498867035

Molecular O 0 0.08466602116823196
analysis O 0 0.027311518788337708
of O 0 0.008999451994895935
the O 0 0.018495110794901848
APC B-Disease 1 0.979621410369873
gene O 0 0.08237291872501373
in O 0 0.016616934910416603
205 O 0 0.09569048136472702
families O 0 0.03701077401638031
: O 0 0.028222581371665
extended O 0 0.05984921753406525
genotype O 1 0.9888914823532104
- O 0 0.17500628530979156
phenotype O 1 0.8464380502700806
correlations O 0 0.11554276198148727
in O 0 0.02885398641228676
FAP B-Disease 1 0.9999934434890747
and O 0 0.011040054261684418
evidence O 0 0.01083177886903286
for O 0 0.00650796527042985
the O 0 0.007987926714122295
role O 0 0.02081620879471302
of O 0 0.015971915796399117
APC B-Disease 1 0.9932594895362854
amino O 0 0.11207396537065506
acid O 1 0.516747236251831
changes O 0 0.03508986160159111
in O 0 0.0496419221162796
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999511241912842
. O 0 0.04246674105525017

BACKGROUND O 0 0.1312292069196701
/ O 1 0.64399254322052
AIMS O 0 0.05614904314279556
The O 0 0.014138861559331417
development O 0 0.02617758885025978
of O 0 0.027078144252300262
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.012721186503767967
a O 0 0.01775786094367504
variable O 0 0.06250829249620438
range O 0 0.024327324703335762
of O 0 0.011765887960791588
extracolonic O 1 0.9949900507926941
manifestations O 1 0.9701405167579651
in O 0 0.03651397302746773
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9810796976089478
FAP B-Disease 1 0.9999997615814209
) O 0 0.023073263466358185
is O 0 0.008171924389898777
the O 0 0.007132600527256727
result O 0 0.012131021358072758
of O 0 0.005189572926610708
the O 0 0.011961210519075394
dominant O 0 0.059878233820199966
inheritance O 0 0.2699914872646332
of O 0 0.0540396049618721
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
( O 0 0.22947807610034943
APC B-Disease 1 0.9994698166847229
) O 0 0.06026970222592354
gene O 0 0.12611126899719238
mutations O 0 0.15074588358402252
. O 0 0.036347877234220505

In O 0 0.01896667666733265
this O 0 0.010136921890079975
study O 0 0.02260364592075348
, O 0 0.01294036116451025
direct O 0 0.02993541583418846
mutation O 0 0.09781546145677567
analysis O 0 0.019534118473529816
of O 0 0.007464895956218243
the O 0 0.017933569848537445
APC B-Disease 1 0.9912399649620056
gene O 0 0.07753518968820572
was O 0 0.017495980486273766
performed O 0 0.024488553404808044
to O 0 0.013186473399400711
determine O 0 0.0412079393863678
genotype O 1 0.9874686002731323
- O 0 0.1536484807729721
phenotype O 1 0.8207451701164246
correlations O 0 0.08066541701555252
for O 0 0.012970509938895702
nine O 0 0.028630340471863747
extracolonic O 1 0.8638302683830261
manifestations O 0 0.07177723944187164
and O 0 0.008223317563533783
to O 0 0.00858998391777277
investigate O 0 0.03236684575676918
the O 0 0.01641388237476349
incidence O 1 0.9751409292221069
of O 0 0.018858663737773895
APC B-Disease 1 0.9992832541465759
mutations O 0 0.1278659850358963
in O 0 0.022726692259311676
non O 1 0.9768273234367371
- O 1 0.9999914169311523
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.05731230974197388

METHODS O 0 0.061880651861429214
The O 0 0.027544643729925156
APC B-Disease 1 0.9754002690315247
gene O 0 0.07828474789857864
was O 0 0.02076800912618637
analysed O 0 0.05353989824652672
in O 0 0.015281477943062782
190 O 0 0.07773926109075546
unrelated O 0 0.08912985026836395
FAP B-Disease 1 0.9999727010726929
and O 0 0.0197647362947464
15 O 0 0.03331026807427406
non O 1 0.8376529216766357
- O 1 0.9999827146530151
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999910593032837
using O 0 0.05162195861339569
denaturing O 1 0.9981654286384583
gradient O 1 0.9686038494110107
gel O 1 0.9979540109634399
electrophoresis O 0 0.22592732310295105
, O 0 0.01828056387603283
the O 0 0.016929009929299355
protein O 0 0.06549198180437088
truncation O 0 0.1262889802455902
test O 0 0.04261178523302078
, O 0 0.011326508596539497
and O 0 0.009288158267736435
direct O 0 0.03090698830783367
sequencing O 0 0.07495605200529099
. O 0 0.029172956943511963

RESULTS O 0 0.0993131622672081
Chain O 0 0.11940997838973999
terminating O 0 0.12115965038537979
signals O 0 0.045421771705150604
were O 0 0.008865207433700562
only O 0 0.009334387257695198
identified O 0 0.02183437906205654
in O 0 0.012091223150491714
patients O 1 0.998293936252594
belonging O 0 0.029767846688628197
to O 0 0.011217490769922733
the O 0 0.021466458216309547
FAP B-Disease 1 0.9999946355819702
group O 0 0.06348307430744171
( O 0 0.043223533779382706
105 O 0 0.11670219153165817
patients O 1 0.9998165965080261
) O 0 0.03323281556367874
. O 0 0.02590026520192623

Amino O 0 0.13788427412509918
acid O 0 0.14328870177268982
changes O 0 0.019139563664793968
were O 0 0.008267308585345745
identified O 0 0.018885059282183647
in O 0 0.00828472338616848
four O 0 0.015741562470793724
patients O 1 0.9986737966537476
, O 0 0.00728919543325901
three O 0 0.006355528254061937
of O 0 0.006984848063439131
whom O 0 0.02277512289583683
belonged O 0 0.026087677106261253
to O 0 0.008003735914826393
the O 0 0.011980464681982994
non O 0 0.06265930831432343
- O 1 0.9582852721214294
FAP O 1 0.9999992847442627
group O 0 0.07449506223201752
of O 0 0.052754584699869156
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999990463256836
. O 0 0.03597963973879814

Genotype O 1 0.9956676959991455
- O 0 0.4989764988422394
phenotype O 1 0.9078981876373291
correlations O 0 0.11509180068969727
identified O 0 0.03154788538813591
significant O 0 0.015479380264878273
differences O 0 0.015437361784279346
in O 0 0.006632558535784483
the O 0 0.009603160433471203
nature O 0 0.01879231445491314
of O 0 0.007394745480269194
certain O 0 0.021059591323137283
extracolonic O 1 0.9976131916046143
manifestations O 1 0.9172840118408203
in O 0 0.0319129079580307
FAP B-Disease 1 1.0
patients O 1 0.9999456405639648
belonging O 0 0.038264814764261246
to O 0 0.012297304347157478
three O 0 0.021709881722927094
mutation O 0 0.16918039321899414
subgroups O 0 0.11816219240427017
. O 0 0.039033569395542145

CONCLUSIONS O 0 0.10045577585697174
Extended O 0 0.09368851035833359
genotype O 1 0.9964218139648438
- O 0 0.18607348203659058
phenotype O 1 0.7987412810325623
correlations O 0 0.07316012680530548
made O 0 0.009743435308337212
in O 0 0.00756914122030139
this O 0 0.0068428791128098965
study O 0 0.018345965072512627
may O 0 0.012677626684308052
have O 0 0.005576904397457838
the O 0 0.006773826666176319
potential O 0 0.017402779310941696
to O 0 0.006777520757168531
determine O 0 0.01286036241799593
the O 0 0.007461193483322859
most O 0 0.008870000950992107
appropriate O 0 0.024112412706017494
surveillance O 0 0.045974522829055786
and O 0 0.01642654277384281
prophylactic O 1 0.9999946355819702
treatment O 1 0.9999980926513672
regimens O 1 0.9999722242355347
for O 0 0.012650784105062485
those O 0 0.014540388248860836
patients O 1 0.9999760389328003
with O 0 0.017718305811285973
mutations O 0 0.09268853813409805
associated O 0 0.02276199869811535
with O 0 0.012865417636930943
life O 0 0.02857118844985962
threatening O 1 0.8134362101554871
conditions O 0 0.07162069529294968
. O 0 0.028334015980362892

This O 0 0.016777735203504562
study O 0 0.023672951385378838
also O 0 0.008857822977006435
provided O 0 0.013583458960056305
evidence O 0 0.011874265968799591
for O 0 0.006753166206181049
the O 0 0.012932063080370426
pathological O 0 0.4789029657840729
nature O 0 0.030258188024163246
of O 0 0.01307894941419363
amino O 0 0.0731814056634903
acid O 0 0.11815722286701202
changes O 0 0.0233113095164299
in O 0 0.015925241634249687
APC O 1 0.9569528102874756
associated O 0 0.022573551163077354
with O 0 0.01044158823788166
both O 0 0.01652706228196621
FAP B-Disease 1 0.999996542930603
and O 0 0.023770049214363098
non O 1 0.9945906400680542
- O 1 0.9999978542327881
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 0 0.02472538687288761
. O 0 0.02819610945880413

Inherited B-Disease 1 0.9999991655349731
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.28447088599205017
cancer B-Disease 1 1.0
risk O 1 0.9496935606002808
of O 0 0.009845751337707043
the O 0 0.019591230899095535
APC O 1 0.9994163513183594
I1307K O 1 0.6883584856987
polymorphism O 0 0.17093059420585632
. O 0 0.0385727696120739

Germ O 1 0.9995631575584412
- O 0 0.11208420991897583
line O 0 0.04014710709452629
and O 0 0.022136954590678215
somatic O 0 0.18485888838768005
truncating O 0 0.43759146332740784
mutations O 0 0.10449659079313278
of O 0 0.013762123882770538
the O 0 0.023091444745659828
APC B-Disease 1 0.9960595369338989
gene O 0 0.08228818327188492
are O 0 0.01066132914274931
thought O 0 0.024602621793746948
to O 0 0.018874937668442726
initiate O 1 0.9571321606636047
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999978542327881
formation O 0 0.4729117155075073
in O 0 0.05268580839037895
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.07161960005760193
sporadic O 1 0.9998024106025696
colorectal O 1 1.0
carcinogenesis O 1 0.9999850988388062
, O 0 0.023144103586673737
respectively O 0 0.037451792508363724
. O 0 0.026903389021754265

Recently O 0 0.05047411099076271
, O 0 0.017219053581357002
an O 0 0.024927286431193352
isoleucine O 1 0.9957717061042786
- O 1 0.6496524810791016
- O 0 0.2262478619813919
> O 0 0.276142954826355
lysine O 0 0.23970982432365417
polymorphism O 0 0.18128743767738342
at O 0 0.06250851601362228
codon O 0 0.2096347212791443
1307 O 1 0.6098324060440063
( O 0 0.05800866708159447
I1307K O 0 0.1434154510498047
) O 0 0.01867344230413437
of O 0 0.009622094221413136
the O 0 0.020935045555233955
APC B-Disease 1 0.9936655163764954
gene O 0 0.07838484644889832
has O 0 0.015396030619740486
been O 0 0.011535856872797012
identified O 0 0.022248156368732452
in O 0 0.010958780534565449
6 O 0 0.029724756255745888
% O 0 0.02626149356365204
- O 0 0.04931802675127983
7 O 0 0.025640202686190605
% O 0 0.017024653032422066
of O 0 0.006884090136736631
the O 0 0.015560380183160305
Ashkenazi O 0 0.13034425675868988
Jewish O 0 0.045792143791913986
population O 0 0.03468405455350876
. O 0 0.026735300198197365

To O 0 0.026407435536384583
assess O 0 0.06440369039773941
the O 0 0.016304129734635353
risk O 0 0.05784725397825241
of O 0 0.00748405558988452
this O 0 0.01040781382471323
common O 0 0.03879211097955704
APC B-Disease 1 0.9998194575309753
allelic O 1 0.9952142238616943
variant O 1 0.8849977850914001
in O 0 0.04439397528767586
colorectal O 1 1.0
carcinogenesis O 1 0.9999728202819824
, O 0 0.015287687070667744
we O 0 0.008490119129419327
have O 0 0.007246986497193575
analyzed O 0 0.02925315499305725
a O 0 0.01410359051078558
large O 0 0.020441213622689247
cohort O 0 0.12596845626831055
of O 0 0.0204333383589983
unselected O 1 0.5216472744941711
Ashkenazi O 0 0.186090886592865
Jewish O 0 0.047175001353025436
subjects O 0 0.04272165149450302
with O 0 0.032442785799503326
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999943971633911
and O 0 0.02049737237393856
. O 0 0.01846851408481598
or O 1 0.9912360906600952
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.013504894450306892
for O 0 0.010358170606195927
the O 0 0.019998930394649506
APC O 1 0.9979177117347717
I1307K O 0 0.44905945658683777
polymorphism O 0 0.1642853170633316
. O 0 0.03725247457623482

The O 0 0.05950751155614853
APC O 1 0.9288703799247742
I1307K O 0 0.24756428599357605
allele O 0 0.16153810918331146
was O 0 0.024676920846104622
identified O 0 0.024960611015558243
in O 0 0.012151949107646942
48 O 0 0.032834697514772415
( O 0 0.01910306327044964
10 O 0 0.014180336147546768
. O 0 0.009171247482299805
1 O 0 0.02051147073507309
% O 0 0.022102145478129387
) O 0 0.01877855509519577
of O 0 0.01512463204562664
476 O 1 0.9976987242698669
patients O 1 0.9999270439147949
. O 0 0.03719799220561981

Compared O 0 0.04071451351046562
with O 0 0.011393407359719276
the O 0 0.011863116174936295
frequency O 0 0.030123509466648102
in O 0 0.006406167056411505
two O 0 0.007011898327618837
separate O 0 0.014205747283995152
population O 0 0.020455989986658096
control O 0 0.028347782790660858
groups O 0 0.016285724937915802
, O 0 0.011188408359885216
the O 0 0.01790463924407959
APC O 1 0.9959582686424255
I1307K O 0 0.3723359704017639
allele O 0 0.15483500063419342
is O 0 0.01671271212399006
associated O 0 0.017065780237317085
with O 0 0.008294939063489437
an O 0 0.010663433000445366
estimated O 0 0.02652985230088234
relative O 0 0.04075905680656433
risk O 0 0.07261420786380768
of O 0 0.012191387824714184
1 O 0 0.030336903408169746
. O 0 0.022830186411738396

5 O 0 0.07441192120313644
- O 0 0.09098444133996964
1 O 0 0.04184476286172867
. O 0 0.02849903330206871

7 O 0 0.06870961934328079
for O 0 0.04109146445989609
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999955892562866
( O 0 0.04645724594593048
both O 0 0.02314203605055809
P O 1 0.9831241369247437
= O 0 0.1275663822889328
. O 0 0.023585926741361618
01 O 1 0.9305854439735413
) O 0 0.034268155694007874
. O 0 0.028012126684188843

Furthermore O 0 0.06334564834833145
, O 0 0.014555906876921654
compared O 0 0.025962891057133675
with O 0 0.018690863624215126
noncarriers O 1 0.9243643283843994
, O 0 0.029566213488578796
APC O 1 0.9978196620941162
I1307K O 1 0.8165558576583862
carriers O 0 0.07330482453107834
had O 0 0.01813523657619953
increased O 0 0.023138251155614853
numbers O 0 0.016554318368434906
of O 0 0.01748831570148468
adenomas B-Disease 1 0.9999978542327881
and O 0 0.058838918805122375
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999988079071045
per O 0 0.04984360933303833
patient O 1 0.9999301433563232
( O 0 0.05639487877488136
P O 1 0.9966977834701538
= O 0 0.11215391755104065
. O 0 0.01779533550143242
03 O 1 0.8374335765838623
) O 0 0.017139099538326263
, O 0 0.007554712705314159
as O 0 0.005735763814300299
well O 0 0.007841890677809715
as O 0 0.007307532709091902
a O 0 0.015814241021871567
younger O 0 0.040217045694589615
age O 0 0.0352754108607769
at O 0 0.03964701667428017
diagnosis O 1 0.9999762773513794
. O 0 0.0338737815618515

We O 0 0.023345502093434334
conclude O 0 0.04813035577535629
that O 0 0.011769808828830719
the O 0 0.021395668387413025
APC O 1 0.989816427230835
I1307K O 1 0.7675426602363586
variant O 0 0.14967387914657593
leads O 0 0.06712426990270615
to O 0 0.019739151000976562
increased O 0 0.06933166086673737
adenoma B-Disease 1 1.0
formation O 0 0.064698226749897
and O 0 0.01143275573849678
directly O 0 0.022431494668126106
contributes O 0 0.057052358984947205
to O 0 0.009982600808143616
3 O 0 0.024191761389374733
% O 0 0.026404831558465958
- O 0 0.050461843609809875
4 O 0 0.0218632984906435
% O 0 0.015015636570751667
of O 0 0.006381888873875141
all O 0 0.013429088518023491
Ashkenazi O 1 0.9986476302146912
Jewish O 1 0.9992916584014893
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04545480012893677

The O 0 0.025157349184155464
estimated O 0 0.04265382140874863
relative O 0 0.05386974290013313
risk O 0 0.23601484298706055
for O 0 0.015211975201964378
carriers O 0 0.13097871840000153
may O 0 0.027670197188854218
justify O 0 0.050644319504499435
specific O 0 0.026240725070238113
clinical O 1 0.9900339245796204
screening O 0 0.06253131479024887
for O 0 0.008781775832176208
the O 0 0.011481210589408875
360 O 0 0.05590561777353287
, O 0 0.012279657647013664
000 O 0 0.042526423931121826
Americans O 0 0.024966275319457054
expected O 0 0.013458192348480225
to O 0 0.012648342177271843
harbor O 0 0.05713283270597458
this O 0 0.012643268331885338
allele O 0 0.10247097164392471
, O 0 0.013458647765219212
and O 0 0.011015736497938633
genetic O 0 0.051750291138887405
testing O 0 0.03377889096736908
in O 0 0.006949860602617264
the O 0 0.007281335536390543
setting O 0 0.0170453954488039
of O 0 0.008099038153886795
long O 0 0.03174571320414543
- O 0 0.06638973951339722
term O 0 0.0409419946372509
- O 0 0.06957563012838364
outcome O 0 0.045622218400239944
studies O 0 0.03239603340625763
may O 0 0.02172607183456421
impact O 0 0.036280225962400436
significantly O 0 0.05105244368314743
on O 0 0.03798246383666992
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999642372131348
in O 0 0.012924134731292725
this O 0 0.00998769048601389
population O 0 0.024193303659558296
. O 0 0.0234126728028059

Localization O 0 0.1215810552239418
of O 0 0.016335299238562584
human O 0 0.037761326879262924
BRCA1 O 1 0.9659915566444397
and O 0 0.011335248127579689
its O 0 0.010633260011672974
loss O 0 0.034761350601911545
in O 0 0.010731194168329239
high O 0 0.030392678454518318
- O 0 0.06268994510173798
grade O 0 0.05412610247731209
, O 0 0.019431399181485176
non B-Disease 0 0.07583486288785934
- I-Disease 1 0.994053304195404
inherited I-Disease 1 0.9999724626541138
breast I-Disease 1 1.0
carcinomas I-Disease 1 0.9999983310699463
. O 0 0.05023173987865448

Although O 0 0.021793264895677567
the O 0 0.013725940138101578
link O 0 0.0438494011759758
between O 0 0.018220581114292145
the O 0 0.032069139182567596
BRCA1 O 1 0.9999974966049194
tumour B-Disease 1 1.0
- O 1 0.9913148283958435
suppressor O 1 0.9874059557914734
gene O 0 0.1106448769569397
and O 0 0.024993307888507843
hereditary B-Disease 1 0.9999953508377075
breast I-Disease 1 1.0
and I-Disease 1 0.9720951914787292
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.015155453234910965
established O 0 0.013573214411735535
, O 0 0.00599290058016777
the O 0 0.006756615359336138
role O 0 0.014504950493574142
, O 0 0.007739122025668621
if O 0 0.007519999053329229
any O 0 0.0063979229889810085
, O 0 0.008010879158973694
of O 0 0.01136693824082613
BRCA1 O 1 0.9959661960601807
in O 0 0.019695118069648743
non B-Disease 0 0.22599786520004272
- I-Disease 1 0.996335506439209
familial I-Disease 1 0.9999971389770508
cancers I-Disease 1 0.9999945163726807
is O 0 0.02729148603975773
unclear O 0 0.042586278170347214
. O 0 0.026803849264979362

BRCA1 O 1 0.9989151954650879
mutations O 0 0.14465823769569397
are O 0 0.011694049462676048
rare O 0 0.03572029247879982
in O 0 0.016768578439950943
sporadic B-Disease 1 0.9428334832191467
cancers I-Disease 1 0.9999947547912598
, O 0 0.01343700010329485
but O 0 0.011695334687829018
loss O 0 0.045748502016067505
of O 0 0.014703107997775078
BRCA1 O 1 0.9990872144699097
resulting O 0 0.05398600548505783
from O 0 0.01896301843225956
reduced O 0 0.04079015925526619
expression O 0 0.0421474389731884
or O 0 0.023762954398989677
incorrect O 0 0.06751611083745956
subcellular O 0 0.11886098980903625
localization O 0 0.08423175662755966
is O 0 0.017713576555252075
postulated O 0 0.049941617995500565
to O 0 0.006857127416878939
be O 0 0.006612117867916822
important O 0 0.008772015571594238
in O 0 0.010684842243790627
non B-Disease 0 0.1348840743303299
- I-Disease 1 0.9988609552383423
familial I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.9703685641288757
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.04271555691957474

Epigenetic O 1 0.55091792345047
loss O 0 0.09168390929698944
, O 0 0.015174775384366512
however O 0 0.011083339340984821
, O 0 0.008370391093194485
has O 0 0.00886551197618246
not O 0 0.006821674294769764
received O 0 0.017821526154875755
general O 0 0.015454459935426712
acceptance O 0 0.04063458368182182
due O 0 0.01735319197177887
to O 0 0.009312164038419724
controversy O 0 0.02787911333143711
regarding O 0 0.01713319681584835
the O 0 0.015084956772625446
subcellular O 0 0.10728451609611511
localization O 0 0.08104714006185532
of O 0 0.021302733570337296
BRCA1 O 1 0.9888023734092712
proteins O 0 0.04561421275138855
, O 0 0.012003188021481037
reports O 0 0.013042905367910862
of O 0 0.00627589737996459
which O 0 0.008945802226662636
have O 0 0.009586688131093979
ranged O 0 0.039846114814281464
from O 0 0.009859556332230568
exclusively O 0 0.019241053611040115
nuclear O 0 0.027337396517395973
, O 0 0.009196517057716846
to O 0 0.010571755468845367
conditionally O 0 0.08048751950263977
nuclear O 0 0.03145173564553261
, O 0 0.009134825319051743
to O 0 0.01002104114741087
the O 0 0.022531967610120773
ER O 1 0.9999769926071167
/ O 1 0.9929249286651611
golgi O 1 0.7751584053039551
, O 0 0.014971551485359669
to O 0 0.014701098203659058
cytoplasmic O 0 0.1096983253955841
invaginations O 0 0.13857601583003998
into O 0 0.01908237487077713
the O 0 0.019405480474233627
nucleus O 0 0.11427316814661026
. O 0 0.0320277139544487

In O 0 0.01790694333612919
an O 0 0.012531548738479614
attempt O 0 0.023350127041339874
to O 0 0.008963672444224358
resolve O 0 0.029944876208901405
this O 0 0.007878070697188377
issue O 0 0.012882979586720467
, O 0 0.008256875909864902
we O 0 0.006817833054810762
have O 0 0.009655339643359184
comprehensively O 0 0.07057393342256546
characterized O 0 0.07839822769165039
19 O 0 0.044603850692510605
anti O 0 0.27741649746894836
- O 1 0.5797930955886841
BRCA1 O 1 0.9990179538726807
antibodies O 1 0.5910428166389465
. O 0 0.04460539668798447

These O 0 0.03552958369255066
reagents O 0 0.1461217701435089
detect O 0 0.10565048456192017
a O 0 0.033077407628297806
220 O 0 0.09861327707767487
- O 0 0.1488805115222931
kD O 1 0.9673404693603516
protein O 0 0.09978140145540237
localized O 0 0.11016339063644409
in O 0 0.017757529392838478
discrete O 0 0.06079749017953873
nuclear O 0 0.051066793501377106
foci O 0 0.13246840238571167
in O 0 0.014190658926963806
all O 0 0.013389088213443756
epithelial O 1 0.9944635033607483
cell O 0 0.0861591249704361
lines O 0 0.026896890252828598
, O 0 0.008683125488460064
including O 0 0.007873048074543476
those O 0 0.008894696831703186
derived O 0 0.03240159898996353
from O 0 0.031797073781490326
breast B-Disease 1 0.9999995231628418
malignancies I-Disease 1 0.9998911619186401
. O 0 0.04099997505545616

Immunohistochemical O 1 0.9961121678352356
staining O 1 0.8131936192512512
of O 0 0.02267645113170147
human O 0 0.051648132503032684
breast O 1 0.9999940395355225
specimens O 0 0.055371347814798355
also O 0 0.017331186681985855
revealed O 0 0.05348866432905197
BRCA1 O 1 0.997514009475708
nuclear O 0 0.08576765656471252
foci O 1 0.7499145865440369
in O 0 0.030293375253677368
benign O 1 0.9999991655349731
breast O 1 0.9999998807907104
, O 0 0.04759185016155243
invasive B-Disease 1 0.999992847442627
lobular I-Disease 1 1.0
cancers I-Disease 1 0.999997615814209
and O 0 0.022651176899671555
low B-Disease 0 0.3107511103153229
- I-Disease 1 0.8476507663726807
grade I-Disease 1 0.9854655265808105
ductal I-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.999996542930603
. O 0 0.04802824929356575

Conversely O 0 0.15232913196086884
, O 0 0.03568068519234657
BRCA1 O 1 0.9846127033233643
expression O 0 0.06039007008075714
was O 0 0.020704390481114388
reduced O 0 0.04027426987886429
or O 0 0.021946420893073082
undetectable O 1 0.6555903553962708
in O 0 0.008211339823901653
the O 0 0.008217696100473404
majority O 0 0.015146111138164997
of O 0 0.009759698063135147
high O 0 0.038588061928749084
- O 0 0.099189892411232
grade O 0 0.09303655475378036
, O 0 0.03593593090772629
ductal B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999992847442627
, O 0 0.02165476232767105
suggesting O 0 0.034767430275678635
that O 0 0.008975574746727943
absence O 0 0.03165803849697113
of O 0 0.015475737862288952
BRCA1 O 1 0.999599277973175
may O 0 0.02772887423634529
contribute O 0 0.032924819737672806
to O 0 0.008810034021735191
the O 0 0.012413620948791504
pathogenesis O 1 0.9975172281265259
of O 0 0.00971467699855566
a O 0 0.01394975371658802
significant O 0 0.016985412687063217
percentage O 0 0.026107540354132652
of O 0 0.014674943871796131
sporadic B-Disease 1 0.9992306232452393
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999991655349731
. O 0 0.01883181743323803
. O 0 0.026624662801623344

